{"id": "train-0", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lipoatrophies", "role": "Effect"}, {"name": "insulin", "role": "Treatment"}, {"name": "insulin", "role": "Treatment.Drug"}, {"name": "diabetic", "role": "Treatment.Disorder"}]}]}
{"id": "train-1", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "women of reproductive age", "role": "Subject"}, {"name": "women", "role": "Subject.Gender"}, {"name": "reproductive age", "role": "Subject.Age"}, {"name": "menstrual cycle disturbances", "role": "Effect"}, {"name": "valproate for epilepsy", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}, {"name": "epilepsy", "role": "Treatment.Disorder"}]}]}
{"id": "train-2", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "an 8-month-old infant", "role": "Subject"}, {"name": "8-month-old infant", "role": "Subject.Age"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "Phenobarbital", "role": "Treatment"}, {"name": "Phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-3", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Balint syndrome with irreversible posterior leukoencephalopathy on MRI", "role": "Effect"}, {"name": "intrathecal methotrexate and cytarabine", "role": "Treatment"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "cytarabine", "role": "Treatment.Drug"}, {"name": "cytarabine", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}]}]}
{"id": "train-4", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "delirium", "role": "Effect"}, {"name": "flecainide", "role": "Treatment"}, {"name": "flecainide", "role": "Treatment.Drug"}, {"name": "flecainide", "role": "Treatment.Drug"}, {"name": "paroxetine", "role": "Treatment.Drug"}, {"name": "flecainide", "role": "Combination.Drug"}, {"name": "paroxetine", "role": "Combination.Drug"}]}]}
{"id": "train-5", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Contact dermatitis", "role": "Effect"}, {"name": "budesonide", "role": "Treatment"}, {"name": "budesonide", "role": "Treatment.Drug"}]}]}
{"id": "train-6", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a Japanese patient with vivax malaria", "role": "Subject"}, {"name": "Japanese", "role": "Subject.Race"}, {"name": "Prolongation of the QT interval", "role": "Effect"}, {"name": "halofantrine", "role": "Treatment"}, {"name": "vivax malaria", "role": "Treatment.Disorder"}, {"name": "halofantrine", "role": "Treatment.Drug"}]}]}
{"id": "train-7", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "three cases", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "severe hepatotoxicity", "role": "Effect"}, {"name": "benzarone", "role": "Treatment"}, {"name": "benzarone", "role": "Treatment.Drug"}]}]}
{"id": "train-8", "event": [{"trigger": "symptoms of", "type": "adverse_event", "arguments": [{"name": "Four patients", "role": "Subject"}, {"name": "Four", "role": "Subject.Population"}, {"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "antiepileptic drug (AED)", "role": "Treatment"}, {"name": "during therapy with carbamazepine", "role": "Treatment"}, {"name": "antiepileptic drug (AED)", "role": "Treatment.Drug"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-9", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "autoimmune hepatitis", "role": "Effect"}, {"name": "Minocycline", "role": "Treatment"}, {"name": "Minocycline", "role": "Treatment.Drug"}]}]}
{"id": "train-10", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Secondary acute myeloid leukemia", "role": "Effect"}, {"name": "etoposide therapy", "role": "Treatment"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "haemophagocytic lymphohistiocytosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-11", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Allergic contact angioedema", "role": "Effect"}, {"name": "benzoyl peroxide", "role": "Treatment"}, {"name": "benzoyl peroxide", "role": "Treatment.Drug"}]}]}
{"id": "train-12", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "A 60-year-old white man with chronic bronchitis", "role": "Subject"}, {"name": "60-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "chronic bronchitis", "role": "Subject.Disorder"}, {"name": "acute respiratory failure and metabolic acidosis", "role": "Effect"}, {"name": "methazolamide (Neptazane)", "role": "Treatment"}, {"name": "methazolamide", "role": "Treatment.Drug"}, {"name": "ophthalmologic problem", "role": "Treatment.Disorder"}, {"name": "four days after", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-13", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "daytime sleepiness", "role": "Effect"}, {"name": "L-DOPA", "role": "Treatment"}, {"name": "DOPA", "role": "Treatment.Drug"}]}]}
{"id": "train-14", "event": [{"trigger": "contributed", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "electrolyte disorders and symptomatology", "role": "Effect"}, {"name": "foscarnet", "role": "Treatment"}, {"name": "foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-15", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Acute drug induced hepatitis", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-16", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "3 diabetic patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "intolerable dizziness followed by nausea and vomiting", "role": "Effect"}, {"name": "an initial administration of the alpha-glucosidase inhibitor, voglibose", "role": "Treatment"}, {"name": "diabetic", "role": "Treatment.Disorder"}, {"name": "voglibose", "role": "Treatment.Drug"}]}]}
{"id": "train-17", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "the presence in 3 out of 5 of our patients of pre-existing lung disease, represented by diffuse interstitial changes on chest X-ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA", "role": "Subject"}, {"name": "3 out of 5", "role": "Subject.Population"}, {"name": "pre-existing lung disease, represented by diffuse interstitial changes on chest X-ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA", "role": "Subject.Disorder"}, {"name": "pulmonary toxicity", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-18", "event": [{"trigger": "be", "type": "adverse_event", "arguments": [{"name": "toxicity", "role": "Effect"}, {"name": "esmolol", "role": "Treatment"}, {"name": "esmolol", "role": "Treatment.Drug"}]}]}
{"id": "train-19", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "development of ovarian endometrioid carcinoma", "role": "Effect"}, {"name": "prolonged unopposed estrogen-like stimulation with tamoxifen", "role": "Treatment"}, {"name": "prolonged", "role": "Treatment.Duration"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-20", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "The other woman had rheumatoid arthritis", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "acute tubular necrosis", "role": "Effect"}, {"name": "gentamicin and cefoxitin", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "gentamicin", "role": "Treatment.Drug"}, {"name": "cefoxitin", "role": "Treatment.Drug"}, {"name": "gentamicin", "role": "Combination.Drug"}, {"name": "cefoxitin", "role": "Combination.Drug"}]}]}
{"id": "train-21", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "One patient", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "marked cholestasis, portal inflammation, bile duct injury and bile duct paucity (ductopenia)", "role": "Effect"}, {"name": "clindamycin", "role": "Treatment"}, {"name": "clindamycin", "role": "Treatment.Drug"}]}]}
{"id": "train-22", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "3 case reports", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "delirium", "role": "Effect"}, {"name": "flecainide", "role": "Treatment"}, {"name": "flecainide", "role": "Treatment.Drug"}]}]}
{"id": "train-23", "event": [{"trigger": "develops.", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "diarrhoea", "role": "Effect"}, {"name": "spironolactone", "role": "Treatment"}, {"name": "spironolactone", "role": "Treatment.Drug"}]}]}
{"id": "train-24", "event": [{"trigger": "produced", "type": "adverse_event", "arguments": [{"name": "exaggerated immune response", "role": "Effect"}, {"name": "pain, redness, and swelling at the injection site", "role": "Effect"}, {"name": "nicotinic acid", "role": "Treatment"}, {"name": "nicotinic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-25", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "a 32-year-old man diagnosed with schizophrenia", "role": "Subject"}, {"name": "32-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "heatstroke", "role": "Effect"}, {"name": "clozapine monotherapy", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "schizophrenia", "role": "Treatment.Disorder"}]}]}
{"id": "train-26", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Paraplegia", "role": "Effect"}, {"name": "intrathecal cytosine arabinoside", "role": "Treatment"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}]}]}
{"id": "train-27", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "fever", "role": "Effect"}, {"name": "Cimetidine", "role": "Treatment"}, {"name": "Cimetidine", "role": "Treatment.Drug"}]}]}
{"id": "train-28", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "This case", "role": "Subject"}, {"name": "neurotoxicity unique", "role": "Effect"}, {"name": "HDARAC", "role": "Treatment"}, {"name": "HDARAC", "role": "Treatment.Drug"}]}]}
{"id": "train-29", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Agranulocytosis", "role": "Effect"}, {"name": "ticlopidine", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-30", "event": [{"trigger": "lead to", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "potentially lethal consequences", "role": "Effect"}, {"name": "SSRI or mirtazapine in combination with opioids", "role": "Treatment"}, {"name": "SSRI", "role": "Treatment.Drug"}, {"name": "mirtazapine", "role": "Treatment.Drug"}, {"name": "opioids", "role": "Treatment.Drug"}, {"name": "mirtazapine", "role": "Combination.Drug"}, {"name": "opioids", "role": "Combination.Drug"}, {"name": "SSRI", "role": "Combination.Drug"}]}]}
{"id": "train-31", "event": [{"trigger": "induces", "type": "adverse_event", "arguments": [{"name": "gynaecomastia", "role": "Effect"}, {"name": "sunitinib", "role": "Treatment"}, {"name": "sunitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-32", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "Some patients", "role": "Subject"}, {"name": "Some", "role": "Subject.Population"}, {"name": "hypersensitivity rash", "role": "Effect"}, {"name": "HCQ", "role": "Treatment"}, {"name": "HCQ", "role": "Treatment.Drug"}]}]}
{"id": "train-33", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "serotonin toxicity", "role": "Effect"}, {"name": "paroxetine", "role": "Treatment"}, {"name": "fentanyl", "role": "Treatment"}, {"name": "paroxetine", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "paroxetine", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}]}]}
{"id": "train-34", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "newborns", "role": "Subject"}, {"name": "newborns", "role": "Subject.Age"}, {"name": "thrombocytosis", "role": "Effect"}, {"name": "enoxaparin", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-35", "event": [{"trigger": "ingested", "type": "adverse_event", "arguments": [{"name": "28-year-old man", "role": "Subject"}, {"name": "28-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "adverse cardiac effects", "role": "Effect"}, {"name": "24 mg of risperidone", "role": "Treatment"}, {"name": "24 mg", "role": "Treatment.Dosage"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-36", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Anaphylaxis", "role": "Effect"}, {"name": "cisplatin following nine previous uncomplicated cycles", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "nine previous uncomplicated cycles", "role": "Treatment.Duration"}]}]}
{"id": "train-37", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "cataract", "role": "Effect"}, {"name": "Propecia", "role": "Treatment"}, {"name": "Propecia", "role": "Treatment.Drug"}]}]}
{"id": "train-38", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome", "role": "Effect"}, {"name": "citalopram and fentanyl", "role": "Treatment"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "citalopram", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}]}]}
{"id": "train-39", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "parkinsonian patients", "role": "Subject"}, {"name": "parkinsonian", "role": "Subject.Disorder"}, {"name": "diphasic dyskinesias", "role": "Effect"}, {"name": "levo-dopa", "role": "Treatment"}, {"name": "levo-dopa", "role": "Treatment.Drug"}]}]}
{"id": "train-40", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "acute lung injury", "role": "Effect"}, {"name": "persistent despite halofantrine therapy", "role": "Effect"}, {"name": "administration of mefloquine for a low-level Plasmodium falciparum malaria", "role": "Treatment"}, {"name": "halofantrine therapy", "role": "Treatment"}, {"name": "within hours", "role": "Treatment.Time_elapsed"}, {"name": "mefloquine", "role": "Treatment.Drug"}, {"name": "halofantrine", "role": "Treatment.Drug"}, {"name": "low-level Plasmodium falciparum malaria", "role": "Treatment.Disorder"}]}]}
{"id": "train-41", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "bleeding", "role": "Effect"}, {"name": "Warfarin", "role": "Treatment"}, {"name": "Warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-42", "event": [{"trigger": "increase", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "opioid-associated adverse effects", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "receiving multiple doses of oxycodone", "role": "Treatment"}, {"name": "pain relief", "role": "Treatment.Disorder"}, {"name": "oxycodone", "role": "Treatment.Drug"}, {"name": "itraconazole", "role": "Treatment.Drug"}, {"name": "multiple doses", "role": "Treatment.Dosage"}, {"name": "itraconazole", "role": "Combination.Drug"}, {"name": "oxycodone", "role": "Combination.Drug"}]}]}
{"id": "train-43", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "Three cases", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "neuropathy", "role": "Effect"}, {"name": "gold", "role": "Treatment"}, {"name": "gold", "role": "Treatment.Drug"}]}]}
{"id": "train-44", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a man", "role": "Subject"}, {"name": "man", "role": "Subject.Gender"}, {"name": "drug-induced pericarditis", "role": "Effect"}, {"name": "mesalazine", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "mesalazine", "role": "Treatment.Drug"}]}]}
{"id": "train-45", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "an human immunodeficiency virus (HIV)-infected adolescent with hemophilia A", "role": "Subject"}, {"name": "spontaneous intracranial bleeding", "role": "Effect"}, {"name": "amprenavir (APV)", "role": "Treatment"}, {"name": "immunodeficiency virus (HIV)-infected adolescent with hemophilia A", "role": "Treatment.Disorder"}, {"name": "amprenavir (APV)", "role": "Treatment.Drug"}]}]}
{"id": "train-46", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-47", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "patients with atrial flutter", "role": "Subject"}, {"name": "dangerous worsening of arrhythmia", "role": "Effect"}, {"name": "adenosine", "role": "Treatment"}, {"name": "atrial flutter.", "role": "Treatment.Disorder"}, {"name": "adenosine", "role": "Treatment.Drug"}]}]}
{"id": "train-48", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "hepato toxicity", "role": "Effect"}, {"name": "Salicylate", "role": "Treatment"}, {"name": "rheumatic fever", "role": "Treatment.Disorder"}, {"name": "Salicylate", "role": "Treatment.Drug"}]}]}
{"id": "train-49", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "concurrent linezolid and fluoxetine", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "fluoxetine", "role": "Combination.Drug"}]}]}
{"id": "train-50", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "four patients who underwent liver transplantation", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "liver transplantation", "role": "Subject.Disorder"}, {"name": "neutropenia", "role": "Effect"}, {"name": "MMF", "role": "Treatment"}, {"name": "MMF", "role": "Treatment.Drug"}]}]}
{"id": "train-51", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with Hashimoto's disease", "role": "Subject"}, {"name": "leukopenia", "role": "Effect"}, {"name": "L-T4", "role": "Treatment"}, {"name": "Hashimoto's disease", "role": "Treatment.Disorder"}, {"name": "L-T4", "role": "Treatment.Drug"}]}]}
{"id": "train-52", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Methemoglobinemia", "role": "Effect"}, {"name": "transient pallor", "role": "Effect"}, {"name": "dapsone therapy", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-53", "event": [{"trigger": "seen", "type": "adverse_event", "arguments": [{"name": "the patient's", "role": "Subject"}, {"name": "dysarthria and ataxia", "role": "Effect"}, {"name": "HDARAC", "role": "Treatment"}, {"name": "HDARAC", "role": "Treatment.Drug"}]}]}
{"id": "train-54", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "hepatopathy", "role": "Effect"}, {"name": "carbamazepine, lynestrenol and sodium valproate", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "lynestrenol", "role": "Treatment.Drug"}, {"name": "sodium valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-55", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "asterixis", "role": "Effect"}, {"name": "even at low or moderate dosage levels", "role": "Treatment"}, {"name": "certain drugs as lithium or clozapine are used in combination with CBZ", "role": "Treatment"}, {"name": "CBZ", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "low or moderate dosage", "role": "Treatment.Dosage"}, {"name": "CBZ", "role": "Combination.Drug"}, {"name": "lithium", "role": "Combination.Drug"}, {"name": "CBZ", "role": "Combination.Drug"}, {"name": "clozapine", "role": "Combination.Drug"}]}]}
{"id": "train-56", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "a rare case", "role": "Subject"}, {"name": "pleuropericarditis", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-57", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hepatitis with mononucleosis", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-58", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "severe toxicities", "role": "Effect"}, {"name": "5-FU treatment", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-59", "event": [{"trigger": "undergoing", "type": "adverse_event", "arguments": [{"name": "a 16-year-old girl with acute myelogenous leukemia (AML)", "role": "Subject"}, {"name": "16-year-old", "role": "Subject.Age"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "reversible encephalopathy syndrome", "role": "Effect"}, {"name": "consolidation chemotherapy composed of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosyl cytosine) and idarubicin", "role": "Treatment"}, {"name": "acute myelogenous leukemia", "role": "Treatment.Disorder"}, {"name": "idarubicin", "role": "Treatment.Drug"}, {"name": "BH-AC", "role": "Treatment.Drug"}, {"name": "idarubicin", "role": "Combination.Drug"}, {"name": "BH-AC", "role": "Combination.Drug"}]}]}
{"id": "train-60", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "acute INR elevation", "role": "Effect"}, {"name": "vismodegib and warfarin", "role": "Treatment"}, {"name": "vismodegib", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "vismodegib", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-61", "event": [{"trigger": "documented,", "type": "adverse_event", "arguments": [{"name": "cutaneous side-effects", "role": "Effect"}, {"name": "Captopril", "role": "Treatment"}, {"name": "Captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-62", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a pregnant woman with Crohn's disease", "role": "Subject"}, {"name": "pregnant", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "adrenal suppression in her newborn", "role": "Effect"}, {"name": "High-dose methylprednisolone", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "High-dose", "role": "Treatment.Drug"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}]}]}
{"id": "train-63", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "Cardiac hypersensitivity and myopericarditis", "role": "Effect"}, {"name": "long-term treatment with mesalazine", "role": "Treatment"}, {"name": "long-term", "role": "Treatment.Duration"}, {"name": "mesalazine", "role": "Treatment.Drug"}]}]}
{"id": "train-64", "event": [{"trigger": "represent", "type": "adverse_event", "arguments": [{"name": "cerebral atrophy", "role": "Effect"}, {"name": "ACTH", "role": "Treatment"}, {"name": "ACTH", "role": "Treatment.Drug"}, {"name": "ACTH", "role": "Treatment.Drug"}]}]}
{"id": "train-65", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "polymorphic ventricular tachycardia", "role": "Effect"}, {"name": "verapamil", "role": "Treatment"}, {"name": "paroxysmal supraventricular tachycardia", "role": "Treatment.Disorder"}, {"name": "verapamil", "role": "Treatment.Drug"}]}]}
{"id": "train-66", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Fatal acute encephalomyelitis", "role": "Effect"}, {"name": "single dose of intrathecal methotrexate", "role": "Treatment"}, {"name": "single dose", "role": "Treatment.Dosage"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-67", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "one case", "role": "Subject"}, {"name": "incomplete posterior hyaloid detachment (PHD)", "role": "Effect"}, {"name": "intravitreal pegaptanib", "role": "Treatment"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "pegaptanib", "role": "Treatment.Drug"}, {"name": "DME", "role": "Treatment.Disorder"}]}]}
{"id": "train-68", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Pulmonary edema", "role": "Effect"}, {"name": "ritodrine", "role": "Treatment"}, {"name": "ritodrine", "role": "Treatment.Drug"}]}]}
{"id": "train-69", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Carbamazepine toxicity", "role": "Effect"}, {"name": "Oxybutynin and Dantrolene", "role": "Treatment"}, {"name": "Oxybutynin", "role": "Treatment.Drug"}, {"name": "Dantrolene", "role": "Treatment.Drug"}, {"name": "Dantrolene", "role": "Combination.Drug"}, {"name": "Oxybutynin", "role": "Combination.Drug"}]}]}
{"id": "train-70", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a small child", "role": "Subject"}, {"name": "small child", "role": "Subject.Age"}, {"name": "Multiple seizures", "role": "Effect"}, {"name": "bupropion overdose", "role": "Treatment"}, {"name": "bupropion", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-71", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Sorafenib", "role": "Treatment"}, {"name": "a multitargeted kinase inhibitor", "role": "Treatment"}, {"name": "Sorafenib", "role": "Treatment.Drug"}, {"name": "unresectable hepatocellular carcinoma", "role": "Treatment.Disorder"}, {"name": "advanced renal cell carcinomas", "role": "Treatment.Disorder"}]}]}
{"id": "train-72", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thyrotoxicosis", "role": "Effect"}, {"name": "Triiodothyronine", "role": "Treatment"}, {"name": "ophthalmic Graves", "role": "Treatment.Disorder"}, {"name": "Triiodothyronine", "role": "Treatment.Drug"}]}]}
{"id": "train-73", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyperpigmentation with yolk sac tumor", "role": "Effect"}, {"name": "Bleomycin", "role": "Treatment"}, {"name": "Bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-74", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient with Parkinson disease", "role": "Subject"}, {"name": "bilateral corneal endothelial dysfunction", "role": "Effect"}, {"name": "long-term amantadine", "role": "Treatment"}, {"name": "Parkinson disease", "role": "Treatment.Disorder"}, {"name": "amantadine", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-75", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "a 71 year old man with prostatic carcinoma", "role": "Subject"}, {"name": "71 year old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "acute hepatitis", "role": "Effect"}, {"name": "cyproterone acetate", "role": "Treatment"}, {"name": "cyproterone acetate", "role": "Treatment.Drug"}, {"name": "prostatic carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-76", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Insulin-dependent diabetes mellitus", "role": "Effect"}, {"name": "danazol", "role": "Treatment"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-77", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "infants", "role": "Subject"}, {"name": "infants", "role": "Subject.Age"}, {"name": "central nervous system depression", "role": "Effect"}, {"name": "Topical brimonidine", "role": "Treatment"}, {"name": "brimonidine", "role": "Treatment.Drug"}, {"name": "Topical", "role": "Treatment.Route"}]}]}
{"id": "train-78", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient with the LEOPARD syndrome", "role": "Subject"}, {"name": "pneumonitis with acute respiratory failure", "role": "Effect"}, {"name": "Flecainide", "role": "Treatment"}, {"name": "Flecainide", "role": "Treatment.Drug"}, {"name": "LEOPARD syndrome.", "role": "Treatment.Disorder"}]}]}
{"id": "train-79", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Seizure with hyponatremia", "role": "Effect"}, {"name": "desmopressin", "role": "Treatment"}, {"name": "desmopressin", "role": "Treatment.Drug"}, {"name": "nocturnal enuresis", "role": "Treatment.Disorder"}]}]}
{"id": "train-80", "event": [{"trigger": "recommended", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with central DI", "role": "Subject"}, {"name": "in order to improve DDAVP safety", "role": "Effect"}, {"name": "therapeutic alternatives to NSAIDs", "role": "Treatment"}, {"name": "central DI", "role": "Treatment.Disorder"}, {"name": "NSAIDs", "role": "Treatment.Drug"}]}]}
{"id": "train-81", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "She", "role": "Subject"}, {"name": "Carbamazepine 1000 mg/day", "role": "Treatment"}, {"name": "neuropathic pain", "role": "Treatment.Disorder"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}, {"name": "1000 mg/day", "role": "Treatment.Dosage"}, {"name": "2 years", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-82", "event": [{"trigger": "given", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity developed", "role": "Effect"}, {"name": "vincristine and actinomycin D", "role": "Treatment"}, {"name": "vincristine", "role": "Treatment.Drug"}, {"name": "actinomycin D", "role": "Treatment.Drug"}, {"name": "vincristine", "role": "Combination.Drug"}, {"name": "actinomycin D", "role": "Combination.Drug"}]}]}
{"id": "train-83", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, and hypertension", "role": "Effect"}, {"name": "second dose of metoclopramide", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-84", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "tuberculous uveitis", "role": "Effect"}, {"name": "etanercept", "role": "Treatment"}, {"name": "etanercept", "role": "Treatment.Drug"}]}]}
{"id": "train-85", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "a patient with liver dysfunction and chronic renal failure", "role": "Subject"}, {"name": "liver dysfunction and chronic renal failure", "role": "Subject.Disorder"}, {"name": "Acute hyperphosphatemia", "role": "Effect"}, {"name": "sodium phosphate enema", "role": "Treatment"}, {"name": "sodium phosphate", "role": "Treatment.Drug"}, {"name": "enema", "role": "Treatment.Route"}]}]}
{"id": "train-86", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "hyponatremia", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-87", "event": [{"trigger": "a probable relationship between", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "treatment with lithium and venlafaxine", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Combination.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}]}]}
{"id": "train-88", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "IVIG", "role": "Treatment"}, {"name": "IVIG", "role": "Treatment.Drug"}]}]}
{"id": "train-89", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "7 patients (2 women, 5 men) with chronic renal failure", "role": "Subject"}, {"name": "chronic renal failure", "role": "Subject.Disorder"}, {"name": "7", "role": "Subject.Population"}, {"name": "fatal neuromyeloencephalopathy", "role": "Effect"}, {"name": "a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day)", "role": "Treatment"}, {"name": "diuretic muzolimine", "role": "Treatment.Drug"}, {"name": "per day", "role": "Treatment.Freq"}, {"name": "range 240 to 1440 mg", "role": "Treatment.Dosage"}]}]}
{"id": "train-90", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two renal transplant patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "renal transplant", "role": "Subject.Disorder"}, {"name": "anemia", "role": "Effect"}, {"name": "enalapril medication", "role": "Treatment"}, {"name": "hypertension", "role": "Treatment.Disorder"}, {"name": "enalapril", "role": "Treatment.Drug"}]}]}
{"id": "train-91", "event": [{"trigger": "reversed", "type": "potential_therapeutic_event", "arguments": [{"name": "glucagon", "role": "Treatment"}, {"name": "Sotalol-induced bradycardia", "role": "Treatment.Disorder"}, {"name": "glucagon", "role": "Treatment.Drug"}]}]}
{"id": "train-92", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "cutaneous ecchymosis", "role": "Effect"}, {"name": "a sudden fall in hemoglobin", "role": "Effect"}, {"name": "diffuse subfascial hematoma", "role": "Effect"}, {"name": "alteplase", "role": "Treatment"}, {"name": "alteplase", "role": "Treatment.Drug"}]}]}
{"id": "train-93", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "papillary necrosis", "role": "Effect"}, {"name": "indinavir", "role": "Treatment"}, {"name": "indinavir", "role": "Treatment.Drug"}]}]}
{"id": "train-94", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Generalized maculopapular and papular purpuric eruptions", "role": "Effect"}, {"name": "reactions", "role": "Effect"}, {"name": "thionamide", "role": "Treatment"}, {"name": "thionamide", "role": "Treatment.Drug"}]}]}
{"id": "train-95", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "intoxication", "role": "Effect"}, {"name": "Imidazoline", "role": "Treatment"}, {"name": "overdose or accidental ingestion but also after normal therapeutic usage", "role": "Treatment"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "overdose or accidental", "role": "Treatment.Dosage"}, {"name": "but also after normal therapeutic usage", "role": "Treatment.Dosage"}]}]}
{"id": "train-96", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "50-year-old diabetic and hypertensive male patient", "role": "Subject"}, {"name": "diabetic and hypertensive", "role": "Subject.Disorder"}, {"name": "50-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "marrow aplasia", "role": "Effect"}, {"name": "ticlopidine", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-97", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma", "role": "Subject"}, {"name": "hereditary retinoblastoma", "role": "Subject.Disorder"}, {"name": "cerebral edema and brainstem herniation", "role": "Effect"}, {"name": "a single dose of intravenous methotrexate", "role": "Treatment"}, {"name": "intracranial osteosarcoma", "role": "Treatment.Disorder"}, {"name": "a single dose", "role": "Treatment.Freq"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-98", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Neutropenia", "role": "Effect"}, {"name": "the angiotensin-converting enzyme (ACE) inhibitor, captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-99", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "severe cerebral swelling and raised intracranial pressure (ICP)", "role": "Effect"}, {"name": "intoxication", "role": "Effect"}, {"name": "sodium valproic acid (VPA)", "role": "Treatment"}, {"name": "sodium valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-100", "event": [{"trigger": "because", "type": "adverse_event", "arguments": [{"name": "polyuria", "role": "Effect"}, {"name": "Lithium", "role": "Treatment"}]}]}
{"id": "train-101", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "sensorineural hearing loss", "role": "Effect"}, {"name": "PAN and methotrexate", "role": "Treatment"}, {"name": "PAN", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "PAN", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}]}]}
{"id": "train-102", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 26-year-old man with bipolar disorder", "role": "Subject"}, {"name": "26-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "hyperammonemia", "role": "Effect"}, {"name": "three weeks after initiating carbamazepine therapy", "role": "Treatment"}, {"name": "three weeks", "role": "Treatment.Time_elapsed"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "bipolar disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-103", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two adults", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "adults", "role": "Subject.Age"}, {"name": "behavioural side effects", "role": "Effect"}, {"name": "gabapentin (GBP)", "role": "Treatment"}, {"name": "gabapentin", "role": "Treatment.Drug"}]}]}
{"id": "train-104", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "Atrial fibrillation", "role": "Effect"}, {"name": "diltiazem", "role": "Treatment"}, {"name": "diltiazem", "role": "Treatment.Drug"}]}]}
{"id": "train-105", "event": [{"trigger": "adverse effect", "type": "adverse_event", "arguments": [{"name": "this case", "role": "Subject"}, {"name": "akathisia", "role": "Effect"}, {"name": "psychopharmacs", "role": "Treatment"}, {"name": "psychopharmacs", "role": "Treatment.Drug"}]}]}
{"id": "train-106", "event": [{"trigger": "side effects", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "non-adherence to medications", "role": "Effect"}, {"name": "HAART", "role": "Treatment"}, {"name": "HIV", "role": "Treatment.Disorder"}, {"name": "HAART", "role": "Treatment.Drug"}]}]}
{"id": "train-107", "event": [{"trigger": "presented.", "type": "adverse_event", "arguments": [{"name": "an angiomatous meningioma in a patient", "role": "Subject"}, {"name": "acute subdural haematoma", "role": "Effect"}, {"name": "aspirin", "role": "Treatment"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-108", "event": [{"trigger": "precipitate", "type": "adverse_event", "arguments": [{"name": "hypertensive crisis or serotonin syndrome", "role": "Effect"}, {"name": "monoamine oxidase inhibitors (MAOIs)", "role": "Treatment"}, {"name": "monoamine oxidase inhibitors", "role": "Treatment.Drug"}]}]}
{"id": "train-109", "event": [{"trigger": "adverse drug reaction", "type": "adverse_event", "arguments": [{"name": "fever", "role": "Effect"}, {"name": "temozolomide", "role": "Treatment"}, {"name": "temozolomide", "role": "Treatment.Drug"}]}]}
{"id": "train-110", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "women with epilepsy", "role": "Subject"}, {"name": "women", "role": "Subject.Gender"}, {"name": "reproductive endocrine disorders", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}, {"name": "epilepsy", "role": "Treatment.Disorder"}]}]}
{"id": "train-111", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two clinical cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "mania", "role": "Effect"}, {"name": "Alprazolam", "role": "Treatment"}, {"name": "Alprazolam", "role": "Treatment.Drug"}]}]}
{"id": "train-112", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "Bronchiolitis obliterans organising pneumonia", "role": "Effect"}, {"name": "use of nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-113", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-114", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "itraconazole (ITCZ)", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}, {"name": "Aspergillus flavus-induced chronic hypertrophic pachymeningitis", "role": "Treatment.Disorder"}]}]}
{"id": "train-115", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient with a lymphoproliferative disorder", "role": "Subject"}, {"name": "Severe autoimmune hemolytic anemia", "role": "Effect"}, {"name": "rituximab therapy", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}, {"name": "lymphoproliferative disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-116", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "nephrotoxicity", "role": "Effect"}, {"name": "indinavir", "role": "Treatment"}, {"name": "indinavir", "role": "Treatment.Drug"}]}]}
{"id": "train-117", "event": [{"trigger": "reported.", "type": "adverse_event", "arguments": [{"name": "delated cutaneous reactions", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-118", "event": [{"trigger": "prescribed", "type": "potential_therapeutic_event", "arguments": [{"name": "Bismuth subsalicylate 30 mL every 4 hours", "role": "Treatment"}, {"name": "Bismuth subsalicylate", "role": "Treatment.Drug"}, {"name": "30 mL", "role": "Treatment.Dosage"}, {"name": "every 4 hours", "role": "Treatment.Freq"}, {"name": "diarrhea", "role": "Treatment.Disorder"}]}]}
{"id": "train-119", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "subcutaneous administration of relatively large doses of lignocaine under medetomidine sedation", "role": "Treatment"}, {"name": "lignocaine", "role": "Treatment.Drug"}, {"name": "medetomidine", "role": "Treatment.Drug"}, {"name": "subcutaneous", "role": "Treatment.Route"}, {"name": "medetomidine", "role": "Combination.Drug"}, {"name": "lignocaine", "role": "Combination.Drug"}]}]}
{"id": "train-120", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "Oesophageal ulceration", "role": "Effect"}, {"name": "emepronium bromide", "role": "Treatment"}, {"name": "emepronium bromide", "role": "Treatment.Drug"}]}]}
{"id": "train-121", "event": [{"trigger": "Development", "type": "adverse_event", "arguments": [{"name": "sarcoidosis", "role": "Effect"}, {"name": "interferon alpha 2b and ribavirin", "role": "Treatment"}, {"name": "interferon alpha 2b", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C", "role": "Treatment.Disorder"}, {"name": "ribavirin", "role": "Combination.Drug"}, {"name": "interferon alpha 2b", "role": "Combination.Drug"}]}]}
{"id": "train-122", "event": [{"trigger": "delay", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "delay corneal wound healing", "role": "Effect"}, {"name": "colchicine", "role": "Treatment"}, {"name": "colchicine", "role": "Treatment.Drug"}, {"name": "corneal wound", "role": "Treatment.Disorder"}]}]}
{"id": "train-123", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hemolytic-uremic syndrome", "role": "Effect"}, {"name": "Gemcitabine", "role": "Treatment"}, {"name": "Gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-124", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "adverse response", "role": "Effect"}, {"name": "clonidine", "role": "Treatment"}, {"name": "clonidine", "role": "Treatment.Drug"}]}]}
{"id": "train-125", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "malignant hypertension", "role": "Subject.Disorder"}, {"name": "thrombosis of the central retinal vein", "role": "Effect"}, {"name": "on immunosuppressive therapy consisting of cyclosporin, prednisone and azathioprine", "role": "Treatment"}, {"name": "undergone a renal transplantation as a result of malignant hypertension", "role": "Treatment"}, {"name": "cyclosporin", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "azathioprine", "role": "Treatment.Drug"}, {"name": "5 years", "role": "Treatment.Time_elapsed"}, {"name": "cyclosporin", "role": "Combination.Drug"}, {"name": "prednisone", "role": "Combination.Drug"}, {"name": "azathioprine", "role": "Combination.Drug"}]}]}
{"id": "train-126", "event": [{"trigger": "evident", "type": "adverse_event", "arguments": [{"name": "three reported patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "alteration of eyelid appearance with deepening of the lid sulcus", "role": "Effect"}, {"name": "topical bimatoprost", "role": "Treatment"}, {"name": "bimatoprost", "role": "Treatment.Drug"}]}]}
{"id": "train-127", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "traumatic flap dehiscence and Enterobacter keratitis", "role": "Effect"}, {"name": "34 months after LASIK", "role": "Treatment"}, {"name": "34 months after", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-128", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis", "role": "Effect"}, {"name": "lovastatin", "role": "Treatment"}, {"name": "azithromycin", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment"}, {"name": "lovastatin", "role": "Treatment.Drug"}, {"name": "azithromycin", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "lovastatin", "role": "Combination.Drug"}, {"name": "azithromycin", "role": "Combination.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}]}]}
{"id": "train-129", "event": [{"trigger": "exacerbating", "type": "adverse_event", "arguments": [{"name": "maladaptive behaviors", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-130", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "cholestatic liver disease.", "role": "Effect"}, {"name": "Terbinafine", "role": "Treatment"}, {"name": "Terbinafine", "role": "Treatment.Drug"}]}]}
{"id": "train-131", "event": [{"trigger": "induced", "type": "potential_therapeutic_event", "arguments": [{"name": "apoptosis in several human cancers", "role": "Effect"}, {"name": "proteasome inhibitor Bortezomib has been identified as a potent enhancer of TRAIL", "role": "Treatment"}, {"name": "Bortezomib", "role": "Treatment.Drug"}]}]}
{"id": "train-132", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "a patient with metastatic pancreatic adenocarcinoma", "role": "Subject"}, {"name": "HUS", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "metastatic pancreatic adenocarcinoma,", "role": "Treatment.Disorder"}]}]}
{"id": "train-133", "event": [{"trigger": "improved", "type": "potential_therapeutic_event", "arguments": [{"name": "Their parkinsonism", "role": "Subject"}, {"name": "discontinuation of metoclopramide therapy", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}, {"name": "parkinsonism", "role": "Treatment.Disorder"}]}]}
{"id": "train-134", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Lichen planus", "role": "Effect"}, {"name": "hepatitis B vaccination", "role": "Treatment"}, {"name": "hepatitis B vaccination", "role": "Treatment.Drug"}]}]}
{"id": "train-135", "event": [{"trigger": "start", "type": "potential_therapeutic_event", "arguments": [{"name": "40 healthy volunteers", "role": "Subject"}, {"name": "40", "role": "Subject.Population"}, {"name": "600 mg rifampicin once daily from days 1-5", "role": "Treatment"}, {"name": "600 mg", "role": "Treatment.Dosage"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "once daily", "role": "Treatment.Freq"}]}]}
{"id": "train-136", "event": [{"trigger": "secondary to", "type": "adverse_event", "arguments": [{"name": "a patient with antiphospholipid antibody syndrome", "role": "Subject"}, {"name": "Skin necrosis", "role": "Effect"}, {"name": "low-molecular weight heparin", "role": "Treatment"}, {"name": "antiphospholipid antibody syndrome", "role": "Treatment.Disorder"}, {"name": "low-molecular weight heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-137", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "early chronic cardiomyopathy", "role": "Effect"}, {"name": "anthracycline", "role": "Treatment"}, {"name": "with ATRA", "role": "Treatment"}, {"name": "anthracycline", "role": "Treatment.Drug"}, {"name": "ATRA", "role": "Treatment.Drug"}, {"name": "anthracycline", "role": "Combination.Drug"}, {"name": "ATRA", "role": "Combination.Drug"}]}]}
{"id": "train-138", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Fixed drug eruption in hands", "role": "Effect"}, {"name": "omeprazole", "role": "Treatment"}, {"name": "omeprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-139", "event": [{"trigger": "before", "type": "adverse_event", "arguments": [{"name": "neurologic abnormalities began", "role": "Effect"}, {"name": "FK506, which began to be administered 12 days earlier, rose to a level of 44 ng/mL (normal range, 10-20 ng/mL)", "role": "Treatment"}, {"name": "FK506", "role": "Treatment.Drug"}, {"name": "12 days earlier", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-140", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "Sweet's syndrome is an acute febrile neutrophilic dermatosis", "role": "Effect"}, {"name": "increased neutrophil proliferation and differentiation", "role": "Effect"}, {"name": "filgrastim", "role": "Treatment"}, {"name": "filgrastim", "role": "Treatment.Drug"}]}]}
{"id": "train-141", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "cardiotoxicity", "role": "Effect"}, {"name": "diphenhydramine", "role": "Treatment"}, {"name": "diphenhydramine", "role": "Treatment.Drug"}]}]}
{"id": "train-142", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "mild renal insufficiency", "role": "Subject.Disorder"}, {"name": "chronic nausea and an episode of confusion", "role": "Effect"}, {"name": "a small, stable dose of oral morphine", "role": "Treatment"}, {"name": "small, stable dose", "role": "Treatment.Dosage"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "morphine", "role": "Treatment.Drug"}]}]}
{"id": "train-143", "event": [{"trigger": "complicating", "type": "adverse_event", "arguments": [{"name": "children with leukemia", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "Bulbar and pseudobulbar palsy", "role": "Effect"}, {"name": "high-dose cytosine arabinoside", "role": "Treatment"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-144", "event": [{"trigger": "suggests", "type": "adverse_event", "arguments": [{"name": "two men", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "men", "role": "Subject.Gender"}, {"name": "development of erythroid leukemia plus carcinoma", "role": "Effect"}, {"name": "mutagenic change", "role": "Effect"}, {"name": "cyclophosphamide therapy", "role": "Treatment"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}]}]}
{"id": "train-145", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "hyponatremia", "role": "Effect"}, {"name": "thiazide diuretics", "role": "Treatment"}, {"name": "thiazide diuretics", "role": "Treatment.Drug"}]}]}
{"id": "train-146", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Serotonin syndrome", "role": "Effect"}, {"name": "proserotoninergic medications", "role": "Treatment"}, {"name": "proserotoninergic", "role": "Treatment.Drug"}, {"name": "Serotonin syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-147", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "aplasia cutis congenita", "role": "Effect"}, {"name": "methimazole", "role": "Treatment"}, {"name": "methimazole (MMI)", "role": "Treatment.Drug"}]}]}
{"id": "train-148", "event": [{"trigger": "prescribed", "type": "potential_therapeutic_event", "arguments": [{"name": "An 18-year-old man with attention-deficit-hyperactivity disorder (ADHD)", "role": "Subject"}, {"name": "18-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "attention-deficit-hyperactivity disorder (ADHD)", "role": "Subject.Disorder"}, {"name": "varenicline", "role": "Treatment"}, {"name": "varenicline", "role": "Treatment.Drug"}, {"name": "smoking cessation", "role": "Treatment.Disorder"}]}]}
{"id": "train-149", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "unexplained abdominal pain or collapse", "role": "Effect"}, {"name": "vasopressin", "role": "Treatment"}, {"name": "vasopressin", "role": "Treatment.Drug"}]}]}
{"id": "train-150", "event": [{"trigger": "after treatment", "type": "adverse_event", "arguments": [{"name": "an allergic type of contact dermatitis", "role": "Effect"}, {"name": "an irritant type of reaction", "role": "Effect"}, {"name": "calcipotriol", "role": "Treatment"}, {"name": "calcipotriol", "role": "Treatment.Drug"}]}]}
{"id": "train-151", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "Acute erythroid leukemia", "role": "Effect"}, {"name": "cyclophosphamide therapy", "role": "Treatment"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "multiple myeloma", "role": "Treatment.Disorder"}]}]}
{"id": "train-152", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "eating disorder", "role": "Effect"}, {"name": "triazolam", "role": "Treatment"}, {"name": "triazolam", "role": "Treatment.Drug"}]}]}
{"id": "train-153", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "peripheral neuropathy", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-154", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lipoatrophy", "role": "Effect"}, {"name": "Insulin", "role": "Treatment"}, {"name": "type I diabetes", "role": "Treatment.Disorder"}, {"name": "Insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-155", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "interstitial nephritis", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-156", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "3 cases of HIV-1 infected patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "symptomatic angiolipomas", "role": "Effect"}, {"name": "antiretroviral therapy including the protease inhibitor indinavir", "role": "Treatment"}, {"name": "HIV-1", "role": "Treatment.Disorder"}, {"name": "indinavir", "role": "Treatment.Drug"}]}]}
{"id": "train-157", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Depressive symptoms", "role": "Effect"}, {"name": "interferon therapy", "role": "Treatment"}, {"name": "interferon", "role": "Treatment.Drug"}]}]}
{"id": "train-158", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "elevate liver function tests (LFT) values", "role": "Effect"}, {"name": "Coumarin", "role": "Treatment"}, {"name": "Coumarin", "role": "Treatment.Drug"}]}]}
{"id": "train-159", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Decreased plasma cortisol level", "role": "Effect"}, {"name": "alprazolam", "role": "Treatment"}, {"name": "alprazolam", "role": "Treatment.Drug"}, {"name": "panic disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-160", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "diffuse interstitial pneumonitis", "role": "Effect"}, {"name": "carmustine (BCNU)", "role": "Treatment"}, {"name": "carmustine", "role": "Treatment.Drug"}]}]}
{"id": "train-161", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Fever, pulmonary infiltrates, and pleural effusion", "role": "Effect"}, {"name": "acyclovir therapy for herpes zoster ophthalmicus", "role": "Treatment"}, {"name": "herpes zoster ophthalmicus", "role": "Treatment.Disorder"}, {"name": "acyclovir", "role": "Treatment.Drug"}]}]}
{"id": "train-162", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "mast cell degranulation and subsequent release of eosinophil chemotactic factor as a cause of CSFE", "role": "Effect"}, {"name": "vancomycin", "role": "Treatment"}, {"name": "vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-163", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "acute renal failure", "role": "Effect"}, {"name": "Within 3 weeks of beginning continuous daily isoniazid and rifampin", "role": "Treatment"}, {"name": "pulmonary tuberculosis", "role": "Treatment.Disorder"}, {"name": "Within 3 weeks of beginning", "role": "Treatment.Time_elapsed"}, {"name": "daily", "role": "Treatment.Freq"}, {"name": "isoniazid", "role": "Treatment.Drug"}, {"name": "rifampin", "role": "Treatment.Drug"}, {"name": "isoniazid", "role": "Combination.Drug"}, {"name": "rifampin", "role": "Combination.Drug"}]}]}
{"id": "train-164", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "four cases", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "corneal ulceration", "role": "Effect"}, {"name": "methamphetamine", "role": "Treatment"}, {"name": "methamphetamine", "role": "Treatment.Drug"}]}]}
{"id": "train-165", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "sclerosing peritonitis", "role": "Effect"}, {"name": "practolol", "role": "Treatment"}, {"name": "practolol", "role": "Treatment.Drug"}]}]}
{"id": "train-166", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "acute interstitial nephritis", "role": "Effect"}, {"name": "Sunitinib", "role": "Treatment"}, {"name": "metastatic renal cell cancer", "role": "Treatment.Disorder"}, {"name": "Sunitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-167", "event": [{"trigger": "presentation", "type": "adverse_event", "arguments": [{"name": "Multiple pulmonary nodules", "role": "Effect"}, {"name": "fludarabine", "role": "Treatment"}, {"name": "fludarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-168", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "schizophrenic patients", "role": "Subject"}, {"name": "tardive dyskinesia", "role": "Effect"}, {"name": "Clozapine", "role": "Treatment"}, {"name": "Clozapine", "role": "Treatment.Drug"}, {"name": "schizophrenic", "role": "Treatment.Disorder"}]}]}
{"id": "train-169", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "her", "role": "Subject"}, {"name": "her", "role": "Subject.Gender"}, {"name": "theophylline levels had increased to the toxic range", "role": "Effect"}, {"name": "zafirlukast", "role": "Treatment"}, {"name": "zafirlukast", "role": "Treatment.Drug"}]}]}
{"id": "train-170", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "an infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "Withdrawal emergent syndrome", "role": "Effect"}, {"name": "maternal haloperidol therapy", "role": "Treatment"}, {"name": "haloperidol", "role": "Treatment.Drug"}, {"name": "maternal", "role": "Treatment.Route"}]}]}
{"id": "train-171", "event": [{"trigger": "affected", "type": "adverse_event", "arguments": [{"name": "adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria", "role": "Effect"}, {"name": "Diphenylhydantoin", "role": "Treatment"}, {"name": "Diphenylhydantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-172", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "interstitial pneumonitis", "role": "Effect"}, {"name": "bicalutamide and leuprorelin acetate", "role": "Treatment"}, {"name": "bicalutamide", "role": "Treatment.Drug"}, {"name": "leuprorelin acetate", "role": "Treatment.Drug"}, {"name": "prostate cancer", "role": "Treatment.Disorder"}, {"name": "bicalutamide", "role": "Combination.Drug"}, {"name": "leuprorelin acetate", "role": "Combination.Drug"}]}]}
{"id": "train-173", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pneumonitis", "role": "Effect"}, {"name": "Gold", "role": "Treatment"}, {"name": "Gold", "role": "Treatment.Drug"}]}]}
{"id": "train-174", "event": [{"trigger": "use", "type": "adverse_event", "arguments": [{"name": "a patient with heparin-induced thrombocytopenia (HIT) requiring continuous veno-veno hemodialysis (CVVHD)", "role": "Subject"}, {"name": "heparin-induced thrombocytopenia (HIT)", "role": "Subject.Disorder"}, {"name": "significant hepatic and renal failure", "role": "Effect"}, {"name": "argatroban", "role": "Treatment"}, {"name": "argatroban", "role": "Treatment.Drug"}]}]}
{"id": "train-175", "event": [{"trigger": "under", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "Visceral leishmaniasis and macrophagic activation syndrome", "role": "Effect"}, {"name": "adalimumab", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "adalimumab", "role": "Treatment.Drug"}]}]}
{"id": "train-176", "event": [{"trigger": "resolved", "type": "adverse_event", "arguments": [{"name": "He", "role": "Subject"}, {"name": "He", "role": "Subject.Gender"}, {"name": "possible serotonin syndrome", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-177", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria", "role": "Effect"}, {"name": "Rh(0)(D) immune globulin intravenous", "role": "Treatment"}, {"name": "Rh(0)(D) immune globulin", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "immune thrombocytopenic purpura", "role": "Treatment.Disorder"}]}]}
{"id": "train-178", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "ampicillin", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-179", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "restless legs symptoms", "role": "Effect"}, {"name": "interferon-alpha (IFN alpha) therapy", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-180", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "some individuals", "role": "Subject"}, {"name": "SS", "role": "Effect"}, {"name": "coadministration of serotonergic antidepressants and opioids", "role": "Treatment"}, {"name": "serotonergic antidepressants", "role": "Treatment.Drug"}, {"name": "opioids", "role": "Treatment.Drug"}, {"name": "opioids", "role": "Combination.Drug"}, {"name": "serotonergic antidepressants", "role": "Combination.Drug"}]}]}
{"id": "train-181", "event": [{"trigger": "toxicities", "type": "adverse_event", "arguments": [{"name": "diarrhea", "role": "Effect"}, {"name": "dermatitis", "role": "Effect"}, {"name": "myelosuppression", "role": "Effect"}, {"name": "Stomatitis", "role": "Effect"}, {"name": "5-FU", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-182", "event": [{"trigger": "was", "type": "adverse_event", "arguments": [{"name": "a rapid deterioration with decreased oxygen saturation and arterial PO2 values", "role": "Effect"}, {"name": "cimetidine", "role": "Treatment"}, {"name": "cimetidine", "role": "Treatment.Drug"}]}]}
{"id": "train-183", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a case of advanced ovarian carcinoma", "role": "Subject"}, {"name": "difficulty walking because of marked pain in the lower extremities and loss of proprioception", "role": "Effect"}, {"name": "25 days after treatment with weekly taxol (80 mg/m(2)x3)", "role": "Treatment"}, {"name": "25 days", "role": "Treatment.Time_elapsed"}, {"name": "taxol", "role": "Treatment.Drug"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "80 mg/m(2)x3", "role": "Treatment.Dosage"}, {"name": "advanced ovarian carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-184", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Agranulocytosis and granulocytopenia", "role": "Effect"}, {"name": "quetiapine", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}]}]}
{"id": "train-185", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "multiple comedones and ruptured epidermoid cysts", "role": "Effect"}, {"name": "imiquimod therapy", "role": "Treatment"}, {"name": "imiquimod", "role": "Treatment.Drug"}]}]}
{"id": "train-186", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "ileus", "role": "Effect"}, {"name": "calcium antagonist", "role": "Treatment"}, {"name": "nimodipine", "role": "Treatment"}, {"name": "nimodipine", "role": "Treatment.Drug"}]}]}
{"id": "train-187", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Hyperpigmentation", "role": "Effect"}, {"name": "interferon-alpha therapy", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C virus infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-188", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "chromosome damage", "role": "Effect"}, {"name": "Chlorambucil", "role": "Treatment"}, {"name": "Chlorambucil", "role": "Treatment.Drug"}]}]}
{"id": "train-189", "event": [{"trigger": "is", "type": "adverse_event", "arguments": [{"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "Carbamazepine", "role": "Treatment"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-190", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-191", "event": [{"trigger": "exposed", "type": "adverse_event", "arguments": [{"name": "a healthy normal volunteer", "role": "Subject"}, {"name": "Acute asymptomatic hepatitis", "role": "Effect"}, {"name": "2 oral doses of amodiaquine and artesunate", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "2", "role": "Treatment.Dosage"}, {"name": "amodiaquine", "role": "Treatment.Drug"}, {"name": "artesunate", "role": "Treatment.Drug"}, {"name": "artesunate", "role": "Combination.Drug"}, {"name": "amodiaquine", "role": "Combination.Drug"}]}]}
{"id": "train-192", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient without coronary artery disease", "role": "Subject"}, {"name": "focal myocardial necrosis, presenting clinically as an acute myocardial infarction", "role": "Effect"}, {"name": "amsacrine", "role": "Treatment"}, {"name": "amsacrine", "role": "Treatment.Drug"}]}]}
{"id": "train-193", "event": [{"trigger": "prescribed", "type": "potential_therapeutic_event", "arguments": [{"name": "oxazepam", "role": "Treatment"}, {"name": "Baclofen", "role": "Treatment"}, {"name": "right-sided hemiparesis contractures", "role": "Treatment.Disorder"}, {"name": "Baclofen", "role": "Treatment.Drug"}, {"name": "oxazepam", "role": "Treatment.Drug"}, {"name": "oxazepam", "role": "Combination.Drug"}, {"name": "Baclofen", "role": "Combination.Drug"}]}]}
{"id": "train-194", "event": [{"trigger": "implication of", "type": "adverse_event", "arguments": [{"name": "SS", "role": "Effect"}, {"name": "mirtazapine", "role": "Treatment"}, {"name": "mirtazapine", "role": "Treatment.Drug"}]}]}
{"id": "train-195", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "hemolytic and/or thrombocytopenic reactions", "role": "Effect"}, {"name": "oxaliplatin", "role": "Treatment"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-196", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 39-year-old white Jewish schizophrenic man", "role": "Subject"}, {"name": "39-year-old", "role": "Subject.Age"}, {"name": "white Jewish", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "an elevated serum CK concentration", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "schizophrenic", "role": "Treatment.Disorder"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-197", "event": [{"trigger": "secondary to", "type": "adverse_event", "arguments": [{"name": "Severe water intoxication", "role": "Effect"}, {"name": "the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin", "role": "Treatment"}, {"name": "non-steroidal anti-inflammatory drugs", "role": "Treatment.Drug"}, {"name": "desmopressin", "role": "Treatment.Drug"}, {"name": "non-steroidal anti-inflammatory drugs", "role": "Combination.Drug"}, {"name": "desmopressin", "role": "Combination.Drug"}]}]}
{"id": "train-198", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "red blood cell anemia", "role": "Effect"}, {"name": "MMF with prednisone to treat pemphigus vulgaris", "role": "Treatment"}, {"name": "pemphigus vulgaris", "role": "Treatment.Disorder"}, {"name": "MMF", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "MMF", "role": "Combination.Drug"}, {"name": "prednisone", "role": "Combination.Drug"}]}]}
{"id": "train-199", "event": [{"trigger": "recovered", "type": "potential_therapeutic_event", "arguments": [{"name": "our patient", "role": "Subject"}, {"name": "his renal function gradually recovered", "role": "Effect"}, {"name": "cessation of suramin treatment", "role": "Treatment"}, {"name": "suramin", "role": "Treatment.Drug"}, {"name": "cessation", "role": "Treatment.Dosage"}]}]}
{"id": "train-200", "event": [{"trigger": "produce", "type": "adverse_event", "arguments": [{"name": "reversible encephalopathy that includes cortical hyperexcitability, a profound burst-suppression EEG pattern, and cranial nerve areflexia", "role": "Effect"}, {"name": "Massive CBZ OD", "role": "Treatment"}, {"name": "OD", "role": "Treatment.Dosage"}, {"name": "CBZ", "role": "Treatment.Drug"}]}]}
{"id": "train-201", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism", "role": "Subject.Disorder"}, {"name": "death", "role": "Effect"}, {"name": "fluoxetine", "role": "Treatment"}, {"name": "fluoxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-202", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "demented patient", "role": "Subject"}, {"name": "reversible DKA and new-onset DM", "role": "Effect"}, {"name": "quetiapine for 14 days", "role": "Treatment"}, {"name": "demented", "role": "Treatment.Disorder"}, {"name": "quetiapine", "role": "Treatment.Drug"}, {"name": "14 days", "role": "Treatment.Duration"}]}]}
{"id": "train-203", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "3 cases", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "cardiac toxicity", "role": "Effect"}, {"name": "diphenhydramine", "role": "Treatment"}, {"name": "diphenhydramine", "role": "Treatment.Drug"}]}]}
{"id": "train-204", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "patient's", "role": "Subject"}, {"name": "arthritis flared", "role": "Effect"}, {"name": "second infusion of infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "second", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-205", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Marked visual field constriction", "role": "Effect"}, {"name": "vigabatrin therapy", "role": "Treatment"}, {"name": "vigabatrin", "role": "Treatment.Drug"}]}]}
{"id": "train-206", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome associated with clomipramine", "role": "Effect"}, {"name": "withdrawal of clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "clomipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-207", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 14-year-old female", "role": "Subject"}, {"name": "14-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA)", "role": "Effect"}, {"name": "administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "benign Rolandic epilepsy", "role": "Treatment.Disorder"}]}]}
{"id": "train-208", "event": [{"trigger": "a clear relationship", "type": "adverse_event", "arguments": [{"name": "recurrence of the transient myopia", "role": "Effect"}, {"name": "Accutane", "role": "Treatment"}, {"name": "Accutane", "role": "Treatment.Drug"}]}]}
{"id": "train-209", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Graves' hyperthyroidism following transient thyrotoxicosis", "role": "Effect"}, {"name": "interferon therapy", "role": "Treatment"}, {"name": "interferon therapy", "role": "Treatment.Drug"}, {"name": "chronic hepatitis type C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-210", "event": [{"trigger": "exposed", "type": "adverse_event", "arguments": [{"name": "5 of 39 (12.8%)", "role": "Subject"}, {"name": "5 of 39 (12.8%)", "role": "Subject.Population"}, {"name": "Masculinization of a female fetus", "role": "Effect"}, {"name": "clitoral hypertrophy", "role": "Effect"}, {"name": "norethisterone", "role": "Treatment"}, {"name": "norethisterone", "role": "Treatment.Drug"}]}]}
{"id": "train-211", "event": [{"trigger": "disappeared.", "type": "potential_therapeutic_event", "arguments": [{"name": "She", "role": "Subject"}, {"name": "She", "role": "Subject.Gender"}, {"name": "continued taking verapamil for 6 months, then, on her own, stopped all medications including the sustained-release verapamil", "role": "Treatment"}, {"name": "asthma", "role": "Treatment.Disorder"}, {"name": "verapamil", "role": "Treatment.Drug"}, {"name": "for 6 months", "role": "Treatment.Duration"}]}]}
{"id": "train-212", "event": [{"trigger": "reactions", "type": "adverse_event", "arguments": [{"name": "one", "role": "Subject"}, {"name": "manifested general erythema, dyspnea, and hypotension", "role": "Effect"}, {"name": "cisplatin", "role": "Treatment"}, {"name": "involving intrahepatic artery infusion", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "ovarian cancer", "role": "Treatment.Disorder"}, {"name": "intrahepatic artery infusion", "role": "Treatment.Route"}]}]}
{"id": "train-213", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "HUS", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-214", "event": [{"trigger": "trigger", "type": "adverse_event", "arguments": [{"name": "these patients", "role": "Subject"}, {"name": "serious hypoglycemia", "role": "Effect"}, {"name": "long-acting octreotide", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}]}]}
{"id": "train-215", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "thrombocytopenia and thrombosis", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-216", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "intertrigo-like eruption", "role": "Effect"}, {"name": "pegylated liposomal doxorubicin", "role": "Treatment"}, {"name": "doxorubicin", "role": "Treatment.Drug"}]}]}
{"id": "train-217", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "for lupus nephritis", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "NEH masquerading as cutaneous vasculitis", "role": "Effect"}, {"name": "cyclophosphamide", "role": "Treatment"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "lupus nephritis.", "role": "Treatment.Disorder"}]}]}
{"id": "train-218", "event": [{"trigger": "resolved", "type": "potential_therapeutic_event", "arguments": [{"name": "discontinuation of risperidone and continuation of clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "risperidone", "role": "Treatment.Drug"}, {"name": "hypothermia", "role": "Treatment.Disorder"}]}]}
{"id": "train-219", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "Unaccountable severe hypercalcemia", "role": "Effect"}, {"name": "dihydrotachysterol", "role": "Treatment"}, {"name": "hypoparathyroidism", "role": "Treatment.Disorder"}, {"name": "dihydrotachysterol", "role": "Treatment.Drug"}]}]}
{"id": "train-220", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Anaphylaxis", "role": "Effect"}, {"name": "calcitonin", "role": "Treatment"}, {"name": "calcitonin", "role": "Treatment.Drug"}]}]}
{"id": "train-221", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "acute renal failure, hyperkalemia, and hyperuricemia", "role": "Effect"}, {"name": "sorafenib", "role": "Treatment"}, {"name": "sorafenib", "role": "Treatment.Drug"}, {"name": "30 d", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-222", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "infliximab", "role": "Treatment"}, {"name": "Mycobacterium marinum infection complicating Crohn's disease", "role": "Treatment.Disorder"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-223", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "significant adverse reactions.", "role": "Effect"}, {"name": "Current immunosuppressive therapies", "role": "Treatment"}, {"name": "immunosuppressive", "role": "Treatment.Drug"}]}]}
{"id": "train-224", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "symptomatic torsades de pointes", "role": "Effect"}, {"name": "terfenadine", "role": "Treatment"}, {"name": "taking the recommended prescribed dose of this drug in addition to cefaclor, ketoconazole, and medroxyprogesterone", "role": "Treatment"}, {"name": "cefaclor", "role": "Treatment.Drug"}, {"name": "ketoconazole", "role": "Treatment.Drug"}, {"name": "medroxyprogesterone", "role": "Treatment.Drug"}, {"name": "terfenadine", "role": "Treatment.Drug"}, {"name": "terfenadine", "role": "Combination.Drug"}, {"name": "cefaclor", "role": "Combination.Drug"}, {"name": "ketoconazole", "role": "Combination.Drug"}, {"name": "medroxyprogesterone", "role": "Combination.Drug"}]}]}
{"id": "train-225", "event": [{"trigger": "suggested", "type": "adverse_event", "arguments": [{"name": "carcinogenic both through direct genotoxic and epigenetic mechanisms", "role": "Effect"}, {"name": "Tamoxifen", "role": "Treatment"}, {"name": "Tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-226", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "patients with impaired renal and hepatic function", "role": "Subject"}, {"name": "impaired renal and hepatic function", "role": "Subject.Disorder"}, {"name": "myopathy", "role": "Effect"}, {"name": "Colchicine", "role": "Treatment"}, {"name": "Colchicine", "role": "Treatment.Drug"}, {"name": "FMF", "role": "Treatment.Disorder"}]}]}
{"id": "train-227", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "fluvoxamine-induced akathisia in an OCD patient", "role": "Subject"}, {"name": "5-HT2A/5-HT2C antagonist mianserin", "role": "Treatment"}, {"name": "akathisia", "role": "Treatment.Disorder"}, {"name": "OCD", "role": "Treatment.Disorder"}, {"name": "mianserin", "role": "Treatment.Drug"}]}]}
{"id": "train-228", "event": [{"trigger": "resolved", "type": "potential_therapeutic_event", "arguments": [{"name": "interferon was stopped and after immunosuppressive treatment", "role": "Treatment"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "immunosuppressive", "role": "Treatment.Drug"}, {"name": "nephrosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-229", "event": [{"trigger": "increased", "type": "adverse_event", "arguments": [{"name": "In two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "intensity of the dyskinesias in the afternoon", "role": "Effect"}, {"name": "apomorphine", "role": "Treatment"}, {"name": "apomorphine", "role": "Treatment.Drug"}]}]}
{"id": "train-230", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Transient asymptomatic bradycardia", "role": "Effect"}, {"name": "infusional 5-fluorouracil.", "role": "Treatment"}, {"name": "infusional", "role": "Treatment.Route"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-231", "event": [{"trigger": "started", "type": "potential_therapeutic_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Population"}, {"name": "warfarin", "role": "Treatment"}, {"name": "deep vein thrombosis and pulmonary embolism", "role": "Treatment.Disorder"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-232", "event": [{"trigger": "complicating", "type": "adverse_event", "arguments": [{"name": "Scleritis", "role": "Effect"}, {"name": "zoledronic acid infusion", "role": "Treatment"}, {"name": "zoledronic acid", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-233", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 22-year-old black man", "role": "Subject"}, {"name": "22-year-old", "role": "Subject.Age"}, {"name": "black", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "fever, chills, fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption", "role": "Effect"}, {"name": "minocycline therapy", "role": "Treatment"}, {"name": "acne", "role": "Treatment.Disorder"}, {"name": "minocycline", "role": "Treatment.Drug"}, {"name": "3 weeks", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-234", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "aplastic anemia", "role": "Effect"}, {"name": "Ticlopidine", "role": "Treatment"}, {"name": "Ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-235", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "acute lung injury and diffuse alveolar damage", "role": "Effect"}, {"name": "mefloquine", "role": "Treatment"}, {"name": "mefloquine", "role": "Treatment.Drug"}]}]}
{"id": "train-236", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "patient of lepromatous leprosy with pulmonary tuberculosis", "role": "Subject"}, {"name": "Erythema Multiforme Bullosum", "role": "Effect"}, {"name": "Rifampicin", "role": "Treatment"}, {"name": "pulmonary tuberculosis", "role": "Treatment.Disorder"}, {"name": "lepromatous leprosy", "role": "Treatment.Disorder"}, {"name": "Rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-237", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Life-threatening alterations in heart rate", "role": "Effect"}, {"name": "adenosine", "role": "Treatment"}, {"name": "adenosine", "role": "Treatment.Drug"}]}]}
{"id": "train-238", "event": [{"trigger": "treated with", "type": "adverse_event", "arguments": [{"name": "a 23-year-old man with Crohn's disease", "role": "Subject"}, {"name": "23-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "pancytopenia", "role": "Effect"}, {"name": "5-aminosalicylic acid (Pentasa; Nisshin, Tokyo, Japan) 3.0 g/day", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "5-aminosalicylic acid", "role": "Treatment.Drug"}, {"name": "Pentasa", "role": "Treatment.Drug"}, {"name": "3.0 g/day", "role": "Treatment.Dosage"}]}]}
{"id": "train-239", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "The ampicillin rash", "role": "Effect"}, {"name": "ampicillin", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}, {"name": "infectious mononucleosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-240", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "infection", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-241", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "An asymptomatic HIV-infected woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "right-sided renal colicky pain", "role": "Effect"}, {"name": "indinavir", "role": "Treatment"}, {"name": "indinavir", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}]}]}
{"id": "train-242", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "patients with Wilson's disease", "role": "Subject"}, {"name": "optic neuropathy", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}, {"name": "Wilson's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-243", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Cutaneous ulceration", "role": "Effect"}, {"name": "intravenous pentamidine", "role": "Treatment"}, {"name": "pentamidine", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-244", "event": [{"trigger": "appear", "type": "adverse_event", "arguments": [{"name": "Pulmonary hemorrhage", "role": "Effect"}, {"name": "MMC", "role": "Treatment"}, {"name": "MMC", "role": "Treatment.Drug"}]}]}
{"id": "train-245", "event": [{"trigger": "generalized", "type": "adverse_event", "arguments": [{"name": "mite infestation", "role": "Effect"}, {"name": "extensive administration of prednisolone", "role": "Treatment"}, {"name": "prednisolone", "role": "Treatment.Drug"}]}]}
{"id": "train-246", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "The episode appeared to have been precipitated by toxicity", "role": "Effect"}, {"name": "a large amount of phenytoin.", "role": "Treatment"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "large amount", "role": "Treatment.Dosage"}]}]}
{"id": "train-247", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Cardiopulmonary arrest", "role": "Effect"}, {"name": "intravenous phenytoin loading", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-248", "event": [{"trigger": "toxicity.", "type": "adverse_event", "arguments": [{"name": "peripheral neuropathy", "role": "Effect"}, {"name": "taxol", "role": "Treatment"}, {"name": "taxol", "role": "Treatment.Drug"}]}]}
{"id": "train-249", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a child with psoriatic arthritis", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Syringotropic hypersensitivity reaction", "role": "Effect"}, {"name": "infliximab and leflunomide combination therapy", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}, {"name": "leflunomide", "role": "Treatment.Drug"}, {"name": "psoriatic arthritis", "role": "Treatment.Disorder"}, {"name": "leflunomide", "role": "Combination.Drug"}, {"name": "infliximab", "role": "Combination.Drug"}]}]}
{"id": "train-250", "event": [{"trigger": "improvement", "type": "potential_therapeutic_event", "arguments": [{"name": "Corticosteroid", "role": "Treatment"}, {"name": "for 8 months", "role": "Treatment"}, {"name": "pulmonary function", "role": "Treatment.Disorder"}, {"name": "Corticosteroid", "role": "Treatment.Drug"}, {"name": "for 8 months", "role": "Treatment.Duration"}]}]}
{"id": "train-251", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an elderly patient with dementia and comorbidities", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "rhabdomyolysis", "role": "Effect"}, {"name": "sertraline", "role": "Treatment"}, {"name": "comorbidities", "role": "Treatment.Disorder"}, {"name": "dementia", "role": "Treatment.Disorder"}, {"name": "sertraline", "role": "Treatment.Drug"}]}]}
{"id": "train-252", "event": [{"trigger": "causing", "type": "adverse_event", "arguments": [{"name": "overt hypothyroidism or thyrotoxicosis", "role": "Effect"}, {"name": "iodine-rich amiodarone", "role": "Treatment"}, {"name": "iodine-rich amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-253", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Toxic epidermal necrolysis", "role": "Effect"}, {"name": "interleukin-2", "role": "Treatment"}, {"name": "interleukin-2", "role": "Treatment.Drug"}]}]}
{"id": "train-254", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity", "role": "Effect"}, {"name": "life-threatening respiratory failure", "role": "Effect"}, {"name": "gold salts", "role": "Treatment"}, {"name": "gold", "role": "Treatment.Drug"}]}]}
{"id": "train-255", "event": [{"trigger": "compromise", "type": "adverse_event", "arguments": [{"name": "compromise hemodynamic stability", "role": "Effect"}, {"name": "tizanidine", "role": "Treatment"}, {"name": "during concomitant angiotensin-converting enzyme inhibitor use", "role": "Treatment"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "angiotensin-converting enzyme inhibitor", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Combination.Drug"}, {"name": "angiotensin-converting enzyme inhibitor", "role": "Combination.Drug"}]}]}
{"id": "train-256", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "monozygotic twins", "role": "Subject"}, {"name": "Premature closure of the ductus arteriosus", "role": "Effect"}, {"name": "in utero exposure to indomethacin", "role": "Treatment"}, {"name": "indomethacin", "role": "Treatment.Drug"}, {"name": "in utero exposure", "role": "Treatment.Route"}]}]}
{"id": "train-257", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "bradycardia", "role": "Effect"}, {"name": "clonidine", "role": "Treatment"}, {"name": "clonidine", "role": "Treatment.Drug"}, {"name": "spinal cord injured", "role": "Treatment.Disorder"}]}]}
{"id": "train-258", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "an acute cardiovascular event", "role": "Effect"}, {"name": "venlafaxine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-259", "event": [{"trigger": "prescribed", "type": "potential_therapeutic_event", "arguments": [{"name": "cimetidine", "role": "Treatment"}, {"name": "gastrointestinal symptoms", "role": "Treatment.Disorder"}, {"name": "cimetidine", "role": "Treatment.Drug"}]}]}
{"id": "train-260", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Acute renal failure", "role": "Effect"}, {"name": "suramin", "role": "Treatment"}, {"name": "suramin", "role": "Treatment.Drug"}]}]}
{"id": "train-261", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "anaphylactoid reaction", "role": "Effect"}, {"name": "methylprednisolone", "role": "Treatment"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}]}]}
{"id": "train-262", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Pulmonary hemorrhage", "role": "Effect"}, {"name": "hemolytic-uremic syndrome", "role": "Effect"}, {"name": "mitomycin C therapy", "role": "Treatment"}, {"name": "mitomycin C", "role": "Treatment.Drug"}]}]}
{"id": "train-263", "event": [{"trigger": "observed", "type": "adverse_event", "arguments": [{"name": "two of the nine children", "role": "Subject"}, {"name": "two of the nine", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "EEG abnormalities", "role": "Effect"}, {"name": "chlorambucil", "role": "Treatment"}, {"name": "chlorambucil", "role": "Treatment.Drug"}]}]}
{"id": "train-264", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "drug eruption", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-265", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "in children with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "varying degrees of neurotoxicity", "role": "Effect"}, {"name": "The addition of intrathecal methotrexate to treatment protocols", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-266", "event": [{"trigger": "results in", "type": "adverse_event", "arguments": [{"name": "this metabolic defect", "role": "Subject"}, {"name": "metabolic defect", "role": "Subject.Disorder"}, {"name": "unusual presentation of life-threatening toxicity", "role": "Effect"}, {"name": "topical 5-FU (a drug demonstrating a narrow therapeutic index)", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "topical", "role": "Treatment.Route"}]}]}
{"id": "train-267", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Six patients with rheumatoid arthritis", "role": "Subject"}, {"name": "Six", "role": "Subject.Population"}, {"name": "syndrome resembling lupus erythematosus", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-268", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patients treated with 6-TG", "role": "Subject"}, {"name": "hepatic injury", "role": "Effect"}, {"name": "thiopurine", "role": "Treatment"}, {"name": "thiopurine", "role": "Treatment.Drug"}]}]}
{"id": "train-269", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "four out of the seven patients", "role": "Subject"}, {"name": "four out of the seven", "role": "Subject.Population"}, {"name": "moderate-to-severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia", "role": "Effect"}, {"name": "During clarithromycin coadministration", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "During", "role": "Treatment.Time_elapsed"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}, {"name": "carbamazepine", "role": "Combination.Drug"}]}]}
{"id": "train-270", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "5-Fluorouracil (5-FU) is an analogue of pyrimidine nucleosides", "role": "Treatment"}, {"name": "5-Fluorouracil (5-FU)", "role": "Treatment.Drug"}, {"name": "head and neck, breast, ovarian, and colon cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-271", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Fulminant fatal cardiotoxicity", "role": "Effect"}, {"name": "cyclophosphamide", "role": "Treatment"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}]}]}
{"id": "train-272", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "reaction", "role": "Effect"}, {"name": "tizanidine initiation", "role": "Treatment"}, {"name": "tizanidine", "role": "Treatment.Drug"}]}]}
{"id": "train-273", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "a patient with previously diagnosed CLL in minimal residual disease status", "role": "Subject"}, {"name": "AML", "role": "Effect"}, {"name": "lung cancer", "role": "Effect"}, {"name": "fludarabine", "role": "Treatment"}, {"name": "autologous peripheral blood stem-cell transplantation", "role": "Treatment"}, {"name": "CLL in minimal residual disease status", "role": "Treatment.Disorder"}, {"name": "fludarabine", "role": "Treatment.Drug"}, {"name": "autologous peripheral blood stem-cell", "role": "Treatment.Drug"}, {"name": "transplantation", "role": "Treatment.Route"}, {"name": "fludarabine", "role": "Combination.Drug"}, {"name": "autologous peripheral blood stem-cell", "role": "Combination.Drug"}]}]}
{"id": "train-274", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "altered mental status", "role": "Effect"}, {"name": "hyperammonemia", "role": "Effect"}, {"name": "Valproate", "role": "Treatment"}, {"name": "Valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-275", "event": [{"trigger": "onset of treatment", "type": "adverse_event", "arguments": [{"name": "patients with severe drug-resistant hypertension", "role": "Subject"}, {"name": "acute reversible renal failure", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}, {"name": "severe drug-resistant hypertension", "role": "Treatment.Disorder"}]}]}
{"id": "train-276", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "contact dermatitis", "role": "Effect"}, {"name": "sodium bisulfite", "role": "Treatment"}, {"name": "sodium bisulfite", "role": "Treatment.Drug"}]}]}
{"id": "train-277", "event": [{"trigger": "having", "type": "adverse_event", "arguments": [{"name": "The first patient", "role": "Subject"}, {"name": "significant fatigue and hypertension", "role": "Effect"}, {"name": "sunitinib", "role": "Treatment"}, {"name": "sunitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-278", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "CCBs", "role": "Treatment"}, {"name": "CCBs", "role": "Treatment.Drug"}, {"name": "headaches", "role": "Treatment.Disorder"}]}]}
{"id": "train-279", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "reaction", "role": "Effect"}, {"name": "Furosemide, spironolactone, allopurinol, and hydroxyurea", "role": "Treatment"}, {"name": "Furosemide", "role": "Treatment.Drug"}, {"name": "spironolactone", "role": "Treatment.Drug"}, {"name": "allopurinol", "role": "Treatment.Drug"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}]}]}
{"id": "train-280", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "One patient", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "mucositis", "role": "Effect"}, {"name": "chemotherapy", "role": "Treatment"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-281", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "A patient with monocular open-angle glaucoma", "role": "Subject"}, {"name": "trichiasis", "role": "Effect"}, {"name": "a prostaglandin analog", "role": "Treatment"}, {"name": "monocular open-angle glaucoma", "role": "Treatment.Disorder"}, {"name": "prostaglandin analog", "role": "Treatment.Drug"}]}]}
{"id": "train-282", "event": [{"trigger": "prescribed", "type": "potential_therapeutic_event", "arguments": [{"name": "A 53-year-old African American male with HIV", "role": "Subject"}, {"name": "53-year-old", "role": "Subject.Age"}, {"name": "African American", "role": "Subject.Race"}, {"name": "male", "role": "Subject.Gender"}, {"name": "HIV", "role": "Subject.Disorder"}, {"name": "warfarin 5 mg/day for 12 months", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "5 mg/day", "role": "Treatment.Dosage"}, {"name": "12 months", "role": "Treatment.Duration"}, {"name": "idiopathic deep vein thrombosis and bilateral pulmonary emboli", "role": "Treatment.Disorder"}]}]}
{"id": "train-283", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "one fetus", "role": "Subject"}, {"name": "fetus", "role": "Subject.Age"}, {"name": "supraventricular tachycardia.", "role": "Effect"}, {"name": "a beta-sympathomimetic drug (Partusisten)", "role": "Treatment"}, {"name": "Partusisten", "role": "Treatment.Drug"}]}]}
{"id": "train-284", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Serotonin syndrome", "role": "Effect"}, {"name": "concurrent linezolid and fluoxetine", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "fluoxetine", "role": "Combination.Drug"}]}]}
{"id": "train-285", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "A male and a female patient with spasticity", "role": "Subject"}, {"name": "male", "role": "Subject.Gender"}, {"name": "female", "role": "Subject.Gender"}, {"name": "sexual dysfunction", "role": "Effect"}, {"name": "intrathecal baclofen", "role": "Treatment"}, {"name": "spasticity", "role": "Treatment.Disorder"}, {"name": "baclofen", "role": "Treatment.Drug"}, {"name": "intrathecal", "role": "Treatment.Route"}]}]}
{"id": "train-286", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "nonconvulsive status epilepticus", "role": "Effect"}, {"name": "ifosfamide", "role": "Treatment"}, {"name": "ifosfamide", "role": "Treatment.Drug"}]}]}
{"id": "train-287", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Upper gastrointestinal haemorrhage", "role": "Effect"}, {"name": "aspirin and clopidogrel (dual)", "role": "Treatment"}]}]}
{"id": "train-288", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "profound cardiovascular collapse, and is associated with a relatively high mortality", "role": "Effect"}, {"name": "Flecainide overdose", "role": "Treatment"}, {"name": "Flecainide", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-289", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lupus erythematosus", "role": "Effect"}, {"name": "Sulfasalazine", "role": "Treatment"}, {"name": "Sulfasalazine", "role": "Treatment.Drug"}]}]}
{"id": "train-290", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "Reye syndrome (RS)", "role": "Effect"}, {"name": "long-term aspirin", "role": "Treatment"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-291", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "bilateral cataract", "role": "Effect"}, {"name": "Propecia", "role": "Treatment"}, {"name": "Propecia", "role": "Treatment.Drug"}]}]}
{"id": "train-292", "event": [{"trigger": "After", "type": "adverse_event", "arguments": [{"name": "minor bleeding was observed with a concurrent activated partial thromboplastin time (aPTT) of 100 seconds", "role": "Effect"}, {"name": "argatroban", "role": "Treatment"}, {"name": "39 hours", "role": "Treatment.Time_elapsed"}, {"name": "argatroban", "role": "Treatment.Drug"}]}]}
{"id": "train-293", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Anaphylactoid reaction", "role": "Effect"}, {"name": "methylprednisolone pulsed therapy", "role": "Treatment"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}]}]}
{"id": "train-294", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "skin necrosis", "role": "Effect"}, {"name": "Warfarin", "role": "Treatment"}, {"name": "Warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-295", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "three patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "tardive OGC", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-296", "event": [{"trigger": "resulting from", "type": "adverse_event", "arguments": [{"name": "toxic epidermal necrolysis (TEN)", "role": "Effect"}, {"name": "high dose of cytosine arabinoside (ARA-C)", "role": "Treatment"}, {"name": "cytosine arabinoside (ARA-C)", "role": "Treatment.Drug"}, {"name": "high dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-297", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death", "role": "Effect"}, {"name": "high dose of ARA-C", "role": "Treatment"}, {"name": "ARA-C", "role": "Treatment.Drug"}, {"name": "high dose", "role": "Treatment.Dosage"}, {"name": "2 g/m2", "role": "Treatment.Dosage"}, {"name": "the fifth day", "role": "Treatment.Time_elapsed"}, {"name": "the 22nd day", "role": "Treatment.Time_elapsed"}, {"name": "12 hours", "role": "Treatment.Freq"}]}]}
{"id": "train-298", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "2 patients with cutaneous lupus erythematosus", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "severe dapsone reaction", "role": "Effect"}, {"name": "with a fatal outcome in one", "role": "Effect"}, {"name": "low dose therapy", "role": "Treatment"}, {"name": "cutaneous lupus erythematosus", "role": "Treatment.Disorder"}, {"name": "low dose", "role": "Treatment.Dosage"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-299", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with ulcerative colitis", "role": "Subject"}, {"name": "skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology", "role": "Effect"}, {"name": "sulfasalazine", "role": "Treatment"}, {"name": "sulfasalazine", "role": "Treatment.Drug"}, {"name": "ulcerative colitis", "role": "Treatment.Disorder"}]}]}
{"id": "train-300", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "a severe case of angioedema", "role": "Effect"}, {"name": "topical 5-FU cream", "role": "Treatment"}, {"name": "topical", "role": "Treatment.Route"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-301", "event": [{"trigger": "followed", "type": "potential_therapeutic_event", "arguments": [{"name": "recovery from bicytopenia", "role": "Effect"}, {"name": "Cessation of D-Pen and the start of corticosteroid therapy", "role": "Treatment"}, {"name": "D-Pen", "role": "Treatment.Drug"}, {"name": "corticosteroid", "role": "Treatment.Drug"}, {"name": "bicytopenia", "role": "Treatment.Disorder"}]}]}
{"id": "train-302", "event": [{"trigger": "Prevention", "type": "potential_therapeutic_event", "arguments": [{"name": "immunization, together with early recognition and prompt antiviral treatment", "role": "Treatment"}, {"name": "infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-303", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A case", "role": "Subject"}, {"name": "normotensive scleroderma renal crisis", "role": "Effect"}, {"name": "high-dose methylprednisolone treatment", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}]}]}
{"id": "train-304", "event": [{"trigger": "has been observed", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "childhood leukemia", "role": "Subject"}, {"name": "childhood", "role": "Subject.Age"}, {"name": "delayed stroke-like leukoencephalopathy", "role": "Effect"}, {"name": "methotrexate (MTX)", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "childhood leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-305", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an elderly patient treated with thiazide diuretics", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "hyponatremia", "role": "Effect"}, {"name": "Duloxetine", "role": "Treatment"}, {"name": "Duloxetine", "role": "Treatment.Drug"}, {"name": "thiazide diuretics", "role": "Treatment.Drug"}, {"name": "thiazide diuretics", "role": "Combination.Drug"}, {"name": "Duloxetine", "role": "Combination.Drug"}]}]}
{"id": "train-306", "event": [{"trigger": "relationship", "type": "adverse_event", "arguments": [{"name": "metabolic changes manifested as uncontrolled diabetes mellitus and weight gain", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-307", "event": [{"trigger": "treat", "type": "potential_therapeutic_event", "arguments": [{"name": "Arsenic trioxide", "role": "Treatment"}, {"name": "Arsenic trioxide", "role": "Treatment.Drug"}, {"name": "refractory acute promyelocytic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-308", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "the t-AML", "role": "Effect"}, {"name": "oral etoposide therapy", "role": "Treatment"}, {"name": "high-dose, multiagent chemotherapy", "role": "Treatment"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "chemotherapy", "role": "Combination.Drug"}, {"name": "etoposide", "role": "Combination.Drug"}]}]}
{"id": "train-309", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Heat stroke", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "schizophrenia", "role": "Treatment.Disorder"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-310", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "same symptoms", "role": "Effect"}, {"name": "nitrendipine", "role": "Treatment"}, {"name": "few days after", "role": "Treatment"}, {"name": "few days after", "role": "Treatment.Time_elapsed"}, {"name": "nitrendipine", "role": "Treatment.Drug"}]}]}
{"id": "train-311", "event": [{"trigger": "effect", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "acute dystonic reactions (ADRs)", "role": "Effect"}, {"name": "lamivudine", "role": "Treatment"}, {"name": "lamivudine", "role": "Treatment.Drug"}]}]}
{"id": "train-312", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "anaphylaxis", "role": "Effect"}, {"name": "Isoniazid", "role": "Treatment"}, {"name": "Isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-313", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypothyroidism", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-314", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "Deepening of lid sulcus", "role": "Effect"}, {"name": "bimatoprost", "role": "Treatment"}, {"name": "bimatoprost", "role": "Treatment.Drug"}]}]}
{"id": "train-315", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Gastro-oesophageal reflux", "role": "Effect"}, {"name": "nifedipine", "role": "Treatment"}, {"name": "nifedipine", "role": "Treatment.Drug"}]}]}
{"id": "train-316", "event": [{"trigger": "starting", "type": "adverse_event", "arguments": [{"name": "A 68-year-old woman", "role": "Subject"}, {"name": "68-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "a dry, irritating cough", "role": "Effect"}, {"name": "quinapril therapy", "role": "Treatment"}, {"name": "within one month", "role": "Treatment.Time_elapsed"}, {"name": "quinapril", "role": "Treatment.Drug"}, {"name": "essential hypertension", "role": "Treatment.Disorder"}]}]}
{"id": "train-317", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an elderly patient with dementia and comorbidities", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "dementia", "role": "Subject.Disorder"}, {"name": "comorbidities", "role": "Subject.Disorder"}, {"name": "rhabdomyolysis", "role": "Effect"}, {"name": "Sertraline", "role": "Treatment"}, {"name": "Sertraline", "role": "Treatment.Drug"}]}]}
{"id": "train-318", "event": [{"trigger": "disappeared", "type": "potential_therapeutic_event", "arguments": [{"name": "After the dose of methylprednisolone was reduced from 40 mg to 20 mg i.v. q6h and shifted to other anti-asthma treatment by procaterol metered dose inhaler via spacer", "role": "Treatment"}, {"name": "a few hours later", "role": "Treatment"}, {"name": "psychotic reaction", "role": "Treatment.Disorder"}, {"name": "a few hours", "role": "Treatment.Time_elapsed"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}, {"name": "reduced from 40 mg to 20 mg i.v. q6h", "role": "Treatment.Dosage"}, {"name": "spacer", "role": "Treatment.Route"}]}]}
{"id": "train-319", "event": [{"trigger": "for", "type": "adverse_event", "arguments": [{"name": "increased lipid levels", "role": "Effect"}, {"name": "Sirolimus works differently from the immunosuppressants currently available", "role": "Treatment"}, {"name": "Sirolimus", "role": "Treatment.Drug"}, {"name": "immunosuppressants", "role": "Treatment.Drug"}, {"name": "sirolimus", "role": "Treatment.Drug"}, {"name": "cyclosporine", "role": "Treatment.Drug"}, {"name": "tacrolimus", "role": "Treatment.Drug"}]}]}
{"id": "train-320", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "warfarin", "role": "Treatment"}, {"name": "a prior deep venous thrombosis", "role": "Treatment.Disorder"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-321", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "myoclonus", "role": "Effect"}, {"name": "Quetiapine", "role": "Treatment"}, {"name": "Quetiapine", "role": "Treatment.Drug"}]}]}
{"id": "train-322", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Dyspnea", "role": "Effect"}, {"name": "controlled-release morphine sulfate tablets", "role": "Treatment"}, {"name": "morphine sulfate", "role": "Treatment.Drug"}, {"name": "tablets", "role": "Treatment.Route"}, {"name": "controlled-release", "role": "Treatment.Dosage"}]}]}
{"id": "train-323", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "ARE", "role": "Effect"}, {"name": "melarsoprol", "role": "Treatment"}, {"name": "melarsoprol", "role": "Treatment.Drug"}, {"name": "August 1992 and September 1993", "role": "Treatment.Duration"}]}]}
{"id": "train-324", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with disseminated herpes zoster", "role": "Subject"}, {"name": "syndrome of inappropriate antidiuretic hormone and profound hyponatremia", "role": "Effect"}, {"name": "adenine arabinoside", "role": "Treatment"}, {"name": "adenine arabinoside", "role": "Treatment.Drug"}, {"name": "disseminated herpes zoster", "role": "Treatment.Disorder"}]}]}
{"id": "train-325", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "One patient with systemic lupus erythematosus", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "systemic lupus erythematosus", "role": "Subject.Disorder"}, {"name": "erythema multiforme", "role": "Effect"}, {"name": "griseofulvin", "role": "Treatment"}, {"name": "griseofulvin", "role": "Treatment.Drug"}]}]}
{"id": "train-326", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a 34-yr-old man", "role": "Subject"}, {"name": "34-yr-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "colonic mucosal necrosis", "role": "Effect"}, {"name": "Kalimate (calcium polystryrene sulfonate), an analogue of Kayexalate without sorbitol", "role": "Treatment"}, {"name": "Kalimate", "role": "Treatment.Drug"}, {"name": "(calcium polystryrene sulfonate)", "role": "Treatment.Drug"}, {"name": "Kayexalate", "role": "Treatment.Drug"}]}]}
{"id": "train-327", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Bilateral anterior uveitis", "role": "Effect"}, {"name": "clomiphene citrate", "role": "Treatment"}, {"name": "clomiphene citrate", "role": "Treatment.Drug"}]}]}
{"id": "train-328", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient with metastatic renal cell carcinoma", "role": "Subject"}, {"name": "Progressive anemia", "role": "Effect"}, {"name": "combination therapy with interferon-alpha and interleukin-2", "role": "Treatment"}, {"name": "metastatic renal cell carcinoma", "role": "Treatment.Disorder"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}, {"name": "interleukin-2", "role": "Treatment.Drug"}, {"name": "interferon-alpha", "role": "Combination.Drug"}, {"name": "interleukin-2", "role": "Combination.Drug"}]}]}
{"id": "train-329", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "parkinsonism", "role": "Effect"}, {"name": "Metoclopramide", "role": "Treatment"}, {"name": "Metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-330", "event": [{"trigger": "followed by", "type": "adverse_event", "arguments": [{"name": "12 year old patient with atrial flutter", "role": "Subject"}, {"name": "12 year old", "role": "Subject.Age"}, {"name": "acceleration of the heart rate to a potentially dangerous arrhythmia", "role": "Effect"}, {"name": "intravenous adenosine", "role": "Treatment"}, {"name": "adenosine", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "atrial flutter", "role": "Treatment.Disorder"}]}]}
{"id": "train-331", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "erlotinib pulmonary toxicity.", "role": "Effect"}, {"name": "gefitinib", "role": "Treatment"}, {"name": "gefitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-332", "event": [{"trigger": "hospitalized", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "seizures suggesting a secondary generalized grand-mal episode", "role": "Effect"}, {"name": "Eleven days after increase of the trimipramine dosage to 100 mg/d", "role": "Treatment"}, {"name": "Eleven days", "role": "Treatment.Time_elapsed"}, {"name": "100 mg/d", "role": "Treatment.Dosage"}, {"name": "trimipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-333", "event": [{"trigger": "suffered", "type": "adverse_event", "arguments": [{"name": "patient with diabetic rubeosis", "role": "Subject"}, {"name": "acute retinal ischemic change and stroke", "role": "Effect"}, {"name": "intravitreal injection of bevacizumab", "role": "Treatment"}, {"name": "diabetic rubeosis", "role": "Treatment.Disorder"}, {"name": "bevacizumab", "role": "Treatment.Drug"}, {"name": "intravitreal injection", "role": "Treatment.Route"}]}]}
{"id": "train-334", "event": [{"trigger": "caused by", "type": "adverse_event", "arguments": [{"name": "Stevens-Johnson syndrome", "role": "Effect"}, {"name": "antiretroviral drug nevirapine", "role": "Treatment"}, {"name": "nevirapine", "role": "Treatment.Drug"}]}]}
{"id": "train-335", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "WD patients", "role": "Subject"}, {"name": "acute generalized dystonia with brainstem and thalamic lesions", "role": "Effect"}, {"name": "an initial d-penicillamine therapy", "role": "Treatment"}, {"name": "WD", "role": "Treatment.Disorder"}, {"name": "d-penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-336", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pediatric cases", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "TMP-SMX", "role": "Treatment"}, {"name": "TMP-SMX", "role": "Treatment.Drug"}]}]}
{"id": "train-337", "event": [{"trigger": "requires", "type": "potential_therapeutic_event", "arguments": [{"name": "complex and longer treatment with alternative substances", "role": "Treatment"}, {"name": "Drug resistant tuberculosis", "role": "Treatment.Disorder"}, {"name": "substances", "role": "Treatment.Drug"}, {"name": "complex and longer treatment", "role": "Treatment.Duration"}]}]}
{"id": "train-338", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Intracranial haemorrhage from a meningioma", "role": "Effect"}, {"name": "aspirin", "role": "Treatment"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-339", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "fixed drug eruption", "role": "Effect"}, {"name": "during omeprazole treatment", "role": "Treatment"}, {"name": "omeprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-340", "event": [{"trigger": "complained", "type": "adverse_event", "arguments": [{"name": "A 43-year-old male alcoholic", "role": "Subject"}, {"name": "43-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "general fatigue", "role": "Effect"}, {"name": "completely abstinent with cyanamide treatment for 5 years", "role": "Treatment"}, {"name": "alcoholic", "role": "Treatment.Disorder"}, {"name": "cyanamide", "role": "Treatment.Drug"}, {"name": "5 years", "role": "Treatment.Duration"}]}]}
{"id": "train-341", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Delayed hypersensitivity", "role": "Effect"}, {"name": "flurbiprofen", "role": "Treatment"}, {"name": "flurbiprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-342", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "three cases", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "ataxia", "role": "Effect"}, {"name": "Propafenone", "role": "Treatment"}, {"name": "Propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-343", "event": [{"trigger": "consistent with", "type": "adverse_event", "arguments": [{"name": "clinical hazards", "role": "Effect"}, {"name": "Delavirdine and efavirenz (but not nevirapine)", "role": "Treatment"}, {"name": "Delavirdine", "role": "Treatment.Drug"}, {"name": "efavirenz", "role": "Treatment.Drug"}]}]}
{"id": "train-344", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "scleroderma-like reaction", "role": "Effect"}, {"name": "UFT", "role": "Treatment"}, {"name": "UFT", "role": "Treatment.Drug"}]}]}
{"id": "train-345", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "roxithromycin and betamethasone", "role": "Treatment"}, {"name": "roxithromycin", "role": "Treatment.Drug"}, {"name": "betamethasone", "role": "Treatment.Drug"}, {"name": "roxithromycin", "role": "Combination.Drug"}, {"name": "betamethasone", "role": "Combination.Drug"}]}]}
{"id": "train-346", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "Up to four percent of patients", "role": "Subject"}, {"name": "Up to four percent", "role": "Subject.Population"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "imatinib", "role": "Treatment"}, {"name": "imatinib", "role": "Treatment.Drug"}]}]}
{"id": "train-347", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Schneiderian first-rank symptoms", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-348", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Peripheral and optic neuropathy", "role": "Effect"}, {"name": "lactic acidosis after several weeks (median 6 wks), and serotonin syndrome after several days (median 4 days)", "role": "Effect"}, {"name": "several months of linezolid therapy (median 5 mo)", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "several months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-349", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "neuromyeloencephalopathy", "role": "Effect"}, {"name": "Muzolimine", "role": "Treatment"}, {"name": "Muzolimine", "role": "Treatment.Dosage"}]}]}
{"id": "train-350", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "peripheral neuropathy", "role": "Effect"}, {"name": "5-FU", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-351", "event": [{"trigger": "produces", "type": "adverse_event", "arguments": [{"name": "10% of women", "role": "Subject"}, {"name": "10%", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "hepatocellular damage", "role": "Effect"}, {"name": "danazol", "role": "Treatment"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-352", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "patients with severe AMD", "role": "Subject"}, {"name": "typical symptoms of Charles-Bonnet syndrome (CBS)", "role": "Effect"}, {"name": "intravitreal Avastin-injections", "role": "Treatment"}, {"name": "Avastin", "role": "Treatment.Drug"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "injections", "role": "Treatment.Route"}, {"name": "AMD", "role": "Treatment.Disorder"}]}]}
{"id": "train-353", "event": [{"trigger": "side effects.", "type": "adverse_event", "arguments": [{"name": "Proconvulsive tendency", "role": "Effect"}, {"name": "imipenem/cilastatin", "role": "Treatment"}, {"name": "cilastatin", "role": "Treatment.Drug"}, {"name": "imipenem", "role": "Treatment.Drug"}, {"name": "imipenem", "role": "Combination.Drug"}, {"name": "cilastatin", "role": "Combination.Drug"}]}]}
{"id": "train-354", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "49-year-old man with Crohn's disease", "role": "Subject"}, {"name": "49-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "worsening respiratory distress and fever.", "role": "Effect"}, {"name": "prednisone and mesalamine (5-ASA)", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "mesalamine", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Combination.Drug"}, {"name": "mesalamine", "role": "Combination.Drug"}]}]}
{"id": "train-355", "event": [{"trigger": "use", "type": "adverse_event", "arguments": [{"name": "This case", "role": "Subject"}, {"name": "a significant type of morbidity", "role": "Effect"}, {"name": "gabapentin", "role": "Treatment"}, {"name": "gabapentin", "role": "Treatment.Drug"}]}]}
{"id": "train-356", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "elderly patients", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "Acute delirium", "role": "Effect"}, {"name": "levofloxacin", "role": "Treatment"}, {"name": "levofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-357", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "aggravation of nonalcoholic steatohepatitis", "role": "Effect"}, {"name": "raloxifene", "role": "Treatment"}, {"name": "raloxifene", "role": "Treatment.Drug"}]}]}
{"id": "train-358", "event": [{"trigger": "complained", "type": "adverse_event", "arguments": [{"name": "severe back pain and urinary retention", "role": "Effect"}, {"name": "The day after methotrexate administration", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "The day after", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-359", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "Pulmonary toxicity", "role": "Effect"}, {"name": "procarbazine", "role": "Treatment"}, {"name": "procarbazine", "role": "Treatment.Drug"}]}]}
{"id": "train-360", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "aortic wall in this case was damaged", "role": "Effect"}, {"name": "irradiation and Bleomycin treatment.", "role": "Treatment"}, {"name": "Bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-361", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "PPE", "role": "Effect"}, {"name": "cytarabine", "role": "Treatment"}, {"name": "cytarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-362", "event": [{"trigger": "may not reduce", "type": "adverse_event", "arguments": [{"name": "endometrial lesions", "role": "Effect"}, {"name": "carcinoma", "role": "Effect"}, {"name": "addition of progestogens to tamoxifen", "role": "Treatment"}, {"name": "progestogens", "role": "Treatment.Drug"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "progestogens", "role": "Combination.Drug"}, {"name": "tamoxifen", "role": "Combination.Drug"}]}]}
{"id": "train-363", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Inappropriate antidiuretic hormone", "role": "Effect"}, {"name": "adenine arabinoside", "role": "Treatment"}, {"name": "adenine arabinoside", "role": "Treatment.Drug"}]}]}
{"id": "train-364", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "Ampicillin", "role": "Treatment"}, {"name": "Ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-365", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "fibrosing alveolitis", "role": "Effect"}, {"name": "amiodarone which responded to corticosteroid therapy", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "corticosteroid", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Combination.Drug"}, {"name": "corticosteroid", "role": "Combination.Drug"}]}]}
{"id": "train-366", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "fever", "role": "Effect"}, {"name": "Furosemide", "role": "Treatment"}, {"name": "Furosemide", "role": "Treatment.Drug"}]}]}
{"id": "train-367", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient with juvenile idiopathic arthritis", "role": "Subject"}, {"name": "juvenile", "role": "Subject.Age"}, {"name": "Thymic enlargement", "role": "Effect"}, {"name": "etanercept", "role": "Treatment"}, {"name": "etanercept", "role": "Treatment.Drug"}, {"name": "idiopathic arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-368", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "serotonin toxicity", "role": "Effect"}, {"name": "methylene blue", "role": "Treatment"}, {"name": "methylene blue", "role": "Treatment.Drug"}]}]}
{"id": "train-369", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "ARF", "role": "Effect"}, {"name": "anuria", "role": "Effect"}, {"name": "renal failure", "role": "Effect"}, {"name": "Mannitol", "role": "Treatment"}, {"name": "Mannitol", "role": "Treatment.Drug"}]}]}
{"id": "train-370", "event": [{"trigger": "while", "type": "adverse_event", "arguments": [{"name": "a patient with protein C deficiency", "role": "Subject"}, {"name": "recurrent (stuttering) priapism", "role": "Effect"}, {"name": "maintained on Warfarin therapy", "role": "Treatment"}, {"name": "protein C deficiency", "role": "Treatment.Disorder"}, {"name": "Warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-371", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Angioedema and maculopapular eruptions", "role": "Effect"}, {"name": "carbamazepine administration.", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-372", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "Mental nerve neuropathy", "role": "Effect"}, {"name": "hepatitis B vaccination", "role": "Treatment"}, {"name": "hepatitis B vaccination.", "role": "Treatment.Drug"}]}]}
{"id": "train-373", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a premenopausal woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "premenopausal", "role": "Subject.Age"}, {"name": "endometriosis", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "in situ ductal carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-374", "event": [{"trigger": "in the setting of", "type": "adverse_event", "arguments": [{"name": "Disseminated cellulitic cryptococcosis", "role": "Effect"}, {"name": "prednisone monotherapy", "role": "Treatment"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "pemphigus vulgaris", "role": "Treatment.Disorder"}]}]}
{"id": "train-375", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 63 year old woman with a suppurative mediastinitis", "role": "Subject"}, {"name": "63 year old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "acute oliguric renal failure", "role": "Effect"}, {"name": "continuous PI irrigation", "role": "Treatment"}, {"name": "PI", "role": "Treatment.Drug"}, {"name": "suppurative mediastinitis", "role": "Treatment.Disorder"}, {"name": "irrigation", "role": "Treatment.Route"}]}]}
{"id": "train-376", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "A young woman with epilepsy", "role": "Subject"}, {"name": "young", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "tonic-clonic seizures", "role": "Effect"}, {"name": "antineoplastic therapy with adriamycin and cisplatin.", "role": "Treatment"}, {"name": "adriamycin", "role": "Treatment.Drug"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "epilepsy", "role": "Treatment.Disorder"}, {"name": "adriamycin", "role": "Combination.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}]}]}
{"id": "train-377", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "This patient", "role": "Subject"}, {"name": "rhabdomyolysis", "role": "Effect"}, {"name": "sertraline", "role": "Treatment"}, {"name": "sertraline", "role": "Treatment.Drug"}]}]}
{"id": "train-378", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "a multiple sclerosis patient", "role": "Subject"}, {"name": "Nephrotic syndrome", "role": "Effect"}, {"name": "interferon beta 1a", "role": "Treatment"}, {"name": "interferon beta 1a", "role": "Treatment.Drug"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-379", "event": [{"trigger": "related to", "type": "adverse_event", "arguments": [{"name": "our patient", "role": "Subject"}, {"name": "DIAN", "role": "Effect"}, {"name": "cefuroxime", "role": "Treatment"}, {"name": "cefuroxime", "role": "Treatment.Drug"}]}]}
{"id": "train-380", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a nonatopic 17-year-old girl with bronchial asthma and aspirin intolerance", "role": "Subject"}, {"name": "nonatopic", "role": "Subject.Disorder"}, {"name": "aspirin intolerance", "role": "Subject.Disorder"}, {"name": "17-year-old", "role": "Subject.Age"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "a dramatic anaphylactic reaction", "role": "Effect"}, {"name": "oral prednisone", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "bronchial asthma", "role": "Treatment.Disorder"}]}]}
{"id": "train-381", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 10-year-old white girl with bilateral optic glioma", "role": "Subject"}, {"name": "10-year-old", "role": "Subject.Age"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "white", "role": "Subject.Race"}, {"name": "hypersensitivity reaction", "role": "Effect"}, {"name": "carboplatin after nine courses", "role": "Treatment"}, {"name": "bilateral optic glioma", "role": "Treatment.Disorder"}, {"name": "carboplatin", "role": "Treatment.Drug"}, {"name": "nine courses", "role": "Treatment.Duration"}]}]}
{"id": "train-382", "event": [{"trigger": "when", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Liver function should be carefully monitored", "role": "Effect"}, {"name": "rifampicin and lopinavir/ritonavir are combined", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "lopinavir/ritonavir", "role": "Treatment.Drug"}, {"name": "rifampicin", "role": "Combination.Drug"}, {"name": "lopinavir/ritonavir", "role": "Combination.Drug"}]}]}
{"id": "train-383", "event": [{"trigger": "initiation", "type": "potential_therapeutic_event", "arguments": [{"name": "three patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "profound reduction in plasma HDL cholesterol and apolipoprotein AI levels", "role": "Effect"}, {"name": "rosiglitazone therapy", "role": "Treatment"}, {"name": "rosiglitazone", "role": "Treatment.Drug"}, {"name": "soon after", "role": "Treatment.Time_elapsed"}, {"name": "preexisting diabetic dyslipidemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-384", "event": [{"trigger": "precipitate", "type": "adverse_event", "arguments": [{"name": "some susceptible patients", "role": "Subject"}, {"name": "Schneiderian first-rank symptoms", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-385", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "an elderly woman", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "thoracic aortic dissection", "role": "Effect"}, {"name": "Warfarin", "role": "Treatment"}, {"name": "Warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-386", "event": [{"trigger": "adverse effect", "type": "adverse_event", "arguments": [{"name": "first report of an adverse effect of fetal renal circulation", "role": "Subject"}, {"name": "fetal renal circulation", "role": "Effect"}, {"name": "maternal ingestion of nimesulide", "role": "Treatment"}, {"name": "nimesulide", "role": "Treatment"}, {"name": "nimesulide", "role": "Treatment.Drug"}, {"name": "maternal ingestion", "role": "Treatment.Route"}]}]}
{"id": "train-387", "event": [{"trigger": "over-anticoagulation", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "Diarrhea-associated over-anticoagulation", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-388", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 72-year-old white man", "role": "Subject"}, {"name": "72-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "combative behavior, refused to leave his room, stopped eating, and began falling to the floor", "role": "Effect"}, {"name": "6 weeks after being given ticlopidine", "role": "Treatment"}, {"name": "6 weeks", "role": "Treatment.Time_elapsed"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-389", "event": [{"trigger": "give rise", "type": "adverse_event", "arguments": [{"name": "in the same patient,", "role": "Subject"}, {"name": "wide range of skin disturbances, which in many cases do not break out until long after the drug has been withdrawn", "role": "Effect"}, {"name": "gold", "role": "Treatment"}, {"name": "gold", "role": "Treatment.Drug"}]}]}
{"id": "train-390", "event": [{"trigger": "considered", "type": "adverse_event", "arguments": [{"name": "Lithium neurotoxicity", "role": "Effect"}, {"name": "Lithium", "role": "Treatment"}, {"name": "Creutzfeldt-Jakob disease", "role": "Treatment.Disorder"}, {"name": "Lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-391", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "neuroleptic malignant syndrome", "role": "Effect"}, {"name": "amitriptyline and lithium carbonate", "role": "Treatment"}, {"name": "amitriptyline", "role": "Treatment.Drug"}, {"name": "lithium carbonate", "role": "Treatment.Drug"}, {"name": "amitriptyline", "role": "Combination.Drug"}, {"name": "lithium carbonate", "role": "Combination.Drug"}]}]}
{"id": "train-392", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "soft-tissue injury", "role": "Effect"}, {"name": "intravenous administration of phenytoin", "role": "Treatment"}, {"name": "intravenous administration", "role": "Treatment.Route"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-393", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "liver injury is insidious and temporally variable", "role": "Effect"}, {"name": "troglitazone", "role": "Treatment"}, {"name": "troglitazone", "role": "Treatment.Drug"}]}]}
{"id": "train-394", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "symptoms resembling Parkinson's disease", "role": "Effect"}, {"name": "chlorpromazine", "role": "Treatment"}, {"name": "chlorpromazine", "role": "Treatment.Drug"}]}]}
{"id": "train-395", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "increase the risk of lovastatin-induced rhabdomyolysis", "role": "Effect"}, {"name": "Erythromycin", "role": "Treatment"}, {"name": "Erythromycin", "role": "Treatment.Drug"}, {"name": "lovastatin", "role": "Treatment.Drug"}, {"name": "lovastatin", "role": "Combination.Drug"}, {"name": "Erythromycin", "role": "Combination.Drug"}]}]}
{"id": "train-396", "event": [{"trigger": "receive", "type": "potential_therapeutic_event", "arguments": [{"name": "A 23-year-old white male patient", "role": "Subject"}, {"name": "23-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "male", "role": "Subject.Gender"}, {"name": "intravenous chemotherapy", "role": "Treatment"}, {"name": "chemotherapy", "role": "Treatment.Drug"}, {"name": "acute myelogenous leukemia", "role": "Treatment.Disorder"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-397", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two children with acute lymphocytic leukemia", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "leukoencephalopathy", "role": "Effect"}, {"name": "administration of a combination of intravenous ara = C and methotrexate during the consolidation phase of chemotherapy", "role": "Treatment"}, {"name": "acute lymphocytic leukemia", "role": "Treatment.Disorder"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "ara = C", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "ara = C", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}]}]}
{"id": "train-398", "event": [{"trigger": "complicating", "type": "adverse_event", "arguments": [{"name": "a breast cancer patient with an impaired renal function", "role": "Subject"}, {"name": "an impaired renal function", "role": "Subject.Disorder"}, {"name": "anuria", "role": "Effect"}, {"name": "high dose ifosfamide chemotherapy", "role": "Treatment"}, {"name": "breast cancer", "role": "Treatment.Disorder"}, {"name": "ifosfamide", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}, {"name": "high dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-399", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a delayed, severe maculopathy", "role": "Effect"}, {"name": "Low dosages of quinacrine used for malaria prophylaxis", "role": "Treatment"}, {"name": "delayed", "role": "Treatment.Time_elapsed"}, {"name": "Low dosages", "role": "Treatment.Dosage"}, {"name": "quinacrine", "role": "Treatment.Drug"}, {"name": "malaria prophylaxis", "role": "Treatment.Disorder"}]}]}
{"id": "train-400", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "patients with coronary artery disease or renal dysfunction,", "role": "Subject"}, {"name": "coronary artery disease", "role": "Subject.Disorder"}, {"name": "renal dysfunction", "role": "Subject.Disorder"}, {"name": "life-threatening arrhythmias", "role": "Effect"}, {"name": "pilsicainide", "role": "Treatment"}, {"name": "pilsicainide", "role": "Treatment.Drug"}]}]}
{"id": "train-401", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "severe aplastic anemia (AA)", "role": "Effect"}, {"name": "lenalidomide", "role": "Treatment"}, {"name": "lenalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-402", "event": [{"trigger": "subsequent to", "type": "adverse_event", "arguments": [{"name": "a patient with typhoid fever", "role": "Subject"}, {"name": "hypersensitivity reaction", "role": "Effect"}, {"name": "the infusion of chloramphenicol sodium succinate", "role": "Treatment"}, {"name": "typhoid fever", "role": "Treatment.Disorder"}, {"name": "chloramphenicol sodium succinate", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-403", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "asthma", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-404", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Four cases", "role": "Subject"}, {"name": "Four", "role": "Subject.Population"}, {"name": "adverse experiences", "role": "Effect"}, {"name": "clonidine", "role": "Treatment"}, {"name": "clonidine", "role": "Treatment.Drug"}]}]}
{"id": "train-405", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "reversible nonthrombocytopenic palpable purpura", "role": "Effect"}, {"name": "metoclopramide", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-406", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Three patients", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "bilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia", "role": "Effect"}, {"name": "received respectively 190 mg, 175 mg, and 196 mg of methotrexate", "role": "Treatment"}, {"name": "190 mg", "role": "Treatment.Dosage"}, {"name": "175 mg", "role": "Treatment.Dosage"}, {"name": "196 mg", "role": "Treatment.Dosage"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-407", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "SIADH and possibly hypokalemia", "role": "Effect"}, {"name": "vinorelbine", "role": "Treatment"}, {"name": "vinorelbine", "role": "Treatment.Drug"}]}]}
{"id": "train-408", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "a 34-year-old man", "role": "Subject"}, {"name": "34-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "acute liver and renal failure", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "less than 2.5 grams a day of acetaminophen", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "acetaminophen", "role": "Treatment.Drug"}, {"name": "complex partial seizures", "role": "Treatment.Disorder"}, {"name": "less than 2.5 grams", "role": "Treatment.Dosage"}, {"name": "a day", "role": "Treatment.Freq"}, {"name": "acetaminophen", "role": "Combination.Drug"}, {"name": "carbamazepine", "role": "Combination.Drug"}]}]}
{"id": "train-409", "event": [{"trigger": "appeared", "type": "adverse_event", "arguments": [{"name": "Fever and maculopapular rashes", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "10 days", "role": "Treatment.Time_elapsed"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-410", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two cases of systemic scleroderma with polymyositis", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "drug eruption", "role": "Effect"}, {"name": "AZA", "role": "Treatment"}, {"name": "AZA", "role": "Treatment.Drug"}, {"name": "systemic scleroderma with polymyositis", "role": "Treatment.Disorder"}]}]}
{"id": "train-411", "event": [{"trigger": "Safety aspects", "type": "adverse_event", "arguments": [{"name": "liver function", "role": "Effect"}, {"name": "coumarin-troxerutin combination", "role": "Treatment"}, {"name": "coumarin", "role": "Treatment.Drug"}, {"name": "troxerutin", "role": "Treatment.Drug"}, {"name": "troxerutin", "role": "Combination.Drug"}, {"name": "coumarin", "role": "Combination.Drug"}]}]}
{"id": "train-412", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "Vogt-Koyanagi-Harada disease", "role": "Effect"}, {"name": "interferon alpha", "role": "Treatment"}, {"name": "interferon alpha", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-413", "event": [{"trigger": "exert", "type": "adverse_event", "arguments": [{"name": "healthy humans", "role": "Subject"}, {"name": "additive ocular and renal vasodilator effects", "role": "Effect"}, {"name": "Glucose and insulin", "role": "Treatment"}, {"name": "Glucose", "role": "Treatment.Drug"}, {"name": "insulin", "role": "Treatment.Drug"}, {"name": "Glucose", "role": "Combination.Drug"}, {"name": "insulin", "role": "Combination.Drug"}]}]}
{"id": "train-414", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two patients with osteomyelitis", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "reversible cholestatic jaundice", "role": "Effect"}, {"name": "oxacillin", "role": "Treatment"}, {"name": "osteomyelitis", "role": "Treatment.Disorder"}, {"name": "oxacillin", "role": "Treatment.Drug"}]}]}
{"id": "train-415", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 49-year-old man", "role": "Subject"}, {"name": "49-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "psychosis", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "250 mg bid", "role": "Treatment.Dosage"}]}]}
{"id": "train-416", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "obsessive-compulsive patient", "role": "Subject"}, {"name": "akathisia", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "obsessive-compulsive", "role": "Treatment.Disorder"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-417", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "keratitis", "role": "Effect"}, {"name": "methamphetamine", "role": "Treatment"}, {"name": "methamphetamine", "role": "Treatment.Drug"}]}]}
{"id": "train-418", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Pulmonary oedema", "role": "Effect"}, {"name": "hexoprenaline", "role": "Treatment"}, {"name": "preterm labour", "role": "Treatment.Disorder"}, {"name": "hexoprenaline", "role": "Treatment.Drug"}]}]}
{"id": "train-419", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "Venlafaxine", "role": "Treatment"}, {"name": "Venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-420", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patients with rheumatoid arthritis and psoriatic arthritis", "role": "Subject"}, {"name": "pneumonitis", "role": "Effect"}, {"name": "Methotrexate", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "psoriatic arthritis", "role": "Treatment.Disorder"}, {"name": "Methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-421", "event": [{"trigger": "because", "type": "adverse_event", "arguments": [{"name": "leukopenia", "role": "Effect"}, {"name": "carbamazepine 200 mg four times daily", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "200 mg", "role": "Treatment.Dosage"}, {"name": "four times daily", "role": "Treatment.Freq"}]}]}
{"id": "train-422", "event": [{"trigger": "attributable", "type": "adverse_event", "arguments": [{"name": "fibrotic lesions", "role": "Effect"}, {"name": "bleomycin or cyclophosphamide", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}]}]}
{"id": "train-423", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "hemolytic-uremic syndrome", "role": "Effect"}, {"name": "during the 4th cycle of combination chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin", "role": "Treatment"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}, {"name": "fluorouracil", "role": "Treatment.Drug"}, {"name": "leucovorin", "role": "Treatment.Drug"}]}]}
{"id": "train-424", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "lung cancer patient with bronquiloalveolar carcinoma (BAC)", "role": "Subject"}, {"name": "producing severe respiratory insufficiency, and simulating a progression of the tumor", "role": "Effect"}, {"name": "BOOP", "role": "Effect"}, {"name": "chemotherapy with docetaxel and gemcitabine", "role": "Treatment"}, {"name": "lung cancer", "role": "Treatment.Disorder"}, {"name": "bronquiloalveolar carcinoma (BAC)", "role": "Treatment.Disorder"}, {"name": "docetaxel", "role": "Treatment.Drug"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}, {"name": "docetaxel", "role": "Combination.Drug"}, {"name": "gemcitabine", "role": "Combination.Drug"}]}]}
{"id": "train-425", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Relapse in the external auditory canal of acute promyelocytic leukemia", "role": "Effect"}, {"name": "treatment with all-trans retinoic acid", "role": "Treatment"}, {"name": "all-trans retinoic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-426", "event": [{"trigger": "induced by", "type": "adverse_event", "arguments": [{"name": "Acute neutrophilic dermatosis", "role": "Effect"}, {"name": "all-trans-retinoic acid", "role": "Treatment"}, {"name": "acute promyelocytic leukemia", "role": "Treatment.Disorder"}, {"name": "all-trans-retinoic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-427", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a schizophrenic patient", "role": "Subject"}, {"name": "neuroleptic malignant syndrome", "role": "Effect"}, {"name": "Fluphenazine", "role": "Treatment"}, {"name": "Fluphenazine", "role": "Treatment.Drug"}, {"name": "schizophrenic", "role": "Treatment.Disorder"}]}]}
{"id": "train-428", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute interstitial nephritis", "role": "Effect"}, {"name": "tyrosine kinase inhibitor sunitinib", "role": "Treatment"}, {"name": "sunitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-429", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "two women", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "HUS", "role": "Effect"}, {"name": "massive pulmonary bleeding", "role": "Effect"}, {"name": "MMC", "role": "Treatment"}, {"name": "MMC", "role": "Treatment.Drug"}]}]}
{"id": "train-430", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "a 57-year-old woman", "role": "Subject"}, {"name": "57-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "Alternating sinus rhythm and intermittent sinoatrial (S-A) block", "role": "Effect"}, {"name": "80 mg propranolol daily.", "role": "Treatment"}, {"name": "80 mg", "role": "Treatment.Dosage"}, {"name": "propranolol", "role": "Treatment.Drug"}, {"name": "daily", "role": "Treatment.Freq"}, {"name": "angina", "role": "Treatment.Disorder"}]}]}
{"id": "train-431", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "5-aminosalicylic acid", "role": "Treatment"}, {"name": "5-aminosalicylic acid", "role": "Treatment.Drug"}, {"name": "long term", "role": "Treatment.Duration"}]}]}
{"id": "train-432", "event": [{"trigger": "taking", "type": "potential_therapeutic_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "amphetamine-dextroamphetamine (Adderall)", "role": "Treatment"}, {"name": "ADHD", "role": "Treatment.Disorder"}, {"name": "amphetamine-dextroamphetamine", "role": "Treatment.Drug"}]}]}
{"id": "train-433", "event": [{"trigger": "diagnosed", "type": "adverse_event", "arguments": [{"name": "her eruption as contact dermatitis", "role": "Effect"}, {"name": "sodium bisulfite", "role": "Treatment"}, {"name": "sodium bisulfite", "role": "Treatment.Drug"}]}]}
{"id": "train-434", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Macular infarction", "role": "Effect"}, {"name": "endophthalmitis treated with vitrectomy and intravitreal gentamicin", "role": "Treatment"}, {"name": "endophthalmitis", "role": "Treatment.Disorder"}, {"name": "vitrectomy and intravitreal", "role": "Treatment.Route"}, {"name": "gentamicin", "role": "Treatment.Drug"}]}]}
{"id": "train-435", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "women", "role": "Subject"}, {"name": "women", "role": "Subject.Gender"}, {"name": "endometrial disorders", "role": "Effect"}, {"name": "tamoxifen therapy", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-436", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "bleeding complication saved life", "role": "Effect"}, {"name": "Warfarin", "role": "Treatment"}, {"name": "Warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-437", "event": [{"trigger": "presents", "type": "adverse_event", "arguments": [{"name": "new case", "role": "Subject"}, {"name": "uveitis", "role": "Effect"}, {"name": "rifabutin", "role": "Treatment"}, {"name": "rifabutin", "role": "Treatment.Drug"}]}]}
{"id": "train-438", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "Acute abdomen due to endometriosis", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-439", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patients with acute exacerbation of collagen vascular diseases", "role": "Subject"}, {"name": "acute exacerbation of collagen vascular diseases", "role": "Subject.Disorder"}, {"name": "papular eruption", "role": "Effect"}, {"name": "Methotrexate", "role": "Treatment"}, {"name": "Methotrexate", "role": "Treatment.Drug"}, {"name": "shortly after", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-440", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "3 patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "amiodarone-induced thyrotoxicosis", "role": "Effect"}, {"name": "concomitant amiodarone and warfarin", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-441", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "NMB", "role": "Effect"}, {"name": "rocuronium", "role": "Treatment"}, {"name": "rocuronium", "role": "Treatment.Drug"}]}]}
{"id": "train-442", "event": [{"trigger": "appeared.", "type": "adverse_event", "arguments": [{"name": "All patients", "role": "Subject"}, {"name": "skin lesions", "role": "Effect"}, {"name": "phenytoin for variable time periods (range 16-80 days; mean: 40)", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "16-80 days;", "role": "Treatment.Duration"}, {"name": "40", "role": "Treatment.Duration"}]}]}
{"id": "train-443", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "extrapyramidal side effects", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-444", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "secondary hypothyroidism", "role": "Effect"}, {"name": "thyroid hormone withdrawal", "role": "Treatment"}, {"name": "thyroid hormone", "role": "Treatment.Drug"}]}]}
{"id": "train-445", "event": [{"trigger": "give", "type": "adverse_event", "arguments": [{"name": "toxicities", "role": "Effect"}, {"name": "concurrent viral infection", "role": "Effect"}, {"name": "valproic acid, lamotrigine, and phenytoin", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "valproic acid", "role": "Combination.Drug"}, {"name": "lamotrigine", "role": "Combination.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}]}]}
{"id": "train-446", "event": [{"trigger": "showed", "type": "adverse_event", "arguments": [{"name": "postprandial hyperglycemia", "role": "Effect"}, {"name": "betamethasone valerate cream 0.1%", "role": "Treatment"}, {"name": "betamethasone valerate", "role": "Treatment.Drug"}, {"name": "cream", "role": "Treatment.Route"}]}]}
{"id": "train-447", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypersensitivity reactions.", "role": "Effect"}, {"name": "Phenytoin", "role": "Treatment"}, {"name": "Phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-448", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 54-year-old man", "role": "Subject"}, {"name": "complex partial seizures related to a glioblastoma multiforme brain tumor", "role": "Subject"}, {"name": "54-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "glioblastoma multiforme brain tumor", "role": "Subject.Disorder"}, {"name": "TEN", "role": "Effect"}, {"name": "4 weeks after beginning lamotrigine", "role": "Treatment"}, {"name": "4 weeks", "role": "Treatment.Time_elapsed"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "complex partial seizures", "role": "Treatment.Disorder"}]}]}
{"id": "train-449", "event": [{"trigger": "for", "type": "adverse_event", "arguments": [{"name": "acute hepatitis", "role": "Effect"}, {"name": "ketoconazole", "role": "Treatment"}, {"name": "ketoconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-450", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "Optic neuropathy", "role": "Effect"}, {"name": "D-penicillamine for about 1 year", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}, {"name": "1 year", "role": "Treatment.Duration"}]}]}
{"id": "train-451", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Stupor", "role": "Effect"}, {"name": "fast activity on electroencephalography", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-452", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "palmar pruritus, urticaria, and edema", "role": "Effect"}, {"name": "cisplatin 100 mg/m2 over 30 minutes", "role": "Treatment"}, {"name": "30 minutes", "role": "Treatment.Time_elapsed"}, {"name": "100 mg/m2", "role": "Treatment.Dosage"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-453", "event": [{"trigger": "showed", "type": "adverse_event", "arguments": [{"name": "a patient with infectious mononucleosis", "role": "Subject"}, {"name": "rash", "role": "Effect"}, {"name": "cephalexin", "role": "Treatment"}, {"name": "cephalexin", "role": "Treatment.Drug"}, {"name": "infectious mononucleosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-454", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "her", "role": "Subject"}, {"name": "her", "role": "Subject.Gender"}, {"name": "headache, confusion, and \"gray areas\" in her vision, without abnormal ophthalmologic findings", "role": "Effect"}, {"name": "After 1 week of nefazodone therapy", "role": "Treatment"}, {"name": "1 week", "role": "Treatment.Time_elapsed"}, {"name": "nefazodone", "role": "Treatment.Drug"}]}]}
{"id": "train-455", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity", "role": "Effect"}, {"name": "Nitrofurantoin", "role": "Treatment"}, {"name": "Nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-456", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "enuresis", "role": "Effect"}, {"name": "Methylphenidate", "role": "Treatment"}, {"name": "Methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-457", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "the first case", "role": "Subject"}, {"name": "fever", "role": "Effect"}, {"name": "low-dose amifostine", "role": "Treatment"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "amifostine", "role": "Treatment.Drug"}]}]}
{"id": "train-458", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypoglycemia", "role": "Effect"}, {"name": "rebound hyperglycemia", "role": "Effect"}, {"name": "Administration of excessive insulin", "role": "Treatment"}, {"name": "insulin", "role": "Treatment.Drug"}, {"name": "excessive", "role": "Treatment.Dosage"}, {"name": "4 to 8 hours", "role": "Treatment.Duration"}]}]}
{"id": "train-459", "event": [{"trigger": "started", "type": "adverse_event", "arguments": [{"name": "symptoms of autonomic instability and severe agitation", "role": "Effect"}, {"name": "within hours of initiation of cyclobenzaprine", "role": "Treatment"}, {"name": "cyclobenzaprine", "role": "Treatment.Drug"}, {"name": "within hours of initiation", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-460", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a child with neuroblastoma", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Secondary leukemia", "role": "Effect"}, {"name": "oral etoposide", "role": "Treatment"}, {"name": "neuroblastoma", "role": "Treatment.Disorder"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "etoposide", "role": "Treatment.Drug"}]}]}
{"id": "train-461", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "multiple organ failure", "role": "Effect"}, {"name": "Atorvastatin", "role": "Treatment"}, {"name": "Atorvastatin", "role": "Treatment.Drug"}]}]}
{"id": "train-462", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "SSIRs", "role": "Treatment"}, {"name": "SSIRs", "role": "Treatment.Drug"}]}]}
{"id": "train-463", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 73-year-old woman with non-Hodgkin's lymphoma", "role": "Subject"}, {"name": "73-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "two episodes of severe, bilateral, sensori-neural hearing loss", "role": "Effect"}, {"name": "vincristine therapy", "role": "Treatment"}, {"name": "vincristine", "role": "Treatment.Drug"}, {"name": "non-Hodgkin's lymphoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-464", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "an advanced ovarian cancer patient", "role": "Subject"}, {"name": "Severe hemolytic uremic syndrome", "role": "Effect"}, {"name": "carboplatin and gemcitabine", "role": "Treatment"}, {"name": "ovarian cancer", "role": "Treatment.Disorder"}, {"name": "carboplatin", "role": "Treatment.Drug"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "carboplatin", "role": "Combination.Drug"}, {"name": "gemcitabine", "role": "Combination.Drug"}]}]}
{"id": "train-465", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Ulcerative proctitis in juvenile systemic lupus erythematosus", "role": "Effect"}, {"name": "ibuprofen", "role": "Treatment"}, {"name": "ibuprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-466", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Acute asthma", "role": "Effect"}, {"name": "sustained-release verapamil", "role": "Treatment"}, {"name": "sustained-release verapamil", "role": "Treatment.Drug"}]}]}
{"id": "train-467", "event": [{"trigger": "implicate", "type": "adverse_event", "arguments": [{"name": "three patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "renal insufficiency", "role": "Effect"}, {"name": "seizures", "role": "Effect"}, {"name": "accumulation of ofloxacin", "role": "Treatment"}, {"name": "ofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-468", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Hemolytic uremic syndrome", "role": "Effect"}, {"name": "cis-platinum, vinblastine and bleomycin", "role": "Treatment"}, {"name": "cis-platinum", "role": "Treatment.Drug"}, {"name": "vinblastine", "role": "Treatment.Drug"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-469", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "15 patients", "role": "Subject"}, {"name": "15", "role": "Subject.Population"}, {"name": "acute hemoglobinemia or hemoglobinuria", "role": "Effect"}, {"name": "anti-D IGIV", "role": "Treatment"}, {"name": "ITP or secondary thrombocytopenia", "role": "Treatment.Disorder"}, {"name": "anti-D IGIV", "role": "Treatment.Drug"}, {"name": "administration", "role": "Treatment.Route"}]}]}
{"id": "train-470", "event": [{"trigger": "was discontinued,", "type": "potential_therapeutic_event", "arguments": [{"name": "thyrotoxicosis gradually abated", "role": "Effect"}, {"name": "Amiodarone", "role": "Treatment"}, {"name": "Amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-471", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "De novo absence status of late onset", "role": "Effect"}, {"name": "withdrawal of lorazepam", "role": "Treatment"}, {"name": "lorazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-472", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "two HIV-infected adolescent males", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "adolescent", "role": "Subject.Age"}, {"name": "males", "role": "Subject.Gender"}, {"name": "nephrotoxicity", "role": "Effect"}, {"name": "Tenofovir", "role": "Treatment"}, {"name": "Tenofovir", "role": "Treatment.Drug"}, {"name": "HIV-infected", "role": "Treatment.Disorder"}]}]}
{"id": "train-473", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "colonic perforation", "role": "Effect"}, {"name": "calcium polystyrene sulfonate", "role": "Treatment"}, {"name": "sorbitol", "role": "Treatment"}, {"name": "calcium polystyrene sulfonate", "role": "Treatment.Drug"}, {"name": "sorbitol", "role": "Treatment.Drug"}, {"name": "the administration", "role": "Treatment.Route"}, {"name": "calcium polystyrene sulfonate", "role": "Combination.Drug"}, {"name": "sorbitol", "role": "Combination.Drug"}]}]}
{"id": "train-474", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "neurotoxic effects", "role": "Effect"}, {"name": "ofloxacin", "role": "Treatment"}, {"name": "ofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-475", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Atypical neuroleptic malignant syndrome", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-476", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychiatrically ill patients with hepatitis C.", "role": "Subject"}, {"name": "psychiatrically ill", "role": "Subject.Disorder"}, {"name": "psychosis", "role": "Effect"}, {"name": "interferon", "role": "Treatment"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "hepatitis C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-477", "event": [{"trigger": "caution", "type": "adverse_event", "arguments": [{"name": "patients with early unruptured tubal pregnancy", "role": "Subject"}, {"name": "systemic toxicity", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "early unruptured tubal pregnancy", "role": "Treatment.Disorder"}]}]}
{"id": "train-478", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "cataract", "role": "Effect"}, {"name": "intravitreal injection of triamcinolone acetonide", "role": "Treatment"}, {"name": "intravitreal injection", "role": "Treatment.Route"}, {"name": "triamcinolone acetonide", "role": "Treatment.Drug"}]}]}
{"id": "train-479", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute endophthalmitis", "role": "Effect"}, {"name": "intravitreal bevacizumab (Avastin) injection", "role": "Treatment"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "bevacizumab", "role": "Treatment.Drug"}]}]}
{"id": "train-480", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "bullous eruption,", "role": "Effect"}, {"name": "starting nicardipine and lercanidipine.", "role": "Treatment"}, {"name": "one month", "role": "Treatment.Time_elapsed"}, {"name": "nicardipine", "role": "Treatment.Drug"}, {"name": "lercanidipine", "role": "Treatment.Drug"}, {"name": "nicardipine", "role": "Combination.Drug"}, {"name": "lercanidipine", "role": "Combination.Drug"}]}]}
{"id": "train-481", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Pulmonary fibrosis", "role": "Effect"}, {"name": "nabumetone", "role": "Treatment"}, {"name": "nabumetone", "role": "Treatment.Drug"}]}]}
{"id": "train-482", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "disseminated cryptococcosis", "role": "Effect"}, {"name": "tumor necrosis factor (TNF)-alpha inhibitors", "role": "Treatment"}, {"name": "tumor necrosis factor (TNF)-alpha inhibitors", "role": "Treatment.Drug"}]}]}
{"id": "train-483", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "conduction disorder", "role": "Effect"}, {"name": "propranolol", "role": "Treatment"}, {"name": "propranolol", "role": "Treatment.Drug"}]}]}
{"id": "train-484", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "6-week-old infant with Escherichia coli sepsis", "role": "Subject"}, {"name": "6-week-old", "role": "Subject.Age"}, {"name": "infant", "role": "Subject.Age"}, {"name": "TEN", "role": "Effect"}, {"name": "received ampicillin and other antibiotics", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}, {"name": "other antibiotics", "role": "Treatment.Drug"}, {"name": "Escherichia coli sepsis", "role": "Treatment.Disorder"}, {"name": "ampicillin", "role": "Combination.Drug"}, {"name": "other antibiotics", "role": "Combination.Drug"}]}]}
{"id": "train-485", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "case", "role": "Subject"}, {"name": "bilateral anterior uveitis", "role": "Effect"}, {"name": "ovulation induction therapy using clomiphene citrate", "role": "Treatment"}, {"name": "clomiphene citrate", "role": "Treatment.Drug"}]}]}
{"id": "train-486", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A 57-year-old woman", "role": "Subject"}, {"name": "57-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "dysphagia for solids", "role": "Effect"}, {"name": "nifedipine", "role": "Treatment"}, {"name": "6 months", "role": "Treatment.Time_elapsed"}, {"name": "nifedipine", "role": "Treatment.Drug"}]}]}
{"id": "train-487", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "anticonvulsant hypersensitivity syndrome", "role": "Effect"}, {"name": "combinations of belladonna, ergotamine, and phenobarbital", "role": "Treatment"}, {"name": "belladonna", "role": "Treatment.Drug"}, {"name": "ergotamine", "role": "Treatment.Drug"}, {"name": "phenobarbital", "role": "Treatment.Drug"}, {"name": "menopausal symptoms", "role": "Treatment.Disorder"}, {"name": "belladonna", "role": "Combination.Drug"}, {"name": "ergotamine", "role": "Combination.Drug"}, {"name": "phenobarbital", "role": "Combination.Drug"}]}]}
{"id": "train-488", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hepatitis, acute renal failure, hemolytic anemia, and thrombocytopenia", "role": "Effect"}, {"name": "Rifampin", "role": "Treatment"}, {"name": "Rifampin", "role": "Treatment.Drug"}]}]}
{"id": "train-489", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "cholestasis", "role": "Effect"}, {"name": "azathioprine", "role": "Treatment"}, {"name": "azathioprine", "role": "Treatment.Drug"}]}]}
{"id": "train-490", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression", "role": "Effect"}, {"name": "methanol", "role": "Treatment"}, {"name": "methanol", "role": "Treatment.Drug"}]}]}
{"id": "train-491", "event": [{"trigger": "receive", "type": "potential_therapeutic_event", "arguments": [{"name": "Patients with inoperable or metastatic colorectal cancer", "role": "Subject"}, {"name": "monthly FU 400 mg/m2/day plus LV 20 mg/m2/day as intravenous push daily for five days", "role": "Treatment"}, {"name": "metastatic colorectal cancer", "role": "Treatment.Disorder"}, {"name": "inoperable", "role": "Treatment.Disorder"}, {"name": "400 mg/m2/day", "role": "Treatment.Dosage"}, {"name": "20 mg/m2/day", "role": "Treatment.Dosage"}, {"name": "FU", "role": "Treatment.Drug"}, {"name": "LV", "role": "Treatment.Drug"}, {"name": "intravenous push", "role": "Treatment.Route"}, {"name": "daily", "role": "Treatment.Freq"}, {"name": "monthly", "role": "Treatment.Freq"}, {"name": "five days", "role": "Treatment.Duration"}, {"name": "FU", "role": "Combination.Drug"}, {"name": "LV", "role": "Combination.Drug"}]}]}
{"id": "train-492", "event": [{"trigger": "induces", "type": "adverse_event", "arguments": [{"name": "carbamazepine", "role": "Subject"}, {"name": "increased plasma carbamazepine concentrations", "role": "Effect"}, {"name": "carbamazepine toxicity.", "role": "Effect"}, {"name": "clarithromycin", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}]}]}
{"id": "train-493", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 33-yr-old male patient with history of chronic hepatitis B.", "role": "Subject"}, {"name": "33-yr-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "polymyositis and cardiomyopathy", "role": "Effect"}, {"name": "interferon alpha", "role": "Treatment"}, {"name": "interferon alpha", "role": "Treatment.Drug"}, {"name": "history of chronic hepatitis B.", "role": "Treatment.Disorder"}]}]}
{"id": "train-494", "event": [{"trigger": "leading", "type": "adverse_event", "arguments": [{"name": "elderly residents", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "opioids", "role": "Treatment"}, {"name": "serotonergic antidepressants", "role": "Treatment"}, {"name": "opioids", "role": "Treatment.Drug"}, {"name": "serotonergic antidepressants", "role": "Treatment.Drug"}, {"name": "opioids", "role": "Combination.Drug"}, {"name": "serotonergic antidepressants", "role": "Combination.Drug"}]}]}
{"id": "train-495", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Erythema multiforme bullosum", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-496", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with acute leukemia", "role": "Subject"}, {"name": "Horner's syndrome and a severe demyelinating peripheral neuropathy leading to death", "role": "Effect"}, {"name": "high-dose cytosine arabinoside.", "role": "Treatment"}, {"name": "acute leukemia", "role": "Treatment.Disorder"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-497", "event": [{"trigger": "trigger", "type": "adverse_event", "arguments": [{"name": "behavioral side effects or exacerbation of preexisting maladaptive behaviors", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-498", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "patients with chronic hepatitis C.", "role": "Subject"}, {"name": "Retinal abnormalities, including retinal hemorrhage and \"cotton-wool\" spots", "role": "Effect"}, {"name": "interferon", "role": "Treatment"}, {"name": "8 weeks", "role": "Treatment.Time_elapsed"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-499", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pneumonitis", "role": "Effect"}, {"name": "Rapamycin/sirolimus", "role": "Treatment"}, {"name": "Rapamycin", "role": "Treatment.Drug"}, {"name": "sirolimus", "role": "Treatment.Drug"}, {"name": "Rapamycin", "role": "Combination.Drug"}, {"name": "sirolimus", "role": "Combination.Drug"}]}]}
{"id": "train-500", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "recurrence of Graves' disease", "role": "Effect"}, {"name": "IFNalpha", "role": "Treatment"}, {"name": "ten years after thyroidectomy", "role": "Treatment"}, {"name": "chronic viral hepatitis C.", "role": "Treatment.Disorder"}, {"name": "IFNalpha", "role": "Treatment.Drug"}]}]}
{"id": "train-501", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "respiratory dyskinesia", "role": "Effect"}, {"name": "Risperidone", "role": "Treatment"}, {"name": "Risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-502", "event": [{"trigger": "reported,", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Paralytic ileus", "role": "Effect"}, {"name": "bortezomib treatment", "role": "Treatment"}, {"name": "bortezomib", "role": "Treatment.Drug"}]}]}
{"id": "train-503", "event": [{"trigger": "induced by", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "mirtazapine monotherapy", "role": "Treatment"}, {"name": "mirtazapine", "role": "Treatment.Drug"}]}]}
{"id": "train-504", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "polyuria and polydipsia and was found to have severe hyperglycemia, which led to the diagnosis of Cushing syndrome", "role": "Effect"}, {"name": "Three days after starting fluconazole", "role": "Treatment"}, {"name": "fluconazole", "role": "Treatment.Drug"}, {"name": "Three days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-505", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "hypocalcemic tetany", "role": "Effect"}, {"name": "fleet phospho-soda", "role": "Treatment"}, {"name": "alendronate sodium", "role": "Treatment"}, {"name": "fleet phospho-soda", "role": "Treatment.Drug"}, {"name": "alendronate sodium", "role": "Treatment.Drug"}]}]}
{"id": "train-506", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "leukoencephalopathy", "role": "Effect"}, {"name": "levamisole", "role": "Treatment"}, {"name": "levamisole", "role": "Treatment.Drug"}]}]}
{"id": "train-507", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "in five patients with thalassemia intermedia", "role": "Subject"}, {"name": "five", "role": "Subject.Population"}, {"name": "increases in total Hb and decreased transfusion needs", "role": "Effect"}, {"name": "HU alone or in combination with SPB", "role": "Treatment"}, {"name": "HU", "role": "Treatment.Drug"}, {"name": "SPB", "role": "Treatment.Drug"}, {"name": "thalassemia intermedia", "role": "Treatment.Disorder"}, {"name": "HU", "role": "Combination.Drug"}, {"name": "SPB", "role": "Combination.Drug"}]}]}
{"id": "train-508", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "enoxaparin", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-509", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "hepatolithiasis", "role": "Effect"}, {"name": "octreotide", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}]}]}
{"id": "train-510", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thyrotoxicosis (AIT)", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-511", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Six patients with no previous signs or symptoms suggestive of coronary artery disease", "role": "Subject"}, {"name": "Six", "role": "Subject.Population"}, {"name": "acute coronary ischemia/infarction", "role": "Effect"}, {"name": "cis-diamine-dichloroplatinum II (cisplatin) -based chemotherapy", "role": "Treatment"}, {"name": "cis-diamine-dichloroplatinum II", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-512", "event": [{"trigger": "resulted", "type": "adverse_event", "arguments": [{"name": "all 3 women", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "a decrease in serum testosterone concentrations", "role": "Effect"}, {"name": "Replacing valproate with lamotrigine", "role": "Treatment"}, {"name": "lamotrigine", "role": "Treatment.Drug"}]}]}
{"id": "train-513", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "A 65-year-old woman, in the intensive care unit because of septic shock and acute renal failure", "role": "Subject"}, {"name": "septic shock", "role": "Subject.Disorder"}, {"name": "acute renal failure", "role": "Subject.Disorder"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "small-bowel obstruction", "role": "Effect"}, {"name": "concretions", "role": "Effect"}, {"name": "Amphojel", "role": "Treatment"}, {"name": "Amphojel", "role": "Treatment.Drug"}]}]}
{"id": "train-514", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "syncope", "role": "Effect"}, {"name": "atrioventricular block", "role": "Effect"}, {"name": "oral dose of propranolol", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "propranolol", "role": "Treatment.Drug"}]}]}
{"id": "train-515", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an advanced hepatocellular carcinoma patient", "role": "Subject"}, {"name": "tumor lysis syndrome", "role": "Effect"}, {"name": "Sorafenib", "role": "Treatment"}, {"name": "Sorafenib", "role": "Treatment.Drug"}, {"name": "hepatocellular carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-516", "event": [{"trigger": "effective", "type": "potential_therapeutic_event", "arguments": [{"name": "The symptoms did not recur", "role": "Effect"}, {"name": "the 36 months of itraconazole treatment after discharge", "role": "Treatment"}, {"name": "A. flavus hypertrophic pachymeningitis", "role": "Treatment.Disorder"}, {"name": "36 months", "role": "Treatment.Duration"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-517", "event": [{"trigger": "provides", "type": "potential_therapeutic_event", "arguments": [{"name": "postmenopausal patients", "role": "Subject"}, {"name": "postmenopausal", "role": "Subject.Disorder"}, {"name": "improved clinical benefit in the adjuvant treatment", "role": "Effect"}, {"name": "the concomitant or the sequential addition of tamoxifen to chemotherapy", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}, {"name": "breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-518", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "Increased libido", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-519", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "acute interstitial nephritis with renal failure and exfoliative dermatitis", "role": "Effect"}, {"name": "ampicillin therapy", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-520", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Severe symptoms associated with serotonin toxicity", "role": "Effect"}, {"name": "linezolid and selected serotonin reuptake inhibitors", "role": "Treatment"}, {"name": "serotonin", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "serotonin reuptake inhibitors", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "serotonin reuptake inhibitors", "role": "Combination.Drug"}]}]}
{"id": "train-521", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "colon cancer patient who suffered severe mucositis, desquamating dermatitis, prolonged myelosuppression, and neurologic toxicity that required admission to the intensive care unit", "role": "Subject"}, {"name": "mucositis", "role": "Subject.Disorder"}, {"name": "desquamating dermatitis", "role": "Subject.Disorder"}, {"name": "myelosuppression", "role": "Subject.Disorder"}, {"name": "neurologic toxicity", "role": "Subject.Disorder"}, {"name": "side effects", "role": "Effect"}, {"name": "5-FU", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "colon cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-522", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "organic brain syndromes", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "when serum lithium levels are within or close to the therapeutic range", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-523", "event": [{"trigger": "because", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "weight gain and uncontrolled diabetes", "role": "Effect"}, {"name": "olanzapine was discontinued", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-524", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thrombocytopenia and skin necrosis", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-525", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Gefitinib", "role": "Treatment"}, {"name": "advanced non-small-cell lung cancer", "role": "Treatment.Disorder"}, {"name": "Gefitinib", "role": "Treatment.Drug"}, {"name": "IRESSA", "role": "Treatment.Drug"}, {"name": "ZD1839", "role": "Treatment.Drug"}, {"name": "epidermal growth factor receptor tyrosine kinase inhibitor", "role": "Treatment.Drug"}]}]}
{"id": "train-526", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 4-year-old girl", "role": "Subject"}, {"name": "4-year-old", "role": "Subject.Age"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "stupor and electroencephalographic pattern of increased fast activity", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-527", "event": [{"trigger": "improved", "type": "potential_therapeutic_event", "arguments": [{"name": "all three patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "levodopa induced dyskinesia", "role": "Effect"}, {"name": "treatment with amantadine (400 mg/day, po)", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}, {"name": "400 mg/day", "role": "Treatment.Dosage"}]}]}
{"id": "train-528", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypomagnesemia and other electrolyte disorders", "role": "Effect"}, {"name": "Foscarnet", "role": "Treatment"}, {"name": "Foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-529", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "child with fatal pulmonary fibrosis", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "fatal pulmonary fibrosis", "role": "Effect"}, {"name": "BCNU therapy", "role": "Treatment"}, {"name": "BCNU", "role": "Treatment.Drug"}]}]}
{"id": "train-530", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 64-year-old man with schizophrenia", "role": "Subject"}, {"name": "64-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "myoclonic jerks", "role": "Effect"}, {"name": "higher doses of quetiapine", "role": "Treatment"}, {"name": "schizophrenia", "role": "Treatment.Disorder"}, {"name": "quetiapine", "role": "Treatment.Drug"}, {"name": "higher doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-531", "event": [{"trigger": "contributing", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "5-FU or its active metabolites (fluoro-beta-alanine)", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "fluoro-beta-alanine", "role": "Treatment.Drug"}]}]}
{"id": "train-532", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "reversible corneal edema", "role": "Effect"}, {"name": "Amantadine", "role": "Treatment"}, {"name": "Amantadine", "role": "Treatment.Drug"}]}]}
{"id": "train-533", "event": [{"trigger": "received", "type": "adverse_event", "arguments": [{"name": "several infants", "role": "Subject"}, {"name": "infants", "role": "Subject.Age"}, {"name": "gastric-outlet obstruction", "role": "Effect"}, {"name": "prostaglandin E1", "role": "Treatment"}, {"name": "prostaglandin E1", "role": "Treatment.Drug"}]}]}
{"id": "train-534", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "adverse central nervous system effects", "role": "Effect"}, {"name": "dizziness", "role": "Effect"}, {"name": "propafenone", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-535", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "patients with CF", "role": "Subject"}, {"name": "CF", "role": "Subject.Disorder"}, {"name": "Iatrogenic Cushing syndrome", "role": "Effect"}, {"name": "inhaled corticosteroids and CYP3A4 inhibitors", "role": "Treatment"}, {"name": "inhaled", "role": "Treatment.Route"}, {"name": "corticosteroids", "role": "Treatment.Drug"}, {"name": "CYP3A4 inhibitors", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Combination.Drug"}, {"name": "CYP3A4 inhibitors", "role": "Combination.Drug"}]}]}
{"id": "train-536", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with pemphigus vulgaris", "role": "Subject"}, {"name": "Red blood cell anemia", "role": "Effect"}, {"name": "mycophenolate mofetil and prednisone", "role": "Treatment"}, {"name": "pemphigus vulgaris", "role": "Treatment.Disorder"}, {"name": "mycophenolate mofetil", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "mycophenolate mofetil", "role": "Combination.Drug"}, {"name": "prednisone", "role": "Combination.Drug"}]}]}
{"id": "train-537", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "systemic lupus erythematosus", "role": "Effect"}, {"name": "interferon-gamma", "role": "Treatment"}, {"name": "interferon-gamma", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis.", "role": "Treatment.Disorder"}]}]}
{"id": "train-538", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "hyponatremia", "role": "Effect"}, {"name": "switching from citalopram to mirtazapine", "role": "Treatment"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "mirtazapine", "role": "Treatment.Drug"}, {"name": "5 months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-539", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a 7-year-old boy", "role": "Subject"}, {"name": "7-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "acute compromise of renal function", "role": "Effect"}, {"name": "hypotension", "role": "Effect"}, {"name": "ACE inhibitor lisinopril and the ARB losartan", "role": "Treatment"}, {"name": "lisinopril", "role": "Treatment.Drug"}, {"name": "losartan", "role": "Treatment.Drug"}, {"name": "lisinopril", "role": "Combination.Drug"}, {"name": "losartan", "role": "Combination.Drug"}]}]}
{"id": "train-540", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a male patient with advanced AIDS", "role": "Subject"}, {"name": "male", "role": "Subject.Gender"}, {"name": "hypercalcemia", "role": "Effect"}, {"name": "2 weeks after institution of rhGH therapy", "role": "Treatment"}, {"name": "advanced AIDS", "role": "Treatment.Disorder"}, {"name": "rhGH", "role": "Treatment.Drug"}, {"name": "2 weeks", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-541", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Both patients", "role": "Subject"}, {"name": "Both", "role": "Subject.Population"}, {"name": "falling backward", "role": "Effect"}, {"name": "bupropion", "role": "Treatment"}, {"name": "bupropion", "role": "Treatment.Drug"}]}]}
{"id": "train-542", "event": [{"trigger": "followed", "type": "adverse_event", "arguments": [{"name": "jaundice", "role": "Effect"}, {"name": "intravaginal administration of a mixture of furazolidone and nifuroxime", "role": "Treatment"}, {"name": "furazolidone", "role": "Treatment.Drug"}, {"name": "nifuroxime", "role": "Treatment.Drug"}, {"name": "intravaginal", "role": "Treatment.Route"}, {"name": "furazolidone", "role": "Combination.Drug"}, {"name": "nifuroxime", "role": "Combination.Drug"}]}]}
{"id": "train-543", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an erythematous and exfoliative rash", "role": "Effect"}, {"name": "temozolomide", "role": "Treatment"}, {"name": "temozolomide", "role": "Treatment.Drug"}]}]}
{"id": "train-544", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two cardiac patients with trisomy 21", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "cardiac", "role": "Subject.Disorder"}, {"name": "trisomy 21", "role": "Subject.Disorder"}, {"name": "bone marrow suppression", "role": "Effect"}, {"name": "Captopril", "role": "Treatment"}, {"name": "Captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-545", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A 65-year-old woman with angina pectoris", "role": "Subject"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "syncope", "role": "Effect"}, {"name": "sublingual ingestion of isosorbide dinitrate (5 mg)", "role": "Treatment"}, {"name": "angina pectoris", "role": "Treatment.Disorder"}, {"name": "sublingual ingestion", "role": "Treatment.Route"}, {"name": "isosorbide dinitrate", "role": "Treatment.Drug"}, {"name": "5 mg", "role": "Treatment.Dosage"}]}]}
{"id": "train-546", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "a mentally healthy man", "role": "Subject"}, {"name": "man", "role": "Subject.Gender"}, {"name": "short-lived, obsessional-like suicidal ideas and images", "role": "Effect"}, {"name": "ingestion of the anti-fungal drug ketoconazole", "role": "Treatment"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "ketoconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-547", "event": [{"trigger": "noted", "type": "adverse_event", "arguments": [{"name": "Flaccid quadriparesis", "role": "Effect"}, {"name": "vecuronium", "role": "Treatment"}, {"name": "vecuronium", "role": "Treatment.Drug"}]}]}
{"id": "train-548", "event": [{"trigger": "side effects", "type": "adverse_event", "arguments": [{"name": "conjunctiva-cornea intraepithelial neoplasia (CIN) of a patient that rejected any surgical procedure", "role": "Subject"}, {"name": "tumor side effects", "role": "Effect"}, {"name": "topical interferon (INF) alpha 2-beta", "role": "Treatment"}, {"name": "topical", "role": "Treatment.Route"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "alpha 2-beta", "role": "Treatment.Drug"}, {"name": "conjunctiva-cornea intraepithelial neoplasia", "role": "Treatment.Disorder"}]}]}
{"id": "train-549", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "skin necrosis", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-550", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "severe unilateral posterior scleritis", "role": "Effect"}, {"name": "zoledronic acid", "role": "Treatment"}, {"name": "zoledronic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-551", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis", "role": "Effect"}, {"name": "sertraline", "role": "Treatment"}, {"name": "sertraline", "role": "Treatment.Drug"}]}]}
{"id": "train-552", "event": [{"trigger": "provoked", "type": "adverse_event", "arguments": [{"name": "seizures as singular expression of central nervous toxicity", "role": "Effect"}, {"name": "L-asparaginase", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}]}]}
{"id": "train-553", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "patients with ovarian carcinoma", "role": "Subject"}, {"name": "Acute non-lymphocytic leukemia", "role": "Effect"}, {"name": "long-term treatment with Treosulfan (= dihydroxybusulfan)", "role": "Treatment"}, {"name": "Treosulfan", "role": "Treatment.Drug"}, {"name": "ovarian carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-554", "event": [{"trigger": "detect", "type": "adverse_event", "arguments": [{"name": "Children", "role": "Subject"}, {"name": "Children", "role": "Subject.Age"}, {"name": "presymptomatic or progressive peripheral neuropathy", "role": "Effect"}, {"name": "thalidomide", "role": "Treatment"}, {"name": "thalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-555", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Nevirapine is a non-nucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents", "role": "Treatment"}, {"name": "Nevirapine", "role": "Treatment.Drug"}, {"name": "other antiretroviral agents", "role": "Treatment.Drug"}, {"name": "HIV infection", "role": "Treatment.Disorder"}, {"name": "Nevirapine", "role": "Combination.Drug"}, {"name": "other antiretroviral agents", "role": "Combination.Drug"}]}]}
{"id": "train-556", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 72-year-old man with hormone-refractory prostate cancer", "role": "Subject"}, {"name": "72-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "subacute interstitial pneumonitis-related pulmonary fibrosis", "role": "Effect"}, {"name": "and died", "role": "Effect"}, {"name": "weekly administration of 30 mg/m2 docetaxel", "role": "Treatment"}, {"name": "seven doses", "role": "Treatment"}, {"name": "despite mechanical ventilation and high-dose corticosteroid treatment", "role": "Treatment"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "administration", "role": "Treatment.Route"}, {"name": "30 mg/m2", "role": "Treatment.Dosage"}, {"name": "seven doses", "role": "Treatment.Dosage"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "docetaxel", "role": "Treatment.Drug"}, {"name": "corticosteroid", "role": "Treatment.Drug"}, {"name": "hormone-refractory prostate cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-557", "event": [{"trigger": "promoted", "type": "adverse_event", "arguments": [{"name": "pulmonary fibrosis", "role": "Subject"}, {"name": "pulmonary fibrosis", "role": "Subject.Disorder"}, {"name": "the development of lung cancer", "role": "Effect"}, {"name": "low-dose methotrexate therapy", "role": "Treatment"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-558", "event": [{"trigger": "onset", "type": "adverse_event", "arguments": [{"name": "a patient with cystic fibrosis-related liver disease", "role": "Subject"}, {"name": "cystic fibrosis-related liver disease", "role": "Subject.Disorder"}, {"name": "iatrogenic adrenal insufficiency", "role": "Effect"}, {"name": "inhaled corticosteroids and a moderate CYP3A4 inhibitor", "role": "Treatment"}, {"name": "inhaled corticosteroids", "role": "Treatment.Drug"}, {"name": "CYP3A4 inhibitor.", "role": "Treatment.Drug"}, {"name": "inhaled corticosteroids", "role": "Combination.Drug"}, {"name": "CYP3A4 inhibitor.", "role": "Combination.Drug"}]}]}
{"id": "train-559", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "thrombocytopenia and thrombosis", "role": "Effect"}, {"name": "Heparin", "role": "Treatment"}, {"name": "Heparin", "role": "Treatment.Drug"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-560", "event": [{"trigger": "disappeared", "type": "potential_therapeutic_event", "arguments": [{"name": "2 of the women", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "polycystic changes disappeared from the ovaries", "role": "Effect"}, {"name": "lost weight and resumed menstruating", "role": "Effect"}, {"name": "after valproate therapy was discontinued", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-561", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thrombocytopoaenia", "role": "Effect"}, {"name": "chronic ingestion of quinine", "role": "Treatment"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-562", "event": [{"trigger": "increase", "type": "adverse_event", "arguments": [{"name": "adverse reaction", "role": "Effect"}, {"name": "concomitant use of antidepressant drugs associated with lithium as a co-adjuvant", "role": "Treatment"}, {"name": "antidepressant drugs", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "antidepressant drugs", "role": "Combination.Drug"}, {"name": "lithium", "role": "Combination.Drug"}]}]}
{"id": "train-563", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Peripheral nervous system disturbances", "role": "Effect"}, {"name": "cytosine arabinoside", "role": "Treatment"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}]}]}
{"id": "train-564", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a fit 41-year-old patient with malignant teratoma", "role": "Subject"}, {"name": "41-year-old", "role": "Subject.Age"}, {"name": "renal tubular salt wasting", "role": "Effect"}, {"name": "cisplatin", "role": "Treatment"}, {"name": "malignant teratoma", "role": "Treatment.Disorder"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-565", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "This case", "role": "Subject"}, {"name": "reversible encephalopathy syndrome", "role": "Effect"}, {"name": "BH-AC, a derivative of cytosine arabinoside (1-beta-D-arabinofuranosylcytosine)", "role": "Treatment"}, {"name": "BH-AC", "role": "Treatment.Drug"}]}]}
{"id": "train-566", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "agitation, dysarthria, diaphoresis, and a movement disorder", "role": "Effect"}, {"name": "metoclopramide", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}, {"name": "nausea", "role": "Treatment.Disorder"}, {"name": "within 2 hours", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-567", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "aplastic anemia", "role": "Effect"}, {"name": "methazolamide", "role": "Treatment"}, {"name": "methazolamide", "role": "Treatment.Drug"}]}]}
{"id": "train-568", "event": [{"trigger": "treat", "type": "potential_therapeutic_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "Amprenavir", "role": "Treatment"}, {"name": "HIV-infected", "role": "Treatment.Disorder"}, {"name": "Amprenavir", "role": "Treatment.Drug"}]}]}
{"id": "train-569", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "papular eruption", "role": "Effect"}, {"name": "Methotrexate", "role": "Treatment"}, {"name": "Methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-570", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level", "role": "Effect"}, {"name": "hepatitis", "role": "Effect"}, {"name": "linezolid", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-571", "event": [{"trigger": "treated with", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "for a brain tumor", "role": "Subject"}, {"name": "acute interstitial pneumonitis", "role": "Effect"}, {"name": "carmustine (BCNU)", "role": "Treatment"}, {"name": "carmustine (BCNU)", "role": "Treatment.Drug"}, {"name": "a brain tumor", "role": "Treatment.Disorder"}]}]}
{"id": "train-572", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "three reported cases", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "irreversible liver injury", "role": "Effect"}, {"name": "troglitazone", "role": "Treatment"}, {"name": "troglitazone", "role": "Treatment.Drug"}]}]}
{"id": "train-573", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "High-grade atrioventricular block", "role": "Effect"}, {"name": "dipyridamole stress testing", "role": "Treatment"}, {"name": "dipyridamole", "role": "Treatment.Drug"}]}]}
{"id": "train-574", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "anaphylaxis", "role": "Effect"}, {"name": "intraoperative gelatine", "role": "Treatment"}, {"name": "gelatine", "role": "Treatment.Drug"}, {"name": "intraoperative", "role": "Treatment.Route"}]}]}
{"id": "train-575", "event": [{"trigger": "got", "type": "adverse_event", "arguments": [{"name": "a 29-year-old man suffering from falciparum malaria disease", "role": "Subject"}, {"name": "29-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "reversible hearing loss", "role": "Effect"}, {"name": "quinine", "role": "Treatment"}, {"name": "falciparum malaria disease", "role": "Treatment.Disorder"}, {"name": "quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-576", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "two asthmatic patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "hypokalemic", "role": "Effect"}, {"name": "inhalation of normal doses of albuterol", "role": "Treatment"}, {"name": "asthmatic", "role": "Treatment.Disorder"}, {"name": "inhalation", "role": "Treatment.Route"}, {"name": "normal doses", "role": "Treatment.Dosage"}, {"name": "albuterol", "role": "Treatment.Drug"}]}]}
{"id": "train-577", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "an atypical localized cutaneous eruption with an unusual course and protracted resolution time", "role": "Effect"}, {"name": "sorafenib therapy", "role": "Treatment"}, {"name": "sorafenib", "role": "Treatment.Drug"}]}]}
{"id": "train-578", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "diabetic ketoacidosis", "role": "Effect"}, {"name": "quetiapine and risperidone", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-579", "event": [{"trigger": "inhibits", "type": "adverse_event", "arguments": [{"name": "metabolism of tacrolimus", "role": "Effect"}, {"name": "nefazodone", "role": "Treatment"}, {"name": "nefazodone", "role": "Treatment.Drug"}]}]}
{"id": "train-580", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "one", "role": "Subject.Population"}, {"name": "pneumonitis", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "RA", "role": "Treatment.Disorder"}, {"name": "PsA", "role": "Treatment.Disorder"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-581", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an Indian mid-borderline leprosy patient", "role": "Subject"}, {"name": "Indian", "role": "Subject.Race"}, {"name": "mid-borderline leprosy", "role": "Subject.Disorder"}, {"name": "agranulocytosis", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-582", "event": [{"trigger": "side-effect", "type": "adverse_event", "arguments": [{"name": "Autoimmune thyroid disease", "role": "Effect"}, {"name": "interferon-alpha (IFN-alpha)", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}, {"name": "viral hepatitis C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-583", "event": [{"trigger": "reported.", "type": "adverse_event", "arguments": [{"name": "bone marrow toxicity", "role": "Effect"}, {"name": "MMF", "role": "Treatment"}, {"name": "MMF", "role": "Treatment.Drug"}]}]}
{"id": "train-584", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "He", "role": "Subject"}, {"name": "He", "role": "Subject.Gender"}, {"name": "late secondary infection", "role": "Effect"}, {"name": "imiquimod", "role": "Treatment"}, {"name": "imiquimod", "role": "Treatment.Drug"}]}]}
{"id": "train-585", "event": [{"trigger": "followed", "type": "adverse_event", "arguments": [{"name": "a 51-year-old man", "role": "Subject"}, {"name": "51-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "recurrence of Graves' disease", "role": "Effect"}, {"name": "IFN-alpha treatment", "role": "Treatment"}, {"name": "10 years after thyroidectomy", "role": "Treatment"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-586", "event": [{"trigger": "infected", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "maculopapular eruption and fever", "role": "Effect"}, {"name": "ritonavir", "role": "Treatment"}, {"name": "human immunodeficiency virus", "role": "Treatment.Disorder"}, {"name": "ritonavir", "role": "Treatment.Drug"}, {"name": "2nd day of first administration", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-587", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "photo-onycholysis on multiple nails", "role": "Effect"}, {"name": "uptake of olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "after uptake", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-588", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "fever", "role": "Effect"}, {"name": "Cimetidine", "role": "Treatment"}, {"name": "Cimetidine", "role": "Treatment.Drug"}]}]}
{"id": "train-589", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "lymphoproliferative disorder", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-590", "event": [{"trigger": "persist", "type": "adverse_event", "arguments": [{"name": "field defects and some electrophysiological abnormalities persist", "role": "Effect"}, {"name": "vigabatrin therapy is withdrawn", "role": "Treatment"}, {"name": "vigabatrin", "role": "Treatment.Drug"}]}]}
{"id": "train-591", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "A possible case", "role": "Subject"}, {"name": "pancreatitis", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-592", "event": [{"trigger": "Subsequent", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "seizures, bradycardia and prolonged QRS as well as QTc intervals on EKG", "role": "Effect"}, {"name": "mirtazapine", "role": "Treatment"}, {"name": "mirtazapine", "role": "Treatment.Drug"}]}]}
{"id": "train-593", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient with protein C deficiency", "role": "Subject"}, {"name": "Stuttering priapism", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "protein C deficiency", "role": "Treatment.Disorder"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-594", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "pulmonary tuberculosis", "role": "Effect"}, {"name": "steroid and lobenzarit disodium for the first 3 years, and then continued with a combined treatment of steroid and bucillamine for the following years", "role": "Treatment"}, {"name": "steroid", "role": "Treatment.Drug"}, {"name": "bucillamine", "role": "Treatment.Drug"}, {"name": "lobenzarit disodium", "role": "Treatment.Drug"}, {"name": "steroid", "role": "Treatment.Drug"}, {"name": "3 years", "role": "Treatment.Time_elapsed"}, {"name": "for the following years", "role": "Treatment.Duration"}, {"name": "steroid", "role": "Combination.Drug"}, {"name": "bucillamine", "role": "Combination.Drug"}, {"name": "lobenzarit disodium", "role": "Combination.Drug"}, {"name": "steroid", "role": "Combination.Drug"}]}]}
{"id": "train-595", "event": [{"trigger": "leading", "type": "adverse_event", "arguments": [{"name": "a rare case", "role": "Subject"}, {"name": "propafenone toxicity", "role": "Effect"}, {"name": "propafenone and mirtazapine", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}, {"name": "mirtazapine", "role": "Treatment.Drug"}, {"name": "propafenone", "role": "Combination.Drug"}, {"name": "mirtazapine", "role": "Combination.Drug"}]}]}
{"id": "train-596", "event": [{"trigger": "provoking", "type": "adverse_event", "arguments": [{"name": "acral necrosis", "role": "Effect"}, {"name": "Raynaud's phenomenon", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "vinca alkaloids", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "vinca alkaloids", "role": "Treatment.Drug"}, {"name": "bleomycin", "role": "Combination.Drug"}, {"name": "vinca alkaloids", "role": "Combination.Drug"}]}]}
{"id": "train-597", "event": [{"trigger": "resolved", "type": "potential_therapeutic_event", "arguments": [{"name": "discontinuation of levetiracetam", "role": "Treatment"}, {"name": "psychotic behavior", "role": "Treatment.Disorder"}, {"name": "soon after", "role": "Treatment.Time_elapsed"}, {"name": "levetiracetam", "role": "Treatment.Drug"}]}]}
{"id": "train-598", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "Male volunteers ( n=12)", "role": "Subject"}, {"name": "Male", "role": "Subject.Gender"}, {"name": "n=12", "role": "Subject.Population"}, {"name": "repaglinide metabolism", "role": "Effect"}, {"name": "multiple doses of 600 mg rifampicin once daily for 7 days", "role": "Treatment"}, {"name": "multiple doses of 600 mg", "role": "Treatment.Dosage"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "once daily", "role": "Treatment.Freq"}, {"name": "7 days", "role": "Treatment.Duration"}]}]}
{"id": "train-599", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "anemia", "role": "Effect"}, {"name": "MMF", "role": "Treatment"}, {"name": "prednisone", "role": "Treatment"}, {"name": "MMF", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "MMF", "role": "Combination.Drug"}, {"name": "prednisone", "role": "Combination.Drug"}]}]}
{"id": "train-600", "event": [{"trigger": "prophylaxis", "type": "potential_therapeutic_event", "arguments": [{"name": "patient's inability to ambulate", "role": "Subject"}, {"name": "inability to ambulate", "role": "Subject.Disorder"}, {"name": "Warfarin was initiated for deep vein thrombosis", "role": "Treatment"}, {"name": "deep vein thrombosis", "role": "Treatment.Disorder"}, {"name": "Warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-601", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "sarcoidosis", "role": "Effect"}, {"name": "treatment by interferon alpha and ribavirin", "role": "Treatment"}, {"name": "chronic hepatitis C (CHC)", "role": "Treatment.Disorder"}, {"name": "interferon alpha", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "interferon alpha", "role": "Combination.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}]}]}
{"id": "train-602", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "appearance of pigmentation", "role": "Effect"}, {"name": "topical tacrolimus", "role": "Treatment"}, {"name": "tacrolimus", "role": "Treatment.Drug"}, {"name": "topical", "role": "Treatment.Route"}]}]}
{"id": "train-603", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "bradycardia", "role": "Effect"}, {"name": "clonidine", "role": "Treatment"}, {"name": "clonidine", "role": "Treatment.Drug"}]}]}
{"id": "train-604", "event": [{"trigger": "reactions to", "type": "adverse_event", "arguments": [{"name": "hypersensitivity", "role": "Effect"}, {"name": "cloxacillin", "role": "Treatment"}, {"name": "cloxacillin", "role": "Treatment.Drug"}]}]}
{"id": "train-605", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patient with Wolff-Parkinson-White syndrome", "role": "Subject"}, {"name": "Brugada type electrocardiographic changes", "role": "Effect"}, {"name": "concomitant use of lithium and propafenone", "role": "Treatment"}, {"name": "Wolff-Parkinson-White syndrome", "role": "Treatment.Disorder"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "propafenone", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Combination.Drug"}, {"name": "propafenone", "role": "Combination.Drug"}]}]}
{"id": "train-606", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Meibomian duct inflammation and blockage leading to chalazion formation", "role": "Effect"}, {"name": "Docetaxel", "role": "Treatment"}, {"name": "Docetaxel", "role": "Treatment.Drug"}]}]}
{"id": "train-607", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "allergic skin eruptions", "role": "Effect"}, {"name": "AZA", "role": "Treatment"}, {"name": "AZA", "role": "Treatment.Drug"}]}]}
{"id": "train-608", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "obsessive-compulsive symptoms (OCS)", "role": "Effect"}, {"name": "OCS", "role": "Effect"}, {"name": "antipsychotic", "role": "Treatment"}, {"name": "antipsychotic", "role": "Treatment.Drug"}]}]}
{"id": "train-609", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "pregnancy in women", "role": "Subject"}, {"name": "women", "role": "Subject.Gender"}, {"name": "all-trans retinoic acid", "role": "Treatment"}, {"name": "all-trans retinoic acid", "role": "Treatment.Drug"}, {"name": "pregnancy", "role": "Treatment.Disorder"}]}]}
{"id": "train-610", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "SJS/TEN, a severe life-threatening illness", "role": "Effect"}, {"name": "TMP-Sx", "role": "Treatment"}, {"name": "SSTIs", "role": "Treatment.Disorder"}, {"name": "TMP", "role": "Treatment.Drug"}, {"name": "Sx", "role": "Treatment.Drug"}, {"name": "TMP", "role": "Combination.Drug"}, {"name": "Sx", "role": "Combination.Drug"}]}]}
{"id": "train-611", "event": [{"trigger": "resolved", "type": "potential_therapeutic_event", "arguments": [{"name": "a 15-year-old boy", "role": "Subject"}, {"name": "15-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "incapacitating tardive dyskinesia", "role": "Effect"}, {"name": "deanol", "role": "Treatment"}, {"name": "deanol", "role": "Treatment.Drug"}]}]}
{"id": "train-612", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "mammary hyperplasias", "role": "Effect"}, {"name": "Drug", "role": "Treatment"}, {"name": "D-penicillamine and Neothetazone", "role": "Treatment"}, {"name": "Drug", "role": "Treatment.Drug"}, {"name": "Neothetazone", "role": "Treatment.Drug"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}, {"name": "D-penicillamine", "role": "Combination.Drug"}, {"name": "Neothetazone", "role": "Combination.Drug"}]}]}
{"id": "train-613", "event": [{"trigger": "exposure", "type": "adverse_event", "arguments": [{"name": "multiple congenital anomalies", "role": "Effect"}, {"name": "CP embryopathy", "role": "Effect"}, {"name": "CP", "role": "Treatment"}, {"name": "CP", "role": "Treatment.Drug"}]}]}
{"id": "train-614", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "adverse effect", "role": "Effect"}, {"name": "antiretroviral medication Nevirapine (NVP)", "role": "Treatment"}, {"name": "Nevirapine", "role": "Treatment.Drug"}]}]}
{"id": "train-615", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia", "role": "Subject"}, {"name": "27-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "bronchial asthma", "role": "Subject.Disorder"}, {"name": "eosinophilic enteritis", "role": "Subject.Disorder"}, {"name": "eosinophilic pneumonia", "role": "Subject.Disorder"}, {"name": "fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia", "role": "Effect"}, {"name": "trimethoprim (TMP)-sulfamethoxazole (SMX)", "role": "Treatment"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "two weeks after", "role": "Treatment.Time_elapsed"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}, {"name": "trimethoprim", "role": "Combination.Drug"}]}]}
{"id": "train-616", "event": [{"trigger": "produce", "type": "adverse_event", "arguments": [{"name": "increase of autoantibodies (antinuclear antibodies, anti-double-stranded DNA), but not clinical disease", "role": "Effect"}, {"name": "Treatment with infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-617", "event": [{"trigger": "occurs", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome,", "role": "Effect"}, {"name": "serotonin-active medications", "role": "Treatment"}]}]}
{"id": "train-618", "event": [{"trigger": "remains", "type": "potential_therapeutic_event", "arguments": [{"name": "PEI", "role": "Treatment"}, {"name": "PEI", "role": "Treatment.Drug"}, {"name": "HCC", "role": "Treatment.Disorder"}]}]}
{"id": "train-619", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a pediatric patient", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "Trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "Trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "Trimethoprim", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}]}]}
{"id": "train-620", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "mild reversible hematologic or hepatic toxicity and no further increases in Hb", "role": "Effect"}, {"name": "HU (3-10 mg/kg/day) and higher doses", "role": "Treatment"}, {"name": "HU", "role": "Treatment.Drug"}, {"name": "higher doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-621", "event": [{"trigger": "intoxication", "type": "adverse_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "Imidazoline intoxication", "role": "Effect"}, {"name": "Imidazoline", "role": "Treatment"}, {"name": "Imidazoline", "role": "Treatment.Drug"}]}]}
{"id": "train-622", "event": [{"trigger": "affected", "type": "adverse_event", "arguments": [{"name": "liver function", "role": "Effect"}, {"name": "cytarabine", "role": "Treatment"}, {"name": "cytarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-623", "event": [{"trigger": "developing", "type": "adverse_event", "arguments": [{"name": "acute leukemia", "role": "Effect"}, {"name": "the total cumulative dosage of Treosulfan", "role": "Treatment"}, {"name": "Treosulfan", "role": "Treatment.Drug"}]}]}
{"id": "train-624", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two patients.", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "cerebrospinal fluid eosinophilia", "role": "Effect"}, {"name": "Intraventricular vancomycin", "role": "Treatment"}, {"name": "Intraventricular", "role": "Treatment.Route"}, {"name": "vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-625", "event": [{"trigger": "as", "type": "potential_therapeutic_event", "arguments": [{"name": "a prolonged treatment with corticosteroids", "role": "Treatment"}, {"name": "in gold-induced pneumonitis", "role": "Treatment.Disorder"}, {"name": "gold", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Treatment.Drug"}]}]}
{"id": "train-626", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "bone marrow toxicity", "role": "Effect"}, {"name": "Massive plasmocytosis", "role": "Effect"}, {"name": "methimazole", "role": "Treatment"}, {"name": "methimazole", "role": "Treatment.Drug"}]}]}
{"id": "train-627", "event": [{"trigger": "achieve", "type": "adverse_event", "arguments": [{"name": "one patient", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}, {"name": "glucose levels of all patients increased and achieve criteria of diabetes diagnoses", "role": "Effect"}, {"name": "6-month period of monotherapy with indapamide (2.5 mg/day)", "role": "Treatment"}, {"name": "6-month", "role": "Treatment.Duration"}, {"name": "indapamide", "role": "Treatment.Drug"}, {"name": "2.5 mg/day", "role": "Treatment.Dosage"}]}]}
{"id": "train-628", "event": [{"trigger": "damage", "type": "adverse_event", "arguments": [{"name": "a non-alcoholic woman", "role": "Subject"}, {"name": "non-alcoholic", "role": "Subject.Disorder"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "reversible toxic liver damage", "role": "Effect"}, {"name": "disulfiram", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-629", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 60 year-old woman with chronic renal failure", "role": "Subject"}, {"name": "60 year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "acute proximal muscle weakness", "role": "Effect"}, {"name": "regular dosage of colchicine", "role": "Treatment"}, {"name": "chronic renal failure", "role": "Treatment.Disorder"}, {"name": "colchicine", "role": "Treatment.Drug"}, {"name": "regular dosage", "role": "Treatment.Dosage"}]}]}
{"id": "train-630", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "prostaglandin-mediated vasodilatation, hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of pain to the teeth", "role": "Effect"}, {"name": "niacin", "role": "Treatment"}, {"name": "niacin", "role": "Treatment.Drug"}]}]}
{"id": "train-631", "event": [{"trigger": "infectious agent", "type": "adverse_event", "arguments": [{"name": "immunocompromised hosts", "role": "Subject"}, {"name": "immunocompromised", "role": "Subject.Disorder"}, {"name": "Nocardia", "role": "Effect"}, {"name": "corticosteroids", "role": "Treatment"}, {"name": "corticosteroids", "role": "Treatment.Drug"}]}]}
{"id": "train-632", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Hepatobiliary disorders", "role": "Effect"}, {"name": "orally administered terbinafine", "role": "Treatment"}, {"name": "terbinafine", "role": "Treatment.Drug"}, {"name": "orally", "role": "Treatment.Route"}]}]}
{"id": "train-633", "event": [{"trigger": "provoked", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "generalized pustular psoriasis (GPP)", "role": "Effect"}, {"name": "trazodone hydrochloride (Molipaxin, Roussel)", "role": "Treatment"}, {"name": "trazodone hydrochloride", "role": "Treatment.Drug"}]}]}
{"id": "train-634", "event": [{"trigger": "can", "type": "potential_therapeutic_event", "arguments": [{"name": "Early recognition of hereditary motor and sensory neuropathy type 1", "role": "Treatment"}]}]}
{"id": "train-635", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "enoxaparin", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-636", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Interstitial pneumonitis", "role": "Effect"}, {"name": "sirolimus", "role": "Treatment"}, {"name": "sirolimus", "role": "Treatment.Drug"}]}]}
{"id": "train-637", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "He", "role": "Subject"}, {"name": "He", "role": "Subject.Gender"}, {"name": "elevated serum ammonia levels", "role": "Effect"}, {"name": "valproic acid", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-638", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Cutaneous rashes and eruptions", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-639", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "the increase in the INR value with associated bruising", "role": "Effect"}, {"name": "amoxycillin", "role": "Treatment"}, {"name": "amoxycillin", "role": "Treatment.Drug"}, {"name": "acenocoumarol", "role": "Treatment.Drug"}, {"name": "amoxycillin", "role": "Treatment.Drug"}, {"name": "acenocoumarol", "role": "Combination.Drug"}, {"name": "amoxycillin", "role": "Combination.Drug"}]}]}
{"id": "train-640", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "serious interstitial lung disease", "role": "Effect"}, {"name": "sorafenib", "role": "Treatment"}, {"name": "sorafenib", "role": "Treatment.Drug"}, {"name": "lung cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-641", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "A 26-year-old man with bipolar disorder, seizures, and mild mental retardation secondary to a traumatic brain injury", "role": "Subject"}, {"name": "bipolar disorder", "role": "Subject.Disorder"}, {"name": "seizures", "role": "Subject.Disorder"}, {"name": "mild mental retardation secondary to a traumatic brain injury", "role": "Subject.Disorder"}, {"name": "26-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "aggression", "role": "Treatment.Disorder"}, {"name": "seizure", "role": "Treatment.Disorder"}]}]}
{"id": "train-642", "event": [{"trigger": "precipitated", "type": "adverse_event", "arguments": [{"name": "Serotonin toxicity", "role": "Effect"}, {"name": "fentanyl", "role": "Treatment"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "SSRIs", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}, {"name": "SSRIs", "role": "Combination.Drug"}]}]}
{"id": "train-643", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "a severe adverse drug reaction", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-644", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Visual system side effects caused by parasympathetic dysfunction", "role": "Effect"}, {"name": "botulinum toxin type B injections", "role": "Treatment"}, {"name": "botulinum toxin type B", "role": "Treatment.Drug"}, {"name": "injections", "role": "Treatment.Route"}]}]}
{"id": "train-645", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Renal failure", "role": "Effect"}, {"name": "acetazolamide therapy", "role": "Treatment"}, {"name": "acetazolamide", "role": "Treatment.Drug"}, {"name": "glaucoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-646", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Acute onset of nephrotic syndrome", "role": "Effect"}, {"name": "interferon-alpha retreatment", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}, {"name": "chronic active hepatitis C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-647", "event": [{"trigger": "while", "type": "adverse_event", "arguments": [{"name": "A 16-year-old boy", "role": "Subject"}, {"name": "16-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "fever, generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels", "role": "Effect"}, {"name": "olanzapine and lithium", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "olanzapine", "role": "Combination.Drug"}, {"name": "lithium", "role": "Combination.Drug"}]}]}
{"id": "train-648", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "hyperpigmentation was diffuse scattered, flagellate like and linear streaking", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-649", "event": [{"trigger": "toxicities", "type": "adverse_event", "arguments": [{"name": "dermatologic toxicities", "role": "Effect"}, {"name": "5-FU", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-650", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Bowel perforation", "role": "Effect"}, {"name": "intraperitoneal chromic phosphate instillation", "role": "Treatment"}, {"name": "intraperitoneal", "role": "Treatment.Route"}, {"name": "instillation", "role": "Treatment.Route"}, {"name": "chromic phosphate", "role": "Treatment.Drug"}]}]}
{"id": "train-651", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 62-year-old woman who was being treated for squamous cell carcinoma of the head and neck", "role": "Subject"}, {"name": "62-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "a chemotherapy-related hemolytic-uremic syndrome", "role": "Effect"}, {"name": "the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate", "role": "Treatment"}, {"name": "squamous cell carcinoma of the head and neck", "role": "Treatment.Disorder"}, {"name": "second cycle", "role": "Treatment.Dosage"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}, {"name": "bleomycin", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}]}]}
{"id": "train-652", "event": [{"trigger": "therapeutic value", "type": "potential_therapeutic_event", "arguments": [{"name": "arsenic trioxide", "role": "Treatment"}, {"name": "relapsed/resistant APL", "role": "Treatment.Disorder"}]}]}
{"id": "train-653", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "patients with prostate cancer", "role": "Subject"}, {"name": "Avascular necrosis of the femoral head", "role": "Effect"}, {"name": "cyproterone acetate and radiotherapy", "role": "Treatment"}, {"name": "prostate cancer", "role": "Treatment.Disorder"}, {"name": "cyproterone acetate", "role": "Treatment.Drug"}]}]}
{"id": "train-654", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "Ectropion", "role": "Effect"}, {"name": "bolus injection of 5-fluorouracil", "role": "Treatment"}, {"name": "bolus injection", "role": "Treatment.Route"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-655", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patients with renal failure", "role": "Subject"}, {"name": "renal failure", "role": "Subject.Disorder"}, {"name": "parkinsonism", "role": "Effect"}, {"name": "Metoclopramide", "role": "Treatment"}, {"name": "Metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-656", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Posterior reversible encephalopathy syndrome", "role": "Effect"}, {"name": "methotrexate neurotoxicity", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-657", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "A 6-year-old boy (weight: 16 kg, at the start of treatment)", "role": "Subject"}, {"name": "6-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "sodium valproate (valproate syrup 5%)", "role": "Treatment"}, {"name": "epilepsy", "role": "Treatment.Disorder"}, {"name": "sodium valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-658", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "children with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "myelotoxicity and therapeutic failure", "role": "Effect"}, {"name": "6-mercaptopurine", "role": "Treatment"}, {"name": "6-mercaptopurine", "role": "Treatment.Drug"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-659", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "identical twin brothers", "role": "Subject"}, {"name": "brothers", "role": "Subject.Gender"}, {"name": "leukoencephalopathy and hydrocephalus", "role": "Effect"}, {"name": "intrathecally administered methotrexate", "role": "Treatment"}, {"name": "intrathecally administered methotrexate and cranial irradiation", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "intrathecally", "role": "Treatment.Route"}, {"name": "intrathecally", "role": "Treatment.Route"}]}]}
{"id": "train-660", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "moderate toxicity", "role": "Effect"}, {"name": "TMZ", "role": "Treatment"}, {"name": "TMZ", "role": "Treatment.Drug"}]}]}
{"id": "train-661", "event": [{"trigger": "prevent", "type": "potential_therapeutic_event", "arguments": [{"name": "antidepressants", "role": "Treatment"}, {"name": "changes in serotonergic or noradrenergic neurotransmission caused by IFN-alpha", "role": "Treatment.Disorder"}, {"name": "antidepressants", "role": "Treatment.Drug"}]}]}
{"id": "train-662", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "interaction between fentanyl and citalopram", "role": "Treatment"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}, {"name": "citalopram", "role": "Combination.Drug"}]}]}
{"id": "train-663", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an otherwise healthy individual", "role": "Subject"}, {"name": "meningitis", "role": "Effect"}, {"name": "ibuprofen", "role": "Treatment"}, {"name": "ibuprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-664", "event": [{"trigger": "shared", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly", "role": "Effect"}, {"name": "in utero exposure to cyclosposphamide", "role": "Treatment"}, {"name": "cyclosposphamide", "role": "Treatment.Drug"}]}]}
{"id": "train-665", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with Hashimoto's disease", "role": "Subject"}, {"name": "leukopenia", "role": "Effect"}, {"name": "L-Thyroxine", "role": "Treatment"}, {"name": "L-Thyroxine", "role": "Treatment.Drug"}, {"name": "Hashimoto's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-666", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "systemic lupus erythematosus-like disease", "role": "Effect"}, {"name": "Carbamazepine", "role": "Treatment"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-667", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "an elderly patient", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "increase of INR", "role": "Effect"}, {"name": "levamisole and 5-FU", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment"}, {"name": "levamisole", "role": "Treatment.Drug"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "levamisole", "role": "Combination.Drug"}, {"name": "5-FU", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-668", "event": [{"trigger": "enhanced", "type": "adverse_event", "arguments": [{"name": "hepatoxicity", "role": "Effect"}, {"name": "alcoholic", "role": "Treatment"}, {"name": "alcoholic", "role": "Treatment.Drug"}]}]}
{"id": "train-669", "event": [{"trigger": "is", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "anemia", "role": "Effect"}, {"name": "MMF", "role": "Treatment"}, {"name": "pemphigus", "role": "Treatment.Disorder"}]}]}
{"id": "train-670", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "rapidly progressive glomerulonephritis", "role": "Effect"}, {"name": "D-penicillamine", "role": "Treatment"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-671", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a heroin abuser", "role": "Subject"}, {"name": "acute hepatitis B and C", "role": "Effect"}, {"name": "subcutaneous naltrexone implant", "role": "Treatment"}, {"name": "heroin abuser", "role": "Treatment.Disorder"}, {"name": "subcutaneous", "role": "Treatment.Route"}, {"name": "naltrexone", "role": "Treatment.Drug"}]}]}
{"id": "train-672", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychosis", "role": "Effect"}, {"name": "Ciprofloxacin", "role": "Treatment"}, {"name": "Ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-673", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "teratogenic effects", "role": "Effect"}, {"name": "Thalidomide", "role": "Treatment"}, {"name": "Thalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-674", "event": [{"trigger": "in", "type": "potential_therapeutic_event", "arguments": [{"name": "Weekly AUC2 carboplatin", "role": "Treatment"}, {"name": "with or without oral phenoxodiol", "role": "Treatment"}, {"name": "Weekly", "role": "Treatment.Freq"}, {"name": "AUC2 carboplatin", "role": "Treatment.Drug"}, {"name": "phenoxodiol", "role": "Treatment.Drug"}, {"name": "platinum-resistant ovarian cancer", "role": "Treatment.Disorder"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "phenoxodiol", "role": "Combination.Drug"}, {"name": "AUC2 carboplatin", "role": "Combination.Drug"}]}]}
{"id": "train-675", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "esmolol", "role": "Treatment"}, {"name": "esmolol", "role": "Treatment.Drug"}, {"name": "caffeine", "role": "Treatment.Drug"}, {"name": "esmolol", "role": "Treatment.Drug"}, {"name": "dysrhythmias", "role": "Treatment.Disorder"}]}]}
{"id": "train-676", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "visual disturbances", "role": "Effect"}, {"name": "BTX-B", "role": "Treatment"}, {"name": "BTX-B", "role": "Treatment.Drug"}]}]}
{"id": "train-677", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "hemolytic uremic syndrome", "role": "Effect"}, {"name": "Gemcitabine", "role": "Treatment"}, {"name": "Gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-678", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "four patients", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "subacute neurotoxicity", "role": "Effect"}, {"name": "intrathecal MTX", "role": "Treatment"}, {"name": "intrathecal MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-679", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient with Wolff-Parkinson-White syndrome", "role": "Subject"}, {"name": "ST elevation in right precordial leads compatible with type 1 Brugada syndrome", "role": "Effect"}, {"name": "administration of propafenone", "role": "Treatment"}, {"name": "receiving lithium at concentrations within therapeutic levels", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "Wolff-Parkinson-White syndrome", "role": "Treatment.Disorder"}, {"name": "propafenone", "role": "Combination.Drug"}, {"name": "lithium", "role": "Combination.Drug"}]}]}
{"id": "train-680", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "cutaneous eruptions", "role": "Effect"}, {"name": "exanthemas", "role": "Effect"}, {"name": "dihydropyridines", "role": "Treatment"}, {"name": "dihydropyridines", "role": "Treatment.Drug"}]}]}
{"id": "train-681", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Polymyositis", "role": "Effect"}, {"name": "propylthiouracil", "role": "Treatment"}, {"name": "propylthiouracil", "role": "Treatment.Drug"}, {"name": "hyperthyroidism", "role": "Treatment.Disorder"}]}]}
{"id": "train-682", "event": [{"trigger": "offer", "type": "potential_therapeutic_event", "arguments": [{"name": "Methamphetamine's", "role": "Treatment"}, {"name": "injury to the cornea", "role": "Treatment.Disorder"}, {"name": "Methamphetamine's", "role": "Treatment.Drug"}]}]}
{"id": "train-683", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "serum concentration elevations of ethambutol sufficient to produce optic neuropathy", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-684", "event": [{"trigger": "beginning", "type": "adverse_event", "arguments": [{"name": "Renal failure", "role": "Effect"}, {"name": "creatinine clearances 4 to 10 ml/min, urine to plasma creatinine ratios less than 20, urinary sodium concentrations 16 to 60 mEq/liter, proteinuria, and cylindruria", "role": "Effect"}, {"name": "gentamicin therapy", "role": "Treatment"}, {"name": "8 to 17 days", "role": "Treatment.Time_elapsed"}, {"name": "gentamicin", "role": "Treatment.Drug"}]}]}
{"id": "train-685", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Seizures", "role": "Effect"}, {"name": "ofloxacin", "role": "Treatment"}, {"name": "ofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-686", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Cutaneous seeding", "role": "Effect"}, {"name": "ultrasound-guided percutaneous ethanol injection", "role": "Treatment"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "ethanol", "role": "Treatment.Drug"}, {"name": "hepatocellular carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-687", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Mycobacterium avium-intracellulare infection", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "decreased visual acuity", "role": "Effect"}, {"name": "bitemporal visual field defects", "role": "Effect"}, {"name": "optic chiasm damage", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "Mycobacterium avium-intracellulare infection", "role": "Treatment.Disorder"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-688", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "reversible nonthrombocytopenic vascular-type palpable purpura", "role": "Effect"}, {"name": "Metoclopramide", "role": "Treatment"}, {"name": "Metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-689", "event": [{"trigger": "requiring", "type": "potential_therapeutic_event", "arguments": [{"name": "a newborn, whose mother had received high-dose methylprednisolone in late pregnancy", "role": "Subject"}, {"name": "newborn", "role": "Subject.Age"}, {"name": "successfully treated", "role": "Effect"}, {"name": "hydrocortisone supplementation and intensive therapy", "role": "Treatment"}, {"name": "hydrocortisone", "role": "Treatment.Drug"}]}]}
{"id": "train-690", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented", "role": "Subject"}, {"name": "man", "role": "Subject.Gender"}, {"name": "developmental disabilities", "role": "Subject.Disorder"}, {"name": "extrapyramidal symptoms (EPS)", "role": "Effect"}, {"name": "aripiprazole", "role": "Treatment"}, {"name": "aripiprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-691", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "a fatal rise in intracranial pressure", "role": "Effect"}, {"name": "high-dose methotrexate", "role": "Treatment"}, {"name": "primary osteogenic sarcoma", "role": "Treatment.Disorder"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-692", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "occurrence of ILD", "role": "Effect"}, {"name": "taking erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-693", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a prolonged seizure", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-694", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "4 Chinese women with autoimmune thyroiditis", "role": "Subject"}, {"name": "4", "role": "Subject.Population"}, {"name": "Chinese", "role": "Subject.Race"}, {"name": "women", "role": "Subject.Gender"}, {"name": "autoimmune thyroiditis", "role": "Subject.Disorder"}, {"name": "transient thyrotoxicosis", "role": "Effect"}, {"name": "Lithium", "role": "Treatment"}, {"name": "Lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-695", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "an episode of acute chest pain", "role": "Effect"}, {"name": "intravenous ritodrine therapy", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "ritodrine", "role": "Treatment.Drug"}]}]}
{"id": "train-696", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "neurological effects", "role": "Effect"}, {"name": "desferrioxamine and prochlorperazine", "role": "Treatment"}, {"name": "desferrioxamine", "role": "Treatment.Drug"}, {"name": "prochlorperazine", "role": "Treatment.Drug"}, {"name": "desferrioxamine", "role": "Combination.Drug"}, {"name": "prochlorperazine", "role": "Combination.Drug"}]}]}
{"id": "train-697", "event": [{"trigger": "outcome", "type": "potential_therapeutic_event", "arguments": [{"name": "after liver transplantation with lamivudine and adefovir therapy", "role": "Treatment"}, {"name": "lamivudine", "role": "Treatment.Drug"}, {"name": "adefovir", "role": "Treatment.Drug"}, {"name": "hepatitis B infection", "role": "Treatment.Disorder"}, {"name": "lamivudine", "role": "Combination.Drug"}, {"name": "adefovir", "role": "Combination.Drug"}]}]}
{"id": "train-698", "event": [{"trigger": "seen", "type": "adverse_event", "arguments": [{"name": "a patient with pulmonary tuberculosis", "role": "Subject"}, {"name": "Pemphigus foliaceus", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "pulmonary tuberculosis", "role": "Treatment.Disorder"}, {"name": "rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-699", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "serotonin syndrome with serious extrapyramidal reactions", "role": "Effect"}, {"name": "sertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose", "role": "Treatment"}, {"name": "sertraline", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "metoclopramide", "role": "Treatment.Drug"}, {"name": "single, conventional dose", "role": "Treatment.Dosage"}, {"name": "metoclopramide", "role": "Combination.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}, {"name": "sertraline", "role": "Combination.Drug"}]}]}
{"id": "train-700", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "polyserositis (pericardial effusion, pleural effusion, and pericarditis)", "role": "Effect"}, {"name": "started on clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-701", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "cholestatic hepatitis with cholestasis and duct paucity on rebiopsy", "role": "Effect"}, {"name": "ampicillin", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}, {"name": "Three years later", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-702", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "permanent vision loss", "role": "Effect"}, {"name": "9-month course of treatment with ethambutol and isoniazid", "role": "Treatment"}, {"name": "pulmonary tuberculosis", "role": "Treatment.Disorder"}, {"name": "9-month", "role": "Treatment.Time_elapsed"}, {"name": "ethambutol", "role": "Treatment.Drug"}, {"name": "isoniazid", "role": "Treatment.Drug"}, {"name": "ethambutol", "role": "Combination.Drug"}, {"name": "isoniazid", "role": "Combination.Drug"}]}]}
{"id": "train-703", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "urinary incontinence (UI)", "role": "Effect"}, {"name": "venlafaxine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-704", "event": [{"trigger": "accelerated", "type": "adverse_event", "arguments": [{"name": "underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of nephrotic syndrome", "role": "Effect"}, {"name": "M-CSF", "role": "Treatment"}, {"name": "M-CSF", "role": "Treatment.Drug"}]}]}
{"id": "train-705", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two ELBW infants affected by hyperkalaemia", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "infants", "role": "Subject.Age"}, {"name": "ELBW", "role": "Subject.Disorder"}, {"name": "serious hypernatraemia", "role": "Effect"}, {"name": "Kayexalate", "role": "Treatment"}, {"name": "hyperkalaemia", "role": "Treatment.Disorder"}, {"name": "Kayexalate", "role": "Treatment.Drug"}]}]}
{"id": "train-706", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Electrolyte disorders", "role": "Effect"}, {"name": "foscarnet", "role": "Treatment"}, {"name": "foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-707", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "acute myeloid leukaemia (AML)", "role": "Effect"}, {"name": "tamoxifen therapy for breast cancer", "role": "Treatment"}, {"name": "breast cancer", "role": "Treatment.Disorder"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-708", "event": [{"trigger": "become", "type": "adverse_event", "arguments": [{"name": "a 72-year-old man with advanced Parkinson's disease (PD)", "role": "Subject"}, {"name": "72-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "completely bald", "role": "Effect"}, {"name": "levodopa and anti-cholinergic drugs", "role": "Treatment"}, {"name": "advanced Parkinson's disease (PD)", "role": "Treatment.Disorder"}, {"name": "levodopa", "role": "Treatment.Drug"}, {"name": "anti-cholinergic drugs", "role": "Treatment.Drug"}]}]}
{"id": "train-709", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "hallucinations, agitation, vomiting, tachycardia and seizures", "role": "Effect"}, {"name": "ingestion of 1050 (48 mg/kg) of extended-release bupropion", "role": "Treatment"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "1050 (48 mg/kg)", "role": "Treatment.Dosage"}, {"name": "bupropion", "role": "Treatment.Drug"}]}]}
{"id": "train-710", "event": [{"trigger": "suspected", "type": "adverse_event", "arguments": [{"name": "38-year-old male", "role": "Subject"}, {"name": "a seizure disorder", "role": "Subject"}, {"name": "38-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "SIADH", "role": "Effect"}, {"name": "Tegretol", "role": "Treatment"}, {"name": "Tegretol", "role": "Treatment.Drug"}, {"name": "seizure", "role": "Treatment.Disorder"}]}]}
{"id": "train-711", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "nephrotoxicity", "role": "Effect"}, {"name": "cyclosporine dependency", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}]}]}
{"id": "train-712", "event": [{"trigger": "side effects", "type": "adverse_event", "arguments": [{"name": "testicular swelling and pain", "role": "Effect"}, {"name": "desipramine", "role": "Treatment"}, {"name": "desipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-713", "event": [{"trigger": "adverse effects", "type": "adverse_event", "arguments": [{"name": "haematological adverse effects", "role": "Effect"}, {"name": "quetiapine", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}]}]}
{"id": "train-714", "event": [{"trigger": "occurs", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "drug-induced neutropenia", "role": "Effect"}, {"name": "a semisynthetic penicillin for two weeks or more", "role": "Treatment"}, {"name": "semisynthetic penicillin", "role": "Treatment.Drug"}, {"name": "two weeks", "role": "Treatment.Duration"}]}]}
{"id": "train-715", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "Peripheral nerve dysfunction", "role": "Effect"}, {"name": "cytosine arabinoside", "role": "Treatment"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-716", "event": [{"trigger": "increase", "type": "adverse_event", "arguments": [{"name": "a case of conjunctiva-cornea intraepithelial neoplasia", "role": "Subject"}, {"name": "Tumor-volume increase", "role": "Effect"}, {"name": "primary treatment with topical interferon alpha 2-beta", "role": "Treatment"}, {"name": "interferon alpha 2-beta", "role": "Treatment.Drug"}, {"name": "topical", "role": "Treatment.Route"}, {"name": "beginning", "role": "Treatment.Time_elapsed"}, {"name": "conjunctiva-cornea intraepithelial neoplasia", "role": "Treatment.Disorder"}]}]}
{"id": "train-717", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "posterior reversible encephalopathy syndrome", "role": "Effect"}, {"name": "L-asparaginase", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-718", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pneumonitis", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-719", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "Ototoxicity", "role": "Effect"}, {"name": "cis-platinum administration", "role": "Treatment"}, {"name": "cis-platinum", "role": "Treatment.Drug"}]}]}
{"id": "train-720", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Massive subfascial hematoma", "role": "Effect"}, {"name": "alteplase therapy", "role": "Treatment"}, {"name": "alteplase", "role": "Treatment.Drug"}, {"name": "acute myocardial infarction", "role": "Treatment.Disorder"}]}]}
{"id": "train-721", "event": [{"trigger": "responsible", "type": "adverse_event", "arguments": [{"name": "drug-induced vanishing bile duct syndrome", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-722", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "A 67-year-old man", "role": "Subject"}, {"name": "67-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "increased international normalized ratio (INR)", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-723", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "SLE", "role": "Effect"}, {"name": "CBZ", "role": "Treatment"}, {"name": "CBZ", "role": "Treatment.Drug"}]}]}
{"id": "train-724", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hemorrhagic vasculitis", "role": "Effect"}, {"name": "Ciprofloxacin", "role": "Treatment"}, {"name": "Ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-725", "event": [{"trigger": "occur.", "type": "adverse_event", "arguments": [{"name": "growth may be retarded and adrenal suppression", "role": "Effect"}, {"name": "high doses of fluticasone propionate", "role": "Treatment"}, {"name": "high doses", "role": "Treatment.Dosage"}, {"name": "fluticasone propionate", "role": "Treatment.Drug"}]}]}
{"id": "train-726", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "pediatric population", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "hypotension", "role": "Effect"}, {"name": "intravenous valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "status epilepticus", "role": "Treatment.Disorder"}]}]}
{"id": "train-727", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "worsening diarrhea with abdominal pain and fever", "role": "Effect"}, {"name": "albendazole", "role": "Treatment"}, {"name": "albendazole", "role": "Treatment.Drug"}]}]}
{"id": "train-728", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome.", "role": "Effect"}, {"name": "Linezolid", "role": "Treatment"}, {"name": "Linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-729", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Bone marrow aplasia and severe skin rash", "role": "Effect"}, {"name": "a single low dose of methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "single low dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-730", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A woman 38-year-old, suffering for about ten years from multiple sclerosis", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "38-year-old", "role": "Subject.Age"}, {"name": "a spastic paraparesis at the lower limbs", "role": "Effect"}, {"name": "repeated therapy cycles of intrathecal Depo-Medrol", "role": "Treatment"}, {"name": "Depo-Medrol", "role": "Treatment.Drug"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "repeated", "role": "Treatment.Freq"}]}]}
{"id": "train-731", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "poisoning", "role": "Effect"}, {"name": "P450 2E1-activated toxins", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}, {"name": "P450 2E1-activated toxins", "role": "Treatment.Drug"}, {"name": "single-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-732", "event": [{"trigger": "presenting", "type": "adverse_event", "arguments": [{"name": "25 additional patients with Wilson's disease", "role": "Subject"}, {"name": "25", "role": "Subject.Population"}, {"name": "neurologic disease", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}, {"name": "Wilson's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-733", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a child with metastatic neuroblastoma", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "t-AML", "role": "Effect"}, {"name": "oral etoposide", "role": "Treatment"}, {"name": "18 months", "role": "Treatment.Time_elapsed"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "metastatic neuroblastoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-734", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypoglycaemia", "role": "Effect"}, {"name": "mefloquine and some other anti-malarial quinine analogues", "role": "Treatment"}, {"name": "mefloquine", "role": "Treatment.Drug"}, {"name": "quinine analogues", "role": "Treatment.Drug"}, {"name": "mefloquine", "role": "Combination.Drug"}, {"name": "quinine analogues", "role": "Combination.Drug"}]}]}
{"id": "train-735", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "patients who are at risk for mucositis", "role": "Subject"}, {"name": "mucositis", "role": "Subject.Disorder"}, {"name": "nondepolarizing muscle relaxants", "role": "Treatment"}, {"name": "nondepolarizing muscle relaxants", "role": "Treatment.Drug"}]}]}
{"id": "train-736", "event": [{"trigger": "medication", "type": "potential_therapeutic_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Carbamazepine medication", "role": "Treatment"}, {"name": "a spinal cord lesion", "role": "Treatment.Disorder"}, {"name": "Dantrolene", "role": "Treatment.Drug"}, {"name": "Oxybutynin", "role": "Treatment.Drug"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}, {"name": "Dantrolene", "role": "Combination.Drug"}, {"name": "Oxybutynin", "role": "Combination.Drug"}]}]}
{"id": "train-737", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 15-year-old female patient diagnosed with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "15-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "presenting with status epilepticus", "role": "Effect"}, {"name": "receiving intrathecal methotrexate", "role": "Treatment"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-738", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Duodenal ulceration", "role": "Effect"}, {"name": "tolazoline", "role": "Treatment"}, {"name": "tolazoline", "role": "Treatment.Drug"}]}]}
{"id": "train-739", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Hepatic damage", "role": "Effect"}, {"name": "danazol", "role": "Treatment"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-740", "event": [{"trigger": "secondary to", "type": "adverse_event", "arguments": [{"name": "Hepato-biliary abnormalities", "role": "Effect"}, {"name": "ceftriaxone use", "role": "Treatment"}, {"name": "ceftriaxone", "role": "Treatment.Drug"}]}]}
{"id": "train-741", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Rhabdomyolysis", "role": "Effect"}, {"name": "diltiazem", "role": "Treatment"}, {"name": "atorvastatin", "role": "Treatment"}, {"name": "atorvastatin", "role": "Treatment.Drug"}, {"name": "diltiazem", "role": "Treatment.Drug"}, {"name": "atorvastatin", "role": "Combination.Drug"}, {"name": "diltiazem", "role": "Combination.Drug"}]}]}
{"id": "train-742", "event": [{"trigger": "syndrome:", "type": "adverse_event", "arguments": [{"name": "nephrotoxicity", "role": "Effect"}, {"name": "mannitol", "role": "Treatment"}, {"name": "mannitol", "role": "Treatment.Drug"}]}]}
{"id": "train-743", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Uveitis", "role": "Effect"}, {"name": "combination of rifabutin, clarithromycin and ethambutol", "role": "Treatment"}, {"name": "disseminated Mycobacterium avium-intracellulare complex infection", "role": "Treatment.Disorder"}, {"name": "rifabutin", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "ethambutol", "role": "Treatment.Drug"}, {"name": "rifabutin", "role": "Combination.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}, {"name": "ethambutol", "role": "Combination.Drug"}]}]}
{"id": "train-744", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "visual loss", "role": "Effect"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "phenol", "role": "Treatment"}, {"name": "phenol", "role": "Treatment.Drug"}]}]}
{"id": "train-745", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "augmentation of restless legs syndrome", "role": "Effect"}, {"name": "levodopa", "role": "Treatment"}, {"name": "levodopa", "role": "Treatment.Drug"}]}]}
{"id": "train-746", "event": [{"trigger": "side-effect", "type": "adverse_event", "arguments": [{"name": "These cases", "role": "Subject"}, {"name": "livedo reticularis", "role": "Effect"}, {"name": "interferon alpha", "role": "Treatment"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-747", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "pulmonary side effects", "role": "Effect"}, {"name": "ticlopidine", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-748", "event": [{"trigger": "Abnormal", "type": "adverse_event", "arguments": [{"name": "patient with suspected Cushing's syndrome", "role": "Subject"}, {"name": "Abnormal dexamethasone suppression tests", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "Cushing's syndrome", "role": "Treatment.Disorder"}, {"name": "rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-749", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "radiation recall reactions", "role": "Effect"}, {"name": "Gemcitabine", "role": "Treatment"}, {"name": "Gemcitabine", "role": "Treatment.Drug"}, {"name": "carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-750", "event": [{"trigger": "are", "type": "adverse_event", "arguments": [{"name": "Increased lash length, thickness, and pigmentation", "role": "Effect"}, {"name": "prostaglandin analog glaucoma drops", "role": "Treatment"}, {"name": "drops", "role": "Treatment.Route"}, {"name": "prostaglandin analog", "role": "Treatment.Drug"}, {"name": "glaucoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-751", "event": [{"trigger": "Associated", "type": "adverse_event", "arguments": [{"name": "Bullous Eruption", "role": "Effect"}, {"name": "Dihydropyridines", "role": "Treatment"}, {"name": "Dihydropyridines", "role": "Treatment.Drug"}]}]}
{"id": "train-752", "event": [{"trigger": "acted", "type": "adverse_event", "arguments": [{"name": "CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an increase in serum levels and clinical toxicity", "role": "Effect"}, {"name": "Ritonavir", "role": "Treatment"}, {"name": "Ritonavir", "role": "Treatment.Drug"}]}]}
{"id": "train-753", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Acute generalized exanthematous pustulosis", "role": "Effect"}, {"name": "nimesulide", "role": "Treatment"}, {"name": "nimesulide", "role": "Treatment.Drug"}]}]}
{"id": "train-754", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "coagulopathy--a near fatal experience", "role": "Effect"}, {"name": "Quinine", "role": "Treatment"}, {"name": "Quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-755", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 58-year-old man with rheumatoid arthritis", "role": "Subject"}, {"name": "58-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "lichen planus during", "role": "Effect"}, {"name": "treatment with gold", "role": "Treatment"}, {"name": "gold", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-756", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pseudolymphoma", "role": "Effect"}, {"name": "Atenolol", "role": "Treatment"}, {"name": "Atenolol", "role": "Treatment.Drug"}]}]}
{"id": "train-757", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "convulsive seizures", "role": "Effect"}, {"name": "co-administration of valproic acid and tebipenem", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}, {"name": "tebipenem", "role": "Treatment.Drug"}, {"name": "valproic acid", "role": "Combination.Drug"}, {"name": "tebipenem", "role": "Combination.Drug"}]}]}
{"id": "train-758", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "child with cytochrome P-450 2D6 genetic deficiency", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "cytochrome P-450 2D6 genetic deficiency", "role": "Subject.Disorder"}, {"name": "death", "role": "Effect"}, {"name": "Fluoxetine", "role": "Treatment"}, {"name": "Fluoxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-759", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "glaucoma", "role": "Subject"}, {"name": "Aplastic anemia and agranulocytosis", "role": "Effect"}, {"name": "methazolamide", "role": "Treatment"}, {"name": "methazolamide", "role": "Treatment.Drug"}, {"name": "glaucoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-760", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a 44-year-old woman", "role": "Subject"}, {"name": "44-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "a", "role": "Subject.Population"}, {"name": "t-MDS (refractory anemia with excess blasts)", "role": "Effect"}, {"name": "treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ)", "role": "Treatment"}, {"name": "recurrent anaplastic astrocytoma", "role": "Treatment.Disorder"}, {"name": "temozolomide", "role": "Treatment.Drug"}]}]}
{"id": "train-761", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "An infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "pancreatitis", "role": "Effect"}, {"name": "a combination of allopurinol and ketoconazole", "role": "Treatment"}, {"name": "allopurinol", "role": "Treatment.Drug"}, {"name": "ketoconazole", "role": "Treatment.Drug"}, {"name": "allopurinol", "role": "Combination.Drug"}, {"name": "ketoconazole", "role": "Combination.Drug"}]}]}
{"id": "train-762", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hepatotoxic effects", "role": "Effect"}, {"name": "valproic acid", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-763", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "ovarian cancer patients", "role": "Subject"}, {"name": "Clostridium difficile colitis", "role": "Effect"}, {"name": "cisplatin-based combination chemotherapy", "role": "Treatment"}, {"name": "chemotherapy", "role": "Treatment.Route"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "ovarian cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-764", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Cerebral demyelinating disease", "role": "Effect"}, {"name": "adjuvant therapy with levamisole", "role": "Treatment"}, {"name": "levamisole", "role": "Treatment.Drug"}, {"name": "malignant melanoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-765", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "cognitive impairment", "role": "Effect"}, {"name": "Amoxapine", "role": "Treatment"}, {"name": "Amoxapine", "role": "Treatment.Drug"}]}]}
{"id": "train-766", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "both patients", "role": "Subject"}, {"name": "Granisetron hydrochloride (3 mg on days 1, 8, and 15) and dexamethasone (13.2 mg on day 1 and 6.6 mg on days 2, 3, 8, and 15)", "role": "Treatment"}, {"name": "irinotecan", "role": "Treatment"}, {"name": "Granisetron hydrochloride", "role": "Treatment.Drug"}, {"name": "dexamethasone", "role": "Treatment.Drug"}, {"name": "3 mg", "role": "Treatment.Dosage"}, {"name": "13.2 mg", "role": "Treatment.Dosage"}, {"name": "6.6 mg", "role": "Treatment.Dosage"}, {"name": "on day 1", "role": "Treatment.Freq"}, {"name": "on days 1, 8, and 15", "role": "Treatment.Freq"}, {"name": "on days 2, 3, 8, and 15", "role": "Treatment.Freq"}, {"name": "dexamethasone", "role": "Combination.Drug"}, {"name": "Granisetron hydrochloride", "role": "Combination.Drug"}]}]}
{"id": "train-767", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "leukemic patients", "role": "Subject"}, {"name": "Visceral herpesvirus infections", "role": "Effect"}, {"name": "cytarabine", "role": "Treatment"}, {"name": "cytarabine.", "role": "Treatment.Drug"}, {"name": "leukemic", "role": "Treatment.Disorder"}]}]}
{"id": "train-768", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "pseudomembranous colitis", "role": "Effect"}, {"name": "metronidazole", "role": "Treatment"}, {"name": "metronidazole", "role": "Treatment.Drug"}]}]}
{"id": "train-769", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Oral mucositis", "role": "Effect"}, {"name": "cancer chemotherapy", "role": "Treatment"}, {"name": "chemotherapy", "role": "Treatment.Route"}, {"name": "cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-770", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "One case", "role": "Subject"}, {"name": "priapism", "role": "Effect"}, {"name": "during heparin therapy", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}, {"name": "surgical operation to the knee", "role": "Treatment.Disorder"}]}]}
{"id": "train-771", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "permanent visual changes", "role": "Effect"}, {"name": "amiodarone and digoxin", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "digoxin", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Combination.Drug"}, {"name": "digoxin", "role": "Combination.Drug"}]}]}
{"id": "train-772", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a woman patient", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "celiac disease", "role": "Effect"}, {"name": "pegylated interferon alpha-2a and ribavirin use for chronic hepatitis C.", "role": "Treatment"}, {"name": "pegylated interferon alpha-2a", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}, {"name": "ribavirin", "role": "Combination.Drug"}, {"name": "pegylated interferon alpha-2a", "role": "Combination.Drug"}]}]}
{"id": "train-773", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "ectropion", "role": "Effect"}, {"name": "5-FU", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-774", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "In rare cases", "role": "Subject"}, {"name": "cancer-associated hemolytic uremic syndrome", "role": "Effect"}, {"name": "hemolytic anemia, thrombocytopenia and progressive renal failure", "role": "Effect"}, {"name": "mitomycin C (MMC)", "role": "Treatment"}, {"name": "mitomycin C", "role": "Treatment.Drug"}]}]}
{"id": "train-775", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Hemolytic uremic syndrome", "role": "Effect"}, {"name": "oxaliplatin", "role": "Treatment"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-776", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "mutism", "role": "Effect"}, {"name": "Tacrolimus (FK506)", "role": "Treatment"}, {"name": "Tacrolimus", "role": "Treatment.Drug"}]}]}
{"id": "train-777", "event": [{"trigger": "adverse effect", "type": "adverse_event", "arguments": [{"name": "MS patients", "role": "Subject"}, {"name": "proteinuria and nephrotic syndrome", "role": "Effect"}, {"name": "IFN-beta-1b", "role": "Treatment"}, {"name": "IFN-beta-1b", "role": "Treatment.Drug"}, {"name": "MS", "role": "Treatment.Disorder"}]}]}
{"id": "train-778", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lupus, which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms", "role": "Effect"}, {"name": "sulfasalazine", "role": "Treatment"}, {"name": "sulfasalazine", "role": "Treatment.Drug"}]}]}
{"id": "train-779", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "platelet activation", "role": "Effect"}, {"name": "standard heparin and the LMW heparins Fragmin and Fraxiparin (Sanofi Labaz, Munich, FRG), as well as the enoxaparine Clexane (Nattermann, Cologne, FRG)", "role": "Treatment"}, {"name": "Fragmin", "role": "Treatment.Drug"}, {"name": "Fraxiparin", "role": "Treatment.Drug"}, {"name": "Clexane", "role": "Treatment.Drug"}]}]}
{"id": "train-780", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "This case", "role": "Subject"}, {"name": "hyperlactatemia relapse", "role": "Effect"}, {"name": "zidovudine", "role": "Treatment"}, {"name": "zidovudine", "role": "Treatment.Drug"}]}]}
{"id": "train-781", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Acute leukaemia", "role": "Effect"}, {"name": "tamoxifen therapy", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-782", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "thrombocytopenia", "role": "Effect"}, {"name": "Heparin", "role": "Treatment"}, {"name": "Heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-783", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "painful, oedematous, cyanosed hand", "role": "Effect"}, {"name": "injected a solution of diamorphine and methylphenidate into his radial artery", "role": "Treatment"}, {"name": "injected", "role": "Treatment.Route"}, {"name": "into his radial artery", "role": "Treatment.Route"}, {"name": "diamorphine", "role": "Treatment.Drug"}, {"name": "methylphenidate", "role": "Treatment.Drug"}, {"name": "diamorphine", "role": "Combination.Drug"}, {"name": "methylphenidate", "role": "Combination.Drug"}]}]}
{"id": "train-784", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "vincristine and actinomycin D", "role": "Treatment"}, {"name": "vincristine", "role": "Treatment.Drug"}, {"name": "actinomycin D", "role": "Treatment.Drug"}, {"name": "vincristine", "role": "Combination.Drug"}, {"name": "actinomycin D", "role": "Combination.Drug"}]}]}
{"id": "train-785", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Pure red cell aplasia", "role": "Effect"}, {"name": "fenoprofen", "role": "Treatment"}, {"name": "fenoprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-786", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 56-year-old white woman with a diagnosis of reactive depression", "role": "Subject"}, {"name": "56-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "severe UI", "role": "Effect"}, {"name": "30 days' treatment with venlafaxine 75 mg/day.", "role": "Treatment"}, {"name": "reactive depression", "role": "Treatment.Disorder"}, {"name": "30 days", "role": "Treatment.Time_elapsed"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "75 mg/day", "role": "Treatment.Dosage"}]}]}
{"id": "train-787", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Three patients", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "reproductive endocrine disorder", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-788", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "marked elevation of serum creatine kinase", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-789", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "2 patients (6.1%)", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "(6.1%)", "role": "Subject.Population"}, {"name": "Severe C. difficile colitis", "role": "Effect"}, {"name": "cisplatin-based combination chemotherapy", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "ovarian malignancies", "role": "Treatment.Disorder"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-790", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 56-year-old woman with scleroderma", "role": "Subject"}, {"name": "56-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis", "role": "Effect"}, {"name": "27 months of D-penicillamine therapy and a cumulative dose of 1,200 g.", "role": "Treatment"}, {"name": "scleroderma", "role": "Treatment.Disorder"}, {"name": "27 months", "role": "Treatment.Time_elapsed"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}, {"name": "1,200 g.", "role": "Treatment.Dosage"}]}]}
{"id": "train-791", "event": [{"trigger": "leads", "type": "adverse_event", "arguments": [{"name": "hypokalemia", "role": "Effect"}, {"name": "High-dose phosphate", "role": "Treatment"}, {"name": "hypophosphatemic osteomalacia", "role": "Treatment.Disorder"}, {"name": "phosphate", "role": "Treatment.Drug"}, {"name": "High-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-792", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "heparin associated thrombocytopenia", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "continuous arteriovenous haemofiltration", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-793", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "fulminant hepatitis", "role": "Effect"}, {"name": "nevirapine", "role": "Treatment"}, {"name": "nevirapine", "role": "Treatment.Drug"}]}]}
{"id": "train-794", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "ARF", "role": "Effect"}, {"name": "mannitol infusion", "role": "Treatment"}, {"name": "mannitol", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-795", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a case with chronic hepatitis B", "role": "Subject"}, {"name": "a", "role": "Subject.Population"}, {"name": "acute dystonia", "role": "Effect"}, {"name": "the first dose of pegylated interferon alpha.", "role": "Treatment"}, {"name": "chronic hepatitis B", "role": "Treatment.Disorder"}, {"name": "first dose", "role": "Treatment.Dosage"}, {"name": "pegylated interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-796", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Trichiasis", "role": "Effect"}, {"name": "prostaglandin analog", "role": "Treatment"}, {"name": "prostaglandin analog", "role": "Treatment.Drug"}]}]}
{"id": "train-797", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "drug-induced vasculitis or lupus-like syndrome", "role": "Effect"}, {"name": "vancomycin", "role": "Treatment"}, {"name": "vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-798", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "fentanyl and other phenylpiperidine opioids", "role": "Treatment"}, {"name": "treated with SSRIs", "role": "Treatment"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "phenylpiperidine opioids", "role": "Treatment.Drug"}, {"name": "SSRIs", "role": "Treatment.Drug"}, {"name": "phenylpiperidine opioids", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}, {"name": "SSRIs", "role": "Combination.Drug"}]}]}
{"id": "train-799", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute myocardial ischemia", "role": "Effect"}, {"name": "accidental intravenous administration of epinephrine in high concentration", "role": "Treatment"}, {"name": "intravenous administration", "role": "Treatment.Route"}, {"name": "epinephrine", "role": "Treatment.Drug"}, {"name": "high concentration", "role": "Treatment.Dosage"}]}]}
{"id": "train-800", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "Bromide intoxication", "role": "Effect"}, {"name": "pyridostigmine bromide", "role": "Treatment"}, {"name": "pyridostigmine bromide", "role": "Treatment.Drug"}]}]}
{"id": "train-801", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke", "role": "Subject"}, {"name": "thrombotic left middle cerebral artery distribution stroke", "role": "Effect"}, {"name": "pFVIII", "role": "Treatment"}, {"name": "acquired haemophilia", "role": "Treatment.Disorder"}, {"name": "pFVIII", "role": "Treatment.Drug"}]}]}
{"id": "train-802", "event": [{"trigger": "precipitated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "long-term treatment with sertraline", "role": "Treatment"}, {"name": "sertraline", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-803", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "15 patients", "role": "Subject"}, {"name": "4", "role": "Subject"}, {"name": "15", "role": "Subject.Population"}, {"name": "drowsiness and dry mouth", "role": "Effect"}, {"name": "tizanidine and mexiletine", "role": "Treatment"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "mexiletine", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Combination.Drug"}, {"name": "mexiletine", "role": "Combination.Drug"}]}]}
{"id": "train-804", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Type I second-degree AV block (Mobitz type I, Wenckebach AV block)", "role": "Effect"}, {"name": "ritodrine", "role": "Treatment"}, {"name": "preterm labor", "role": "Treatment.Disorder"}, {"name": "ritodrine", "role": "Treatment.Drug"}]}]}
{"id": "train-805", "event": [{"trigger": "determined", "type": "adverse_event", "arguments": [{"name": "acute liver toxicity", "role": "Effect"}, {"name": "TMP-SMX", "role": "Treatment"}, {"name": "TMP", "role": "Treatment.Drug"}, {"name": "SMX", "role": "Treatment.Drug"}, {"name": "TMP", "role": "Combination.Drug"}, {"name": "SMX", "role": "Combination.Drug"}]}]}
{"id": "train-806", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "One of the patients", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "brain metastatic condition", "role": "Effect"}, {"name": "dexamethasone", "role": "Treatment"}, {"name": "dexamethasone", "role": "Treatment.Drug"}, {"name": "brain metastatic condition", "role": "Treatment.Disorder"}]}]}
{"id": "train-807", "event": [{"trigger": "revealed", "type": "adverse_event", "arguments": [{"name": "amiodarone corneal deposits", "role": "Effect"}, {"name": "Biomicroscopy", "role": "Treatment"}, {"name": "Biomicroscopy", "role": "Treatment.Drug"}]}]}
{"id": "train-808", "event": [{"trigger": "unpredictable", "type": "adverse_event", "arguments": [{"name": "irreversible vision loss", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-809", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "patients with juvenile rheumatoid arthritis (JRA", "role": "Subject"}, {"name": "malignant lymphoma", "role": "Effect"}, {"name": "Methotrexate (MTX)", "role": "Treatment"}, {"name": "Methotrexate", "role": "Treatment.Drug"}, {"name": "juvenile rheumatoid arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-810", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "The two middle aged women", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "middle aged", "role": "Subject.Age"}, {"name": "women", "role": "Subject.Gender"}, {"name": "respiratory symptoms", "role": "Effect"}, {"name": "prolonged treatment with nitrofurantoin", "role": "Treatment"}, {"name": "prolonged treatment", "role": "Treatment.Freq"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-811", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "rheumatoid arthritis", "role": "Subject.Disorder"}, {"name": "fever, pancytopenia, splenomegaly, and extreme hyperferritinemia", "role": "Effect"}, {"name": "adalimumab", "role": "Treatment"}, {"name": "adalimumab", "role": "Treatment.Drug"}]}]}
{"id": "train-812", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "Visual hallucinations", "role": "Effect"}, {"name": "zonisamide", "role": "Treatment"}, {"name": "zonisamide", "role": "Treatment.Drug"}]}]}
{"id": "train-813", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with hypoparathyroidism.", "role": "Subject"}, {"name": "Milk-alkali syndrome", "role": "Effect"}, {"name": "1,25(OH)2D", "role": "Treatment"}, {"name": "1,25(OH)2D", "role": "Treatment.Drug"}, {"name": "hypoparathyroidism", "role": "Treatment.Disorder"}]}]}
{"id": "train-814", "event": [{"trigger": "appeared", "type": "adverse_event", "arguments": [{"name": "a female acromegalic patient", "role": "Subject"}, {"name": "acromegalic", "role": "Subject.Disorder"}, {"name": "female", "role": "Subject.Gender"}, {"name": "hepatic adenomas", "role": "Effect"}, {"name": "danazol treatment", "role": "Treatment"}, {"name": "uterine fibromatosis.", "role": "Treatment.Disorder"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-815", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychiatric patients", "role": "Subject"}, {"name": "psychiatric", "role": "Subject.Disorder"}, {"name": "Carbamazepine toxicity", "role": "Effect"}, {"name": "clarithromycin", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}, {"name": "Carbamazepine", "role": "Combination.Drug"}]}]}
{"id": "train-816", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "gastrointestinal or intracranial bleeding", "role": "Effect"}, {"name": "tissue plasminogen activator", "role": "Treatment"}, {"name": "acute myocardial infarction", "role": "Treatment.Disorder"}, {"name": "tissue plasminogen activator", "role": "Treatment.Drug"}]}]}
{"id": "train-817", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "hemolytic-uremic syndrome", "role": "Effect"}, {"name": "oxaliplatin-based chemotherapy", "role": "Treatment"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-818", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "staphylococcus aureus sepsis", "role": "Effect"}, {"name": "CyA therapy", "role": "Treatment"}, {"name": "CyA", "role": "Treatment.Drug"}]}]}
{"id": "train-819", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "interstitial nephritis", "role": "Effect"}, {"name": "Nabumetone", "role": "Treatment"}, {"name": "Nabumetone", "role": "Treatment.Drug"}]}]}
{"id": "train-820", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "imatinib", "role": "Treatment"}, {"name": "imatinib", "role": "Treatment.Drug"}]}]}
{"id": "train-821", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient with hormone-refractory prostate cancer", "role": "Subject"}, {"name": "Fatal interstitial pneumonitis", "role": "Effect"}, {"name": "docetaxel", "role": "Treatment"}, {"name": "docetaxel", "role": "Treatment.Drug"}, {"name": "hormone-refractory prostate cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-822", "event": [{"trigger": "licensed", "type": "potential_therapeutic_event", "arguments": [{"name": "adult and juvenile rheumatoid arthritis as well as psoriatic arthritis", "role": "Subject"}, {"name": "adult", "role": "Subject.Age"}, {"name": "juvenile", "role": "Subject.Age"}, {"name": "Etanercept", "role": "Treatment"}, {"name": "a tumor necrosis factor (TNF) inhibitor", "role": "Treatment"}, {"name": "Etanercept", "role": "Treatment.Drug"}, {"name": "adult and juvenile rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "psoriatic arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-823", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Reye-like syndrome", "role": "Effect"}, {"name": "calcium hopantenate", "role": "Treatment"}, {"name": "calcium hopantenate", "role": "Treatment.Drug"}]}]}
{"id": "train-824", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "an infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "Sudden death", "role": "Effect"}, {"name": "methemoglobinemia", "role": "Effect"}, {"name": "sweet spirits of nitre", "role": "Treatment"}, {"name": "sweet spirits of nitre", "role": "Treatment.Drug"}]}]}
{"id": "train-825", "event": [{"trigger": "have", "type": "adverse_event", "arguments": [{"name": "Six children with growth retardation", "role": "Subject"}, {"name": "Six", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "adrenal suppression", "role": "Effect"}, {"name": "high-dose fluticasone propionate", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "fluticasone propionate", "role": "Treatment.Drug"}, {"name": "growth retardation", "role": "Treatment.Disorder"}]}]}
{"id": "train-826", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "nephropathy", "role": "Effect"}, {"name": "Methotrexate", "role": "Treatment"}, {"name": "Methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-827", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Four cases", "role": "Subject"}, {"name": "Four", "role": "Subject.Population"}, {"name": "oesophageal damage", "role": "Effect"}, {"name": "ingestion of the urinary anti-spasmodic agent emepronium bromide", "role": "Treatment"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "emepronium bromide", "role": "Treatment.Drug"}]}]}
{"id": "train-828", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 66-year-old Japanese woman with severe scleroderma", "role": "Subject"}, {"name": "66-year-old", "role": "Subject.Age"}, {"name": "Japanese", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "anemia and thrombocytopenia", "role": "Effect"}, {"name": "D-penicillamine (D-Pen) treatment", "role": "Treatment"}, {"name": "severe scleroderma", "role": "Treatment.Disorder"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-829", "event": [{"trigger": "treatments", "type": "potential_therapeutic_event", "arguments": [{"name": "Corticosteroid injections", "role": "Treatment"}, {"name": "Corticosteroid", "role": "Treatment.Drug"}, {"name": "injections", "role": "Treatment.Route"}, {"name": "pain disorders", "role": "Treatment.Disorder"}]}]}
{"id": "train-830", "event": [{"trigger": "occurred", "type": "potential_therapeutic_event", "arguments": [{"name": "return of spontaneous circulation", "role": "Effect"}, {"name": "epinephrine", "role": "Treatment"}, {"name": "administration of the alpha-agonist metaraminol", "role": "Treatment"}, {"name": "anaphylaxis under anaesthesia", "role": "Treatment.Disorder"}, {"name": "metaraminol", "role": "Treatment.Drug"}, {"name": "epinephrine", "role": "Treatment.Drug"}, {"name": "epinephrine", "role": "Combination.Drug"}, {"name": "metaraminol", "role": "Combination.Drug"}]}]}
{"id": "train-831", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 51-yr-old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria", "role": "Subject"}, {"name": "51-yr-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "attacks of asthma", "role": "Effect"}, {"name": "captopril was added to the nadolol and dyazide", "role": "Treatment"}, {"name": "high blood pressure", "role": "Treatment.Disorder"}, {"name": "captopril", "role": "Treatment.Drug"}, {"name": "nadolol", "role": "Treatment.Drug"}, {"name": "dyazide", "role": "Treatment.Drug"}, {"name": "captopril", "role": "Combination.Drug"}, {"name": "nadolol", "role": "Combination.Drug"}, {"name": "dyazide", "role": "Combination.Drug"}]}]}
{"id": "train-832", "event": [{"trigger": "toxicity.", "type": "adverse_event", "arguments": [{"name": "toxicity", "role": "Effect"}, {"name": "After ticlopidine was discontinued", "role": "Treatment"}, {"name": "rechallenged with the same dose of phenytoin", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-833", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Rhabdomyolysis", "role": "Effect"}, {"name": "interaction of ciprofloxacin with simvastatin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "simvastatin", "role": "Treatment.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}, {"name": "simvastatin", "role": "Combination.Drug"}]}]}
{"id": "train-834", "event": [{"trigger": "found", "type": "potential_therapeutic_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "unresponsive", "role": "Effect"}, {"name": "ifosfamide/mesna", "role": "Treatment"}, {"name": "ifosfamide", "role": "Treatment.Drug"}, {"name": "mesna", "role": "Treatment.Drug"}, {"name": "ifosfamide", "role": "Combination.Drug"}, {"name": "mesna", "role": "Combination.Drug"}]}]}
{"id": "train-835", "event": [{"trigger": "secondary to", "type": "adverse_event", "arguments": [{"name": "Symptomatic hypoglycemia", "role": "Effect"}, {"name": "glipizide-trimethoprim/sulfamethoxazole drug interaction", "role": "Treatment"}, {"name": "glipizide", "role": "Treatment.Drug"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "glipizide", "role": "Combination.Drug"}, {"name": "trimethoprim", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}]}]}
{"id": "train-836", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 51-year-old man", "role": "Subject"}, {"name": "51-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "type 1 diabetes mellitus", "role": "Effect"}, {"name": "24 weeks of treatment with recombinant alpha-2b peginterferon plus ribavirin", "role": "Treatment"}, {"name": "24 weeks", "role": "Treatment.Time_elapsed"}, {"name": "recombinant alpha-2b peginterferon", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}, {"name": "recombinant alpha-2b peginterferon", "role": "Combination.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}]}]}
{"id": "train-837", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "severely preeclamptic patient", "role": "Subject"}, {"name": "severely preeclamptic", "role": "Subject.Disorder"}, {"name": "protracted neuromuscular block", "role": "Effect"}, {"name": "vecuronium", "role": "Treatment"}, {"name": "vecuronium", "role": "Treatment.Drug"}]}]}
{"id": "train-838", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Paroxysmal supraventricular tachycardia", "role": "Effect"}, {"name": "cisplatin and etoposide combination", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "etoposide", "role": "Combination.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}]}]}
{"id": "train-839", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "diffuse interstitial pulmonary fibrosis", "role": "Effect"}, {"name": "bilateral pulmonary infiltrates", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-840", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "An 83-year-old man", "role": "Subject"}, {"name": "83-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "symptomatic hypoglycemia", "role": "Effect"}, {"name": "receiving glipizide 10 mg", "role": "Treatment"}, {"name": "three days of adding trimethoprim/sulfamethoxazole (TMP/SMX)", "role": "Treatment"}, {"name": "three days", "role": "Treatment.Time_elapsed"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "glipizide", "role": "Treatment.Drug"}, {"name": "10 mg", "role": "Treatment.Dosage"}, {"name": "glipizide", "role": "Combination.Drug"}, {"name": "trimethoprim", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}]}]}
{"id": "train-841", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "a subacute cholestatic hepatitis", "role": "Effect"}, {"name": "herbal related liver injury", "role": "Effect"}, {"name": "senna", "role": "Treatment"}, {"name": "senna", "role": "Treatment.Drug"}]}]}
{"id": "train-842", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "multiorgan failure", "role": "Effect"}, {"name": "lisinopril", "role": "Treatment"}, {"name": "lisinopril", "role": "Treatment.Drug"}]}]}
{"id": "train-843", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "agranulocytosis", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-844", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 54-year-old Turkish woman", "role": "Subject"}, {"name": "54-year-old", "role": "Subject.Age"}, {"name": "Turkish", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "FDE", "role": "Effect"}, {"name": "ceftriaxone", "role": "Treatment"}, {"name": "ceftriaxone", "role": "Treatment.Drug"}]}]}
{"id": "train-845", "event": [{"trigger": "controlled", "type": "potential_therapeutic_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "withdrawal of phenytoin and reduction of drug levels", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-846", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "fulminant hepatic failure", "role": "Effect"}, {"name": "disulfiram", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-847", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "patients with diabetes mellitus", "role": "Subject"}, {"name": "diabetes mellitus", "role": "Subject.Disorder"}, {"name": "a number of drug interactions with coadministered drugs", "role": "Effect"}, {"name": "ketoconazole", "role": "Treatment"}, {"name": "ketoconazole", "role": "Treatment.Drug"}, {"name": "Fungal infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-848", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a surgically untreated eye", "role": "Subject"}, {"name": "choroidal detachment", "role": "Effect"}, {"name": "Dorzolamide", "role": "Treatment"}, {"name": "Dorzolamide", "role": "Treatment.Drug"}]}]}
{"id": "train-849", "event": [{"trigger": "contribute", "type": "adverse_event", "arguments": [{"name": "impaired tissue perfusion", "role": "Effect"}, {"name": "vasopressin", "role": "Treatment"}, {"name": "vasopressin", "role": "Treatment.Drug"}]}]}
{"id": "train-850", "event": [{"trigger": "resolution", "type": "potential_therapeutic_event", "arguments": [{"name": "methylprednisolone and mannitol", "role": "Treatment"}, {"name": "topiramate-induced angle-closure glaucoma", "role": "Treatment.Disorder"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}, {"name": "mannitol", "role": "Treatment.Drug"}, {"name": "methylprednisolone", "role": "Combination.Drug"}, {"name": "mannitol", "role": "Combination.Drug"}]}]}
{"id": "train-851", "event": [{"trigger": "took", "type": "adverse_event", "arguments": [{"name": "A 66-year-old mand suffering from severe coronary heart disease", "role": "Subject"}, {"name": "66-year-old", "role": "Subject.Age"}, {"name": "mand", "role": "Subject.Gender"}, {"name": "coronary heart disease", "role": "Subject.Disorder"}, {"name": "complete atrioventricular block", "role": "Effect"}, {"name": "digoxin", "role": "Treatment"}, {"name": "digoxin", "role": "Treatment.Drug"}]}]}
{"id": "train-852", "event": [{"trigger": "managed", "type": "potential_therapeutic_event", "arguments": [{"name": "MM", "role": "Treatment"}, {"name": "generalized MG", "role": "Treatment.Disorder"}, {"name": "MM", "role": "Treatment.Drug"}]}]}
{"id": "train-853", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "severe erythroderma.", "role": "Effect"}, {"name": "Epoprostenol", "role": "Treatment"}, {"name": "Epoprostenol", "role": "Treatment.Drug"}]}]}
{"id": "train-854", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "increased cerebral cortical excitability", "role": "Effect"}, {"name": "flupirtine", "role": "Treatment"}, {"name": "flupirtine", "role": "Treatment.Drug"}]}]}
{"id": "train-855", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "erythroid aplasia", "role": "Effect"}, {"name": "fenoprofen", "role": "Treatment"}, {"name": "fenoprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-856", "event": [{"trigger": "eruption", "type": "adverse_event", "arguments": [{"name": "Lichenoid drug eruption", "role": "Effect"}, {"name": "salsalate", "role": "Treatment"}, {"name": "salsalate", "role": "Treatment.Drug"}]}]}
{"id": "train-857", "event": [{"trigger": "treated with", "type": "potential_therapeutic_event", "arguments": [{"name": "Two pediatric oncology patients with Ewing's sarcoma and one with mixed germ cell tumor", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "one", "role": "Subject.Population"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "drug regimens that included bleomycin or cyclophosphamide", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "Ewing's sarcoma", "role": "Treatment.Disorder"}, {"name": "mixed germ cell tumor", "role": "Treatment.Disorder"}]}]}
{"id": "train-858", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "fatal complication", "role": "Effect"}, {"name": "retinoic acid", "role": "Treatment"}, {"name": "retinoic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-859", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "38 children", "role": "Subject"}, {"name": "38", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "complication", "role": "Effect"}, {"name": "high-dose cytosine arabinoside", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}]}]}
{"id": "train-860", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient with chronic plaque psoriasis", "role": "Subject"}, {"name": "aseptic pleuropericarditis", "role": "Effect"}, {"name": "methotrexate therapy", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "chronic plaque psoriasis", "role": "Treatment.Disorder"}]}]}
{"id": "train-861", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "dyserythropoiesis", "role": "Effect"}, {"name": "Linezolid", "role": "Treatment"}, {"name": "Linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-862", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "some patients", "role": "Subject"}, {"name": "increased libido", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-863", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "a transient, nonpigmenting fixed drug eruption", "role": "Effect"}, {"name": "iothalamate", "role": "Treatment"}, {"name": "iothalamate", "role": "Treatment.Drug"}]}]}
{"id": "train-864", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "Mucosal pigmentation", "role": "Effect"}, {"name": "topical tacrolimus", "role": "Treatment"}, {"name": "oral lichen planus", "role": "Treatment.Disorder"}, {"name": "tacrolimus", "role": "Treatment.Drug"}, {"name": "topical", "role": "Treatment.Route"}]}]}
{"id": "train-865", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "cancer patient", "role": "Subject"}, {"name": "life-threatening complications", "role": "Effect"}, {"name": "have profound DPD deficiency", "role": "Effect"}, {"name": "topical 5-FU", "role": "Treatment"}, {"name": "cancer", "role": "Treatment.Disorder"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "topical", "role": "Treatment.Route"}]}]}
{"id": "train-866", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "acute manic state is characterized by marked psychotic symptoms and intense anxiety", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-867", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "cachectic patients", "role": "Subject"}, {"name": "with protracted diarrhoea", "role": "Subject"}, {"name": "severe hypoglycaemia", "role": "Effect"}, {"name": "anti-malarial drugs including mefloquine", "role": "Treatment"}, {"name": "mefloquine", "role": "Treatment.Drug"}, {"name": "cachectic", "role": "Treatment.Disorder"}, {"name": "protracted diarrhoea", "role": "Treatment.Disorder"}]}]}
{"id": "train-868", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Arrhythmias and cardiac arrest", "role": "Effect"}, {"name": "amphotericin B administration", "role": "Treatment"}, {"name": "amphotericin B", "role": "Treatment.Drug"}]}]}
{"id": "train-869", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "the hypotension", "role": "Effect"}, {"name": "the interaction between tizanidine and lisinopril", "role": "Treatment"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "lisinopril", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Combination.Drug"}, {"name": "lisinopril", "role": "Combination.Drug"}]}]}
{"id": "train-870", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "prolonged fever", "role": "Effect"}, {"name": "Baclofen withdrawal", "role": "Treatment"}, {"name": "Baclofen", "role": "Treatment.Drug"}]}]}
{"id": "train-871", "event": [{"trigger": "complicating", "type": "adverse_event", "arguments": [{"name": "Interstitial pneumonitis and alveolar hemorrhage", "role": "Effect"}, {"name": "rituximab", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}]}]}
{"id": "train-872", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a sixty years old woman", "role": "Subject"}, {"name": "sixty years old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "several previous episodes of rhinitis, conjunctivitis and perspiration immediately", "role": "Effect"}, {"name": "salmon calcitonin with nasal spray or intramuscular administration (Calsynar)", "role": "Treatment"}, {"name": "nasal spray", "role": "Treatment.Route"}, {"name": "intramuscular", "role": "Treatment.Route"}, {"name": "salmon calcitonin", "role": "Treatment.Drug"}]}]}
{"id": "train-873", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a 46-year-old female patient", "role": "Subject"}, {"name": "46-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "subcutaneous changes", "role": "Effect"}, {"name": "presented as localized panniculitis in the area around the injection sites", "role": "Effect"}, {"name": "repeated glatiramer acetate injection", "role": "Treatment"}, {"name": "glatiramer acetate", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-874", "event": [{"trigger": "received", "type": "potential_therapeutic_event", "arguments": [{"name": "Eighty-two patients with various malignancies", "role": "Subject"}, {"name": "Eighty-two", "role": "Subject.Population"}, {"name": "various malignancies", "role": "Subject.Disorder"}, {"name": "imipenem/cilastatin 143 times for neutropenic fever", "role": "Treatment"}, {"name": "imipenem", "role": "Treatment.Drug"}, {"name": "cilastatin", "role": "Treatment.Drug"}, {"name": "neutropenic fever", "role": "Treatment.Disorder"}, {"name": "imipenem", "role": "Combination.Drug"}, {"name": "cilastatin", "role": "Combination.Drug"}]}]}
{"id": "train-875", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "potentially life-threatening side effects", "role": "Effect"}, {"name": "NSAIDs", "role": "Treatment"}, {"name": "NSAIDs", "role": "Treatment.Drug"}, {"name": "DDAVP", "role": "Treatment.Drug"}, {"name": "NSAIDs", "role": "Combination.Drug"}, {"name": "DDAVP", "role": "Combination.Drug"}]}]}
{"id": "train-876", "event": [{"trigger": "initiation and rechallenge", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "diabetes", "role": "Effect"}, {"name": "weight gain", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-877", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "ototoxicity", "role": "Effect"}, {"name": "azithromycin", "role": "Treatment"}, {"name": "azithromycin", "role": "Treatment.Drug"}]}]}
{"id": "train-878", "event": [{"trigger": "clinical activity,", "type": "potential_therapeutic_event", "arguments": [{"name": "Orally delivered PXD", "role": "Treatment"}, {"name": "weekly AUC2-carboplatin", "role": "Treatment"}, {"name": "PROC", "role": "Treatment.Disorder"}, {"name": "Orally", "role": "Treatment.Route"}, {"name": "PXD", "role": "Treatment.Drug"}, {"name": "AUC2-carboplatin", "role": "Treatment.Drug"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "PXD", "role": "Combination.Drug"}, {"name": "AUC2-carboplatin", "role": "Combination.Drug"}]}]}
{"id": "train-879", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a series of patients", "role": "Subject"}, {"name": "a series", "role": "Subject.Population"}, {"name": "transient asymptomatic bradycardia", "role": "Effect"}, {"name": "continuous infusion 5-FU", "role": "Treatment"}, {"name": "continuous", "role": "Treatment.Freq"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-880", "event": [{"trigger": "in", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with multiple myeloma", "role": "Subject"}, {"name": "Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen", "role": "Treatment"}, {"name": "multiple myeloma", "role": "Treatment.Disorder"}, {"name": "bortezomib", "role": "Treatment.Drug"}, {"name": "lenalidomide/", "role": "Treatment.Drug"}, {"name": "dexamethasone", "role": "Treatment.Drug"}, {"name": "bortezomib", "role": "Treatment.Drug"}, {"name": "dexamethasone", "role": "Treatment.Drug"}, {"name": "bortezomib", "role": "Combination.Drug"}, {"name": "lenalidomide/", "role": "Combination.Drug"}, {"name": "dexamethasone", "role": "Combination.Drug"}, {"name": "bortezomib", "role": "Combination.Drug"}, {"name": "dexamethasone", "role": "Combination.Drug"}]}]}
{"id": "train-881", "event": [{"trigger": "assess", "type": "potential_therapeutic_event", "arguments": [{"name": "PROC patients", "role": "Subject"}, {"name": "potential therapeutic benefit", "role": "Effect"}, {"name": "phenoxodiol (PXD), a novel biomodulator shown to have chemoresistance reversing potential, when combined with weekly AUC2-carboplatin", "role": "Treatment"}, {"name": "phenoxodiol", "role": "Treatment.Drug"}, {"name": "carboplatin", "role": "Treatment.Drug"}, {"name": "PROC", "role": "Treatment.Disorder"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "carboplatin", "role": "Combination.Drug"}, {"name": "phenoxodiol", "role": "Combination.Drug"}]}]}
{"id": "train-882", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "neuromuscular block", "role": "Effect"}, {"name": "curariform muscle relaxant was given simultaneously", "role": "Treatment"}, {"name": "magnesium", "role": "Treatment.Drug"}, {"name": "curariform muscle relaxant", "role": "Treatment.Drug"}, {"name": "magnesium", "role": "Combination.Drug"}, {"name": "curariform muscle relaxant", "role": "Combination.Drug"}]}]}
{"id": "train-883", "event": [{"trigger": "supports", "type": "adverse_event", "arguments": [{"name": "3 patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "scleroderma", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-884", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "disseminated nocardiosis", "role": "Effect"}, {"name": "corticosteroid", "role": "Treatment"}, {"name": "corticosteroid", "role": "Treatment.Drug"}, {"name": "anti-phospholipid syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-885", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "bone marrow transplant patients", "role": "Subject"}, {"name": "bone marrow transplant", "role": "Subject.Disorder"}, {"name": "Eye movement disorders", "role": "Effect"}, {"name": "cyclosporin and ganciclovir", "role": "Treatment"}, {"name": "cyclosporin", "role": "Treatment.Drug"}, {"name": "ganciclovir", "role": "Treatment.Drug"}, {"name": "cyclosporin", "role": "Combination.Drug"}, {"name": "ganciclovir", "role": "Combination.Drug"}]}]}
{"id": "train-886", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Prolonged severe cholestasis", "role": "Effect"}, {"name": "oxacillin derivatives", "role": "Treatment"}, {"name": "oxacillin", "role": "Treatment.Drug"}]}]}
{"id": "train-887", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "the cases", "role": "Subject"}, {"name": "INR elevations", "role": "Effect"}, {"name": "Cisplatin", "role": "Treatment"}, {"name": "Cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-888", "event": [{"trigger": "complicating", "type": "adverse_event", "arguments": [{"name": "cardiotoxicity", "role": "Effect"}, {"name": "5-Fluorouracil", "role": "Treatment"}, {"name": "5-Fluorouracil", "role": "Treatment.Drug"}, {"name": "cervical cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-889", "event": [{"trigger": "owing", "type": "adverse_event", "arguments": [{"name": "fixed drug eruption", "role": "Effect"}, {"name": "PDE5 inhibitor tadalafil (Cialis)", "role": "Treatment"}, {"name": "tadalafil", "role": "Treatment.Drug"}]}]}
{"id": "train-890", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient with Crohn's disease", "role": "Subject"}, {"name": "Pancytopenia", "role": "Effect"}, {"name": "5-aminosalicylic acid", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "5-aminosalicylic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-891", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "all patients who develop unexplained lung disease", "role": "Subject"}, {"name": "lung disease", "role": "Subject.Disorder"}, {"name": "Fludarabine induced lung toxicity", "role": "Effect"}, {"name": "fludarabine", "role": "Treatment"}, {"name": "fludarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-892", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "occupational methemoglobinemia", "role": "Effect"}, {"name": "methyl nitrite", "role": "Treatment"}, {"name": "methyl nitrite", "role": "Treatment.Drug"}]}]}
{"id": "train-893", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "four cases", "role": "Subject"}, {"name": "children aged 10-15 years", "role": "Subject"}, {"name": "myxopapillary ependymoma, Crohn's disease and recurrent giant aphthous ulceration", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "10-15 years", "role": "Subject.Age"}, {"name": "sensorimotor axonal neuropathy", "role": "Effect"}, {"name": "thalidomide", "role": "Treatment"}, {"name": "thalidomide", "role": "Treatment.Drug"}, {"name": "myxopapillary ependymoma", "role": "Treatment.Disorder"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "recurrent giant aphthous ulceration", "role": "Treatment.Disorder"}]}]}
{"id": "train-894", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "The patient", "role": "Subject"}, {"name": "The", "role": "Subject"}, {"name": "died of respiratory failure", "role": "Effect"}, {"name": "8 days of steroid infusion and erlotinib discontinuation.", "role": "Treatment"}, {"name": "after 8 days", "role": "Treatment.Time_elapsed"}, {"name": "steroid", "role": "Treatment.Drug"}, {"name": "erlotinib", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-895", "event": [{"trigger": "side-effects", "type": "adverse_event", "arguments": [{"name": "Hypo-oestrogenic and anabolic/androgenic", "role": "Effect"}, {"name": "danazol", "role": "Treatment"}, {"name": "danazol", "role": "Treatment.Drug"}, {"name": "endometriosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-896", "event": [{"trigger": "idiosyncratic adverse reaction", "type": "adverse_event", "arguments": [{"name": "acute hepatitis", "role": "Effect"}, {"name": "gliclazide", "role": "Treatment"}, {"name": "gliclazide", "role": "Treatment.Drug"}]}]}
{"id": "train-897", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "haemorrhage", "role": "Effect"}, {"name": "initiating warfarin therapy regardless of the dosage", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-898", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "acute pancreatitis", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-899", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "76-year-old man", "role": "Subject"}, {"name": "76-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "acute blistering eruption", "role": "Effect"}, {"name": "high-dose penicillin treatment", "role": "Treatment"}, {"name": "penicillin", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "pneumococcal septicaemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-900", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a teenager with familial Mediterranean fever (FMF)", "role": "Subject"}, {"name": "teenager", "role": "Subject.Age"}, {"name": "myopathy", "role": "Effect"}, {"name": "colchicine", "role": "Treatment"}, {"name": "familial Mediterranean fever", "role": "Treatment.Disorder"}, {"name": "colchicine", "role": "Treatment.Drug"}]}]}
{"id": "train-901", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "mucositis", "role": "Subject"}, {"name": "mucositis", "role": "Subject.Disorder"}, {"name": "fatal hyperkalemia", "role": "Effect"}, {"name": "succinylcholine", "role": "Treatment"}, {"name": "succinylcholine", "role": "Treatment.Drug"}]}]}
{"id": "train-902", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "ESRF patients with atenolol toxicity", "role": "Subject"}, {"name": "ESRF", "role": "Subject.Disorder"}, {"name": "hemodialysis", "role": "Treatment"}, {"name": "hemodialysis", "role": "Treatment.Drug"}, {"name": "atenolol toxicity", "role": "Treatment.Disorder"}]}]}
{"id": "train-903", "event": [{"trigger": "administered", "type": "potential_therapeutic_event", "arguments": [{"name": "postmenopausal node-positive breast cancer patients", "role": "Subject"}, {"name": "Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "Epirubicin-cyclophosphamide", "role": "Treatment.Drug"}, {"name": "node-positive breast cancer", "role": "Treatment.Disorder"}, {"name": "tamoxifen", "role": "Combination.Drug"}, {"name": "Epirubicin-cyclophosphamide", "role": "Combination.Drug"}]}]}
{"id": "train-904", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Rupture of a cerebral aneurysm", "role": "Effect"}, {"name": "nifedipine", "role": "Treatment"}, {"name": "nifedipine", "role": "Treatment.Drug"}]}]}
{"id": "train-905", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "immediate hemolytic reaction", "role": "Effect"}, {"name": "repeated administration of oxaliplatin", "role": "Treatment"}, {"name": "repeated", "role": "Treatment.Freq"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-906", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Patient B", "role": "Subject"}, {"name": "perioral and upper extremity paresthesias", "role": "Effect"}, {"name": "the fourth cycle of CAP alone (2500 mg/m2)", "role": "Treatment"}, {"name": "CAP", "role": "Treatment.Drug"}, {"name": "the fourth cycle", "role": "Treatment.Freq"}, {"name": "2500 mg/m2", "role": "Treatment.Dosage"}]}]}
{"id": "train-907", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "four patients", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "seizures", "role": "Effect"}, {"name": "ofloxacin", "role": "Treatment"}, {"name": "ofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-908", "event": [{"trigger": "involving", "type": "adverse_event", "arguments": [{"name": "an infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "infant fatality", "role": "Effect"}, {"name": "pseudoephedrine, brompheniramine, and dextromethorphan", "role": "Treatment"}, {"name": "pseudoephedrine", "role": "Treatment.Drug"}, {"name": "brompheniramine", "role": "Treatment.Drug"}, {"name": "dextromethorphan", "role": "Treatment.Drug"}]}]}
{"id": "train-909", "event": [{"trigger": "between", "type": "adverse_event", "arguments": [{"name": "drug interaction", "role": "Effect"}, {"name": "zafirlukast and theophylline", "role": "Treatment"}, {"name": "zafirlukast", "role": "Treatment.Drug"}, {"name": "theophylline", "role": "Treatment.Drug"}, {"name": "zafirlukast", "role": "Combination.Drug"}, {"name": "theophylline", "role": "Combination.Drug"}]}]}
{"id": "train-910", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "agranulocytosis", "role": "Effect"}, {"name": "Dipyrone, also known as metamizole", "role": "Treatment"}, {"name": "Dipyrone", "role": "Treatment.Drug"}]}]}
{"id": "train-911", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "A fatal case", "role": "Subject"}, {"name": "pancytopenia", "role": "Effect"}, {"name": "levomepromazine", "role": "Treatment"}, {"name": "levomepromazine", "role": "Treatment.Drug"}]}]}
{"id": "train-912", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Reversible heart failure", "role": "Effect"}, {"name": "etanercept", "role": "Treatment"}, {"name": "etanercept", "role": "Treatment.Drug"}, {"name": "ankylosing spondylitis", "role": "Treatment.Disorder"}]}]}
{"id": "train-913", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "liver failure", "role": "Effect"}, {"name": "clarithromycin", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}]}]}
{"id": "train-914", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Localized panniculitis and subsequent lipoatrophy", "role": "Effect"}, {"name": "subcutaneous glatiramer acetate (Copaxone) injection", "role": "Treatment"}, {"name": "glatiramer acetate (Copaxone)", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-915", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "resolution of bradycardia", "role": "Effect"}, {"name": "an exaggerated increase of arterial blood pressure", "role": "Effect"}, {"name": "glycopyrrolate (5.0 microg/kg)", "role": "Treatment"}, {"name": "glycopyrrolate", "role": "Treatment.Drug"}, {"name": "5.0 microg/kg", "role": "Treatment.Dosage"}]}]}
{"id": "train-916", "event": [{"trigger": "hypersensitivity,", "type": "adverse_event", "arguments": [{"name": "hypersensitivity", "role": "Effect"}, {"name": "sulfadiazine", "role": "Treatment"}, {"name": "sulfadiazine", "role": "Treatment.Drug"}]}]}
{"id": "train-917", "event": [{"trigger": "treating", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with clozapine-induced granulocytopenia", "role": "Subject"}, {"name": "without the risk of recurrence of hematologic side effects", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-918", "event": [{"trigger": "resolution", "type": "potential_therapeutic_event", "arguments": [{"name": "Patients with insulin allergy", "role": "Subject"}, {"name": "concomitant protamine allergy", "role": "Subject"}, {"name": "insulin allergy", "role": "Subject.Disorder"}, {"name": "protamine allergy", "role": "Subject.Disorder"}, {"name": "standard desensitization", "role": "Treatment"}]}]}
{"id": "train-919", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "fever, pulmonary infiltrates, and pleural effusion", "role": "Effect"}, {"name": "acyclovir", "role": "Treatment"}, {"name": "acyclovir", "role": "Treatment.Drug"}]}]}
{"id": "train-920", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "macular lesion", "role": "Effect"}, {"name": "gentamicin", "role": "Treatment"}, {"name": "gentamicin", "role": "Treatment.Drug"}]}]}
{"id": "train-921", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Acute myocardial infarction", "role": "Effect"}, {"name": "high-dose methylprednisolone therapy", "role": "Treatment"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}, {"name": "Graves' ophthalmopathy", "role": "Treatment.Disorder"}, {"name": "high-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-922", "event": [{"trigger": "reported,", "type": "adverse_event", "arguments": [{"name": "hepatotoxic", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-923", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "a 4(1/2)-year-old boy", "role": "Subject"}, {"name": "4(1/2)-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "angioedema", "role": "Effect"}, {"name": "oxcarbazepine", "role": "Treatment"}, {"name": "oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-924", "event": [{"trigger": "used", "type": "adverse_event", "arguments": [{"name": "HIV-infected patients", "role": "Subject"}, {"name": "Caution", "role": "Effect"}, {"name": "coadministering enfuvirtide and niacin", "role": "Treatment"}, {"name": "enfuvirtide", "role": "Treatment.Drug"}, {"name": "niacin", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}, {"name": "enfuvirtide", "role": "Combination.Drug"}, {"name": "niacin", "role": "Combination.Drug"}]}]}
{"id": "train-925", "event": [{"trigger": "reports", "type": "adverse_event", "arguments": [{"name": "Several case", "role": "Subject"}, {"name": "Several", "role": "Subject.Population"}, {"name": "aplastic anemia", "role": "Effect"}, {"name": "acetazolamide", "role": "Treatment"}, {"name": "acetazolamide", "role": "Treatment.Drug"}]}]}
{"id": "train-926", "event": [{"trigger": "in", "type": "potential_therapeutic_event", "arguments": [{"name": "SSRIs and fentanyl are commonly co-administered", "role": "Treatment"}, {"name": "chronic or malignant pain", "role": "Treatment.Disorder"}, {"name": "underlying depression", "role": "Treatment.Disorder"}, {"name": "SSRIs", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "SSRIs", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}]}]}
{"id": "train-927", "event": [{"trigger": "triggered", "type": "adverse_event", "arguments": [{"name": "four patients", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "asterixis", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-928", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "Squamous-cell carcinoma arising", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-929", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "The case of a bipolar patient", "role": "Subject"}, {"name": "thyrotoxicosis with severe exophthalmos", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "bipolar", "role": "Treatment.Disorder"}]}]}
{"id": "train-930", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "The patient", "role": "Subject"}, {"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "Stevens-Johnson syndrome", "role": "Effect"}, {"name": "ophthalmic sulfonamide, and it was used for one day", "role": "Treatment"}, {"name": "ophthalmic", "role": "Treatment.Route"}, {"name": "sulfonamide", "role": "Treatment.Drug"}, {"name": "one day", "role": "Treatment.Duration"}]}]}
{"id": "train-931", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Papillary necrosis", "role": "Effect"}, {"name": "indinavir", "role": "Treatment"}, {"name": "indinavir", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}]}]}
{"id": "train-932", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 40 year old woman", "role": "Subject"}, {"name": "40 year old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "progressive cognitive dysfunction", "role": "Effect"}, {"name": "intraventricular IL-2", "role": "Treatment"}, {"name": "leptomeningeal disease", "role": "Treatment.Disorder"}, {"name": "IL-2", "role": "Treatment.Drug"}, {"name": "intraventricular", "role": "Treatment.Route"}]}]}
{"id": "train-933", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "surgically untreated eye with primary open-angle glaucoma", "role": "Subject"}, {"name": "extensive choroidal detachment", "role": "Effect"}, {"name": "dorzolamide therapy", "role": "Treatment"}, {"name": "dorzolamide", "role": "Treatment.Drug"}, {"name": "surgically untreated eye with primary open-angle glaucoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-934", "event": [{"trigger": "consequence", "type": "adverse_event", "arguments": [{"name": "Serotonin toxicity", "role": "Effect"}, {"name": "linezolid use in revision hip arthroplasty", "role": "Treatment"}, {"name": "Serotonin", "role": "Treatment"}, {"name": "Serotonin", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-935", "event": [{"trigger": "side effects of", "type": "adverse_event", "arguments": [{"name": "Gallstones and bile sludge", "role": "Effect"}, {"name": "octreotide therapy", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}]}]}
{"id": "train-936", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "some patients with Parkinson's disease", "role": "Subject"}, {"name": "daytime somnolence", "role": "Effect"}, {"name": "L-dopa", "role": "Treatment"}, {"name": "L-dopa", "role": "Treatment.Drug"}, {"name": "Parkinson's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-937", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "Seventy-four per cent of patients with epileptogenic disorders", "role": "Subject"}, {"name": "11.6% of these", "role": "Subject"}, {"name": "Seventy-four per cent", "role": "Subject.Population"}, {"name": "11.6%", "role": "Subject.Population"}, {"name": "blood levels in the toxic range", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "epileptogenic", "role": "Treatment.Disorder"}]}]}
{"id": "train-938", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lipohypertrophy", "role": "Effect"}, {"name": "insulin", "role": "Treatment"}, {"name": "insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-939", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "spontaneous sub-conjunctival haematoma", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-940", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "congestive heart failure", "role": "Effect"}, {"name": "5 days after administration of cyclophosphamide", "role": "Treatment"}, {"name": "5 days", "role": "Treatment.Time_elapsed"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}]}]}
{"id": "train-941", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Fulminant liver failure", "role": "Effect"}, {"name": "clarithromycin", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}]}]}
{"id": "train-942", "event": [{"trigger": "induce, or aggravate,", "type": "adverse_event", "arguments": [{"name": "gastro-oesophageal reflux", "role": "Effect"}, {"name": "Nifedipine", "role": "Treatment"}, {"name": "Nifedipine", "role": "Treatment.Drug"}]}]}
{"id": "train-943", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "thrombocytopenia secondary to poor compliance", "role": "Effect"}, {"name": "Rifampin", "role": "Treatment"}, {"name": "Rifampin", "role": "Treatment.Drug"}]}]}
{"id": "train-944", "event": [{"trigger": "relationship", "type": "adverse_event", "arguments": [{"name": "onset of nonconvulsive status epilepticus", "role": "Effect"}, {"name": "initiation of ifosfamide infusion", "role": "Treatment"}, {"name": "ifosfamide", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-945", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pericardial effusion and tamponade", "role": "Effect"}, {"name": "Gemcitabine", "role": "Treatment"}, {"name": "Gemcitabine", "role": "Treatment.Drug"}, {"name": "unblocked cardiac irradiation", "role": "Treatment.Disorder"}]}]}
{"id": "train-946", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a wide spectrum of side effects and untoward medical sequelae, which now include catatonia", "role": "Effect"}, {"name": "disulfiram", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}, {"name": "chronic alcoholism", "role": "Treatment.Disorder"}]}]}
{"id": "train-947", "event": [{"trigger": "relationship", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis", "role": "Effect"}, {"name": "sertraline", "role": "Treatment"}, {"name": "sertraline", "role": "Treatment.Drug"}]}]}
{"id": "train-948", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Raynaud's phenomenon", "role": "Effect"}, {"name": "yohimbine", "role": "Treatment"}, {"name": "yohimbine", "role": "Treatment.Drug"}, {"name": "erectile dysfunction", "role": "Treatment.Disorder"}]}]}
{"id": "train-949", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "theophylline toxicity", "role": "Effect"}, {"name": "anesthesia", "role": "Treatment"}, {"name": "anesthesia", "role": "Treatment.Drug"}]}]}
{"id": "train-950", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Calcification and ossification of the spinal arachnoid", "role": "Effect"}, {"name": "intrathecal administration of Depo-Medrol", "role": "Treatment"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "Depo-Medrol", "role": "Treatment.Drug"}]}]}
{"id": "train-951", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lupus syndrome", "role": "Effect"}, {"name": "procainamide", "role": "Treatment"}, {"name": "procainamide", "role": "Treatment.Drug"}]}]}
{"id": "train-952", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "bilateral ptosis", "role": "Effect"}, {"name": "chloroquine", "role": "Treatment"}, {"name": "chloroquine", "role": "Treatment.Drug"}]}]}
{"id": "train-953", "event": [{"trigger": "proposed.", "type": "adverse_event", "arguments": [{"name": "57 patients", "role": "Subject"}, {"name": "57", "role": "Subject.Population"}, {"name": "cytotoxic effect", "role": "Effect"}, {"name": "ticlopidine", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-954", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a child with yolk sac tumor", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "localized pigmentation", "role": "Effect"}, {"name": "the first course of chemotherapy regimen that included cisplatin, etoposide and bleomycin", "role": "Treatment"}, {"name": "the first course", "role": "Treatment.Duration"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "yolk sac tumor", "role": "Treatment.Disorder"}, {"name": "cisplatin", "role": "Combination.Drug"}, {"name": "etoposide", "role": "Combination.Drug"}, {"name": "bleomycin", "role": "Combination.Drug"}]}]}
{"id": "train-955", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "hypothyroidism", "role": "Effect"}, {"name": "radioiodine treatment (euthyroid under substitutional therapy)", "role": "Treatment"}, {"name": "radioiodine", "role": "Treatment.Drug"}]}]}
{"id": "train-956", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Late lethal hepatitis B virus reactivation", "role": "Effect"}, {"name": "rituximab", "role": "Treatment"}, {"name": "low-grade cutaneous B-cell lymphoma", "role": "Treatment.Disorder"}, {"name": "rituximab", "role": "Treatment.Drug"}]}]}
{"id": "train-957", "event": [{"trigger": "developed.", "type": "adverse_event", "arguments": [{"name": "international normalized ratio (INR) was markedly elevated", "role": "Effect"}, {"name": "bleeding symptoms", "role": "Effect"}, {"name": "low dosage of warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "low dosage", "role": "Treatment.Dosage"}, {"name": "1.15", "role": "Treatment.Dosage"}, {"name": "11.28", "role": "Treatment.Dosage"}, {"name": "4 days", "role": "Treatment.Duration"}]}]}
{"id": "train-958", "event": [{"trigger": "role", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "sarcoidosis", "role": "Effect"}, {"name": "interferon beta", "role": "Treatment"}, {"name": "interferon beta", "role": "Treatment.Drug"}]}]}
{"id": "train-959", "event": [{"trigger": "inducing", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "venlafaxine and trimipramine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "trimipramine", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}, {"name": "trimipramine", "role": "Combination.Drug"}]}]}
{"id": "train-960", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "severe splenic hemorrhage and rupture", "role": "Effect"}, {"name": "3 h after completion of tPA infusion", "role": "Treatment"}, {"name": "suspected acute myocardial infarction", "role": "Treatment.Disorder"}, {"name": "3 h", "role": "Treatment.Time_elapsed"}, {"name": "tPA", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-961", "event": [{"trigger": "initiated", "type": "potential_therapeutic_event", "arguments": [{"name": "decerebrate rigidity and high BP", "role": "Subject"}, {"name": "hypertension control and motor recovery", "role": "Effect"}, {"name": "tizanidine", "role": "Treatment"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "decerebrate rigidity and high BP", "role": "Treatment.Disorder"}]}]}
{"id": "train-962", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "neonates", "role": "Subject"}, {"name": "neonates", "role": "Subject.Age"}, {"name": "gastric-outlet obstruction due to antral hyperplasia", "role": "Effect"}, {"name": "prostaglandin E1", "role": "Treatment"}, {"name": "prostaglandin E1", "role": "Treatment.Drug"}]}]}
{"id": "train-963", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "IDDM as well as other autoimmune diseases", "role": "Effect"}, {"name": "IFN therapy", "role": "Treatment"}, {"name": "IFN therapy", "role": "Treatment.Drug"}, {"name": "During and after", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-964", "event": [{"trigger": "resolved", "type": "adverse_event", "arguments": [{"name": "two of these cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "akathisia", "role": "Effect"}, {"name": "withdrawal of olanzapine and substitution by a classical", "role": "Treatment"}, {"name": "neuroleptic agent", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "neuroleptic agent", "role": "Treatment.Drug"}]}]}
{"id": "train-965", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "asthma", "role": "Effect"}, {"name": "Captopril", "role": "Treatment"}, {"name": "Captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-966", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-967", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "papular eruption", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-968", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "teratogenicity", "role": "Effect"}, {"name": "methimazole", "role": "Treatment"}, {"name": "methimazole", "role": "Treatment.Drug"}]}]}
{"id": "train-969", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "liver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia", "role": "Effect"}, {"name": "Itraconazole", "role": "Treatment"}, {"name": "Itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-970", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "Rhabdomyolysis", "role": "Effect"}, {"name": "diltiazem and other HMG-CoA reductase inhibitors", "role": "Treatment"}, {"name": "diltiazem", "role": "Treatment.Drug"}, {"name": "HMG-CoA reductase inhibitors", "role": "Treatment.Drug"}, {"name": "diltiazem", "role": "Combination.Drug"}, {"name": "HMG-CoA reductase inhibitors", "role": "Combination.Drug"}]}]}
{"id": "train-971", "event": [{"trigger": "response", "type": "adverse_event", "arguments": [{"name": "angioedema", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-972", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Hypersensitivity reactions", "role": "Effect"}, {"name": "chloramphenicol", "role": "Treatment"}, {"name": "chloramphenicol", "role": "Treatment.Drug"}]}]}
{"id": "train-973", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "sclerosing glomerulonephritis", "role": "Effect"}, {"name": "anastrozole", "role": "Treatment"}, {"name": "anastrozole", "role": "Treatment.Drug"}]}]}
{"id": "train-974", "event": [{"trigger": "treated with", "type": "adverse_event", "arguments": [{"name": "A patient with coccidioidal meningitis", "role": "Subject"}, {"name": "an acute toxic delirium with EEG abnormalities", "role": "Effect"}, {"name": "intrathecally administered amphotericin B", "role": "Treatment"}, {"name": "coccidioidal meningitis", "role": "Treatment.Disorder"}, {"name": "amphotericin B", "role": "Treatment.Drug"}, {"name": "intrathecally", "role": "Treatment.Route"}]}]}
{"id": "train-975", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "non-ketotic, hyperosmolar diabetic coma", "role": "Effect"}, {"name": "hyperglycaemia and hyperthermia", "role": "Effect"}, {"name": "antipsychotics", "role": "Treatment"}, {"name": "antipsychotics", "role": "Treatment.Drug"}]}]}
{"id": "train-976", "event": [{"trigger": "side effect", "type": "adverse_event", "arguments": [{"name": "Reversible lupus-like syndrome", "role": "Effect"}, {"name": "5-ASA", "role": "Treatment"}, {"name": "5-ASA", "role": "Treatment.Drug"}]}]}
{"id": "train-977", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with chronic myeloid leukaemia", "role": "Subject"}, {"name": "busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice", "role": "Effect"}, {"name": "busulphan for 4-5 years", "role": "Treatment"}, {"name": "4-5 years", "role": "Treatment.Duration"}, {"name": "busulphan", "role": "Treatment.Drug"}, {"name": "chronic myeloid leukaemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-978", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "elderly patients", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "Creutzfeldt-Jakob syndrome", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "\"therapeutic\" lithium serum levels", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-979", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "combined hyperglycaemia and hyperinsulinaemia", "role": "Subject"}, {"name": "diabetic patients", "role": "Subject"}, {"name": "renal and ocular blood flow", "role": "Effect"}, {"name": "insulin therapy", "role": "Treatment"}, {"name": "hyperglycaemia", "role": "Treatment.Drug"}, {"name": "hyperinsulinaemia", "role": "Treatment.Drug"}, {"name": "diabetic", "role": "Treatment.Disorder"}, {"name": "hyperglycaemia", "role": "Combination.Drug"}, {"name": "hyperinsulinaemia", "role": "Combination.Drug"}]}]}
{"id": "train-980", "event": [{"trigger": "precipitated", "type": "adverse_event", "arguments": [{"name": "Pemphigus vulgaris", "role": "Effect"}, {"name": "glibenclamide", "role": "Treatment"}, {"name": "glibenclamide", "role": "Treatment.Drug"}]}]}
{"id": "train-981", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "cholestatic liver injury", "role": "Effect"}, {"name": "Methimazole", "role": "Treatment"}, {"name": "Methimazole", "role": "Treatment.Drug"}]}]}
{"id": "train-982", "event": [{"trigger": "is", "type": "adverse_event", "arguments": [{"name": "hyponatremic episode", "role": "Effect"}, {"name": "vinblastine", "role": "Treatment"}, {"name": "vinblastine", "role": "Treatment.Drug"}]}]}
{"id": "train-983", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "optic neuritis secondary", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-984", "event": [{"trigger": "prevention", "type": "potential_therapeutic_event", "arguments": [{"name": "children with a history of EA with propofol TIVA", "role": "Subject"}, {"name": "EA with propofol TIVA", "role": "Subject.Disorder"}, {"name": "children", "role": "Subject.Age"}, {"name": "low-dose ketamine added to propofol", "role": "Treatment"}, {"name": "EA", "role": "Treatment.Disorder"}, {"name": "ketamine", "role": "Treatment.Drug"}, {"name": "propofol", "role": "Treatment.Drug"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "ketamine", "role": "Combination.Drug"}, {"name": "propofol", "role": "Combination.Drug"}]}]}
{"id": "train-985", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a child with AIDS", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "AIDS", "role": "Subject.Disorder"}, {"name": "Tetany", "role": "Effect"}, {"name": "intravenous tobramycin", "role": "Treatment"}, {"name": "tobramycin", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-986", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "patient with a left ventricular assist device", "role": "Subject"}, {"name": "Sideroblastic anemia", "role": "Effect"}, {"name": "linezolid", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "left ventricular assist device", "role": "Treatment.Disorder"}]}]}
{"id": "train-987", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "dose-dependent haematological reactions", "role": "Effect"}, {"name": "Oral dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}, {"name": "Oral", "role": "Treatment.Route"}, {"name": "dermatitis herpetiformis", "role": "Treatment.Disorder"}, {"name": "Hansen's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-988", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two kidney transplant recipients", "role": "Subject"}, {"name": "anemia", "role": "Effect"}, {"name": "Enalapril", "role": "Treatment"}, {"name": "Enalapril", "role": "Treatment.Drug"}, {"name": "kidney transplant", "role": "Treatment.Disorder"}]}]}
{"id": "train-989", "event": [{"trigger": "resulted", "type": "adverse_event", "arguments": [{"name": "an infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "apparent central nervous system depression and unresponsiveness", "role": "Effect"}, {"name": "topical brimonidine", "role": "Treatment"}, {"name": "topical", "role": "Treatment.Route"}, {"name": "brimonidine", "role": "Treatment.Drug"}]}]}
{"id": "train-990", "event": [{"trigger": "standard therapy", "type": "potential_therapeutic_event", "arguments": [{"name": "Interferon beta", "role": "Treatment"}, {"name": "Interferon beta", "role": "Treatment.Drug"}, {"name": "relapsing/remitting Multiple Sclerosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-991", "event": [{"trigger": "implicated", "type": "adverse_event", "arguments": [{"name": "Epstein's anomaly", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-992", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "gastrointestinal bleeding", "role": "Effect"}, {"name": "antiagregants and anticoagulants", "role": "Treatment"}, {"name": "antiagregants", "role": "Treatment.Drug"}, {"name": "anticoagulants", "role": "Treatment.Drug"}, {"name": "antiagregants", "role": "Combination.Drug"}, {"name": "anticoagulants", "role": "Combination.Drug"}]}]}
{"id": "train-993", "event": [{"trigger": "enhanced", "type": "adverse_event", "arguments": [{"name": "two cases.", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "Hepatotoxicity", "role": "Effect"}, {"name": "paracetamol", "role": "Treatment"}, {"name": "ingestion of alcohol", "role": "Treatment"}, {"name": "paracetamol", "role": "Treatment.Drug"}, {"name": "alcohol", "role": "Treatment.Drug"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "alcohol", "role": "Combination.Drug"}, {"name": "paracetamol", "role": "Combination.Drug"}]}]}
{"id": "train-994", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "Cancer patients", "role": "Subject"}, {"name": "are DPD deficient", "role": "Subject"}, {"name": "DPD deficient", "role": "Subject.Disorder"}, {"name": "severe side effects", "role": "Effect"}, {"name": "receiving 5-FU", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "Cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-995", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "his rheumatoid arthritis", "role": "Subject"}, {"name": "his", "role": "Subject.Gender"}, {"name": "poorly differentiated sarcoma", "role": "Effect"}, {"name": "cyclophosphamide", "role": "Treatment"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-996", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Photo-onycholysis", "role": "Effect"}, {"name": "olanzapine and aripiprazole", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "aripiprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-997", "event": [{"trigger": "precipitating", "type": "adverse_event", "arguments": [{"name": "3 patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "anaphylactoid reactions", "role": "Effect"}, {"name": "high dose-infusion time ratio", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment"}, {"name": "high dose", "role": "Treatment.Dosage"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-998", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Fixed drug eruption", "role": "Effect"}, {"name": "omeprazole", "role": "Treatment"}, {"name": "omeprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-999", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "SMON", "role": "Effect"}, {"name": "acrodermatitis enteropathica", "role": "Effect"}, {"name": "clioquinol", "role": "Treatment"}, {"name": "clioquinol", "role": "Treatment.Drug"}]}]}
{"id": "train-1000", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "thyrotoxicosis", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1001", "event": [{"trigger": "led", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "chronic simvastatin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "chronic simvastatin", "role": "Treatment.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}, {"name": "chronic simvastatin", "role": "Combination.Drug"}]}]}
{"id": "train-1002", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Nephropathy", "role": "Effect"}, {"name": "methicillin therapy for staphylococcal septicemia", "role": "Treatment"}, {"name": "staphylococcal septicemia", "role": "Treatment.Disorder"}, {"name": "methicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-1003", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Four patients", "role": "Subject"}, {"name": "Four", "role": "Subject.Population"}, {"name": "pulmonary oedema", "role": "Effect"}, {"name": "tocolysis with hexoprenaline", "role": "Treatment"}, {"name": "hexoprenaline", "role": "Treatment.Drug"}]}]}
{"id": "train-1004", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 35-year-old woman suffering from rheumatoid arthritis", "role": "Subject"}, {"name": "35-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "skeletal fluorosis", "role": "Effect"}, {"name": "niflumic acid", "role": "Treatment"}, {"name": "in addition, with corticosteroids", "role": "Treatment"}, {"name": "niflumic acid", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "corticosteroids", "role": "Combination.Drug"}, {"name": "niflumic acid", "role": "Combination.Drug"}]}]}
{"id": "train-1005", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "A 65-year-old man", "role": "Subject"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "a sudden spontaneous onset of sub-conjunctival haematoma associated with bloody tears", "role": "Effect"}, {"name": "warfarin therapy", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1006", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "asymptomatic visual field defects", "role": "Effect"}, {"name": "tiagabine", "role": "Treatment"}, {"name": "bipolar disorder", "role": "Treatment.Disorder"}, {"name": "tiagabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1007", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "Cardiorespiratory toxicity", "role": "Effect"}, {"name": "miconazole", "role": "Treatment"}, {"name": "miconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1008", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis", "role": "Effect"}, {"name": "clarithromycin", "role": "Treatment"}, {"name": "azithromycin", "role": "Treatment"}, {"name": "Lovastatin", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "azithromycin", "role": "Treatment.Drug"}, {"name": "Lovastatin", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}, {"name": "azithromycin", "role": "Combination.Drug"}]}]}
{"id": "train-1009", "event": [{"trigger": "to", "type": "potential_therapeutic_event", "arguments": [{"name": "a second DSF dose", "role": "Treatment"}, {"name": "protoxicant", "role": "Treatment.Drug"}, {"name": "DSF", "role": "Treatment.Drug"}, {"name": "a second DSF dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1010", "event": [{"trigger": "treated with", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "bilateral interstitial pulmonary abnormalities", "role": "Effect"}, {"name": "gold salts", "role": "Treatment"}, {"name": "gold salts", "role": "Treatment.Drug"}, {"name": "corticosteroid", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1011", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Pneumonitis", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-1012", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "irreversible pulmonary fibrosis", "role": "Effect"}, {"name": "long-term treatment with nitrofurantoin", "role": "Treatment"}, {"name": "long-term treatment", "role": "Treatment.Dosage"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1013", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pregnancy", "role": "Subject"}, {"name": "acute liver damage", "role": "Effect"}, {"name": "Nitrofurantoin", "role": "Treatment"}, {"name": "Nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1014", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 58-yr-old male patient with essential thrombocythaemia (ET)", "role": "Subject"}, {"name": "58-yr-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "chronic myeloid leukaemia (CML)", "role": "Effect"}, {"name": "continuous uneventful treatment with hydroxyurea for 18 yr", "role": "Treatment"}, {"name": "essential thrombocythaemia (ET)", "role": "Treatment.Disorder"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}, {"name": "18 yr", "role": "Treatment.Duration"}]}]}
{"id": "train-1015", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck", "role": "Subject"}, {"name": "64 year old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "skin rash and bone marrow aplasia", "role": "Effect"}, {"name": "a single dose of 40 mg/m2 methotrexate (MTX)", "role": "Treatment"}, {"name": "recurrent metastatic squamous cell carcinoma of the head and neck", "role": "Treatment.Disorder"}, {"name": "40 mg/m2", "role": "Treatment.Dosage"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "a single dose", "role": "Treatment.Freq"}, {"name": "4 and 7 days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1016", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "four cases", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "hyperkalemia", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1017", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "hemolytic-uremic syndrome.", "role": "Effect"}, {"name": "chemotherapy", "role": "Treatment"}, {"name": "at the beginning of the fourth cycle", "role": "Treatment"}, {"name": "chemotherapy", "role": "Treatment.Drug"}, {"name": "fourth cycle", "role": "Treatment.Duration"}]}]}
{"id": "train-1018", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "Keratitis", "role": "Effect"}, {"name": "methamphetamine abusers", "role": "Treatment"}, {"name": "methamphetamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1019", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "both patients", "role": "Subject"}, {"name": "pancreatitis", "role": "Effect"}, {"name": "mesalamine", "role": "Treatment"}, {"name": "mesalamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1020", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Central nervous system toxicity", "role": "Effect"}, {"name": "meperidine", "role": "Treatment"}, {"name": "hepatic disease", "role": "Treatment.Disorder"}, {"name": "meperidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1021", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "TEN", "role": "Effect"}, {"name": "levofloxacin", "role": "Treatment"}, {"name": "levofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1022", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "dyspnea and sinus bradycardia", "role": "Effect"}, {"name": "a recent increase in his timolol dosage", "role": "Treatment"}, {"name": "timolol", "role": "Treatment.Drug"}]}]}
{"id": "train-1023", "event": [{"trigger": "while", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "multiple abscesses occurred in the muscles of both thighs", "role": "Effect"}, {"name": "Three months following splenectomy", "role": "Treatment"}, {"name": "third course of the CHOP regimen", "role": "Treatment"}, {"name": "Three months", "role": "Treatment.Duration"}, {"name": "splenectomy", "role": "Treatment.Drug"}, {"name": "CHOP", "role": "Treatment.Drug"}, {"name": "third course", "role": "Treatment.Dosage"}, {"name": "CHOP", "role": "Combination.Drug"}, {"name": "splenectomy", "role": "Combination.Drug"}]}]}
{"id": "train-1024", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Methylene blue", "role": "Treatment"}, {"name": "hypotensive shock", "role": "Treatment.Disorder"}, {"name": "methemoglobinaemia", "role": "Treatment.Disorder"}, {"name": "Methylene blue", "role": "Treatment.Drug"}]}]}
{"id": "train-1025", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "central nervous system insult", "role": "Effect"}, {"name": "Methanol toxicity", "role": "Treatment"}, {"name": "Methanol", "role": "Treatment.Drug"}]}]}
{"id": "train-1026", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "skin eruptions", "role": "Effect"}, {"name": "G-CSF", "role": "Treatment"}, {"name": "G-CSF", "role": "Treatment.Drug"}]}]}
{"id": "train-1027", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "fatal case of type I anaphylaxis", "role": "Effect"}, {"name": "protamine", "role": "Treatment"}, {"name": "protamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1028", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "six cases", "role": "Subject"}, {"name": "six", "role": "Subject.Population"}, {"name": "parkinsonism", "role": "Effect"}, {"name": "metoclopramide", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-1029", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "a lupus patient", "role": "Subject"}, {"name": "Neutrophilic eccrine hidradenitis", "role": "Effect"}, {"name": "cyclophosphamide", "role": "Treatment"}, {"name": "lupus", "role": "Treatment.Disorder"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1030", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute hepatitis", "role": "Effect"}, {"name": "Gliclazide", "role": "Treatment"}, {"name": "Gliclazide", "role": "Treatment.Drug"}]}]}
{"id": "train-1031", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 16-year-old white male with acute biphenotypic leukemia", "role": "Subject"}, {"name": "16-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "male", "role": "Subject.Gender"}, {"name": "acute biphenotypic leukemia", "role": "Subject.Disorder"}, {"name": "eosinophilia myalgia syndrome", "role": "Effect"}, {"name": "total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation", "role": "Treatment"}, {"name": "tryptophan", "role": "Treatment.Drug"}, {"name": "parenteral", "role": "Treatment.Route"}]}]}
{"id": "train-1032", "event": [{"trigger": "related to", "type": "adverse_event", "arguments": [{"name": "Subacute cholestatic hepatitis", "role": "Effect"}, {"name": "use of senna", "role": "Treatment"}, {"name": "senna", "role": "Treatment.Drug"}, {"name": "chronic constipation.", "role": "Treatment.Disorder"}]}]}
{"id": "train-1033", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Palmar-plantar erythrodysaesthesia (PPE)", "role": "Effect"}, {"name": "an uncommon cutaneous complication", "role": "Effect"}, {"name": "a painful erythema involving the palms and soles", "role": "Effect"}, {"name": "cytotoxic chemotherapy", "role": "Treatment"}, {"name": "cytotoxic", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-1034", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "an 11-year-old boy", "role": "Subject"}, {"name": "11-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "an anaphylactic reaction", "role": "Effect"}, {"name": "after administration of bacitracin ointment", "role": "Treatment"}, {"name": "bacitracin", "role": "Treatment.Drug"}]}]}
{"id": "train-1035", "event": [{"trigger": "found", "type": "adverse_event", "arguments": [{"name": "The patient", "role": "Subject"}, {"name": "no motile sperm with a normal sperm count", "role": "Effect"}, {"name": "400 mg/day of carbamazepine", "role": "Treatment"}, {"name": "400 mg/day", "role": "Treatment.Dosage"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1036", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "a patient with an history of depression with hypomanic rebounds", "role": "Subject"}, {"name": "depression", "role": "Subject.Disorder"}, {"name": "hypomanic rebounds", "role": "Subject.Disorder"}, {"name": "A fatal pancytopenia", "role": "Effect"}, {"name": "treated with levomepromazine, diazepam and lithium carbonate", "role": "Treatment"}, {"name": "a manic episode", "role": "Treatment.Disorder"}, {"name": "levomepromazine", "role": "Treatment.Drug"}, {"name": "diazepam", "role": "Treatment.Drug"}, {"name": "lithium carbonate", "role": "Treatment.Drug"}, {"name": "levomepromazine", "role": "Combination.Drug"}, {"name": "diazepam", "role": "Combination.Drug"}, {"name": "lithium carbonate", "role": "Combination.Drug"}]}]}
{"id": "train-1037", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "Oxatomide", "role": "Treatment"}, {"name": "diseases mediated by type I allergy", "role": "Treatment.Disorder"}, {"name": "Oxatomide", "role": "Treatment.Drug"}]}]}
{"id": "train-1038", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a non-alcoholic", "role": "Subject"}, {"name": "Toxic hepatitis", "role": "Effect"}, {"name": "disulfiram", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-1039", "event": [{"trigger": "effect", "type": "adverse_event", "arguments": [{"name": "camptocormia", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-1040", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "leukopenia", "role": "Effect"}, {"name": "long-term use of adequately-dosed AZA and stable non-toxic metabolite levels could not acknowledge TPMT deficiency", "role": "Treatment"}, {"name": "long-term", "role": "Treatment.Duration"}, {"name": "adequately-dosed", "role": "Treatment.Dosage"}, {"name": "AZA", "role": "Treatment.Drug"}]}]}
{"id": "train-1041", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "65-year-old patient", "role": "Subject"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome", "role": "Effect"}, {"name": "chronically treated with the selective serotonin reuptake inhibitor (SSRI) citalopram", "role": "Treatment"}, {"name": "following initiation of fentanyl", "role": "Treatment"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "chronically", "role": "Treatment.Duration"}, {"name": "fentanyl", "role": "Combination.Drug"}, {"name": "citalopram", "role": "Combination.Drug"}]}]}
{"id": "train-1042", "event": [{"trigger": "complicating", "type": "adverse_event", "arguments": [{"name": "a 45 year old woman with pre-excitation", "role": "Subject"}, {"name": "45 year old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "hypothyroidism", "role": "Effect"}, {"name": "long-term therapy with amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}, {"name": "pre-excitation", "role": "Treatment.Disorder"}]}]}
{"id": "train-1043", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "rapid onset of renal failure, presence of eosinophilia, skin rash, and characteristic renal biopsy", "role": "Effect"}, {"name": "ampicillin", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-1044", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "46-year-old woman", "role": "Subject"}, {"name": "46-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "painful ulcers over her lower abdomen in the form of reticulate erythema", "role": "Effect"}, {"name": "injecting interferon beta-1b subcutaneously", "role": "Treatment"}, {"name": "interferon beta-1b", "role": "Treatment.Drug"}, {"name": "injecting", "role": "Treatment.Route"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1045", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "patients with inflammatory bowel disease", "role": "Subject"}, {"name": "Lupus-like syndrome", "role": "Effect"}, {"name": "5-aminosalicylic acid", "role": "Treatment"}, {"name": "inflammatory bowel disease", "role": "Treatment.Disorder"}, {"name": "5-aminosalicylic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1046", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "1 patient", "role": "Subject"}, {"name": "1", "role": "Subject.Population"}, {"name": "acute tubular necrosis", "role": "Effect"}, {"name": "intravesical formalin", "role": "Treatment"}, {"name": "massive persistent hemorrhage from radiation cystitis", "role": "Treatment.Disorder"}, {"name": "intravesical", "role": "Treatment.Route"}, {"name": "formalin", "role": "Treatment.Drug"}]}]}
{"id": "train-1047", "event": [{"trigger": "responded", "type": "potential_therapeutic_event", "arguments": [{"name": "has not recurred in 8 months of follow-up", "role": "Effect"}, {"name": "discontinuation of rhGH and a single dose of intravenous pamidronate disodium", "role": "Treatment"}, {"name": "hypercalcemia", "role": "Treatment.Disorder"}, {"name": "rhGH", "role": "Treatment.Drug"}, {"name": "pamidronate disodium", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-1048", "event": [{"trigger": "followed", "type": "adverse_event", "arguments": [{"name": "infant twins", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "acute methemoglobinemia and severe anoxic metabolic acidosis", "role": "Effect"}, {"name": "\"sweet spirits of nitre\" (4% ethyl nitrite CH3CH2ONO in 70% ethyl alcohol)", "role": "Treatment"}, {"name": "sweet spirits of nitre", "role": "Treatment.Drug"}]}]}
{"id": "train-1049", "event": [{"trigger": "susceptibility", "type": "adverse_event", "arguments": [{"name": "three families", "role": "Subject"}, {"name": "all the siblings", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "FVS", "role": "Effect"}, {"name": "valproic acid-induced", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1050", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "headache", "role": "Effect"}, {"name": "capecitabine", "role": "Treatment"}, {"name": "capecitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1051", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "A lupus-like syndrome", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-1052", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with probable cisplatin", "role": "Subject"}, {"name": "TMA", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "probable cisplatin", "role": "Treatment.Disorder"}]}]}
{"id": "train-1053", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "diarrhoea", "role": "Effect"}, {"name": "spironolactone", "role": "Treatment"}, {"name": "spironolactone", "role": "Treatment.Drug"}]}]}
{"id": "train-1054", "event": [{"trigger": "observed", "type": "adverse_event", "arguments": [{"name": "two children", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "Painful neutrophilic skin lesions", "role": "Effect"}, {"name": "granulocyte colony-stimulating factor (G-CSF)", "role": "Treatment"}, {"name": "granulocyte colony-stimulating factor", "role": "Treatment.Drug"}, {"name": "idiopathic neutropenia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1055", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "infants", "role": "Subject"}, {"name": "infants", "role": "Subject.Age"}, {"name": "Apparent central nervous system depression", "role": "Effect"}, {"name": "topical brimonidine", "role": "Treatment"}, {"name": "brimonidine", "role": "Treatment.Drug"}, {"name": "topical", "role": "Treatment.Route"}]}]}
{"id": "train-1056", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lipohypertrophy", "role": "Effect"}, {"name": "insulin", "role": "Treatment"}, {"name": "insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-1057", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "Tigecycline", "role": "Treatment"}, {"name": "Tigecycline", "role": "Treatment.Drug"}]}]}
{"id": "train-1058", "event": [{"trigger": "complication of", "type": "adverse_event", "arguments": [{"name": "Polymyositis", "role": "Effect"}, {"name": "interferon alpha treatment", "role": "Treatment"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1059", "event": [{"trigger": "protects", "type": "potential_therapeutic_event", "arguments": [{"name": "protects against renal damage", "role": "Effect"}, {"name": "Sodium thiosulfate is a neutralizing agent for cisplatin", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "Sodium thiosulfate", "role": "Treatment.Drug"}, {"name": "renal damage", "role": "Treatment.Disorder"}, {"name": "Sodium thiosulfate", "role": "Combination.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}]}]}
{"id": "train-1060", "event": [{"trigger": "reaction", "type": "adverse_event", "arguments": [{"name": "Anaphylactic", "role": "Effect"}, {"name": "bacitracin ointment", "role": "Treatment"}, {"name": "bacitracin", "role": "Treatment.Drug"}]}]}
{"id": "train-1061", "event": [{"trigger": "toxicity:", "type": "adverse_event", "arguments": [{"name": "Severe bleomycin lung toxicity", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1062", "event": [{"trigger": "bearing", "type": "adverse_event", "arguments": [{"name": "frail, elderly patients with underlying chronic conditions", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "underlying chronic conditions", "role": "Subject.Disorder"}, {"name": "SS", "role": "Effect"}, {"name": "mirtazapine", "role": "Treatment"}, {"name": "mirtazapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1063", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "leukaemic patients", "role": "Subject"}, {"name": "leukaemic", "role": "Subject.Disorder"}, {"name": "pseudomembranous colitis", "role": "Effect"}, {"name": "clindamycin", "role": "Treatment"}, {"name": "clindamycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1064", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "acute vision loss and change of consciousness", "role": "Effect"}, {"name": "intravitreal injection of bevacizumab (1.25 mg in 0.1 ml),", "role": "Treatment"}, {"name": "intravitreal injection", "role": "Treatment.Route"}, {"name": "bevacizumab", "role": "Treatment.Drug"}, {"name": "1.25 mg in 0.1 ml", "role": "Treatment.Dosage"}]}]}
{"id": "train-1065", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "nausea and anorexia was digoxin toxicity", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "digoxin", "role": "Treatment.Drug"}, {"name": "digoxin", "role": "Combination.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}]}]}
{"id": "train-1066", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "the hemolytic-uremic syndrome (HUS)", "role": "Effect"}, {"name": "Mitomycin C (MMC)", "role": "Treatment"}, {"name": "Mitomycin C", "role": "Treatment.Drug"}]}]}
{"id": "train-1067", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "variation in muscle fiber size and few vacuolated fibers", "role": "Effect"}, {"name": "myopathy", "role": "Effect"}, {"name": "colchicine", "role": "Treatment"}, {"name": "colchicine", "role": "Treatment.Drug"}]}]}
{"id": "train-1068", "event": [{"trigger": "provoked", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "NEH", "role": "Effect"}, {"name": "cytarabine and mitoxantrone", "role": "Treatment"}, {"name": "cytarabine", "role": "Treatment.Drug"}, {"name": "mitoxantrone", "role": "Treatment.Drug"}, {"name": "cytarabine", "role": "Combination.Drug"}, {"name": "mitoxantrone", "role": "Combination.Drug"}]}]}
{"id": "train-1069", "event": [{"trigger": "appeared", "type": "adverse_event", "arguments": [{"name": "Orofacial dyskinesia", "role": "Effect"}, {"name": "5 hours after methylphenidate", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}, {"name": "5 hours after", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1070", "event": [{"trigger": "enhanced", "type": "potential_therapeutic_event", "arguments": [{"name": "tizanidine pharmacodynamics in terms of reduction in blood pressure and adverse symptoms", "role": "Effect"}, {"name": "coadministration of mexiletine increased blood tizanidine concentrations", "role": "Treatment"}, {"name": "mexiletine", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "mexiletine", "role": "Combination.Drug"}, {"name": "tizanidine", "role": "Combination.Drug"}]}]}
{"id": "train-1071", "event": [{"trigger": "most likely", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "Bilateral acoustic (VIII) nerve palsy", "role": "Effect"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "vincristine", "role": "Treatment"}, {"name": "vincristine", "role": "Treatment.Drug"}]}]}
{"id": "train-1072", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Acute leukopenia", "role": "Effect"}, {"name": "silver sulfadiazine", "role": "Treatment"}, {"name": "silver sulfadiazine", "role": "Treatment.Drug"}]}]}
{"id": "train-1073", "event": [{"trigger": "changed", "type": "adverse_event", "arguments": [{"name": "two cases of PSVT", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "non-sustained polymorphic ventricular tachycardia", "role": "Effect"}, {"name": "administration of verapamil.", "role": "Treatment"}, {"name": "verapamil", "role": "Treatment.Drug"}, {"name": "PSVT", "role": "Treatment.Disorder"}]}]}
{"id": "train-1074", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "case of parkinsonism", "role": "Subject"}, {"name": "myoclonus and seizures", "role": "Effect"}, {"name": "L-dopa", "role": "Treatment"}, {"name": "L-dopa", "role": "Treatment.Drug"}, {"name": "parkinsonism", "role": "Treatment.Disorder"}]}]}
{"id": "train-1075", "event": [{"trigger": "cause of", "type": "adverse_event", "arguments": [{"name": "giant hypertrophy", "role": "Effect"}, {"name": "bucillamine", "role": "Treatment"}, {"name": "bucillamine", "role": "Treatment.Drug"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1076", "event": [{"trigger": "contributed", "type": "adverse_event", "arguments": [{"name": "thrombosis", "role": "Effect"}, {"name": "pFVIII", "role": "Treatment"}, {"name": "pFVIII", "role": "Treatment.Drug"}, {"name": "cardiovascular", "role": "Treatment.Disorder"}]}]}
{"id": "train-1077", "event": [{"trigger": "by", "type": "potential_therapeutic_event", "arguments": [{"name": "Restoration of vancomycin susceptibility in Enterococcus faecalis", "role": "Effect"}, {"name": "antiresistance determinant gene transfer", "role": "Treatment"}, {"name": "vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1078", "event": [{"trigger": "side effects", "type": "adverse_event", "arguments": [{"name": "Dental and gingival pain", "role": "Effect"}, {"name": "niacin", "role": "Treatment"}, {"name": "niacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1079", "event": [{"trigger": "elevation", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "significant elevation of serum transaminases", "role": "Effect"}, {"name": "6-TG", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "6-TG", "role": "Treatment.Drug"}]}]}
{"id": "train-1080", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "acne", "role": "Subject"}, {"name": "A patient", "role": "Subject"}, {"name": "transient, acute myopia", "role": "Effect"}, {"name": "isotretinoin (Accutane)", "role": "Treatment"}, {"name": "acne", "role": "Treatment.Disorder"}, {"name": "isotretinoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1081", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "papular eruption", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "collagen vascular diseases", "role": "Treatment.Disorder"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1082", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Aminophylline hypersensitivity", "role": "Effect"}, {"name": "ethylenediamine", "role": "Treatment"}, {"name": "ethylenediamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1083", "event": [{"trigger": "demonstrated", "type": "adverse_event", "arguments": [{"name": "this 58-year-old female", "role": "Subject"}, {"name": "58-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis", "role": "Effect"}, {"name": "antithyroid therapy with 20 mg methimazole daily", "role": "Treatment"}, {"name": "20 days after", "role": "Treatment.Time_elapsed"}, {"name": "methimazole", "role": "Treatment.Drug"}, {"name": "20 mg", "role": "Treatment.Dosage"}, {"name": "daily", "role": "Treatment.Freq"}]}]}
{"id": "train-1084", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "hemorrhagic vasculitis was superimposed on a severe forefoot infection, leading to progressive gangrene and a below-knee amputation", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1085", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "pancytopenia", "role": "Effect"}, {"name": "Pentasa", "role": "Treatment"}, {"name": "Pentasa", "role": "Treatment.Drug"}]}]}
{"id": "train-1086", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Effect"}, {"name": "bilaterally symmetric bull's-eye maculopathy", "role": "Effect"}, {"name": "45 years after taking quinacrine for 18 months", "role": "Treatment"}, {"name": "45 years after", "role": "Treatment.Time_elapsed"}, {"name": "18 months", "role": "Treatment.Time_elapsed"}, {"name": "quinacrine", "role": "Treatment.Drug"}, {"name": "malaria", "role": "Treatment.Disorder"}]}]}
{"id": "train-1087", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "digoxin toxicity", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "digoxin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "digoxin", "role": "Treatment.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}, {"name": "digoxin", "role": "Combination.Drug"}]}]}
{"id": "train-1088", "event": [{"trigger": "improved", "type": "potential_therapeutic_event", "arguments": [{"name": "within 72 hours of the withdrawal of lithium", "role": "Treatment"}, {"name": "exophthalmos", "role": "Treatment.Disorder"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "within 72 hours", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1089", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "two cases of", "role": "Subject"}, {"name": "cardiac patients with trisomy 21", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "cardiac", "role": "Subject.Disorder"}, {"name": "trisomy 21", "role": "Subject.Disorder"}, {"name": "neutropenia", "role": "Effect"}, {"name": "captopril use", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-1090", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 28 month-old child", "role": "Subject"}, {"name": "28 month-old child", "role": "Subject.Age"}, {"name": "hyponatremia associated with a grand mal seizure", "role": "Effect"}, {"name": "intra-nasal desmopressin administration", "role": "Treatment"}, {"name": "high fluid intake with nocturnal enuresis", "role": "Treatment.Disorder"}, {"name": "desmopressin", "role": "Treatment.Drug"}, {"name": "intra-nasal", "role": "Treatment.Route"}]}]}
{"id": "train-1091", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "He", "role": "Subject"}, {"name": "He", "role": "Subject.Gender"}, {"name": "fever, nausea, diarrhea, and malaise", "role": "Effect"}, {"name": "Pentasa", "role": "Treatment"}, {"name": "Pentasa", "role": "Treatment.Drug"}, {"name": "third day", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1092", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "two melanoma patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "Livedo reticularis", "role": "Effect"}, {"name": "interferon alpha therapy", "role": "Treatment"}, {"name": "melanoma", "role": "Treatment.Disorder"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1093", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 60-year-old woman with diabetes mellitus (type 2)", "role": "Subject"}, {"name": "60-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "an acute icteric hepatitis-like illness", "role": "Effect"}, {"name": "6 weeks after the initiation of gliclazide therapy", "role": "Treatment"}, {"name": "6 weeks", "role": "Treatment.Time_elapsed"}, {"name": "gliclazide", "role": "Treatment.Drug"}, {"name": "diabetes mellitus (type 2)", "role": "Treatment.Disorder"}]}]}
{"id": "train-1094", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "pleuropulmonary abnormalities", "role": "Effect"}, {"name": "bromocriptine", "role": "Treatment"}, {"name": "cabergoline", "role": "Treatment"}, {"name": "cabergoline", "role": "Treatment.Drug"}, {"name": "bromocriptine", "role": "Treatment.Drug"}]}]}
{"id": "train-1095", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "transient coronary vasoconstriction", "role": "Effect"}, {"name": "dopamine", "role": "Treatment"}, {"name": "dopamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1096", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute sensorineural hearing loss", "role": "Effect"}, {"name": "intravenous ketoralac", "role": "Treatment"}, {"name": "ketoralac", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-1097", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypersensitivity syndrome associated with reactivation of human herpesvirus-6", "role": "Effect"}, {"name": "Trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "Trimethoprim-sulfamethoxazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1098", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "pulmonary fibrosis", "role": "Effect"}, {"name": "nabumetone", "role": "Treatment"}, {"name": "nabumetone", "role": "Treatment.Drug"}]}]}
{"id": "train-1099", "event": [{"trigger": "case", "type": "adverse_event", "arguments": [{"name": "a geriatric patient", "role": "Subject"}, {"name": "geriatric", "role": "Subject.Age"}, {"name": "increased international normalized ratio (INR)", "role": "Effect"}, {"name": "warfarin and ropinirole", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "ropinirole", "role": "Treatment.Drug"}, {"name": "ropinirole", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-1100", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "ocular toxicity", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1101", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "k bipolar manic-depressive patient", "role": "Subject"}, {"name": "bucco-linguo-masticatory dyskinesia", "role": "Effect"}, {"name": "akathisia", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "at therapeutic serum lithium levels", "role": "Treatment"}, {"name": "k bipolar manic-depressive", "role": "Treatment.Disorder"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1102", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "systemic allergic contact dermatitis to 8-MOP", "role": "Effect"}, {"name": "PUVA", "role": "Treatment"}, {"name": "psoriasis", "role": "Treatment.Disorder"}, {"name": "PUVA", "role": "Treatment.Drug"}]}]}
{"id": "train-1103", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "diazepam", "role": "Treatment"}, {"name": "Seizures", "role": "Treatment.Disorder"}, {"name": "diazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-1104", "event": [{"trigger": "seizures", "type": "adverse_event", "arguments": [{"name": "Paradoxical seizures", "role": "Effect"}, {"name": "phenytoin toxicity", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1105", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two children with attention deficit disorder", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "fixed drug eruption of the scrotum", "role": "Effect"}, {"name": "methylphenidate as a simple drug", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}, {"name": "attention deficit disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-1106", "event": [{"trigger": "revealed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "less platelet inhibition than would be expected", "role": "Effect"}, {"name": "taking a concomitant inducer of ticagrelor metabolism.", "role": "Treatment"}, {"name": "ticagrelor", "role": "Treatment.Drug"}, {"name": "inducer of ticagrelor metabolism", "role": "Treatment.Drug"}, {"name": "inducer of ticagrelor metabolism", "role": "Combination.Drug"}, {"name": "ticagrelor", "role": "Combination.Drug"}]}]}
{"id": "train-1107", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "lactic acidosis", "role": "Effect"}, {"name": "Metformin", "role": "Treatment"}, {"name": "Metformin", "role": "Treatment.Drug"}]}]}
{"id": "train-1108", "event": [{"trigger": "attributable", "type": "adverse_event", "arguments": [{"name": "1", "role": "Subject"}, {"name": "1", "role": "Subject.Population"}, {"name": "death", "role": "Effect"}, {"name": "risperidone overdose", "role": "Treatment"}, {"name": "risperidone", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1109", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Systemic allergic contact dermatitis", "role": "Effect"}, {"name": "8-methoxypsoralen (8-MOP)", "role": "Treatment"}, {"name": "8-methoxypsoralen", "role": "Treatment.Drug"}]}]}
{"id": "train-1110", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "a 21-year-old woman", "role": "Subject"}, {"name": "21-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "mild hepatotoxicity", "role": "Effect"}, {"name": "choline magnesium trisalicylate", "role": "Treatment"}, {"name": "choline magnesium trisalicylate", "role": "Treatment.Drug"}]}]}
{"id": "train-1111", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "maculopapular eruption", "role": "Effect"}, {"name": "ritonavir", "role": "Treatment"}, {"name": "ritonavir", "role": "Treatment.Drug"}]}]}
{"id": "train-1112", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "our patient", "role": "Subject"}, {"name": "his renal and hepatic function were normal", "role": "Subject"}, {"name": "his", "role": "Subject.Gender"}, {"name": "myopathy", "role": "Effect"}, {"name": "therapeutic doses of colchicine for FMF", "role": "Treatment"}, {"name": "colchicine", "role": "Treatment.Drug"}, {"name": "FMF", "role": "Treatment.Disorder"}, {"name": "therapeutic doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-1113", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Thrombocytosis", "role": "Effect"}, {"name": "enoxaparin", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1114", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A woman with a 20-year history of acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "a B-cell lymphoma of the lip", "role": "Effect"}, {"name": "4 1/2 years of treatment with razoxane", "role": "Treatment"}, {"name": "following 4 1/2 years", "role": "Treatment.Duration"}, {"name": "razoxane", "role": "Treatment.Drug"}, {"name": "acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs", "role": "Treatment.Disorder"}]}]}
{"id": "train-1115", "event": [{"trigger": "precipitating", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "overdose of CBZ", "role": "Treatment"}, {"name": "CBZ", "role": "Treatment.Drug"}]}]}
{"id": "train-1116", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with gallbladder metastatic adenocarcinoma", "role": "Subject"}, {"name": "pulmonary toxicity", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gallbladder metastatic adenocarcinoma", "role": "Treatment.Disorder"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1117", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a psoriatic patient", "role": "Subject"}, {"name": "Progressive interstitial fibrosis with roentgenographic honeycombing", "role": "Effect"}, {"name": "a regimen of methotrexate for 18 years", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "18 years", "role": "Treatment.Duration"}, {"name": "psoriatic", "role": "Treatment.Disorder"}]}]}
{"id": "train-1118", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "one patient", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}, {"name": "gangrene", "role": "Effect"}, {"name": "bleomycin and vincristine/vinblastine", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "vincristine", "role": "Treatment.Drug"}, {"name": "vinblastine", "role": "Treatment.Drug"}, {"name": "bleomycin", "role": "Combination.Drug"}, {"name": "vincristine", "role": "Combination.Drug"}, {"name": "vinblastine", "role": "Combination.Drug"}]}]}
{"id": "train-1119", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "rhabdomyolysis", "role": "Effect"}, {"name": "vasopressin", "role": "Treatment"}, {"name": "vasopressin", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-1120", "event": [{"trigger": "reaction.", "type": "adverse_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "life-threatening, immunemediated hypersensitivity", "role": "Effect"}, {"name": "TMP-SMX", "role": "Treatment"}, {"name": "TMP-SMX", "role": "Treatment.Drug"}]}]}
{"id": "train-1121", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "toxic liver damage", "role": "Effect"}, {"name": "nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1122", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "Slow acetylators", "role": "Subject"}, {"name": "Slow acetylators", "role": "Subject.Disorder"}, {"name": "clinical and biochemical features of phenytoin toxicity", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "together with antituberculosis", "role": "Treatment"}, {"name": "antituberculosis", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}, {"name": "antituberculosis", "role": "Combination.Drug"}]}]}
{"id": "train-1123", "event": [{"trigger": "potential", "type": "adverse_event", "arguments": [{"name": "significant concentration-related adverse effects", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "other CYP2C9 substrates", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "other CYP2C9 substrates", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}, {"name": "other CYP2C9 substrates", "role": "Combination.Drug"}]}]}
{"id": "train-1124", "event": [{"trigger": "intoxication:", "type": "adverse_event", "arguments": [{"name": "Putaminal infarct in methanol intoxication", "role": "Effect"}, {"name": "methanol", "role": "Treatment"}, {"name": "methanol", "role": "Treatment.Drug"}]}]}
{"id": "train-1125", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "Progressive interstitial lung disease", "role": "Effect"}, {"name": "prolonged methotrexate therapy", "role": "Treatment"}, {"name": "prolonged", "role": "Treatment.Duration"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1126", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "systemic iron toxicity", "role": "Effect"}, {"name": "a large dose of intravenous iron sucrose", "role": "Treatment"}, {"name": "iron sucrose", "role": "Treatment.Drug"}, {"name": "16 mg/kg", "role": "Treatment.Dosage"}, {"name": "3 hours", "role": "Treatment.Duration"}]}]}
{"id": "train-1127", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with advanced colonic carcinoma who was treated with concomitant chemoirradiation with oxaliplatin", "role": "Subject"}, {"name": "a peculiar dermnatitis in the irradiated field", "role": "Effect"}, {"name": "exposed to subsequent chemotherapy with oxaliplatin", "role": "Treatment"}, {"name": "advanced colonic carcinoma", "role": "Treatment.Disorder"}, {"name": "concomitant chemoirradiation", "role": "Treatment.Drug"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-1128", "event": [{"trigger": "trigger", "type": "adverse_event", "arguments": [{"name": "exacerbate psoriasis", "role": "Effect"}, {"name": "Recombinant human interferon-alpha", "role": "Treatment"}, {"name": "Recombinant human interferon-alpha", "role": "Treatment.Drug"}, {"name": "cancers", "role": "Treatment.Disorder"}]}]}
{"id": "train-1129", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "HBV reactivation", "role": "Effect"}, {"name": "the year following rituximab monotherapy in the absence of any other immunosuppressive factor", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}, {"name": "year following", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1130", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Systemic lupus erythematosus", "role": "Effect"}, {"name": "penicillamine therapy", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis.", "role": "Treatment.Disorder"}]}]}
{"id": "train-1131", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "dermatologic toxicity", "role": "Effect"}, {"name": "an 'allergic' or acute hypersensitivity reaction", "role": "Effect"}, {"name": "a single low dose of the drug", "role": "Treatment"}, {"name": "MTX", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}, {"name": "single low dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1132", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Erosion of psoriatic plaques", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1133", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "infants with supraventricular tachycardia", "role": "Subject"}, {"name": "infants", "role": "Subject.Age"}, {"name": "Cardiac decompensation", "role": "Effect"}, {"name": "verapamil therapy", "role": "Treatment"}, {"name": "supraventricular tachycardia", "role": "Treatment.Disorder"}, {"name": "verapamil", "role": "Treatment.Drug"}]}]}
{"id": "train-1134", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "perinatally HIV-infected adolescents", "role": "Subject"}, {"name": "adolescents", "role": "Subject.Age"}, {"name": "nephrotoxicity", "role": "Effect"}, {"name": "tenofovir (TDF)", "role": "Treatment"}, {"name": "tenofovir", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}]}]}
{"id": "train-1135", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "HUS", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1136", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity", "role": "Effect"}, {"name": "respiratory symptoms", "role": "Effect"}, {"name": "docetaxel", "role": "Treatment"}, {"name": "docetaxel", "role": "Treatment.Drug"}]}]}
{"id": "train-1137", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 7-year-old male patient", "role": "Subject"}, {"name": "7-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "orofacial and limb dyskinesia", "role": "Effect"}, {"name": "first dose of methylphenidate", "role": "Treatment"}, {"name": "attention-deficit/hyperactivity disorder", "role": "Treatment.Disorder"}, {"name": "first dose", "role": "Treatment.Time_elapsed"}, {"name": "methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-1138", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "70-year-old man", "role": "Subject"}, {"name": "70-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "severe aplastic anemia", "role": "Effect"}, {"name": "7 weeks after treatment with 500 mg of ticlopidine daily", "role": "Treatment"}, {"name": "7 weeks", "role": "Treatment.Time_elapsed"}, {"name": "500 mg", "role": "Treatment.Dosage"}, {"name": "ticlopidine", "role": "Treatment.Drug"}, {"name": "daily", "role": "Treatment.Freq"}]}]}
{"id": "train-1139", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A six-year-old boy with transfusion-dependent beta-thalassaemia", "role": "Subject"}, {"name": "six-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "a unilateral hearing loss", "role": "Effect"}, {"name": "commencing desferrioxamine therapy", "role": "Treatment"}, {"name": "transfusion-dependent beta-thalassaemia", "role": "Treatment.Disorder"}, {"name": "shortly after", "role": "Treatment.Time_elapsed"}, {"name": "desferrioxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1140", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 65-year-old woman", "role": "Subject"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "Syncope", "role": "Effect"}, {"name": "nitrate ingestion", "role": "Treatment"}, {"name": "nitrate", "role": "Treatment.Drug"}, {"name": "ingestion", "role": "Treatment.Route"}]}]}
{"id": "train-1141", "event": [{"trigger": "appeared", "type": "adverse_event", "arguments": [{"name": "longitudinal melanonychia and the multiple skin cancers", "role": "Effect"}, {"name": "approximately 6 months of hydroxyurea treatment", "role": "Treatment"}, {"name": "6 months", "role": "Treatment.Duration"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}]}]}
{"id": "train-1142", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "Multifocal inflammatory leukoencephalopathy", "role": "Effect"}, {"name": "levamisole therapy", "role": "Treatment"}, {"name": "levamisole", "role": "Treatment.Drug"}]}]}
{"id": "train-1143", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "cutaneous vasculitis", "role": "Effect"}, {"name": "propylthiouracil", "role": "Treatment"}, {"name": "propylthiouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-1144", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "radiation recall reaction resulting in hemodynamically significant pericardial effusion", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1145", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a critically ill patient", "role": "Subject"}, {"name": "critically ill", "role": "Subject.Disorder"}, {"name": "leukopenia", "role": "Effect"}, {"name": "cefazolin", "role": "Treatment"}, {"name": "cefazolin", "role": "Treatment.Drug"}]}]}
{"id": "train-1146", "event": [{"trigger": "controlled", "type": "potential_therapeutic_event", "arguments": [{"name": "The second patient suffered from high blood pressure", "role": "Subject"}, {"name": "beta-blocker drugs", "role": "Treatment"}, {"name": "high blood pressure", "role": "Treatment.Disorder"}, {"name": "beta-blocker drugs", "role": "Treatment.Drug"}]}]}
{"id": "train-1147", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "The female patient", "role": "Subject"}, {"name": "female", "role": "Subject.Gender"}, {"name": "agranulocytosis", "role": "Effect"}, {"name": "clozapine in a daily dose of 400 mg", "role": "Treatment"}, {"name": "after 2 months", "role": "Treatment"}, {"name": "2 months", "role": "Treatment.Duration"}, {"name": "400 mg", "role": "Treatment.Dosage"}, {"name": "daily", "role": "Treatment.Freq"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1148", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "interstitial pulmonary disease", "role": "Effect"}, {"name": "lymphocytic colitis", "role": "Effect"}, {"name": "ticlopidine", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1149", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "two patients with narrow angle glaucoma", "role": "Subject"}, {"name": "narrow angle glaucoma", "role": "Subject.Disorder"}, {"name": "two", "role": "Subject.Population"}, {"name": "Increased ocular pressure", "role": "Effect"}, {"name": "venlafaxine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-1150", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "ampicillin therapy", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-1151", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "Glaucoma", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-1152", "event": [{"trigger": "at", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "fluctuation of the QT interval", "role": "Effect"}, {"name": "a stable dose of methadone", "role": "Treatment"}, {"name": "methadone", "role": "Treatment.Drug"}, {"name": "a stable dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1153", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute kidney injury due to", "role": "Effect"}, {"name": "DRESS/DIHS", "role": "Effect"}, {"name": "zonisamide", "role": "Treatment"}, {"name": "zonisamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1154", "event": [{"trigger": "considered", "type": "adverse_event", "arguments": [{"name": "SLE", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1155", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "various degrees of hepatic lesion with ground-glass inclusion bodies", "role": "Effect"}, {"name": "Cyanamide", "role": "Treatment"}, {"name": "Cyanamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1156", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "angioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing (or both)", "role": "Effect"}, {"name": "Oxcarbazepine", "role": "Treatment"}, {"name": "Oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1157", "event": [{"trigger": "given", "type": "potential_therapeutic_event", "arguments": [{"name": "a 50-year-old female with CHC who had not responded to a previous treatment by interferon alpha", "role": "Subject"}, {"name": "50-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "combination therapy of interferon alpha and ribavirin", "role": "Treatment"}, {"name": "CHC", "role": "Treatment.Disorder"}, {"name": "interferon alpha", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "interferon alpha", "role": "Combination.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}]}]}
{"id": "train-1158", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Peripheral neuropathy", "role": "Effect"}, {"name": "capecitabine.", "role": "Treatment"}, {"name": "capecitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1159", "event": [{"trigger": "intrathecal", "type": "adverse_event", "arguments": [{"name": "medical records of four patients", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "a central neurological syndrome", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}, {"name": "within days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1160", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "priapism", "role": "Effect"}, {"name": "Prothipendylhydrochloride", "role": "Treatment"}, {"name": "Prothipendylhydrochloride", "role": "Treatment.Drug"}]}]}
{"id": "train-1161", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Interstitial pneumonia", "role": "Effect"}, {"name": "sorafenib treatment:", "role": "Treatment"}, {"name": "sorafenib", "role": "Treatment.Drug"}]}]}
{"id": "train-1162", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypokalemia (K 2.3 mmol/L)", "role": "Effect"}, {"name": "licorice and also had received disopyramide for arrhythmia, bicalutamide for prostate cancer, and silodosin for prostate hypertrophy", "role": "Treatment"}, {"name": "licorice", "role": "Treatment.Drug"}, {"name": "disopyramide", "role": "Treatment.Drug"}, {"name": "bicalutamide", "role": "Treatment.Drug"}, {"name": "silodosin", "role": "Treatment.Drug"}, {"name": "prostate hypertrophy", "role": "Treatment.Disorder"}, {"name": "prostate cancer", "role": "Treatment.Disorder"}, {"name": "arrhythmia", "role": "Treatment.Disorder"}, {"name": "disopyramide", "role": "Combination.Drug"}, {"name": "bicalutamide", "role": "Combination.Drug"}, {"name": "silodosin", "role": "Combination.Drug"}, {"name": "licorice", "role": "Combination.Drug"}]}]}
{"id": "train-1163", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "patient's", "role": "Subject"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "TMP-SMX therapy", "role": "Treatment"}, {"name": "TMP-SMX", "role": "Treatment.Drug"}]}]}
{"id": "train-1164", "event": [{"trigger": "implicated", "type": "adverse_event", "arguments": [{"name": "seven reports of patient", "role": "Subject"}, {"name": "seven", "role": "Subject.Population"}, {"name": "deaths", "role": "Effect"}, {"name": "vismodegib", "role": "Treatment"}, {"name": "vismodegib", "role": "Treatment.Drug"}]}]}
{"id": "train-1165", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Acceleration of ventricular response", "role": "Effect"}, {"name": "intravenous adenosine.", "role": "Treatment"}, {"name": "adenosine", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "atrial flutter", "role": "Treatment.Disorder"}]}]}
{"id": "train-1166", "event": [{"trigger": "induction", "type": "adverse_event", "arguments": [{"name": "diabetes", "role": "Effect"}, {"name": "indapamide", "role": "Treatment"}, {"name": "hypertension", "role": "Treatment.Disorder"}, {"name": "indapamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1167", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "RS", "role": "Effect"}, {"name": "long-term aspirin therapy", "role": "Treatment"}, {"name": "systemic inflammatory illnesses", "role": "Treatment.Disorder"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-1168", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "adverse reaction", "role": "Effect"}, {"name": "oleic acid", "role": "Treatment"}, {"name": "oleic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1169", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "Baclofen withdrawal syndrome", "role": "Effect"}, {"name": "prolonged fever in the intensive care unit", "role": "Effect"}, {"name": "underdosing of oral baclofen", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "baclofen", "role": "Treatment.Drug"}]}]}
{"id": "train-1170", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "bradycardia", "role": "Effect"}, {"name": "sotalol", "role": "Treatment"}, {"name": "sotalol", "role": "Treatment.Drug"}]}]}
{"id": "train-1171", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Hyperammonemia", "role": "Effect"}, {"name": "valproic acid therapy", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1172", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "several cases", "role": "Subject"}, {"name": "serotonin toxicity", "role": "Effect"}, {"name": "Methylene blue", "role": "Treatment"}, {"name": "Methylene blue", "role": "Treatment.Drug"}]}]}
{"id": "train-1173", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "elevated serum tobramycin trough level 1 week before the onset of tetany", "role": "Effect"}, {"name": "a 3-week course of intravenous tobramycin", "role": "Treatment"}, {"name": "tobramycin", "role": "Treatment.Drug"}, {"name": "3-week course", "role": "Treatment.Duration"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "bronchiectasis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1174", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "blood pressure decreased", "role": "Effect"}, {"name": "syncope", "role": "Effect"}, {"name": "a sudden decrease in pulse rate", "role": "Effect"}, {"name": "administration of isosorbide dinitrate (5 mg)", "role": "Treatment"}, {"name": "isosorbide dinitrate", "role": "Treatment.Drug"}, {"name": "5 mg", "role": "Treatment.Dosage"}]}]}
{"id": "train-1175", "event": [{"trigger": "stopping", "type": "adverse_event", "arguments": [{"name": "condition improved", "role": "Effect"}, {"name": "steroids", "role": "Treatment"}, {"name": "steroids", "role": "Treatment.Drug"}]}]}
{"id": "train-1176", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "acute liver failure", "role": "Effect"}, {"name": "Acetaminophen", "role": "Treatment"}, {"name": "Acetaminophen", "role": "Treatment.Drug"}]}]}
{"id": "train-1177", "event": [{"trigger": "experience", "type": "adverse_event", "arguments": [{"name": "Patients", "role": "Subject"}, {"name": "who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease", "role": "Subject"}, {"name": "lupus-like reaction", "role": "Effect"}, {"name": "5-ASA compounds", "role": "Treatment"}, {"name": "5-ASA", "role": "Treatment.Drug"}, {"name": "gastrointestinal disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1178", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "a patient with ATRA-resistant relapse of acute promyelocytic leukemia", "role": "Subject"}, {"name": "arsenic trioxide", "role": "Treatment"}, {"name": "arsenic trioxide", "role": "Treatment.Drug"}, {"name": "ATRA-resistant relapse of acute promyelocytic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1179", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Drug rash with eosinophilia and systemic symptoms", "role": "Effect"}, {"name": "chlorambucil", "role": "Treatment"}, {"name": "chlorambucil", "role": "Treatment.Drug"}, {"name": "chronic lymphocytic leukaemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1180", "event": [{"trigger": "manifested", "type": "adverse_event", "arguments": [{"name": "She", "role": "Subject"}, {"name": "She", "role": "Subject.Gender"}, {"name": "all the clinical symptoms and signs of caffeine toxicity.", "role": "Effect"}, {"name": "caffeine", "role": "Treatment"}, {"name": "caffeine", "role": "Treatment.Drug"}]}]}
{"id": "train-1181", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hearing loss", "role": "Effect"}, {"name": "Quinine", "role": "Treatment"}, {"name": "Quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-1182", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "Ezetimibe", "role": "Treatment"}, {"name": "Ezetimibe", "role": "Treatment.Drug"}]}]}
{"id": "train-1183", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "pemphigus", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-1184", "event": [{"trigger": "therapy", "type": "potential_therapeutic_event", "arguments": [{"name": "in patients with thalassemia intermedia", "role": "Subject"}, {"name": "increase total Hb levels", "role": "Effect"}, {"name": "low-dose HU therapy", "role": "Treatment"}, {"name": "thalassemia intermedia", "role": "Treatment.Disorder"}, {"name": "HU", "role": "Treatment.Drug"}, {"name": "low-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1185", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "susceptible patients", "role": "Subject"}, {"name": "convulsions", "role": "Effect"}, {"name": "the use of the new anaesthetic agents which are capable of inducing CNS excitability", "role": "Treatment"}, {"name": "anaesthetic", "role": "Treatment.Drug"}]}]}
{"id": "train-1186", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes", "role": "Subject"}, {"name": "an abnormal response to the glucose tolerance test without other evidence of diabetes", "role": "Subject.Disorder"}, {"name": "postprandial hyperglycemia and glycosuria", "role": "Effect"}, {"name": "a period of topical administration of a corticosteroid cream, halcinonide cream 0.1%, under occlusion", "role": "Treatment"}, {"name": "psoriasis", "role": "Treatment.Disorder"}, {"name": "halcinonide", "role": "Treatment.Drug"}, {"name": "cream", "role": "Treatment.Route"}]}]}
{"id": "train-1187", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "atheroembolic acute renal failure", "role": "Effect"}, {"name": "t-PA therapy", "role": "Treatment"}, {"name": "t-PA", "role": "Treatment.Drug"}]}]}
{"id": "train-1188", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A young woman", "role": "Subject"}, {"name": "young", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "galactorrhea", "role": "Effect"}, {"name": "during treatment with a new dibenzoxazepine antidepressant, amoxapine", "role": "Treatment"}, {"name": "amoxapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1189", "event": [{"trigger": "linked to", "type": "adverse_event", "arguments": [{"name": "the patient's", "role": "Subject"}, {"name": "fluorosis", "role": "Effect"}, {"name": "chronic use of niflumic acid", "role": "Treatment"}, {"name": "niflumic acid", "role": "Treatment.Drug"}, {"name": "chronic", "role": "Treatment.Duration"}]}]}
{"id": "train-1190", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "IVIG", "role": "Treatment"}, {"name": "IVIG", "role": "Treatment.Drug"}]}]}
{"id": "train-1191", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "3 cases of children with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "seizures and altered sensorium", "role": "Effect"}, {"name": "L-asparaginase", "role": "Treatment"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}]}]}
{"id": "train-1192", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "upper gastrointestinal bleeding", "role": "Effect"}, {"name": "tolazoline", "role": "Treatment"}, {"name": "tolazoline", "role": "Treatment.Drug"}]}]}
{"id": "train-1193", "event": [{"trigger": "provide", "type": "potential_therapeutic_event", "arguments": [{"name": "thiazolidinediones", "role": "Treatment"}, {"name": "thiazolidinediones", "role": "Treatment.Drug"}]}]}
{"id": "train-1194", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "schizophrenic patient", "role": "Subject"}, {"name": "a case of neuroleptic malignant syndrome (NMS)", "role": "Effect"}, {"name": "fluphenazine", "role": "Treatment"}, {"name": "schizophrenic", "role": "Treatment.Disorder"}, {"name": "fluphenazine", "role": "Treatment.Drug"}]}]}
{"id": "train-1195", "event": [{"trigger": "responsible", "type": "adverse_event", "arguments": [{"name": "SIADH", "role": "Effect"}, {"name": "vinorelbine", "role": "Treatment"}, {"name": "vinorelbine", "role": "Treatment.Drug"}]}]}
{"id": "train-1196", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Abnormal retinal function", "role": "Effect"}, {"name": "isotretinoin", "role": "Treatment"}, {"name": "acne", "role": "Treatment.Disorder"}, {"name": "isotretinoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1197", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "first reported case", "role": "Subject"}, {"name": "first", "role": "Subject.Population"}, {"name": "bromide intoxication", "role": "Effect"}, {"name": "pyridostigmine bromide", "role": "Treatment"}, {"name": "pyridostigmine bromide", "role": "Treatment.Drug"}]}]}
{"id": "train-1198", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "potentially life-threatening adverse_events", "role": "Effect"}, {"name": "including endometrial adenocarcinoma or uterine sarcoma", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-1199", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient with chronic lymphocytic leukemia (CLL)", "role": "Subject"}, {"name": "fatal intravascular autoimmune hemolytic anemia (AIHA)", "role": "Effect"}, {"name": "fludarabine treatment", "role": "Treatment"}, {"name": "fludarabine", "role": "Treatment.Drug"}, {"name": "chronic lymphocytic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1200", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 59-year-old woman with myasthenia gravis", "role": "Subject"}, {"name": "59-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "postoperative psychosis and was diagnosed as having bromide intoxication.", "role": "Effect"}, {"name": "a large dose of pyridostigmine bromide", "role": "Treatment"}, {"name": "pyridostigmine bromide", "role": "Treatment.Drug"}, {"name": "myasthenia gravis", "role": "Treatment.Disorder"}, {"name": "a large dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1201", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a renal transplant patient with Pneumocystis pneumonia", "role": "Subject"}, {"name": "renal transplant", "role": "Subject.Disorder"}, {"name": "chemical cellulitis and ulceration", "role": "Effect"}, {"name": "intravenous pentamidine into the soft tissues of the left hand and forearm", "role": "Treatment"}, {"name": "Pneumocystis pneumonia", "role": "Treatment.Disorder"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "pentamidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1202", "event": [{"trigger": "became", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "reaction to the drug became more toxic", "role": "Effect"}, {"name": "theophylline therapy", "role": "Treatment"}, {"name": "theophylline", "role": "Treatment.Drug"}, {"name": "99.9 and 149.9 micromol/L", "role": "Treatment.Dosage"}, {"name": "18 and 27 microg/mL", "role": "Treatment.Dosage"}]}]}
{"id": "train-1203", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "Dyspnea, hypoxemia, and pleuritic chest pain", "role": "Effect"}, {"name": "rituximab administration", "role": "Treatment"}, {"name": "24 hours", "role": "Treatment.Time_elapsed"}, {"name": "rituximab", "role": "Treatment.Drug"}]}]}
{"id": "train-1204", "event": [{"trigger": "to", "type": "potential_therapeutic_event", "arguments": [{"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}, {"name": "Dermatitis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1205", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "dacryolith", "role": "Effect"}, {"name": "breakdown products of adrenaline", "role": "Treatment"}, {"name": "adrenaline", "role": "Treatment.Drug"}]}]}
{"id": "train-1206", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "diabetic coma", "role": "Effect"}, {"name": "a combination of a thiazide diuretic and propranolol", "role": "Treatment"}, {"name": "thiazide", "role": "Treatment.Drug"}, {"name": "propranolol", "role": "Treatment.Drug"}, {"name": "thiazide", "role": "Combination.Drug"}, {"name": "propranolol", "role": "Combination.Drug"}]}]}
{"id": "train-1207", "event": [{"trigger": "from", "type": "potential_therapeutic_event", "arguments": [{"name": "limited efficacy", "role": "Effect"}, {"name": "traditional cytotoxic agents", "role": "Treatment"}, {"name": "Platinum-resistant ovarian cancer (PROC)", "role": "Treatment.Disorder"}, {"name": "traditional cytotoxic agents", "role": "Treatment.Drug"}]}]}
{"id": "train-1208", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "thrombocytopenia (HAT), recurrent arteriothromboses, and acute renal failure", "role": "Effect"}, {"name": "standard heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1209", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "increased risk of lymphoproliferative", "role": "Effect"}, {"name": "MG with MM", "role": "Treatment"}, {"name": "MG", "role": "Treatment.Disorder"}, {"name": "MM", "role": "Treatment.Drug"}]}]}
{"id": "train-1210", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with multiple myeloma", "role": "Subject"}, {"name": "acute life-threatening water intoxication", "role": "Effect"}, {"name": "oral indomethacin and low dose intravenous cyclophosphamide", "role": "Treatment"}, {"name": "multiple myeloma", "role": "Treatment.Disorder"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "indomethacin", "role": "Treatment.Drug"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "low dose", "role": "Treatment.Dosage"}, {"name": "indomethacin", "role": "Combination.Drug"}, {"name": "cyclophosphamide", "role": "Combination.Drug"}]}]}
{"id": "train-1211", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "visual loss", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1212", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "She", "role": "Subject"}, {"name": "She", "role": "Subject.Gender"}, {"name": "etanercept and methotrexate", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "etanercept", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "etanercept", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}]}]}
{"id": "train-1213", "event": [{"trigger": "consist", "type": "adverse_event", "arguments": [{"name": "minor dizziness or mild headache, although rare occurrences of seizures and hallucinations", "role": "Effect"}, {"name": "secondary to ciprofloxacin treatment", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1214", "event": [{"trigger": "ingested", "type": "adverse_event", "arguments": [{"name": "a 20-year-old woman", "role": "Subject"}, {"name": "20-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "refractory hypoglycemia", "role": "Effect"}, {"name": "900 mg of glyburide", "role": "Treatment"}, {"name": "900 mg", "role": "Treatment.Dosage"}, {"name": "glyburide", "role": "Treatment.Drug"}]}]}
{"id": "train-1215", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "myocardial infarction", "role": "Effect"}, {"name": "Etoposide", "role": "Treatment"}, {"name": "Etoposide", "role": "Treatment.Drug"}]}]}
{"id": "train-1216", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "PPE", "role": "Effect"}, {"name": "high-dose cytarabine", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "cytarabine", "role": "Treatment.Drug"}, {"name": "haematologic malignancies", "role": "Treatment.Disorder"}]}]}
{"id": "train-1217", "event": [{"trigger": "exhibited", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "gastrointestinal symptoms", "role": "Effect"}, {"name": "Copaxone 20 mg/day treatment for 2 years", "role": "Treatment"}, {"name": "Copaxone", "role": "Treatment.Drug"}, {"name": "20 mg/day", "role": "Treatment.Dosage"}, {"name": "2 years", "role": "Treatment.Duration"}]}]}
{"id": "train-1218", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "elderly patient with mixed dementia", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "TD at multiple sites, (including respiratory dyskinesia [RD], limb dyskinesia, and orofacial dyskinesia)", "role": "Effect"}, {"name": "abrupt withdrawal of risperidone therapy", "role": "Treatment"}, {"name": "risperidone", "role": "Treatment.Drug"}, {"name": "mixed dementia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1219", "event": [{"trigger": "complicated", "type": "adverse_event", "arguments": [{"name": "neuropsychiatric symptoms", "role": "Effect"}, {"name": "Interferon", "role": "Treatment"}, {"name": "Interferon", "role": "Treatment.Drug"}]}]}
{"id": "train-1220", "event": [{"trigger": "efficacy", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with persistent elevated triglycerides", "role": "Subject"}, {"name": "adding fenofibric acid to moderate-dose statin therapy", "role": "Treatment"}, {"name": "persistent elevated triglycerides", "role": "Treatment.Disorder"}, {"name": "fenofibric acid", "role": "Treatment.Drug"}, {"name": "statin", "role": "Treatment.Drug"}, {"name": "moderate-dose", "role": "Treatment.Dosage"}, {"name": "fenofibric acid", "role": "Combination.Drug"}, {"name": "statin", "role": "Combination.Drug"}]}]}
{"id": "train-1221", "event": [{"trigger": "provoked", "type": "adverse_event", "arguments": [{"name": "Type 1 diabetes mellitus", "role": "Effect"}, {"name": "peginterferon alpha-2b plus ribavirin treatment", "role": "Treatment"}, {"name": "peginterferon alpha-2b", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}, {"name": "ribavirin", "role": "Combination.Drug"}, {"name": "peginterferon alpha-2b", "role": "Combination.Drug"}]}]}
{"id": "train-1222", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "A 61-year-old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia", "role": "Subject"}, {"name": "61-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "early diffuse cutaneous scleroderma with myositis", "role": "Subject.Disorder"}, {"name": "progressive interstitial pneumonia", "role": "Subject.Disorder"}, {"name": "generalized erythema with high fever", "role": "Effect"}, {"name": "sulfamethoxazole/trimethoprim", "role": "Treatment"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "3 weeks after", "role": "Treatment.Time_elapsed"}, {"name": "trimethoprim", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}]}]}
{"id": "train-1223", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Serotonin toxicity", "role": "Effect"}, {"name": "an interaction between fentanyl and paroxetine", "role": "Treatment"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "paroxetine", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}, {"name": "paroxetine", "role": "Combination.Drug"}]}]}
{"id": "train-1224", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "sub-conjunctival haematoma", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1225", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Toxic optic neuropathy", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1226", "event": [{"trigger": "causation", "type": "adverse_event", "arguments": [{"name": "venous thrombosis", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-1227", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "an acute exacerbation of Crohn's disease, the patient", "role": "Subject"}, {"name": "fulminant cardiomyopathy", "role": "Effect"}, {"name": "One week after the initial-dose of adalimumab (160 mg)", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "adalimumab", "role": "Treatment.Drug"}, {"name": "160 mg", "role": "Treatment.Dosage"}, {"name": "One week", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1228", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "visually related side effects", "role": "Effect"}, {"name": "Ethambutol", "role": "Treatment"}, {"name": "isoniazid", "role": "Treatment"}, {"name": "isoniazid", "role": "Treatment.Drug"}, {"name": "Ethambutol", "role": "Treatment.Drug"}, {"name": "Ethambutol", "role": "Combination.Drug"}, {"name": "isoniazid", "role": "Combination.Drug"}]}]}
{"id": "train-1229", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "an enterally fed patient", "role": "Subject"}, {"name": "inadvertent increase in the international normalized ratio (INR)", "role": "Effect"}, {"name": "addition of bismuth subsalicylate", "role": "Treatment"}, {"name": "warfarin therapy", "role": "Treatment"}, {"name": "diarrhea", "role": "Treatment.Disorder"}, {"name": "bismuth subsalicylate", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "bismuth subsalicylate", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-1230", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "hazardous", "role": "Effect"}, {"name": "triazolam", "role": "Treatment"}, {"name": "triazolam", "role": "Treatment.Drug"}, {"name": "ketoconazole", "role": "Treatment.Drug"}, {"name": "itraconazole", "role": "Treatment.Drug"}, {"name": "Oral", "role": "Treatment.Route"}]}]}
{"id": "train-1231", "event": [{"trigger": "the low risk", "type": "adverse_event", "arguments": [{"name": "SB-LOT", "role": "Treatment"}, {"name": "increase LFT value", "role": "Treatment.Disorder"}, {"name": "SB-LOT", "role": "Treatment.Drug"}]}]}
{"id": "train-1232", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "Nineteen cases", "role": "Subject"}, {"name": "children", "role": "Subject"}, {"name": "Nineteen", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "unusual enhanced vincristine neurotoxicity", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1233", "event": [{"trigger": "prescribed", "type": "potential_therapeutic_event", "arguments": [{"name": "Extended-release tolterodine 4 mg/day", "role": "Treatment"}, {"name": "overactive bladder", "role": "Treatment.Disorder"}, {"name": "Extended-release tolterodine", "role": "Treatment.Drug"}, {"name": "4 mg/day", "role": "Treatment.Dosage"}]}]}
{"id": "train-1234", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a single case", "role": "Subject"}, {"name": "single", "role": "Subject.Population"}, {"name": "hypothyroidism", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1235", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "the first case", "role": "Subject"}, {"name": "acute pancreatitis", "role": "Effect"}, {"name": "danazol treatment of endometriosis", "role": "Treatment"}, {"name": "endometriosis", "role": "Treatment.Disorder"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-1236", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "neurologic or psychiatric symptoms", "role": "Effect"}, {"name": "large amounts of lidocaine cream are being used", "role": "Treatment"}, {"name": "lidocaine", "role": "Treatment.Drug"}, {"name": "cream", "role": "Treatment.Route"}, {"name": "large amounts", "role": "Treatment.Dosage"}]}]}
{"id": "train-1237", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "leukopenia", "role": "Effect"}, {"name": "cefoxitin", "role": "Treatment"}, {"name": "Cephalosporin", "role": "Treatment"}, {"name": "Cephalosporin", "role": "Treatment.Drug"}, {"name": "cefoxitin", "role": "Treatment.Drug"}]}]}
{"id": "train-1238", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a Jehovah's Witness", "role": "Subject"}, {"name": "Thrombotic thrombocytopenic purpura", "role": "Effect"}, {"name": "trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "trimethoprim-sulfamethoxazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1239", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "eruption", "role": "Effect"}, {"name": "distinct cutaneous toxicity", "role": "Effect"}, {"name": "PLD", "role": "Treatment"}, {"name": "PLD", "role": "Treatment.Drug"}]}]}
{"id": "train-1240", "event": [{"trigger": "among", "type": "adverse_event", "arguments": [{"name": "Granulocytopenia and agranulocytosis", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1241", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with radiation fibrosis", "role": "Subject"}, {"name": "radiation fibrosis", "role": "Subject.Disorder"}, {"name": "ILD", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1242", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "a critically ill patient", "role": "Subject"}, {"name": "critically ill", "role": "Subject.Disorder"}, {"name": "Unusual hypersensitivity", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1243", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with severe pre-ECT anxiety", "role": "Subject"}, {"name": "severe pre-ECT anxiety", "role": "Subject.Disorder"}, {"name": "sedation", "role": "Effect"}, {"name": "benzodiazepine", "role": "Treatment"}, {"name": "benzodiazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1244", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "seizure", "role": "Effect"}, {"name": "L-asparaginase therapy", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}]}]}
{"id": "train-1245", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with Crohn's disease", "role": "Subject"}, {"name": "severe infliximab infusion reaction (IIR), complicated 1 day later by severe swelling of the forearm and hand ipsilateral", "role": "Effect"}, {"name": "infliximab infusion", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1246", "event": [{"trigger": "despite", "type": "potential_therapeutic_event", "arguments": [{"name": "died within six weeks of developing congestive heart failure coupled with liver failure", "role": "Effect"}, {"name": "regular use of desferrioxamine", "role": "Treatment"}, {"name": "desferrioxamine", "role": "Treatment.Drug"}, {"name": "haemosiderosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1247", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 56-year-old Caucasian man", "role": "Subject"}, {"name": "56-year-old", "role": "Subject.Age"}, {"name": "Caucasian", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "fever", "role": "Effect"}, {"name": "concomitant chemotherapy and radiation for head and neck cancer", "role": "Treatment"}, {"name": "concurrent with the administration of amifostine", "role": "Treatment"}, {"name": "head and neck cancer", "role": "Treatment.Disorder"}, {"name": "amifostine", "role": "Treatment.Drug"}, {"name": "radiation", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Drug"}, {"name": "amifostine", "role": "Combination.Drug"}, {"name": "radiation", "role": "Combination.Drug"}, {"name": "chemotherapy", "role": "Combination.Drug"}]}]}
{"id": "train-1248", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "three individual patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "parasympathetic dysfunction of the visual system", "role": "Effect"}, {"name": "BTX-B", "role": "Treatment"}, {"name": "BTX-B", "role": "Treatment"}, {"name": "BTX-B", "role": "Treatment.Drug"}, {"name": "BTX-B", "role": "Treatment.Drug"}]}]}
{"id": "train-1249", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "autoimmune hepatitis", "role": "Effect"}, {"name": "Minocycline", "role": "Treatment"}, {"name": "sporadic autoimmune hepatitis", "role": "Treatment.Disorder"}, {"name": "Minocycline", "role": "Treatment.Drug"}]}]}
{"id": "train-1250", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "women", "role": "Subject"}, {"name": "women", "role": "Subject.Gender"}, {"name": "Reproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and hyperandrogenism", "role": "Effect"}, {"name": "sodium valproate for epilepsy", "role": "Treatment"}, {"name": "sodium valproate", "role": "Treatment.Drug"}, {"name": "epilepsy", "role": "Treatment.Disorder"}]}]}
{"id": "train-1251", "event": [{"trigger": "showed", "type": "adverse_event", "arguments": [{"name": "Two cases of lepromatous leprosy with erythema nodosum leprosum", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "discoloration of nail plate, subungual hyperkeratosis and onycholysis", "role": "Effect"}, {"name": "high doses of clofazimine", "role": "Treatment"}, {"name": "lepromatous leprosy with erythema nodosum leprosum", "role": "Treatment.Disorder"}, {"name": "clofazimine", "role": "Treatment.Drug"}, {"name": "high doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-1252", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "photo-onycholysis", "role": "Effect"}, {"name": "Doxycycline", "role": "Treatment"}, {"name": "Doxycycline", "role": "Treatment.Drug"}]}]}
{"id": "train-1253", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "administering intravenous immunoglobulin", "role": "Treatment"}, {"name": "immunoglobulin", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-1254", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Sweet's syndrome", "role": "Effect"}, {"name": "sargramostim (granulocyte-macrophage colony stimulating factor) treatment", "role": "Treatment"}, {"name": "sargramostim", "role": "Treatment.Drug"}]}]}
{"id": "train-1255", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "ARDS", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1256", "event": [{"trigger": "reported.", "type": "adverse_event", "arguments": [{"name": "multiform ventricular tachycardia", "role": "Effect"}, {"name": "Intravenous haloperidol", "role": "Treatment"}]}]}
{"id": "train-1257", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis and acute hepatitis", "role": "Effect"}, {"name": "coadministration of atorvastatin and diltiazem", "role": "Treatment"}, {"name": "atorvastatin", "role": "Treatment.Drug"}, {"name": "diltiazem", "role": "Treatment.Drug"}, {"name": "atorvastatin", "role": "Combination.Drug"}, {"name": "diltiazem", "role": "Combination.Drug"}]}]}
{"id": "train-1258", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "diffuse pruritic papular eruption located mainly on the limbs", "role": "Effect"}, {"name": "Ten hours after the second methotrexate injection", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "Ten hours", "role": "Treatment.Time_elapsed"}, {"name": "second", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1259", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "susceptible patients", "role": "Subject"}, {"name": "delirium", "role": "Effect"}, {"name": "Flecainide and pharmacologically similar agents that interact with sodium channels", "role": "Treatment"}, {"name": "Flecainide", "role": "Treatment.Drug"}]}]}
{"id": "train-1260", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "An elderly man", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "lupus", "role": "Effect"}, {"name": "procainamide hydrochloride", "role": "Treatment"}, {"name": "procainamide hydrochloride", "role": "Treatment.Drug"}]}]}
{"id": "train-1261", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "one patient", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}, {"name": "decrease in blood lactate levels", "role": "Effect"}, {"name": "DCA", "role": "Treatment"}, {"name": "DCA", "role": "Treatment.Drug"}, {"name": "16 h later", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1262", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "noncardiogenic pulmonary edema", "role": "Effect"}, {"name": "EO", "role": "Treatment"}, {"name": "EO", "role": "Treatment.Drug"}, {"name": "esophageal varix", "role": "Treatment.Disorder"}]}]}
{"id": "train-1263", "event": [{"trigger": "complications", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "hemoglobinemia, particularly disseminated intravascular coagulation (DIC)", "role": "Effect"}, {"name": "receiving anti-D IGIV", "role": "Treatment"}, {"name": "anti-D IGIV", "role": "Treatment.Drug"}]}]}
{"id": "train-1264", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Seizures", "role": "Effect"}, {"name": "therapeutic doses of venlafaxine and trimipramine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "trimipramine", "role": "Treatment.Drug"}, {"name": "therapeutic doses", "role": "Treatment.Dosage"}, {"name": "venlafaxine", "role": "Combination.Drug"}, {"name": "trimipramine", "role": "Combination.Drug"}]}]}
{"id": "train-1265", "event": [{"trigger": "become", "type": "adverse_event", "arguments": [{"name": "over 75s", "role": "Subject"}, {"name": "over 75s", "role": "Subject.Age"}, {"name": "haemorrhagic side-effects", "role": "Effect"}, {"name": "warfarin therapy", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1266", "event": [{"trigger": "accounted", "type": "adverse_event", "arguments": [{"name": "69 pregnancies", "role": "Subject"}, {"name": "69", "role": "Subject.Population"}, {"name": "clitoral hypertrophy", "role": "Effect"}, {"name": "Norethisterone", "role": "Treatment"}, {"name": "Norethisterone", "role": "Treatment.Drug"}]}]}
{"id": "train-1267", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Interstitial fibrosis of the lung", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "psoriasis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1268", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "oxcarbazepine", "role": "Treatment"}, {"name": "oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1269", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Purple glove syndrome", "role": "Effect"}, {"name": "purple discoloration and swelling of the hands in the distribution of a glove", "role": "Effect"}, {"name": "intravenous phenytoin administration through small dorsal veins of the hands", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1270", "event": [{"trigger": "linkage", "type": "adverse_event", "arguments": [{"name": "an HIV-infected hemophiliac", "role": "Subject"}, {"name": "intracranial bleeding", "role": "Effect"}, {"name": "amprenavir", "role": "Treatment"}, {"name": "amprenavir", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}]}]}
{"id": "train-1271", "event": [{"trigger": "led to", "type": "adverse_event", "arguments": [{"name": "recurrence of the pneumonitis", "role": "Effect"}, {"name": "Inadvertent subsequent rechallenge with celiprolol", "role": "Treatment"}, {"name": "10 weeks after drug readministration", "role": "Treatment"}, {"name": "celiprolol", "role": "Treatment.Drug"}, {"name": "10 weeks", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1272", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "Flecainide", "role": "Treatment"}, {"name": "atrial fibrillation", "role": "Treatment.Disorder"}, {"name": "Flecainide", "role": "Treatment.Drug"}]}]}
{"id": "train-1273", "event": [{"trigger": "suspected", "type": "adverse_event", "arguments": [{"name": "liver damage", "role": "Effect"}, {"name": "an interaction between the herbal preparation and tibolone", "role": "Treatment"}, {"name": "herbal preparation", "role": "Treatment.Drug"}, {"name": "tibolone", "role": "Treatment.Drug"}, {"name": "herbal preparation", "role": "Combination.Drug"}, {"name": "tibolone", "role": "Combination.Drug"}]}]}
{"id": "train-1274", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with APL", "role": "Subject"}, {"name": "symptom complex referred to as \"retinoic acid syndrome.\"", "role": "Effect"}, {"name": "a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis", "role": "Treatment"}, {"name": "ATRA", "role": "Treatment.Drug"}, {"name": "a few weeks", "role": "Treatment.Time_elapsed"}, {"name": "APL", "role": "Treatment.Disorder"}]}]}
{"id": "train-1275", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 50-year-old male with no history of heart disease", "role": "Subject"}, {"name": "50-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "a newly prolonged QT interval and torsade de pointes", "role": "Effect"}, {"name": "During intravenous treatment with terlipressin for recurrent gastrointestinal (GI) bleeding", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "terlipressin", "role": "Treatment.Drug"}, {"name": "recurrent gastrointestinal", "role": "Treatment.Disorder"}]}]}
{"id": "train-1276", "event": [{"trigger": "caution", "type": "adverse_event", "arguments": [{"name": "chloral hydrate and methaqualone", "role": "Treatment"}, {"name": "during oral anticoagulant therapy", "role": "Treatment"}, {"name": "chloral hydrate", "role": "Treatment.Drug"}, {"name": "methaqualone", "role": "Treatment.Drug"}, {"name": "anticoagulant", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "chloral hydrate", "role": "Combination.Drug"}, {"name": "methaqualone", "role": "Combination.Drug"}, {"name": "anticoagulant", "role": "Combination.Drug"}]}]}
{"id": "train-1277", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates", "role": "Effect"}, {"name": "Amiodarone hydrochloride", "role": "Treatment"}, {"name": "Amiodarone hydrochloride", "role": "Treatment.Drug"}]}]}
{"id": "train-1278", "event": [{"trigger": "major hazards", "type": "adverse_event", "arguments": [{"name": "secondary hyperparathyroidism and vitamin D intoxication, potassium loss", "role": "Effect"}, {"name": "hypophosphatemic osteomalacia with phosphate and calcitriol", "role": "Treatment"}, {"name": "phosphate", "role": "Treatment.Drug"}, {"name": "calcitriol", "role": "Treatment.Drug"}, {"name": "hypophosphatemic osteomalacia", "role": "Treatment.Disorder"}, {"name": "phosphate", "role": "Combination.Drug"}, {"name": "calcitriol", "role": "Combination.Drug"}]}]}
{"id": "train-1279", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "priapism", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1280", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "side effect", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1281", "event": [{"trigger": "responsible", "type": "adverse_event", "arguments": [{"name": "these patients", "role": "Subject"}, {"name": "subsequent development of carcinoma of the corpus uteri", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-1282", "event": [{"trigger": "be useful", "type": "potential_therapeutic_event", "arguments": [{"name": "Corticosteroids", "role": "Treatment"}, {"name": "Corticosteroids", "role": "Treatment.Drug"}, {"name": "thrombocytopenia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1283", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Eosinophilic cystitis", "role": "Effect"}, {"name": "bladder instillation with dimethyl sulfoxide", "role": "Treatment"}, {"name": "dimethyl sulfoxide", "role": "Treatment.Drug"}, {"name": "bladder instillation", "role": "Treatment.Route"}]}]}
{"id": "train-1284", "event": [{"trigger": "responsible", "type": "adverse_event", "arguments": [{"name": "two", "role": "Subject"}, {"name": "ductopenia", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "prolonged drug-induced cholangiopathy", "role": "Treatment.Disorder"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1285", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "A 15-kg weight gain", "role": "Effect"}, {"name": "ibuprofen", "role": "Treatment"}, {"name": "ibuprofen", "role": "Treatment.Drug"}, {"name": "the third week", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1286", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "renal failure", "role": "Effect"}, {"name": "Cefoxitin", "role": "Treatment"}, {"name": "Cefoxitin", "role": "Treatment.Drug"}]}]}
{"id": "train-1287", "event": [{"trigger": "seen", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "rash", "role": "Effect"}, {"name": "cephalexin", "role": "Treatment"}, {"name": "cephalexin", "role": "Treatment.Drug"}]}]}
{"id": "train-1288", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two of our patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "TD", "role": "Effect"}, {"name": "ziprasidone", "role": "Treatment"}, {"name": "ziprasidone", "role": "Treatment.Drug"}, {"name": "23 months", "role": "Treatment.Time_elapsed"}, {"name": "34 months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1289", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "two dark-skinned patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "dark-skinned", "role": "Subject.Race"}, {"name": "hyperpigmented skin and tongue lesions", "role": "Effect"}, {"name": "combination therapy with IFN and ribavirin.", "role": "Treatment"}, {"name": "IFN", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "IFN", "role": "Combination.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}]}]}
{"id": "train-1290", "event": [{"trigger": "after", "type": "potential_therapeutic_event", "arguments": [{"name": "Attenuation of asparaginase-induced hyperglycemia", "role": "Effect"}, {"name": "substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation", "role": "Treatment"}, {"name": "Erwinia carotovora", "role": "Treatment.Drug"}, {"name": "Escherichia coli enzyme preparation", "role": "Treatment.Drug"}]}]}
{"id": "train-1291", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "troglitazone", "role": "Treatment"}, {"name": "troglitazone", "role": "Treatment.Drug"}]}]}
{"id": "train-1292", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "interstitial nephritis with generalised exfoliative dermatitis", "role": "Effect"}, {"name": "Ampicillin", "role": "Treatment"}, {"name": "Ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-1293", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "High-dose intravenous mannitol infusion", "role": "Treatment"}, {"name": "mannitol", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "High-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1294", "event": [{"trigger": "therapy.", "type": "potential_therapeutic_event", "arguments": [{"name": "A 7-year-old boy developed a severe unilateral grand mal seizure", "role": "Subject"}, {"name": "7-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "a severe unilateral grand mal seizure", "role": "Subject.Disorder"}, {"name": "at the age of 5 years (phenobarbitone therapy); 1.5 years later valproate (2-propylpentanoic acid, VPA) was added to the therapy.", "role": "Treatment"}, {"name": "phenobarbitone", "role": "Treatment.Drug"}, {"name": "valproate", "role": "Treatment.Drug"}, {"name": "1.5 years later", "role": "Treatment.Time_elapsed"}, {"name": "valproate", "role": "Combination.Drug"}, {"name": "phenobarbitone", "role": "Combination.Drug"}]}]}
{"id": "train-1295", "event": [{"trigger": "related to", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis", "role": "Effect"}, {"name": "administration of clarithromycin without concurrent use of other medications", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1296", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a further case", "role": "Subject"}, {"name": "eleven previous cases", "role": "Subject"}, {"name": "eleven", "role": "Subject.Population"}, {"name": "liver damage", "role": "Effect"}, {"name": "methimazole", "role": "Treatment"}, {"name": "methimazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1297", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 67-year-old patient, with primary polymyositis and without previous evidence of liver disease", "role": "Subject"}, {"name": "67-year-old", "role": "Subject.Age"}, {"name": "cholestasis", "role": "Effect"}, {"name": "3 months after initiation of azathioprine", "role": "Treatment"}, {"name": "azathioprine", "role": "Treatment.Drug"}, {"name": "3 months", "role": "Treatment.Time_elapsed"}, {"name": "primary polymyositis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1298", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient with typhoid fever", "role": "Subject"}, {"name": "Hypersensitivity reaction", "role": "Effect"}, {"name": "chloramphenicol", "role": "Treatment"}, {"name": "chloramphenicol", "role": "Treatment.Drug"}, {"name": "typhoid fever", "role": "Treatment.Disorder"}]}]}
{"id": "train-1299", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "contact dermatitis", "role": "Effect"}, {"name": "calcipotriol", "role": "Treatment"}, {"name": "calcipotriol", "role": "Treatment.Drug"}]}]}
{"id": "train-1300", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "A 23-year-old woman with systemic lupus erythematosus", "role": "Subject"}, {"name": "23-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "hypersensitivity reaction", "role": "Effect"}, {"name": "ibuprofen", "role": "Treatment"}, {"name": "systemic lupus erythematosus", "role": "Treatment.Disorder"}, {"name": "ibuprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-1301", "event": [{"trigger": "case", "type": "adverse_event", "arguments": [{"name": "an infant born to a mother", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "WES", "role": "Effect"}, {"name": "haloperidol", "role": "Treatment"}, {"name": "haloperidol", "role": "Treatment.Drug"}]}]}
{"id": "train-1302", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "high fevers", "role": "Effect"}, {"name": "levofloxacin, acyclovir, and voriconazole", "role": "Treatment"}, {"name": "levofloxacin", "role": "Treatment.Drug"}, {"name": "acyclovir", "role": "Treatment.Drug"}, {"name": "voriconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1303", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "The 5 patients had severe renovascular disease", "role": "Subject"}, {"name": "5", "role": "Subject.Population"}, {"name": "renovascular disease", "role": "Subject.Disorder"}, {"name": "acute renal failure", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-1304", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "six severely asthmatic children", "role": "Subject"}, {"name": "six", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "Growth retardation", "role": "Effect"}, {"name": "introduction of high-dose fluticasone propionate treatment (dry powder)", "role": "Treatment"}, {"name": "severely asthmatic", "role": "Treatment.Disorder"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "fluticasone propionate", "role": "Treatment.Drug"}, {"name": "dry powder", "role": "Treatment.Route"}]}]}
{"id": "train-1305", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "toxic effects", "role": "Effect"}, {"name": "elevated liver transaminases (3/4), nausea (2/4), abdominal pain (2/4), bone pain (2/4), mild neutropenia (1/4), and mild pruritus (1/4)", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1306", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "anaemia", "role": "Effect"}, {"name": "Zidovudine", "role": "Treatment"}, {"name": "Zidovudine", "role": "Treatment.Drug"}]}]}
{"id": "train-1307", "event": [{"trigger": "established", "type": "potential_therapeutic_event", "arguments": [{"name": "A 60-yr-old woman", "role": "Subject"}, {"name": "depression", "role": "Subject"}, {"name": "60-yr-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "paroxetine", "role": "Treatment"}, {"name": "underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction", "role": "Treatment"}, {"name": "paroxetine", "role": "Treatment.Drug"}, {"name": "depression", "role": "Treatment.Disorder"}, {"name": "myxofibrosarcoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1308", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Papilloedema and hepatic dysfunction", "role": "Effect"}, {"name": "perhexiline maleate (Pexid)", "role": "Treatment"}, {"name": "perhexiline maleate", "role": "Treatment.Drug"}]}]}
{"id": "train-1309", "event": [{"trigger": "mediate", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "volatile anesthetic halothane", "role": "Treatment"}, {"name": "halothane", "role": "Treatment.Drug"}, {"name": "volatile", "role": "Treatment.Route"}]}]}
{"id": "train-1310", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "61-year-old male alcoholic who remained completely abstinent", "role": "Subject"}, {"name": "61-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "elevation of serum transaminases", "role": "Effect"}, {"name": "cyanamide for 3 years", "role": "Treatment"}, {"name": "cyanamide", "role": "Treatment.Drug"}, {"name": "3 years", "role": "Treatment.Duration"}, {"name": "alcoholic", "role": "Treatment.Disorder"}]}]}
{"id": "train-1311", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "submassive hepatic necrosis", "role": "Effect"}, {"name": "propylthiouracil", "role": "Treatment"}, {"name": "propylthiouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-1312", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two children with rheumatic fever", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "anicteric hepatitis", "role": "Effect"}, {"name": "high-dose aspirin", "role": "Treatment"}, {"name": "rheumatic fever", "role": "Treatment.Disorder"}, {"name": "aspirin", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1313", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an 88-year-old man", "role": "Subject"}, {"name": "88-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "hyperammonemia and mental status changes", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-1314", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 24-year-old hypertensive patient with hypophosphatemic osteomalacia, who was the youngest of four patients, belonging to a 23 number kindred of five generations", "role": "Subject"}, {"name": "24-year-old", "role": "Subject.Age"}, {"name": "hypertensive", "role": "Subject.Disorder"}, {"name": "decrease in plasma potassium", "role": "Effect"}, {"name": "phosphate treatment", "role": "Treatment"}, {"name": "phosphate", "role": "Treatment.Drug"}, {"name": "hypophosphatemic osteomalacia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1315", "event": [{"trigger": "inhibit ex vivo", "type": "potential_therapeutic_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "iloprost, a stable prostacyclin analogue (1 to 2 ng/kg/mn) with aspirin and dipyridamole", "role": "Treatment"}, {"name": "heparin-induced platelet aggregation", "role": "Treatment.Disorder"}, {"name": "1 to 2 ng/kg/mn", "role": "Treatment.Dosage"}, {"name": "iloprost", "role": "Treatment.Drug"}, {"name": "aspirin", "role": "Treatment.Drug"}, {"name": "dipyridamole", "role": "Treatment.Drug"}, {"name": "iloprost", "role": "Combination.Drug"}, {"name": "aspirin", "role": "Combination.Drug"}, {"name": "dipyridamole", "role": "Combination.Drug"}]}]}
{"id": "train-1316", "event": [{"trigger": "Adrenaline dacryolith:", "type": "adverse_event", "arguments": [{"name": "dacryolith", "role": "Effect"}, {"name": "Adrenaline", "role": "Treatment"}, {"name": "Adrenaline", "role": "Treatment.Drug"}, {"name": "nasolacrimal duct", "role": "Treatment.Route"}]}]}
{"id": "train-1317", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1318", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "increased libido", "role": "Effect"}, {"name": "fluvoxamine therapy.", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1319", "event": [{"trigger": "exhibited", "type": "adverse_event", "arguments": [{"name": "An 8-year-old child", "role": "Subject"}, {"name": "8-year-old", "role": "Subject.Age"}, {"name": "child", "role": "Subject.Age"}, {"name": "colchicine intoxication", "role": "Effect"}, {"name": "prophylactic doses of the drug", "role": "Treatment"}, {"name": "prophylactic doses", "role": "Treatment.Dosage"}, {"name": "familial Mediterranean fever", "role": "Treatment.Disorder"}, {"name": "colchicine", "role": "Treatment.Drug"}]}]}
{"id": "train-1320", "event": [{"trigger": "due to", "type": "potential_therapeutic_event", "arguments": [{"name": "the warfarin dose was again increased after discontinuation of ropinirole", "role": "Treatment"}, {"name": "gastrointestinal adverse effects", "role": "Treatment.Disorder"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1321", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome", "role": "Effect"}, {"name": "metaxalone overdose", "role": "Treatment"}, {"name": "metaxalone", "role": "Treatment.Drug"}, {"name": "selective serotonin reuptake inhibitor", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}, {"name": "metaxalone", "role": "Combination.Drug"}, {"name": "selective serotonin reuptake inhibitor", "role": "Combination.Drug"}]}]}
{"id": "train-1322", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "an elderly woman", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "nonconvulsive generalized status epilepticus", "role": "Effect"}, {"name": "acute withdrawal of lorazepam", "role": "Treatment"}, {"name": "lorazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-1323", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient with androgen-independent prostate cancer", "role": "Subject"}, {"name": "PSA continued to decrease for a period of 15 months", "role": "Effect"}, {"name": "flutamide withdrawal", "role": "Treatment"}, {"name": "flutamide", "role": "Treatment.Drug"}, {"name": "androgen-independent prostate cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1324", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a HIV-infected patient", "role": "Subject"}, {"name": "HIV", "role": "Subject.Disorder"}, {"name": "Acute renal failure", "role": "Effect"}, {"name": "intravenous immunoglobulin therapy", "role": "Treatment"}, {"name": "immunoglobulin", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-1325", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "further discomfort", "role": "Effect"}, {"name": "a total of four doses of linezolid", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "four doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-1326", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "aplastic anemia", "role": "Effect"}, {"name": "lenalidomide", "role": "Treatment"}, {"name": "lenalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-1327", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "reactions in the oral cavity", "role": "Effect"}, {"name": "antiretroviral medication", "role": "Treatment"}, {"name": "antiretroviral medication", "role": "Treatment.Drug"}]}]}
{"id": "train-1328", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "Persistent light reactivity", "role": "Effect"}, {"name": "systemic quinine", "role": "Treatment"}, {"name": "quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-1329", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "abnormal hypersensitivity", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1330", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "teratogenic effect", "role": "Effect"}, {"name": "retinoids", "role": "Treatment"}, {"name": "retinoids", "role": "Treatment.Drug"}]}]}
{"id": "train-1331", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "neonate", "role": "Subject"}, {"name": "neonate", "role": "Subject.Age"}, {"name": "later presentation of withdrawal symptoms in the neonate", "role": "Effect"}, {"name": "Diazepam", "role": "Treatment"}, {"name": "Diazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-1332", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 65-year-old patient", "role": "Subject"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome", "role": "Effect"}, {"name": "chronically treated with the selective serotonin reuptake inhibitor (SSRI) citalopram", "role": "Treatment"}, {"name": "following initiation of fentanyl", "role": "Treatment"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "chronically", "role": "Treatment.Time_elapsed"}, {"name": "citalopram", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}]}]}
{"id": "train-1333", "event": [{"trigger": "onset", "type": "adverse_event", "arguments": [{"name": "a patient with CF-related liver disease", "role": "Subject"}, {"name": "rapid onset of adrenal insufficiency", "role": "Effect"}, {"name": "briefly with a moderate CYP3A4 inhibitor", "role": "Treatment"}, {"name": "CYP3A4 inhibitor", "role": "Treatment.Drug"}, {"name": "CF-related liver disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1334", "event": [{"trigger": "remarked", "type": "adverse_event", "arguments": [{"name": "alcoholic patients", "role": "Subject"}, {"name": "hepatotoxic effects", "role": "Effect"}, {"name": "paracetamol", "role": "Treatment"}, {"name": "paracetamol", "role": "Treatment.Drug"}]}]}
{"id": "train-1335", "event": [{"trigger": "manifested", "type": "adverse_event", "arguments": [{"name": "newborn", "role": "Subject"}, {"name": "newborn", "role": "Subject.Age"}, {"name": "four day course of lethargy with unexplained high lithium levels", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1336", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "CLL patients", "role": "Subject"}, {"name": "severe AIHA", "role": "Effect"}, {"name": "fludarabine", "role": "Treatment"}, {"name": "CLL", "role": "Treatment.Disorder"}, {"name": "fludarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1337", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Corneal endothelial dysfunction", "role": "Effect"}, {"name": "amantadine", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}]}]}
{"id": "train-1338", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "3 patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "cutaneous scleroderma", "role": "Effect"}, {"name": "the use of bleomycin in low cumulative doses of less than 100 U.", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "less than 100 U.", "role": "Treatment.Dosage"}]}]}
{"id": "train-1339", "event": [{"trigger": "interact", "type": "adverse_event", "arguments": [{"name": "humans.", "role": "Subject"}, {"name": "severe clinical myotonia", "role": "Effect"}, {"name": "pravastatin", "role": "Treatment"}, {"name": "pravastatin", "role": "Treatment.Drug"}]}]}
{"id": "train-1340", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "heart block", "role": "Effect"}, {"name": "Disopyramide", "role": "Treatment"}, {"name": "Disopyramide", "role": "Treatment.Drug"}]}]}
{"id": "train-1341", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 69-year-old male with severe chronic tophaceous gout", "role": "Subject"}, {"name": "69-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "Telescoped digits of the hands and feet", "role": "Effect"}, {"name": "allopurinol treatment", "role": "Treatment"}, {"name": "severe chronic tophaceous gout", "role": "Treatment.Disorder"}, {"name": "allopurinol", "role": "Treatment.Drug"}]}]}
{"id": "train-1342", "event": [{"trigger": "treat", "type": "potential_therapeutic_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Jet-injection devices", "role": "Treatment"}, {"name": "insulin-induced lipoatrophy", "role": "Treatment.Disorder"}, {"name": "Jet-injection", "role": "Treatment.Route"}]}]}
{"id": "train-1343", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "a relatively healthy, 9-year-old boy", "role": "Subject"}, {"name": "9-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "TMP-SMX", "role": "Treatment"}, {"name": "CA-MRSA skin and soft tissue infection", "role": "Treatment.Disorder"}, {"name": "TMP-SMX", "role": "Treatment.Drug"}]}]}
{"id": "train-1344", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Recurrent septicemia with lethal outcome", "role": "Effect"}, {"name": "cyclosporine", "role": "Treatment"}, {"name": "severe ulcerative colitis", "role": "Treatment.Disorder"}, {"name": "cyclosporine", "role": "Treatment.Drug"}]}]}
{"id": "train-1345", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "fever", "role": "Effect"}, {"name": "Amifostine", "role": "Treatment"}, {"name": "Amifostine", "role": "Treatment.Drug"}]}]}
{"id": "train-1346", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "spontaneous splenic infarction", "role": "Effect"}, {"name": "sumatriptan", "role": "Treatment"}, {"name": "migraine headache", "role": "Treatment.Disorder"}, {"name": "sumatriptan", "role": "Treatment.Drug"}]}]}
{"id": "train-1347", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Hepatotoxicity", "role": "Effect"}, {"name": "6-thioguanine", "role": "Treatment"}, {"name": "6-thioguanine", "role": "Treatment.Drug"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1348", "event": [{"trigger": "side effect", "type": "adverse_event", "arguments": [{"name": "Neuropathy", "role": "Effect"}, {"name": "thalidomide", "role": "Treatment"}, {"name": "thalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-1349", "event": [{"trigger": "mechanism", "type": "adverse_event", "arguments": [{"name": "brain-damaged patients", "role": "Subject"}, {"name": "focal neurological deficit", "role": "Effect"}, {"name": "phenytoin therapy", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "brain-damaged", "role": "Treatment.Disorder"}]}]}
{"id": "train-1350", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Pulmonary toxicity", "role": "Effect"}, {"name": "mefloquine", "role": "Treatment"}, {"name": "mefloquine", "role": "Treatment.Drug"}]}]}
{"id": "train-1351", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "interstitial nephritis", "role": "Effect"}, {"name": "Ciprofloxacin", "role": "Treatment"}, {"name": "Ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1352", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Acute renal failure", "role": "Effect"}, {"name": "lisinopril and losartan", "role": "Treatment"}, {"name": "proteinuria", "role": "Treatment.Disorder"}, {"name": "lisinopril", "role": "Treatment.Drug"}, {"name": "losartan", "role": "Treatment.Drug"}, {"name": "lisinopril", "role": "Combination.Drug"}, {"name": "losartan", "role": "Combination.Drug"}]}]}
{"id": "train-1353", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "priapism", "role": "Effect"}, {"name": "oral intake of the phenothiazine prothipendylhydrochloride", "role": "Treatment"}, {"name": "prothipendylhydrochloride", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-1354", "event": [{"trigger": "because", "type": "adverse_event", "arguments": [{"name": "also exhibits type IA sodium channel blockade, cardiac toxicity", "role": "Effect"}, {"name": "diphenhydramine", "role": "Treatment"}, {"name": "diphenhydramine", "role": "Treatment.Drug"}]}]}
{"id": "train-1355", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "interstitial pulmonary disease", "role": "Effect"}, {"name": "Ticlopidine", "role": "Treatment"}, {"name": "Ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1356", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Linezolid", "role": "Treatment"}, {"name": "orthopedic-related MRSA infections", "role": "Treatment.Disorder"}, {"name": "Linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-1357", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "photo-onycholysis", "role": "Effect"}, {"name": "doxycycline", "role": "Treatment"}, {"name": "doxycycline", "role": "Treatment.Drug"}, {"name": "acne vulgaris", "role": "Treatment.Disorder"}]}]}
{"id": "train-1358", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Anticonvulsant hypersensitivity syndrome", "role": "Effect"}, {"name": "Bellamine S, a therapy for menopausal symptoms", "role": "Treatment"}, {"name": "menopausal symptoms.", "role": "Treatment.Disorder"}, {"name": "Bellamine S", "role": "Treatment.Drug"}]}]}
{"id": "train-1359", "event": [{"trigger": "control.", "type": "potential_therapeutic_event", "arguments": [{"name": "A 66-year-old white woman with a 10-year history of hypertension and bronchial asthma", "role": "Subject"}, {"name": "66-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "bronchial asthma", "role": "Subject.Disorder"}, {"name": "switched from immediate-release verapamil hydrocloride 40 mg tid to sustained-release verapamil 240 mg/d po", "role": "Treatment"}, {"name": "hypertension", "role": "Treatment.Disorder"}, {"name": "hypertension", "role": "Treatment.Disorder"}, {"name": "immediate-release verapamil hydrocloride", "role": "Treatment.Drug"}, {"name": "sustained-release verapamil", "role": "Treatment.Drug"}, {"name": "240 mg/d", "role": "Treatment.Dosage"}, {"name": "40 mg tid", "role": "Treatment.Dosage"}, {"name": "po", "role": "Treatment.Route"}]}]}
{"id": "train-1360", "event": [{"trigger": "Due", "type": "adverse_event", "arguments": [{"name": "rash", "role": "Effect"}, {"name": "temozolomide", "role": "Treatment"}, {"name": "temozolomide", "role": "Treatment.Drug"}]}]}
{"id": "train-1361", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a postmenopausal breast cancer patient", "role": "Subject"}, {"name": "postmenopausal", "role": "Subject.Disorder"}, {"name": "Ovarian endometrioid carcinoma and endometriosis", "role": "Effect"}, {"name": "tamoxifen therapy", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1362", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "central nervous system-related adverse effects, including headache, dizziness and insomnia", "role": "Effect"}, {"name": "The new quinolone derivatives (levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin), also called gyrase inhibitors", "role": "Treatment"}, {"name": "levofloxacin", "role": "Treatment.Drug"}, {"name": "sparfloxacin", "role": "Treatment.Drug"}, {"name": "grepafloxacin", "role": "Treatment.Drug"}, {"name": "trovafloxacin", "role": "Treatment.Drug"}, {"name": "gatifloxacin", "role": "Treatment.Drug"}, {"name": "moxifloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1363", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "ventricular arrhythmia", "role": "Effect"}, {"name": "Terlipressin", "role": "Treatment"}, {"name": "Terlipressin", "role": "Treatment.Drug"}]}]}
{"id": "train-1364", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "a patient with locally advanced pancreatic cancer", "role": "Subject"}, {"name": "acute severe hepatitis", "role": "Effect"}, {"name": "erlotinib monotherapy", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}, {"name": "locally advanced pancreatic cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1365", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "two instances", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "systemic allergic reaction", "role": "Effect"}, {"name": "potential side effects", "role": "Effect"}, {"name": "aprotinin", "role": "Treatment"}, {"name": "aprotinin", "role": "Treatment.Drug"}, {"name": "injections", "role": "Treatment.Route"}]}]}
{"id": "train-1366", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Acute pancreatitis", "role": "Effect"}, {"name": "danazol treatment", "role": "Treatment"}, {"name": "danazol", "role": "Treatment.Drug"}, {"name": "endometriosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1367", "event": [{"trigger": "manifested", "type": "adverse_event", "arguments": [{"name": "a 58 year old patient", "role": "Subject"}, {"name": "58 year old", "role": "Subject.Age"}, {"name": "acute pancreatitis", "role": "Effect"}, {"name": "after 2 days of treatment with roxithromycin", "role": "Treatment"}, {"name": "betamethasone", "role": "Treatment"}, {"name": "roxithromycin", "role": "Treatment.Drug"}, {"name": "betamethasone", "role": "Treatment.Drug"}, {"name": "2 days", "role": "Treatment.Time_elapsed"}, {"name": "roxithromycin", "role": "Combination.Drug"}, {"name": "betamethasone", "role": "Combination.Drug"}]}]}
{"id": "train-1368", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "salt and water retention", "role": "Effect"}, {"name": "ibuprofen", "role": "Treatment"}, {"name": "ibuprofen", "role": "Treatment.Drug"}, {"name": "phenylbutazone", "role": "Treatment.Drug"}, {"name": "indomethacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1369", "event": [{"trigger": "detected", "type": "adverse_event", "arguments": [{"name": "Gastric tumor, endometrial carcinoma and cervical adenocarcinoma in situ", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "breast cancer", "role": "Treatment.Disorder"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-1370", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "skin necrosis", "role": "Effect"}, {"name": "Warfarin", "role": "Treatment"}, {"name": "Warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1371", "event": [{"trigger": "led", "type": "adverse_event", "arguments": [{"name": "increased calcium-release", "role": "Effect"}, {"name": "dihydrotachysterol", "role": "Treatment"}, {"name": "dihydrotachysterol", "role": "Treatment.Drug"}]}]}
{"id": "train-1372", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thyroiditis", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1373", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "neurotoxicity", "role": "Effect"}, {"name": "methotrexate therapy", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1374", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "metabolic acidosis", "role": "Effect"}, {"name": "absorbed formic acid", "role": "Treatment"}, {"name": "formic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1375", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hand and foot deformities", "role": "Effect"}, {"name": "Allopurinol", "role": "Treatment"}, {"name": "Allopurinol", "role": "Treatment.Drug"}, {"name": "chronic tophaceous gout", "role": "Treatment.Disorder"}]}]}
{"id": "train-1376", "event": [{"trigger": "reaction.", "type": "adverse_event", "arguments": [{"name": "anaphylactic reaction", "role": "Effect"}, {"name": "25 UI of Miacalcic", "role": "Treatment"}, {"name": "immediate", "role": "Treatment"}, {"name": "Miacalcic", "role": "Treatment.Drug"}, {"name": "25 UI", "role": "Treatment.Dosage"}, {"name": "immediate", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1377", "event": [{"trigger": "reports", "type": "adverse_event", "arguments": [{"name": "several documented case", "role": "Subject"}, {"name": "several", "role": "Subject.Population"}, {"name": "serotonin toxicity", "role": "Effect"}, {"name": "selective serotonin reuptake inhibitors", "role": "Treatment"}, {"name": "selective serotonin reuptake inhibitors", "role": "Treatment.Drug"}, {"name": "serotonin", "role": "Treatment.Drug"}, {"name": "selective serotonin reuptake inhibitors", "role": "Combination.Drug"}, {"name": "serotonin", "role": "Combination.Drug"}]}]}
{"id": "train-1378", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "83 other reported cases", "role": "Subject"}, {"name": "83", "role": "Subject.Population"}, {"name": "renal insufficiency", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-1379", "event": [{"trigger": "regression", "type": "potential_therapeutic_event", "arguments": [{"name": "a patient with tubercular pericarditis", "role": "Subject"}, {"name": "tubercular pericarditis", "role": "Subject.Disorder"}, {"name": "corticosteroid", "role": "Treatment"}, {"name": "Kaposi's sarcoma", "role": "Treatment.Disorder"}, {"name": "corticosteroid", "role": "Treatment.Drug"}]}]}
{"id": "train-1380", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "immunosuppression", "role": "Effect"}, {"name": "T-cell lymphocytopenia", "role": "Effect"}, {"name": "Pneumocystis jiroveci pneumonia", "role": "Effect"}, {"name": "brain abscess with Listeria monocytogenes", "role": "Effect"}, {"name": "cutaneous Kaposi's sarcoma", "role": "Effect"}, {"name": "temozolomide", "role": "Treatment"}, {"name": "exacerbated by corticosteroids", "role": "Treatment"}, {"name": "temozolomide", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Combination.Drug"}, {"name": "temozolomide", "role": "Combination.Drug"}]}]}
{"id": "train-1381", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "transplant recipients", "role": "Subject"}, {"name": "transplant", "role": "Subject.Disorder"}, {"name": "cholelithiasis", "role": "Effect"}, {"name": "cyclosporin", "role": "Treatment"}, {"name": "cyclosporin", "role": "Treatment.Drug"}]}]}
{"id": "train-1382", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "adrenal insufficiency", "role": "Effect"}, {"name": "Rifampicin", "role": "Treatment"}, {"name": "Rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-1383", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "osteonecrosis of the skull base", "role": "Effect"}, {"name": "Bisphosphonate", "role": "Treatment"}, {"name": "Bisphosphonate", "role": "Treatment.Drug"}]}]}
{"id": "train-1384", "event": [{"trigger": "inhaled", "type": "adverse_event", "arguments": [{"name": "contact allergy", "role": "Effect"}, {"name": "Angioedema and dysphagia", "role": "Effect"}, {"name": "budesonide", "role": "Treatment"}, {"name": "budesonide", "role": "Treatment.Drug"}]}]}
{"id": "train-1385", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "Emergence of Philadelphia positive chronic myeloid leukaemia", "role": "Effect"}, {"name": "hydroxyurea", "role": "Treatment"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}, {"name": "Philadelphia negative essential thrombocythaemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1386", "event": [{"trigger": "increases", "type": "potential_therapeutic_event", "arguments": [{"name": "concentrations and hypotensive effect of tizanidine", "role": "Effect"}, {"name": "Ciprofloxacin", "role": "Treatment"}, {"name": "Ciprofloxacin", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1387", "event": [{"trigger": "induces", "type": "potential_therapeutic_event", "arguments": [{"name": "patient's psoriasis", "role": "Subject"}, {"name": "lymphocytopenia", "role": "Effect"}, {"name": "2-CdA", "role": "Treatment"}, {"name": "2-CdA", "role": "Treatment.Drug"}, {"name": "psoriasis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1388", "event": [{"trigger": "relationship", "type": "adverse_event", "arguments": [{"name": "symptomatic cardiac failure", "role": "Effect"}, {"name": "doxorubicin", "role": "Treatment"}, {"name": "doxorubicin", "role": "Treatment.Drug"}]}]}
{"id": "train-1389", "event": [{"trigger": "evidence", "type": "adverse_event", "arguments": [{"name": "damages the retina", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1390", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "profuse hematochezia", "role": "Effect"}, {"name": "diffuse colonic mucosal necrosis in the rectum", "role": "Effect"}, {"name": "Two days after administration of Kalimate enema", "role": "Treatment"}, {"name": "enema", "role": "Treatment.Route"}, {"name": "Kalimate", "role": "Treatment.Drug"}, {"name": "Two days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1391", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "sub-acute neurotoxicity", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1392", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "a patient with multiple sclerosis and monoclonal gammopathy", "role": "Subject"}, {"name": "monoclonal gammopathy", "role": "Subject.Disorder"}, {"name": "Scleromyxedema", "role": "Effect"}, {"name": "interferon beta-1a", "role": "Treatment"}, {"name": "interferon beta-1a", "role": "Treatment.Drug"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1393", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "22 cases", "role": "Subject"}, {"name": "22", "role": "Subject.Population"}, {"name": "hypersensitivity reaction", "role": "Effect"}, {"name": "cyclosporine", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}]}]}
{"id": "train-1394", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "3 RA patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "a lymphocyte alveolitis with a predominance of CD4+ T cells", "role": "Effect"}, {"name": "pneumonitis", "role": "Effect"}, {"name": "CD8+ T cells with a concomitant increase in neutrophils", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "RA", "role": "Treatment.Disorder"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-1395", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "patients receiving ciprofloxacin", "role": "Subject"}, {"name": "delayed elimination", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1396", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Severe acute encephalopathy", "role": "Effect"}, {"name": "intrathecal doxorubicin administration", "role": "Treatment"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "doxorubicin", "role": "Treatment.Drug"}]}]}
{"id": "train-1397", "event": [{"trigger": "increase", "type": "adverse_event", "arguments": [{"name": "patients with congenital or acquired haemophilia who have high-titre neutralizing antibodies to human FVIII", "role": "Subject"}, {"name": "risk of arterial or venous thrombosis.", "role": "Effect"}, {"name": "Porcine factor VIII (pFVIII)", "role": "Treatment"}, {"name": "high-titre neutralizing antibodies to human FVIII", "role": "Treatment.Disorder"}, {"name": "bleeding", "role": "Treatment.Disorder"}, {"name": "congenital or acquired haemophilia", "role": "Treatment.Disorder"}, {"name": "Porcine factor VIII", "role": "Treatment.Drug"}]}]}
{"id": "train-1398", "event": [{"trigger": "appeared", "type": "adverse_event", "arguments": [{"name": "all the patients", "role": "Subject"}, {"name": "pellagra symptoms", "role": "Effect"}, {"name": "isoniazid therapy", "role": "Treatment"}, {"name": "isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-1399", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "metastatic gallbladder adenocarcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1400", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyperglycaemic coma and neuroleptic malignant syndrome", "role": "Effect"}, {"name": "Olanzapine", "role": "Treatment"}, {"name": "Olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1401", "event": [{"trigger": "after", "type": "potential_therapeutic_event", "arguments": [{"name": "Neurologic symptoms resolved", "role": "Effect"}, {"name": "stopping CAP for 4 weeks", "role": "Treatment"}, {"name": "CAP", "role": "Treatment.Drug"}, {"name": "4 weeks", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1402", "event": [{"trigger": "interaction", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "fentanyl and citalopram", "role": "Treatment"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}, {"name": "citalopram", "role": "Combination.Drug"}]}]}
{"id": "train-1403", "event": [{"trigger": "emergence", "type": "adverse_event", "arguments": [{"name": "a 12-year old white girl", "role": "Subject"}, {"name": "heterozygous gene polymorphism of the CYP2B6-G516T.", "role": "Subject"}, {"name": "12-year old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "psychosis", "role": "Effect"}, {"name": "increased efavirenz concentration", "role": "Treatment"}, {"name": "efavirenz", "role": "Treatment.Drug"}]}]}
{"id": "train-1404", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Severe erythroderma", "role": "Effect"}, {"name": "continuous epoprostenol", "role": "Treatment"}, {"name": "epoprostenol", "role": "Treatment.Drug"}, {"name": "continuous", "role": "Treatment.Freq"}]}]}
{"id": "train-1405", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "FDE", "role": "Effect"}, {"name": "cephalosporins", "role": "Treatment"}, {"name": "cephalosporins", "role": "Treatment.Drug"}]}]}
{"id": "train-1406", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 58-year-old white woman", "role": "Subject"}, {"name": "58-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "fulminant liver failure", "role": "Effect"}, {"name": "macrolide antibiotic clarithromycin for pneumonia", "role": "Treatment"}, {"name": "pneumonia", "role": "Treatment.Disorder"}, {"name": "clarithromycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1407", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Marked elevation of serum CK", "role": "Effect"}, {"name": "olanzapine therapy", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1408", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "a patient with catecholamine-resistant septic shock", "role": "Subject"}, {"name": "skin necrosis", "role": "Effect"}, {"name": "peripheral intravenous administration of low-dose vasopressin", "role": "Treatment"}, {"name": "peripheral intravenous administration", "role": "Treatment.Route"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "vasopressin", "role": "Treatment.Drug"}, {"name": "catecholamine-resistant septic shock", "role": "Treatment.Disorder"}]}]}
{"id": "train-1409", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "PV", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1410", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "Recurrent hypotension immediately after seizures", "role": "Effect"}, {"name": "nortriptyline overdose", "role": "Treatment"}, {"name": "nortriptyline", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1411", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "recurrent, increasingly severe episodes of PPE, ultimately complicated by a severe bullous eruption", "role": "Effect"}, {"name": "cycles of high-dose cytarabine for the treatment of acute lymphoblastic leukaemia", "role": "Treatment"}, {"name": "acute lymphoblastic leukaemia", "role": "Treatment.Disorder"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "cytarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1412", "event": [{"trigger": "exacerbated", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "Intravenous diazepam", "role": "Treatment"}, {"name": "Intravenous", "role": "Treatment.Route"}, {"name": "diazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-1413", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "severe anaphylaxis", "role": "Effect"}, {"name": "cisplatin", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-1414", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "Cefuroxime", "role": "Treatment"}, {"name": "Cefuroxime", "role": "Treatment.Drug"}]}]}
{"id": "train-1415", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "4 patients", "role": "Subject"}, {"name": "4", "role": "Subject.Population"}, {"name": "autoimmune hepatitis", "role": "Effect"}, {"name": "minocycline", "role": "Treatment"}, {"name": "minocycline", "role": "Treatment.Drug"}]}]}
{"id": "train-1416", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "Intravitreal triamcinolone acetonide", "role": "Treatment"}, {"name": "persisting cystoid macular edema", "role": "Treatment.Disorder"}, {"name": "triamcinolone acetonide", "role": "Treatment.Drug"}, {"name": "Intravitreal", "role": "Treatment.Route"}]}]}
{"id": "train-1417", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 29-year-old liver transplant patient", "role": "Subject"}, {"name": "29-year-old", "role": "Subject.Age"}, {"name": "liver transplant", "role": "Subject.Disorder"}, {"name": "liver injury", "role": "Effect"}, {"name": "drug interaction between capecitabine and warfarin", "role": "Treatment"}, {"name": "capecitabine", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "capecitabine", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-1418", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Patients with 5-FU-induced ectropion", "role": "Subject"}, {"name": "ectropion", "role": "Effect"}, {"name": "tender, red, scaled lids", "role": "Effect"}, {"name": "5-FU", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-1419", "event": [{"trigger": "adverse effect", "type": "adverse_event", "arguments": [{"name": "Restless legs syndrome", "role": "Effect"}, {"name": "IFN alpha treatment.", "role": "Treatment"}, {"name": "IFN alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1420", "event": [{"trigger": "contraindicated", "type": "adverse_event", "arguments": [{"name": "patients with psychiatric disorders", "role": "Subject"}, {"name": "psychiatric disorders", "role": "Subject.Disorder"}, {"name": "possible severe psychiatric side effects", "role": "Effect"}, {"name": "interferon alpha (IFN-alpha)", "role": "Treatment"}, {"name": "chronic hepatitis C", "role": "Treatment.Disorder"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1421", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "anaphylactic reaction", "role": "Effect"}, {"name": "intravenous infusion of cyclosporine", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}, {"name": "intravenous infusion", "role": "Treatment.Route"}]}]}
{"id": "train-1422", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "renal failure", "role": "Effect"}, {"name": "Gabapentin", "role": "Treatment"}, {"name": "Gabapentin", "role": "Treatment.Drug"}]}]}
{"id": "train-1423", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a man", "role": "Subject"}, {"name": "man", "role": "Subject.Gender"}, {"name": "skin manifestations localized in an uncommon area and with an atypical evolution", "role": "Effect"}, {"name": "EGFR-inhibitor (erlotinib)", "role": "Treatment"}, {"name": "cell lung cancer", "role": "Treatment.Disorder"}, {"name": "EGFR-inhibitor", "role": "Treatment.Drug"}]}]}
{"id": "train-1424", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with treatment-resistant schizophrenia", "role": "Subject"}, {"name": "seizures", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "treatment-resistant schizophrenia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1425", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "Two fatal cases", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "poisoning", "role": "Effect"}, {"name": "paracetamol", "role": "Treatment"}, {"name": "paracetamol", "role": "Treatment.Drug"}]}]}
{"id": "train-1426", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "60 percent of treated patients", "role": "Subject"}, {"name": "60 percent", "role": "Subject.Population"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "HDARAC", "role": "Treatment"}, {"name": "HDARAC", "role": "Treatment.Drug"}]}]}
{"id": "train-1427", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "nephrolithiasis and interstitial nephritis", "role": "Effect"}, {"name": "HIV protease inhibitor indinavir", "role": "Treatment"}, {"name": "indinavir", "role": "Treatment.Drug"}]}]}
{"id": "train-1428", "event": [{"trigger": "adverse effect", "type": "adverse_event", "arguments": [{"name": "wound healing", "role": "Effect"}, {"name": "Colchicine", "role": "Treatment"}, {"name": "Colchicine", "role": "Treatment.Drug"}]}]}
{"id": "train-1429", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Pneumocystis carinii pneumonia", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "asthma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1430", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "a long-lasting state of immunodeficiency", "role": "Effect"}, {"name": "emergence of secondary neoplasms after its use", "role": "Effect"}, {"name": "2-CdA", "role": "Treatment"}, {"name": "2-CdA", "role": "Treatment.Drug"}]}]}
{"id": "train-1431", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "acute myopia and angle-closure glaucoma", "role": "Effect"}, {"name": "Topiramate", "role": "Treatment"}, {"name": "Topiramate", "role": "Treatment.Drug"}]}]}
{"id": "train-1432", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "rheumatoid arthritis patients", "role": "Subject"}, {"name": "LPD", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-1433", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}, {"name": "leprosy", "role": "Treatment.Disorder"}]}]}
{"id": "train-1434", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Intravitreal injection of triamcinolone acetonide", "role": "Treatment"}, {"name": "Intravitreal injection", "role": "Treatment.Route"}, {"name": "triamcinolone acetonide", "role": "Treatment.Drug"}, {"name": "therapy-resistant cystoid macular edema", "role": "Treatment.Disorder"}]}]}
{"id": "train-1435", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pancreatitis", "role": "Effect"}, {"name": "ezetimibe", "role": "Treatment"}, {"name": "ezetimibe", "role": "Treatment.Drug"}]}]}
{"id": "train-1436", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Acute acoustic nerve palsy", "role": "Effect"}, {"name": "vincristine therapy", "role": "Treatment"}, {"name": "vincristine", "role": "Treatment.Drug"}]}]}
{"id": "train-1437", "event": [{"trigger": "revealed", "type": "adverse_event", "arguments": [{"name": "in pregnancy", "role": "Subject"}, {"name": "pregnancy", "role": "Subject.Disorder"}, {"name": "adverse outcomes or congenital anomalies", "role": "Effect"}, {"name": "ATRA", "role": "Treatment"}, {"name": "ATRA", "role": "Treatment.Drug"}]}]}
{"id": "train-1438", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 57-year-old man with HIV and bipolar disease", "role": "Subject"}, {"name": "57-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "rapid and severe weight gain", "role": "Effect"}, {"name": "quetiapine was added to a stable atazanavir-ritonavir-based antiretroviral regimen", "role": "Treatment"}, {"name": "HIV", "role": "Treatment.Disorder"}, {"name": "bipolar disease", "role": "Treatment.Disorder"}, {"name": "atazanavir", "role": "Treatment.Drug"}, {"name": "ritonavir", "role": "Treatment.Drug"}, {"name": "quetiapine", "role": "Treatment.Drug"}, {"name": "quetiapine", "role": "Combination.Drug"}, {"name": "atazanavir", "role": "Combination.Drug"}, {"name": "ritonavir", "role": "Combination.Drug"}]}]}
{"id": "train-1439", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "A 43-year-old woman with multiple sclerosis (MS)", "role": "Subject"}, {"name": "43-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "nephrotic syndrome", "role": "Effect"}, {"name": "21 months after starting treatment with interferon (IFN)-beta-1b (subcutaneous administration)", "role": "Treatment"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}, {"name": "interferon (IFN)-beta-1b", "role": "Treatment.Drug"}, {"name": "21 months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1440", "event": [{"trigger": "referred", "type": "adverse_event", "arguments": [{"name": "An 81-year-old man with a history of neoplasies of the colon and prostate", "role": "Subject"}, {"name": "81-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "an ocular surface neoplasia on his left eye", "role": "Effect"}, {"name": "anticoagulant", "role": "Treatment"}, {"name": "anticoagulant", "role": "Treatment.Drug"}, {"name": "neoplasies of the colon and prostate", "role": "Treatment.Disorder"}]}]}
{"id": "train-1441", "event": [{"trigger": "exerts", "type": "potential_therapeutic_event", "arguments": [{"name": "anti-dyskinetic effect", "role": "Effect"}, {"name": "amantadine", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}]}]}
{"id": "train-1442", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a previously healthy, postmenopausal woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "anticonvulsant hypersensitivity syndrome", "role": "Effect"}, {"name": "Bellamine S (belladonna alkaloids; ergotamine; phenobarbital)", "role": "Treatment"}, {"name": "hot flashes", "role": "Treatment.Disorder"}, {"name": "Bellamine S", "role": "Treatment.Drug"}, {"name": "belladonna alkaloids", "role": "Treatment.Drug"}, {"name": "ergotamine", "role": "Treatment.Drug"}, {"name": "phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-1443", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Skin rash", "role": "Effect"}, {"name": "hepatocellular failure", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "3 weeks", "role": "Treatment.Time_elapsed"}, {"name": "2 weeks", "role": "Treatment.Time_elapsed"}, {"name": "phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-1444", "event": [{"trigger": "association of", "type": "adverse_event", "arguments": [{"name": "elevated hepato-biliary enzymes and transient biliary stasis", "role": "Effect"}, {"name": "ceftriaxone", "role": "Treatment"}, {"name": "otitis media", "role": "Treatment.Disorder"}, {"name": "ceftriaxone", "role": "Treatment.Drug"}]}]}
{"id": "train-1445", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A rare case of advanced ovarian carcinoma", "role": "Subject"}, {"name": "difficulty walking", "role": "Effect"}, {"name": "25 days after treatment with weekly paclitaxel", "role": "Treatment"}, {"name": "advanced ovarian carcinoma", "role": "Treatment.Disorder"}, {"name": "25 days", "role": "Treatment.Time_elapsed"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "paclitaxel", "role": "Treatment.Drug"}]}]}
{"id": "train-1446", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "patient with essential hypertension", "role": "Subject"}, {"name": "cough", "role": "Effect"}, {"name": "the administration of quinapril", "role": "Treatment"}, {"name": "quinapril", "role": "Treatment.Drug"}, {"name": "hypertension", "role": "Treatment.Disorder"}]}]}
{"id": "train-1447", "event": [{"trigger": "induced by", "type": "adverse_event", "arguments": [{"name": "Liver disease", "role": "Effect"}, {"name": "perhexiline maleate", "role": "Treatment"}, {"name": "perhexiline maleate", "role": "Treatment.Drug"}]}]}
{"id": "train-1448", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "3 patients.", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "anaphylactoid reactions", "role": "Effect"}, {"name": "intraperitoneal cisplatin", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "intraperitoneal", "role": "Treatment.Route"}]}]}
{"id": "train-1449", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "female with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "female", "role": "Subject.Gender"}, {"name": "severe, life-threatening, acute encephalopathy with high-pressure hydrocephalus", "role": "Effect"}, {"name": "inadvertent doxorubicin administration intrathecally", "role": "Treatment"}, {"name": "doxorubicin", "role": "Treatment.Drug"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}, {"name": "intrathecally", "role": "Treatment.Route"}]}]}
{"id": "train-1450", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "skin lesions", "role": "Effect"}, {"name": "antiviral therapy with interferon-alpha (IFN)", "role": "Treatment"}, {"name": "interferon-alpha (IFN).", "role": "Treatment.Drug"}]}]}
{"id": "train-1451", "event": [{"trigger": "eventually", "type": "adverse_event", "arguments": [{"name": "increase the risk of seizures", "role": "Effect"}, {"name": "venlafaxine and trimipramine at therapeutic doses", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "trimipramine", "role": "Treatment.Drug"}, {"name": "therapeutic doses", "role": "Treatment.Dosage"}, {"name": "venlafaxine", "role": "Combination.Drug"}, {"name": "trimipramine", "role": "Combination.Drug"}]}]}
{"id": "train-1452", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the case of a 43-year-old man with ITP refractory to steroids and intravenous immunoglobulin", "role": "Subject"}, {"name": "43-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "refractory to steroids and intravenous immunoglobulin", "role": "Subject.Disorder"}, {"name": "acute respiratory distress syndrome (ARDS)", "role": "Effect"}, {"name": "single infusion of rituximab", "role": "Treatment"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "rituximab", "role": "Treatment.Drug"}, {"name": "ITP", "role": "Treatment.Disorder"}]}]}
{"id": "train-1453", "event": [{"trigger": "suffered from", "type": "adverse_event", "arguments": [{"name": "anticholinergic adverse effects and the movement disorder tardive dyskinesia (TD)", "role": "Effect"}, {"name": "prescribed two mood stabilizers", "role": "Treatment"}, {"name": "mood stabilizers", "role": "Treatment.Drug"}]}]}
{"id": "train-1454", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a case of a 60 year old female", "role": "Subject"}, {"name": "60 year old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "relapse of symptomatic hyperlactatemia", "role": "Effect"}, {"name": "switched from stavudine to zidovudine", "role": "Treatment"}, {"name": "stavudine", "role": "Treatment.Drug"}, {"name": "zidovudine", "role": "Treatment.Drug"}]}]}
{"id": "train-1455", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "acute myelocytic leukemia", "role": "Effect"}, {"name": "exposure to cyclophosphamide, methotrexate, and 5-fluorouracil adjuvant therapy", "role": "Treatment"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}, {"name": "5-fluorouracil", "role": "Combination.Drug"}, {"name": "cyclophosphamide", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}]}]}
{"id": "train-1456", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Reversible corneal keratinization", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil.", "role": "Treatment.Drug"}]}]}
{"id": "train-1457", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "severe human insulin-induced lipoatrophy", "role": "Effect"}, {"name": "recombinant DNA human insulin", "role": "Treatment"}, {"name": "recombinant DNA human insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-1458", "event": [{"trigger": "presenting", "type": "adverse_event", "arguments": [{"name": "mixed SS/NMS features", "role": "Effect"}, {"name": "a poly-drug overdose (venlafaxine, topiramate, divalproex sodium, risperidone, and carbamazepine)", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "topiramate", "role": "Treatment.Drug"}, {"name": "divalproex sodium", "role": "Treatment.Drug"}, {"name": "risperidone", "role": "Treatment.Drug"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1459", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "Hyperpigmentation", "role": "Effect"}, {"name": "chemotherapautic agents", "role": "Treatment"}, {"name": "chemotherapautic agents", "role": "Treatment.Drug"}]}]}
{"id": "train-1460", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "four cases", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "pancreatitis", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1461", "event": [{"trigger": "adverse effects", "type": "adverse_event", "arguments": [{"name": "one such case", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}, {"name": "less gastrointestinal intolerance", "role": "Effect"}, {"name": "liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and allergic reactions", "role": "Effect"}, {"name": "Macrodantin", "role": "Treatment"}, {"name": "Macrodantin", "role": "Treatment.Drug"}]}]}
{"id": "train-1462", "event": [{"trigger": "began", "type": "potential_therapeutic_event", "arguments": [{"name": "A 29-year-old black man, HIV-infected since 1996", "role": "Subject"}, {"name": "29-year-old", "role": "Subject.Age"}, {"name": "black", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "highly active antiretroviral therapy (HAART) with zidovudine, lamivudine, and indinavir", "role": "Treatment"}, {"name": "zidovudine", "role": "Treatment.Drug"}, {"name": "lamivudine", "role": "Treatment.Drug"}, {"name": "indinavir", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}, {"name": "zidovudine", "role": "Combination.Drug"}, {"name": "lamivudine", "role": "Combination.Drug"}, {"name": "indinavir", "role": "Combination.Drug"}]}]}
{"id": "train-1463", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with chronic HCV", "role": "Subject"}, {"name": "hallucinations", "role": "Effect"}, {"name": "interferon and ribavirin", "role": "Treatment"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "chronic HCV", "role": "Treatment.Disorder"}, {"name": "interferon", "role": "Combination.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}]}]}
{"id": "train-1464", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms (DRESS) syndrome", "role": "Effect"}, {"name": "linezolid", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-1465", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypoxemia and hypotension", "role": "Effect"}, {"name": "nimodipine", "role": "Treatment"}, {"name": "nimodipine", "role": "Treatment.Drug"}]}]}
{"id": "train-1466", "event": [{"trigger": "including", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and thyroid diseases", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1467", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "four patients", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "Chronic photosensitivity", "role": "Effect"}, {"name": "hydrochlorothiazide ingestion", "role": "Treatment"}, {"name": "hydrochlorothiazide", "role": "Treatment.Drug"}, {"name": "ingestion", "role": "Treatment.Route"}]}]}
{"id": "train-1468", "event": [{"trigger": "side effect", "type": "adverse_event", "arguments": [{"name": "central nervous toxicity", "role": "Effect"}, {"name": "Chlorambucil", "role": "Treatment"}, {"name": "Chlorambucil", "role": "Treatment.Drug"}, {"name": "childhood nephrotic syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-1469", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "centrally acting muscle relaxant", "role": "Treatment"}, {"name": "metaxalone overdose", "role": "Treatment"}, {"name": "centrally acting muscle relaxant", "role": "Treatment.Drug"}, {"name": "metaxalone", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1470", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "pregnancy", "role": "Subject"}, {"name": "pregnancy", "role": "Subject.Disorder"}, {"name": "ACE fetopathy", "role": "Effect"}, {"name": "angiotensin converting enzyme (ACE) inhibitors", "role": "Treatment"}, {"name": "angiotensin converting enzyme (ACE) inhibitors", "role": "Treatment.Drug"}]}]}
{"id": "train-1471", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Of 371 patients", "role": "Subject"}, {"name": "three (0.8%)", "role": "Subject"}, {"name": "371", "role": "Subject.Population"}, {"name": "three (0.8%)", "role": "Subject.Population"}, {"name": "acute dermatitis", "role": "Effect"}, {"name": "treated with 8MOP", "role": "Treatment"}, {"name": "8MOP", "role": "Treatment.Drug"}]}]}
{"id": "train-1472", "event": [{"trigger": "precipitating or activating", "type": "adverse_event", "arguments": [{"name": "hyperthyroidism", "role": "Effect"}, {"name": "liothyronine", "role": "Treatment"}, {"name": "liothyronine", "role": "Treatment.Drug"}]}]}
{"id": "train-1473", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Neutropenic colitis", "role": "Effect"}, {"name": "standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer", "role": "Treatment"}, {"name": "testicular cancer", "role": "Treatment.Disorder"}, {"name": "standard dose", "role": "Treatment.Dosage"}, {"name": "nedaplatin", "role": "Treatment.Drug"}, {"name": "irinotecan", "role": "Treatment.Drug"}, {"name": "nedaplatin", "role": "Combination.Drug"}, {"name": "irinotecan", "role": "Combination.Drug"}]}]}
{"id": "train-1474", "event": [{"trigger": "necessary", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with advanced non-small cell lung cancer", "role": "Subject"}, {"name": "advanced non-small cell lung cancer", "role": "Subject.Disorder"}, {"name": "concomitant administration of antiepileptic and chemotherapeutic drugs or epidermal growth factor receptor (EGFR) inhibitor", "role": "Treatment"}, {"name": "antiepileptic", "role": "Treatment.Drug"}, {"name": "chemotherapeutic", "role": "Treatment.Drug"}, {"name": "epidermal growth factor receptor (EGFR) inhibitor", "role": "Treatment.Drug"}, {"name": "Brain metastases", "role": "Treatment.Disorder"}, {"name": "antiepileptic", "role": "Combination.Drug"}, {"name": "chemotherapeutic", "role": "Combination.Drug"}]}]}
{"id": "train-1475", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A female patient with HER2 positive, metastatic breast cancer", "role": "Subject"}, {"name": "female", "role": "Subject.Gender"}, {"name": "pulmonary infiltrates, and a plural effusion dyspnoea", "role": "Effect"}, {"name": "trastuzumab", "role": "Treatment"}, {"name": "HER2 positive, metastatic breast cancer", "role": "Treatment.Disorder"}, {"name": "trastuzumab", "role": "Treatment.Drug"}, {"name": "several months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1476", "event": [{"trigger": "under", "type": "adverse_event", "arguments": [{"name": "Thrombocytosis", "role": "Effect"}, {"name": "ciprofloxacin and tazobactam/piperacillin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "tazobactam", "role": "Treatment.Drug"}, {"name": "piperacillin", "role": "Treatment.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}, {"name": "tazobactam", "role": "Combination.Drug"}, {"name": "piperacillin", "role": "Combination.Drug"}]}]}
{"id": "train-1477", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "iatrogenic hypoglycaemia, due to excessive insulin secretion", "role": "Effect"}, {"name": "Quinine and its isomer quinidine", "role": "Treatment"}, {"name": "Quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-1478", "event": [{"trigger": "induce", "type": "potential_therapeutic_event", "arguments": [{"name": "durable complete remission", "role": "Effect"}, {"name": "2-CdA", "role": "Treatment"}, {"name": "MCD", "role": "Treatment.Disorder"}, {"name": "2-CdA", "role": "Treatment.Drug"}]}]}
{"id": "train-1479", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "a postictal patient", "role": "Subject"}, {"name": "Hyperammonemia", "role": "Effect"}, {"name": "valproic acid", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1480", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "clomipramine", "role": "Treatment"}, {"name": "clomipramine", "role": "Treatment.Drug"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "clomipramine", "role": "Combination.Drug"}, {"name": "clozapine", "role": "Combination.Drug"}]}]}
{"id": "train-1481", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 27-year-old man with mitral leaflet prolapse syndrome", "role": "Subject"}, {"name": "27-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "Fatal ventricular fibrillation", "role": "Effect"}, {"name": "digoxin", "role": "Treatment"}, {"name": "digoxin", "role": "Treatment.Drug"}, {"name": "mitral leaflet prolapse syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-1482", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "ovarian cancer patients.", "role": "Subject"}, {"name": "Clostridium difficile colitis", "role": "Effect"}, {"name": "cisplatin-based chemotherapy", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "ovarian cancer", "role": "Treatment.Disorder"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-1483", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Creutzfeldt-Jakob syndrome", "role": "Effect"}, {"name": "Lithium", "role": "Treatment"}, {"name": "Lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1484", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "marked thrombocytosis", "role": "Effect"}, {"name": "simultaneous administration of ciprofloxacin and tazobactam/piperacillin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "tazobactam/piperacillin", "role": "Treatment.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}, {"name": "tazobactam/piperacillin", "role": "Combination.Drug"}]}]}
{"id": "train-1485", "event": [{"trigger": "is", "type": "potential_therapeutic_event", "arguments": [{"name": "resistant patients", "role": "Subject"}, {"name": "Alone or in combination with corticosteroids, cyclosporine", "role": "Treatment"}, {"name": "corticosteroids", "role": "Treatment.Drug"}, {"name": "cyclosporine", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Combination.Drug"}, {"name": "cyclosporine", "role": "Combination.Drug"}]}]}
{"id": "train-1486", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Bull's-eye maculopathy", "role": "Effect"}, {"name": "quinacrine", "role": "Treatment"}, {"name": "quinacrine", "role": "Treatment.Drug"}, {"name": "malaria", "role": "Treatment.Disorder"}]}]}
{"id": "train-1487", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "papillary necrosis", "role": "Effect"}, {"name": "indinavir nephrolithiasis", "role": "Treatment"}, {"name": "indinavir", "role": "Treatment.Drug"}]}]}
{"id": "train-1488", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "fever, hemoptysis, and a pleural friction rub", "role": "Effect"}, {"name": "acyclovir", "role": "Treatment"}, {"name": "acyclovir", "role": "Treatment.Drug"}]}]}
{"id": "train-1489", "event": [{"trigger": "Due to", "type": "adverse_event", "arguments": [{"name": "discomfort, diplopia and lagophthalmos, the haematoma", "role": "Effect"}, {"name": "warfarin therapy and a surgical evacuation", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1490", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Acute dystonia with thalamic and brainstem lesions", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}, {"name": "Wilson's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1491", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "mid-borderline leprosy in type I reaction with triple nerve paralysis", "role": "Subject"}, {"name": "Indian", "role": "Subject.Race"}, {"name": "male", "role": "Subject.Gender"}, {"name": "Fatal agranulocytosis", "role": "Effect"}, {"name": "100mg of dapsone daily", "role": "Treatment"}, {"name": "100mg", "role": "Treatment.Dosage"}, {"name": "dapsone", "role": "Treatment.Drug"}, {"name": "daily", "role": "Treatment.Freq"}, {"name": "mid-borderline leprosy in type I reaction with triple nerve paralysis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1492", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "pulmonary hypertension", "role": "Effect"}, {"name": "lithium therapy", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "6 years", "role": "Treatment.Duration"}]}]}
{"id": "train-1493", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Oxaliplatin is a platinum derivative", "role": "Treatment"}, {"name": "Oxaliplatin", "role": "Treatment.Drug"}, {"name": "platinum derivative", "role": "Treatment.Drug"}, {"name": "colorectal cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1494", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "dry cough, subfebrile temperatures and dyspnea within 48 h.", "role": "Effect"}, {"name": "received gemcitabine on day 1 of the second course", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "within 48 h.", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1495", "event": [{"trigger": "have", "type": "adverse_event", "arguments": [{"name": "hematologic side effects", "role": "Effect"}, {"name": "linezolid", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-1496", "event": [{"trigger": "production", "type": "adverse_event", "arguments": [{"name": "cardiotoxicity", "role": "Effect"}, {"name": "Adriamycin", "role": "Treatment"}, {"name": "Adriamycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1497", "event": [{"trigger": "taking", "type": "potential_therapeutic_event", "arguments": [{"name": "propafenone", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}, {"name": "atrial fibrillation", "role": "Treatment.Disorder"}, {"name": "fatigue", "role": "Treatment.Disorder"}]}]}
{"id": "train-1498", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 53-year-old man", "role": "Subject"}, {"name": "53-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "NMS without rigidity", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1499", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 14-year-old boy with severe haemophilia A", "role": "Subject"}, {"name": "14-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "a portal vein thrombosis", "role": "Effect"}, {"name": "continuous infusion of F VIII", "role": "Treatment"}, {"name": "continuous", "role": "Treatment.Freq"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "F VIII", "role": "Treatment.Drug"}, {"name": "haemophilia A", "role": "Treatment.Disorder"}]}]}
{"id": "train-1500", "event": [{"trigger": "terminated", "type": "potential_therapeutic_event", "arguments": [{"name": "Suxamethonium apnoea", "role": "Effect"}, {"name": "commercial serumcholinesterase", "role": "Treatment"}, {"name": "commercial serumcholinesterase", "role": "Treatment.Drug"}]}]}
{"id": "train-1501", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "multiple drug intoxication", "role": "Effect"}, {"name": "acute sertraline use", "role": "Treatment"}, {"name": "sertraline", "role": "Treatment.Drug"}]}]}
{"id": "train-1502", "event": [{"trigger": "observed", "type": "adverse_event", "arguments": [{"name": "aggravation and spreading of a psoriatic plaque", "role": "Effect"}, {"name": "the toll-like receptor (TLR) 7 agonist imiquimod", "role": "Treatment"}, {"name": "imiquimod", "role": "Treatment.Drug"}, {"name": "topically", "role": "Treatment.Route"}]}]}
{"id": "train-1503", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "an AIDS patient", "role": "Subject"}, {"name": "Hypercalcemia", "role": "Effect"}, {"name": "growth hormone", "role": "Treatment"}, {"name": "AIDS", "role": "Treatment.Disorder"}, {"name": "growth hormone", "role": "Treatment.Drug"}]}]}
{"id": "train-1504", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "phenytoin toxicity", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1505", "event": [{"trigger": "interaction", "type": "adverse_event", "arguments": [{"name": "a patient treated for major depression and obsessive-compulsive disorder", "role": "Subject"}, {"name": "A pharmacokinetic interaction", "role": "Effect"}, {"name": "the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine", "role": "Treatment"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "clomipramine", "role": "Treatment.Drug"}, {"name": "depression", "role": "Treatment.Disorder"}, {"name": "obsessive-compulsive disorder", "role": "Treatment.Disorder"}, {"name": "citalopram", "role": "Combination.Drug"}, {"name": "clomipramine", "role": "Combination.Drug"}]}]}
{"id": "train-1506", "event": [{"trigger": "suspected.", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "salicylate", "role": "Treatment"}, {"name": "salicylate", "role": "Treatment.Drug"}]}]}
{"id": "train-1507", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "neuromuscular blockade", "role": "Effect"}, {"name": "potentiation of muscle relaxants", "role": "Effect"}, {"name": "magnesium sulfate", "role": "Treatment"}, {"name": "magnesium sulfate (MgSO4)", "role": "Treatment.Drug"}]}]}
{"id": "train-1508", "event": [{"trigger": "diagnosed", "type": "adverse_event", "arguments": [{"name": "diabetes insipidus", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1509", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "adults", "role": "Subject"}, {"name": "adults", "role": "Subject.Age"}, {"name": "mood changes with hypomanic features", "role": "Effect"}, {"name": "Gabapentin", "role": "Treatment"}, {"name": "Gabapentin", "role": "Treatment.Drug"}]}]}
{"id": "train-1510", "event": [{"trigger": "secondary to", "type": "adverse_event", "arguments": [{"name": "Drug induced polymyositis", "role": "Effect"}, {"name": "leuprolide acetate (Lupron) therapy", "role": "Treatment"}, {"name": "prostate carcinoma", "role": "Treatment.Disorder"}, {"name": "leuprolide acetate (Lupron)", "role": "Treatment.Drug"}]}]}
{"id": "train-1511", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Incomplete posterior hyaloid detachment", "role": "Effect"}, {"name": "intravitreal pegaptanib injection in diabetic macular edema", "role": "Treatment"}, {"name": "diabetic macular edema", "role": "Treatment.Disorder"}, {"name": "pegaptanib", "role": "Treatment.Drug"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-1512", "event": [{"trigger": "a case of", "type": "adverse_event", "arguments": [{"name": "liver injury", "role": "Effect"}, {"name": "perhexiline maleate", "role": "Treatment"}, {"name": "perhexiline maleate", "role": "Treatment.Drug"}]}]}
{"id": "train-1513", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "akathisia", "role": "Effect"}, {"name": "antipsychotic treatment combined with an antidepressant", "role": "Treatment"}, {"name": "antipsychotic", "role": "Treatment.Drug"}, {"name": "antidepressant", "role": "Treatment.Drug"}, {"name": "antidepressant", "role": "Combination.Drug"}, {"name": "antipsychotic", "role": "Combination.Drug"}]}]}
{"id": "train-1514", "event": [{"trigger": "neurotoxicity", "type": "adverse_event", "arguments": [{"name": "isoniazid (INH) neurotoxicity", "role": "Effect"}, {"name": "isoniazid (INH)", "role": "Treatment"}, {"name": "isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-1515", "event": [{"trigger": "be", "type": "adverse_event", "arguments": [{"name": "toxic", "role": "Effect"}, {"name": "doses 4 times a moderate dose", "role": "Treatment"}, {"name": "Clozapine", "role": "Treatment"}, {"name": "4 times a moderate dose", "role": "Treatment.Dosage"}, {"name": "Clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1516", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 3(1/2)-year-old child", "role": "Subject"}, {"name": "3(1/2)-year-old", "role": "Subject.Age"}, {"name": "child", "role": "Subject.Age"}, {"name": "simultaneous hepatotoxicity and bone marrow toxicity", "role": "Effect"}, {"name": "valproic acid, lamotrigine, and phenytoin", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}, {"name": "lamotrigine", "role": "Combination.Drug"}, {"name": "valproic acid", "role": "Combination.Drug"}]}]}
{"id": "train-1517", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Reversible cholestasis with bile duct injury", "role": "Effect"}, {"name": "azathioprine", "role": "Treatment"}, {"name": "azathioprine", "role": "Treatment.Drug"}]}]}
{"id": "train-1518", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "tremor", "role": "Effect"}, {"name": "itraconazole therapy,", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}, {"name": "within 1-12 months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1519", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case of", "role": "Subject"}, {"name": "a patient", "role": "Subject"}, {"name": "toxic epidermal necrolysis (TEN)", "role": "Effect"}, {"name": "phenolphthalein", "role": "Treatment"}, {"name": "maintained on several other medications more commonly known to be associated with TEN", "role": "Treatment"}, {"name": "phenolphthalein", "role": "Treatment.Drug"}]}]}
{"id": "train-1520", "event": [{"trigger": "normalized", "type": "potential_therapeutic_event", "arguments": [{"name": "Clinical symptoms and leukopenia normalized", "role": "Effect"}, {"name": "discontinuation of CBZ and administration of prednisolone at 40 mg", "role": "Treatment"}, {"name": "CBZ", "role": "Treatment.Drug"}, {"name": "prednisolone", "role": "Treatment.Drug"}, {"name": "40 mg", "role": "Treatment.Dosage"}, {"name": "CBZ", "role": "Combination.Drug"}, {"name": "prednisolone", "role": "Combination.Drug"}]}]}
{"id": "train-1521", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "A patient with alcoholic cerebellar degeneration", "role": "Subject"}, {"name": "alcoholic cerebellar degeneration", "role": "Subject.Disorder"}, {"name": "periodic alternating nystagmus", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1522", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Extensive forearm deep venous thrombosis", "role": "Effect"}, {"name": "infusion reaction", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-1523", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "a diabetic patient", "role": "Subject"}, {"name": "diabetic", "role": "Subject.Disorder"}, {"name": "Severe acidosis", "role": "Effect"}, {"name": "acetazolamide", "role": "Treatment"}, {"name": "acetazolamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1524", "event": [{"trigger": "effect", "type": "adverse_event", "arguments": [{"name": "Crohn's disease", "role": "Effect"}, {"name": "Copaxone", "role": "Treatment"}, {"name": "Copaxone", "role": "Treatment.Drug"}]}]}
{"id": "train-1525", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "ADR", "role": "Effect"}, {"name": "lamivudine", "role": "Treatment"}, {"name": "lamivudine", "role": "Treatment.Drug"}]}]}
{"id": "train-1526", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an increase in the alpha(1)-adrenoceptor occupancy by endogenous norepinephrine", "role": "Effect"}, {"name": "milnacipran", "role": "Treatment"}, {"name": "milnacipran", "role": "Treatment.Drug"}]}]}
{"id": "train-1527", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome", "role": "Effect"}, {"name": "interaction of cyclobenzaprine with other serotoninergic drugs", "role": "Treatment"}, {"name": "cyclobenzaprine", "role": "Treatment.Drug"}, {"name": "serotoninergic drugs", "role": "Treatment.Drug"}]}]}
{"id": "train-1528", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "4 among approximately 2 000 Japanese patients", "role": "Subject"}, {"name": "Japanese", "role": "Subject.Race"}, {"name": "4 among approximately 2 000", "role": "Subject.Population"}, {"name": "interstitial pneumonia", "role": "Effect"}, {"name": "sorafenib", "role": "Treatment"}, {"name": "sorafenib", "role": "Treatment.Drug"}]}]}
{"id": "train-1529", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "The other patient", "role": "Subject"}, {"name": "transient intraoperative hypertension immediately", "role": "Effect"}, {"name": "inadvertent submucosal injection of concentrated epinephrine", "role": "Treatment"}, {"name": "epinephrine", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-1530", "event": [{"trigger": "readministered", "type": "potential_therapeutic_event", "arguments": [{"name": "heparin", "role": "Treatment"}, {"name": "antiplatelet therapy is given", "role": "Treatment"}, {"name": "heparin-associated thrombocytopenia", "role": "Treatment.Disorder"}, {"name": "heparin", "role": "Treatment.Drug"}, {"name": "antiplatelet", "role": "Treatment.Drug"}, {"name": "antiplatelet", "role": "Combination.Drug"}, {"name": "heparin", "role": "Combination.Drug"}]}]}
{"id": "train-1531", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Pneumonitis with pleural and pericardial effusion and neuropathy", "role": "Effect"}, {"name": "amiodarone therapy", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1532", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "interstitial pneumonitis", "role": "Effect"}, {"name": "bicalutamide and/or leuprorelin acetate given as therapy for prostate cancer", "role": "Treatment"}, {"name": "prostate cancer", "role": "Treatment.Disorder"}, {"name": "bicalutamide", "role": "Treatment.Drug"}, {"name": "leuprorelin acetate", "role": "Treatment.Drug"}, {"name": "bicalutamide", "role": "Combination.Drug"}, {"name": "leuprorelin acetate", "role": "Combination.Drug"}]}]}
{"id": "train-1533", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "patients with a history of NMS", "role": "Subject"}, {"name": "a history of NMS", "role": "Subject.Disorder"}, {"name": "isolated serum CK elevation", "role": "Effect"}, {"name": "antipsychotic therapy", "role": "Treatment"}]}]}
{"id": "train-1534", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "Children with acute lymphoblastic leukemia (ALL)", "role": "Subject"}, {"name": "Children", "role": "Subject.Age"}, {"name": "cerebral thrombosis or hemorrhage", "role": "Effect"}, {"name": "coagulation protein deficiencies", "role": "Effect"}, {"name": "L-asparaginase", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}, {"name": "acute lymphoblastic leukemia (ALL)", "role": "Treatment.Disorder"}]}]}
{"id": "train-1535", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two of the five patients who worsened motorically", "role": "Subject"}, {"name": "Two of the five", "role": "Subject.Population"}, {"name": "worsened motorically", "role": "Subject.Disorder"}, {"name": "encephalopathy", "role": "Effect"}, {"name": "risperidone treatment", "role": "Treatment"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-1536", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "neuromuscular blockade (NMB)", "role": "Effect"}, {"name": "rocuronium", "role": "Treatment"}, {"name": "rocuronium", "role": "Treatment.Drug"}]}]}
{"id": "train-1537", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thyrotoxicosis (AIT)", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1538", "event": [{"trigger": "experience", "type": "adverse_event", "arguments": [{"name": "neurotoxicity", "role": "Effect"}, {"name": "Acyclovir", "role": "Treatment"}, {"name": "Acyclovir", "role": "Treatment.Drug"}]}]}
{"id": "train-1539", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "an enterally fed patient", "role": "Subject"}, {"name": "Inadvertent exaggerated anticoagulation", "role": "Effect"}, {"name": "bismuth subsalicylate", "role": "Treatment"}, {"name": "warfarin therapy", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "bismuth subsalicylate", "role": "Treatment.Drug"}]}]}
{"id": "train-1540", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "12 cases", "role": "Subject"}, {"name": "12", "role": "Subject.Population"}, {"name": "hypertension", "role": "Effect"}, {"name": "intraoperative use of topical phenylephrine, submucosal epinephrine, or both", "role": "Treatment"}, {"name": "phenylephrine", "role": "Treatment.Drug"}, {"name": "epinephrine", "role": "Treatment.Drug"}, {"name": "topical", "role": "Treatment.Route"}, {"name": "submucosal", "role": "Treatment.Route"}, {"name": "epinephrine", "role": "Combination.Drug"}, {"name": "phenylephrine", "role": "Combination.Drug"}]}]}
{"id": "train-1541", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "muscle twitches, tremulousness, and anxiety", "role": "Effect"}, {"name": "foscarnet therapy", "role": "Treatment"}, {"name": "foscarnet", "role": "Treatment.Drug"}, {"name": "on day 17", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1542", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a 73-year old white man", "role": "Subject"}, {"name": "73-year old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "heart failure", "role": "Effect"}, {"name": "timolol", "role": "Treatment"}, {"name": "timolol", "role": "Treatment.Drug"}]}]}
{"id": "train-1543", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "160 mg/day tebipenem pivoxil", "role": "Treatment"}, {"name": "inflammation of the tympanic membrane", "role": "Treatment.Disorder"}, {"name": "160 mg/day", "role": "Treatment.Dosage"}, {"name": "tebipenem pivoxil", "role": "Treatment.Drug"}]}]}
{"id": "train-1544", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A 65-year-old female patient", "role": "Subject"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "jaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat", "role": "Effect"}, {"name": "1 week after the fourth dose of adalimumab", "role": "Treatment"}, {"name": "adalimumab", "role": "Treatment.Drug"}, {"name": "1 week after", "role": "Treatment.Time_elapsed"}, {"name": "fourth dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1545", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Renal failure", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "tuberculosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1546", "event": [{"trigger": "poisoning.", "type": "adverse_event", "arguments": [{"name": "An autopsy case", "role": "Subject"}, {"name": "poisoning", "role": "Effect"}, {"name": "multiple psychotropic drug", "role": "Treatment"}, {"name": "psychotropic", "role": "Treatment.Drug"}]}]}
{"id": "train-1547", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "thrombocytopenia", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1548", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Six patients", "role": "Subject"}, {"name": "Six", "role": "Subject.Population"}, {"name": "indinavir", "role": "Treatment"}, {"name": "indinavir", "role": "Treatment.Drug"}]}]}
{"id": "train-1549", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "A 52-year-old woman with Parkinson disease", "role": "Subject"}, {"name": "52-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "bilateral corneal edema for 2 months at baseline", "role": "Effect"}, {"name": "taken amantadine for 6 years", "role": "Treatment"}, {"name": "Parkinson disease", "role": "Treatment.Disorder"}, {"name": "amantadine", "role": "Treatment.Drug"}, {"name": "6 years", "role": "Treatment.Duration"}]}]}
{"id": "train-1550", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "a patient with pulmonary hypertension and undifferentiated connective tissue disease", "role": "Subject"}, {"name": "rapidly progressive erythema, scaling, nausea and vomiting, and fever", "role": "Effect"}, {"name": "2 months of treatment with epoprostenol", "role": "Treatment"}, {"name": "epoprostenol", "role": "Treatment.Drug"}, {"name": "after 2 months", "role": "Treatment.Time_elapsed"}, {"name": "pulmonary hypertension", "role": "Treatment.Disorder"}, {"name": "undifferentiated connective tissue disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1551", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "adolescent", "role": "Subject"}, {"name": "Neuroleptic malignant syndrome", "role": "Effect"}, {"name": "olanzapine-lithium combination therapy", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Combination.Drug"}, {"name": "olanzapine", "role": "Combination.Drug"}]}]}
{"id": "train-1552", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "complication", "role": "Effect"}, {"name": "peripheral vein vasopressin infusion", "role": "Treatment"}, {"name": "peripheral vein", "role": "Treatment.Route"}, {"name": "vasopressin", "role": "Treatment.Drug"}]}]}
{"id": "train-1553", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "Cutaneous eruptions", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1554", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "A 27 year old female with a complex history of congenital heart disease, cardiac surgery, heart failure, and arrhythmias", "role": "Subject"}, {"name": "27 year old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "congenital heart disease", "role": "Subject.Disorder"}, {"name": "cardiac surgery", "role": "Subject.Disorder"}, {"name": "heart failure", "role": "Subject.Disorder"}, {"name": "arrhythmias", "role": "Subject.Disorder"}, {"name": "intravenous antibiotics", "role": "Treatment"}, {"name": "antibiotics", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "a Pseudomonas aeruginosa sternal wound infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-1555", "event": [{"trigger": "described", "type": "adverse_event", "arguments": [{"name": "2 elderly Japanese patients with lymphoid malignancy", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "Japanese", "role": "Subject.Race"}, {"name": "lymphoid malignancy", "role": "Subject.Disorder"}, {"name": "Hyperkalaemia with renal tubular dysfunction", "role": "Effect"}, {"name": "oral therapy of sulfamethoxazole-trimethoprim (co-trimoxazole)", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "sulfamethoxazole-trimethoprim", "role": "Treatment.Drug"}, {"name": "Pneumocystis carinii pneumonia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1556", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypothyroidism", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1557", "event": [{"trigger": "are", "type": "adverse_event", "arguments": [{"name": "Acute pulmonary reactions", "role": "Effect"}, {"name": "can cause minor or life-threatening pulmonary dysfunction", "role": "Effect"}, {"name": "nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1558", "event": [{"trigger": "benefit", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with refractory acute leukemia", "role": "Subject"}, {"name": "High-dose cytosine arabinoside", "role": "Treatment"}, {"name": "refractory acute leukemia", "role": "Treatment.Disorder"}, {"name": "High-dose", "role": "Treatment.Dosage"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}]}]}
{"id": "train-1559", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "hyponatremia", "role": "Effect"}, {"name": "vinblastine", "role": "Treatment"}, {"name": "vinblastine", "role": "Treatment.Drug"}]}]}
{"id": "train-1560", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a myeloma patient", "role": "Subject"}, {"name": "paralytic ileus", "role": "Effect"}, {"name": "presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation", "role": "Effect"}, {"name": "bortezomib therapy", "role": "Treatment"}, {"name": "myeloma", "role": "Treatment.Disorder"}, {"name": "bortezomib", "role": "Treatment.Drug"}]}]}
{"id": "train-1561", "event": [{"trigger": "respect", "type": "adverse_event", "arguments": [{"name": "liver reaction", "role": "Effect"}, {"name": "coumarin", "role": "Treatment"}, {"name": "coumarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1562", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "human", "role": "Subject"}, {"name": "noncardiogenic pulmonary edema", "role": "Effect"}, {"name": "EO", "role": "Treatment"}, {"name": "EO", "role": "Treatment.Drug"}]}]}
{"id": "train-1563", "event": [{"trigger": "Since", "type": "adverse_event", "arguments": [{"name": "the thrombocyte count started to increase immediately after initiation and dropped immediately", "role": "Effect"}, {"name": "discontinuation of ciprofloxacin and tazobactam/piperacillin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "tazobactam/piperacillin", "role": "Treatment.Drug"}, {"name": "discontinuation", "role": "Treatment.Dosage"}, {"name": "tazobactam/piperacillin", "role": "Combination.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}]}]}
{"id": "train-1564", "event": [{"trigger": "effects", "type": "adverse_event", "arguments": [{"name": "400 patients on the Thai-Burmese border", "role": "Subject"}, {"name": "400", "role": "Subject.Population"}, {"name": "cardiac effects", "role": "Effect"}, {"name": "sudden death", "role": "Effect"}, {"name": "halofantrine", "role": "Treatment"}, {"name": "halofantrine", "role": "Treatment.Drug"}, {"name": "antimalarial treatment", "role": "Treatment.Drug"}, {"name": "halofantrine", "role": "Combination.Drug"}, {"name": "antimalarial treatment", "role": "Combination.Drug"}]}]}
{"id": "train-1565", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "benign intracranial hypertension", "role": "Effect"}, {"name": "Tetracycline", "role": "Treatment"}, {"name": "Tetracycline", "role": "Treatment.Drug"}]}]}
{"id": "train-1566", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "one case", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}, {"name": "generalized maculopapular rash", "role": "Effect"}, {"name": "enoxaparin", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1567", "event": [{"trigger": "After", "type": "potential_therapeutic_event", "arguments": [{"name": "glucose levels of all patients decreased and diabetes disappeared", "role": "Effect"}, {"name": "3- to 13-month period of therapy without indapamide", "role": "Treatment"}, {"name": "indapamide", "role": "Treatment.Drug"}, {"name": "3- to 13-month", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1568", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "BOOP", "role": "Effect"}, {"name": "nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1569", "event": [{"trigger": "extravasation", "type": "adverse_event", "arguments": [{"name": "Skin necrosis", "role": "Effect"}, {"name": "vasopressin", "role": "Treatment"}, {"name": "vasopressin", "role": "Treatment.Drug"}, {"name": "septic shock", "role": "Treatment.Disorder"}]}]}
{"id": "train-1570", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "The patient", "role": "Subject"}, {"name": "previously on phenytoin", "role": "Treatment"}, {"name": "initiated on ticagrelor", "role": "Treatment"}, {"name": "following stent placement", "role": "Treatment"}, {"name": "antiplatelet therapy", "role": "Treatment.Disorder"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "ticagrelor", "role": "Treatment.Drug"}]}]}
{"id": "train-1571", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patients with spinal cord injury", "role": "Subject"}, {"name": "bradycardia", "role": "Effect"}, {"name": "Clonidine", "role": "Treatment"}, {"name": "spinal cord injury", "role": "Treatment.Disorder"}, {"name": "Clonidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1572", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "young patients who often have no preceding history of, or risk factors for, MI", "role": "Subject"}, {"name": "young", "role": "Subject.Age"}, {"name": "MI", "role": "Effect"}, {"name": "activated and non-activated PCCs", "role": "Treatment"}, {"name": "large cumulative doses of concentrate", "role": "Treatment"}, {"name": "non-activated PCCs", "role": "Treatment.Drug"}, {"name": "activated", "role": "Treatment.Drug"}, {"name": "PCCs", "role": "Treatment.Drug"}, {"name": "large cumulative doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-1573", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "isolated paresthesia and peripheral neuropathy", "role": "Effect"}, {"name": "sulindac administration", "role": "Treatment"}, {"name": "sulindac", "role": "Treatment.Drug"}]}]}
{"id": "train-1574", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a probable case", "role": "Subject"}, {"name": "phenytoin toxicity", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "ticlopidine", "role": "Combination.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}]}]}
{"id": "train-1575", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "subtle cognitive impairments", "role": "Effect"}, {"name": "therapeutic doses of amoxapine", "role": "Treatment"}, {"name": "therapeutic doses", "role": "Treatment.Dosage"}, {"name": "amoxapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1576", "event": [{"trigger": "prophylaxis", "type": "potential_therapeutic_event", "arguments": [{"name": "cancer patients", "role": "Subject"}, {"name": "cancer", "role": "Subject.Disorder"}, {"name": "Itraconazole", "role": "Treatment"}, {"name": "fungal", "role": "Treatment.Disorder"}, {"name": "Itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1577", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "ADRs", "role": "Effect"}, {"name": "lamivudine", "role": "Treatment"}, {"name": "lamivudine", "role": "Treatment.Drug"}]}]}
{"id": "train-1578", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Psoriasis", "role": "Effect"}, {"name": "interferon-alpha", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1579", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "the first case", "role": "Subject"}, {"name": "IHA", "role": "Effect"}, {"name": "cefuroxime", "role": "Treatment"}, {"name": "cefuroxime", "role": "Treatment.Drug"}]}]}
{"id": "train-1580", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 16-year-old male", "role": "Subject"}, {"name": "16-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "nephrotic syndrome related to membranous glomerulopathy with clinical and serological evidence of systemic lupus erythematosus", "role": "Effect"}, {"name": "treatment with griseofulvin", "role": "Treatment"}, {"name": "griseofulvin", "role": "Treatment.Drug"}]}]}
{"id": "train-1581", "event": [{"trigger": "In", "type": "adverse_event", "arguments": [{"name": "some abstainers", "role": "Subject"}, {"name": "thin septum-like liver fibrosis progresses along with the emergence of ground-glass hepatocytes", "role": "Effect"}, {"name": "take cyanamide for several years", "role": "Treatment"}, {"name": "cyanamide", "role": "Treatment.Drug"}, {"name": "several years", "role": "Treatment.Freq"}]}]}
{"id": "train-1582", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Metabolic acidosis", "role": "Effect"}, {"name": "acetazolamide", "role": "Treatment"}, {"name": "acetazolamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1583", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "prolonged hypotension and hypoxemia", "role": "Effect"}, {"name": "nimodipine overdosage", "role": "Treatment"}, {"name": "overdosage", "role": "Treatment.Dosage"}, {"name": "nimodipine", "role": "Treatment.Drug"}]}]}
{"id": "train-1584", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "significant INR changes", "role": "Effect"}, {"name": "Valproic acid also displaces warfarin from the protein binding sites", "role": "Treatment"}, {"name": "Valproic acid", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "Valproic acid", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-1585", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders", "role": "Effect"}, {"name": "Therapy with IFN-alpha", "role": "Treatment"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1586", "event": [{"trigger": "effects", "type": "adverse_event", "arguments": [{"name": "diarrhea, nausea, liver enzyme elevation, hypertension, alopecia, and allergic skin reactions", "role": "Effect"}, {"name": "leflunomide", "role": "Treatment"}, {"name": "leflunomide", "role": "Treatment.Drug"}]}]}
{"id": "train-1587", "event": [{"trigger": "incidence", "type": "adverse_event", "arguments": [{"name": "pregnancies", "role": "Subject"}, {"name": "gestational diabetes", "role": "Effect"}, {"name": "norethisterone", "role": "Treatment"}, {"name": "norethisterone", "role": "Treatment.Drug"}]}]}
{"id": "train-1588", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis.", "role": "Subject"}, {"name": "systemic lupus erythematosus", "role": "Effect"}, {"name": "after 38 months", "role": "Treatment"}, {"name": "recombinant human interferon gamma", "role": "Treatment"}, {"name": "after 38 months", "role": "Treatment.Time_elapsed"}, {"name": "recombinant human interferon gamma", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis.", "role": "Treatment.Disorder"}]}]}
{"id": "train-1589", "event": [{"trigger": "complications", "type": "adverse_event", "arguments": [{"name": "patients with brain tumours", "role": "Subject"}, {"name": "brain tumours", "role": "Subject.Disorder"}, {"name": "aspirin prophylaxis", "role": "Treatment"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-1590", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "28-yr-old male", "role": "Subject"}, {"name": "relapsing/remitting Multiple Sclerosis (RRMS)", "role": "Subject"}, {"name": "28-yr-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "nephrotic syndrome", "role": "Effect"}, {"name": "weekly injections of interferon beta 1a", "role": "Treatment"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "injections", "role": "Treatment.Route"}, {"name": "interferon beta 1a", "role": "Treatment.Drug"}, {"name": "relapsing/remitting Multiple Sclerosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1591", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "patients with rheumatoid arthritis", "role": "Subject"}, {"name": "reversible hepatic decompensation", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-1592", "event": [{"trigger": "observed", "type": "adverse_event", "arguments": [{"name": "Acute severe hepatitis", "role": "Effect"}, {"name": "EGFR inhibitors gefitinib or erlotinib", "role": "Treatment"}, {"name": "gefitinib", "role": "Treatment.Drug"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1593", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "Propafenone", "role": "Treatment"}, {"name": "atrial fibrillation", "role": "Treatment.Disorder"}, {"name": "Propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-1594", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Reversible nonthrombocytopenic palpable purpura", "role": "Effect"}, {"name": "metoclopramide", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-1595", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lupus syndrome", "role": "Effect"}, {"name": "sulfasalazine", "role": "Treatment"}, {"name": "sulfasalazine", "role": "Treatment"}, {"name": "sulfasalazine", "role": "Treatment.Drug"}, {"name": "sulfasalazine", "role": "Treatment.Drug"}, {"name": "inflammatory bowel disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1596", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Transient hemiparesis", "role": "Effect"}, {"name": "phenytoin toxicity", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1597", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Sensorineural hearing loss", "role": "Effect"}, {"name": "quinine", "role": "Treatment"}, {"name": "malaria", "role": "Treatment.Disorder"}, {"name": "quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-1598", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 78-year-old man", "role": "Subject"}, {"name": "78-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "acute unilateral total visual loss", "role": "Effect"}, {"name": "retrogasserian phenol injection", "role": "Treatment"}, {"name": "trigeminal neuralgia", "role": "Treatment.Disorder"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "phenol", "role": "Treatment.Drug"}]}]}
{"id": "train-1599", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "Four months after receiving an orthotopic liver transplant, a 51-year-old man", "role": "Subject"}, {"name": "a 51-year-old", "role": "Subject.Age"}, {"name": "progressive liver failure and severe hepatocellular necrosis", "role": "Effect"}, {"name": "tacrolimus", "role": "Treatment"}, {"name": "tacrolimus", "role": "Treatment.Drug"}, {"name": "Four months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1600", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "Patients", "role": "Subject"}, {"name": "protamine hypersensitivity", "role": "Effect"}, {"name": "neutral protamine Hagedorn (NPH) insulin", "role": "Treatment"}, {"name": "neutral protamine Hagedorn (NPH) insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-1601", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "The second patient", "role": "Subject"}, {"name": "cholestasis", "role": "Effect"}, {"name": "duct paucity", "role": "Effect"}, {"name": "trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "trimethoprim-sulfamethoxazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1602", "event": [{"trigger": "became", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "hypothyroid", "role": "Effect"}, {"name": "ferrous sulfate", "role": "Treatment"}, {"name": "ferrous sulfate", "role": "Treatment.Drug"}]}]}
{"id": "train-1603", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Allergy", "role": "Effect"}, {"name": "cloxacillin", "role": "Treatment"}, {"name": "cloxacillin", "role": "Treatment.Drug"}, {"name": "amoxicillin", "role": "Treatment.Drug"}, {"name": "cefuroxime", "role": "Treatment.Drug"}]}]}
{"id": "train-1604", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "nocturnal bingeing with amnesia", "role": "Effect"}, {"name": "Triazolam", "role": "Treatment"}, {"name": "Triazolam", "role": "Treatment.Drug"}]}]}
{"id": "train-1605", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "aplastic anemia (TIAA)", "role": "Effect"}, {"name": "Ticlopidine", "role": "Treatment"}, {"name": "Ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1606", "event": [{"trigger": "resulted", "type": "adverse_event", "arguments": [{"name": "One case", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "elevated INR", "role": "Effect"}, {"name": "simvastatin and the anticoagulant acenocoumarol", "role": "Treatment"}, {"name": "simvastatin", "role": "Treatment.Drug"}, {"name": "anticoagulant acenocoumarol", "role": "Treatment.Drug"}, {"name": "simvastatin", "role": "Combination.Drug"}, {"name": "anticoagulant acenocoumarol", "role": "Combination.Drug"}]}]}
{"id": "train-1607", "event": [{"trigger": "correlated", "type": "adverse_event", "arguments": [{"name": "A 35-year-old woman", "role": "Subject"}, {"name": "35-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum", "role": "Effect"}, {"name": "an i.v. regimen of 5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}, {"name": "i.v.", "role": "Treatment.Route"}]}]}
{"id": "train-1608", "event": [{"trigger": "aggravate", "type": "adverse_event", "arguments": [{"name": "myasthenia gravis", "role": "Effect"}, {"name": "Ampicillin", "role": "Treatment"}, {"name": "Ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-1609", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Japanese vivax malaria patient", "role": "Subject"}, {"name": "Japanese", "role": "Subject.Race"}, {"name": "QT interval was prolonged", "role": "Effect"}, {"name": "halofantrine", "role": "Treatment"}, {"name": "vivax malaria", "role": "Treatment.Disorder"}, {"name": "halofantrine", "role": "Treatment.Drug"}]}]}
{"id": "train-1610", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "eosinophilia-myalgia syndrome", "role": "Effect"}, {"name": "products containing L-tryptophan", "role": "Treatment"}, {"name": "L-tryptophan", "role": "Treatment.Drug"}]}]}
{"id": "train-1611", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypoglycemia", "role": "Effect"}, {"name": "Disopyramide (Norpace)", "role": "Treatment"}, {"name": "Disopyramide", "role": "Treatment.Drug"}]}]}
{"id": "train-1612", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}, {"name": "brown recluse spider bite", "role": "Treatment.Disorder"}]}]}
{"id": "train-1613", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "piloerection", "role": "Effect"}, {"name": "fluvoxamine maleate", "role": "Treatment"}, {"name": "fluvoxamine maleate", "role": "Treatment.Drug"}, {"name": "milnacipran hydrochloride", "role": "Treatment.Drug"}]}]}
{"id": "train-1614", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome", "role": "Effect"}, {"name": "linezolid and meperidine", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "meperidine", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "meperidine", "role": "Combination.Drug"}]}]}
{"id": "train-1615", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "She", "role": "Subject"}, {"name": "She", "role": "Subject.Gender"}, {"name": "nausea and anorexia", "role": "Effect"}, {"name": "addition of ciprofloxacin to her current regimen of medications, which included digoxin", "role": "Treatment"}, {"name": "within a few days", "role": "Treatment.Time_elapsed"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "digoxin", "role": "Treatment.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}, {"name": "digoxin", "role": "Combination.Drug"}]}]}
{"id": "train-1616", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an active duty soldier", "role": "Subject"}, {"name": "fulminant hepatic failure", "role": "Effect"}, {"name": "Disulfiram", "role": "Treatment"}, {"name": "Disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-1617", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "six cases", "role": "Subject"}, {"name": "patients with akinetic-rigid syndromes", "role": "Subject"}, {"name": "six", "role": "Subject.Population"}, {"name": "akinetic-rigid syndromes", "role": "Subject.Disorder"}, {"name": "risperidone", "role": "Treatment"}, {"name": "psychosis", "role": "Treatment.Disorder"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-1618", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Colonic necrosis", "role": "Effect"}, {"name": "Kayexalate (sodium polystryrene sulfonate) in sorbitol", "role": "Treatment"}, {"name": "Kayexalate", "role": "Treatment.Drug"}, {"name": "sorbitol", "role": "Treatment.Drug"}, {"name": "sorbitol", "role": "Combination.Drug"}, {"name": "Kayexalate", "role": "Combination.Drug"}]}]}
{"id": "train-1619", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Anaphylaxis", "role": "Effect"}, {"name": "cisplatin", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-1620", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Piloerection", "role": "Effect"}, {"name": "replacing fluvoxamine with milnacipran", "role": "Treatment"}, {"name": "milnacipran", "role": "Treatment.Drug"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1621", "event": [{"trigger": "treat", "type": "potential_therapeutic_event", "arguments": [{"name": "Ethambutol", "role": "Treatment"}, {"name": "tuberculosis", "role": "Treatment.Disorder"}, {"name": "Ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1622", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "DIC", "role": "Effect"}, {"name": "anti-D IGIV", "role": "Treatment"}, {"name": "anti-D IGIV", "role": "Treatment.Drug"}]}]}
{"id": "train-1623", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Four Chinese female patients who suffered from manic-depressive disorder and underlying autoimmune thyroiditis", "role": "Subject"}, {"name": "Four", "role": "Subject.Population"}, {"name": "Chinese", "role": "Subject.Race"}, {"name": "female", "role": "Subject.Gender"}, {"name": "underlying autoimmune thyroiditis", "role": "Subject.Disorder"}, {"name": "transient episodes of thyrotoxicosis", "role": "Effect"}, {"name": "maintenance lithium therapy", "role": "Treatment"}, {"name": "manic-depressive disorder", "role": "Treatment.Disorder"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1624", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "raised intracranial pressure", "role": "Effect"}, {"name": "valproic acid", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1625", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "patient with juvenile rheumatoid arthritis", "role": "Subject"}, {"name": "Primary ovarian large B-cell lymphoma", "role": "Effect"}, {"name": "low dose Methotrexate", "role": "Treatment"}, {"name": "juvenile rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "Methotrexate", "role": "Treatment.Drug"}, {"name": "low dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1626", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Asterixis", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1627", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "tubulopathies", "role": "Effect"}, {"name": "Ifosfamide", "role": "Treatment"}, {"name": "Ifosfamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1628", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "A case", "role": "Subject"}, {"name": "noncardiogenic pulmonary edema", "role": "Effect"}, {"name": "ethanolamine oleate", "role": "Treatment"}, {"name": "ethanolamine oleate", "role": "Treatment.Drug"}]}]}
{"id": "train-1629", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A boy with chronic neutropenia and recurrent inflammatory skin lesions", "role": "Subject"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "multiple erythematous nodules", "role": "Effect"}, {"name": "G-CSF", "role": "Treatment"}, {"name": "chronic neutropenia and recurrent inflammatory skin lesions", "role": "Treatment.Disorder"}, {"name": "G-CSF", "role": "Treatment.Drug"}]}]}
{"id": "train-1630", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Fulminant hepatitis", "role": "Effect"}, {"name": "lymphocyte sensitization", "role": "Effect"}, {"name": "propylthiouracil", "role": "Treatment"}, {"name": "propylthiouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-1631", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "three patients with acute schizophrenia", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "akathisia", "role": "Effect"}, {"name": "olanzapine (20-25 mg/d)", "role": "Treatment"}, {"name": "acute schizophrenia", "role": "Treatment.Disorder"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "20-25 mg/d", "role": "Treatment.Dosage"}]}]}
{"id": "train-1632", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "renal and ocular vasodilation", "role": "Effect"}, {"name": "insulin and glucose", "role": "Treatment"}, {"name": "glucose", "role": "Treatment.Drug"}, {"name": "insulin", "role": "Treatment.Drug"}, {"name": "insulin", "role": "Combination.Drug"}, {"name": "glucose", "role": "Combination.Drug"}]}]}
{"id": "train-1633", "event": [{"trigger": "relationship to", "type": "adverse_event", "arguments": [{"name": "headache", "role": "Effect"}, {"name": "capecitabine", "role": "Treatment"}, {"name": "capecitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1634", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "anuric ARF", "role": "Effect"}, {"name": "high-dose mannitol infusion", "role": "Treatment"}, {"name": "mannitol", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "narrow-angle glaucoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1635", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "She", "role": "Subject"}, {"name": "She", "role": "Subject.Gender"}, {"name": "sorafenib at 400 mg daily", "role": "Treatment"}, {"name": "sorafenib", "role": "Treatment.Drug"}, {"name": "400 mg", "role": "Treatment.Dosage"}, {"name": "daily", "role": "Treatment.Freq"}]}]}
{"id": "train-1636", "event": [{"trigger": "provoked", "type": "adverse_event", "arguments": [{"name": "type 1 diabetes mellitus", "role": "Effect"}, {"name": "recombinant alpha-2b peginterferon plus ribavirin", "role": "Treatment"}, {"name": "recombinant alpha-2b peginterferon", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}, {"name": "recombinant alpha-2b peginterferon", "role": "Combination.Drug"}]}]}
{"id": "train-1637", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Rhabdomyolysis", "role": "Effect"}, {"name": "clarithromycin monotherapy", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1638", "event": [{"trigger": "effect on", "type": "adverse_event", "arguments": [{"name": "gallbladder stasis", "role": "Effect"}, {"name": "alters bile acid composition and may thus hasten intrahepatic sludge and stone formation", "role": "Effect"}, {"name": "octreotide", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}]}]}
{"id": "train-1639", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "17-year-old boy with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "17-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "acute renal failure", "role": "Effect"}, {"name": "intravenous high-dose methotrexate (5 g/m2) infusion", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "5 g/m2", "role": "Treatment.Dosage"}, {"name": "within 48 h", "role": "Treatment.Time_elapsed"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1640", "event": [{"trigger": "complication of", "type": "adverse_event", "arguments": [{"name": "Splenic hemorrhage", "role": "Effect"}, {"name": "tissue plasminogen activator treatment", "role": "Treatment"}, {"name": "tissue plasminogen activator", "role": "Treatment.Drug"}]}]}
{"id": "train-1641", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "leukopenia", "role": "Effect"}, {"name": "Cefazolin", "role": "Treatment"}, {"name": "Cefazolin", "role": "Treatment.Drug"}]}]}
{"id": "train-1642", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Paradoxical cerebral cortical hyperexcitability", "role": "Effect"}, {"name": "flupirtine overdose", "role": "Treatment"}, {"name": "flupirtine", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1643", "event": [{"trigger": "found", "type": "adverse_event", "arguments": [{"name": "four leukemic patients", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "herpesvirus infection", "role": "Effect"}, {"name": "large doses of cytarabine", "role": "Treatment"}, {"name": "cytarabine (cytosine arabinoside; Ara-C)", "role": "Treatment.Drug"}, {"name": "leukemic", "role": "Treatment.Disorder"}]}]}
{"id": "train-1644", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyperkalemia", "role": "Effect"}, {"name": "Heparin", "role": "Treatment"}, {"name": "Heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1645", "event": [{"trigger": "hazards", "type": "adverse_event", "arguments": [{"name": "myelosuppression", "role": "Effect"}, {"name": "immunosuppression and superinfection", "role": "Effect"}, {"name": "DCF", "role": "Treatment"}, {"name": "DCF", "role": "Treatment.Drug"}]}]}
{"id": "train-1646", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "photosensitivity is still present 3 years", "role": "Effect"}, {"name": "withdrawal of quinine", "role": "Treatment"}, {"name": "quinine", "role": "Treatment.Drug"}]}]}
{"id": "train-1647", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "Interference with the cortisol axis", "role": "Effect"}, {"name": "CPH82", "role": "Treatment"}, {"name": "CPH82", "role": "Treatment.Drug"}]}]}
{"id": "train-1648", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "subfascial hemorrhage", "role": "Effect"}, {"name": "alteplase", "role": "Treatment"}, {"name": "alteplase", "role": "Treatment.Drug"}]}]}
{"id": "train-1649", "event": [{"trigger": "triggered", "type": "adverse_event", "arguments": [{"name": "an autoimmune cell-mediated hypersensitivity reaction", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-1650", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "Anaphylactic reaction", "role": "Effect"}, {"name": "oral prednisone", "role": "Treatment"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-1651", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "Prolonged prostate-specific antigen response", "role": "Effect"}, {"name": "flutamide", "role": "Treatment"}, {"name": "flutamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1652", "event": [{"trigger": "received", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "cardiac arrest", "role": "Effect"}, {"name": "doxorubicin", "role": "Treatment"}, {"name": "doxorubicin", "role": "Treatment.Drug"}]}]}
{"id": "train-1653", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "IDDM", "role": "Effect"}, {"name": "interferon therapy", "role": "Treatment"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "chronic hepatitis.", "role": "Treatment.Disorder"}]}]}
{"id": "train-1654", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "patients with HIV", "role": "Subject"}, {"name": "SJS", "role": "Effect"}, {"name": "nevirapine", "role": "Treatment"}, {"name": "nevirapine", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}]}]}
{"id": "train-1655", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "baclofen withdrawal syndrome", "role": "Effect"}, {"name": "oral baclofen underdosing", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "baclofen", "role": "Treatment.Drug"}, {"name": "underdosing", "role": "Treatment.Dosage"}]}]}
{"id": "train-1656", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 35-year-old nephrotic man", "role": "Subject"}, {"name": "35-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "acute renal failure with serum creatinine to 1543 micromol/l", "role": "Effect"}, {"name": "a month of therapy with enalapril", "role": "Treatment"}, {"name": "nephrotic", "role": "Treatment.Disorder"}, {"name": "a month", "role": "Treatment.Duration"}, {"name": "enalapril", "role": "Treatment.Drug"}]}]}
{"id": "train-1657", "event": [{"trigger": "been reported", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "disorientation and temporary amnesia", "role": "Effect"}, {"name": "propranolol", "role": "Treatment"}, {"name": "propranolol", "role": "Treatment.Drug"}]}]}
{"id": "train-1658", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 13-year-old boy", "role": "Subject"}, {"name": "13-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "severe rash and systemic symptoms", "role": "Effect"}, {"name": "oxcarbazepine", "role": "Treatment"}, {"name": "oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1659", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Renal damage", "role": "Effect"}, {"name": "lithium carbonate", "role": "Treatment"}, {"name": "lithium carbonate.", "role": "Treatment.Drug"}]}]}
{"id": "train-1660", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "secondary adrenal insufficiency", "role": "Effect"}, {"name": "Triamcinolone acetonide", "role": "Treatment"}, {"name": "coadministration of nefazodone", "role": "Treatment"}, {"name": "Triamcinolone acetonide", "role": "Treatment.Drug"}, {"name": "nefazodone", "role": "Treatment.Drug"}, {"name": "nefazodone", "role": "Combination.Drug"}, {"name": "Triamcinolone acetonide", "role": "Combination.Drug"}]}]}
{"id": "train-1661", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Hepatocellular damage", "role": "Effect"}, {"name": "intravenous iron sucrose infusion", "role": "Treatment"}, {"name": "iron sucrose", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-1662", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 43-year-old woman", "role": "Subject"}, {"name": "43-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "sore throat, swelling of the lips and oral cavity and dysphagia", "role": "Effect"}, {"name": "2 weeks after the use of budesonide spray (Budefat)", "role": "Treatment"}, {"name": "2 weeks after", "role": "Treatment.Time_elapsed"}, {"name": "budesonide", "role": "Treatment.Drug"}, {"name": "Budefat", "role": "Treatment.Drug"}, {"name": "bronchial asthma.", "role": "Treatment.Disorder"}, {"name": "spray", "role": "Treatment.Route"}]}]}
{"id": "train-1663", "event": [{"trigger": "appear to", "type": "adverse_event", "arguments": [{"name": "increase the risk of ARE", "role": "Effect"}, {"name": "prescription of thiabendazole", "role": "Treatment"}, {"name": "during the melarsoprol cure", "role": "Treatment"}, {"name": "thiabendazole", "role": "Treatment.Drug"}, {"name": "melarsoprol", "role": "Treatment.Drug"}, {"name": "strongyloidiasis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1664", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "pneumonitis", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1665", "event": [{"trigger": "increasing", "type": "adverse_event", "arguments": [{"name": "hepatic toxicity", "role": "Effect"}, {"name": "interaction between clarithromycin and isradipine", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "isradipine", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}, {"name": "isradipine", "role": "Combination.Drug"}]}]}
{"id": "train-1666", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "cerebrospinal fluid eosinophilia (CSFE)", "role": "Effect"}, {"name": "intraventricular administration of vancomycin", "role": "Treatment"}, {"name": "intraventricular", "role": "Treatment.Route"}, {"name": "vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1667", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "serious quetiapine adverse effects", "role": "Effect"}, {"name": "ritonavir-boosted atazanavir", "role": "Treatment"}, {"name": "ritonavir", "role": "Treatment.Drug"}, {"name": "atazanavir", "role": "Treatment.Drug"}, {"name": "ritonavir", "role": "Combination.Drug"}, {"name": "atazanavir", "role": "Combination.Drug"}]}]}
{"id": "train-1668", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "carbamazepine toxicity", "role": "Effect"}, {"name": "ritonavir", "role": "Treatment"}, {"name": "ritonavir", "role": "Treatment.Drug"}]}]}
{"id": "train-1669", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "respiratory depression", "role": "Effect"}, {"name": "fentanyl", "role": "Treatment"}, {"name": "voriconazole", "role": "Treatment.Drug"}, {"name": "fluconazole", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "voriconazole", "role": "Combination.Drug"}, {"name": "fluconazole", "role": "Combination.Drug"}]}]}
{"id": "train-1670", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "DIC associated with acute hemoglobinemia or hemoglobinuria", "role": "Effect"}, {"name": "anti-D IGIV administration", "role": "Treatment"}, {"name": "IGIV administration", "role": "Treatment.Route"}, {"name": "anti-D", "role": "Treatment.Drug"}, {"name": "ITP", "role": "Treatment.Disorder"}]}]}
{"id": "train-1671", "event": [{"trigger": "results", "type": "adverse_event", "arguments": [{"name": "tardive dyskinesia", "role": "Effect"}, {"name": "Risperidone", "role": "Treatment"}, {"name": "Risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-1672", "event": [{"trigger": "became", "type": "adverse_event", "arguments": [{"name": "A 5-month-old infant", "role": "Subject"}, {"name": "5-month-old", "role": "Subject.Age"}, {"name": "infant", "role": "Subject.Age"}, {"name": "lethargic and poorly responsive", "role": "Effect"}, {"name": "receiving 1 drop of brimonidine in each eye", "role": "Treatment"}, {"name": "brimonidine", "role": "Treatment.Drug"}, {"name": "1 drop", "role": "Treatment.Dosage"}, {"name": "in each eye", "role": "Treatment.Route"}]}]}
{"id": "train-1673", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "2 cases", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "renal damage", "role": "Effect"}, {"name": "lithium carbonate treatment", "role": "Treatment"}, {"name": "lithium carbonate", "role": "Treatment.Drug"}]}]}
{"id": "train-1674", "event": [{"trigger": "leading", "type": "adverse_event", "arguments": [{"name": "increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite", "role": "Effect"}, {"name": "valproic acid may interfere with glucuronidation of lamotrigine", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "valproic acid", "role": "Combination.Drug"}, {"name": "lamotrigine", "role": "Combination.Drug"}]}]}
{"id": "train-1675", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient with severe haemophilia A and F V G1691A mutation", "role": "Subject"}, {"name": "haemophilia A and F V G1691A mutation", "role": "Subject.Disorder"}, {"name": "Portal vein thrombosis", "role": "Effect"}, {"name": "continuous infusion of F VIII", "role": "Treatment"}, {"name": "intramural jejunal bleeding", "role": "Treatment.Disorder"}, {"name": "continuous infusion", "role": "Treatment.Route"}, {"name": "F VIII", "role": "Treatment.Drug"}]}]}
{"id": "train-1676", "event": [{"trigger": "exposed", "type": "adverse_event", "arguments": [{"name": "A healthy, 30-year-old man", "role": "Subject"}, {"name": "30-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "incapacitating isolated idential sensory neuropathy", "role": "Effect"}, {"name": "sulindac", "role": "Treatment"}, {"name": "sulindac", "role": "Treatment.Drug"}]}]}
{"id": "train-1677", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patients with diabetes insipidus", "role": "Subject"}, {"name": "myopathy", "role": "Effect"}, {"name": "Clofibrate", "role": "Treatment"}, {"name": "diabetes insipidus", "role": "Treatment.Disorder"}, {"name": "Clofibrate", "role": "Treatment.Drug"}]}]}
{"id": "train-1678", "event": [{"trigger": "aggravated", "type": "adverse_event", "arguments": [{"name": "the first histologically confirmed case", "role": "Subject"}, {"name": "NASH", "role": "Effect"}, {"name": "raloxifene", "role": "Treatment"}, {"name": "raloxifene", "role": "Treatment.Drug"}]}]}
{"id": "train-1679", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "TEN", "role": "Effect"}, {"name": "SJS", "role": "Effect"}, {"name": "lamotrigine", "role": "Treatment"}, {"name": "lamotrigine", "role": "Treatment.Drug"}]}]}
{"id": "train-1680", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "dermatologic toxicity", "role": "Effect"}, {"name": "ARA-C", "role": "Treatment"}, {"name": "ARA-C", "role": "Treatment.Drug"}]}]}
{"id": "train-1681", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Hyperglycemia and diabetic coma", "role": "Effect"}, {"name": "propranolol", "role": "Treatment"}, {"name": "propranolol", "role": "Treatment.Drug"}]}]}
{"id": "train-1682", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "ischemic colitis", "role": "Effect"}, {"name": "tegaserod", "role": "Treatment"}, {"name": "tegaserod", "role": "Treatment.Drug"}]}]}
{"id": "train-1683", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "case", "role": "Subject"}, {"name": "Anaphylaxis", "role": "Effect"}, {"name": "intravenous cyclosporine", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-1684", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A woman of 80 years", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "80 years", "role": "Subject.Age"}, {"name": "acute dissecting thoracic aortic aneurysm", "role": "Effect"}, {"name": "on long-term warfarin", "role": "Treatment"}, {"name": "long-term", "role": "Treatment.Duration"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-1685", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with an allergy to a macrolide antibiotic", "role": "Subject"}, {"name": "allergy to a macrolide antibiotic", "role": "Subject.Disorder"}, {"name": "sudden cutaneous reaction", "role": "Effect"}, {"name": "given tacrolimus", "role": "Treatment"}, {"name": "tacrolimus", "role": "Treatment.Drug"}]}]}
{"id": "train-1686", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "extramedullary relapse", "role": "Effect"}, {"name": "ATRA", "role": "Treatment"}, {"name": "ATRA", "role": "Treatment.Drug"}]}]}
{"id": "train-1687", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "neuroleptic malignant syndrome", "role": "Effect"}, {"name": "Olanzapine", "role": "Treatment"}, {"name": "Olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1688", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Acute dystonia", "role": "Effect"}, {"name": "lamivudine", "role": "Treatment"}, {"name": "lamivudine", "role": "Treatment.Drug"}]}]}
{"id": "train-1689", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lupus-like clinical syndrome", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-1690", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "leucopenia", "role": "Effect"}, {"name": "Quetiapine", "role": "Treatment"}, {"name": "Quetiapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1691", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "the ileus spontaneously resolved", "role": "Effect"}, {"name": "Oral intake and acarbose", "role": "Treatment"}, {"name": "acarbose", "role": "Treatment.Drug"}, {"name": "Oral intake", "role": "Treatment.Route"}]}]}
{"id": "train-1692", "event": [{"trigger": "impeded", "type": "adverse_event", "arguments": [{"name": "lactogenesis", "role": "Effect"}, {"name": "magnesium sulfate", "role": "Treatment"}, {"name": "magnesium sulfate", "role": "Treatment.Drug"}]}]}
{"id": "train-1693", "event": [{"trigger": "increases", "type": "adverse_event", "arguments": [{"name": "incidence of proliferative lesions of the endometrium", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-1694", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Three senile patients", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "senile", "role": "Subject.Age"}, {"name": "encephalopathy", "role": "Effect"}, {"name": "calcium hopantenate", "role": "Treatment"}, {"name": "calcium hopantenate", "role": "Treatment.Drug"}]}]}
{"id": "train-1695", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Renal injury", "role": "Effect"}, {"name": "anastrozole", "role": "Treatment"}, {"name": "anastrozole", "role": "Treatment.Drug"}]}]}
{"id": "train-1696", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Facial, tongue, and arm movements", "role": "Effect"}, {"name": "initiation of aripiprazole", "role": "Treatment"}, {"name": "five weeks", "role": "Treatment.Time_elapsed"}, {"name": "aripiprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1697", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Restless legs syndrome", "role": "Effect"}, {"name": "interferon-alpha", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1698", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "HUS", "role": "Effect"}, {"name": "several anticancer chemotherapies and most often after mitomycin C-based chemotherapy regimens", "role": "Treatment"}, {"name": "mitomycin C", "role": "Treatment.Drug"}]}]}
{"id": "train-1699", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "CA-MRSA", "role": "Subject"}, {"name": "CA-MRSA", "role": "Subject.Disorder"}, {"name": "SJS/TEN", "role": "Effect"}, {"name": "sulfonamide class of antibiotics", "role": "Treatment"}, {"name": "sulfonamide class of antibiotics", "role": "Treatment.Drug"}, {"name": "skin and soft tissue infections (SSTIs)", "role": "Treatment.Disorder"}]}]}
{"id": "train-1700", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "eight women", "role": "Subject"}, {"name": "eight", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "Acute non-lymphocytic leukemia", "role": "Effect"}, {"name": "Treosulfan (= dihydroxybusulfan)", "role": "Treatment"}, {"name": "Treosulfan", "role": "Treatment.Drug"}, {"name": "dihydroxybusulfan", "role": "Treatment.Drug"}, {"name": "ovarian carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1701", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "Elderly patients", "role": "Subject"}, {"name": "Elderly", "role": "Subject.Age"}, {"name": "hypotension", "role": "Effect"}, {"name": "unconsciousness", "role": "Effect"}, {"name": "nitrate", "role": "Treatment"}, {"name": "nitrate", "role": "Treatment.Drug"}]}]}
{"id": "train-1702", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "a lupus-like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips", "role": "Effect"}, {"name": "vancomycin", "role": "Treatment"}, {"name": "vancomycin", "role": "Treatment.Drug"}, {"name": "serious staphylococcal infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-1703", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Seven patients with hematologic malignancies", "role": "Subject"}, {"name": "Seven", "role": "Subject.Population"}, {"name": "hematologic malignancies", "role": "Subject.Disorder"}, {"name": "eight episodes of major adverse cardiorespiratory and anaphylactic reactions", "role": "Effect"}, {"name": "miconazole", "role": "Treatment"}, {"name": "miconazole", "role": "Treatment.Drug"}, {"name": "fungal infections", "role": "Treatment.Disorder"}]}]}
{"id": "train-1704", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "autoimmune hemolytic anemia", "role": "Effect"}, {"name": "rituximab", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}]}]}
{"id": "train-1705", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Anaphylactoid reactions", "role": "Effect"}, {"name": "intraperitoneal cisplatin", "role": "Treatment"}, {"name": "intraperitoneal", "role": "Treatment.Route"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-1706", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Tremor", "role": "Effect"}, {"name": "long-term itraconazole therapy", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-1707", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "myelodysplastic syndrome", "role": "Effect"}, {"name": "temozolomide", "role": "Treatment"}, {"name": "temozolomide", "role": "Treatment.Drug"}, {"name": "recurrent high-grade glioma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1708", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "thrombocytopenia and thrombosis syndrome", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1709", "event": [{"trigger": "resulting in", "type": "adverse_event", "arguments": [{"name": "an unusual case", "role": "Subject"}, {"name": "neurological and cardiovascular toxicity resulting in death", "role": "Effect"}, {"name": "massive fluoxetine ingestion", "role": "Treatment"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "massive", "role": "Treatment.Dosage"}, {"name": "ingestion", "role": "Treatment.Route"}]}]}
{"id": "train-1710", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "an elderly asymptomatic asthmatic patient with hypertension", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "asymptomatic asthmatic", "role": "Subject.Disorder"}, {"name": "an acute asthma attack", "role": "Effect"}, {"name": "sustained-release verapamil administration", "role": "Treatment"}, {"name": "sustained-release verapamil", "role": "Treatment.Drug"}, {"name": "hypertension", "role": "Treatment.Disorder"}]}]}
{"id": "train-1711", "event": [{"trigger": "resolved", "type": "potential_therapeutic_event", "arguments": [{"name": "discontinuation of APV", "role": "Treatment"}, {"name": "The bleeding", "role": "Treatment.Disorder"}, {"name": "APV", "role": "Treatment.Drug"}]}]}
{"id": "train-1712", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "a 67-year-old woman", "role": "Subject"}, {"name": "RA", "role": "Subject"}, {"name": "67-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "infection with Mycobacterium abscessus", "role": "Effect"}, {"name": "infliximab as a component of her therapy", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}, {"name": "RA", "role": "Treatment.Disorder"}]}]}
{"id": "train-1713", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "less than one percent of the patients", "role": "Subject"}, {"name": "less than one percent", "role": "Subject.Population"}, {"name": "Renal toxicities", "role": "Effect"}, {"name": "ciprofloxacin therapy.", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1714", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "glaucoma", "role": "Effect"}, {"name": "Taxane", "role": "Treatment"}, {"name": "Taxane", "role": "Treatment.Drug"}]}]}
{"id": "train-1715", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with systemic lupus erythematosus.", "role": "Subject"}, {"name": "toxic epidermal necrolysis", "role": "Effect"}, {"name": "Ciprofloxacin", "role": "Treatment"}, {"name": "Ciprofloxacin", "role": "Treatment.Drug"}, {"name": "systemic lupus erythematosus", "role": "Treatment.Disorder"}]}]}
{"id": "train-1716", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "Hypotension", "role": "Effect"}, {"name": "interaction between lisinopril and tizanidine", "role": "Treatment"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "lisinopril", "role": "Treatment.Drug"}, {"name": "lisinopril", "role": "Combination.Drug"}, {"name": "tizanidine", "role": "Combination.Drug"}]}]}
{"id": "train-1717", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "extensive skin rash", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-1718", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Anaphylactoid reaction", "role": "Effect"}, {"name": "50% solution of dextrose", "role": "Treatment"}, {"name": "dextrose", "role": "Treatment.Drug"}]}]}
{"id": "train-1719", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Hypokalemia", "role": "Effect"}, {"name": "normal doses of neubulized albuterol (salbutamol)", "role": "Treatment"}, {"name": "albuterol", "role": "Treatment.Drug"}, {"name": "salbutamol", "role": "Treatment.Drug"}, {"name": "normal doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-1720", "event": [{"trigger": "production", "type": "adverse_event", "arguments": [{"name": "parasite in both patients", "role": "Subject"}, {"name": "both", "role": "Subject.Population"}, {"name": "marked inflammation", "role": "Effect"}, {"name": "praziquantel", "role": "Treatment"}, {"name": "praziquantel", "role": "Treatment.Drug"}, {"name": "parasite", "role": "Treatment.Disorder"}]}]}
{"id": "train-1721", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "granulocytopenia and fever", "role": "Effect"}, {"name": "taking dipyrone", "role": "Treatment"}, {"name": "dipyrone", "role": "Treatment.Drug"}]}]}
{"id": "train-1722", "event": [{"trigger": "before", "type": "adverse_event", "arguments": [{"name": "symptomatic vision loss", "role": "Effect"}, {"name": "hydroxychloroquine", "role": "Treatment"}, {"name": "hydroxychloroquine", "role": "Treatment.Drug"}]}]}
{"id": "train-1723", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "A 64-year-old man", "role": "Subject"}, {"name": "64-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "proteinuria", "role": "Effect"}, {"name": "postoperative interferon (IFN)-beta therapy", "role": "Treatment"}, {"name": "interferon (IFN)-beta", "role": "Treatment.Drug"}, {"name": "malignant melanoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1724", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "acute onset psychosis", "role": "Effect"}, {"name": "Ethambutol", "role": "Treatment"}, {"name": "Ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1725", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Cholesterol crystal embolization-associated renal failure", "role": "Effect"}, {"name": "therapy with recombinant tissue-type plasminogen activator", "role": "Treatment"}, {"name": "plasminogen activator", "role": "Treatment.Drug"}]}]}
{"id": "train-1726", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 76-year-old woman with primary open-angle glaucoma and no history of ocular surgery", "role": "Subject"}, {"name": "76-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "choroidal detachment", "role": "Effect"}, {"name": "12 hours after initiation of therapy with dorzolamide eye drops", "role": "Treatment"}, {"name": "12 hours", "role": "Treatment.Time_elapsed"}, {"name": "dorzolamide", "role": "Treatment.Drug"}, {"name": "open-angle glaucoma", "role": "Treatment.Disorder"}, {"name": "eye drops", "role": "Treatment.Route"}]}]}
{"id": "train-1727", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyperkalemia", "role": "Effect"}, {"name": "arginine", "role": "Treatment"}, {"name": "arginine", "role": "Treatment.Drug"}]}]}
{"id": "train-1728", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "three patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "acute liver damage", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1729", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 68-year-old man", "role": "Subject"}, {"name": "68-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "intense conjunctival hyperemia and cystoid macula edema", "role": "Effect"}, {"name": "bimatoprost", "role": "Treatment"}, {"name": "cataract surgery", "role": "Treatment.Disorder"}, {"name": "bimatoprost", "role": "Treatment.Drug"}]}]}
{"id": "train-1730", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "adults after liver transplant", "role": "Subject"}, {"name": "adults", "role": "Subject.Age"}, {"name": "liver transplant.", "role": "Subject.Disorder"}, {"name": "mutism", "role": "Effect"}, {"name": "Tacrolimus (FK506), an immunosuppressant", "role": "Treatment"}, {"name": "Tacrolimus", "role": "Treatment.Drug"}]}]}
{"id": "train-1731", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity", "role": "Effect"}, {"name": "Gemcitabine", "role": "Treatment"}, {"name": "Gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1732", "event": [{"trigger": "resulted in", "type": "adverse_event", "arguments": [{"name": "Cushingoid features", "role": "Effect"}, {"name": "prednisone", "role": "Treatment"}, {"name": "to maintain normotension", "role": "Treatment"}, {"name": "prednisone", "role": "Treatment.Drug"}]}]}
{"id": "train-1733", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "acenocoumarol", "role": "Treatment"}, {"name": "acenocoumarol", "role": "Treatment.Drug"}, {"name": "deep vein thrombosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1734", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a thirteen-year-old male", "role": "Subject"}, {"name": "thirteen-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "Development of tics", "role": "Effect"}, {"name": "atomoxetine", "role": "Treatment"}, {"name": "atomoxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-1735", "event": [{"trigger": "resolution", "type": "potential_therapeutic_event", "arguments": [{"name": "chronic, nonproductive cough secondary to the angiotensin-converting enzyme (ACE) inhibitor quinapril", "role": "Effect"}, {"name": "switching to another ACE inhibitor, fosinopril", "role": "Treatment"}, {"name": "fosinopril", "role": "Treatment.Drug"}]}]}
{"id": "train-1736", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a renal transplant recipient", "role": "Subject"}, {"name": "renal transplant", "role": "Subject.Disorder"}, {"name": "Cholelithiasis and thrombosis of the central retinal vein", "role": "Effect"}, {"name": "cyclosporin", "role": "Treatment"}, {"name": "cyclosporin", "role": "Treatment.Drug"}]}]}
{"id": "train-1737", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a 37 year old male with acromegaly", "role": "Subject"}, {"name": "37 year old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "hepatolithiasis (intrahepatic stone) complicated by gram-negative sepsis", "role": "Effect"}, {"name": "octreotide", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}, {"name": "acromegaly", "role": "Treatment.Disorder"}]}]}
{"id": "train-1738", "event": [{"trigger": "undesired effect", "type": "adverse_event", "arguments": [{"name": "a patient with Hurler's syndrome", "role": "Subject"}, {"name": "Proliferation of abnormal bone marrow histiocytes", "role": "Effect"}, {"name": "granulocyte macrophage-colony-stimulating factor", "role": "Treatment"}, {"name": "granulocyte macrophage-colony-stimulating factor", "role": "Treatment.Drug"}, {"name": "Hurler's syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-1739", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "2", "role": "Subject"}, {"name": "acral cyanosis, livedo reticularis, or Raynaud phenomenon", "role": "Effect"}, {"name": "dextroamphetamine", "role": "Treatment"}, {"name": "dextroamphetamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1740", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "2 patients", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "thrombotic microangiopathy of the kidneys", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "high cumulative doses", "role": "Treatment.Dosage"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1741", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "NMS", "role": "Effect"}, {"name": "fluphenazine", "role": "Treatment"}, {"name": "fluphenazine", "role": "Treatment.Drug"}]}]}
{"id": "train-1742", "event": [{"trigger": "show", "type": "adverse_event", "arguments": [{"name": "reduced prevalence of extrapyramidal side effects", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "neuroleptic drugs.", "role": "Treatment.Drug"}]}]}
{"id": "train-1743", "event": [{"trigger": "present", "type": "adverse_event", "arguments": [{"name": "all ED patients", "role": "Subject"}, {"name": "altered mental status", "role": "Effect"}, {"name": "valproic acid therapy", "role": "Treatment"}, {"name": "ED", "role": "Treatment.Disorder"}, {"name": "valproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1744", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "myelosuppression, hypertension, hyperlipidemia, and infection", "role": "Effect"}, {"name": "Rapamycin/sirolimus (SR), trade named Rapammune (Wyeth-Ayerst, Sydney, Australia)", "role": "Treatment"}, {"name": "Rapamycin/sirolimus", "role": "Treatment.Drug"}]}]}
{"id": "train-1745", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "generalized exanthem", "role": "Effect"}, {"name": "Enoxaparin", "role": "Treatment"}, {"name": "Enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1746", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "(sub)fulminant hepatitis and cirrhosis", "role": "Effect"}, {"name": "benzarone", "role": "Treatment"}, {"name": "benzarone", "role": "Treatment.Drug"}, {"name": "benzarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1747", "event": [{"trigger": "noted", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "INR increased from 2.56 to 3.54 and minor bleeding was noted from the patient's tracheostomy site", "role": "Effect"}, {"name": "Within 3 days after starting bismuth subsalicylate therapy", "role": "Treatment"}, {"name": "3 days", "role": "Treatment.Duration"}, {"name": "bismuth subsalicylate", "role": "Treatment.Drug"}]}]}
{"id": "train-1748", "event": [{"trigger": "After", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "severe agitation and aggressive behavior", "role": "Effect"}, {"name": "After three weeks of carbamazepine therapy", "role": "Treatment"}, {"name": "three weeks", "role": "Treatment.Duration"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1749", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychosis", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1750", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 77-year-old man", "role": "Subject"}, {"name": "77-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "ankle, hand, and facial swelling", "role": "Effect"}, {"name": "2 weeks after starting rosiglitazone", "role": "Treatment"}, {"name": "2 weeks", "role": "Treatment.Time_elapsed"}, {"name": "rosiglitazone", "role": "Treatment.Drug"}]}]}
{"id": "train-1751", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "massive pulmonary embolus", "role": "Effect"}, {"name": "thrombolytic", "role": "Treatment"}, {"name": "thrombolytic", "role": "Treatment.Drug"}]}]}
{"id": "train-1752", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a cachectic AIDS patient with protracted diarrhoea", "role": "Subject"}, {"name": "cachectic AIDS", "role": "Subject.Disorder"}, {"name": "protracted diarrhoea", "role": "Subject.Disorder"}, {"name": "hypoglycaemia", "role": "Effect"}, {"name": "mefloquine therapy (1,500 mg over two days)", "role": "Treatment"}, {"name": "severe gastrointestinal cryptosporidiasis", "role": "Treatment.Disorder"}, {"name": "mefloquine", "role": "Treatment.Drug"}, {"name": "1,500 mg", "role": "Treatment.Dosage"}]}]}
{"id": "train-1753", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "syndrome of inappropriate antidiuretic hormone (SIADH)", "role": "Effect"}, {"name": "vinorelbine", "role": "Treatment"}, {"name": "vinorelbine", "role": "Treatment.Drug"}, {"name": "advanced breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1754", "event": [{"trigger": "exert", "type": "potential_therapeutic_event", "arguments": [{"name": "thiazolidinediones", "role": "Treatment"}, {"name": "insulin resistance", "role": "Treatment.Disorder"}]}]}
{"id": "train-1755", "event": [{"trigger": "detected", "type": "adverse_event", "arguments": [{"name": "exacerbation of psoriasis", "role": "Effect"}, {"name": "a massive induction of lesional type I interferon activity", "role": "Effect"}, {"name": "imiquimod", "role": "Treatment"}, {"name": "imiquimod", "role": "Treatment.Drug"}]}]}
{"id": "train-1756", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "a bipolar disorder", "role": "Subject.Disorder"}, {"name": "lithium-responsive manic episodes", "role": "Effect"}, {"name": "alprazolam", "role": "Treatment"}, {"name": "alprazolam", "role": "Treatment.Drug"}]}]}
{"id": "train-1757", "event": [{"trigger": "complications", "type": "adverse_event", "arguments": [{"name": "children with leukemia", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "Cerebrovascular complications", "role": "Effect"}, {"name": "aphasia and other neuropsychological deficits", "role": "Effect"}, {"name": "L-asparaginase", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}, {"name": "leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1758", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "intense livedo reticularis", "role": "Effect"}, {"name": "interferon alpha 2b as an adjuvant therapy for melanoma", "role": "Treatment"}, {"name": "interferon alpha 2b", "role": "Treatment.Drug"}, {"name": "melanoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1759", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "an elderly depressed woman", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "SIADH", "role": "Effect"}, {"name": "desipramine treatment", "role": "Treatment"}, {"name": "depressed", "role": "Treatment.Disorder"}, {"name": "desipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-1760", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "skeletal fluorosis", "role": "Effect"}, {"name": "Niflumic acid", "role": "Treatment"}, {"name": "Niflumic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1761", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Both patients", "role": "Subject"}, {"name": "severe complications", "role": "Effect"}, {"name": "aminoglutethimide", "role": "Treatment"}, {"name": "cancer", "role": "Treatment.Disorder"}, {"name": "aminoglutethimide", "role": "Treatment.Drug"}]}]}
{"id": "train-1762", "event": [{"trigger": "became", "type": "adverse_event", "arguments": [{"name": "An 11-day-old infant", "role": "Subject"}, {"name": "11-day-old", "role": "Subject.Age"}, {"name": "infant", "role": "Subject.Age"}, {"name": "lethargic and apneic", "role": "Effect"}, {"name": "a single drop of brimonidine", "role": "Treatment"}, {"name": "single drop", "role": "Treatment.Dosage"}, {"name": "brimonidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1763", "event": [{"trigger": "responsible", "type": "adverse_event", "arguments": [{"name": "the reaction", "role": "Effect"}, {"name": "dextrose", "role": "Treatment"}, {"name": "dextrose", "role": "Treatment.Drug"}]}]}
{"id": "train-1764", "event": [{"trigger": "initiated,", "type": "potential_therapeutic_event", "arguments": [{"name": "the inflammatory signs and symptoms gradually subsided.", "role": "Effect"}, {"name": "daily administration of 200 mg of ITCZ", "role": "Treatment"}, {"name": "renal insufficiency", "role": "Treatment.Disorder"}, {"name": "200 mg", "role": "Treatment.Dosage"}, {"name": "daily administration", "role": "Treatment.Freq"}, {"name": "ITCZ", "role": "Treatment.Drug"}]}]}
{"id": "train-1765", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "cardiac arrhythmia", "role": "Effect"}, {"name": "amphotericin B administration", "role": "Treatment"}, {"name": "amphotericin B", "role": "Treatment.Drug"}]}]}
{"id": "train-1766", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute myopathy with selective degeneration of myosin filaments", "role": "Effect"}, {"name": "methylprednisolone", "role": "Treatment"}, {"name": "vecuronium", "role": "Treatment"}, {"name": "asthmaticus", "role": "Treatment.Disorder"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}, {"name": "vecuronium", "role": "Treatment.Drug"}, {"name": "vecuronium", "role": "Combination.Drug"}, {"name": "methylprednisolone", "role": "Combination.Drug"}]}]}
{"id": "train-1767", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "acetazolamide therapy for glaucoma", "role": "Treatment"}, {"name": "acetazolamide", "role": "Treatment.Drug"}, {"name": "glaucoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1768", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "abstinence in alcoholics", "role": "Subject"}, {"name": "liver dysfunction", "role": "Effect"}, {"name": "Cyanamide", "role": "Treatment"}, {"name": "Cyanamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1769", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "nausea and headache", "role": "Effect"}, {"name": "desipramine or cinacalcet", "role": "Treatment"}, {"name": "desipramine", "role": "Treatment.Drug"}, {"name": "cinacalcet", "role": "Treatment.Drug"}, {"name": "desipramine", "role": "Treatment.Drug"}, {"name": "desipramine", "role": "Treatment.Drug"}, {"name": "cinacalcet", "role": "Treatment.Drug"}, {"name": "desipramine", "role": "Combination.Drug"}, {"name": "cinacalcet", "role": "Combination.Drug"}]}]}
{"id": "train-1770", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Three patients", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "proteinuria", "role": "Effect"}, {"name": "gold", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "gold", "role": "Treatment.Drug"}]}]}
{"id": "train-1771", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a case of a patient", "role": "Subject"}, {"name": "spontaneous subfascial hematoma without any evidence of direct trauma", "role": "Effect"}, {"name": "alteplase", "role": "Treatment"}, {"name": "acute myocardial infarction", "role": "Treatment.Disorder"}, {"name": "alteplase", "role": "Treatment.Drug"}]}]}
{"id": "train-1772", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "marrow aplasia", "role": "Effect"}, {"name": "Ticlopidine", "role": "Treatment"}, {"name": "Ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1773", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two children with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "Dural sinus thrombosis", "role": "Effect"}, {"name": "induction treatment with vincristine sulfate, prednisone, and asparaginase", "role": "Treatment"}, {"name": "vincristine sulfate", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "asparaginase", "role": "Treatment.Drug"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}, {"name": "vincristine sulfate", "role": "Combination.Drug"}, {"name": "prednisone", "role": "Combination.Drug"}, {"name": "asparaginase", "role": "Combination.Drug"}]}]}
{"id": "train-1774", "event": [{"trigger": "involved", "type": "adverse_event", "arguments": [{"name": "a 39-year-old obese male", "role": "Subject"}, {"name": "39-year-old", "role": "Subject.Age"}, {"name": "obese", "role": "Subject.Disorder"}, {"name": "male", "role": "Subject.Gender"}, {"name": "death", "role": "Effect"}, {"name": "Zolpidem (Ambien)", "role": "Treatment"}, {"name": "depression and insomnia", "role": "Treatment.Disorder"}, {"name": "Zolpidem", "role": "Treatment.Drug"}]}]}
{"id": "train-1775", "event": [{"trigger": "reactions", "type": "adverse_event", "arguments": [{"name": "hypersensitivity reactions", "role": "Effect"}, {"name": "cyclosporine", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}]}]}
{"id": "train-1776", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 79-year-old woman", "role": "Subject"}, {"name": "79-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "verrucous plaque", "role": "Effect"}, {"name": "imiquimod 5 days per week", "role": "Treatment"}, {"name": "after 7 weeks", "role": "Treatment"}, {"name": "nodular basal cell", "role": "Treatment.Disorder"}, {"name": "imiquimod", "role": "Treatment.Drug"}, {"name": "5 days per week", "role": "Treatment.Freq"}, {"name": "7 weeks", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1777", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "antiepileptic, analgesic", "role": "Effect"}, {"name": "Oxcarbazepine", "role": "Treatment"}, {"name": "neuropathic pain", "role": "Treatment.Disorder"}, {"name": "affective disorders", "role": "Treatment.Disorder"}, {"name": "Oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1778", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 34-year-old woman with chronic hepatitis C, genotype 3", "role": "Subject"}, {"name": "34-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "genotype 3", "role": "Subject.Disorder"}, {"name": "progressive malaise and anemia", "role": "Effect"}, {"name": "pegylated interferon alpha-2a and ribavirin for 6 months", "role": "Treatment"}, {"name": "6 months", "role": "Treatment.Duration"}, {"name": "pegylated interferon alpha-2a", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "6 months", "role": "Treatment.Time_elapsed"}, {"name": "chronic hepatitis C", "role": "Treatment.Disorder"}, {"name": "ribavirin", "role": "Combination.Drug"}, {"name": "pegylated interferon alpha-2a", "role": "Combination.Drug"}]}]}
{"id": "train-1779", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "bradycardia with i.v", "role": "Effect"}, {"name": "treatment of dexmedetomidine", "role": "Treatment"}, {"name": "dexmedetomidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1780", "event": [{"trigger": "controlled", "type": "potential_therapeutic_event", "arguments": [{"name": "her", "role": "Subject"}, {"name": "Esmolol, an ultrashort-acting beta 1-selective antagonist", "role": "Treatment"}, {"name": "multiple dysrhythmias and symptoms of sympathetic nervous system hyperstimulation", "role": "Treatment.Disorder"}, {"name": "Esmolol", "role": "Treatment.Drug"}]}]}
{"id": "train-1781", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A 29-year-old woman", "role": "Subject"}, {"name": "29-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "altered mental status, seizure-like activity, hyperthermia, rigidity in the lower extremities, myoclonus, and hyperreflexia", "role": "Effect"}, {"name": "metaxalone", "role": "Treatment"}, {"name": "metaxalone", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1782", "event": [{"trigger": "causing", "type": "adverse_event", "arguments": [{"name": "subtherapeutic international normalized ratio", "role": "Effect"}, {"name": "Warfarin", "role": "Treatment"}, {"name": "boceprevir", "role": "Treatment"}, {"name": "Warfarin", "role": "Treatment.Drug"}, {"name": "boceprevir", "role": "Treatment.Drug"}, {"name": "Warfarin", "role": "Combination.Drug"}, {"name": "boceprevir", "role": "Combination.Drug"}]}]}
{"id": "train-1783", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "hypersensitivity", "role": "Effect"}, {"name": "chloramphenicol", "role": "Treatment"}, {"name": "chloramphenicol", "role": "Treatment.Drug"}]}]}
{"id": "train-1784", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "amiodarone pulmonary toxicity", "role": "Effect"}, {"name": "corticosteroid", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "corticosteroid", "role": "Treatment.Drug"}]}]}
{"id": "train-1785", "event": [{"trigger": "given", "type": "potential_therapeutic_event", "arguments": [{"name": "56-year-old female patient", "role": "Subject"}, {"name": "56-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "arsenic trioxide", "role": "Treatment"}, {"name": "arsenic trioxide", "role": "Treatment.Drug"}, {"name": "chemotherapy/ATRA-resistant APL", "role": "Treatment.Disorder"}, {"name": "42 days", "role": "Treatment.Duration"}]}]}
{"id": "train-1786", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "our patient", "role": "Subject"}, {"name": "the de novo development of SLE", "role": "Effect"}, {"name": "rIFN-gamma", "role": "Treatment"}, {"name": "rIFN-gamma", "role": "Treatment.Drug"}]}]}
{"id": "train-1787", "event": [{"trigger": "and", "type": "adverse_event", "arguments": [{"name": "Interstitial pneumopathy", "role": "Effect"}, {"name": "low-dosage amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "low-dosage", "role": "Treatment.Dosage"}]}]}
{"id": "train-1788", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "TD", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1789", "event": [{"trigger": "discontinued", "type": "potential_therapeutic_event", "arguments": [{"name": "Hepatotoxicity", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "Hepatotoxicity", "role": "Treatment.Disorder"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1790", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "asthma attack", "role": "Effect"}, {"name": "Sustained-release verapamil", "role": "Treatment"}, {"name": "verapamil", "role": "Treatment.Drug"}]}]}
{"id": "train-1791", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "cholestatic hepatitis", "role": "Effect"}, {"name": "nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1792", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "an infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "apnea", "role": "Effect"}, {"name": "lamotrigine", "role": "Treatment"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "breast milk", "role": "Treatment.Route"}]}]}
{"id": "train-1793", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 43-year-old man", "role": "Subject"}, {"name": "43-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "Pneumonitis, bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and positive autoantibodies", "role": "Effect"}, {"name": "long-term sulfasalazine", "role": "Treatment"}, {"name": "chronic ulcerative colitis", "role": "Treatment.Disorder"}, {"name": "sulfasalazine", "role": "Treatment.Drug"}]}]}
{"id": "train-1794", "event": [{"trigger": "induced", "type": "potential_therapeutic_event", "arguments": [{"name": "an infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "Bone formation", "role": "Effect"}, {"name": "systemic prostaglandin-E2 administration", "role": "Treatment"}, {"name": "prostaglandin-E2", "role": "Treatment.Drug"}, {"name": "systemic", "role": "Treatment.Route"}, {"name": "administration", "role": "Treatment.Route"}]}]}
{"id": "train-1795", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "these patients", "role": "Subject"}, {"name": "hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N-acetyl glucosaminase", "role": "Effect"}, {"name": "A high dose of cotrimoxazole", "role": "Treatment"}, {"name": "after several days of the drug administration", "role": "Treatment"}, {"name": "high dose", "role": "Treatment.Dosage"}, {"name": "cotrimoxazole", "role": "Treatment.Drug"}, {"name": "several days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1796", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "Angioedema", "role": "Effect"}, {"name": "involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1797", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pneumonitis", "role": "Effect"}, {"name": "trastuzumab", "role": "Treatment"}, {"name": "trastuzumab", "role": "Treatment.Drug"}]}]}
{"id": "train-1798", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "HUS", "role": "Effect"}, {"name": "carboplatin and gemcitabine", "role": "Treatment"}, {"name": "advanced ovarian cancer", "role": "Treatment.Disorder"}, {"name": "carboplatin", "role": "Treatment.Drug"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "carboplatin", "role": "Combination.Drug"}, {"name": "gemcitabine", "role": "Combination.Drug"}]}]}
{"id": "train-1799", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Several such HBV reactivations", "role": "Effect"}, {"name": "combined rituximab and multiagent chemotherapy", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}, {"name": "B-cell lymphomas", "role": "Treatment.Disorder"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-1800", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "eosinophilia myalgia syndrome", "role": "Effect"}, {"name": "parenteral tryptophan", "role": "Treatment"}, {"name": "tryptophan", "role": "Treatment.Drug"}, {"name": "parenteral", "role": "Treatment.Route"}]}]}
{"id": "train-1801", "event": [{"trigger": "precipitated", "type": "adverse_event", "arguments": [{"name": "Generalized pustular psoriasis", "role": "Effect"}, {"name": "trazodone", "role": "Treatment"}, {"name": "depression", "role": "Treatment.Disorder"}, {"name": "trazodone", "role": "Treatment.Drug"}]}]}
{"id": "train-1802", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "Sweet's syndrome", "role": "Effect"}, {"name": "sargramostim treatment following chemotherapy", "role": "Treatment"}, {"name": "sargramostim", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}, {"name": "acute myelogenous leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1803", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "hypersensitivity reactions", "role": "Effect"}, {"name": "carboplatin", "role": "Treatment"}, {"name": "carboplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-1804", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a neonate with a seizure disorder", "role": "Subject"}, {"name": "neonate", "role": "Subject.Age"}, {"name": "pupillary mydriasis", "role": "Effect"}, {"name": "lidocaine overdose", "role": "Treatment"}, {"name": "lidocaine", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}, {"name": "seizure disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-1805", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "myeloproliferative disorder", "role": "Effect"}, {"name": "hydroxyurea chemotherapy", "role": "Treatment"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-1806", "event": [{"trigger": "induced by", "type": "adverse_event", "arguments": [{"name": "patients with depression and obsessive-compulsive disorder (OCD)", "role": "Subject"}, {"name": "Extrapyramidal side effects", "role": "Effect"}, {"name": "some selective serotonin reuptake inhibitors (SSRIs), i.e. fluoxetine and sertraline", "role": "Treatment"}, {"name": "depression", "role": "Treatment.Disorder"}, {"name": "obsessive-compulsive disorder (OCD)", "role": "Treatment.Disorder"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "sertraline", "role": "Treatment.Drug"}, {"name": "serotonin reuptake inhibitors", "role": "Treatment.Drug"}]}]}
{"id": "train-1807", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "five patients (4 males and 1 female) with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "five", "role": "Subject.Population"}, {"name": "4 males and 1 female", "role": "Subject.Gender"}, {"name": "incapacitating myalgias in neck, thighs and arms", "role": "Effect"}, {"name": "Ten-17 days after receiving chemotherapy", "role": "Treatment"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}, {"name": "Ten-17 days", "role": "Treatment.Time_elapsed"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-1808", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "a first injection of high-dose methotrexate", "role": "Treatment"}, {"name": "a T-lymphoblastic lymphoma", "role": "Treatment.Disorder"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-1809", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "myocardial infarction", "role": "Effect"}, {"name": "increased blood pressure", "role": "Effect"}, {"name": "high-dose glucocorticoids", "role": "Treatment"}, {"name": "glucocorticoids", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "Graves' ophthalmopathy", "role": "Treatment.Disorder"}]}]}
{"id": "train-1810", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "40-year-old man with relapsing-remitting multiple sclerosis (MS)", "role": "Subject"}, {"name": "40-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "primary central nervous system lymphoma (PCNSL)", "role": "Effect"}, {"name": "21 doses of natalizumab monotherapy", "role": "Treatment"}, {"name": "relapsing-remitting multiple sclerosis (MS)", "role": "Treatment.Disorder"}, {"name": "21 doses", "role": "Treatment.Dosage"}, {"name": "natalizumab", "role": "Treatment.Drug"}]}]}
{"id": "train-1811", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome", "role": "Effect"}, {"name": "selective serotonin reuptake-inhibitors-metoclopramide interaction", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}, {"name": "selective serotonin reuptake-inhibitors", "role": "Treatment.Drug"}, {"name": "metoclopramide", "role": "Combination.Drug"}, {"name": "selective serotonin reuptake-inhibitors", "role": "Combination.Drug"}]}]}
{"id": "train-1812", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "first reported case", "role": "Subject"}, {"name": "DIAN", "role": "Effect"}, {"name": "cefuroxime", "role": "Treatment"}, {"name": "cefuroxime", "role": "Treatment.Drug"}]}]}
{"id": "train-1813", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a cae", "role": "Subject"}, {"name": "paranoid psychosis", "role": "Effect"}, {"name": "decongestant containing PPA", "role": "Treatment"}, {"name": "PPA", "role": "Treatment.Drug"}]}]}
{"id": "train-1814", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "Liver transplantation for fulminant hepatitis", "role": "Effect"}, {"name": "nevirapine therapy", "role": "Treatment"}, {"name": "nevirapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1815", "event": [{"trigger": "owing", "type": "adverse_event", "arguments": [{"name": "a patient with mucositis secondary to chemotherapy", "role": "Subject"}, {"name": "hyperkalemia", "role": "Effect"}, {"name": "succinylcholine administration", "role": "Treatment"}, {"name": "mucositis", "role": "Treatment.Disorder"}, {"name": "succinylcholine", "role": "Treatment.Drug"}]}]}
{"id": "train-1816", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "cholestatic liver disease", "role": "Effect"}, {"name": "prolonged terbinafine", "role": "Treatment"}, {"name": "terbinafine", "role": "Treatment.Drug"}]}]}
{"id": "train-1817", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "a patient with the LEOPARD syndrome", "role": "Subject"}, {"name": "interstitial hypoxaemiant pneumonitis", "role": "Effect"}, {"name": "flecainide", "role": "Treatment"}, {"name": "flecainide", "role": "Treatment.Drug"}, {"name": "LEOPARD syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-1818", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "This case", "role": "Subject"}, {"name": "Graves' hyperthyroidism", "role": "Effect"}, {"name": "IFN therapy", "role": "Treatment"}, {"name": "IFN", "role": "Treatment.Drug"}]}]}
{"id": "train-1819", "event": [{"trigger": "resolution", "type": "potential_therapeutic_event", "arguments": [{"name": "case", "role": "Subject"}, {"name": "methionine", "role": "Treatment"}, {"name": "Halothane hepatitis", "role": "Treatment.Disorder"}, {"name": "methionine", "role": "Treatment.Drug"}]}]}
{"id": "train-1820", "event": [{"trigger": "exposed", "type": "adverse_event", "arguments": [{"name": "a previously healthy young woman", "role": "Subject"}, {"name": "young", "role": "Subject.Gender"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "hepatitis", "role": "Effect"}, {"name": "2 doses of amodiaquine and artesunate", "role": "Treatment"}, {"name": "2 doses", "role": "Treatment.Dosage"}, {"name": "amodiaquine", "role": "Treatment.Drug"}, {"name": "artesunate", "role": "Treatment.Drug"}, {"name": "amodiaquine", "role": "Combination.Drug"}, {"name": "artesunate", "role": "Combination.Drug"}]}]}
{"id": "train-1821", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "fulminant hepatic failure", "role": "Effect"}, {"name": "10 weeks after", "role": "Treatment"}, {"name": "nicotinic acid", "role": "Treatment"}, {"name": "10 weeks after", "role": "Treatment.Time_elapsed"}, {"name": "nicotinic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1822", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "a patient with the antiphospholipid syndrome", "role": "Subject"}, {"name": "skin necrosis", "role": "Effect"}, {"name": "low-molecular weight heparin therapy at sites distant from injection sites", "role": "Treatment"}, {"name": "antiphospholipid syndrome", "role": "Treatment.Disorder"}, {"name": "low-molecular weight heparin", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-1823", "event": [{"trigger": "induction", "type": "adverse_event", "arguments": [{"name": "liver and thyroid gland tumour formation in rodents", "role": "Effect"}, {"name": "Pyrethrins, Phenobarbital and related compounds", "role": "Treatment"}, {"name": "Pyrethrins", "role": "Treatment.Drug"}, {"name": "Phenobarbital", "role": "Treatment.Drug"}, {"name": "related compounds", "role": "Treatment.Drug"}, {"name": "related compounds", "role": "Combination.Drug"}, {"name": "Phenobarbital", "role": "Combination.Drug"}, {"name": "Pyrethrins", "role": "Combination.Drug"}]}]}
{"id": "train-1824", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "catatonia syndrome", "role": "Effect"}, {"name": "encephalopathy", "role": "Effect"}, {"name": "Disulfiram", "role": "Treatment"}, {"name": "Disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-1825", "event": [{"trigger": "interaction", "type": "adverse_event", "arguments": [{"name": "adverse effects of the exposure of the liver", "role": "Effect"}, {"name": "ethanol with its congeners and acetaldehyde", "role": "Treatment"}, {"name": "acetaldehyde", "role": "Treatment.Drug"}, {"name": "ethanol", "role": "Treatment.Drug"}, {"name": "ethanol", "role": "Combination.Drug"}, {"name": "acetaldehyde", "role": "Combination.Drug"}]}]}
{"id": "train-1826", "event": [{"trigger": "precipitated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "oxcarbazepine", "role": "Treatment"}, {"name": "oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1827", "event": [{"trigger": "emerged", "type": "adverse_event", "arguments": [{"name": "eruption", "role": "Effect"}, {"name": "after 1 month of therapy with salsalate", "role": "Treatment"}, {"name": "1 month", "role": "Treatment.Time_elapsed"}, {"name": "salsalate", "role": "Treatment.Drug"}]}]}
{"id": "train-1828", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "pulmonary vasoconstriction and right ventricular failure", "role": "Effect"}, {"name": "infusion of protamine", "role": "Treatment"}, {"name": "undergoing coronary artery bypass surgery and mitral valve replacement", "role": "Treatment"}, {"name": "protamine", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-1829", "event": [{"trigger": "develops", "type": "adverse_event", "arguments": [{"name": "cyanamide-treated alcoholics", "role": "Subject"}, {"name": "inflammation", "role": "Effect"}, {"name": "cyanamide", "role": "Treatment"}, {"name": "cyanamide", "role": "Treatment.Drug"}, {"name": "alcoholics", "role": "Treatment.Disorder"}]}]}
{"id": "train-1830", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Acute renal failure", "role": "Effect"}, {"name": "suramin treatment", "role": "Treatment"}, {"name": "suramin", "role": "Treatment.Drug"}]}]}
{"id": "train-1831", "event": [{"trigger": "After", "type": "adverse_event", "arguments": [{"name": "her", "role": "Subject"}, {"name": "her", "role": "Subject.Gender"}, {"name": "asystole", "role": "Effect"}, {"name": "induction of general anesthesia and administration of a standard dose of intravenous esmolol hydrochloride", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "esmolol hydrochloride", "role": "Treatment.Drug"}, {"name": "general anesthesia", "role": "Treatment.Drug"}, {"name": "general anesthesia", "role": "Combination.Drug"}, {"name": "esmolol hydrochloride", "role": "Combination.Drug"}]}]}
{"id": "train-1832", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Exacerbation of schizophrenia", "role": "Effect"}, {"name": "amantadine", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}]}]}
{"id": "train-1833", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Priapism", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-1834", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "Torsades de pointes", "role": "Effect"}, {"name": "terfenadine", "role": "Treatment"}, {"name": "terfenadine", "role": "Treatment.Drug"}]}]}
{"id": "train-1835", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "hypersensitivity", "role": "Effect"}, {"name": "Protamine allergy", "role": "Effect"}, {"name": "insulin", "role": "Treatment"}, {"name": "insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-1836", "event": [{"trigger": "treatment with", "type": "adverse_event", "arguments": [{"name": "recurrent torsades de pointes", "role": "Effect"}, {"name": "pentavalent antimonial drugs and amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "pentavalent antimonial drugs", "role": "Treatment.Drug"}, {"name": "pentavalent antimonial drugs", "role": "Combination.Drug"}, {"name": "amiodarone", "role": "Combination.Drug"}]}]}
{"id": "train-1837", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "clinical appearance of epiglottitis", "role": "Effect"}, {"name": "actually had an oro-pharyngeal dystonic reaction", "role": "Effect"}, {"name": "prochlorperazine", "role": "Treatment"}, {"name": "prochlorperazine", "role": "Treatment.Drug"}]}]}
{"id": "train-1838", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Localized dyskeratotic plaque with milia", "role": "Effect"}, {"name": "sorafenib", "role": "Treatment"}, {"name": "sorafenib", "role": "Treatment.Drug"}]}]}
{"id": "train-1839", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "catatonia syndrome", "role": "Effect"}, {"name": "disulfiram therapy", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-1840", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "both polyuric conditions and bleeding disorders", "role": "Subject"}, {"name": "desmopressin (DDAVP)", "role": "Treatment"}, {"name": "desmopressin", "role": "Treatment.Drug"}, {"name": "polyuric conditions", "role": "Treatment.Disorder"}, {"name": "bleeding disorders", "role": "Treatment.Disorder"}]}]}
{"id": "train-1841", "event": [{"trigger": "contribute", "type": "potential_therapeutic_event", "arguments": [{"name": "central nervous system effects", "role": "Effect"}, {"name": "Propafenone", "role": "Treatment"}, {"name": "propranolol", "role": "Treatment.Drug"}, {"name": "Propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-1842", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "serotonin toxicity", "role": "Effect"}, {"name": "post-operative delirium", "role": "Effect"}, {"name": "co-administration of methylene blue and serotonin reuptake inhibitors", "role": "Treatment"}, {"name": "methylene blue", "role": "Treatment.Drug"}, {"name": "serotonin reuptake inhibitors", "role": "Treatment.Drug"}, {"name": "methylene blue", "role": "Combination.Drug"}, {"name": "serotonin reuptake inhibitors", "role": "Combination.Drug"}]}]}
{"id": "train-1843", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "the patient had both shown normal cardiac function", "role": "Subject"}, {"name": "cardiotoxicity", "role": "Effect"}, {"name": "Cyclophosphamide", "role": "Treatment"}, {"name": "high-dose chemotherapy and had received a lower dose of cyclophosphamide", "role": "Treatment"}, {"name": "Cyclophosphamide", "role": "Treatment.Drug"}, {"name": "lower dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1844", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "A 64 year old woman with previous history of coronary stenting", "role": "Subject"}, {"name": "64 year old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "intracranial bleeding", "role": "Effect"}, {"name": "five days before", "role": "Treatment"}, {"name": "aspirin and clopidogrel", "role": "Treatment"}, {"name": "clopidogrel", "role": "Treatment.Drug"}, {"name": "aspirin", "role": "Treatment.Drug"}, {"name": "coronary stenting", "role": "Treatment.Disorder"}, {"name": "five days", "role": "Treatment.Time_elapsed"}, {"name": "aspirin", "role": "Combination.Drug"}, {"name": "clopidogrel", "role": "Combination.Drug"}]}]}
{"id": "train-1845", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 45-year-old woman", "role": "Subject"}, {"name": "45-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "HUS", "role": "Effect"}, {"name": "prolonged gemcitabine treatment", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "prolonged", "role": "Treatment.Duration"}, {"name": "ovarian cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1846", "event": [{"trigger": "replacement", "type": "adverse_event", "arguments": [{"name": "development of adrenal insufficiency", "role": "Effect"}, {"name": "systemic steroids", "role": "Treatment"}, {"name": "steroids", "role": "Treatment.Drug"}]}]}
{"id": "train-1847", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "pneumonitis", "role": "Effect"}, {"name": "local administration of methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "ectopic pregnancy", "role": "Treatment.Disorder"}]}]}
{"id": "train-1848", "event": [{"trigger": "use", "type": "potential_therapeutic_event", "arguments": [{"name": "one", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}]}]}
{"id": "train-1849", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyperammonemia", "role": "Effect"}, {"name": "Carbamazepine", "role": "Treatment"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1850", "event": [{"trigger": "complained", "type": "adverse_event", "arguments": [{"name": "A 29-year-old female alcoholic", "role": "Subject"}, {"name": "29-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "general fatigue and a slight fever", "role": "Effect"}, {"name": "after 1.5 years of abstinence with cyanamide", "role": "Treatment"}, {"name": "alcoholic", "role": "Treatment.Disorder"}, {"name": "1.5 years", "role": "Treatment.Duration"}, {"name": "cyanamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1851", "event": [{"trigger": "lead to", "type": "adverse_event", "arguments": [{"name": "protracted Cushing's syndrome", "role": "Effect"}, {"name": "TCA", "role": "Treatment"}, {"name": "TCA", "role": "Treatment.Drug"}]}]}
{"id": "train-1852", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Unusual pigmentary changes", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-1853", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Syndrome of inappropriate antidiuretic hormone", "role": "Effect"}, {"name": "vinorelbine", "role": "Treatment"}, {"name": "vinorelbine", "role": "Treatment.Drug"}]}]}
{"id": "train-1854", "event": [{"trigger": "when", "type": "adverse_event", "arguments": [{"name": "adverse_events", "role": "Effect"}, {"name": "higher than standard dose of the new lopinavir/ritonavir tablets was combined with rifampicin", "role": "Treatment"}, {"name": "higher than standard dose", "role": "Treatment.Dosage"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "lopinavir", "role": "Treatment.Drug"}, {"name": "ritonavir", "role": "Treatment.Drug"}, {"name": "ritonavir", "role": "Combination.Drug"}, {"name": "lopinavir", "role": "Combination.Drug"}, {"name": "rifampicin", "role": "Combination.Drug"}]}]}
{"id": "train-1855", "event": [{"trigger": "Onset", "type": "adverse_event", "arguments": [{"name": "male", "role": "Subject"}, {"name": "a patient", "role": "Subject"}, {"name": "male", "role": "Subject.Gender"}, {"name": "gynaecomastia", "role": "Effect"}, {"name": "sunitinib for metastatic renal cell carcinoma", "role": "Treatment"}, {"name": "metastatic renal cell carcinoma", "role": "Treatment.Disorder"}, {"name": "sunitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1856", "event": [{"trigger": "preceded", "type": "adverse_event", "arguments": [{"name": "30 reported cases", "role": "Subject"}, {"name": "30", "role": "Subject.Population"}, {"name": "Systemic disease, most commonly renal dysfunction", "role": "Effect"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "acyclovir", "role": "Treatment"}, {"name": "acyclovir", "role": "Treatment.Drug"}]}]}
{"id": "train-1857", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "renal failure", "role": "Effect"}, {"name": "Rifampicin", "role": "Treatment"}, {"name": "Rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-1858", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "A case of high-grade endometrial stromal sarcoma, confined into an intrauterine polypoid growth, in a woman with a history of breast cancer", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "breast cancer", "role": "Subject.Disorder"}, {"name": "A", "role": "Subject.Population"}, {"name": "adjuvant tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "high-grade endometrial stromal sarcoma, confined into an intrauterine polypoid growth", "role": "Treatment.Disorder"}]}]}
{"id": "train-1859", "event": [{"trigger": "After", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "increasing myalgia, developed a high fever and respiratory and metabolic acidosis and lost consciousness", "role": "Effect"}, {"name": "therapy for diabetic coma with insulin (containing the preservative cresol) and electrolyte solutions", "role": "Treatment"}, {"name": "diabetic coma", "role": "Treatment.Disorder"}, {"name": "insulin", "role": "Treatment.Drug"}, {"name": "preservative cresol", "role": "Treatment.Drug"}, {"name": "electrolyte solutions", "role": "Treatment.Drug"}, {"name": "electrolyte solutions", "role": "Combination.Drug"}, {"name": "preservative cresol", "role": "Combination.Drug"}, {"name": "insulin", "role": "Combination.Drug"}]}]}
{"id": "train-1860", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "A case", "role": "Subject"}, {"name": "severe aplastic anemia", "role": "Effect"}, {"name": "lenalidomide for multiple myeloma", "role": "Treatment"}, {"name": "multiple myeloma", "role": "Treatment.Disorder"}, {"name": "lenalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-1861", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "vaginal candidiasis", "role": "Effect"}, {"name": "Seven weeks after the initiation of inhaled fluticasone", "role": "Treatment"}, {"name": "inhaled", "role": "Treatment.Route"}, {"name": "fluticasone", "role": "Treatment.Drug"}, {"name": "Seven weeks", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1862", "event": [{"trigger": "led to", "type": "adverse_event", "arguments": [{"name": "hypoglycaemic coma", "role": "Effect"}, {"name": "The introduction of para-aminosalicylic acid (PAS)", "role": "Treatment"}, {"name": "para-aminosalicylic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-1863", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "sAML", "role": "Effect"}, {"name": "2-20 years after exposure to etoposide", "role": "Treatment"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "2-20 years", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1864", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate mental retardation", "role": "Effect"}, {"name": "methimazole and propranolol", "role": "Treatment"}, {"name": "methimazole", "role": "Treatment.Drug"}, {"name": "propranolol", "role": "Treatment.Drug"}, {"name": "hyperthyroidism", "role": "Treatment.Disorder"}, {"name": "methimazole", "role": "Combination.Drug"}, {"name": "propranolol", "role": "Combination.Drug"}]}]}
{"id": "train-1865", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "Ethambutol", "role": "Treatment"}, {"name": "tuberculosis", "role": "Treatment.Disorder"}, {"name": "Ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1866", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "serum sickness-like reactions", "role": "Effect"}, {"name": "phenylbutazone", "role": "Treatment"}, {"name": "phenylbutazone", "role": "Treatment.Drug"}]}]}
{"id": "train-1867", "event": [{"trigger": "Development", "type": "adverse_event", "arguments": [{"name": "a patient with multiple sclerosis", "role": "Subject"}, {"name": "Crohn's disease", "role": "Effect"}, {"name": "copaxone", "role": "Treatment"}, {"name": "multiple sclerosis", "role": "Treatment.Disorder"}, {"name": "copaxone", "role": "Treatment.Drug"}]}]}
{"id": "train-1868", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "Aliskiren", "role": "Treatment"}, {"name": "Aliskiren", "role": "Treatment.Drug"}]}]}
{"id": "train-1869", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Fever", "role": "Effect"}, {"name": "furosemide", "role": "Treatment"}, {"name": "furosemide", "role": "Treatment.Drug"}]}]}
{"id": "train-1870", "event": [{"trigger": "accelerate", "type": "adverse_event", "arguments": [{"name": "HIV disease", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "methotrexate (MTX)", "role": "Treatment.Drug"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-1871", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "dapsone gel, 5%", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}, {"name": "acne vulgaris", "role": "Treatment.Disorder"}]}]}
{"id": "train-1872", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "pediatric patients", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "irreversible renal failure and rickets", "role": "Effect"}, {"name": "TDF", "role": "Treatment"}, {"name": "TDF", "role": "Treatment.Drug"}]}]}
{"id": "train-1873", "event": [{"trigger": "described", "type": "adverse_event", "arguments": [{"name": "adverse effect", "role": "Effect"}, {"name": "mefloquine (Lariam)", "role": "Treatment"}, {"name": "mefloquine", "role": "Treatment.Drug"}]}]}
{"id": "train-1874", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thyrotoxicosis", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-1875", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "The patient", "role": "Subject"}, {"name": "a painful hand ulcer", "role": "Effect"}, {"name": "new skin cancers", "role": "Effect"}, {"name": "hydroxyurea", "role": "Treatment"}, {"name": "skin lesions", "role": "Treatment.Disorder"}, {"name": "10-month", "role": "Treatment.Duration"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}]}]}
{"id": "train-1876", "event": [{"trigger": "mediated", "type": "adverse_event", "arguments": [{"name": "an adult with developmental disabilities", "role": "Subject"}, {"name": "adult", "role": "Subject.Age"}, {"name": "extrapyramidal symptoms", "role": "Effect"}, {"name": "aripiprazole", "role": "Treatment"}, {"name": "aripiprazole", "role": "Treatment.Drug"}, {"name": "developmental disabilities", "role": "Treatment.Disorder"}]}]}
{"id": "train-1877", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "a patient with extranodal non-Hodgkin lymphoma", "role": "Subject"}, {"name": "systemic candidiasis", "role": "Effect"}, {"name": "a cyclophosphamide-based chemotherapy regimen.", "role": "Treatment"}, {"name": "extranodal non-Hodgkin lymphoma", "role": "Treatment.Disorder"}, {"name": "cyclophosphamide-based chemotherapy", "role": "Treatment.Drug"}]}]}
{"id": "train-1878", "event": [{"trigger": "treatment with", "type": "adverse_event", "arguments": [{"name": "de novo asthma", "role": "Effect"}, {"name": "the angiotensin converting enzyme (ACE) inhibitor captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-1879", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 53-year-old male, without any prior history of psychosis", "role": "Subject"}, {"name": "macroprolactinoma", "role": "Subject"}, {"name": "53-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "schizophrenia", "role": "Effect"}, {"name": "4 days after starting low-dose bromocriptine therapy", "role": "Treatment"}, {"name": "bromocriptine", "role": "Treatment.Drug"}, {"name": "macroprolactinoma", "role": "Treatment.Disorder"}, {"name": "4 days after", "role": "Treatment.Time_elapsed"}, {"name": "low-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-1880", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "rapid progression of reticular infiltration in both lung fields", "role": "Effect"}, {"name": "Six days", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "Six days", "role": "Treatment.Time_elapsed"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1881", "event": [{"trigger": "stopped.", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "antidepressants", "role": "Treatment"}, {"name": "antidepressants", "role": "Treatment.Drug"}]}]}
{"id": "train-1882", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "co-administration of citalopram and fentanyl", "role": "Treatment"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "citalopram", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}]}]}
{"id": "train-1883", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patient with rheumatoid arthritis", "role": "Subject"}, {"name": "infection with both M. tuberculosis and M. chelonae", "role": "Effect"}, {"name": "low-dose methotrexate (15 mg/week)", "role": "Treatment"}, {"name": "15 mg/week", "role": "Treatment.Dosage"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-1884", "event": [{"trigger": "undergoing", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "Thrombotic microangiopathy with renal failure", "role": "Effect"}, {"name": "gemcitabine chemotherapy", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-1885", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "pulmonary side effects", "role": "Effect"}, {"name": "nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-1886", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "TD", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1887", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "68-year-old man", "role": "Subject"}, {"name": "68-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "delirious", "role": "Effect"}, {"name": "withdrawn from a low dosage of alprazolam", "role": "Treatment"}, {"name": "alprazolam", "role": "Treatment.Drug"}, {"name": "low dosage", "role": "Treatment.Dosage"}]}]}
{"id": "train-1888", "event": [{"trigger": "followed", "type": "adverse_event", "arguments": [{"name": "bilateral breast enlargement", "role": "Effect"}, {"name": "sunitinib", "role": "Treatment"}, {"name": "sunitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1889", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "mucocutaneous adverse_events and nail hyperpigmentation", "role": "Effect"}, {"name": "Hydroxyurea is a cytostatic agent", "role": "Treatment"}, {"name": "Hydroxyurea", "role": "Treatment.Drug"}, {"name": "myeloproliferative disorders", "role": "Treatment.Disorder"}]}]}
{"id": "train-1890", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute reversible renal failure", "role": "Effect"}, {"name": "Captopril", "role": "Treatment"}, {"name": "Captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-1891", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyperthyroidism", "role": "Effect"}, {"name": "IFN-alpha", "role": "Treatment"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1892", "event": [{"trigger": "occured", "type": "adverse_event", "arguments": [{"name": "NMS", "role": "Effect"}, {"name": "clozapine, risperidone, and amisulpride", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "risperidone", "role": "Treatment.Drug"}, {"name": "amisulpride", "role": "Treatment.Drug"}, {"name": "clozapine", "role": "Combination.Drug"}, {"name": "risperidone", "role": "Combination.Drug"}, {"name": "amisulpride", "role": "Combination.Drug"}]}]}
{"id": "train-1893", "event": [{"trigger": "During", "type": "adverse_event", "arguments": [{"name": "a rapid decrease in the D-dimers was seen (normal values reached until day 7), together with a slight decrease in peripheral blood leukocytes", "role": "Effect"}, {"name": "the first days of arsenic trioxide treatment", "role": "Treatment"}, {"name": "arsenic trioxide", "role": "Treatment.Drug"}, {"name": "the first days", "role": "Treatment.Duration"}]}]}
{"id": "train-1894", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "Graves' disease", "role": "Subject"}, {"name": "Graves' disease", "role": "Subject.Disorder"}, {"name": "IFN-alpha", "role": "Treatment"}, {"name": "chronic viral C hepatitis", "role": "Treatment.Disorder"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1895", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "gastritis", "role": "Effect"}, {"name": "dexamethasone", "role": "Treatment"}, {"name": "dexamethasone", "role": "Treatment.Drug"}]}]}
{"id": "train-1896", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "patients with Crohn's disease", "role": "Subject"}, {"name": "hypersensitivity pneumonitis", "role": "Effect"}, {"name": "Mesalamine", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "Mesalamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1897", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "high-grade atrioventricular (AV) block", "role": "Effect"}, {"name": "dipyridamole", "role": "Treatment"}, {"name": "dipyridamole", "role": "Treatment.Drug"}]}]}
{"id": "train-1898", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "an autopsy case of a 78-year-old male", "role": "Subject"}, {"name": "prostatic cancer", "role": "Subject"}, {"name": "78-year-old", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "multiple nodules in the liver", "role": "Effect"}, {"name": "phosphate diethylstilbestrol (PDES)", "role": "Treatment"}, {"name": "prostatic cancer", "role": "Treatment.Disorder"}, {"name": "phosphate diethylstilbestrol", "role": "Treatment.Drug"}]}]}
{"id": "train-1899", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "one patient", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}, {"name": "Fracture of the femoral neck", "role": "Effect"}, {"name": "PSL therapy", "role": "Treatment"}, {"name": "PSL", "role": "Treatment.Drug"}]}]}
{"id": "train-1900", "event": [{"trigger": "subsided", "type": "potential_therapeutic_event", "arguments": [{"name": "because of that the depressive symptom also disappeared", "role": "Effect"}, {"name": "etizolam and flunitrazepam", "role": "Treatment"}, {"name": "mianserin 30 mg/day", "role": "Treatment"}, {"name": "panic anxiety", "role": "Treatment.Disorder"}, {"name": "depressive symptom", "role": "Treatment.Disorder"}, {"name": "flunitrazepam", "role": "Treatment.Drug"}, {"name": "etizolam", "role": "Treatment.Drug"}, {"name": "mianserin", "role": "Treatment.Drug"}, {"name": "30 mg/day", "role": "Treatment.Dosage"}, {"name": "etizolam", "role": "Combination.Drug"}, {"name": "flunitrazepam", "role": "Combination.Drug"}, {"name": "mianserin", "role": "Combination.Drug"}]}]}
{"id": "train-1901", "event": [{"trigger": "stopped", "type": "potential_therapeutic_event", "arguments": [{"name": "red cell aplasia resolved", "role": "Effect"}, {"name": "co-trimoxazole", "role": "Treatment"}, {"name": "co-trimoxazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1902", "event": [{"trigger": "co-administered", "type": "potential_therapeutic_event", "arguments": [{"name": "HIV-positive patients", "role": "Subject"}, {"name": "Interaction of sildenafil and indinavir", "role": "Treatment"}, {"name": "HIV-positive", "role": "Treatment.Disorder"}, {"name": "sildenafil", "role": "Treatment.Drug"}, {"name": "indinavir", "role": "Treatment.Drug"}, {"name": "sildenafil", "role": "Combination.Drug"}, {"name": "indinavir", "role": "Combination.Drug"}]}]}
{"id": "train-1903", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Cerebral and ocular toxicity", "role": "Effect"}, {"name": "desferrioxamine", "role": "Treatment"}, {"name": "desferrioxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1904", "event": [{"trigger": "while", "type": "adverse_event", "arguments": [{"name": "A patient", "role": "Subject"}, {"name": "papilloedema and hepatic dysfunction", "role": "Effect"}, {"name": "perhexiline maleate", "role": "Treatment"}, {"name": "perhexiline maleate", "role": "Treatment.Drug"}]}]}
{"id": "train-1905", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "subcutaneous metastasis", "role": "Effect"}, {"name": "percutaneous ethanol injection (PEI)", "role": "Treatment"}, {"name": "ethanol", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "hepatocellular carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-1906", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "episodic movements possibly consistent with EPS", "role": "Effect"}, {"name": "secondary to aripiprazole usage", "role": "Treatment"}, {"name": "aripiprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-1907", "event": [{"trigger": "show", "type": "adverse_event", "arguments": [{"name": "side effects on the cardiovascular system, such as QT prolongation, ventricular arrhythmia and cardiac arrest", "role": "Effect"}, {"name": "terfenadine and astemizole", "role": "Treatment"}, {"name": "terfenadine", "role": "Treatment.Drug"}, {"name": "astemizole", "role": "Treatment.Drug"}, {"name": "terfenadine", "role": "Combination.Drug"}, {"name": "astemizole", "role": "Combination.Drug"}]}]}
{"id": "train-1908", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "3 patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "acute generalized dystonia and akinetic rigid syndrome", "role": "Effect"}, {"name": "d-penicillamine 125-500 mg daily", "role": "Treatment"}, {"name": "d-penicillamine", "role": "Treatment.Drug"}, {"name": "125-500 mg daily", "role": "Treatment.Dosage"}]}]}
{"id": "train-1909", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Priapism", "role": "Effect"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1910", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "QT prolongation and T wave inversion", "role": "Effect"}, {"name": "pirmenol", "role": "Treatment"}, {"name": "pirmenol", "role": "Treatment.Drug"}]}]}
{"id": "train-1911", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "symptomatic hyponatremia", "role": "Effect"}, {"name": "Five months after initiating mirtazapine", "role": "Treatment"}, {"name": "Five months", "role": "Treatment.Time_elapsed"}, {"name": "mirtazapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1912", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "babies", "role": "Subject"}, {"name": "babies", "role": "Subject.Age"}, {"name": "apnea, hypotension, and bradycardia", "role": "Effect"}, {"name": "Intravenous verapamil", "role": "Treatment"}, {"name": "Intravenous", "role": "Treatment.Route"}, {"name": "verapamil", "role": "Treatment.Drug"}]}]}
{"id": "train-1913", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "The renal biopsy showed focal segmental glomerulosclerosis", "role": "Effect"}, {"name": "IFNalpha", "role": "Treatment"}, {"name": "CML", "role": "Treatment.Disorder"}, {"name": "IFNalpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1914", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "neurologic toxic effects", "role": "Effect"}, {"name": "Sulindac (Clinoril)", "role": "Treatment"}, {"name": "Sulindac", "role": "Treatment.Drug"}]}]}
{"id": "train-1915", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 32-year-old woman with HIV, anxiety disorder, and a history of intravenous drug abuse", "role": "Subject"}, {"name": "32-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "intravenous drug abuse", "role": "Subject.Disorder"}, {"name": "increased sedation and mental confusion", "role": "Effect"}, {"name": "atazanavir-ritonavir-based antiretroviral regimen was added to her stable antianxiety drug regimen, which included quetiapine", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}, {"name": "atazanavir", "role": "Treatment.Drug"}, {"name": "ritonavir", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}, {"name": "anxiety disorder", "role": "Treatment.Disorder"}, {"name": "ritonavir", "role": "Combination.Drug"}, {"name": "atazanavir", "role": "Combination.Drug"}, {"name": "quetiapine", "role": "Combination.Drug"}]}]}
{"id": "train-1916", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Fulminant hepatitis", "role": "Effect"}, {"name": "disulfiram", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-1917", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Anhedonic ejaculation", "role": "Effect"}, {"name": "desipramine", "role": "Treatment"}, {"name": "desipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-1918", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "four patient", "role": "Subject"}, {"name": "Serotonin syndrome", "role": "Effect"}, {"name": "phenelzine to venlafaxine", "role": "Treatment"}, {"name": "phenelzine", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-1919", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Lower extremity arterial thrombosis", "role": "Effect"}, {"name": "thrombin injection of a femoral pseudoaneurysm", "role": "Treatment"}, {"name": "thrombin", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "femoral pseudoaneurysm", "role": "Treatment.Disorder"}]}]}
{"id": "train-1920", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "exophthalmos", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1921", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "nephrogenic diabetes insipidus", "role": "Effect"}, {"name": "foscarnet treatment", "role": "Treatment"}, {"name": "foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-1922", "event": [{"trigger": "resolution", "type": "potential_therapeutic_event", "arguments": [{"name": "Cough", "role": "Effect"}, {"name": "fosinopril", "role": "Treatment"}, {"name": "quinapril", "role": "Treatment.Drug"}, {"name": "fosinopril", "role": "Treatment.Drug"}]}]}
{"id": "train-1923", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "interstitial lung disease (ILD)", "role": "Effect"}, {"name": "gefitinib", "role": "Treatment"}, {"name": "non-small-cell lung cancer", "role": "Treatment.Disorder"}, {"name": "gefitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-1924", "event": [{"trigger": "resulted in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "elevated phenytoin levels", "role": "Effect"}, {"name": "a potential drug interaction", "role": "Treatment"}, {"name": "initiation of erlotinib therapy", "role": "Treatment"}, {"name": "receiving phenytoin", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "erlotinib", "role": "Treatment.Drug"}, {"name": "erlotinib", "role": "Combination.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}]}]}
{"id": "train-1925", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient with breast cancer.", "role": "Subject"}, {"name": "sclerosing glomerulonephritis", "role": "Effect"}, {"name": "Anastrozole", "role": "Treatment"}, {"name": "Anastrozole", "role": "Treatment.Drug"}, {"name": "breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1926", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "cases", "role": "Subject"}, {"name": "hemolytic-uremic syndrome (HUS)", "role": "Effect"}, {"name": "renal toxicity", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-1927", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "palmar-plantar erythrodysaesthesia", "role": "Effect"}, {"name": "high-dose cytarabine", "role": "Treatment"}, {"name": "cytarabine", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1928", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "ischemic skin complications", "role": "Effect"}, {"name": "Peripheral administration of low-dose vasopressin", "role": "Treatment"}, {"name": "septic shock", "role": "Treatment.Disorder"}, {"name": "vasopressin", "role": "Treatment.Drug"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "Peripheral administration", "role": "Treatment.Route"}]}]}
{"id": "train-1929", "event": [{"trigger": "adverse_event", "type": "adverse_event", "arguments": [{"name": "akathisia", "role": "Effect"}, {"name": "antipsychotics, antidepressants, antiemetics, antihistamines, and psychoactive substances", "role": "Treatment"}, {"name": "antipsychotics", "role": "Treatment.Drug"}, {"name": "antidepressants", "role": "Treatment.Drug"}, {"name": "antiemetics", "role": "Treatment.Drug"}, {"name": "antihistamines", "role": "Treatment.Drug"}, {"name": "psychoactive substances.", "role": "Treatment.Drug"}, {"name": "antipsychotics", "role": "Combination.Drug"}, {"name": "antidepressants", "role": "Combination.Drug"}, {"name": "antiemetics", "role": "Combination.Drug"}, {"name": "antihistamines", "role": "Combination.Drug"}, {"name": "psychoactive substances.", "role": "Combination.Drug"}]}]}
{"id": "train-1930", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 60-year-old woman", "role": "Subject"}, {"name": "breast cancer", "role": "Subject"}, {"name": "60-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "erythema", "role": "Effect"}, {"name": "erosions in the axilla and groin", "role": "Effect"}, {"name": "PLD", "role": "Treatment"}, {"name": "PLD", "role": "Treatment.Drug"}, {"name": "breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-1931", "event": [{"trigger": "reported with", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome", "role": "Effect"}, {"name": "administration of linezolid and serotonin reuptake inhibitors", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "serotonin reuptake inhibitors", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "serotonin reuptake inhibitors", "role": "Combination.Drug"}]}]}
{"id": "train-1932", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "diabetic individuals who are either allergic or are receiving beta-adrenoreceptor blocking drugs", "role": "Subject"}, {"name": "diabetic", "role": "Subject.Disorder"}, {"name": "a significant risk factor", "role": "Effect"}, {"name": "50% solution of dextrose", "role": "Treatment"}, {"name": "hypoglycaemia", "role": "Treatment.Disorder"}, {"name": "dextrose", "role": "Treatment.Drug"}, {"name": "50% solution", "role": "Treatment.Route"}]}]}
{"id": "train-1933", "event": [{"trigger": "exacerbation", "type": "adverse_event", "arguments": [{"name": "preexisting maladaptive behavior", "role": "Subject"}, {"name": "preexisting maladaptive behavior", "role": "Subject.Disorder"}, {"name": "exacerbation of a preexisting maladaptive behavior", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "partially suppressed by chlorpromazine", "role": "Treatment"}, {"name": "phenobarbital", "role": "Treatment.Drug"}, {"name": "chlorpromazine", "role": "Treatment.Drug"}, {"name": "phenobarbital", "role": "Combination.Drug"}, {"name": "chlorpromazine", "role": "Combination.Drug"}]}]}
{"id": "train-1934", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a teenager with familial Mediterranean fever", "role": "Subject"}, {"name": "teenager", "role": "Subject.Age"}, {"name": "myopathy", "role": "Effect"}, {"name": "Colchicine", "role": "Treatment"}, {"name": "Mediterranean fever", "role": "Treatment.Disorder"}, {"name": "Colchicine", "role": "Treatment.Drug"}]}]}
{"id": "train-1935", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "delirium with psychotic features", "role": "Effect"}, {"name": "Levofloxacin", "role": "Treatment"}, {"name": "Levofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1936", "event": [{"trigger": "production.", "type": "adverse_event", "arguments": [{"name": "Methemoglobinemia", "role": "Effect"}, {"name": "phenylpropanolamine", "role": "Treatment"}, {"name": "phenylpropanolamine", "role": "Treatment.Drug"}]}]}
{"id": "train-1937", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Destructive thyrotoxicosis", "role": "Effect"}, {"name": "Graves' hyperthyroidism", "role": "Effect"}, {"name": "IFN-alpha", "role": "Treatment"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}, {"name": "4-6 months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-1938", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "rhabdomyolysis", "role": "Effect"}, {"name": "5 years with lovastatin", "role": "Treatment"}, {"name": "a newer macrolide antibiotic", "role": "Treatment"}, {"name": "5 years", "role": "Treatment.Duration"}, {"name": "lovastatin", "role": "Treatment.Drug"}, {"name": "macrolide antibiotic", "role": "Treatment.Drug"}, {"name": "lovastatin", "role": "Combination.Drug"}, {"name": "macrolide antibiotic", "role": "Combination.Drug"}]}]}
{"id": "train-1939", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "patient with acquired haemophilia", "role": "Subject"}, {"name": "Thrombotic stroke", "role": "Effect"}, {"name": "porcine factor VIII", "role": "Treatment"}, {"name": "porcine factor VIII", "role": "Treatment.Drug"}, {"name": "acquired haemophilia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1940", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "The intravitreal application of triamcinolone acetonide", "role": "Treatment"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "triamcinolone acetonide", "role": "Treatment.Drug"}, {"name": "cystoid macular edema", "role": "Treatment.Disorder"}]}]}
{"id": "train-1941", "event": [{"trigger": "the risk", "type": "adverse_event", "arguments": [{"name": "Patients", "role": "Subject"}, {"name": "digoxin toxicity", "role": "Effect"}, {"name": "ciprofloxacin and digoxin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}, {"name": "digoxin", "role": "Treatment.Drug"}, {"name": "digoxin", "role": "Combination.Drug"}, {"name": "ciprofloxacin", "role": "Combination.Drug"}]}]}
{"id": "train-1942", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "pancytopenia", "role": "Effect"}, {"name": "MMI", "role": "Treatment"}, {"name": "MMI", "role": "Treatment.Drug"}]}]}
{"id": "train-1943", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "renal insufficiency", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-1944", "event": [{"trigger": "attributed", "type": "adverse_event", "arguments": [{"name": "marrow transplant patient", "role": "Subject"}, {"name": "Fatal eosinophilia myalgia syndrome", "role": "Effect"}, {"name": "total parenteral nutrition with a solution containing tryptophan", "role": "Treatment"}, {"name": "tryptophan", "role": "Treatment.Drug"}, {"name": "parenteral", "role": "Treatment.Route"}]}]}
{"id": "train-1945", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "43-year-old man", "role": "Subject"}, {"name": "43-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "bilateral optic neuropathy", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1946", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "The patient described in this paper was a 78-year-old diabetic man", "role": "Subject"}, {"name": "78-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "oral lesions of PV", "role": "Effect"}, {"name": "institution of glibenclamide", "role": "Treatment"}, {"name": "glibenclamide", "role": "Treatment.Drug"}, {"name": "diabetic", "role": "Treatment.Disorder"}]}]}
{"id": "train-1947", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "patients with Cushing's disease", "role": "Subject"}, {"name": "acute pancreatitis", "role": "Effect"}, {"name": "propofol", "role": "Treatment"}, {"name": "propofol", "role": "Treatment.Drug"}, {"name": "Cushing's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-1948", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "severe bone marrow suppression, typically aplastic anemia", "role": "Effect"}, {"name": "Ticlopidine is an oral antiplatelet agent", "role": "Treatment"}, {"name": "cerebrovascular disease", "role": "Treatment.Disorder"}, {"name": "Ticlopidine", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-1949", "event": [{"trigger": "treating", "type": "potential_therapeutic_event", "arguments": [{"name": "Moxifloxacin and lomefloxacin", "role": "Treatment"}, {"name": "fluoroquinolone antibiotics", "role": "Treatment"}, {"name": "Moxifloxacin", "role": "Treatment.Drug"}, {"name": "lomefloxacin", "role": "Treatment.Drug"}, {"name": "fluoroquinolone antibiotics", "role": "Treatment.Drug"}, {"name": "urinary and respiratory tract infections", "role": "Treatment.Disorder"}]}]}
{"id": "train-1950", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "TEN", "role": "Effect"}, {"name": "laxative", "role": "Treatment"}, {"name": "laxative", "role": "Treatment.Drug"}]}]}
{"id": "train-1951", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "life-threatening neuromuscular symptoms", "role": "Effect"}, {"name": "linezolid", "role": "Treatment"}, {"name": "with a serotonin reuptake inhibitor antidepressant", "role": "Treatment"}, {"name": "serotonin reuptake inhibitor antidepressant", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "serotonin reuptake inhibitor antidepressant", "role": "Combination.Drug"}]}]}
{"id": "train-1952", "event": [{"trigger": "onset", "type": "adverse_event", "arguments": [{"name": "Celiac disease", "role": "Effect"}, {"name": "pegylated interferon and ribavirin treatment of chronic hepatitis C.", "role": "Treatment"}, {"name": "pegylated interferon", "role": "Treatment.Drug"}, {"name": "ribavirin treatment", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}, {"name": "pegylated interferon", "role": "Combination.Drug"}, {"name": "ribavirin treatment", "role": "Combination.Drug"}]}]}
{"id": "train-1953", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "patients with lymphoid malignancy", "role": "Subject"}, {"name": "lymphoid malignancy", "role": "Subject.Disorder"}, {"name": "Hyperkalaemia with renal tubular dysfunction", "role": "Effect"}, {"name": "sulfamethoxazole-trimethoprim for Pneumocystis carinii pneumonia", "role": "Treatment"}, {"name": "Pneumocystis carinii pneumonia", "role": "Treatment.Disorder"}, {"name": "sulfamethoxazole-trimethoprim", "role": "Treatment.Drug"}]}]}
{"id": "train-1954", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "abdominal pain and elevated pancreatic enzymes", "role": "Effect"}, {"name": "7 days of tigecycline", "role": "Treatment"}, {"name": "7 days", "role": "Treatment.Time_elapsed"}, {"name": "tigecycline", "role": "Treatment.Drug"}]}]}
{"id": "train-1955", "event": [{"trigger": "developed.", "type": "adverse_event", "arguments": [{"name": "proximal muscle weakness", "role": "Effect"}, {"name": "interferon alpha", "role": "Treatment"}, {"name": "hepatitis B", "role": "Treatment.Disorder"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-1956", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "lithium and venlafaxine", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Combination.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}]}]}
{"id": "train-1957", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "delirium", "role": "Effect"}, {"name": "Supratherapeutic flecainide plasma concentrations", "role": "Treatment"}, {"name": "flecainide", "role": "Treatment.Drug"}]}]}
{"id": "train-1958", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "abnormally large mammary glands associated with pain and peri-areolar erythema", "role": "Effect"}, {"name": "fifth cycle of sunitinib therapy", "role": "Treatment"}, {"name": "sunitinib", "role": "Treatment.Drug"}, {"name": "fifth cycle", "role": "Treatment.Freq"}]}]}
{"id": "train-1959", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "an 11-year-old boy with attention deficit hyperactivity disorder", "role": "Subject"}, {"name": "11-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "enuresis", "role": "Effect"}, {"name": "methylphenidate", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}, {"name": "attention deficit hyperactivity disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-1960", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "a child with Joubert syndrome", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "neuroleptic malignant syndrome", "role": "Effect"}, {"name": "risperidone", "role": "Treatment"}, {"name": "Joubert syndrome", "role": "Treatment.Disorder"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-1961", "event": [{"trigger": "experiencing", "type": "adverse_event", "arguments": [{"name": "A 47-year-old HIV-infected man with dilated cardiomyopathy and prolonged QT syndrome with an automatic implantable cardiovascular defibrillator device", "role": "Subject"}, {"name": "dilated cardiomyopathy", "role": "Subject.Disorder"}, {"name": "prolonged QT syndrome", "role": "Subject.Disorder"}, {"name": "47-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "extreme redness, edema, and swelling at the injection site that corresponded with the flushing sensation due to niacin", "role": "Effect"}, {"name": "subcutaneous enfuvirtide 90 mg twice daily as part of his antiretroviral regimen and oral extended-release niacin 500 mg/day for a high-density lipoprotein level of 8 mg/dL.", "role": "Treatment"}, {"name": "HIV-infected", "role": "Treatment.Disorder"}, {"name": "90 mg", "role": "Treatment.Dosage"}, {"name": "500 mg", "role": "Treatment.Dosage"}, {"name": "twice daily", "role": "Treatment.Freq"}, {"name": "day", "role": "Treatment.Freq"}, {"name": "enfuvirtide", "role": "Treatment.Drug"}, {"name": "niacin", "role": "Treatment.Drug"}, {"name": "subcutaneous", "role": "Treatment.Route"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "1 week", "role": "Treatment.Time_elapsed"}, {"name": "niacin", "role": "Combination.Drug"}, {"name": "enfuvirtide", "role": "Combination.Drug"}]}]}
{"id": "train-1962", "event": [{"trigger": "diagnosis", "type": "adverse_event", "arguments": [{"name": "seizure", "role": "Effect"}, {"name": "acute INH neurotoxicity", "role": "Effect"}, {"name": "INH", "role": "Treatment"}, {"name": "INH", "role": "Treatment.Drug"}]}]}
{"id": "train-1963", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an elderly patient.", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "toxic epidermal necrolysis", "role": "Effect"}, {"name": "Levofloxacin", "role": "Treatment"}, {"name": "Levofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1964", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "cardiotoxicity", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "dosage", "role": "Treatment"}, {"name": "schedule", "role": "Treatment"}, {"name": "5-fluorouracil (5-FU)", "role": "Treatment.Drug"}]}]}
{"id": "train-1965", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Torsades de Pointes", "role": "Effect"}, {"name": "a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs", "role": "Treatment"}, {"name": "garenoxacin", "role": "Treatment.Drug"}, {"name": "disopyramide", "role": "Treatment.Drug"}, {"name": "cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs", "role": "Treatment.Drug"}, {"name": "garenoxacin", "role": "Combination.Drug"}, {"name": "disopyramide", "role": "Combination.Drug"}, {"name": "cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs", "role": "Combination.Drug"}]}]}
{"id": "train-1966", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Ataxia", "role": "Effect"}, {"name": "propafenone", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-1967", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "The first patient", "role": "Subject"}, {"name": "mild nitritoid symptoms and pain in a band-like distribution", "role": "Effect"}, {"name": "gold sodium thiomalate (GSTM) injection", "role": "Treatment"}, {"name": "gold sodium thiomalate", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-1968", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "an elderly woman", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "febrile agranulocytosis", "role": "Effect"}, {"name": "several weeks after commencing ticlopidine", "role": "Treatment"}, {"name": "several weeks", "role": "Treatment.Time_elapsed"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-1969", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two 65-year-old white men with coronary heart disease", "role": "Subject"}, {"name": "coronary heart disease", "role": "Subject.Disorder"}, {"name": "Two", "role": "Subject.Population"}, {"name": "65-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "men", "role": "Subject.Gender"}, {"name": "intense dental and gingival pain", "role": "Effect"}, {"name": "niacin therapy for dyslipidemia for 5 months", "role": "Treatment"}, {"name": "increases in dose", "role": "Treatment"}, {"name": "dyslipidemia", "role": "Treatment.Disorder"}, {"name": "niacin", "role": "Treatment.Drug"}, {"name": "increases in dose", "role": "Treatment.Dosage"}, {"name": "5 months", "role": "Treatment.Duration"}]}]}
{"id": "train-1970", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "testicular swelling and pain", "role": "Effect"}, {"name": "desipramine", "role": "Treatment"}, {"name": "desipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-1971", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyponatremia", "role": "Effect"}, {"name": "thiazide", "role": "Treatment"}, {"name": "hydrochlorothiazide", "role": "Treatment.Drug"}, {"name": "thiazide", "role": "Treatment.Drug"}]}]}
{"id": "train-1972", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Paradoxical pulmonary vasoconstriction", "role": "Effect"}, {"name": "nitroglycerin", "role": "Treatment"}, {"name": "nitroglycerin", "role": "Treatment.Drug"}, {"name": "idiopathic pulmonary hypertension", "role": "Treatment.Disorder"}]}]}
{"id": "train-1973", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "complex visual hallucinations and altered mental status", "role": "Effect"}, {"name": "zonisamide", "role": "Treatment"}, {"name": "zonisamide", "role": "Treatment.Drug"}]}]}
{"id": "train-1974", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "case", "role": "Subject"}, {"name": "angioneurotic edema", "role": "Effect"}, {"name": "oxcarbazepine", "role": "Treatment"}, {"name": "oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-1975", "event": [{"trigger": "predisposed", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "intrahepatic bile stasis", "role": "Effect"}, {"name": "octreotide or its long-acting analog", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}, {"name": "long-acting analog", "role": "Treatment.Drug"}]}]}
{"id": "train-1976", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "minority of patients", "role": "Subject"}, {"name": "sexual dysfunction", "role": "Effect"}, {"name": "Fluoxetine", "role": "Treatment"}, {"name": "Fluoxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-1977", "event": [{"trigger": "presenting", "type": "adverse_event", "arguments": [{"name": "a 45-year-old Chinese man with CML and chronic hepatitis B virus infection", "role": "Subject"}, {"name": "45-year-old", "role": "Subject.Age"}, {"name": "Chinese", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "herpetic rash and acute liver failure", "role": "Effect"}, {"name": "on imatinib treatment", "role": "Treatment"}, {"name": "imatinib", "role": "Treatment.Drug"}, {"name": "CML and chronic hepatitis B", "role": "Treatment.Disorder"}]}]}
{"id": "train-1978", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "One patient", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "temporary weakness", "role": "Effect"}, {"name": "an ampicillin sodium challenge", "role": "Treatment"}, {"name": "ampicillin sodium", "role": "Treatment.Drug"}]}]}
{"id": "train-1979", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "a chronic lymphocytic leukemia patient", "role": "Subject"}, {"name": "Acute myeloid leukemia and lung cancer", "role": "Effect"}, {"name": "fludarabine and autologous peripheral blood stem-cell transplantation", "role": "Treatment"}, {"name": "fludarabine", "role": "Treatment.Drug"}, {"name": "chronic lymphocytic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-1980", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "arterial thrombotic", "role": "Effect"}, {"name": "thrombin injection", "role": "Treatment"}, {"name": "thrombin", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "pseudoaneurysms", "role": "Treatment.Disorder"}]}]}
{"id": "train-1981", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism", "role": "Effect"}, {"name": "CPH82", "role": "Treatment"}, {"name": "CPH82", "role": "Treatment.Drug"}]}]}
{"id": "train-1982", "event": [{"trigger": "side effects,", "type": "adverse_event", "arguments": [{"name": "fetus", "role": "Subject"}, {"name": "fetus", "role": "Subject.Age"}, {"name": "premature closure of the ductus arteriosus", "role": "Effect"}, {"name": "indomethacin", "role": "Treatment"}, {"name": "indomethacin", "role": "Treatment.Drug"}]}]}
{"id": "train-1983", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "She", "role": "Subject"}, {"name": "She", "role": "Subject.Gender"}, {"name": "Epstein-Barr virus-associated polymorphic lymphoproliferative disorder (LPD)", "role": "Effect"}, {"name": "immunodeficiency caused by MTX administration", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-1984", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Pulmonary hypertension", "role": "Effect"}, {"name": "lithium therapy", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-1985", "event": [{"trigger": "adverse reaction", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "neurologic symptoms", "role": "Effect"}, {"name": "vancomycin", "role": "Treatment"}, {"name": "vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-1986", "event": [{"trigger": "when", "type": "adverse_event", "arguments": [{"name": "Corneal edema", "role": "Effect"}, {"name": "the administration of amantadine was resumed", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}]}]}
{"id": "train-1987", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "skin rash", "role": "Effect"}, {"name": "Vitamin K1", "role": "Treatment"}, {"name": "Vitamin K1", "role": "Treatment.Drug"}]}]}
{"id": "train-1988", "event": [{"trigger": "resulted", "type": "adverse_event", "arguments": [{"name": "fatal intracerebral haemorrhage", "role": "Effect"}, {"name": "thrombolysis", "role": "Treatment"}, {"name": "thrombolysis", "role": "Treatment.Drug"}]}]}
{"id": "train-1989", "event": [{"trigger": "effect", "type": "adverse_event", "arguments": [{"name": "optic neuropathy", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-1990", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a child with Wilms' tumor", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "congestive heart failure", "role": "Effect"}, {"name": "Adriamycin", "role": "Treatment"}, {"name": "Adriamycin", "role": "Treatment.Drug"}, {"name": "Wilms' tumor", "role": "Treatment.Disorder"}]}]}
{"id": "train-1991", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Hypersensitivity reactions", "role": "Effect"}, {"name": "cyclosporine", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}]}]}
{"id": "train-1992", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "first case", "role": "Subject"}, {"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "reactivation of a latent viral infection", "role": "Effect"}, {"name": "TMP-SMX", "role": "Treatment"}, {"name": "TMP", "role": "Treatment.Drug"}, {"name": "SMX", "role": "Treatment.Drug"}, {"name": "SMX", "role": "Combination.Drug"}, {"name": "TMP", "role": "Combination.Drug"}]}]}
{"id": "train-1993", "event": [{"trigger": "inactive", "type": "potential_therapeutic_event", "arguments": [{"name": "a homogenously defined population of PROC", "role": "Subject"}, {"name": "single-agent weekly AUC2-carboplatin", "role": "Treatment"}, {"name": "PROC", "role": "Treatment.Disorder"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "AUC2-carboplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-1994", "event": [{"trigger": "impair", "type": "adverse_event", "arguments": [{"name": "some patients", "role": "Subject"}, {"name": "impair sexual function and ejaculation", "role": "Effect"}, {"name": "Intrathecal baclofen", "role": "Treatment"}, {"name": "Intrathecal", "role": "Treatment.Route"}, {"name": "baclofen", "role": "Treatment.Drug"}]}]}
{"id": "train-1995", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "A case", "role": "Subject"}, {"name": "tonic-clonic seizures", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-1996", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "a 38-year-old woman diagnosed with anxiety, depression and right sacroileitis", "role": "Subject"}, {"name": "38-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "phenylbutazone, ranitidine, clomipramine and levomepromazine", "role": "Treatment"}, {"name": "phenylbutazone", "role": "Treatment.Drug"}, {"name": "clomipramine", "role": "Treatment.Drug"}, {"name": "levomepromazine", "role": "Treatment.Drug"}, {"name": "ranitidine", "role": "Treatment.Drug"}, {"name": "anxiety, depression and right sacroileitis", "role": "Treatment.Disorder"}, {"name": "levomepromazine", "role": "Combination.Drug"}, {"name": "clomipramine", "role": "Combination.Drug"}, {"name": "ranitidine", "role": "Combination.Drug"}, {"name": "phenylbutazone", "role": "Combination.Drug"}]}]}
{"id": "train-1997", "event": [{"trigger": "symptomatology", "type": "adverse_event", "arguments": [{"name": "18 other paediatric cases", "role": "Subject"}, {"name": "18", "role": "Subject.Population"}, {"name": "paediatric", "role": "Subject.Age"}, {"name": "naphthylimidazoline exposure", "role": "Effect"}, {"name": "naphthylimidazoline", "role": "Treatment"}, {"name": "naphthylimidazoline", "role": "Treatment.Drug"}]}]}
{"id": "train-1998", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Anterior spinal artery syndrome", "role": "Effect"}, {"name": "cervical intrathecal phenol injection", "role": "Treatment"}, {"name": "phenol", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-1999", "event": [{"trigger": "developed.", "type": "adverse_event", "arguments": [{"name": "swelling of the face and legs and pruritus", "role": "Effect"}, {"name": "phenytoin 1 g i.v.", "role": "Treatment"}, {"name": "a tonic-clonic seizure", "role": "Treatment.Disorder"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "1 g", "role": "Treatment.Dosage"}, {"name": "i.v.", "role": "Treatment.Route"}]}]}
{"id": "train-2000", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "histological abnormalities of the glomerulus", "role": "Effect"}, {"name": "postoperative IFN-beta therapy", "role": "Treatment"}, {"name": "IFN-beta", "role": "Treatment.Drug"}, {"name": "malignant melanoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-2001", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "carbamazepine toxicity", "role": "Effect"}, {"name": "Protease inhibitor", "role": "Treatment"}, {"name": "Protease inhibitor", "role": "Treatment.Drug"}]}]}
{"id": "train-2002", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "bilateral avascular necrosis of the femoral heads", "role": "Effect"}, {"name": "'standard' doses of dexamethasone", "role": "Treatment"}, {"name": "'standard' doses", "role": "Treatment.Dosage"}, {"name": "dexamethasone", "role": "Treatment.Drug"}]}]}
{"id": "train-2003", "event": [{"trigger": "recovered", "type": "potential_therapeutic_event", "arguments": [{"name": "He", "role": "Subject"}, {"name": "He", "role": "Subject.Gender"}, {"name": "very high doses of corticosteroids and azathioprine", "role": "Treatment"}, {"name": "very high doses", "role": "Treatment.Dosage"}, {"name": "corticosteroids", "role": "Treatment.Drug"}, {"name": "azathioprine", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Combination.Drug"}, {"name": "azathioprine", "role": "Combination.Drug"}]}]}
{"id": "train-2004", "event": [{"trigger": "observed", "type": "adverse_event", "arguments": [{"name": "two patients with severe hepatic disease and moderate renal insufficiency", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "moderate renal insufficiency", "role": "Subject.Disorder"}, {"name": "Marked hyperkalemia", "role": "Effect"}, {"name": "during and immediately after an infusion of arginine monohydrochloride", "role": "Treatment"}, {"name": "arginine monohydrochloride", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "immediately", "role": "Treatment.Time_elapsed"}, {"name": "hepatic disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2005", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "reserpine toxicity, in particular central nervous system (CNS) disturbances", "role": "Effect"}, {"name": "additive CNS effects", "role": "Effect"}, {"name": "reserpine", "role": "Treatment"}, {"name": "also receiving barbiturates,", "role": "Treatment"}, {"name": "barbiturates", "role": "Treatment.Drug"}, {"name": "reserpine", "role": "Treatment.Drug"}, {"name": "barbiturates", "role": "Combination.Drug"}, {"name": "reserpine", "role": "Combination.Drug"}]}]}
{"id": "train-2006", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "fever", "role": "Effect"}, {"name": "sepsis and fevers of neutropenia", "role": "Effect"}, {"name": "amifostine", "role": "Treatment"}, {"name": "amifostine", "role": "Treatment.Drug"}]}]}
{"id": "train-2007", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "hypermagnesemia", "role": "Effect"}, {"name": "oral administration of magnesium sulfate", "role": "Treatment"}, {"name": "magnesium sulfate", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-2008", "event": [{"trigger": "noted.", "type": "adverse_event", "arguments": [{"name": "Markedly increased pigmementation of skin immediately overlying veins", "role": "Effect"}, {"name": "multiple 5-fluorouracil infusions", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}, {"name": "infusions", "role": "Treatment.Route"}]}]}
{"id": "train-2009", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Severe hepatitis", "role": "Effect"}, {"name": "cyproterone acetate", "role": "Treatment"}, {"name": "cyproterone acetate", "role": "Treatment.Drug"}]}]}
{"id": "train-2010", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "three patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "Erythema multiforme", "role": "Effect"}, {"name": "phenytoin and cranial radiation therapy", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2011", "event": [{"trigger": "of", "type": "potential_therapeutic_event", "arguments": [{"name": "prophylaxis and treatment", "role": "Effect"}, {"name": "Chloroquine", "role": "Treatment"}, {"name": "Chloroquine", "role": "Treatment.Drug"}, {"name": "malaria", "role": "Treatment.Disorder"}]}]}
{"id": "train-2012", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "the patient had suffered from painful mucositis", "role": "Subject"}, {"name": "mucositis", "role": "Subject.Disorder"}, {"name": "severe dysphagia and bleeding", "role": "Effect"}, {"name": "chemotherapy", "role": "Treatment"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-2013", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "a patient with the acquired immunodeficiency syndrome", "role": "Subject"}, {"name": "adrenal failure", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "acquired immunodeficiency syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-2014", "event": [{"trigger": "produce", "type": "adverse_event", "arguments": [{"name": "occasional patients", "role": "Subject"}, {"name": "transient brain stem or neuromuscular dysfunction with eye movement abnormality", "role": "Effect"}, {"name": "cyclosporin", "role": "Treatment"}, {"name": "together with ganciclovir", "role": "Treatment"}, {"name": "ganciclovir", "role": "Treatment.Drug"}, {"name": "cyclosporin", "role": "Treatment.Drug"}, {"name": "cyclosporin", "role": "Combination.Drug"}, {"name": "ganciclovir", "role": "Combination.Drug"}]}]}
{"id": "train-2015", "event": [{"trigger": "resulted", "type": "adverse_event", "arguments": [{"name": "Three patients", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "'phosphate shower syndrome' (hyper-uricaemia, hyperkalaemia and hyperphosphataemia with hypocalcaemia and tetany, with metabolic acidosis and acute renal impairment)", "role": "Effect"}, {"name": "cytotoxic treatment, including high dose methotrexate with folinic acid rescue", "role": "Treatment"}, {"name": "tumour", "role": "Treatment.Disorder"}, {"name": "cytotoxic", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "folinic acid rescue", "role": "Treatment.Drug"}, {"name": "high dose", "role": "Treatment.Dosage"}, {"name": "folinic acid rescue", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}, {"name": "cytotoxic", "role": "Combination.Drug"}]}]}
{"id": "train-2016", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "serotonin toxicity", "role": "Effect"}, {"name": "Methylene blue", "role": "Treatment"}, {"name": "Methylene blue", "role": "Treatment.Drug"}]}]}
{"id": "train-2017", "event": [{"trigger": "found", "type": "adverse_event", "arguments": [{"name": "82-year-old man", "role": "Subject"}, {"name": "82-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "neutropenic with marrow aplasia.", "role": "Effect"}, {"name": "receiving ticlopidine for 2 years", "role": "Treatment"}, {"name": "2 years", "role": "Treatment.Duration"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-2018", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patients on antiretroviral treatment", "role": "Subject"}, {"name": "hyperlactatemia", "role": "Effect"}, {"name": "stavudine", "role": "Treatment"}, {"name": "stavudine", "role": "Treatment.Drug"}]}]}
{"id": "train-2019", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "pediatric", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "multiple seizures", "role": "Effect"}, {"name": "bupropion ingestion", "role": "Treatment"}, {"name": "bupropion", "role": "Treatment.Drug"}, {"name": "ingestion", "role": "Treatment.Route"}]}]}
{"id": "train-2020", "event": [{"trigger": "precipitate", "type": "adverse_event", "arguments": [{"name": "serotonin toxicity", "role": "Effect"}, {"name": "co-administration of SSRIs and fentanyl", "role": "Treatment"}, {"name": "SSRIs", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "SSRIs", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}]}]}
{"id": "train-2021", "event": [{"trigger": "occurred.", "type": "adverse_event", "arguments": [{"name": "acute ocular ischemic syndrome", "role": "Effect"}, {"name": "Three days after intravitreal injection of bevacizumab", "role": "Treatment"}, {"name": "bevacizumab", "role": "Treatment.Drug"}, {"name": "intravitreal injection", "role": "Treatment.Route"}, {"name": "Three days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2022", "event": [{"trigger": "After", "type": "adverse_event", "arguments": [{"name": "eight volunteers", "role": "Subject"}, {"name": "eight", "role": "Subject.Population"}, {"name": "nausea and vomiting", "role": "Effect"}, {"name": "lopinavir/ritonavir", "role": "Treatment"}, {"name": "lopinavir", "role": "Treatment.Drug"}, {"name": "ritonavir", "role": "Treatment.Drug"}, {"name": "lopinavir", "role": "Combination.Drug"}, {"name": "ritonavir", "role": "Combination.Drug"}]}]}
{"id": "train-2023", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "irritation of the skin", "role": "Effect"}, {"name": "Calcipotriol", "role": "Treatment"}, {"name": "Calcipotriol", "role": "Treatment.Drug"}]}]}
{"id": "train-2024", "event": [{"trigger": "resolved.", "type": "potential_therapeutic_event", "arguments": [{"name": "discontinuation of danazol", "role": "Treatment"}, {"name": "diabetes", "role": "Treatment.Disorder"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-2025", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "ischemic colitis", "role": "Effect"}, {"name": "tegaserod", "role": "Treatment"}, {"name": "tegaserod", "role": "Treatment.Drug"}]}]}
{"id": "train-2026", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "cutaneous reaction", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-2027", "event": [{"trigger": "attributed", "type": "adverse_event", "arguments": [{"name": "Three of these patients", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "convulsions", "role": "Effect"}, {"name": "imipenem/cilastatin", "role": "Treatment"}, {"name": "imipenem", "role": "Treatment.Drug"}, {"name": "cilastatin", "role": "Treatment.Drug"}, {"name": "imipenem", "role": "Combination.Drug"}, {"name": "cilastatin", "role": "Combination.Drug"}]}]}
{"id": "train-2028", "event": [{"trigger": "raises", "type": "adverse_event", "arguments": [{"name": "potential renal toxicity", "role": "Effect"}, {"name": "interferons", "role": "Treatment"}, {"name": "interferons", "role": "Treatment.Drug"}, {"name": "MS.", "role": "Treatment.Disorder"}]}]}
{"id": "train-2029", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "red cell aplasia", "role": "Effect"}, {"name": "Co-trimoxazole", "role": "Treatment"}, {"name": "leukaemia", "role": "Treatment.Disorder"}, {"name": "Co-trimoxazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2030", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "MPGN", "role": "Effect"}, {"name": "Interferon-alpha (IFN-alpha)", "role": "Treatment"}, {"name": "Interferon-alpha (IFN-alpha)", "role": "Treatment.Drug"}]}]}
{"id": "train-2031", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Toxic epidermal necrolysis", "role": "Effect"}, {"name": "high-dose cytosine arabinoside", "role": "Treatment"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}]}]}
{"id": "train-2032", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "3 elderly patients", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "3", "role": "Subject.Population"}, {"name": "moderate to severe ataxia", "role": "Effect"}, {"name": "taking propafenone", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-2033", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Gestational diabetes", "role": "Effect"}, {"name": "norethisterone", "role": "Treatment"}, {"name": "norethisterone", "role": "Treatment.Drug"}]}]}
{"id": "train-2034", "event": [{"trigger": "emerging", "type": "adverse_event", "arguments": [{"name": "diabetes mellitus and impaired glucose tolerance", "role": "Effect"}, {"name": "norethisterone", "role": "Treatment"}, {"name": "norethisterone", "role": "Treatment.Drug"}]}]}
{"id": "train-2035", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "cerebellar toxicity", "role": "Effect"}, {"name": "HDARAC", "role": "Treatment"}, {"name": "HDARAC", "role": "Treatment.Drug"}]}]}
{"id": "train-2036", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a girl with juvenile systemic lupus erythematosus", "role": "Subject"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "ulcerative proctitis", "role": "Effect"}, {"name": "ibuprofen treatment", "role": "Treatment"}, {"name": "ibuprofen", "role": "Treatment.Drug"}, {"name": "juvenile systemic lupus erythematosus", "role": "Treatment.Disorder"}]}]}
{"id": "train-2037", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "TEN", "role": "Effect"}, {"name": "phenolphthalein", "role": "Treatment"}, {"name": "phenolphthalein", "role": "Treatment.Drug"}]}]}
{"id": "train-2038", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "diffuse interstitial pulmonary fibrosis", "role": "Effect"}, {"name": "Methotrexate", "role": "Treatment"}, {"name": "Methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2039", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "Abdominal wall ulceration and mucinosis", "role": "Effect"}, {"name": "recombinant human interferon-beta-1b", "role": "Treatment"}, {"name": "recombinant human interferon-beta-1b", "role": "Treatment.Drug"}]}]}
{"id": "train-2040", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "Asthenozoospermia", "role": "Effect"}, {"name": "long-term exposure to an anti-epileptic drug of carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-2041", "event": [{"trigger": "triggered", "type": "adverse_event", "arguments": [{"name": "Psoriasis", "role": "Effect"}, {"name": "imiquimod", "role": "Treatment"}, {"name": "dermal plasmacytoid dendritic cell precursors", "role": "Treatment.Disorder"}, {"name": "imiquimod", "role": "Treatment.Drug"}]}]}
{"id": "train-2042", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 52-year-old Black woman", "role": "Subject"}, {"name": "52-year-old", "role": "Subject.Age"}, {"name": "Black", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "transient hemiparesis contralateral to the injury", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "post-traumatic epilepsy", "role": "Treatment.Disorder"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2043", "event": [{"trigger": "use", "type": "adverse_event", "arguments": [{"name": "leukopenia", "role": "Effect"}, {"name": "cephalosporin", "role": "Treatment"}, {"name": "cephalosporin", "role": "Treatment.Drug"}]}]}
{"id": "train-2044", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "10 patients with Behcet's syndrome", "role": "Subject"}, {"name": "10", "role": "Subject.Population"}, {"name": "chromosome damage", "role": "Effect"}, {"name": "chlorambucil", "role": "Treatment"}, {"name": "Behcet's syndrome", "role": "Treatment.Disorder"}, {"name": "chlorambucil", "role": "Treatment.Drug"}]}]}
{"id": "train-2045", "event": [{"trigger": "complicating", "type": "adverse_event", "arguments": [{"name": "Sarcoma", "role": "Effect"}, {"name": "cyclophosphamide", "role": "Treatment"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2046", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "polyserositis", "role": "Effect"}, {"name": "Clozapine", "role": "Treatment"}, {"name": "Clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2047", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient with radiation fibrosis", "role": "Subject"}, {"name": "radiation fibrosis", "role": "Subject.Disorder"}, {"name": "interstitial lung disease", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-2048", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "8 cardiac arrests", "role": "Effect"}, {"name": "6 deaths", "role": "Effect"}, {"name": "Halfan", "role": "Treatment"}, {"name": "when a higher dose than recommended was used", "role": "Treatment"}, {"name": "Halfan", "role": "Treatment.Drug"}, {"name": "mefloquine", "role": "Treatment.Drug"}, {"name": "a higher dose than recommended", "role": "Treatment.Dosage"}]}]}
{"id": "train-2049", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Fixed drug rash", "role": "Effect"}, {"name": "methylphenidate", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-2050", "event": [{"trigger": "appear", "type": "adverse_event", "arguments": [{"name": "pulmonary symptoms", "role": "Effect"}, {"name": "ticlopidine treatment", "role": "Treatment"}, {"name": "ticlopidine", "role": "Treatment.Drug"}]}]}
{"id": "train-2051", "event": [{"trigger": "using", "type": "adverse_event", "arguments": [{"name": "agranulocytosis", "role": "Effect"}, {"name": "quetiapine", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2052", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Acute renal failure", "role": "Effect"}, {"name": "intravenous immunoglobulin (IVIG)", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "immunoglobulin", "role": "Treatment.Drug"}]}]}
{"id": "train-2053", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "one", "role": "Subject"}, {"name": "one", "role": "Subject.Population"}, {"name": "had an aggravation of the condition", "role": "Effect"}, {"name": "interferon-alpha", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2054", "event": [{"trigger": "followed", "type": "adverse_event", "arguments": [{"name": "Reactivation of cytomegalovirus", "role": "Effect"}, {"name": "corticosteroids and azathioprine", "role": "Treatment"}, {"name": "Wegener's granulomatosis", "role": "Treatment.Disorder"}, {"name": "corticosteroids", "role": "Treatment.Drug"}, {"name": "azathioprine", "role": "Treatment.Drug"}, {"name": "corticosteroids", "role": "Combination.Drug"}, {"name": "azathioprine", "role": "Combination.Drug"}]}]}
{"id": "train-2055", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "a woman at 16 weeks' gestation", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "16 weeks' gestation", "role": "Subject.Disorder"}, {"name": "respiratory failure", "role": "Effect"}, {"name": "being treated with nitrofurantoin for a urinary tract infection", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}, {"name": "urinary tract infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-2056", "event": [{"trigger": "manifested", "type": "adverse_event", "arguments": [{"name": "a case of EGE", "role": "Subject"}, {"name": "EGE", "role": "Subject.Disorder"}, {"name": "allergy", "role": "Effect"}, {"name": "gemfibrozil", "role": "Treatment"}, {"name": "gemfibrozil", "role": "Treatment.Drug"}]}]}
{"id": "train-2057", "event": [{"trigger": "appeared with", "type": "adverse_event", "arguments": [{"name": "children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "INH", "role": "Treatment"}, {"name": "INH", "role": "Treatment.Drug"}]}]}
{"id": "train-2058", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "nephrotic syndrome", "role": "Effect"}, {"name": "long-term lithium therapy", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2059", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Acute psychosis", "role": "Effect"}, {"name": "levetiracetam", "role": "Treatment"}, {"name": "levetiracetam", "role": "Treatment.Drug"}]}]}
{"id": "train-2060", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with nonfunctional neuroendocrine tumor", "role": "Subject"}, {"name": "Hypoglycemia", "role": "Effect"}, {"name": "long-acting somatostatin analogues", "role": "Treatment"}, {"name": "nonfunctional neuroendocrine tumor", "role": "Treatment.Disorder"}, {"name": "long-acting somatostatin analogues", "role": "Treatment.Drug"}]}]}
{"id": "train-2061", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "developed a DAT-positive hemolytic episode", "role": "Effect"}, {"name": "a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin", "role": "Treatment"}, {"name": "oxaliplatin", "role": "Treatment.Drug"}, {"name": "a red cell", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "transfusion", "role": "Treatment.Route"}, {"name": "17th cycle", "role": "Treatment.Duration"}, {"name": "oxaliplatin", "role": "Combination.Drug"}, {"name": "a red cell", "role": "Combination.Drug"}]}]}
{"id": "train-2062", "event": [{"trigger": "Regression", "type": "potential_therapeutic_event", "arguments": [{"name": "lithium withdrawal", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "thyrotoxic ophthalmopathy", "role": "Treatment.Disorder"}]}]}
{"id": "train-2063", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute-onset myopia and angle closure glaucoma", "role": "Effect"}, {"name": "topiramate", "role": "Treatment"}, {"name": "topiramate", "role": "Treatment.Drug"}]}]}
{"id": "train-2064", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "gastric mucosa foveolar hyperplasia", "role": "Effect"}, {"name": "simulate hypertrophic pyloric stenosis", "role": "Effect"}, {"name": "long-term PGE1 therapy", "role": "Treatment"}, {"name": "PGE1", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-2065", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "cardiomyopathy", "role": "Effect"}, {"name": "doxorubicin", "role": "Treatment"}, {"name": "'low' doses", "role": "Treatment"}, {"name": "doxorubicin", "role": "Treatment.Drug"}, {"name": "'low' doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-2066", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Generalized argyria", "role": "Effect"}, {"name": "habitual use of AgNO3", "role": "Treatment"}, {"name": "AgNO3", "role": "Treatment.Drug"}]}]}
{"id": "train-2067", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "giant mammary hyperplasia", "role": "Effect"}, {"name": "bucillamine", "role": "Treatment"}, {"name": "bucillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2068", "event": [{"trigger": "increase", "type": "adverse_event", "arguments": [{"name": "patients with thalassemia intermedia", "role": "Subject"}, {"name": "hemoglobin (Hb F) levels", "role": "Effect"}, {"name": "Hydroxyurea (HU) and sodium phenylbutyrate (SPB)", "role": "Treatment"}, {"name": "Hydroxyurea", "role": "Treatment.Drug"}, {"name": "sodium phenylbutyrate", "role": "Treatment.Drug"}, {"name": "thalassemia intermedia", "role": "Treatment.Disorder"}, {"name": "Hydroxyurea", "role": "Combination.Drug"}, {"name": "sodium phenylbutyrate", "role": "Combination.Drug"}]}]}
{"id": "train-2069", "event": [{"trigger": "symptoms began", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "myositis", "role": "Effect"}, {"name": "within 10 days of receiving leuprolide acetate therapy", "role": "Treatment"}, {"name": "leuprolide acetate", "role": "Treatment.Drug"}, {"name": "10 days", "role": "Treatment.Time_elapsed"}, {"name": "prostate cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2070", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "urinary incontinence", "role": "Effect"}, {"name": "Venlafaxine", "role": "Treatment"}, {"name": "Venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-2071", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "postoperative patients", "role": "Subject"}, {"name": "postoperative", "role": "Subject.Disorder"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "cyclobenzaprine", "role": "Treatment"}, {"name": "duloxetine", "role": "Treatment"}, {"name": "duloxetine", "role": "Treatment.Drug"}, {"name": "cyclobenzaprine", "role": "Combination.Drug"}, {"name": "duloxetine", "role": "Combination.Drug"}]}]}
{"id": "train-2072", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "2 cases", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "serotonin syndrome with serious extrapyramidal movement disorders", "role": "Effect"}, {"name": "metoclopramide was coadministered with sertraline or venlafaxine", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}, {"name": "sertraline", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "metoclopramide", "role": "Combination.Drug"}, {"name": "sertraline", "role": "Combination.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}, {"name": "metoclopramide", "role": "Combination.Drug"}]}]}
{"id": "train-2073", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 31-year-old women with recurrent Hodgkin's lymphoma and unrecognized HMSN-1", "role": "Subject"}, {"name": "31-year-old", "role": "Subject.Age"}, {"name": "women", "role": "Subject.Gender"}, {"name": "unrecognized HMSN-1", "role": "Subject.Disorder"}, {"name": "severe motor neuropathy", "role": "Effect"}, {"name": "3 weeks after the first cycle of treatment including 2 mg of vincristine", "role": "Treatment"}, {"name": "recurrent Hodgkin's lymphoma", "role": "Treatment.Disorder"}, {"name": "3 weeks", "role": "Treatment.Time_elapsed"}, {"name": "2 mg", "role": "Treatment.Dosage"}, {"name": "vincristine", "role": "Treatment.Drug"}]}]}
{"id": "train-2074", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "the DAT became positive with anti-IgG and anti-C3d antiglobulins", "role": "Effect"}, {"name": "fludarabine", "role": "Treatment"}, {"name": "second course of treatment", "role": "Treatment"}, {"name": "fludarabine", "role": "Treatment.Drug"}, {"name": "nine months later", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2075", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "postoperative hypophosphatemia and hypocalcemic tetany", "role": "Effect"}, {"name": "alendronate (Fosamax)", "role": "Treatment"}, {"name": "after bowel preparation with Fleet Phospho-Soda", "role": "Treatment"}, {"name": "alendronate", "role": "Treatment.Drug"}, {"name": "Fleet Phospho-Soda", "role": "Treatment.Drug"}, {"name": "alendronate", "role": "Combination.Drug"}, {"name": "Fleet Phospho-Soda", "role": "Combination.Drug"}]}]}
{"id": "train-2076", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Acute dystonic reaction", "role": "Effect"}, {"name": "low-dose pimozide", "role": "Treatment"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "pimozide", "role": "Treatment.Drug"}]}]}
{"id": "train-2077", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "recurrences of tics", "role": "Effect"}, {"name": "treatment with atomoxetine", "role": "Treatment"}, {"name": "atomoxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-2078", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "fulminant hepatic failure", "role": "Effect"}, {"name": "Nicotinic acid", "role": "Treatment"}, {"name": "Nicotinic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-2079", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pulmonary hypertension.", "role": "Effect"}, {"name": "protamine", "role": "Treatment"}, {"name": "protamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2080", "event": [{"trigger": "treat", "type": "potential_therapeutic_event", "arguments": [{"name": "PCC-related MI", "role": "Subject"}, {"name": "PCC-related MI", "role": "Subject.Disorder"}, {"name": "recombinant factor VIIa", "role": "Treatment"}, {"name": "bleeding", "role": "Treatment.Disorder"}, {"name": "immediate and long-term period", "role": "Treatment.Time_elapsed"}, {"name": "recombinant factor VIIa", "role": "Treatment.Drug"}]}]}
{"id": "train-2081", "event": [{"trigger": "case", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "Lithium and venlafaxine interaction", "role": "Treatment"}, {"name": "Lithium", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "Lithium", "role": "Combination.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}]}]}
{"id": "train-2082", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "reduced concentration of VPA in the blood", "role": "Treatment"}, {"name": "reduced concentration", "role": "Treatment.Dosage"}, {"name": "VPA", "role": "Treatment.Drug"}]}]}
{"id": "train-2083", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "crescentic glomerulonephritis", "role": "Effect"}, {"name": "D-penicillamine", "role": "Treatment"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2084", "event": [{"trigger": "between", "type": "adverse_event", "arguments": [{"name": "adverse interaction", "role": "Effect"}, {"name": "paroxetine and other agent(s)", "role": "Treatment"}, {"name": "paroxetine", "role": "Treatment.Drug"}, {"name": "anaesthesia", "role": "Treatment.Drug"}, {"name": "anaesthesia", "role": "Combination.Drug"}, {"name": "paroxetine", "role": "Combination.Drug"}]}]}
{"id": "train-2085", "event": [{"trigger": "reaction", "type": "adverse_event", "arguments": [{"name": "Neuroleptic malignant syndrome", "role": "Effect"}, {"name": "muscular rigidity, hyperthermia, autonomic dysfunction, altered consciousness, high creatinine phosphokinase levels, and leukocytosis", "role": "Effect"}, {"name": "antipsychotic drugs", "role": "Treatment"}, {"name": "antipsychotic", "role": "Treatment.Drug"}]}]}
{"id": "train-2086", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "nephrolithiasis and chronic interstitial nephritis", "role": "Effect"}, {"name": "Indinavir", "role": "Treatment"}, {"name": "Indinavir", "role": "Treatment.Drug"}]}]}
{"id": "train-2087", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "unpredictable side effects", "role": "Effect"}, {"name": "Gemcitabine", "role": "Treatment"}, {"name": "Gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2088", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pseudomembranous colitis", "role": "Effect"}, {"name": "Albendazole", "role": "Treatment"}, {"name": "Albendazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2089", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Tuberculous uveitis", "role": "Effect"}, {"name": "etanercept", "role": "Treatment"}, {"name": "etanercept", "role": "Treatment.Drug"}]}]}
{"id": "train-2090", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "Salicylate", "role": "Treatment"}, {"name": "Salicylate", "role": "Treatment.Drug"}]}]}
{"id": "train-2091", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "delirium", "role": "Effect"}, {"name": "flecainide", "role": "Treatment"}, {"name": "interaction with paroxetine", "role": "Treatment"}, {"name": "flecainide", "role": "Treatment.Drug"}, {"name": "paroxetine", "role": "Treatment.Drug"}, {"name": "paroxetine", "role": "Combination.Drug"}, {"name": "flecainide", "role": "Combination.Drug"}]}]}
{"id": "train-2092", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "hypersensitivity pneumonitis", "role": "Effect"}, {"name": "celiprolol", "role": "Treatment"}, {"name": "celiprolol", "role": "Treatment.Drug"}]}]}
{"id": "train-2093", "event": [{"trigger": "used to", "type": "potential_therapeutic_event", "arguments": [{"name": "pediatric patients undergoing nonpainful radiological imaging studies", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "provide sedation", "role": "Effect"}, {"name": "dexmedetomidine", "role": "Treatment"}, {"name": "dexmedetomidine", "role": "Treatment.Drug"}]}]}
{"id": "train-2094", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 71-year-old woman", "role": "Subject"}, {"name": "71-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "moderate doses of lithium and venlafaxine", "role": "Treatment"}, {"name": "refractory depression", "role": "Treatment.Disorder"}, {"name": "moderate doses", "role": "Treatment.Dosage"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Combination.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}]}]}
{"id": "train-2095", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "acutely developed moderate hyperglycemia and severe ketonuria with positive islet cell antibody", "role": "Effect"}, {"name": "Four years after the beginning of IFN therapy", "role": "Treatment"}, {"name": "Four years after", "role": "Treatment.Time_elapsed"}, {"name": "IFN", "role": "Treatment.Drug"}]}]}
{"id": "train-2096", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "2 patients", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "Tardive dyskinesia", "role": "Effect"}, {"name": "ziprasidone", "role": "Treatment"}, {"name": "ziprasidone", "role": "Treatment.Drug"}]}]}
{"id": "train-2097", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "neutropenia", "role": "Effect"}, {"name": "MMF", "role": "Treatment"}, {"name": "MMF", "role": "Treatment.Drug"}]}]}
{"id": "train-2098", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Fulminant hepatic failure", "role": "Effect"}, {"name": "bicalutamide", "role": "Treatment"}, {"name": "bicalutamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2099", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "melanonychia and onycholysis", "role": "Effect"}, {"name": "pemetrexed for lung cancer", "role": "Treatment"}, {"name": "lung cancer", "role": "Treatment.Disorder"}, {"name": "pemetrexed", "role": "Treatment.Drug"}]}]}
{"id": "train-2100", "event": [{"trigger": "induced by", "type": "adverse_event", "arguments": [{"name": "two extremely low birth weight newborns", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "newborns", "role": "Subject.Age"}, {"name": "Hypernatraemia", "role": "Effect"}, {"name": "sodium polystyrene sulphonate (Kayexalate)", "role": "Treatment"}, {"name": "sodium polystyrene sulphonate (Kayexalate", "role": "Treatment.Drug"}]}]}
{"id": "train-2101", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "premature ductal closure", "role": "Effect"}, {"name": "maternal indomethacin therapy", "role": "Treatment"}, {"name": "indomethacin", "role": "Treatment.Drug"}, {"name": "maternal", "role": "Treatment.Route"}]}]}
{"id": "train-2102", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a woman with Crohn's disease", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "histological osteomalacia", "role": "Effect"}, {"name": "2 years after ileal resection and the start of cholestyramine", "role": "Treatment"}, {"name": "cholestyramine", "role": "Treatment.Drug"}, {"name": "start", "role": "Treatment.Time_elapsed"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2103", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS)", "role": "Effect"}, {"name": "psychotropic administration", "role": "Treatment"}, {"name": "psychotropic", "role": "Treatment.Drug"}]}]}
{"id": "train-2104", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Drug eruption", "role": "Effect"}, {"name": "azathioprine", "role": "Treatment"}, {"name": "azathioprine", "role": "Treatment.Drug"}]}]}
{"id": "train-2105", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "a complication of CBZ OD", "role": "Treatment"}, {"name": "CBZ OD", "role": "Treatment.Drug"}]}]}
{"id": "train-2106", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "all 3 cases", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "marked densification of trabecular bone", "role": "Effect"}, {"name": "fluorine", "role": "Treatment"}, {"name": "niflumic acid", "role": "Treatment"}, {"name": "fluorine", "role": "Treatment.Drug"}, {"name": "niflumic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-2107", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 17-year-old boy with refractory psoriatic arthritis and alpha-1 antitrypsin deficiency", "role": "Subject"}, {"name": "17-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "alpha-1 antitrypsin deficiency", "role": "Subject.Disorder"}, {"name": "syringotropic hypersensitivity reaction", "role": "Effect"}, {"name": "9 months of therapy with infliximab and leflunomide", "role": "Treatment"}, {"name": "refractory psoriatic arthritis", "role": "Treatment.Disorder"}, {"name": "infliximab", "role": "Treatment.Drug"}, {"name": "leflunomide", "role": "Treatment.Drug"}, {"name": "9 months", "role": "Treatment.Duration"}, {"name": "infliximab", "role": "Combination.Drug"}, {"name": "leflunomide", "role": "Combination.Drug"}]}]}
{"id": "train-2108", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "cardiovascular collapse", "role": "Effect"}, {"name": "severe flecainide overdose", "role": "Treatment"}, {"name": "flecainide", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-2109", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "53-year-old Caucasian male victim of suicide", "role": "Subject"}, {"name": "53-year-old", "role": "Subject.Age"}, {"name": "Caucasian", "role": "Subject.Race"}, {"name": "male", "role": "Subject.Gender"}, {"name": "overdose", "role": "Treatment"}, {"name": "sertraline and alprazolam", "role": "Treatment"}, {"name": "overdose", "role": "Treatment.Dosage"}, {"name": "sertraline", "role": "Treatment.Drug"}, {"name": "alprazolam", "role": "Treatment.Drug"}, {"name": "sertraline", "role": "Combination.Drug"}, {"name": "alprazolam", "role": "Combination.Drug"}]}]}
{"id": "train-2110", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "lupus-like syndrome", "role": "Effect"}, {"name": "Infliximab therapy", "role": "Treatment"}, {"name": "Infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2111", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 7-year-old with congenital toxoplasmosis", "role": "Subject"}, {"name": "7-year-old", "role": "Subject.Age"}, {"name": "fever, severe cutaneous involvement, swelling, abdominal pain and transaminitis", "role": "Effect"}, {"name": "pyrimethamine and sulfadiazine for reactivated chorioretinitis", "role": "Treatment"}, {"name": "reactivated chorioretinitis", "role": "Treatment.Disorder"}, {"name": "congenital toxoplasmosis", "role": "Treatment.Disorder"}, {"name": "pyrimethamine", "role": "Treatment.Drug"}, {"name": "sulfadiazine", "role": "Treatment.Drug"}, {"name": "pyrimethamine", "role": "Combination.Drug"}, {"name": "sulfadiazine", "role": "Combination.Drug"}]}]}
{"id": "train-2112", "event": [{"trigger": "among", "type": "adverse_event", "arguments": [{"name": "serious interaction", "role": "Effect"}, {"name": "frequently used drugs", "role": "Treatment"}, {"name": "chronic pain", "role": "Treatment.Disorder"}, {"name": "frequently", "role": "Treatment.Freq"}, {"name": "drugs", "role": "Treatment.Drug"}]}]}
{"id": "train-2113", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "This kind of reaction", "role": "Effect"}, {"name": "co-administration with tizanidine", "role": "Treatment"}, {"name": "tizanidine", "role": "Treatment.Drug"}]}]}
{"id": "train-2114", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "37 (22%)", "role": "Subject"}, {"name": "37", "role": "Subject.Population"}, {"name": "hepatic angiosarcoma", "role": "Effect"}, {"name": "vinyl chloride, 'Thorotrast', and inorganic arsenic", "role": "Treatment"}, {"name": "vinyl chloride", "role": "Treatment.Drug"}, {"name": "Thorotrast", "role": "Treatment.Drug"}, {"name": "inorganic arsenic", "role": "Treatment.Drug"}, {"name": "vinyl chloride", "role": "Combination.Drug"}, {"name": "Thorotrast", "role": "Combination.Drug"}, {"name": "inorganic arsenic", "role": "Combination.Drug"}]}]}
{"id": "train-2115", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Progressive hypokalemia", "role": "Effect"}, {"name": "phosphate", "role": "Treatment"}, {"name": "phosphate", "role": "Treatment.Drug"}]}]}
{"id": "train-2116", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 69-year-old man", "role": "Subject"}, {"name": "69-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "pure red cell aplasia", "role": "Effect"}, {"name": "taking fenoprofen for ten months", "role": "Treatment"}, {"name": "fenoprofen", "role": "Treatment.Drug"}, {"name": "ten months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2117", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "severe heart failure.", "role": "Effect"}, {"name": "etanercept", "role": "Treatment"}, {"name": "etanercept", "role": "Treatment.Drug"}]}]}
{"id": "train-2118", "event": [{"trigger": "developing", "type": "adverse_event", "arguments": [{"name": "Minimal change nephrotic syndrome", "role": "Effect"}, {"name": "postoperative interferon-beta therapy for malignant melanoma", "role": "Treatment"}, {"name": "malignant melanoma", "role": "Treatment.Disorder"}, {"name": "postoperative interferon-beta", "role": "Treatment.Drug"}]}]}
{"id": "train-2119", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "She was admitted following a fall", "role": "Subject"}, {"name": "She", "role": "Subject.Gender"}, {"name": "fall", "role": "Subject.Disorder"}, {"name": "movement disorder and a period of unresponsiveness", "role": "Effect"}, {"name": "metoclopramide", "role": "Treatment"}, {"name": "metoclopramide", "role": "Treatment.Drug"}]}]}
{"id": "train-2120", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "a patient with neuropsychiatric SLE", "role": "Subject"}, {"name": "transient panhypogammaglobulinaemia", "role": "Effect"}, {"name": "prednisolone and cyclophosphamide", "role": "Treatment"}, {"name": "prednisolone", "role": "Treatment.Drug"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "neuropsychiatric SLE", "role": "Treatment.Disorder"}, {"name": "prednisolone", "role": "Combination.Drug"}, {"name": "cyclophosphamide", "role": "Combination.Drug"}]}]}
{"id": "train-2121", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "poorly nourished patients", "role": "Subject"}, {"name": "poorly nourished", "role": "Subject.Disorder"}, {"name": "pellagra", "role": "Effect"}, {"name": "Isoniazid", "role": "Treatment"}, {"name": "Isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-2122", "event": [{"trigger": "receiving", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with corneal ulcers", "role": "Subject"}, {"name": "colchicine", "role": "Treatment"}, {"name": "colchicine", "role": "Treatment.Drug"}, {"name": "corneal ulcers", "role": "Treatment.Disorder"}]}]}
{"id": "train-2123", "event": [{"trigger": "After", "type": "potential_therapeutic_event", "arguments": [{"name": "skin lesions cleared completely within 5 weeks", "role": "Effect"}, {"name": "patient discontinued rifampicin", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "skin lesions", "role": "Treatment.Disorder"}, {"name": "within 5 weeks", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2124", "event": [{"trigger": "inducing", "type": "adverse_event", "arguments": [{"name": "extrapyramidal symptoms, including tardive dyskinesia (TD)", "role": "Effect"}, {"name": "Ziprasidone", "role": "Treatment"}, {"name": "Ziprasidone", "role": "Treatment.Drug"}, {"name": "antipsychotic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2125", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute ischaemia of the leg", "role": "Effect"}, {"name": "intra-arterial injection of dissolved flunitrazepam tablets", "role": "Treatment"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "flunitrazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-2126", "event": [{"trigger": "use", "type": "adverse_event", "arguments": [{"name": "unlikely to have a major impact on the recovery time", "role": "Effect"}, {"name": "prophylactic antibiotic", "role": "Treatment"}, {"name": "rocuronium-induced NMB with sugammadex reversal", "role": "Treatment.Disorder"}, {"name": "prophylactic antibiotic", "role": "Treatment.Drug"}]}]}
{"id": "train-2127", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "gingival hyperplasia", "role": "Effect"}, {"name": "the angiomatous enlargement of the gingiva", "role": "Effect"}, {"name": "diphenylhydantoin", "role": "Treatment"}, {"name": "diphenylhydantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2128", "event": [{"trigger": "attributed", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "visual field constriction", "role": "Effect"}, {"name": "vigabatrin", "role": "Treatment"}, {"name": "vigabatrin", "role": "Treatment.Drug"}]}]}
{"id": "train-2129", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Two patients with stable hypothyroidism", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "hypothyroidism with increased serum thyroid-stimulating hormone", "role": "Effect"}, {"name": "switching from 1 levothyroxine product to another", "role": "Treatment"}, {"name": "stable hypothyroidism", "role": "Treatment.Disorder"}, {"name": "levothyroxine", "role": "Treatment.Drug"}]}]}
{"id": "train-2130", "event": [{"trigger": "relationship", "type": "adverse_event", "arguments": [{"name": "clotting abnormality", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-2131", "event": [{"trigger": "act", "type": "adverse_event", "arguments": [{"name": "massive cytokines liberation", "role": "Effect"}, {"name": "destruction of CD20 positive cells", "role": "Effect"}, {"name": "rituximab", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2132", "event": [{"trigger": "adverse effects", "type": "adverse_event", "arguments": [{"name": "hypertension, fatigue, hand-foot syndrome, elevated lipase and lymphopenia", "role": "Effect"}, {"name": "sunitinib", "role": "Treatment"}, {"name": "sunitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-2133", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "45-year-old psoriasis patient", "role": "Subject"}, {"name": "45-year-old", "role": "Subject.Age"}, {"name": "eruptive mollusca contagiosa", "role": "Effect"}, {"name": "antipsoriatic treatment with efalizumab", "role": "Treatment"}, {"name": "psoriasis", "role": "Treatment.Disorder"}, {"name": "efalizumab", "role": "Treatment.Drug"}]}]}
{"id": "train-2134", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Skin necrosis", "role": "Effect"}, {"name": "subcutaneous heparin therapy", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}, {"name": "subcutaneous", "role": "Treatment.Route"}]}]}
{"id": "train-2135", "event": [{"trigger": "complications:", "type": "adverse_event", "arguments": [{"name": "renal complications", "role": "Effect"}, {"name": "Epsilon-aminocaproic acid", "role": "Treatment"}, {"name": "Epsilon-aminocaproic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-2136", "event": [{"trigger": "implicated in", "type": "adverse_event", "arguments": [{"name": "systemic and local side effects in patients with lupus", "role": "Effect"}, {"name": "Ibuprofen", "role": "Treatment"}, {"name": "Ibuprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-2137", "event": [{"trigger": "exhibit", "type": "adverse_event", "arguments": [{"name": "3 patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "anaphylactoid reactions", "role": "Effect"}, {"name": "intraperitoneal cisplatin and hyperthermia", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "intraperitoneal", "role": "Treatment.Route"}, {"name": "recurrent ovarian cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2138", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Perinatal vasoconstrictive renal insufficiency", "role": "Effect"}, {"name": "maternal nimesulide use", "role": "Treatment"}, {"name": "nimesulide", "role": "Treatment.Drug"}]}]}
{"id": "train-2139", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "progressive ataxia related to carbamazepine toxicity", "role": "Effect"}, {"name": "Protease inhibitors (ritonavir and saquinavir) were added to the treatment", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "Protease inhibitors", "role": "Treatment.Drug"}, {"name": "Protease inhibitors", "role": "Combination.Drug"}, {"name": "carbamazepine", "role": "Combination.Drug"}]}]}
{"id": "train-2140", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "death", "role": "Effect"}, {"name": "fluoxetine toxicity", "role": "Treatment"}, {"name": "fluoxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-2141", "event": [{"trigger": "effective", "type": "potential_therapeutic_event", "arguments": [{"name": "Hypertonic sodium bicarbonate", "role": "Treatment"}, {"name": "hypotension and arrhythmias", "role": "Treatment.Disorder"}, {"name": "sodium bicarbonate", "role": "Treatment.Drug"}]}]}
{"id": "train-2142", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "toxicity", "role": "Effect"}, {"name": "flecainide is prescribed with paroxetine and other potent CYP2D6 inhibitors", "role": "Treatment"}, {"name": "flecainide", "role": "Treatment.Drug"}, {"name": "paroxetine", "role": "Treatment.Drug"}, {"name": "flecainide", "role": "Combination.Drug"}, {"name": "paroxetine", "role": "Combination.Drug"}]}]}
{"id": "train-2143", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "Gentamicin", "role": "Treatment"}, {"name": "Gentamicin", "role": "Treatment.Drug"}]}]}
{"id": "train-2144", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lung disorder", "role": "Effect"}, {"name": "Sulfasalazine", "role": "Treatment"}, {"name": "Sulfasalazine", "role": "Treatment.Disorder"}]}]}
{"id": "train-2145", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "interstitial nephritis", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2146", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "ischemic colitis", "role": "Effect"}, {"name": "Tegaserod", "role": "Treatment"}, {"name": "Tegaserod", "role": "Treatment.Drug"}]}]}
{"id": "train-2147", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "neurotoxic effects", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2148", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 70-year-old man", "role": "Subject"}, {"name": "70-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "DRESS syndrome", "role": "Effect"}, {"name": "chlorambucil", "role": "Treatment"}, {"name": "chlorambucil", "role": "Treatment.Drug"}, {"name": "chronic lymphocytic leukaemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2149", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "syncope", "role": "Effect"}, {"name": "oxymetazoline", "role": "Treatment"}, {"name": "oxymetazoline", "role": "Treatment.Drug"}]}]}
{"id": "train-2150", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Marked elevation of serum creatine kinase", "role": "Effect"}, {"name": "olanzapine therapy", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2151", "event": [{"trigger": "After", "type": "potential_therapeutic_event", "arguments": [{"name": "the edema resolved, and the endothelial cell densities were <or=600/mm", "role": "Effect"}, {"name": "cessation of amantadine", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}, {"name": "<or=600/mm", "role": "Treatment.Dosage"}]}]}
{"id": "train-2152", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "muscle injury with concomitant elevations of serum CK of muscle origin", "role": "Effect"}, {"name": "Olanzapine", "role": "Treatment"}, {"name": "atypical antipsychotic drugs", "role": "Treatment"}, {"name": "Olanzapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2153", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with partial or generalized epilepsy", "role": "Subject"}, {"name": "valproic acid (VPA), carbamazepine (CBZ), phenytoin (PHT), or topiramate (TPM) as monotherapy", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "topiramate", "role": "Treatment.Drug"}, {"name": "valproic acid", "role": "Combination.Drug"}, {"name": "carbamazepine", "role": "Combination.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}, {"name": "topiramate", "role": "Combination.Drug"}]}]}
{"id": "train-2154", "event": [{"trigger": "prevent", "type": "potential_therapeutic_event", "arguments": [{"name": "aspirin and a P2Y12 receptor antagonist following placement of coronary stents", "role": "Treatment"}, {"name": "stent thrombosis and subsequent myocardial infarction", "role": "Treatment.Disorder"}, {"name": "aspirin", "role": "Treatment.Drug"}, {"name": "P2Y12 receptor antagonist", "role": "Treatment.Drug"}, {"name": "aspirin", "role": "Combination.Drug"}, {"name": "P2Y12 receptor antagonist", "role": "Combination.Drug"}]}]}
{"id": "train-2155", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "compromise the limbic system", "role": "Effect"}, {"name": "deficits in learning and memory", "role": "Effect"}, {"name": "Organometals", "role": "Treatment"}, {"name": "Organometals", "role": "Treatment.Drug"}]}]}
{"id": "train-2156", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "Optic neuropathy", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2157", "event": [{"trigger": "treated with", "type": "adverse_event", "arguments": [{"name": "postmenopausal patient", "role": "Subject"}, {"name": "breast cancer.", "role": "Subject"}, {"name": "ovarian endometrioid carcinoma and endometriosis", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2158", "event": [{"trigger": "correlation", "type": "adverse_event", "arguments": [{"name": "percentage decrease of brain parenchyma", "role": "Effect"}, {"name": "total dose of ACTH", "role": "Treatment"}, {"name": "ACTH", "role": "Treatment.Drug"}]}]}
{"id": "train-2159", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "delirium resembled serotonin toxicity", "role": "Effect"}, {"name": "paroxetine until 2 days before surgery", "role": "Treatment"}, {"name": "paroxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-2160", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Primary central nervous system lymphoma", "role": "Effect"}, {"name": "natalizumab", "role": "Treatment"}, {"name": "natalizumab", "role": "Treatment.Drug"}]}]}
{"id": "train-2161", "event": [{"trigger": "received", "type": "potential_therapeutic_event", "arguments": [{"name": "7 pediatric oncology patients", "role": "Subject"}, {"name": "7", "role": "Subject.Population"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "low-dose ketamine in conjunction with propofol for total intravenous anesthesia (TIVA) repeatedly for radiation therapy", "role": "Treatment"}, {"name": "propofol", "role": "Treatment.Drug"}, {"name": "ketamine", "role": "Treatment.Drug"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "oncology", "role": "Treatment.Disorder"}, {"name": "propofol", "role": "Combination.Drug"}, {"name": "ketamine", "role": "Combination.Drug"}]}]}
{"id": "train-2162", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "multiple organ failure", "role": "Effect"}, {"name": "interaction, atorvastatin and verapamil", "role": "Treatment"}, {"name": "atorvastatin", "role": "Treatment.Drug"}, {"name": "verapamil", "role": "Treatment.Drug"}, {"name": "atorvastatin", "role": "Combination.Drug"}, {"name": "verapamil", "role": "Combination.Drug"}]}]}
{"id": "train-2163", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Hypersensitivity", "role": "Effect"}, {"name": "zonisamide", "role": "Treatment"}, {"name": "zonisamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2164", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "Pulmonary edema", "role": "Effect"}, {"name": "24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy", "role": "Treatment"}, {"name": "24 hours", "role": "Treatment.Time_elapsed"}, {"name": "10 hours", "role": "Treatment.Time_elapsed"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "subcutaneous", "role": "Treatment.Route"}, {"name": "ritodrine", "role": "Treatment.Drug"}, {"name": "terbutaline", "role": "Treatment.Drug"}, {"name": "ritodrine", "role": "Combination.Drug"}, {"name": "terbutaline", "role": "Combination.Drug"}]}]}
{"id": "train-2165", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "Transient acute myopia", "role": "Effect"}, {"name": "isotretinoin (accutane) therapy", "role": "Treatment"}, {"name": "isotretinoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2166", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "a man", "role": "Subject"}, {"name": "man", "role": "Subject.Gender"}, {"name": "fatal fulminant hepatitis", "role": "Effect"}, {"name": "disulfiram", "role": "Treatment"}, {"name": "disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-2167", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "rhabdomyolysis", "role": "Effect"}, {"name": "lovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and azithromycin", "role": "Treatment"}, {"name": "lovastatin", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "azithromycin", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}, {"name": "azithromycin", "role": "Combination.Drug"}]}]}
{"id": "train-2168", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "two children with idiopathic neutropenia", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "children", "role": "Subject.Age"}, {"name": "Neutrophilic dermatoses", "role": "Effect"}, {"name": "granulocyte colony-stimulating factor (G-CSF) therapy", "role": "Treatment"}, {"name": "idiopathic neutropenia", "role": "Treatment.Disorder"}, {"name": "granulocyte colony-stimulating factor", "role": "Treatment.Drug"}]}]}
{"id": "train-2169", "event": [{"trigger": "inhibits", "type": "potential_therapeutic_event", "arguments": [{"name": "antimicrobial effects", "role": "Effect"}, {"name": "inhibits oral disease-related processes", "role": "Effect"}, {"name": "zinc/o-cymen-5-ol system", "role": "Treatment"}, {"name": "zinc", "role": "Treatment.Drug"}, {"name": "o-cymen-5-ol", "role": "Treatment.Drug"}, {"name": "zinc", "role": "Combination.Drug"}, {"name": "o-cymen-5-ol", "role": "Combination.Drug"}]}]}
{"id": "train-2170", "event": [{"trigger": "possessing", "type": "potential_therapeutic_event", "arguments": [{"name": "Paroxetine", "role": "Treatment"}, {"name": "anti-depressant activity", "role": "Treatment.Disorder"}, {"name": "Paroxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-2171", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "A case", "role": "Subject"}, {"name": "polymyositis with dilated cardiomyopathy", "role": "Effect"}, {"name": "interferon alpha", "role": "Treatment"}, {"name": "hepatitis B.", "role": "Treatment.Disorder"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2172", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "cerebellar syndrome", "role": "Effect"}, {"name": "Phenytoin", "role": "Treatment"}, {"name": "Phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2173", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "an infant who developed pancreatitis caused by meglumine antimoniate", "role": "Subject"}, {"name": "pancreatitis caused by meglumine antimoniate", "role": "Subject.Disorder"}, {"name": "infant", "role": "Subject.Age"}, {"name": "visceral leishmaniasis with allopurinol plus ketoconazole", "role": "Treatment"}, {"name": "visceral leishmaniasis", "role": "Treatment.Disorder"}, {"name": "allopurinol", "role": "Treatment.Drug"}, {"name": "ketoconazole", "role": "Treatment.Drug"}, {"name": "ketoconazole", "role": "Combination.Drug"}, {"name": "allopurinol", "role": "Combination.Drug"}]}]}
{"id": "train-2174", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Hepatotoxicity", "role": "Effect"}, {"name": "high-dose methylprednisolone", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}, {"name": "demyelinating disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2175", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "focal segmental glomerulosclerosis in chronic myelogenous leukemia", "role": "Effect"}, {"name": "Interferon-alpha", "role": "Treatment"}, {"name": "Interferon-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2176", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "tubular and interstitial lesions", "role": "Effect"}, {"name": "intermittent or discontinuous rifampin therapy", "role": "Treatment"}, {"name": "rifampin", "role": "Treatment.Drug"}, {"name": "tuberculosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2177", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "an intracranial mass lesion", "role": "Effect"}, {"name": "Transtentorial herniation", "role": "Effect"}, {"name": "high-dose methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-2178", "event": [{"trigger": "terminated", "type": "potential_therapeutic_event", "arguments": [{"name": "prolonged suxamethonium apnoea", "role": "Effect"}, {"name": "the infusion of a commercial preparation of serumcholinesterase", "role": "Treatment"}, {"name": "suxamethonium", "role": "Treatment.Drug"}, {"name": "serumcholinesterase", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-2179", "event": [{"trigger": "prevent", "type": "potential_therapeutic_event", "arguments": [{"name": "53-year-old woman with a history of deep vein thrombosis and pulmonary embolism", "role": "Subject"}, {"name": "53-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "deep vein thrombosis", "role": "Treatment.Disorder"}, {"name": "pulmonary embolism", "role": "Treatment.Disorder"}, {"name": "thromboembolic complications;", "role": "Treatment.Disorder"}]}]}
{"id": "train-2180", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient with asymptomatic bronchial asthma and hypertension", "role": "Subject"}, {"name": "asymptomatic bronchial asthma", "role": "Subject.Disorder"}, {"name": "acute asthma attack", "role": "Effect"}, {"name": "sustained-release verapamil", "role": "Treatment"}, {"name": "hypertension", "role": "Treatment.Disorder"}, {"name": "sustained-release verapamil", "role": "Treatment.Drug"}]}]}
{"id": "train-2181", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "three cases", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "benzarone", "role": "Treatment"}, {"name": "benzarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2182", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 56-year-old female", "role": "Subject"}, {"name": "56-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "drug refractory paroxysmal atrial fibrillation, in which marked prolongation of the QT interval and T wave inversion", "role": "Effect"}, {"name": "pirmenol", "role": "Treatment"}, {"name": "pirmenol", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-2183", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lipohypertrophy", "role": "Effect"}, {"name": "Insulin", "role": "Treatment"}, {"name": "Insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-2184", "event": [{"trigger": "therapy", "type": "potential_therapeutic_event", "arguments": [{"name": "essential hypertension patients", "role": "Subject"}, {"name": "indapamide", "role": "Treatment"}, {"name": "carbohydrate metabolism", "role": "Treatment.Disorder"}, {"name": "hypertension", "role": "Treatment.Disorder"}, {"name": "indapamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2185", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "a patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia)", "role": "Subject"}, {"name": "CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia)", "role": "Subject.Disorder"}, {"name": "worsening of Raynaud's phenomenon", "role": "Effect"}, {"name": "yohimbine", "role": "Treatment"}, {"name": "ED", "role": "Treatment.Disorder"}, {"name": "yohimbine", "role": "Treatment.Drug"}]}]}
{"id": "train-2186", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute renal failure", "role": "Effect"}, {"name": "High-dose methotrexate", "role": "Treatment"}, {"name": "High-dose", "role": "Treatment.Dosage"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2187", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "renal dysfunction", "role": "Effect"}, {"name": "interferon alpha (IFNalpha)", "role": "Treatment"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2188", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Infectious endophthalmitis", "role": "Effect"}, {"name": "intravitreal bevacizumab injection", "role": "Treatment"}, {"name": "bevacizumab", "role": "Treatment.Drug"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-2189", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a platinum hypersensitivity", "role": "Effect"}, {"name": "a carboplatin-based regimen", "role": "Treatment"}, {"name": "carboplatin", "role": "Treatment.Drug"}, {"name": "recurrent primary peritoneal carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-2190", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "rhabdomyolysis", "role": "Effect"}, {"name": "lovastatin", "role": "Treatment"}, {"name": "associated with azithromycin and clarithromycin", "role": "Treatment"}, {"name": "lovastatin", "role": "Treatment.Drug"}, {"name": "azithromycin", "role": "Treatment.Drug"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "azithromycin", "role": "Combination.Drug"}, {"name": "clarithromycin", "role": "Combination.Drug"}, {"name": "lovastatin", "role": "Combination.Drug"}]}]}
{"id": "train-2191", "event": [{"trigger": "exhibited", "type": "adverse_event", "arguments": [{"name": "three patients", "role": "Subject"}, {"name": "medium and severe hypersensitivity reactions", "role": "Effect"}, {"name": "carboplatin", "role": "Treatment"}, {"name": "carboplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2192", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "a patient with a left ventricular assist device drive-line infection", "role": "Subject"}, {"name": "left ventricular assist device drive-line infection", "role": "Subject.Disorder"}, {"name": "sideroblastic anemia", "role": "Effect"}, {"name": "receiving linezolid", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "serious infections with gram-positive organisms", "role": "Treatment.Disorder"}]}]}
{"id": "train-2193", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient with acute myeloblastic leukemia", "role": "Subject"}, {"name": "nephrotic syndrome", "role": "Effect"}, {"name": "macrophage-colony-stimulating factor", "role": "Treatment"}, {"name": "macrophage-colony-stimulating factor", "role": "Treatment.Drug"}, {"name": "acute myeloblastic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2194", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "INH", "role": "Treatment"}, {"name": "INH", "role": "Treatment.Drug"}]}]}
{"id": "train-2195", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "the first case", "role": "Subject"}, {"name": "generalized exanthem", "role": "Effect"}, {"name": "subcutaneous injection of enoxaparin", "role": "Treatment"}, {"name": "subcutaneous injection", "role": "Treatment.Route"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-2196", "event": [{"trigger": "illustrates", "type": "adverse_event", "arguments": [{"name": "potential decoupling of PSA response", "role": "Effect"}, {"name": "flutamide withdrawal", "role": "Treatment"}, {"name": "flutamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2197", "event": [{"trigger": "resolved,", "type": "potential_therapeutic_event", "arguments": [{"name": "her", "role": "Subject"}, {"name": "arthritis", "role": "Subject.Disorder"}, {"name": "her", "role": "Subject.Gender"}, {"name": "discontinuation of MTX", "role": "Treatment"}, {"name": "ascites", "role": "Treatment.Disorder"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-2198", "event": [{"trigger": "administration", "type": "adverse_event", "arguments": [{"name": "uremic patient", "role": "Subject"}, {"name": "Colonic mucosal necrosis", "role": "Effect"}, {"name": "calcium polystryrene sulfonate (Kalimate)", "role": "Treatment"}, {"name": "calcium polystryrene sulfonate", "role": "Treatment.Drug"}, {"name": "uremic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2199", "event": [{"trigger": "secondary to", "type": "adverse_event", "arguments": [{"name": "Intracranial hemorrhage and focal seizures", "role": "Effect"}, {"name": "L-asparaginase", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}]}]}
{"id": "train-2200", "event": [{"trigger": "involving", "type": "adverse_event", "arguments": [{"name": "A fatal poisoning case", "role": "Subject"}, {"name": "A fatal poisoning", "role": "Effect"}, {"name": "etizolam, phenobarbital, promethazine and chlorpromazine", "role": "Treatment"}, {"name": "etizolam", "role": "Treatment.Drug"}, {"name": "phenobarbital", "role": "Treatment.Drug"}, {"name": "promethazine", "role": "Treatment.Drug"}, {"name": "chlorpromazine", "role": "Treatment.Drug"}]}]}
{"id": "train-2201", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patient with metastatic pancreatic adenocarcinoma", "role": "Subject"}, {"name": "hemolytic uremic syndrome", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "metastatic pancreatic adenocarcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-2202", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "parvovirus B19 in a Crohn's disease patient", "role": "Subject"}, {"name": "parvovirus B19", "role": "Subject.Disorder"}, {"name": "Leukopenia", "role": "Effect"}, {"name": "azathioprine", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "azathioprine", "role": "Treatment.Drug"}]}]}
{"id": "train-2203", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Fixed drug eruption of the scrotum", "role": "Effect"}, {"name": "methylphenidate", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-2204", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "cerebellar syndrome", "role": "Effect"}, {"name": "Cytarabine", "role": "Treatment"}, {"name": "Cytarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2205", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "glaucoma", "role": "Effect"}, {"name": "doxetaxel therapy for metastatic breast cancer", "role": "Treatment"}, {"name": "doxetaxel", "role": "Treatment.Drug"}, {"name": "metastatic breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2206", "event": [{"trigger": "induced and enhanced", "type": "adverse_event", "arguments": [{"name": "developing into generalized seizures", "role": "Effect"}, {"name": "Myoclonus", "role": "Effect"}, {"name": "L-dopa", "role": "Treatment"}, {"name": "L-dopa", "role": "Treatment.Drug"}]}]}
{"id": "train-2207", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "peripheral neuropathy", "role": "Effect"}, {"name": "CAP with concomitant radiation (XRT)", "role": "Treatment"}, {"name": "pancreatic cancer", "role": "Treatment.Disorder"}, {"name": "CAP", "role": "Treatment.Drug"}, {"name": "concomitant radiation", "role": "Treatment.Route"}]}]}
{"id": "train-2208", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "fibrosis, leading the patient", "role": "Subject"}, {"name": "peginterferon alfa-2a, ribavirin and boceprevir", "role": "Treatment"}, {"name": "fibrosis", "role": "Treatment.Disorder"}, {"name": "peginterferon alfa-2a", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "boceprevir", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}, {"name": "boceprevir", "role": "Combination.Drug"}, {"name": "peginterferon alfa-2a", "role": "Combination.Drug"}]}]}
{"id": "train-2209", "event": [{"trigger": "adverse effects", "type": "adverse_event", "arguments": [{"name": "neurotoxicity", "role": "Effect"}, {"name": "CAP", "role": "Treatment"}, {"name": "CAP", "role": "Treatment.Drug"}]}]}
{"id": "train-2210", "event": [{"trigger": "over-anticoagulation", "type": "adverse_event", "arguments": [{"name": "protracted diarrhea", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-2211", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "oral therapies", "role": "Treatment"}, {"name": "type 2 diabetes mellitus", "role": "Treatment.Disorder"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-2212", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "lung disease", "role": "Effect"}, {"name": "with histological features of bronchiolitis obliterans organising pneumonia (BOOP)", "role": "Effect"}, {"name": "the use of nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2213", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 57-year-old woman with right bundle branch block +LPH and ventricular premature contractions", "role": "Subject"}, {"name": "57-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "right bundle branch block +LPH", "role": "Subject.Disorder"}, {"name": "ventricular premature contractions", "role": "Subject.Disorder"}, {"name": "complete heart block (CHB)", "role": "Effect"}, {"name": "disopyramide phosphate (Norpace)", "role": "Treatment"}, {"name": "disopyramide phosphate", "role": "Treatment.Drug"}]}]}
{"id": "train-2214", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two women, aged 25 and 45", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "aged 25 and 45", "role": "Subject.Age"}, {"name": "acute myopia", "role": "Effect"}, {"name": "topiramate", "role": "Treatment"}, {"name": "topiramate", "role": "Treatment.Drug"}, {"name": "epilepsy", "role": "Treatment.Disorder"}]}]}
{"id": "train-2215", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "subacute", "role": "Effect"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2216", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "ARDS", "role": "Effect"}, {"name": "severe pulmonary symptoms", "role": "Effect"}, {"name": "infusion", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment"}, {"name": "infusion", "role": "Treatment.Route"}, {"name": "rituximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2217", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "Seven of the eight cases", "role": "Subject"}, {"name": "eight", "role": "Subject.Population"}, {"name": "acute leukemia", "role": "Effect"}, {"name": "Treosulfan", "role": "Treatment"}, {"name": "Treosulfan", "role": "Treatment.Drug"}, {"name": "ovarian cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2218", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "an elderly woman", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "SIADH", "role": "Effect"}, {"name": "Desipramine", "role": "Treatment"}, {"name": "Desipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-2219", "event": [{"trigger": "precipitate", "type": "adverse_event", "arguments": [{"name": "patients with Cushing's syndrome?", "role": "Subject"}, {"name": "pancreatitis", "role": "Effect"}, {"name": "propofol", "role": "Treatment"}, {"name": "propofol", "role": "Treatment.Drug"}, {"name": "Cushing's syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-2220", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "anaphylaxis", "role": "Effect"}, {"name": "5-FU", "role": "Treatment"}, {"name": "angiotensin converting enzyme inhibitors", "role": "Treatment"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "angiotensin converting enzyme inhibitors", "role": "Treatment.Drug"}, {"name": "angiotensin converting enzyme inhibitors", "role": "Combination.Drug"}, {"name": "5-FU", "role": "Combination.Drug"}]}]}
{"id": "train-2221", "event": [{"trigger": "stopping", "type": "potential_therapeutic_event", "arguments": [{"name": "indapamide, glucose tolerance impairing", "role": "Treatment"}, {"name": "glucose tolerance impairing", "role": "Treatment.Disorder"}, {"name": "indapamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2222", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "needle-track cutaneous seeding of hepatocellular carcinoma", "role": "Effect"}, {"name": "sonographically guided percutaneous ethanol injection", "role": "Treatment"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "ethanol", "role": "Treatment.Drug"}]}]}
{"id": "train-2223", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "birth defects", "role": "Effect"}, {"name": "Zidovudine", "role": "Treatment"}, {"name": "Zidovudine", "role": "Treatment.Drug"}]}]}
{"id": "train-2224", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with seropositive rheumatoid arthritis", "role": "Subject"}, {"name": "ascites", "role": "Effect"}, {"name": "taking weekly doses of methotrexate (MTX)", "role": "Treatment"}, {"name": "seropositive rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2225", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "healthy volunteers", "role": "Subject"}, {"name": "High incidence of adverse_events", "role": "Effect"}, {"name": "rifampicin and adjusted doses of lopinavir/ritonavir tablets", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}, {"name": "lopinavir", "role": "Treatment.Drug"}, {"name": "ritonavir", "role": "Treatment.Drug"}, {"name": "tablets", "role": "Treatment.Route"}, {"name": "adjusted doses", "role": "Treatment.Dosage"}, {"name": "rifampicin", "role": "Combination.Drug"}, {"name": "lopinavir", "role": "Combination.Drug"}, {"name": "ritonavir", "role": "Combination.Drug"}]}]}
{"id": "train-2226", "event": [{"trigger": "administration", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "TEN", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2227", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "pure red cell aplasia", "role": "Effect"}, {"name": "Zidovudine", "role": "Treatment"}, {"name": "Zidovudine", "role": "Treatment.Drug"}]}]}
{"id": "train-2228", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "A case", "role": "Subject"}, {"name": "recall pneumonitis", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2229", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypokalemia and its potential cardiac toxicity", "role": "Effect"}, {"name": "Albuterol", "role": "Treatment"}, {"name": "Albuterol", "role": "Treatment.Drug"}]}]}
{"id": "train-2230", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "monthly FU with low-dose LV", "role": "Treatment"}, {"name": "advanced colorectal cancer", "role": "Treatment.Disorder"}, {"name": "monthly", "role": "Treatment.Freq"}, {"name": "FU", "role": "Treatment.Drug"}, {"name": "LV", "role": "Treatment.Drug"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "FU", "role": "Combination.Drug"}, {"name": "LV", "role": "Combination.Drug"}]}]}
{"id": "train-2231", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "fulminant liver failure", "role": "Effect"}, {"name": "clarithromycin", "role": "Treatment"}, {"name": "clarithromycin", "role": "Treatment.Drug"}, {"name": "pneumonia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2232", "event": [{"trigger": "seen.", "type": "adverse_event", "arguments": [{"name": "2/1 S-A block", "role": "Effect"}, {"name": "propranolol", "role": "Treatment"}, {"name": "propranolol", "role": "Treatment.Drug"}]}]}
{"id": "train-2233", "event": [{"trigger": "a probable relationship", "type": "adverse_event", "arguments": [{"name": "in this infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "apnea", "role": "Effect"}, {"name": "lamotrigine through breast-feeding", "role": "Treatment"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "breast-feeding", "role": "Treatment.Route"}]}]}
{"id": "train-2234", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma", "role": "Effect"}, {"name": "temozolomide", "role": "Treatment"}, {"name": "temozolomide", "role": "Treatment.Drug"}]}]}
{"id": "train-2235", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thyrotoxicosis (AIT)", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2236", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a man with no risk factors for coronary heart disease", "role": "Subject"}, {"name": "man", "role": "Subject.Gender"}, {"name": "myocardial infarction", "role": "Effect"}, {"name": "chemotherapy containing etoposide", "role": "Treatment"}, {"name": "etoposide", "role": "Treatment.Drug"}]}]}
{"id": "train-2237", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "eosinophilic pneumonia reaction", "role": "Effect"}, {"name": "beclomethasone diproprionate inhaler", "role": "Treatment"}, {"name": "inhaler", "role": "Treatment.Route"}, {"name": "beclomethasone diproprionate", "role": "Treatment.Drug"}]}]}
{"id": "train-2238", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Nephrotic syndrome related to systemic lupus erythematosus", "role": "Effect"}, {"name": "griseofulvin", "role": "Treatment"}, {"name": "griseofulvin", "role": "Treatment.Drug"}]}]}
{"id": "train-2239", "event": [{"trigger": "mechanisms", "type": "adverse_event", "arguments": [{"name": "poisoning", "role": "Effect"}, {"name": "methanol", "role": "Treatment"}, {"name": "methanol", "role": "Treatment.Drug"}]}]}
{"id": "train-2240", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case of", "role": "Subject"}, {"name": "a 71-year-old man", "role": "Subject"}, {"name": "for pericardial effusion", "role": "Subject"}, {"name": "71-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "Kaposi's sarcoma (KS)", "role": "Effect"}, {"name": "6 months with corticosteroid therapy (prednisolone 25 mg/day)", "role": "Treatment"}, {"name": "6 months", "role": "Treatment.Duration"}, {"name": "25 mg/day", "role": "Treatment.Dosage"}, {"name": "prednisolone", "role": "Treatment.Drug"}, {"name": "pericardial effusion", "role": "Treatment.Disorder"}]}]}
{"id": "train-2241", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "a young boy with combined variable immunodeficiency syndrome", "role": "Subject"}, {"name": "young", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "acute myocardial ischemia", "role": "Effect"}, {"name": "severe allergic reaction", "role": "Effect"}, {"name": "acute epinephrine", "role": "Treatment"}, {"name": "intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously", "role": "Treatment"}, {"name": "epinephrine", "role": "Treatment.Drug"}, {"name": "immunoglobulin", "role": "Treatment.Drug"}, {"name": "combined variable immunodeficiency syndrome", "role": "Treatment.Disorder"}, {"name": "intravenously", "role": "Treatment.Route"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-2242", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Hong Kong Chinese", "role": "Subject"}, {"name": "Hong Kong Chinese", "role": "Subject.Race"}, {"name": "thyroid dysfunctions", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2243", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "Metaxalone", "role": "Treatment"}, {"name": "Metaxalone", "role": "Treatment.Drug"}]}]}
{"id": "train-2244", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "18.6% of patients", "role": "Subject"}, {"name": "18.6%", "role": "Subject.Population"}, {"name": "osteonecrosis of the jaw (BRONJ)", "role": "Effect"}, {"name": "intravenous bisphosphonates", "role": "Treatment"}, {"name": "Bisphosphonate", "role": "Treatment.Drug"}, {"name": "bisphosphonates", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-2245", "event": [{"trigger": "in", "type": "potential_therapeutic_event", "arguments": [{"name": "asthmatic children", "role": "Subject"}, {"name": "children", "role": "Subject.Age"}, {"name": "Growth and adrenal suppression", "role": "Effect"}, {"name": "high-dose fluticasone propionate", "role": "Treatment"}, {"name": "fluticasone propionate", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "asthmatic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2246", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lupus", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2247", "event": [{"trigger": "potential oral", "type": "potential_therapeutic_event", "arguments": [{"name": "rosiglitazone", "role": "Treatment"}, {"name": "rosiglitazone", "role": "Treatment.Drug"}, {"name": "type 2 diabetes-mellitus.", "role": "Treatment.Disorder"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-2248", "event": [{"trigger": "occur", "type": "adverse_event", "arguments": [{"name": "Neurotoxicity", "role": "Effect"}, {"name": "high-dose cytosine", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "cytosine", "role": "Treatment.Drug"}]}]}
{"id": "train-2249", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "phenytoin hypersensitivity", "role": "Effect"}, {"name": "fever, rash, and lymphadenopathy", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2250", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "urinary calculus during pregnancy", "role": "Effect"}, {"name": "Magnesium tocolysis", "role": "Treatment"}, {"name": "Magnesium", "role": "Treatment.Drug"}]}]}
{"id": "train-2251", "event": [{"trigger": "toxicity.", "type": "adverse_event", "arguments": [{"name": "toxicity", "role": "Effect"}, {"name": "Ocular ethambutol", "role": "Treatment"}, {"name": "Ocular", "role": "Treatment.Route"}, {"name": "ethambutol", "role": "Treatment.Drug"}]}]}
{"id": "train-2252", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Fatal intravascular autoimmune hemolytic anemia", "role": "Effect"}, {"name": "fludarabine treatment", "role": "Treatment"}, {"name": "fludarabine", "role": "Treatment.Drug"}, {"name": "chronic lymphocytic leukemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2253", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 74-year-old patient with idiopathic Parkinson's disease", "role": "Subject"}, {"name": "74-year-old", "role": "Subject.Age"}, {"name": "unintended sleep episodes", "role": "Effect"}, {"name": "long-term treatment with 400 mg/day of L-dopa", "role": "Treatment"}, {"name": "idiopathic Parkinson's disease", "role": "Treatment.Disorder"}, {"name": "400 mg/day", "role": "Treatment.Dosage"}, {"name": "L-dopa", "role": "Treatment.Drug"}, {"name": "long-term treatment", "role": "Treatment.Duration"}]}]}
{"id": "train-2254", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with seropositive rheumatoid arthritis (RA)", "role": "Subject"}, {"name": "Thrombotic thrombocytopenic purpura (TTP)", "role": "Effect"}, {"name": "2 1/2 months of treatment with penicillamine", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "penicillamine", "role": "Treatment.Drug"}, {"name": "2 1/2 months", "role": "Treatment.Duration"}]}]}
{"id": "train-2255", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "toxic epidermal necrolysis", "role": "Effect"}, {"name": "Phenolphthalein", "role": "Treatment"}, {"name": "Phenolphthalein", "role": "Treatment.Drug"}]}]}
{"id": "train-2256", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a 46-year-old woman", "role": "Subject"}, {"name": "46-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "delayed hypersensitivity reaction", "role": "Effect"}, {"name": "ethylenediamine", "role": "Treatment"}, {"name": "ethylenediamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2257", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "lethal side effects", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-2258", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Acute myocardial necrosis", "role": "Effect"}, {"name": "amsacrine", "role": "Treatment"}, {"name": "amsacrine", "role": "Treatment.Drug"}]}]}
{"id": "train-2259", "event": [{"trigger": "linked", "type": "adverse_event", "arguments": [{"name": "speech loss", "role": "Effect"}, {"name": "FK506", "role": "Treatment"}, {"name": "FK506", "role": "Treatment.Drug"}]}]}
{"id": "train-2260", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "pulmonary fibrosis", "role": "Effect"}, {"name": "1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy", "role": "Treatment"}, {"name": "1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)", "role": "Treatment.Drug"}]}]}
{"id": "train-2261", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "associated ulcers", "role": "Effect"}, {"name": "keratitis", "role": "Effect"}, {"name": "methamphetamine abuse", "role": "Treatment"}, {"name": "methamphetamine", "role": "Treatment"}, {"name": "methamphetamine", "role": "Treatment.Drug"}, {"name": "methamphetamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2262", "event": [{"trigger": "diagnosed", "type": "adverse_event", "arguments": [{"name": "MDS", "role": "Effect"}, {"name": "8.4 months after beginning TMZ", "role": "Treatment"}, {"name": "TMZ", "role": "Treatment.Drug"}, {"name": "8.4 months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2263", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Uveitis", "role": "Effect"}, {"name": "rifabutin therapy", "role": "Treatment"}, {"name": "rifabutin", "role": "Treatment.Drug"}]}]}
{"id": "train-2264", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "SJS", "role": "Effect"}, {"name": "acute onset of VBDS", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2265", "event": [{"trigger": "trigger", "type": "adverse_event", "arguments": [{"name": "MH", "role": "Effect"}, {"name": "cresol", "role": "Treatment"}, {"name": "cresol", "role": "Treatment.Drug"}]}]}
{"id": "train-2266", "event": [{"trigger": "adverse reaction.", "type": "adverse_event", "arguments": [{"name": "Neonatal", "role": "Subject"}, {"name": "Neonatal", "role": "Subject.Age"}, {"name": "Neonatal mydriasis", "role": "Effect"}, {"name": "lidocaine", "role": "Treatment"}, {"name": "lidocaine", "role": "Treatment.Drug"}]}]}
{"id": "train-2267", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Acute renal failure", "role": "Effect"}, {"name": "continuous povidone-iodine mediastinal irrigation", "role": "Treatment"}, {"name": "povidone", "role": "Treatment.Drug"}, {"name": "iodine", "role": "Treatment.Drug"}, {"name": "irrigation", "role": "Treatment.Route"}, {"name": "povidone", "role": "Combination.Drug"}, {"name": "iodine", "role": "Combination.Drug"}]}]}
{"id": "train-2268", "event": [{"trigger": "exacerbated", "type": "adverse_event", "arguments": [{"name": "the first case", "role": "Subject"}, {"name": "lupus", "role": "Effect"}, {"name": "nephrotic syndrome", "role": "Effect"}, {"name": "griseofulvin", "role": "Treatment"}, {"name": "griseofulvin", "role": "Treatment.Drug"}]}]}
{"id": "train-2269", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "CPM", "role": "Effect"}, {"name": "lithium toxicity", "role": "Effect"}, {"name": "blindness", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2270", "event": [{"trigger": "reaction", "type": "adverse_event", "arguments": [{"name": "A 71-year-old man", "role": "Subject"}, {"name": "71-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "bullous", "role": "Effect"}, {"name": "sulfonamide", "role": "Treatment"}, {"name": "sulfonamide", "role": "Treatment.Drug"}, {"name": "sulfacetamide sodium", "role": "Treatment.Drug"}]}]}
{"id": "train-2271", "event": [{"trigger": "undergoing", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "corneal ulcers", "role": "Effect"}, {"name": "oral colchicine therapy", "role": "Treatment"}, {"name": "colchicine", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}]}]}
{"id": "train-2272", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "vasculitis", "role": "Effect"}, {"name": "Vancomycin", "role": "Treatment"}, {"name": "Vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2273", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "C. difficile colitis", "role": "Effect"}, {"name": "cisplatin", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2274", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Nephrotic syndrome", "role": "Effect"}, {"name": "lithium therapy", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2275", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "2 patients", "role": "Subject"}, {"name": "2", "role": "Subject.Population"}, {"name": "polyarteritis nodosa", "role": "Effect"}, {"name": "vaccination against hepatitis B.", "role": "Treatment"}, {"name": "vaccination against hepatitis B.", "role": "Treatment.Drug"}]}]}
{"id": "train-2276", "event": [{"trigger": "where", "type": "adverse_event", "arguments": [{"name": "patients with underlying illnesses", "role": "Subject"}, {"name": "underlying illnesses", "role": "Subject.Disorder"}, {"name": "NSAID-induced ototoxicity could result in adverse otologic consequences", "role": "Effect"}, {"name": "ketorolac", "role": "Treatment"}, {"name": "ketorolac", "role": "Treatment.Drug"}]}]}
{"id": "train-2277", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Colitis", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2278", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "A 15-month-old girl with rhinopharyngitis", "role": "Subject"}, {"name": "15-month-old", "role": "Subject.Age"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "a nasal solution containing the imidazoline derivative naphazoline", "role": "Treatment"}, {"name": "rhinopharyngitis", "role": "Treatment.Disorder"}, {"name": "imidazoline derivative", "role": "Treatment.Drug"}, {"name": "naphazoline", "role": "Treatment.Route"}]}]}
{"id": "train-2279", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Three diabetic cases", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "acute dizziness", "role": "Effect"}, {"name": "initial administration of voglibose", "role": "Treatment"}, {"name": "voglibose", "role": "Treatment.Drug"}, {"name": "diabetic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2280", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "Fatal cold medication intoxication", "role": "Effect"}, {"name": "cold medication", "role": "Treatment"}, {"name": "cold medication", "role": "Treatment.Drug"}]}]}
{"id": "train-2281", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "necrotizing fasciitis", "role": "Effect"}, {"name": "sodium warfarin", "role": "Treatment"}, {"name": "sodium warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-2282", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "an elderly man", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "Marked QT prolongation and torsades de pointes secondary to acute ischemia", "role": "Effect"}, {"name": "dofetilide", "role": "Treatment"}, {"name": "dofetilide", "role": "Treatment.Drug"}, {"name": "atrial fibrillation", "role": "Treatment.Disorder"}]}]}
{"id": "train-2283", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "peripheral vasculopathy", "role": "Effect"}, {"name": "Methylphenidate and dextroamphetamine", "role": "Treatment"}, {"name": "dextroamphetamine", "role": "Treatment.Drug"}, {"name": "Methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-2284", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "severe hemodynamic deterioration", "role": "Effect"}, {"name": "systemic hypotension, pulmonary hypertension, and bronchoconstriction", "role": "Effect"}, {"name": "The reversal of heparin by protamine", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}, {"name": "protamine", "role": "Treatment.Drug"}, {"name": "heparin", "role": "Combination.Drug"}, {"name": "protamine", "role": "Combination.Drug"}]}]}
{"id": "train-2285", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "an infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "severe apnea", "role": "Effect"}, {"name": "exposed to lamotrigine through breast-feeding", "role": "Treatment"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "breast-feeding", "role": "Treatment.Route"}]}]}
{"id": "train-2286", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Hemodynamic collapse", "role": "Effect"}, {"name": "labetalol", "role": "Treatment"}, {"name": "labetalol", "role": "Treatment.Drug"}, {"name": "preeclampsia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2287", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "35-year old female", "role": "Subject"}, {"name": "35-year old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure", "role": "Effect"}, {"name": "treatment with a SGA", "role": "Treatment"}, {"name": "SGA", "role": "Treatment.Drug"}]}]}
{"id": "train-2288", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "renal failure due to cholesterol crystal embolization", "role": "Effect"}, {"name": "thrombolytic therapy with intravenous recombinant tissue-type plasminogen activator (t-PA)", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "recombinant tissue-type plasminogen activator", "role": "Treatment.Drug"}]}]}
{"id": "train-2289", "event": [{"trigger": "resolved", "type": "potential_therapeutic_event", "arguments": [{"name": "three albuterol inhalations", "role": "Treatment"}, {"name": "asthma", "role": "Treatment.Disorder"}, {"name": "three", "role": "Treatment.Dosage"}, {"name": "albuterol", "role": "Treatment.Drug"}, {"name": "within 24 hours", "role": "Treatment.Time_elapsed"}, {"name": "inhalations", "role": "Treatment.Route"}]}]}
{"id": "train-2290", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "two schizophrenic patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "schizophrenic", "role": "Subject.Disorder"}, {"name": "psychotic decompensations", "role": "Effect"}, {"name": "concomitant neuroleptic medication", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}, {"name": "neuroleptic", "role": "Treatment.Drug"}, {"name": "neuroleptic", "role": "Combination.Drug"}, {"name": "amantadine", "role": "Combination.Drug"}]}]}
{"id": "train-2291", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "fasting hypoglycemia", "role": "Effect"}, {"name": "disopyramide", "role": "Treatment"}, {"name": "disopyramide", "role": "Treatment.Drug"}]}]}
{"id": "train-2292", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "pemphigus", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-2293", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "hypersensitivity reaction", "role": "Effect"}, {"name": "one formulation of cyclosporine", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}]}]}
{"id": "train-2294", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "urticarial rash", "role": "Effect"}, {"name": "Enoxaparin", "role": "Treatment"}, {"name": "3 weeks following", "role": "Treatment.Time_elapsed"}, {"name": "Enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-2295", "event": [{"trigger": "related to", "type": "adverse_event", "arguments": [{"name": "Fatal toxic epidermal necrolysis", "role": "Effect"}, {"name": "lamotrigine administration", "role": "Treatment"}, {"name": "lamotrigine", "role": "Treatment.Drug"}]}]}
{"id": "train-2296", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "serotonin syndrome (SS)", "role": "Effect"}, {"name": "mirtazapine monotherapy", "role": "Treatment"}, {"name": "mirtazapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2297", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "essential hypertension patients", "role": "Subject"}, {"name": "diabetes", "role": "Effect"}, {"name": "indapamide", "role": "Treatment"}, {"name": "indapamide", "role": "Treatment.Drug"}, {"name": "essential hypertension", "role": "Treatment.Disorder"}]}]}
{"id": "train-2298", "event": [{"trigger": "preventing", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with nonmyeloid malignancies", "role": "Subject"}, {"name": "nonmyeloid malignancies", "role": "Subject.Disorder"}, {"name": "recombinant human interleukin-11 (rhIL-11, also known as oprelvekin [Neumega])", "role": "Treatment"}, {"name": "postchemotherapy platelet nadirs of < or = 20,000/microL", "role": "Treatment.Disorder"}, {"name": "recombinant human interleukin-11", "role": "Treatment.Drug"}]}]}
{"id": "train-2299", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with rheumatoid arthritis", "role": "Subject"}, {"name": "acute intrahepatic cholestasis", "role": "Effect"}, {"name": "100 mg of sodium aurothiomalate", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "100 mg", "role": "Treatment.Dosage"}, {"name": "sodium aurothiomalate", "role": "Treatment.Drug"}]}]}
{"id": "train-2300", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "colonic ulcer and the sigmoidovesical fistula", "role": "Effect"}, {"name": "calcium polystyrene sulfonate and sorbitol", "role": "Treatment"}, {"name": "calcium polystyrene sulfonate", "role": "Treatment.Drug"}, {"name": "sorbitol", "role": "Treatment.Drug"}, {"name": "sorbitol", "role": "Combination.Drug"}, {"name": "calcium polystyrene sulfonate", "role": "Combination.Drug"}]}]}
{"id": "train-2301", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "Rosiglitazone", "role": "Treatment"}, {"name": "a thiazolidinedione antidiabetic medication", "role": "Treatment"}, {"name": "Rosiglitazone", "role": "Treatment.Drug"}, {"name": "thiazolidinedione antidiabetic medication", "role": "Treatment.Drug"}, {"name": "Type 2 diabetes mellitus", "role": "Treatment.Disorder"}]}]}
{"id": "train-2302", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "Interstitial lung disease (ILD)", "role": "Effect"}, {"name": "therapy with the drug gefitinib", "role": "Treatment"}, {"name": "gefitinib", "role": "Treatment.Drug"}]}]}
{"id": "train-2303", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "tigecycline", "role": "Treatment"}, {"name": "tigecycline", "role": "Treatment.Drug"}]}]}
{"id": "train-2304", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "severe anemia", "role": "Effect"}, {"name": "IL-2 plus IFN-alpha", "role": "Treatment"}, {"name": "metastatic renal cell carcinoma", "role": "Treatment.Disorder"}, {"name": "IL-2", "role": "Treatment.Drug"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}, {"name": "IFN-alpha", "role": "Combination.Drug"}, {"name": "IL-2", "role": "Combination.Drug"}]}]}
{"id": "train-2305", "event": [{"trigger": "resolved", "type": "potential_therapeutic_event", "arguments": [{"name": "diphenhydramine", "role": "Treatment"}, {"name": "diphenhydramine", "role": "Treatment.Drug"}, {"name": "movements", "role": "Treatment.Disorder"}]}]}
{"id": "train-2306", "event": [{"trigger": "widen.", "type": "adverse_event", "arguments": [{"name": "lung injury", "role": "Effect"}, {"name": "nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2307", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "rhabdomyolysis and accompanying acute renal failure, along with acute hepatitis", "role": "Effect"}, {"name": "atorvastatin", "role": "Treatment"}, {"name": "diltiazem", "role": "Treatment"}, {"name": "atorvastatin", "role": "Treatment.Drug"}, {"name": "diltiazem", "role": "Treatment.Drug"}, {"name": "atorvastatin", "role": "Combination.Drug"}, {"name": "diltiazem", "role": "Combination.Drug"}]}]}
{"id": "train-2308", "event": [{"trigger": "attributed", "type": "adverse_event", "arguments": [{"name": "eight patients", "role": "Subject"}, {"name": "eight", "role": "Subject.Population"}, {"name": "visual field loss", "role": "Effect"}, {"name": "vigabatrin", "role": "Treatment"}, {"name": "vigabatrin", "role": "Treatment.Drug"}]}]}
{"id": "train-2309", "event": [{"trigger": "is", "type": "potential_therapeutic_event", "arguments": [{"name": "elderly patients with dementia", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "use of risperidone", "role": "Treatment"}, {"name": "risperidone", "role": "Treatment.Drug"}, {"name": "dementia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2310", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with metastatic melanoma", "role": "Subject"}, {"name": "desquamative skin rash", "role": "Effect"}, {"name": "Temozolomide", "role": "Treatment"}, {"name": "Temozolomide", "role": "Treatment.Drug"}, {"name": "metastatic melanoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-2311", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "calcium channel blockers", "role": "Treatment"}, {"name": "angina", "role": "Treatment.Disorder"}, {"name": "calcium channel blockers", "role": "Treatment.Drug"}]}]}
{"id": "train-2312", "event": [{"trigger": "attribute", "type": "adverse_event", "arguments": [{"name": "a young adolescent", "role": "Subject"}, {"name": "young adolescent", "role": "Subject.Age"}, {"name": "benign intracranial hypertension", "role": "Effect"}, {"name": "minocycline", "role": "Treatment"}, {"name": "minocycline", "role": "Treatment.Drug"}, {"name": "acne", "role": "Treatment.Disorder"}]}]}
{"id": "train-2313", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 10-year-old asthmatic boy", "role": "Subject"}, {"name": "10-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "urticarial rash and moderately severe bronchospasm", "role": "Effect"}, {"name": "8 weeks' treatment with disodium cromoglycate", "role": "Treatment"}, {"name": "8 weeks'", "role": "Treatment.Time_elapsed"}, {"name": "disodium cromoglycate", "role": "Treatment.Drug"}, {"name": "asthmatic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2314", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Panic anxiety", "role": "Effect"}, {"name": "abrupt discontinuation of mianserin", "role": "Treatment"}, {"name": "mianserin", "role": "Treatment.Drug"}]}]}
{"id": "train-2315", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "This case", "role": "Subject"}, {"name": "ILD", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-2316", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "drug interactions", "role": "Effect"}, {"name": "concomitant administration of CYP3A inhibitors with fentanyl", "role": "Treatment"}, {"name": "CYP3A inhibitors", "role": "Treatment.Drug"}, {"name": "fentanyl", "role": "Treatment.Drug"}, {"name": "CYP3A inhibitors", "role": "Combination.Drug"}, {"name": "fentanyl", "role": "Combination.Drug"}]}]}
{"id": "train-2317", "event": [{"trigger": "prophylaxis", "type": "potential_therapeutic_event", "arguments": [{"name": "newly transplanted renal allograft recipient", "role": "Subject"}, {"name": "transplanted renal allograft", "role": "Subject.Disorder"}, {"name": "safe, effective and well tolerated to prevent H1N1 influenza A virus infection", "role": "Effect"}, {"name": "oseltamivir", "role": "Treatment"}, {"name": "without any interaction with tacrolimus level", "role": "Treatment"}, {"name": "H1N1", "role": "Treatment.Disorder"}, {"name": "oseltamivir", "role": "Treatment.Drug"}, {"name": "tacrolimus", "role": "Treatment.Drug"}, {"name": "tacrolimus", "role": "Combination.Drug"}, {"name": "oseltamivir", "role": "Combination.Drug"}]}]}
{"id": "train-2318", "event": [{"trigger": "described", "type": "adverse_event", "arguments": [{"name": "in the pediatric population", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "Central nervous system (CNS) toxicity", "role": "Effect"}, {"name": "ifosfamide", "role": "Treatment"}, {"name": "ifosfamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2319", "event": [{"trigger": "consistent", "type": "adverse_event", "arguments": [{"name": "this case", "role": "Subject"}, {"name": "renal abnormalities", "role": "Effect"}, {"name": "IFNalpha therapy", "role": "Treatment"}, {"name": "IFNalpha", "role": "Treatment.Drug"}, {"name": "CML", "role": "Treatment.Disorder"}]}]}
{"id": "train-2320", "event": [{"trigger": "intoxication", "type": "adverse_event", "arguments": [{"name": "colchicine intoxication", "role": "Effect"}, {"name": "colchicine", "role": "Treatment"}, {"name": "colchicine", "role": "Treatment.Drug"}]}]}
{"id": "train-2321", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "terminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome", "role": "Effect"}, {"name": "the injection of 0.3 ml of 10% phenol-glycerine into the cervical subarachnoid space at the C4--C5 level", "role": "Treatment"}, {"name": "10% phenol-glycerine", "role": "Treatment.Drug"}, {"name": "severe right arm pain", "role": "Treatment.Disorder"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "cervical subarachnoid space at the C4--C5 level", "role": "Treatment.Route"}, {"name": "0.3 ml", "role": "Treatment.Dosage"}]}]}
{"id": "train-2322", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "myopathy", "role": "Effect"}, {"name": "Colchicine", "role": "Treatment"}, {"name": "Colchicine", "role": "Treatment.Drug"}, {"name": "renal failure", "role": "Treatment.Disorder"}]}]}
{"id": "train-2323", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "lung toxicity", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2324", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "NMS", "role": "Effect"}, {"name": "neuroleptic drugs", "role": "Treatment"}, {"name": "neuroleptic", "role": "Treatment.Drug"}]}]}
{"id": "train-2325", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "3 cases", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "Scleroderma", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2326", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome", "role": "Effect"}, {"name": "Linezolid", "role": "Treatment"}, {"name": "Linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-2327", "event": [{"trigger": "received", "type": "potential_therapeutic_event", "arguments": [{"name": "A 3-year-old boy diagnosed with acute lymphoblastic leukemia", "role": "Subject"}, {"name": "3-year-old", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "induction chemotherapy", "role": "Treatment"}, {"name": "acute lymphoblastic leukemia", "role": "Treatment.Disorder"}, {"name": "induction chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-2328", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "exacerbation of this preexisting low-grade chronic inflammation", "role": "Effect"}, {"name": "Interferon and other immunostimulatory medications", "role": "Treatment"}, {"name": "Interferon", "role": "Treatment.Drug"}]}]}
{"id": "train-2329", "event": [{"trigger": "enhance", "type": "adverse_event", "arguments": [{"name": "central nervous system toxicity", "role": "Effect"}, {"name": "Intravenous cytarabine and methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "cytarabine", "role": "Treatment.Drug"}, {"name": "Intravenous", "role": "Treatment.Route"}, {"name": "methotrexate", "role": "Combination.Drug"}, {"name": "cytarabine", "role": "Combination.Drug"}]}]}
{"id": "train-2330", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "neonates", "role": "Subject"}, {"name": "neonates", "role": "Subject.Age"}, {"name": "side effect", "role": "Effect"}, {"name": "lidocaine", "role": "Treatment"}, {"name": "lidocaine", "role": "Treatment.Drug"}]}]}
{"id": "train-2331", "event": [{"trigger": "a valid choice", "type": "potential_therapeutic_event", "arguments": [{"name": "patients for whom surgery is not possible", "role": "Subject"}, {"name": "Topical INF alpha 2-beta", "role": "Treatment"}, {"name": "CIN", "role": "Treatment.Disorder"}, {"name": "Topical", "role": "Treatment.Route"}, {"name": "INF alpha 2-beta", "role": "Treatment.Drug"}]}]}
{"id": "train-2332", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "3 patients", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "cutaneous vasculitis", "role": "Effect"}, {"name": "during antithyroid drug therapy", "role": "Treatment"}, {"name": "antithyroid", "role": "Treatment.Drug"}]}]}
{"id": "train-2333", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "depression and obsessive-compulsive disorder", "role": "Subject"}, {"name": "Prominent eye movements during NREM sleep and REM sleep behavior disorder", "role": "Effect"}, {"name": "fluoxetine treatment", "role": "Treatment"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "depression", "role": "Treatment.Disorder"}, {"name": "obsessive-compulsive disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-2334", "event": [{"trigger": "Allergic reaction", "type": "adverse_event", "arguments": [{"name": "eosinophilic gastroenteritis", "role": "Effect"}, {"name": "gemfibrozil", "role": "Treatment"}, {"name": "gemfibrozil", "role": "Treatment.Drug"}]}]}
{"id": "train-2335", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "chronic hepatitis C patients", "role": "Subject"}, {"name": "sarcoidosis", "role": "Effect"}, {"name": "interferon alpha and/or ribavirin", "role": "Treatment"}, {"name": "chronic hepatitis C", "role": "Treatment.Disorder"}, {"name": "interferon alpha", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}]}]}
{"id": "train-2336", "event": [{"trigger": "interact", "type": "adverse_event", "arguments": [{"name": "immunosuppressed organ transplant recipients", "role": "Subject"}, {"name": "immunosuppressed organ transplant", "role": "Subject.Disorder"}, {"name": "Azole antifungals", "role": "Treatment"}, {"name": "drug substrates of CYP3A4", "role": "Treatment"}, {"name": "severe infections", "role": "Treatment.Disorder"}, {"name": "Azole antifungals", "role": "Treatment.Drug"}, {"name": "drug substrates of CYP3A4", "role": "Treatment.Drug"}, {"name": "drug substrates of CYP3A4", "role": "Combination.Drug"}, {"name": "Azole antifungals", "role": "Combination.Drug"}]}]}
{"id": "train-2337", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a 5-year-old girl", "role": "Subject"}, {"name": "5-year-old", "role": "Subject.Age"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "bilateral vocal cord paralysis", "role": "Effect"}, {"name": "preoperative peritonsillar bupivacaine infiltration", "role": "Treatment"}, {"name": "bupivacaine", "role": "Treatment.Drug"}, {"name": "peritonsillar", "role": "Treatment.Route"}, {"name": "infiltration", "role": "Treatment.Route"}]}]}
{"id": "train-2338", "event": [{"trigger": "attributed", "type": "adverse_event", "arguments": [{"name": "One patient", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "coronary artery vasospasm", "role": "Effect"}, {"name": "topical 1:1000 epinephrine during surgery", "role": "Treatment"}, {"name": "1:1000", "role": "Treatment.Dosage"}, {"name": "epinephrine", "role": "Treatment.Drug"}]}]}
{"id": "train-2339", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "aseptic meningitis", "role": "Effect"}, {"name": "Trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "Trimethoprim-sulfamethoxazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2340", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient with metastatic prostate cancer", "role": "Subject"}, {"name": "nonoliguric renal failure", "role": "Effect"}, {"name": "suramin", "role": "Treatment"}, {"name": "suramin", "role": "Treatment.Drug"}, {"name": "metastatic prostate cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2341", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "this case", "role": "Subject"}, {"name": "acute icteric liver necro-inflammation", "role": "Effect"}, {"name": "gliclazide", "role": "Treatment"}, {"name": "gliclazide", "role": "Treatment.Drug"}]}]}
{"id": "train-2342", "event": [{"trigger": "After", "type": "adverse_event", "arguments": [{"name": "she", "role": "Subject"}, {"name": "she", "role": "Subject.Gender"}, {"name": "clinical symptoms and laboratory finding of Carbamazepine intoxication", "role": "Effect"}, {"name": "Oxybutynin concomitantly with an increase in the dose of Dantrolene", "role": "Treatment"}, {"name": "Carbamazepine", "role": "Treatment"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}, {"name": "Oxybutynin", "role": "Treatment.Drug"}, {"name": "Dantrolene", "role": "Treatment.Drug"}, {"name": "Oxybutynin", "role": "Combination.Drug"}, {"name": "Dantrolene", "role": "Combination.Drug"}]}]}
{"id": "train-2343", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "methotrexate overdosage was shown at 36 h after infusion", "role": "Effect"}, {"name": "severe renal failure", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2344", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "fixed drug eruption", "role": "Effect"}, {"name": "Ceftriaxone", "role": "Treatment"}, {"name": "Ceftriaxone", "role": "Treatment.Drug"}]}]}
{"id": "train-2345", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "20-year-old female with polyarteritis nodosa (PAN)", "role": "Subject"}, {"name": "20-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "bilateral sensorineural hearing loss", "role": "Effect"}, {"name": "30 mg of intravenous ketoralac", "role": "Treatment"}, {"name": "polyarteritis nodosa", "role": "Treatment.Disorder"}, {"name": "25 minutes after", "role": "Treatment.Time_elapsed"}, {"name": "30 mg", "role": "Treatment.Dosage"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "ketoralac", "role": "Treatment.Drug"}]}]}
{"id": "train-2346", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "an 82-year-old man", "role": "Subject"}, {"name": "82-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "ventricular tachycardia and Torsades de Pointes (TdP)", "role": "Effect"}, {"name": "oral administration of garenoxacin", "role": "Treatment"}, {"name": "pneumonia", "role": "Treatment.Disorder"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "garenoxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2347", "event": [{"trigger": "toxicity", "type": "adverse_event", "arguments": [{"name": "a newborn", "role": "Subject"}, {"name": "newborn", "role": "Subject.Age"}, {"name": "Lethargy", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2348", "event": [{"trigger": "on", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Simultaneous toxicities", "role": "Effect"}, {"name": "multiple anticonvulsants.", "role": "Treatment"}, {"name": "anticonvulsants", "role": "Treatment.Drug"}]}]}
{"id": "train-2349", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 71-year male with castration-resistant metastatic prostate cancer", "role": "Subject"}, {"name": "71-year", "role": "Subject.Age"}, {"name": "male", "role": "Subject.Gender"}, {"name": "significant eye irritation and dryness", "role": "Effect"}, {"name": "weekly docetaxel for 12 weeks", "role": "Treatment"}, {"name": "castration-resistant metastatic prostate cancer", "role": "Treatment.Disorder"}, {"name": "docetaxel", "role": "Treatment.Drug"}, {"name": "weekly", "role": "Treatment.Freq"}, {"name": "12 weeks", "role": "Treatment.Duration"}]}]}
{"id": "train-2350", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 31-year-old man with obsessive-compulsive disorder", "role": "Subject"}, {"name": "31-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "RBD", "role": "Effect"}, {"name": "which persisted at PSG study 19 months after fluoxetine discontinuation", "role": "Effect"}, {"name": "starting fluoxetine therapy", "role": "Treatment"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "soon after starting", "role": "Treatment.Time_elapsed"}, {"name": "obsessive-compulsive disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-2351", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "central nervous system and cardiovascular toxicity", "role": "Effect"}, {"name": "Propafenone", "role": "Treatment"}, {"name": "mirtazapine", "role": "Treatment"}, {"name": "mirtazapine", "role": "Treatment.Drug"}, {"name": "Propafenone", "role": "Treatment.Drug"}, {"name": "Propafenone", "role": "Combination.Drug"}, {"name": "mirtazapine", "role": "Combination.Drug"}]}]}
{"id": "train-2352", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "Neurotoxicity", "role": "Effect"}, {"name": "intrathecal administration of amphotericin B.", "role": "Treatment"}, {"name": "amphotericin B.", "role": "Treatment.Drug"}, {"name": "intrathecal", "role": "Treatment.Route"}]}]}
{"id": "train-2353", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "refractory seizures", "role": "Effect"}, {"name": "INH", "role": "Treatment"}, {"name": "INH", "role": "Treatment.Drug"}]}]}
{"id": "train-2354", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Rhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure", "role": "Effect"}, {"name": "lovastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor", "role": "Treatment"}, {"name": "lovastatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2355", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "newborns", "role": "Subject"}, {"name": "newborns", "role": "Subject.Age"}, {"name": "Thrombocytosis", "role": "Effect"}, {"name": "enoxaparin", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-2356", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "The spectrum of renal lesions occurring", "role": "Effect"}, {"name": "antituberculous therapy, particularly in association with rifampin", "role": "Treatment"}, {"name": "rifampin", "role": "Treatment.Drug"}, {"name": "antituberculous therapy", "role": "Treatment.Drug"}, {"name": "rifampin", "role": "Combination.Drug"}, {"name": "antituberculous therapy", "role": "Combination.Drug"}]}]}
{"id": "train-2357", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Native arterial thrombosis", "role": "Effect"}, {"name": "thrombin injection", "role": "Treatment"}, {"name": "thrombin", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-2358", "event": [{"trigger": "recurred", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "levetiracetam", "role": "Treatment"}, {"name": "levetiracetam", "role": "Treatment.Drug"}]}]}
{"id": "train-2359", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts", "role": "Effect"}, {"name": "tibolone and Hypericum perforatum (St. John's wort)", "role": "Treatment"}, {"name": "tibolone", "role": "Treatment.Drug"}, {"name": "Hypericum perforatum", "role": "Treatment.Drug"}]}]}
{"id": "train-2360", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "Five cases", "role": "Subject"}, {"name": "Five", "role": "Subject.Population"}, {"name": "contact dermatitis", "role": "Effect"}, {"name": "budesonide", "role": "Treatment"}, {"name": "budesonide", "role": "Treatment.Drug"}]}]}
{"id": "train-2361", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "calcium phosphate nephrolithiasis.", "role": "Effect"}, {"name": "acetazolamide", "role": "Treatment"}, {"name": "acetazolamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2362", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "a movement disorder", "role": "Effect"}, {"name": "Aripiprazole", "role": "Treatment"}, {"name": "OCD", "role": "Treatment.Disorder"}, {"name": "Aripiprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2363", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Gigantomastia", "role": "Effect"}, {"name": "bucillamine", "role": "Treatment"}, {"name": "bucillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2364", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "44% of patients", "role": "Subject"}, {"name": "Hypersensitivity", "role": "Effect"}, {"name": "carboplatin", "role": "Treatment"}, {"name": "after several courses of treatment", "role": "Treatment"}, {"name": "carboplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2365", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "reported case", "role": "Subject"}, {"name": "local hyperproduction of TNF-alpha from macrophages", "role": "Effect"}, {"name": "dedifferentiation of the adipocytes of the subcutaneous tissue", "role": "Effect"}, {"name": "injected insulin", "role": "Treatment"}, {"name": "injected", "role": "Treatment.Route"}, {"name": "insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-2366", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "seizures", "role": "Effect"}, {"name": "overdose", "role": "Treatment"}, {"name": "venlafaxine and trimipramine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "trimipramine", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-2367", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "five", "role": "Subject"}, {"name": "five", "role": "Subject.Population"}, {"name": "fever, infectious complications, gastrointestinal tract symptoms and severe myalgias", "role": "Effect"}, {"name": "chemotherapy", "role": "Treatment"}, {"name": "cytosine arabinoside (ARA-C)", "role": "Treatment"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}, {"name": "three-month", "role": "Treatment.Duration"}]}]}
{"id": "train-2368", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "lupus", "role": "Effect"}, {"name": "Infliximab", "role": "Treatment"}, {"name": "Infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2369", "event": [{"trigger": "subside", "type": "potential_therapeutic_event", "arguments": [{"name": "infection tended", "role": "Effect"}, {"name": "AMPH administration", "role": "Treatment"}, {"name": "AMPH", "role": "Treatment.Drug"}]}]}
{"id": "train-2370", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Acute drug induced hepatitis", "role": "Effect"}, {"name": "epidermal growth factor receptor (EGFR) inhibitors", "role": "Treatment"}, {"name": "epidermal growth factor receptor", "role": "Treatment.Drug"}, {"name": "inhibitors", "role": "Treatment.Drug"}]}]}
{"id": "train-2371", "event": [{"trigger": "received", "type": "adverse_event", "arguments": [{"name": "a patient with advanced non-small cell lung cancer", "role": "Subject"}, {"name": "pulmonary toxicity", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "advanced non-small cell lung cancer", "role": "Treatment.Disorder"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-2372", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with idiopathic RLS", "role": "Subject"}, {"name": "augmentation", "role": "Effect"}, {"name": "after 8 months of levodopa treatment", "role": "Treatment"}, {"name": "idiopathic RLS", "role": "Treatment.Disorder"}, {"name": "8 months", "role": "Treatment.Time_elapsed"}, {"name": "levodopa", "role": "Treatment.Drug"}]}]}
{"id": "train-2373", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Schneiderian first-rank symptoms", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2374", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "myocardial necrosis", "role": "Effect"}, {"name": "cardiotoxicity", "role": "Effect"}, {"name": "amsacrine", "role": "Treatment"}, {"name": "amsacrine", "role": "Treatment.Drug"}]}]}
{"id": "train-2375", "event": [{"trigger": "induction of", "type": "adverse_event", "arguments": [{"name": "mania", "role": "Effect"}, {"name": "treatment with alprazolam", "role": "Treatment"}, {"name": "alprazolam", "role": "Treatment.Drug"}]}]}
{"id": "train-2376", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "delayed pulmonary toxicity", "role": "Effect"}, {"name": "rituximab", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2377", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "acute renal failure", "role": "Effect"}, {"name": "anastrozole", "role": "Treatment"}, {"name": "anastrozole", "role": "Treatment.Drug"}]}]}
{"id": "train-2378", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "edema", "role": "Effect"}, {"name": "in both labia", "role": "Effect"}, {"name": "On the fifth day of tocolysis with magnesium sulfate, nifedipine, terbutaline and betamethasone", "role": "Treatment"}, {"name": "the fifth day", "role": "Treatment.Duration"}, {"name": "magnesium sulfate", "role": "Treatment.Drug"}, {"name": "nifedipine", "role": "Treatment.Drug"}, {"name": "terbutaline", "role": "Treatment.Drug"}, {"name": "betamethasone", "role": "Treatment.Drug"}, {"name": "magnesium sulfate", "role": "Combination.Drug"}, {"name": "nifedipine", "role": "Combination.Drug"}, {"name": "terbutaline", "role": "Combination.Drug"}, {"name": "betamethasone", "role": "Combination.Drug"}]}]}
{"id": "train-2379", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Two patients with extrinsic asthma and coexistent insulin-dependent diabetes mellitus", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "extrinsic asthma", "role": "Subject.Disorder"}, {"name": "insulin-dependent diabetes mellitus", "role": "Subject.Disorder"}, {"name": "anaphylactoid reaction", "role": "Effect"}, {"name": "intravenous administration of 50% solution of dextrose", "role": "Treatment"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "dextrose", "role": "Treatment.Drug"}]}]}
{"id": "train-2380", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Cardiac arrest", "role": "Effect"}, {"name": "esmolol", "role": "Treatment"}, {"name": "esmolol", "role": "Treatment.Drug"}]}]}
{"id": "train-2381", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "liver disease", "role": "Effect"}, {"name": "nicotinic acid", "role": "Treatment"}, {"name": "nicotinic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-2382", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "infectious endophthalmitis", "role": "Effect"}, {"name": "intravitreal injection of bevacizumab", "role": "Treatment"}, {"name": "2 days later", "role": "Treatment"}, {"name": "exudative age-related macular degeneration", "role": "Treatment.Disorder"}, {"name": "intravitreal injection", "role": "Treatment.Route"}, {"name": "bevacizumab", "role": "Treatment.Drug"}, {"name": "2 days later.", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2383", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "meningitis", "role": "Effect"}, {"name": "Ibuprofen", "role": "Treatment"}, {"name": "Ibuprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-2384", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "three cases", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "Tardive oculogyric crisis", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2385", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Myasthenia gravis", "role": "Effect"}, {"name": "low-dose IFN-alpha therapy", "role": "Treatment"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-2386", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "acute onset of nephrotic syndrome", "role": "Effect"}, {"name": "interferon-alpha", "role": "Treatment"}, {"name": "interferon-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2387", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with diabetic nephropathy", "role": "Subject"}, {"name": "diabetic nephropathy", "role": "Subject.Disorder"}, {"name": "hypoglycaemia", "role": "Effect"}, {"name": "Para-aminosalicylic acid", "role": "Treatment"}, {"name": "Para-aminosalicylic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-2388", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Ischaemia", "role": "Effect"}, {"name": "selfadministered intra-arterial injection of methylphenidate and diamorphine", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}, {"name": "diamorphine", "role": "Treatment.Drug"}, {"name": "intra-arterial injection", "role": "Treatment.Route"}, {"name": "methylphenidate", "role": "Combination.Drug"}, {"name": "diamorphine", "role": "Combination.Drug"}]}]}
{"id": "train-2389", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "cancer patients", "role": "Subject"}, {"name": "hemolytic uremic syndrome", "role": "Effect"}, {"name": "Mitomycin C", "role": "Treatment"}, {"name": "Mitomycin C", "role": "Treatment.Drug"}, {"name": "cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2390", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the third", "role": "Subject"}, {"name": "myopia", "role": "Effect"}, {"name": "metronidazole treatment", "role": "Treatment"}, {"name": "metronidazole", "role": "Treatment.Drug"}, {"name": "trichomonas vaginalis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2391", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute bilateral phrenic neuropathy", "role": "Effect"}, {"name": "adalimumab", "role": "Treatment"}, {"name": "adalimumab", "role": "Treatment.Drug"}]}]}
{"id": "train-2392", "event": [{"trigger": "occurred.", "type": "adverse_event", "arguments": [{"name": "gastrointestinal bleeding", "role": "Effect"}, {"name": "Hypoxemia improved during continuous tolazoline infusion", "role": "Treatment"}, {"name": "Hypoxemia", "role": "Treatment.Disorder"}, {"name": "tolazoline", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-2393", "event": [{"trigger": "used", "type": "potential_therapeutic_event", "arguments": [{"name": "NVP", "role": "Treatment"}, {"name": "Human Immunodeficiency Virus (HIV) infection", "role": "Treatment.Disorder"}, {"name": "NVP", "role": "Treatment.Drug"}]}]}
{"id": "train-2394", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 62-year-old Indian with diabetic nephropathy", "role": "Subject"}, {"name": "62-year-old", "role": "Subject.Age"}, {"name": "Indian", "role": "Subject.Race"}, {"name": "miliary tuberculosis", "role": "Effect"}, {"name": "metformin", "role": "Treatment"}, {"name": "diabetic nephropathy", "role": "Treatment.Disorder"}, {"name": "metformin", "role": "Treatment.Drug"}]}]}
{"id": "train-2395", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "A patient with acute esophageal variceal bleeding", "role": "Subject"}, {"name": "fatal rhabdomyolysis", "role": "Effect"}, {"name": "continuous intravenous infusion of vasopressin", "role": "Treatment"}, {"name": "continuous intravenous infusion", "role": "Treatment.Route"}, {"name": "vasopressin", "role": "Treatment.Drug"}, {"name": "acute esophageal variceal bleeding", "role": "Treatment.Disorder"}]}]}
{"id": "train-2396", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "diabetic, and particularly diabetic-allergic, individuals", "role": "Subject"}, {"name": "diabetic", "role": "Subject.Disorder"}, {"name": "diabetic-allergic", "role": "Subject.Disorder"}, {"name": "increased histamine release from blood cells", "role": "Effect"}, {"name": "higher concentrations of dextrose", "role": "Treatment"}, {"name": "dextrose", "role": "Treatment.Drug"}, {"name": "higher concentrations", "role": "Treatment.Dosage"}]}]}
{"id": "train-2397", "event": [{"trigger": "regarding", "type": "adverse_event", "arguments": [{"name": "All patients", "role": "Subject"}, {"name": "the signs and symptoms of muscle injury", "role": "Effect"}, {"name": "HMG-CoA reductase inhibitor", "role": "Treatment"}, {"name": "HMG-CoA reductase inhibitor", "role": "Treatment.Drug"}]}]}
{"id": "train-2398", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hyperthyroidism", "role": "Effect"}, {"name": "Graves' disease", "role": "Effect"}, {"name": "Interferon-alpha", "role": "Treatment"}, {"name": "Interferon-alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2399", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Acute severe intoxication", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-2400", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "anaphylaxis", "role": "Effect"}, {"name": "calcitonin", "role": "Treatment"}, {"name": "calcitonin", "role": "Treatment.Drug"}]}]}
{"id": "train-2401", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient with vascular age-related macular degeneration (AMD)", "role": "Subject"}, {"name": "transient structured visual hallucinations", "role": "Effect"}, {"name": "an intravitreal Avastin-injection", "role": "Treatment"}, {"name": "vascular age-related macular degeneration (AMD)", "role": "Treatment.Disorder"}, {"name": "Avastin", "role": "Treatment.Drug"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "injection", "role": "Treatment.Route"}]}]}
{"id": "train-2402", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "paralytic ileus", "role": "Effect"}, {"name": "Bortezomib", "role": "Treatment"}, {"name": "Bortezomib", "role": "Treatment.Drug"}]}]}
{"id": "train-2403", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "pulmonary toxicity", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "metastatic gallbladder adenocarcinoma", "role": "Treatment.Disorder"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2404", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "stroke", "role": "Effect"}, {"name": "arterial spasm", "role": "Effect"}, {"name": "ergotamine overdosage", "role": "Treatment"}, {"name": "ergotamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2405", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "visual loss", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}, {"name": "tuberculosis infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-2406", "event": [{"trigger": "using", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "Elevated International Normalized Ratio", "role": "Effect"}, {"name": "warfarin and vismodegib", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "vismodegib", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}, {"name": "vismodegib", "role": "Combination.Drug"}]}]}
{"id": "train-2407", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "IDDM", "role": "Effect"}, {"name": "interferon therapy", "role": "Treatment"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "chronic viral hepatitis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2408", "event": [{"trigger": "occurs", "type": "adverse_event", "arguments": [{"name": "certain population groups", "role": "Subject"}, {"name": "Pseudomembranous colitis", "role": "Effect"}, {"name": "trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}, {"name": "trimethoprim", "role": "Combination.Drug"}]}]}
{"id": "train-2409", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "contact dermatitis", "role": "Effect"}, {"name": "Budesonide", "role": "Treatment"}, {"name": "Budesonide", "role": "Treatment.Drug"}]}]}
{"id": "train-2410", "event": [{"trigger": "when", "type": "adverse_event", "arguments": [{"name": "most patients", "role": "Subject"}, {"name": "most", "role": "Subject.Population"}, {"name": "Hypertension", "role": "Effect"}, {"name": "after transplantation", "role": "Treatment"}, {"name": "immunosuppression is based on cyclosporine and prednisone", "role": "Treatment"}, {"name": "cyclosporine", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}]}]}
{"id": "train-2411", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "potassium loss", "role": "Effect"}, {"name": "hypokalemia", "role": "Effect"}, {"name": "phosphate", "role": "Treatment"}, {"name": "phosphate", "role": "Treatment.Drug"}]}]}
{"id": "train-2412", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "three patients with hepatitis C", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "Graves' disease", "role": "Subject.Disorder"}, {"name": "two successive phases of silent thyroiditis followed by hyperthryroidism relapse due to Graves' disease", "role": "Effect"}, {"name": "IFN-alpha and ribavirin", "role": "Treatment"}, {"name": "hepatitis C", "role": "Treatment.Disorder"}, {"name": "IFN-alpha", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}]}]}
{"id": "train-2413", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "case", "role": "Subject"}, {"name": "Hepatotoxicity", "role": "Effect"}, {"name": "choline magnesium trisalicylate", "role": "Treatment"}, {"name": "choline magnesium trisalicylate", "role": "Treatment.Drug"}]}]}
{"id": "train-2414", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "The 3 cases", "role": "Subject"}, {"name": "women with epilepsy", "role": "Subject"}, {"name": "3", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "reproductive endocrine disorders", "role": "Effect"}, {"name": "after the initiation of valproate therapy", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}, {"name": "epilepsy", "role": "Treatment.Disorder"}]}]}
{"id": "train-2415", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 43-year-old white man", "role": "Subject"}, {"name": "43-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "shallow erosion of a psoriatic plaque", "role": "Effect"}, {"name": "chronic administration of methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "psoriatic plaque", "role": "Treatment.Disorder"}, {"name": "chronic", "role": "Treatment.Duration"}]}]}
{"id": "train-2416", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "visual field loss", "role": "Effect"}, {"name": "hydroxychloroquine", "role": "Treatment"}, {"name": "hydroxychloroquine", "role": "Treatment.Drug"}]}]}
{"id": "train-2417", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with rheumatoid arthritis", "role": "Subject"}, {"name": "toxic epidermal necrolysis", "role": "Effect"}, {"name": "Leflunomide", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "Leflunomide", "role": "Treatment.Drug"}]}]}
{"id": "train-2418", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Delayed bowel injury", "role": "Effect"}, {"name": "chromic phosphate administration", "role": "Treatment"}, {"name": "chromic phosphate", "role": "Treatment.Drug"}]}]}
{"id": "train-2419", "event": [{"trigger": "was", "type": "adverse_event", "arguments": [{"name": "cornea cleared", "role": "Effect"}, {"name": "amantadine", "role": "Treatment"}, {"name": "amantadine", "role": "Treatment.Drug"}]}]}
{"id": "train-2420", "event": [{"trigger": "treating", "type": "potential_therapeutic_event", "arguments": [{"name": "parkinsonian patients", "role": "Subject"}, {"name": "parkinsonian", "role": "Subject.Disorder"}, {"name": "risperidone", "role": "Treatment"}, {"name": "psychosis", "role": "Treatment.Disorder"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-2421", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Spontaneous splenic infarction", "role": "Effect"}, {"name": "sumatriptan", "role": "Treatment"}, {"name": "sumatriptan", "role": "Treatment.Drug"}]}]}
{"id": "train-2422", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "Anaphylactoid reactions", "role": "Effect"}, {"name": "cisplatin", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2423", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a man", "role": "Subject"}, {"name": "man", "role": "Subject.Gender"}, {"name": "widespread skin rash, acute kidney injury, high-grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus-6 immunoglobulin G titer", "role": "Effect"}, {"name": "zonisamide for epilepsy", "role": "Treatment"}, {"name": "epilepsy", "role": "Treatment.Disorder"}, {"name": "zonisamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2424", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "toxicity", "role": "Effect"}, {"name": "cadmium, zinc, and cadmium/zinc mixtures at concentrations ranging from 10000 to 10 microg/l", "role": "Treatment"}, {"name": "from 10000 to 10 microg/l", "role": "Treatment.Dosage"}, {"name": "cadmium", "role": "Treatment.Drug"}, {"name": "zinc", "role": "Treatment.Drug"}, {"name": "cadmium", "role": "Treatment.Drug"}, {"name": "zinc", "role": "Treatment.Drug"}, {"name": "cadmium", "role": "Combination.Drug"}, {"name": "zinc", "role": "Combination.Drug"}]}]}
{"id": "train-2425", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "an elderly woman with a pre-existing history of ischaemic heart disease", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "ischaemic heart disease", "role": "Subject.Disorder"}, {"name": "acute myocardial ischaemia within the first week of treatment", "role": "Effect"}, {"name": "venlafaxine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "within the first week", "role": "Treatment.Duration"}]}]}
{"id": "train-2426", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "Vogt-Koyanagi-Harada disease", "role": "Effect"}, {"name": "4 months after the start of interferon alpha", "role": "Treatment"}, {"name": "4 months", "role": "Treatment.Time_elapsed"}, {"name": "interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2427", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "headache", "role": "Effect"}, {"name": "Capecitabine", "role": "Treatment"}, {"name": "Capecitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2428", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Serotonin syndrome", "role": "Effect"}, {"name": "concomitant treatment with linezolid and meperidine", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "meperidine", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "meperidine", "role": "Combination.Drug"}]}]}
{"id": "train-2429", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "hepatotoxic effects", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-2430", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "Acute", "role": "Effect"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "isoniazid", "role": "Treatment"}, {"name": "isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-2431", "event": [{"trigger": "inhibition", "type": "adverse_event", "arguments": [{"name": "a patient with systemic sclerosis", "role": "Subject"}, {"name": "vitro inhibition of hematopoiesis", "role": "Effect"}, {"name": "D-penicillamine", "role": "Treatment"}, {"name": "systemic sclerosis", "role": "Treatment.Disorder"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2432", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Rhabdomyolysis", "role": "Effect"}, {"name": "hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors when coadministered with agents that may inhibit their metabolism", "role": "Treatment"}, {"name": "hydroxymethylglutaryl coenzyme A", "role": "Treatment.Drug"}, {"name": "agents that may inhibit their metabolism", "role": "Treatment.Drug"}, {"name": "hydroxymethylglutaryl coenzyme A", "role": "Combination.Drug"}, {"name": "agents that may inhibit their metabolism", "role": "Combination.Drug"}]}]}
{"id": "train-2433", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A 55-year-old woman", "role": "Subject"}, {"name": "a skin abscess", "role": "Subject"}, {"name": "55-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "acute urticaria and labial angioedema", "role": "Effect"}, {"name": "ingesting 500 mg of cloxacillin", "role": "Treatment"}, {"name": "60 minutes", "role": "Treatment.Time_elapsed"}, {"name": "ingesting", "role": "Treatment.Route"}, {"name": "500 mg", "role": "Treatment.Dosage"}, {"name": "cloxacillin", "role": "Treatment.Drug"}, {"name": "skin abscess", "role": "Treatment.Disorder"}]}]}
{"id": "train-2434", "event": [{"trigger": "provoked", "type": "adverse_event", "arguments": [{"name": "Acne", "role": "Effect"}, {"name": "gold", "role": "Treatment"}, {"name": "gold", "role": "Treatment.Drug"}]}]}
{"id": "train-2435", "event": [{"trigger": "induce", "type": "adverse_event", "arguments": [{"name": "pulmonary injury", "role": "Effect"}, {"name": "Taxanes", "role": "Treatment"}, {"name": "Taxanes", "role": "Treatment.Drug"}]}]}
{"id": "train-2436", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "acute endophthalmitis", "role": "Effect"}, {"name": "intravitreal bevacizumab injection", "role": "Treatment"}, {"name": "intravitreal", "role": "Treatment.Route"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "bevacizumab", "role": "Treatment.Drug"}]}]}
{"id": "train-2437", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "a 54-year old female patient", "role": "Subject"}, {"name": "54-year old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "mild hypothermia", "role": "Effect"}, {"name": "risperidone", "role": "Treatment"}, {"name": "risperidone", "role": "Treatment.Drug"}, {"name": "schizophrenia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2438", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "neutropenia in liver transplantation", "role": "Effect"}, {"name": "Mycophenolate mofetil", "role": "Treatment"}, {"name": "Mycophenolate mofetil", "role": "Treatment.Drug"}]}]}
{"id": "train-2439", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "new brain lesions", "role": "Effect"}, {"name": "six weeks and 11 months of penicillamine therapy", "role": "Treatment"}, {"name": "six weeks and 11 months", "role": "Treatment.Duration"}, {"name": "penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2440", "event": [{"trigger": "found", "type": "adverse_event", "arguments": [{"name": "childhood nephrotic syndrome", "role": "Subject"}, {"name": "childhood", "role": "Subject.Age"}, {"name": "nephrotic syndrome", "role": "Subject.Disorder"}, {"name": "central nervous toxicity", "role": "Effect"}, {"name": "chlorambucil", "role": "Treatment"}, {"name": "chlorambucil", "role": "Treatment.Drug"}]}]}
{"id": "train-2441", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "TEN", "role": "Effect"}, {"name": "Administration of lamotrigine", "role": "Treatment"}, {"name": "with valproic acid", "role": "Treatment"}, {"name": "valproic acid", "role": "Treatment.Drug"}, {"name": "lamotrigine", "role": "Treatment.Drug"}, {"name": "valproic acid", "role": "Combination.Drug"}, {"name": "lamotrigine", "role": "Combination.Drug"}]}]}
{"id": "train-2442", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with no history of eyelid masses in the past", "role": "Subject"}, {"name": "Meibomian duct inflammation and blockage", "role": "Effect"}, {"name": "Docetaxel", "role": "Treatment"}, {"name": "Docetaxel", "role": "Treatment.Drug"}]}]}
{"id": "train-2443", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "recipient", "role": "Subject"}, {"name": "an exacerbation of Crohn's disease", "role": "Effect"}, {"name": "a TNF-alpha inhibitor", "role": "Treatment"}, {"name": "TNF-alpha inhibitor", "role": "Treatment.Drug"}]}]}
{"id": "train-2444", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Rhabdomyolysis", "role": "Effect"}, {"name": "intravenous vasopressin", "role": "Treatment"}, {"name": "vasopressin", "role": "Treatment.Drug"}]}]}
{"id": "train-2445", "event": [{"trigger": "Administration", "type": "adverse_event", "arguments": [{"name": "a patient with idiopathic pulmonary hypertension", "role": "Subject"}, {"name": "increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance", "role": "Effect"}, {"name": "intravenous nitroglycerin", "role": "Treatment"}, {"name": "idiopathic pulmonary hypertension", "role": "Treatment.Disorder"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "nitroglycerin", "role": "Treatment.Drug"}]}]}
{"id": "train-2446", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "increased libido", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2447", "event": [{"trigger": "interfere", "type": "adverse_event", "arguments": [{"name": "tacrolimus metabolism", "role": "Effect"}, {"name": "tacrolimus", "role": "Treatment"}, {"name": "Coadministration of antidepressant agents such as nefazodone, or any other drug that inhibits the CYP3A4 isoenzyme subfamily", "role": "Treatment"}, {"name": "tacrolimus", "role": "Treatment.Drug"}, {"name": "nefazodone", "role": "Treatment.Drug"}, {"name": "nefazodone", "role": "Combination.Drug"}, {"name": "tacrolimus", "role": "Combination.Drug"}]}]}
{"id": "train-2448", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "anaphylactoid reactions", "role": "Effect"}, {"name": "a high dose combined with a short infusion time", "role": "Treatment"}, {"name": "administration of intraperitoneal cisplatin", "role": "Treatment"}, {"name": "high dose", "role": "Treatment.Dosage"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "intraperitoneal", "role": "Treatment.Route"}]}]}
{"id": "train-2449", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lipoatrophy", "role": "Effect"}, {"name": "Human insulin", "role": "Treatment"}, {"name": "Human insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-2450", "event": [{"trigger": "from", "type": "adverse_event", "arguments": [{"name": "an infant boy who had a complicated illness with chronic bilateral subdural hematomas and sepsis.", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "boy", "role": "Subject.Gender"}, {"name": "Severe hepatotoxicity", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "phenobarbital", "role": "Treatment.Drug"}, {"name": "chronic bilateral subdural hematomas", "role": "Treatment.Disorder"}, {"name": "sepsis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2451", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Cholestatic liver disease with ductopenia (vanishing bile duct syndrome)", "role": "Effect"}, {"name": "clindamycin and trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "clindamycin", "role": "Treatment.Drug"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "clindamycin", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}, {"name": "trimethoprim", "role": "Combination.Drug"}]}]}
{"id": "train-2452", "event": [{"trigger": "leading", "type": "adverse_event", "arguments": [{"name": "severe and even potentially fatal toxicities", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "vincristine", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}, {"name": "vincristine", "role": "Treatment.Drug"}, {"name": "itraconazole", "role": "Combination.Drug"}, {"name": "vincristine", "role": "Combination.Drug"}]}]}
{"id": "train-2453", "event": [{"trigger": "occurrence", "type": "adverse_event", "arguments": [{"name": "tacrolimus nephrotoxicity", "role": "Effect"}, {"name": "tacrolimus", "role": "Treatment"}, {"name": "tacrolimus", "role": "Treatment.Drug"}]}]}
{"id": "train-2454", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "bicytopenia", "role": "Effect"}, {"name": "D-Pen", "role": "Treatment"}, {"name": "D-Pen", "role": "Treatment.Drug"}]}]}
{"id": "train-2455", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension", "role": "Subject"}, {"name": "poor kidney perfusion", "role": "Subject.Disorder"}, {"name": "lethal anuria", "role": "Effect"}, {"name": "ifosfamide", "role": "Treatment"}, {"name": "having received previous cisplatin chemotherapy", "role": "Treatment"}, {"name": "ifosfamide", "role": "Treatment.Drug"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "ifosfamide", "role": "Combination.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}]}]}
{"id": "train-2456", "event": [{"trigger": "administered", "type": "potential_therapeutic_event", "arguments": [{"name": "thiazide diuretics", "role": "Treatment"}, {"name": "polyuria", "role": "Treatment.Disorder"}, {"name": "nephrogenic diabetes insipidus", "role": "Treatment.Disorder"}, {"name": "thiazide diuretics", "role": "Treatment.Drug"}]}]}
{"id": "train-2457", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute renal failure with hyperkalemia", "role": "Effect"}, {"name": "renin inhibitor aliskiren", "role": "Treatment"}, {"name": "aliskiren", "role": "Treatment.Drug"}]}]}
{"id": "train-2458", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with hemiparesis", "role": "Subject"}, {"name": "hemiparesis", "role": "Subject.Disorder"}, {"name": "irreversible lithium-effectuated neurotoxicity (SILENT)", "role": "Effect"}, {"name": "lithium for a manic episode", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "manic episode", "role": "Treatment.Disorder"}]}]}
{"id": "train-2459", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "uveitis", "role": "Effect"}, {"name": "rifabutin therapy", "role": "Treatment"}, {"name": "rifabutin", "role": "Treatment.Drug"}]}]}
{"id": "train-2460", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "cutaneous vasculitis", "role": "Effect"}, {"name": "Propylthiouracil", "role": "Treatment"}, {"name": "Propylthiouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-2461", "event": [{"trigger": "prolong", "type": "adverse_event", "arguments": [{"name": "corrected QT interval but rarely cause torsade de pointes", "role": "Effect"}, {"name": "fluoroquinolone antimicrobials", "role": "Treatment"}, {"name": "fluoroquinolone", "role": "Treatment.Drug"}]}]}
{"id": "train-2462", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with mucositis", "role": "Subject"}, {"name": "mucositis", "role": "Subject.Disorder"}, {"name": "hyperkalemia", "role": "Effect"}, {"name": "Succinylcholine", "role": "Treatment"}, {"name": "Succinylcholine", "role": "Treatment.Drug"}]}]}
{"id": "train-2463", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "the first case", "role": "Subject"}, {"name": "gastric LPD", "role": "Effect"}, {"name": "MTX", "role": "Treatment"}, {"name": "MTX", "role": "Treatment.Drug"}, {"name": "MTX", "role": "Treatment.Drug"}]}]}
{"id": "train-2464", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient with acute myeloblastic leukemia (AML)", "role": "Subject"}, {"name": "nephrotic syndrome", "role": "Effect"}, {"name": "several courses of chemotherapy, including macrophage-colony-stimulating factor (M-CSF)", "role": "Treatment"}, {"name": "acute myeloblastic leukemia", "role": "Treatment.Disorder"}, {"name": "macrophage-colony-stimulating factor", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-2465", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hepatic veno-occlusive disease", "role": "Effect"}, {"name": "Actinomycin D", "role": "Treatment"}, {"name": "Actinomycin D", "role": "Treatment.Drug"}]}]}
{"id": "train-2466", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "nephrogenic diabetes insipidus and renal tubular acidosis", "role": "Effect"}, {"name": "foscarnet", "role": "Treatment"}, {"name": "foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-2467", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "acne fulminans", "role": "Effect"}, {"name": "13-cis-retinoic acid", "role": "Treatment"}, {"name": "13-cis-retinoic acid", "role": "Treatment.Drug"}, {"name": "cystic acne", "role": "Treatment.Disorder"}]}]}
{"id": "train-2468", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "proarrhythmic effect", "role": "Effect"}, {"name": "Verapamil", "role": "Treatment"}, {"name": "Verapamil", "role": "Treatment.Drug"}, {"name": "paroxysmal supraventricular tachycardia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2469", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "zonisamide", "role": "Treatment"}, {"name": "zonisamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2470", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "patients with diabetes mellitus or chronic renal insufficiency", "role": "Subject"}, {"name": "diabetes mellitus", "role": "Subject.Disorder"}, {"name": "chronic renal insufficiency", "role": "Subject.Disorder"}, {"name": "hyperkalemia", "role": "Effect"}, {"name": "low-dose heparin, within seven days of initiating heparin therapy", "role": "Treatment"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "heparin", "role": "Treatment.Drug"}, {"name": "within seven days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2471", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient infected with HIV", "role": "Subject"}, {"name": "anaemia and bone marrow aplasia", "role": "Effect"}, {"name": "Zidovudine", "role": "Treatment"}, {"name": "Zidovudine", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}]}]}
{"id": "train-2472", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "adult Crohn's disease patient", "role": "Subject"}, {"name": "adult", "role": "Subject.Age"}, {"name": "a parvovirus B19 infection and leukopenia", "role": "Effect"}, {"name": "long-term AZA therapy", "role": "Treatment"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}, {"name": "AZA", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-2473", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "papular eruption in psoriasis", "role": "Effect"}, {"name": "cutaneous vasculitis in collagen vascular disease", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2474", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two postmenopausal women", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "uterine enlargement and intermittent spotting", "role": "Effect"}, {"name": "tamoxifen and progestational", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "breast carcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-2475", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Tumor lysis syndrome", "role": "Effect"}, {"name": "transcatheter arterial infusion of cisplatin and embolization", "role": "Treatment"}, {"name": "liver metastases of melanoma", "role": "Treatment.Disorder"}, {"name": "transcatheter arterial infusion", "role": "Treatment.Route"}, {"name": "cisplatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2476", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Eosinophilia and Systemic Symptoms (DRESS)", "role": "Effect"}, {"name": "Oxcarbazepine", "role": "Treatment"}, {"name": "Oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-2477", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "patients with Wilson's disease", "role": "Subject"}, {"name": "Worsening of neurologic syndrome", "role": "Effect"}, {"name": "penicillamine therapy", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}, {"name": "Wilson's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2478", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Patient A", "role": "Subject"}, {"name": "right leg weakness", "role": "Effect"}, {"name": "week 4 of CAP-XRT (1600 mg/m2)", "role": "Treatment"}, {"name": "week 4", "role": "Treatment.Duration"}, {"name": "CAP-XRT", "role": "Treatment.Drug"}, {"name": "1600 mg/m2", "role": "Treatment.Dosage"}]}]}
{"id": "train-2479", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "hypersensitivity drug reaction", "role": "Effect"}, {"name": "which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein-losing enteropathy, myositis, and nephritis", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-2480", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "asthma", "role": "Effect"}, {"name": "aspirin", "role": "Treatment"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-2481", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "pancreatitis, including abdominal pain", "role": "Effect"}, {"name": "tigecycline", "role": "Treatment"}, {"name": "tigecycline", "role": "Treatment.Drug"}]}]}
{"id": "train-2482", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "lichenoid eruption", "role": "Effect"}, {"name": "the initiation of salsalate", "role": "Treatment"}, {"name": "initiation", "role": "Treatment.Duration"}, {"name": "salsalate", "role": "Treatment.Drug"}, {"name": "arthritic pain", "role": "Treatment.Disorder"}]}]}
{"id": "train-2483", "event": [{"trigger": "administration", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "NMS", "role": "Effect"}, {"name": "lithium", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "lithium", "role": "Combination.Drug"}, {"name": "olanzapine", "role": "Combination.Drug"}]}]}
{"id": "train-2484", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "an 87-year-old white woman with myasthenia gravis", "role": "Subject"}, {"name": "87-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "nausea, shortness of breath, azotemia, and hyperkalemia", "role": "Effect"}, {"name": "intravenous immunoglobulin", "role": "Treatment"}, {"name": "immunoglobulin", "role": "Treatment.Drug"}, {"name": "myasthenia gravis", "role": "Treatment.Disorder"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-2485", "event": [{"trigger": "discontinued", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "adverse effects", "role": "Effect"}, {"name": "Linezolid", "role": "Treatment"}, {"name": "Linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-2486", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Symptomatic visual field constriction", "role": "Effect"}, {"name": "vigabatrin", "role": "Treatment"}, {"name": "vigabatrin", "role": "Treatment.Drug"}]}]}
{"id": "train-2487", "event": [{"trigger": "adverse_events", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "Clinically significant", "role": "Effect"}, {"name": "interaction between quetiapine and atazanavir-ritonavir", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}, {"name": "atazanavir-ritonavir", "role": "Treatment.Drug"}, {"name": "quetiapine", "role": "Combination.Drug"}, {"name": "atazanavir-ritonavir", "role": "Combination.Drug"}]}]}
{"id": "train-2488", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "fixed drug eruption", "role": "Effect"}, {"name": "methylphenidate", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-2489", "event": [{"trigger": "indicated", "type": "potential_therapeutic_event", "arguments": [{"name": "Linezolid", "role": "Treatment"}, {"name": "serious gram-positive infections", "role": "Treatment.Disorder"}, {"name": "Linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-2490", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "pediatric patients aged 16 years and younger", "role": "Subject"}, {"name": "16 years and younger", "role": "Subject.Age"}, {"name": "pediatric", "role": "Subject.Disorder"}, {"name": "angioedema", "role": "Effect"}, {"name": "oxcarbazepine", "role": "Treatment"}, {"name": "oxcarbazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-2491", "event": [{"trigger": "abnormal", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "abnormal liver function", "role": "Effect"}, {"name": "receiving high doses of cyproterone acetate", "role": "Treatment"}, {"name": "cyproterone acetate", "role": "Treatment.Drug"}, {"name": "high doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-2492", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "six cases", "role": "Subject"}, {"name": "six", "role": "Subject.Population"}, {"name": "CT scans did not return to their original state", "role": "Effect"}, {"name": "ACTH", "role": "Treatment"}, {"name": "ACTH", "role": "Treatment.Drug"}]}]}
{"id": "train-2493", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "membranous nephropathy", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2494", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Thrombotic thrombocytopenic purpura", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2495", "event": [{"trigger": "control", "type": "potential_therapeutic_event", "arguments": [{"name": "a patient allergic to both NPH and regular insulin", "role": "Subject"}, {"name": "desensitization to NPH insulin, as well as standard insulin desensitization", "role": "Treatment"}, {"name": "allergic symptoms in a patient allergic to both NPH and regular insulin", "role": "Treatment.Disorder"}, {"name": "NPH insulin", "role": "Treatment.Drug"}, {"name": "standard insulin", "role": "Treatment.Drug"}, {"name": "desensitization", "role": "Treatment.Route"}, {"name": "desensitization", "role": "Treatment.Route"}, {"name": "NPH insulin", "role": "Combination.Drug"}, {"name": "standard insulin", "role": "Combination.Drug"}]}]}
{"id": "train-2496", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 24-year-old black woman", "role": "Subject"}, {"name": "24-year-old", "role": "Subject.Age"}, {"name": "black", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "Fulminant hepatic failure", "role": "Effect"}, {"name": "propylthiouracil and propranolol", "role": "Treatment"}, {"name": "propylthiouracil", "role": "Treatment.Drug"}, {"name": "propranolol", "role": "Treatment.Drug"}, {"name": "hyperthyroidism", "role": "Treatment.Disorder"}, {"name": "propranolol", "role": "Combination.Drug"}, {"name": "propylthiouracil", "role": "Combination.Drug"}]}]}
{"id": "train-2497", "event": [{"trigger": "observed", "type": "adverse_event", "arguments": [{"name": "mental nerve neuropathy", "role": "Effect"}, {"name": "hepatitis B vaccination", "role": "Treatment"}, {"name": "hepatitis B vaccination", "role": "Treatment.Drug"}]}]}
{"id": "train-2498", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Acute coronary events", "role": "Effect"}, {"name": "cisplatin-based chemotherapy", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-2499", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "peripheral neuropathy", "role": "Effect"}, {"name": "CAP", "role": "Treatment"}]}]}
{"id": "train-2500", "event": [{"trigger": "switching", "type": "adverse_event", "arguments": [{"name": "a pseudophakic patient", "role": "Subject"}, {"name": "case of angiographically documented cystoid macula edema", "role": "Effect"}, {"name": "from latanoprost to bimatoprost.", "role": "Treatment"}, {"name": "latanoprost", "role": "Treatment.Drug"}, {"name": "bimatoprost", "role": "Treatment.Drug"}, {"name": "pseudophakic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2501", "event": [{"trigger": "identical", "type": "adverse_event", "arguments": [{"name": "maculopathy", "role": "Effect"}, {"name": "chloroquine and hydroxychloroquine", "role": "Treatment"}, {"name": "chloroquine", "role": "Treatment.Drug"}, {"name": "hydroxychloroquine", "role": "Treatment.Drug"}]}]}
{"id": "train-2502", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "signs and symptoms of hepatotoxicity", "role": "Effect"}, {"name": "enoxaparin every 12 hours", "role": "Treatment"}, {"name": "after the second dose", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}, {"name": "every 12 hours", "role": "Treatment.Freq"}, {"name": "the second dose.", "role": "Treatment.Dosage"}]}]}
{"id": "train-2503", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "liver damage", "role": "Effect"}, {"name": "Danazol", "role": "Treatment"}, {"name": "Danazol", "role": "Treatment.Drug"}, {"name": "fibrocystic breast disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2504", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "hypophosphatemic osteomalacia", "role": "Effect"}, {"name": "Antacid and sucralfate", "role": "Treatment"}, {"name": "sucralfate", "role": "Treatment.Drug"}, {"name": "Antacid", "role": "Treatment.Drug"}]}]}
{"id": "train-2505", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "cholestatic hepatitis", "role": "Effect"}, {"name": "senna", "role": "Treatment"}, {"name": "senna", "role": "Treatment.Drug"}]}]}
{"id": "train-2506", "event": [{"trigger": "responsible", "type": "adverse_event", "arguments": [{"name": "Five patients", "role": "Subject"}, {"name": "Five", "role": "Subject.Population"}, {"name": "acute renal failure", "role": "Effect"}, {"name": "gentamicin sulfate", "role": "Treatment"}, {"name": "gentamicin sulfate", "role": "Treatment.Drug"}]}]}
{"id": "train-2507", "event": [{"trigger": "under", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "neuropathic side effects", "role": "Effect"}, {"name": "thalidomide therapy", "role": "Treatment"}, {"name": "thalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-2508", "event": [{"trigger": "demonstrated", "type": "adverse_event", "arguments": [{"name": "marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with painful dysesthesia", "role": "Effect"}, {"name": "levodopa", "role": "Treatment"}, {"name": "levodopa", "role": "Treatment.Drug"}]}]}
{"id": "train-2509", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "four patients with spinal cord injury", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "Antibiotic-associated colitis (pseudomembranous colitis)", "role": "Effect"}, {"name": "oral trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "spinal cord injury", "role": "Treatment.Disorder"}, {"name": "trimethoprim", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}]}]}
{"id": "train-2510", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 27-year-old Indian woman", "role": "Subject"}, {"name": "27-year-old", "role": "Subject.Age"}, {"name": "Indian", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "maculopapular rash and angioedema", "role": "Effect"}, {"name": "carbamazepine administration", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "administration", "role": "Treatment.Route"}]}]}
{"id": "train-2511", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "aseptic meningitis", "role": "Effect"}, {"name": "TMP/SMX", "role": "Treatment"}, {"name": "TMP", "role": "Treatment.Drug"}, {"name": "SMX", "role": "Treatment.Drug"}, {"name": "SMX", "role": "Combination.Drug"}, {"name": "TMP", "role": "Combination.Drug"}]}]}
{"id": "train-2512", "event": [{"trigger": "onset", "type": "adverse_event", "arguments": [{"name": "HUS", "role": "Effect"}, {"name": "7.4 +/- 3.5 months, or 21.9 +/- 10.9 doses of gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "7.4 +/- 3.5 months", "role": "Treatment.Time_elapsed"}, {"name": "21.9 +/- 10.9 doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-2513", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "TC development", "role": "Effect"}, {"name": "Aluminum intoxication", "role": "Treatment"}, {"name": "Aluminum", "role": "Treatment.Drug"}]}]}
{"id": "train-2514", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Agranulocytosis", "role": "Effect"}, {"name": "clozapine therapy", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2515", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "anterior subcapsular opacity on the lens", "role": "Effect"}, {"name": "finasteride", "role": "Treatment"}, {"name": "finasteride", "role": "Treatment.Drug"}]}]}
{"id": "train-2516", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "cranial dystonia", "role": "Effect"}, {"name": "trihexyphenidyl withdrawal", "role": "Treatment"}, {"name": "trihexyphenidyl", "role": "Treatment.Drug"}]}]}
{"id": "train-2517", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "infants with supraventricular tachycardia and congestive cardiac failure", "role": "Subject"}, {"name": "congestive cardiac failure", "role": "Subject.Disorder"}, {"name": "infants", "role": "Subject.Age"}, {"name": "cardiac decompensation", "role": "Effect"}, {"name": "verapamil", "role": "Treatment"}, {"name": "verapamil", "role": "Treatment.Drug"}, {"name": "supraventricular tachycardia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2518", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a 27-year-old man with acute leukemia", "role": "Subject"}, {"name": "acute leukemia", "role": "Subject.Disorder"}, {"name": "27-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "serotonin syndrome", "role": "Effect"}, {"name": "concomitant use of linezolid and meperidine", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "meperidine", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "meperidine", "role": "Combination.Drug"}]}]}
{"id": "train-2519", "event": [{"trigger": "reduce", "type": "adverse_event", "arguments": [{"name": "patients with primary hypothyroidism", "role": "Subject"}, {"name": "primary hypothyroidism", "role": "Subject.Disorder"}, {"name": "reduce the gastrointestinal absorption of orally administered levothyroxine sodium", "role": "Effect"}, {"name": "ferrous sulfate", "role": "Treatment"}, {"name": "orally administered levothyroxine sodium", "role": "Treatment"}, {"name": "ferrous sulfate", "role": "Treatment.Drug"}, {"name": "levothyroxine sodium", "role": "Treatment.Drug"}, {"name": "orally", "role": "Treatment.Route"}, {"name": "ferrous sulfate", "role": "Combination.Drug"}, {"name": "levothyroxine sodium", "role": "Combination.Drug"}]}]}
{"id": "train-2520", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a toddler", "role": "Subject"}, {"name": "toddler", "role": "Subject.Age"}, {"name": "cardiovascular and neurological depression", "role": "Effect"}, {"name": "oxymetalzoline", "role": "Treatment"}, {"name": "oxymetalzoline", "role": "Treatment.Drug"}]}]}
{"id": "train-2521", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "priapism", "role": "Effect"}, {"name": "heparin", "role": "Treatment"}, {"name": "heparin", "role": "Treatment.Drug"}]}]}
{"id": "train-2522", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Posterior leukoencephalopathy", "role": "Effect"}, {"name": "cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary", "role": "Treatment"}, {"name": "germ cell tumor of the ovary", "role": "Treatment.Disorder"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "vinblastine", "role": "Treatment.Drug"}, {"name": "vinblastine", "role": "Combination.Drug"}, {"name": "bleomycin", "role": "Combination.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}]}]}
{"id": "train-2523", "event": [{"trigger": "case", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "cutaneous and hematologic toxicity", "role": "Effect"}, {"name": "IL-2", "role": "Treatment"}, {"name": "IL-2", "role": "Treatment.Drug"}]}]}
{"id": "train-2524", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "hypersensitivity pneumonitis", "role": "Effect"}, {"name": "Flecainide", "role": "Treatment"}, {"name": "Flecainide", "role": "Treatment.Drug"}]}]}
{"id": "train-2525", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "headache", "role": "Effect"}, {"name": "capecitabine", "role": "Treatment"}, {"name": "capecitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2526", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "biopsy-proven acute tubulointerstitial nephritis", "role": "Effect"}, {"name": "a second course of flurbiprofen", "role": "Treatment"}, {"name": "flurbiprofen", "role": "Treatment.Drug"}, {"name": "second course", "role": "Treatment.Freq"}]}]}
{"id": "train-2527", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "few cases", "role": "Subject"}, {"name": "scleroderma", "role": "Effect"}, {"name": "bleomycin", "role": "Treatment"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2528", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 74-year-old man", "role": "Subject"}, {"name": "74-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "loss of consciousness", "role": "Effect"}, {"name": "oral administration of pilsicainide", "role": "Treatment"}, {"name": "two days later", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "pilsicainide", "role": "Treatment.Drug"}, {"name": "paroxysmal atrial fibrillation", "role": "Treatment.Disorder"}, {"name": "two days later", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2529", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "breast cancer patient", "role": "Subject"}, {"name": "with normal transvaginal ultrasonography", "role": "Subject"}, {"name": "Aggressive endometrial carcinoma", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "breast cancer", "role": "Treatment.Disorder"}, {"name": "tamoxifen", "role": "Treatment.Drug"}]}]}
{"id": "train-2530", "event": [{"trigger": "include", "type": "adverse_event", "arguments": [{"name": "the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-2531", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "ischaemic events", "role": "Effect"}, {"name": "venlafaxine treatment", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-2532", "event": [{"trigger": "response", "type": "adverse_event", "arguments": [{"name": "ductal closure", "role": "Effect"}, {"name": "indomethacin exposure", "role": "Treatment"}, {"name": "indomethacin", "role": "Treatment.Drug"}, {"name": "exposure", "role": "Treatment.Route"}]}]}
{"id": "train-2533", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "renal toxicity", "role": "Effect"}, {"name": "tobramycin", "role": "Treatment"}, {"name": "tobramycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2534", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "severe human", "role": "Effect"}, {"name": "lipoatrophy", "role": "Effect"}, {"name": "insulin", "role": "Treatment"}, {"name": "insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-2535", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "a unique autopsy case", "role": "Subject"}, {"name": "hepatocellular carcinoma", "role": "Effect"}, {"name": "diethylstilbestrol (DES)", "role": "Treatment"}, {"name": "prostatic cancer", "role": "Treatment.Disorder"}, {"name": "diethylstilbestrol", "role": "Treatment.Drug"}]}]}
{"id": "train-2536", "event": [{"trigger": "for", "type": "potential_therapeutic_event", "arguments": [{"name": "Argatroban", "role": "Treatment"}, {"name": "hepato-renal failure", "role": "Treatment.Disorder"}, {"name": "Argatroban", "role": "Treatment.Drug"}]}]}
{"id": "train-2537", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "two elderly patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "Falling backward", "role": "Effect"}, {"name": "bupropion", "role": "Treatment"}, {"name": "bupropion", "role": "Treatment.Drug"}]}]}
{"id": "train-2538", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Three patients", "role": "Subject"}, {"name": "Three", "role": "Subject.Population"}, {"name": "liver injury", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2539", "event": [{"trigger": "normalized", "type": "potential_therapeutic_event", "arguments": [{"name": "all five patients", "role": "Subject"}, {"name": "five", "role": "Subject.Population"}, {"name": "cessation of linezolid", "role": "Treatment"}, {"name": "bone marrow depression", "role": "Treatment.Disorder"}, {"name": "linezolid", "role": "Treatment.Drug"}]}]}
{"id": "train-2540", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "interstitial pneumonitis", "role": "Effect"}, {"name": "fludarabine", "role": "Treatment"}, {"name": "fludarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2541", "event": [{"trigger": "after", "type": "potential_therapeutic_event", "arguments": [{"name": "a case of severe hydroxychloroquine retinopathy", "role": "Subject"}, {"name": "Normalization of generalized retinal function and progression of maculopathy", "role": "Effect"}, {"name": "cessation of therapy", "role": "Treatment"}, {"name": "hydroxychloroquine", "role": "Treatment"}, {"name": "hydroxychloroquine", "role": "Treatment.Drug"}, {"name": "hydroxychloroquine retinopathy", "role": "Treatment.Disorder"}, {"name": "19 years", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2542", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychosis", "role": "Effect"}, {"name": "Interferon", "role": "Treatment"}, {"name": "Interferon", "role": "Treatment.Drug"}, {"name": "hepatitis C", "role": "Treatment.Disorder"}]}]}
{"id": "train-2543", "event": [{"trigger": "described", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Prolongation of the QT interval and ventricular tachyarrhymias", "role": "Effect"}, {"name": "amiodarone therapy", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2544", "event": [{"trigger": "augmentation", "type": "potential_therapeutic_event", "arguments": [{"name": "Aripiprazole", "role": "Treatment"}, {"name": "5 mg daily", "role": "Treatment"}, {"name": "OCD", "role": "Treatment.Disorder"}, {"name": "Aripiprazole", "role": "Treatment.Drug"}, {"name": "5 mg", "role": "Treatment.Dosage"}, {"name": "daily", "role": "Treatment.Freq"}]}]}
{"id": "train-2545", "event": [{"trigger": "experienced", "type": "adverse_event", "arguments": [{"name": "patients with chronic heart failure", "role": "Subject"}, {"name": "chronic heart failure", "role": "Subject.Disorder"}, {"name": "Serious adverse_events", "role": "Effect"}, {"name": "spironolactone", "role": "Treatment"}, {"name": "spironolactone", "role": "Treatment.Drug"}]}]}
{"id": "train-2546", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "nephropathy", "role": "Effect"}, {"name": "hypersensitivity", "role": "Effect"}, {"name": "methicillin", "role": "Treatment"}, {"name": "methicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-2547", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "ARDS", "role": "Effect"}, {"name": "the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and OKT3", "role": "Treatment"}, {"name": "infliximab", "role": "Treatment.Drug"}, {"name": "gemtuzumab", "role": "Treatment.Drug"}, {"name": "ozogamicin", "role": "Treatment.Drug"}, {"name": "OKT3", "role": "Treatment.Drug"}]}]}
{"id": "train-2548", "event": [{"trigger": "after initiation", "type": "adverse_event", "arguments": [{"name": "a 76-year-old man", "role": "Subject"}, {"name": "76-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "symptoms of visual \"shining,\" glare, color vision anomalies, and gradually decreased vision", "role": "Effect"}, {"name": "amiodarone HCl", "role": "Treatment"}, {"name": "amiodarone HCl", "role": "Treatment.Drug"}, {"name": "(200 mg", "role": "Treatment.Dosage"}, {"name": "day", "role": "Treatment.Freq"}]}]}
{"id": "train-2549", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "An insulin-dependent diabetic patient with nephropathy", "role": "Subject"}, {"name": "diabetic", "role": "Subject.Disorder"}, {"name": "nephropathy", "role": "Subject.Disorder"}, {"name": "severe acidosis", "role": "Effect"}, {"name": "acetazolamide for glaucoma", "role": "Treatment"}, {"name": "glaucoma", "role": "Treatment.Disorder"}, {"name": "acetazolamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2550", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "hypo-alpha-lipoproteinemia", "role": "Effect"}, {"name": "rosiglitazone", "role": "Treatment"}, {"name": "rosiglitazone", "role": "Treatment.Drug"}]}]}
{"id": "train-2551", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Peripheral neuropathy and cerebellar syndrome", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2552", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "case", "role": "Subject"}, {"name": "multiple skin cancers and nail changes", "role": "Effect"}, {"name": "hydroxyurea", "role": "Treatment"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}]}]}
{"id": "train-2553", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "a strong delayed-type hypersensitivity response", "role": "Effect"}, {"name": "tuberculin", "role": "Treatment"}, {"name": "tuberculin", "role": "Treatment.Drug"}]}]}
{"id": "train-2554", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "increased vincristine neurotoxicity", "role": "Effect"}, {"name": "Itraconazole", "role": "Treatment"}, {"name": "Itraconazole", "role": "Treatment.Drug"}, {"name": "vincristine", "role": "Treatment.Drug"}, {"name": "Itraconazole", "role": "Combination.Drug"}, {"name": "vincristine", "role": "Combination.Drug"}]}]}
{"id": "train-2555", "event": [{"trigger": "episode", "type": "adverse_event", "arguments": [{"name": "A 62-year-old Caucasian man with atrial fibrillation", "role": "Subject"}, {"name": "62-year-old", "role": "Subject.Age"}, {"name": "Caucasian", "role": "Subject.Race"}, {"name": "man", "role": "Subject.Gender"}, {"name": "hematochezia", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "atrial fibrillation", "role": "Treatment.Disorder"}, {"name": "warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-2556", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "anaemia", "role": "Effect"}, {"name": "oseltamivir during treatment of chronic hepatitis C", "role": "Treatment"}, {"name": "oseltamivir", "role": "Treatment.Drug"}, {"name": "chronic hepatitis C", "role": "Treatment.Disorder"}]}]}
{"id": "train-2557", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychotic patients", "role": "Subject"}, {"name": "agranulocytosis or granulocytopenia", "role": "Effect"}, {"name": "clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "psychotic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2558", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "low-risk patient", "role": "Subject"}, {"name": "Cystoid macular edema", "role": "Effect"}, {"name": "switching from latanoprost to bimatoprost", "role": "Treatment"}, {"name": "bimatoprost", "role": "Treatment.Drug"}, {"name": "latanoprost", "role": "Treatment.Drug"}, {"name": "latanoprost", "role": "Combination.Drug"}, {"name": "bimatoprost", "role": "Combination.Drug"}]}]}
{"id": "train-2559", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "patients with associated hypothyroidism, latent or overt", "role": "Subject"}, {"name": "hypothyroidism", "role": "Subject.Disorder"}, {"name": "latent", "role": "Subject.Disorder"}, {"name": "overt", "role": "Subject.Disorder"}, {"name": "myopathy.", "role": "Effect"}, {"name": "clofibrate", "role": "Treatment"}, {"name": "diabetes insipidus", "role": "Treatment.Disorder"}, {"name": "clofibrate", "role": "Treatment.Drug"}]}]}
{"id": "train-2560", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "acute tubulointerstitial nephritis", "role": "Effect"}, {"name": "Flurbiprofen", "role": "Treatment"}, {"name": "Flurbiprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-2561", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an HIV-infected patient", "role": "Subject"}, {"name": "hypercalcemia", "role": "Effect"}, {"name": "rhGH", "role": "Treatment"}, {"name": "rhGH", "role": "Treatment.Drug"}, {"name": "HIV", "role": "Treatment.Disorder"}]}]}
{"id": "train-2562", "event": [{"trigger": "exposure", "type": "adverse_event", "arguments": [{"name": "basilar invagination", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "intrauterine", "role": "Treatment.Route"}]}]}
{"id": "train-2563", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "Methotrexate pneumonitis", "role": "Effect"}, {"name": "nonsurgical treatment", "role": "Treatment"}, {"name": "ectopic pregnancy", "role": "Treatment.Disorder"}]}]}
{"id": "train-2564", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "Two patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "duodenal ulceration and subsequent intestinal perforation", "role": "Effect"}, {"name": "receiving Tolazoline by infusion", "role": "Treatment"}, {"name": "Tolazoline", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-2565", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a 14-year-old female with acute promyelocytic leukemia", "role": "Subject"}, {"name": "14-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "symptomatic cardiomyopathy", "role": "Effect"}, {"name": "4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA)", "role": "Treatment"}, {"name": "acute promyelocytic leukemia", "role": "Treatment.Disorder"}, {"name": "4 months", "role": "Treatment.Time_elapsed"}, {"name": "daunomycin", "role": "Treatment.Drug"}, {"name": "all-trans retinoic acid", "role": "Treatment.Drug"}, {"name": "daunomycin", "role": "Combination.Drug"}, {"name": "all-trans retinoic acid", "role": "Combination.Drug"}]}]}
{"id": "train-2566", "event": [{"trigger": "seen", "type": "adverse_event", "arguments": [{"name": "Hepatotoxicity", "role": "Effect"}, {"name": "transient with mild elevation of transaminases", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-2567", "event": [{"trigger": "as a consequence of", "type": "adverse_event", "arguments": [{"name": "A previously healthy 42-year-old woman", "role": "Subject"}, {"name": "42-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "acute-onset delirium with psychotic features", "role": "Effect"}, {"name": "levofloxacin therapy", "role": "Treatment"}, {"name": "levofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2568", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "the second reported case", "role": "Subject"}, {"name": "orofacial and limb dyskinesia", "role": "Effect"}, {"name": "methylphenidate", "role": "Treatment"}, {"name": "methylphenidate", "role": "Treatment.Drug"}, {"name": "methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-2569", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychosis", "role": "Effect"}, {"name": "Phenylpropanolamine", "role": "Treatment"}, {"name": "Phenylpropanolamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2570", "event": [{"trigger": "hypersensitivity.", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Graft versus host-like illness", "role": "Effect"}, {"name": "hypersensitivity", "role": "Effect"}, {"name": "phenobarbital", "role": "Treatment"}, {"name": "phenobarbital", "role": "Treatment.Drug"}]}]}
{"id": "train-2571", "event": [{"trigger": "suspect", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "phenytoin toxicity", "role": "Effect"}, {"name": "phenytoin", "role": "Treatment"}, {"name": "tuberculosis", "role": "Treatment.Duration"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2572", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "hemolytic uremic syndrome", "role": "Effect"}, {"name": "MMC", "role": "Treatment"}, {"name": "MMC", "role": "Treatment.Drug"}]}]}
{"id": "train-2573", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "Myasthenic patients", "role": "Subject"}, {"name": "acute exacerbations", "role": "Effect"}, {"name": "ampicillin", "role": "Treatment"}, {"name": "Myasthenic", "role": "Treatment.Disorder"}, {"name": "ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-2574", "event": [{"trigger": "diagnosis", "type": "adverse_event", "arguments": [{"name": "The male patient", "role": "Subject"}, {"name": "male", "role": "Subject.Gender"}, {"name": "agranulocytosis", "role": "Effect"}, {"name": "225-mg/day clozapine", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "225-mg/day", "role": "Treatment.Dosage"}, {"name": "6 weeks", "role": "Treatment.Duration"}]}]}
{"id": "train-2575", "event": [{"trigger": "to", "type": "potential_therapeutic_event", "arguments": [{"name": "diazepam", "role": "Treatment"}, {"name": "Alprazolam withdrawal delirium", "role": "Treatment.Disorder"}, {"name": "diazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-2576", "event": [{"trigger": "development", "type": "adverse_event", "arguments": [{"name": "RS", "role": "Effect"}, {"name": "aspirin", "role": "Treatment"}, {"name": "the antecedent illness", "role": "Treatment.Disorder"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-2577", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "bilateral ptosis", "role": "Effect"}, {"name": "Chloroquine", "role": "Treatment"}, {"name": "Chloroquine", "role": "Treatment.Drug"}]}]}
{"id": "train-2578", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "tuberculous uveitis", "role": "Effect"}, {"name": "etanercept", "role": "Treatment"}, {"name": "etanercept", "role": "Treatment.Drug"}]}]}
{"id": "train-2579", "event": [{"trigger": "adverse", "type": "adverse_event", "arguments": [{"name": "Hyponatremia", "role": "Effect"}, {"name": "potentially life-threatening complications", "role": "Effect"}, {"name": "duloxetine", "role": "Treatment"}, {"name": "duloxetine", "role": "Treatment.Drug"}]}]}
{"id": "train-2580", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A 22-year-old drug-abuser", "role": "Subject"}, {"name": "22-year-old", "role": "Subject.Age"}, {"name": "drug-abuser", "role": "Subject.Disorder"}, {"name": "acute ischaemia of the left leg", "role": "Effect"}, {"name": "injected flunitrazepam tablets dissolved in tap water into her left femoral artery", "role": "Treatment"}, {"name": "flunitrazepam", "role": "Treatment.Drug"}, {"name": "injected", "role": "Treatment.Route"}, {"name": "tablets dissolved in tap water", "role": "Treatment.Route"}]}]}
{"id": "train-2581", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A patient with Parkinson's disease", "role": "Subject"}, {"name": "progressive pleuropulmonary abnormalities during the latter therapy", "role": "Effect"}, {"name": "initially treated with bromocriptine and subsequently with cabergoline", "role": "Treatment"}, {"name": "Parkinson's disease", "role": "Treatment.Disorder"}, {"name": "bromocriptine", "role": "Treatment.Drug"}, {"name": "cabergoline", "role": "Treatment.Drug"}]}]}
{"id": "train-2582", "event": [{"trigger": "pathogenesis", "type": "adverse_event", "arguments": [{"name": "sarcoidosis", "role": "Effect"}, {"name": "interferon gamma", "role": "Treatment"}, {"name": "interferon gamma", "role": "Treatment.Drug"}]}]}
{"id": "train-2583", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "Camptocormia", "role": "Effect"}, {"name": "sodium valproate", "role": "Treatment"}, {"name": "sodium valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-2584", "event": [{"trigger": "require", "type": "potential_therapeutic_event", "arguments": [{"name": "Many patients with cardiac arrhythmias", "role": "Subject"}, {"name": "concomitant therapy with warfarin and amiodarone", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "cardiac arrhythmias", "role": "Treatment.Disorder"}, {"name": "warfarin", "role": "Combination.Drug"}, {"name": "amiodarone", "role": "Combination.Drug"}]}]}
{"id": "train-2585", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "two patients with histologically confirmed adenocarcinoma of the prostate", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "femoral head avascular necrosis.", "role": "Effect"}, {"name": "steroidal anti-androgen therapy in the form of cyproterone acetate prior to radical or palliative pelvic irradiation", "role": "Treatment"}, {"name": "adenocarcinoma of the prostate", "role": "Treatment.Disorder"}, {"name": "cyproterone acetate", "role": "Treatment.Drug"}]}]}
{"id": "train-2586", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lipohypertrophy", "role": "Effect"}, {"name": "insulin", "role": "Treatment"}, {"name": "insulin", "role": "Treatment.Drug"}]}]}
{"id": "train-2587", "event": [{"trigger": "After", "type": "adverse_event", "arguments": [{"name": "desmethylclomipramine plasma level increase and an 8-hydroacy-desmethylclomipramine plasma level decrease", "role": "Effect"}, {"name": "citalopram", "role": "Treatment"}, {"name": "citalopram", "role": "Treatment.Drug"}]}]}
{"id": "train-2588", "event": [{"trigger": "received", "type": "adverse_event", "arguments": [{"name": "a woman", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "severe hypertension followed by myocardial infarction on the fifth day of treatment.", "role": "Effect"}, {"name": "high doses of methylprednisolone (1 g iv daily)", "role": "Treatment"}, {"name": "methylprednisolone", "role": "Treatment.Drug"}, {"name": "1 g", "role": "Treatment.Dosage"}, {"name": "iv", "role": "Treatment.Route"}, {"name": "daily", "role": "Treatment.Freq"}, {"name": "active Graves' ophthalmopathy", "role": "Treatment.Disorder"}]}]}
{"id": "train-2589", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "cardiomyopathy", "role": "Effect"}, {"name": "treatment with the tumour necrosis factor-alpha inhibitor adalimumab", "role": "Treatment"}, {"name": "adalimumab", "role": "Treatment.Drug"}, {"name": "Crohn's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2590", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "childhood cancers", "role": "Subject"}, {"name": "childhood", "role": "Subject.Age"}, {"name": "liver failure", "role": "Effect"}, {"name": "AMD", "role": "Treatment"}, {"name": "cancers", "role": "Treatment.Disorder"}, {"name": "AMD", "role": "Treatment.Drug"}]}]}
{"id": "train-2591", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "a patient with chronic myeloid leukaemia and chronic hepatitis B infection", "role": "Subject"}, {"name": "chronic hepatitis B infection", "role": "Subject.Disorder"}, {"name": "fatal acute hepatic failure", "role": "Effect"}, {"name": "Imatinib mesylate", "role": "Treatment"}, {"name": "Imatinib mesylate", "role": "Treatment.Drug"}, {"name": "chronic myeloid leukaemia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2592", "event": [{"trigger": "effects", "type": "potential_therapeutic_event", "arguments": [{"name": "331 postmenopausal women with osteoporosis (femoral neck BMD T-score, less than -2)", "role": "Subject"}, {"name": "331", "role": "Subject.Population"}, {"name": "women", "role": "Subject.Gender"}, {"name": "postmenopausal", "role": "Subject.Age"}, {"name": "combined RLX and ALN", "role": "Treatment"}, {"name": "osteoporosis", "role": "Treatment.Disorder"}, {"name": "RLX", "role": "Treatment.Drug"}, {"name": "ALN", "role": "Treatment.Drug"}, {"name": "RLX", "role": "Combination.Drug"}, {"name": "ALN", "role": "Combination.Drug"}]}]}
{"id": "train-2593", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Phenytoin toxicity", "role": "Effect"}, {"name": "concomitant antituberculosis therapy.", "role": "Treatment"}, {"name": "Phenytoin", "role": "Treatment.Drug"}, {"name": "antituberculosis", "role": "Treatment.Drug"}, {"name": "antituberculosis", "role": "Combination.Drug"}, {"name": "Phenytoin", "role": "Combination.Drug"}]}]}
{"id": "train-2594", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "ARF", "role": "Effect"}, {"name": "mannitol", "role": "Treatment"}, {"name": "mannitol", "role": "Treatment.Drug"}]}]}
{"id": "train-2595", "event": [{"trigger": "recognized", "type": "adverse_event", "arguments": [{"name": "potential to cause thyroid dysfunction", "role": "Effect"}, {"name": "Amiodarone", "role": "Treatment"}, {"name": "Amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2596", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Pulmonary infiltrates and skin pigmentation", "role": "Effect"}, {"name": "sulfasalazine", "role": "Treatment"}, {"name": "sulfasalazine", "role": "Treatment.Drug"}]}]}
{"id": "train-2597", "event": [{"trigger": "because", "type": "adverse_event", "arguments": [{"name": "lithium intoxication with a diabetes insipidus-like syndrome", "role": "Effect"}, {"name": "Lithium treatment", "role": "Treatment"}, {"name": "Lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2598", "event": [{"trigger": "shortened", "type": "adverse_event", "arguments": [{"name": "a woman with a history of bipolar affective disorder", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "bipolar affective disorder", "role": "Subject.Disorder"}, {"name": "shortened the manic-depressive cycle length", "role": "Effect"}, {"name": "L-dopa", "role": "Treatment"}, {"name": "L-dopa", "role": "Treatment.Drug"}]}]}
{"id": "train-2599", "event": [{"trigger": "causing", "type": "adverse_event", "arguments": [{"name": "breast tissue enlargement", "role": "Effect"}, {"name": "Isoniazid", "role": "Treatment"}, {"name": "Isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-2600", "event": [{"trigger": "induction", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "hypoglycaemia", "role": "Effect"}, {"name": "PAS", "role": "Treatment"}, {"name": "PAS", "role": "Treatment.Drug"}, {"name": "diabetes mellitus", "role": "Treatment.Disorder"}]}]}
{"id": "train-2601", "event": [{"trigger": "recovered", "type": "potential_therapeutic_event", "arguments": [{"name": "both patients", "role": "Subject"}, {"name": "both", "role": "Subject.Population"}, {"name": "vancomycin", "role": "Treatment"}, {"name": "colitis", "role": "Treatment.Disorder"}, {"name": "vancomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2602", "event": [{"trigger": "therapy", "type": "adverse_event", "arguments": [{"name": "Acute dystonia", "role": "Effect"}, {"name": "pegylated interferon alpha", "role": "Treatment"}, {"name": "chronic hepatitis B infection", "role": "Treatment.Disorder"}, {"name": "pegylated interferon alpha", "role": "Treatment.Drug"}]}]}
{"id": "train-2603", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "two patients with kala-azar resistant to sodium stibogluconate", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "resistant to sodium stibogluconate", "role": "Subject.Disorder"}, {"name": "cardiac arrest", "role": "Effect"}, {"name": "amphotericin infusion", "role": "Treatment"}, {"name": "kala-azar", "role": "Treatment.Disorder"}, {"name": "amphotericin", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-2604", "event": [{"trigger": "causative", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "sclerosing glomerulonephritis", "role": "Effect"}, {"name": "Anastrozole", "role": "Treatment"}, {"name": "Anastrozole", "role": "Treatment.Drug"}]}]}
{"id": "train-2605", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "acute pancreatitis", "role": "Effect"}, {"name": "mesalamine", "role": "Treatment"}, {"name": "ulcerative colitis", "role": "Treatment.Disorder"}, {"name": "mesalamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2606", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "toxicity: renal impairment, anaemia, fever, malaise, and hypokalaemia", "role": "Effect"}, {"name": "Amphotericin B (AmB)", "role": "Treatment"}, {"name": "Amphotericin B", "role": "Treatment.Drug"}]}]}
{"id": "train-2607", "event": [{"trigger": "resulted", "type": "adverse_event", "arguments": [{"name": "the elevated terfenadine levels in plasma and in the cardiotoxicity", "role": "Effect"}, {"name": "a drug interaction between terfenadine and ketoconazole", "role": "Treatment"}, {"name": "terfenadine", "role": "Treatment.Drug"}, {"name": "ketoconazole", "role": "Treatment.Drug"}, {"name": "terfenadine", "role": "Combination.Drug"}, {"name": "ketoconazole", "role": "Combination.Drug"}]}]}
{"id": "train-2608", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a middle aged woman", "role": "Subject"}, {"name": "middle aged", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "hepatitis", "role": "Effect"}, {"name": "halothane", "role": "Treatment"}, {"name": "gastric surgery for morbid obesity", "role": "Treatment"}, {"name": "halothane", "role": "Treatment.Drug"}, {"name": "morbid obesity", "role": "Treatment.Disorder"}]}]}
{"id": "train-2609", "event": [{"trigger": "rarely associated", "type": "potential_therapeutic_event", "arguments": [{"name": "blood dyscrasias", "role": "Effect"}, {"name": "Carbonic anhydrase inhibitors", "role": "Treatment"}, {"name": "Carbonic anhydrase inhibitors", "role": "Treatment.Drug"}, {"name": "glaucoma, seizure disorders, and hypertension", "role": "Treatment.Disorder"}]}]}
{"id": "train-2610", "event": [{"trigger": "resulted", "type": "adverse_event", "arguments": [{"name": "one of 30 patients", "role": "Subject"}, {"name": "one of 30", "role": "Subject.Population"}, {"name": "neurological symptoms", "role": "Effect"}, {"name": "Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses", "role": "Treatment"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "Ara-C", "role": "Treatment.Drug"}, {"name": "longer intervals within 3-5 days between consecutive doses", "role": "Treatment.Freq"}]}]}
{"id": "train-2611", "event": [{"trigger": "is", "type": "adverse_event", "arguments": [{"name": "Anaphylaxis", "role": "Effect"}, {"name": "isoniazid", "role": "Treatment"}, {"name": "commonly prescribed antibiotic", "role": "Treatment"}, {"name": "isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-2612", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with arrhythmogenic right ventricular dysplasia", "role": "Subject"}, {"name": "thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin (TSH) receptor antibody (TRAb), or thyrotropin-binding inhibiting immunoglobulin (TBII)", "role": "Effect"}, {"name": "amiodarone for 4 years", "role": "Treatment"}, {"name": "4 years", "role": "Treatment.Duration"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "arrhythmogenic right ventricular dysplasia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2613", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "papular eruption", "role": "Effect"}, {"name": "Methotrexate", "role": "Treatment"}, {"name": "psoriasis", "role": "Treatment.Disorder"}, {"name": "Methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2614", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "two cases", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "Sexual dysfunction", "role": "Effect"}, {"name": "intrathecal baclofen", "role": "Treatment"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "baclofen", "role": "Treatment.Drug"}]}]}
{"id": "train-2615", "event": [{"trigger": "present", "type": "adverse_event", "arguments": [{"name": "Patients", "role": "Subject"}, {"name": "hemorrhagic and thrombotic cerebrovascular events", "role": "Effect"}, {"name": "L-asparaginase", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}]}]}
{"id": "train-2616", "event": [{"trigger": "induces", "type": "adverse_event", "arguments": [{"name": "large amounts of type I interferon production", "role": "Effect"}, {"name": "imiquimod", "role": "Treatment"}, {"name": "imiquimod", "role": "Treatment.Drug"}]}]}
{"id": "train-2617", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "Ptosis", "role": "Effect"}, {"name": "full recovery 48 h after cessation of chloroquine", "role": "Effect"}, {"name": "chloroquine therapy", "role": "Treatment"}, {"name": "24 h", "role": "Treatment.Time_elapsed"}, {"name": "chloroquine", "role": "Treatment.Drug"}]}]}
{"id": "train-2618", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Hypersensitivity pneumonitis-like syndrome", "role": "Effect"}, {"name": "lenalidomide", "role": "Treatment"}, {"name": "lenalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-2619", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "pediatric cancer patients", "role": "Subject"}, {"name": "pediatric", "role": "Subject.Age"}, {"name": "cancer", "role": "Subject.Disorder"}, {"name": "seizures", "role": "Effect"}, {"name": "imipenem/cilastatin", "role": "Treatment"}, {"name": "imipenem", "role": "Treatment.Drug"}, {"name": "cilastatin", "role": "Treatment.Drug"}, {"name": "imipenem", "role": "Combination.Drug"}, {"name": "cilastatin", "role": "Combination.Drug"}]}]}
{"id": "train-2620", "event": [{"trigger": "produce", "type": "adverse_event", "arguments": [{"name": "patients treated with this drug or lepromatous leprosy", "role": "Subject"}, {"name": "a ceroid-like pigment", "role": "Effect"}, {"name": "clofazimine", "role": "Treatment"}, {"name": "lepromatous leprosy", "role": "Treatment.Disorder"}, {"name": "clofazimine", "role": "Treatment.Drug"}]}]}
{"id": "train-2621", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "Deposits of plasma proteins in the skin", "role": "Effect"}, {"name": "carbamazepine and diphenylhydantoin", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "diphenylhydantoin", "role": "Treatment.Drug"}, {"name": "carbamazepine", "role": "Combination.Drug"}, {"name": "diphenylhydantoin", "role": "Combination.Drug"}]}]}
{"id": "train-2622", "event": [{"trigger": "accelerate", "type": "adverse_event", "arguments": [{"name": "non-Hodgkin's lymphoma", "role": "Effect"}, {"name": "2-Chloro-deoxyadenosine", "role": "Treatment"}, {"name": "2-Chloro-deoxyadenosine", "role": "Treatment.Drug"}, {"name": "Castleman's disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2623", "event": [{"trigger": "manifested", "type": "adverse_event", "arguments": [{"name": "acute asthma", "role": "Effect"}, {"name": "urticaria", "role": "Effect"}, {"name": "angioedema", "role": "Effect"}, {"name": "systemic anaphylactoid reaction", "role": "Effect"}, {"name": "Hypersensitivity", "role": "Effect"}, {"name": "aspirin", "role": "Treatment"}, {"name": "aspirin", "role": "Treatment.Drug"}]}]}
{"id": "train-2624", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "bradycardia", "role": "Effect"}, {"name": "high-dose dexmedetomidine", "role": "Treatment"}, {"name": "dexmedetomidine", "role": "Treatment.Drug"}, {"name": "high-dose", "role": "Treatment.Dosage"}]}]}
{"id": "train-2625", "event": [{"trigger": "did well", "type": "potential_therapeutic_event", "arguments": [{"name": "the youngest", "role": "Subject"}, {"name": "risperidone", "role": "Treatment"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-2626", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Two elderly women", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "women", "role": "Subject.Gender"}, {"name": "acute deterioration of renal function", "role": "Effect"}, {"name": "treatment with cefoxitin sodium", "role": "Treatment"}, {"name": "cefoxitin sodium", "role": "Treatment.Drug"}]}]}
{"id": "train-2627", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "patients with respiratory distress", "role": "Subject"}, {"name": "mainly in elderly patients", "role": "Subject"}, {"name": "pulmonary toxicity", "role": "Effect"}, {"name": "gemcitabine chemotherapy", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}, {"name": "respiratory distress", "role": "Treatment.Disorder"}, {"name": "chemotherapy", "role": "Treatment.Route"}]}]}
{"id": "train-2628", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "Delay of corneal wound healing", "role": "Effect"}, {"name": "colchicine", "role": "Treatment"}, {"name": "colchicine", "role": "Treatment.Drug"}]}]}
{"id": "train-2629", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thyrotoxicosis", "role": "Effect"}, {"name": "Amiodarone", "role": "Treatment"}, {"name": "Amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2630", "event": [{"trigger": "regard", "type": "adverse_event", "arguments": [{"name": "renal impairment", "role": "Effect"}, {"name": "gabapentin", "role": "Treatment"}, {"name": "acute illness", "role": "Treatment.Disorder"}, {"name": "gabapentin", "role": "Treatment.Drug"}]}]}
{"id": "train-2631", "event": [{"trigger": "observed", "type": "adverse_event", "arguments": [{"name": "all 7 patients", "role": "Subject"}, {"name": "7", "role": "Subject.Population"}, {"name": "EA signs", "role": "Effect"}, {"name": "propofol TIVA", "role": "Treatment"}, {"name": "low-dose ketamine was added to propofol", "role": "Treatment"}, {"name": "propofol", "role": "Treatment.Drug"}, {"name": "ketamine", "role": "Treatment.Drug"}, {"name": "propofol", "role": "Treatment.Drug"}, {"name": "TIVA", "role": "Treatment.Route"}, {"name": "low-dose", "role": "Treatment.Dosage"}, {"name": "propofol", "role": "Combination.Drug"}, {"name": "ketamine", "role": "Combination.Drug"}]}]}
{"id": "train-2632", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "multiple drug intoxication", "role": "Effect"}, {"name": "sertraline", "role": "Treatment"}, {"name": "sertraline", "role": "Treatment.Drug"}]}]}
{"id": "train-2633", "event": [{"trigger": "occurred.", "type": "adverse_event", "arguments": [{"name": "gingival bleeding and purpura", "role": "Effect"}, {"name": "On the next day, after a total dose of only 600 mg of danazol", "role": "Treatment"}, {"name": "danazol", "role": "Treatment.Drug"}, {"name": "a total dose of only 600 mg", "role": "Treatment.Dosage"}]}]}
{"id": "train-2634", "event": [{"trigger": "after", "type": "potential_therapeutic_event", "arguments": [{"name": "withdrawal of carbamazepine and treatment with anti-inflammatory drugs", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "anti-inflammatory", "role": "Treatment.Drug"}, {"name": "SLE", "role": "Treatment.Disorder"}]}]}
{"id": "train-2635", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a 67-year-old man with bipolar disorder", "role": "Subject"}, {"name": "67-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "Creutzfeldt-Jakob like syndrome", "role": "Effect"}, {"name": "lithium carbonate", "role": "Treatment"}, {"name": "lithium carbonate", "role": "Treatment.Drug"}, {"name": "bipolar disorder", "role": "Treatment.Disorder"}]}]}
{"id": "train-2636", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "42 year old man", "role": "Subject"}, {"name": "42 year old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "interstitial pneumonitis", "role": "Effect"}, {"name": "combination chemotherapy that included bleomycin,", "role": "Treatment"}, {"name": "testicular carcinoma", "role": "Treatment.Disorder"}, {"name": "bleomycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2637", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "an adult psoriasis patient", "role": "Subject"}, {"name": "adult", "role": "Subject.Age"}, {"name": "Disseminated eruptive giant mollusca contagiosa", "role": "Effect"}, {"name": "efalizumab therapy", "role": "Treatment"}, {"name": "psoriasis", "role": "Treatment.Disorder"}, {"name": "efalizumab", "role": "Treatment.Drug"}]}]}
{"id": "train-2638", "event": [{"trigger": "improvement", "type": "potential_therapeutic_event", "arguments": [{"name": "withdrawal of the diphenylhydantoin", "role": "Treatment"}, {"name": "porphyria", "role": "Treatment.Disorder"}, {"name": "diphenylhydantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2639", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "fever", "role": "Effect"}, {"name": "Temozolomide", "role": "Treatment"}, {"name": "Temozolomide", "role": "Treatment.Drug"}]}]}
{"id": "train-2640", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "The patient's previous rash", "role": "Subject"}, {"name": "rash", "role": "Subject.Disorder"}, {"name": "TEN", "role": "Effect"}, {"name": "ingestion of phenolphthalein", "role": "Treatment"}, {"name": "phenolphthalein", "role": "Treatment.Drug"}, {"name": "ingestion", "role": "Treatment.Route"}]}]}
{"id": "train-2641", "event": [{"trigger": "elevates", "type": "potential_therapeutic_event", "arguments": [{"name": "plasma concentrations of tizanidine and dangerously potentiates its hypotensive and sedative effects", "role": "Effect"}, {"name": "Ciprofloxacin", "role": "Treatment"}, {"name": "Ciprofloxacin", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Treatment.Drug"}]}]}
{"id": "train-2642", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "The patient, a 27-year-old married Japanese woman with borderline personality disorder", "role": "Subject"}, {"name": "27-year-old", "role": "Subject.Age"}, {"name": "Japanese", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "increased libido", "role": "Effect"}, {"name": "administration of fluvoxamine", "role": "Treatment"}, {"name": "borderline personality disorder", "role": "Treatment.Disorder"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2643", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "a patient with minimal change nephrotic syndrome", "role": "Subject"}, {"name": "Acute renal failure with severe tubulointerstitial changes", "role": "Effect"}, {"name": "enalapril", "role": "Treatment"}, {"name": "enalapril", "role": "Treatment.Drug"}, {"name": "minimal change nephrotic syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-2644", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "A case", "role": "Subject"}, {"name": "hyperammonemia", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-2645", "event": [{"trigger": "continued", "type": "adverse_event", "arguments": [{"name": "cough", "role": "Effect"}, {"name": "quinapril", "role": "Treatment"}, {"name": "quinapril", "role": "Treatment.Drug"}]}]}
{"id": "train-2646", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Carbamazepine toxicity", "role": "Effect"}, {"name": "Carbamazepine", "role": "Treatment"}, {"name": "Oxybutynin and Dantrolene", "role": "Treatment"}, {"name": "Oxybutynin", "role": "Treatment.Drug"}, {"name": "Dantrolene", "role": "Treatment.Drug"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}, {"name": "Carbamazepine", "role": "Combination.Drug"}, {"name": "Oxybutynin", "role": "Combination.Drug"}, {"name": "Dantrolene", "role": "Combination.Drug"}]}]}
{"id": "train-2647", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "thrombocytopenia", "role": "Effect"}, {"name": "Danazol", "role": "Treatment"}, {"name": "Danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-2648", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "Four elderly LTCF residents", "role": "Subject"}, {"name": "Four", "role": "Subject.Population"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "serotonergic antidepressants including selective serotonin reuptake inhibitor (SSRI) or mirtazapine and opioids", "role": "Treatment"}, {"name": "LTCF", "role": "Treatment.Disorder"}, {"name": "selective serotonin reuptake inhibitor", "role": "Treatment.Drug"}, {"name": "mirtazapine", "role": "Treatment.Drug"}, {"name": "opioids", "role": "Treatment.Drug"}, {"name": "opioids", "role": "Combination.Drug"}, {"name": "mirtazapine", "role": "Combination.Drug"}]}]}
{"id": "train-2649", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "eosinophilia-myalgia syndrome", "role": "Effect"}, {"name": "L-tryptophan", "role": "Treatment"}, {"name": "L-tryptophan", "role": "Treatment.Drug"}]}]}
{"id": "train-2650", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "impaired memory", "role": "Effect"}, {"name": "atenolol", "role": "Treatment"}, {"name": "atenolol", "role": "Treatment.Drug"}]}]}
{"id": "train-2651", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "an unusual array of neurological symptoms", "role": "Effect"}, {"name": "Tiagabine overdose", "role": "Treatment"}, {"name": "Tiagabine", "role": "Treatment.Drug"}, {"name": "overdose", "role": "Treatment.Dosage"}]}]}
{"id": "train-2652", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "6.9-year-old autistic male", "role": "Subject"}, {"name": "6.9-year-old", "role": "Subject.Age"}, {"name": "autistic", "role": "Subject.Disorder"}, {"name": "male", "role": "Subject.Gender"}, {"name": "repeated episodes of acute dystonic reactions", "role": "Effect"}, {"name": "pimozide administration at the doses of 0.096 mg/kg/day and 0.032 mg/kg/day and 32 hours following pimozide withdrawal, as well as during subsequent thioridazine administration", "role": "Treatment"}, {"name": "pimozide", "role": "Treatment.Drug"}, {"name": "pimozide", "role": "Treatment.Drug"}, {"name": "thioridazine", "role": "Treatment.Drug"}, {"name": "0.096 mg/kg", "role": "Treatment.Dosage"}, {"name": "0.032 mg/kg", "role": "Treatment.Dosage"}, {"name": "day", "role": "Treatment.Freq"}, {"name": "day", "role": "Treatment.Freq"}]}]}
{"id": "train-2653", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "Cephalexin rash", "role": "Effect"}, {"name": "Cephalexin", "role": "Treatment"}, {"name": "Cephalexin", "role": "Treatment.Drug"}, {"name": "infectious mononucleosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2654", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "recurrent skin rash, fever, hypereosinophilia, and acute renal failure", "role": "Effect"}, {"name": "rechallenge with chlorambucil", "role": "Treatment"}, {"name": "chlorambucil", "role": "Treatment.Drug"}]}]}
{"id": "train-2655", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Lower extremity arterial insufficiency", "role": "Effect"}, {"name": "long-term methysergide maleate therapy", "role": "Treatment"}, {"name": "methysergide maleate", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-2656", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Hepatolithiasis (intrahepatic stone)", "role": "Effect"}, {"name": "octreotide", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}, {"name": "acromegaly", "role": "Treatment.Disorder"}]}]}
{"id": "train-2657", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Acute unilateral total visual loss", "role": "Effect"}, {"name": "retrogasserian phenol injection", "role": "Treatment"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "retrogasserian phenol", "role": "Treatment.Drug"}, {"name": "trigeminal neuralgia", "role": "Treatment.Disorder"}]}]}
{"id": "train-2658", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "few extrapyramidal symptoms", "role": "Effect"}, {"name": "Clozapine", "role": "Treatment"}, {"name": "Clozapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2659", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute orofacial and extremity dyskinesia", "role": "Effect"}, {"name": "Methylphenidate", "role": "Treatment"}, {"name": "Methylphenidate", "role": "Treatment.Drug"}]}]}
{"id": "train-2660", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Basilar invagination and mid-line skeletal abnormalities", "role": "Effect"}, {"name": "utero exposure to phenytoin", "role": "Treatment"}, {"name": "phenytoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2661", "event": [{"trigger": "triggered", "type": "adverse_event", "arguments": [{"name": "neuralgic amyotrophy", "role": "Effect"}, {"name": "antibiotics vancomycin, tobramycin, and piperacillin/tazobactam", "role": "Treatment"}, {"name": "vancomycin", "role": "Treatment.Drug"}, {"name": "tobramycin", "role": "Treatment.Drug"}, {"name": "piperacillin", "role": "Treatment.Drug"}, {"name": "tazobactam", "role": "Treatment.Drug"}, {"name": "vancomycin", "role": "Combination.Drug"}, {"name": "tobramycin", "role": "Combination.Drug"}, {"name": "piperacillin", "role": "Combination.Drug"}, {"name": "tazobactam", "role": "Combination.Drug"}]}]}
{"id": "train-2662", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Alveolar-interstitial pneumopathy", "role": "Effect"}, {"name": "gold-salts compounds administration", "role": "Treatment"}, {"name": "gold-salts compounds", "role": "Treatment.Drug"}]}]}
{"id": "train-2663", "event": [{"trigger": "leading to", "type": "adverse_event", "arguments": [{"name": "humans", "role": "Subject"}, {"name": "increasing rosiglitazone concentrations that could increase the efficacy of rosiglitazone or its adverse_events", "role": "Effect"}, {"name": "ketoconazole", "role": "Treatment"}, {"name": "ketoconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2664", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an elderly patient", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "hyponatremia", "role": "Effect"}, {"name": "duloxetine", "role": "Treatment"}, {"name": "thiazide diuretics", "role": "Treatment"}, {"name": "duloxetine", "role": "Treatment.Drug"}, {"name": "thiazide diuretics", "role": "Treatment.Drug"}, {"name": "thiazide diuretics", "role": "Combination.Drug"}, {"name": "duloxetine", "role": "Combination.Drug"}]}]}
{"id": "train-2665", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "anaphylaxis", "role": "Effect"}, {"name": "Protamine", "role": "Treatment"}, {"name": "Protamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2666", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "this case", "role": "Subject"}, {"name": "thrombocytopenia", "role": "Effect"}, {"name": "danazol", "role": "Treatment"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-2667", "event": [{"trigger": "treatment,", "type": "adverse_event", "arguments": [{"name": "One patient", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism", "role": "Effect"}, {"name": "risperidone", "role": "Treatment"}, {"name": "risperidone", "role": "Treatment.Drug"}]}]}
{"id": "train-2668", "event": [{"trigger": "response", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "NMS", "role": "Effect"}, {"name": "Haloperidol", "role": "Treatment"}, {"name": "Haloperidol", "role": "Treatment.Drug"}]}]}
{"id": "train-2669", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "visual loss", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "during the early period or when given at lower doses", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}, {"name": "early period", "role": "Treatment.Time_elapsed"}, {"name": "lower doses", "role": "Treatment.Dosage"}]}]}
{"id": "train-2670", "event": [{"trigger": "stopped,", "type": "adverse_event", "arguments": [{"name": "he", "role": "Subject"}, {"name": "he", "role": "Subject.Gender"}, {"name": "behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused", "role": "Effect"}, {"name": "day after clozapine was stopped, while he was still receiving clomipramine 150 mg/d", "role": "Treatment"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "clomipramine", "role": "Treatment.Drug"}, {"name": "150 mg/d", "role": "Treatment.Dosage"}]}]}
{"id": "train-2671", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "Hypersensitivity reactions to cyclosporine", "role": "Effect"}, {"name": "Cremophor EL", "role": "Treatment"}, {"name": "Cremophor EL", "role": "Treatment.Drug"}]}]}
{"id": "train-2672", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "sulfonylurea", "role": "Treatment"}, {"name": "sulfonylurea", "role": "Treatment.Drug"}]}]}
{"id": "train-2673", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Radiation recall pneumonitis", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2674", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "severe dyspnea", "role": "Effect"}, {"name": "worsening pleuritis carcinomatosa", "role": "Effect"}, {"name": "injection of 3.6 mg of goserelin acetate", "role": "Treatment"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "3.6 mg", "role": "Treatment.Dosage"}, {"name": "goserelin acetate", "role": "Treatment.Drug"}]}]}
{"id": "train-2675", "event": [{"trigger": "added", "type": "potential_therapeutic_event", "arguments": [{"name": "Ropinirole", "role": "Treatment"}, {"name": "a corresponding decrease in the dose of levodopa/carbidopa to allow levodopa sparing", "role": "Treatment"}, {"name": "Ropinirole", "role": "Treatment.Drug"}, {"name": "levodopa", "role": "Treatment.Drug"}, {"name": "carbidopa", "role": "Treatment.Drug"}, {"name": "Parkinson disease", "role": "Treatment.Disorder"}, {"name": "Ropinirole", "role": "Combination.Drug"}, {"name": "levodopa", "role": "Combination.Drug"}, {"name": "carbidopa", "role": "Combination.Drug"}]}]}
{"id": "train-2676", "event": [{"trigger": "by", "type": "adverse_event", "arguments": [{"name": "severe neurotoxicity of polychemotherapy", "role": "Effect"}, {"name": "vincristine", "role": "Treatment"}, {"name": "HMSN", "role": "Treatment.Disorder"}, {"name": "vincristine", "role": "Treatment.Drug"}]}]}
{"id": "train-2677", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "an adult patient", "role": "Subject"}, {"name": "adult", "role": "Subject.Age"}, {"name": "pulmonary hypertension", "role": "Effect"}, {"name": "lithium therapy.", "role": "Treatment"}, {"name": "lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2678", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "hypoglycaemic coma", "role": "Effect"}, {"name": "an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases", "role": "Effect"}, {"name": "SP", "role": "Treatment"}, {"name": "SP", "role": "Treatment.Drug"}]}]}
{"id": "train-2679", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "four cases", "role": "Subject"}, {"name": "diabetes insipidus due to hypothalamic lesions", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "myopathy", "role": "Effect"}, {"name": "clofibrate", "role": "Treatment"}, {"name": "clofibrate", "role": "Treatment.Drug"}, {"name": "diabetes insipidus", "role": "Treatment.Disorder"}]}]}
{"id": "train-2680", "event": [{"trigger": "had", "type": "adverse_event", "arguments": [{"name": "One patient", "role": "Subject"}, {"name": "One", "role": "Subject.Population"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "MRI T2 abnormalities", "role": "Effect"}, {"name": "cyclosporin", "role": "Treatment"}, {"name": "cyclosporin", "role": "Treatment.Drug"}]}]}
{"id": "train-2681", "event": [{"trigger": "Post-exposure prophylaxis", "type": "potential_therapeutic_event", "arguments": [{"name": "renal allograft recipient", "role": "Subject"}, {"name": "renal allograft", "role": "Subject.Disorder"}, {"name": "safe and effective without any immunosuppresive drug interaction", "role": "Effect"}, {"name": "oseltamivir", "role": "Treatment"}, {"name": "H1N1", "role": "Treatment.Disorder"}, {"name": "oseltamivir", "role": "Treatment.Drug"}]}]}
{"id": "train-2682", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "the patient", "role": "Subject"}, {"name": "spontaneous bruising, with an INR of 7.1", "role": "Effect"}, {"name": "Seven days after the introduction of amoxycillin (500 mg/8 h)", "role": "Treatment"}, {"name": "a probable respiratory infection", "role": "Treatment.Disorder"}, {"name": "Seven days after", "role": "Treatment.Time_elapsed"}, {"name": "amoxycillin", "role": "Treatment.Drug"}, {"name": "500 mg/8 h", "role": "Treatment.Dosage"}]}]}
{"id": "train-2683", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "a case", "role": "Subject"}, {"name": "hypotension", "role": "Effect"}, {"name": "initiation of tizanidine", "role": "Treatment"}, {"name": "lisinopril", "role": "Treatment"}, {"name": "lisinopril", "role": "Treatment.Drug"}, {"name": "tizanidine", "role": "Treatment.Drug"}]}]}
{"id": "train-2684", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "for central diabetes insipidus (DI)", "role": "Subject"}, {"name": "severe hyponatremia", "role": "Effect"}, {"name": "seizure and coma", "role": "Effect"}, {"name": "intake of non-steroidal anti-inflammatory drugs (NSAIDs)", "role": "Treatment"}, {"name": "on DDAVP replacement therapy", "role": "Treatment"}, {"name": "non-steroidal anti-inflammatory drugs", "role": "Treatment.Drug"}, {"name": "DDAVP", "role": "Treatment.Drug"}, {"name": "central diabetes insipidus", "role": "Treatment.Disorder"}, {"name": "DDAVP", "role": "Combination.Drug"}, {"name": "non-steroidal anti-inflammatory drugs", "role": "Combination.Drug"}]}]}
{"id": "train-2685", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "Each subject", "role": "Subject"}, {"name": "baseline; phase 1 (days 1-6): cisapride 10 mg 4 times/day; washout (days 7-13); phase 2 (days 14-44): fluoxetine 20 mg/day; and phase 3 (days 45-52): cisapride 10 mg 4 times/day (days 45-51) plus fluoxetine 20 mg/day (days 45-52)", "role": "Treatment"}, {"name": "cisapride", "role": "Treatment.Drug"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "cisapride", "role": "Treatment.Drug"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "10 mg", "role": "Treatment.Dosage"}, {"name": "20 mg/day", "role": "Treatment.Dosage"}, {"name": "10 mg", "role": "Treatment.Dosage"}, {"name": "20 mg/day", "role": "Treatment.Dosage"}, {"name": "4 times/day", "role": "Treatment.Freq"}, {"name": "4 times/day", "role": "Treatment.Freq"}, {"name": "cisapride", "role": "Combination.Drug"}, {"name": "fluoxetine", "role": "Combination.Drug"}]}]}
{"id": "train-2686", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "renal disease", "role": "Effect"}, {"name": "gold therapy in rheumatoid arthritis", "role": "Treatment"}, {"name": "gold", "role": "Treatment.Drug"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2687", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a bipolar patient", "role": "Subject"}, {"name": "rapid mood cycling", "role": "Effect"}, {"name": "L-dopa", "role": "Treatment"}, {"name": "L-dopa", "role": "Treatment.Drug"}, {"name": "bipolar", "role": "Treatment.Disorder"}]}]}
{"id": "train-2688", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "seizure", "role": "Effect"}, {"name": "venlafaxine and trimipramine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "trimipramine", "role": "Treatment.Drug"}, {"name": "depression", "role": "Treatment.Disorder"}, {"name": "venlafaxine", "role": "Combination.Drug"}, {"name": "trimipramine", "role": "Combination.Drug"}]}]}
{"id": "train-2689", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a patient with acute myelogenous leukemia in remission", "role": "Subject"}, {"name": "Paraplegia", "role": "Effect"}, {"name": "prophylactic intrathecal cytosine arabinoside (Ara-C)", "role": "Treatment"}, {"name": "doses of 100 mg/m2/d for 5 consecutive days", "role": "Treatment"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}, {"name": "intrathecal", "role": "Treatment.Route"}, {"name": "acute myelogenous leukemia in remission", "role": "Treatment.Disorder"}, {"name": "100 mg/m2/d", "role": "Treatment.Dosage"}, {"name": "5 consecutive days", "role": "Treatment.Duration"}]}]}
{"id": "train-2690", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "gynaecomastia", "role": "Effect"}, {"name": "Isoniazid", "role": "Treatment"}, {"name": "Isoniazid", "role": "Treatment.Drug"}]}]}
{"id": "train-2691", "event": [{"trigger": "noted", "type": "adverse_event", "arguments": [{"name": "four transplant patients", "role": "Subject"}, {"name": "four", "role": "Subject.Population"}, {"name": "transplant", "role": "Subject.Disorder"}, {"name": "anemia", "role": "Effect"}, {"name": "immediate post-transplantation immunosuppression utilized corticosteroids, cyclosporine, MMF, and anti-T-lymphocyte globulin", "role": "Treatment"}, {"name": "corticosteroids", "role": "Treatment.Drug"}, {"name": "cyclosporine", "role": "Treatment.Drug"}, {"name": "MMF", "role": "Treatment.Drug"}, {"name": "anti-T-lymphocyte globulin", "role": "Treatment.Drug"}, {"name": "post-transplantation immunosuppression", "role": "Treatment.Disorder"}, {"name": "corticosteroids", "role": "Combination.Drug"}, {"name": "cyclosporine", "role": "Combination.Drug"}, {"name": "MMF", "role": "Combination.Drug"}, {"name": "anti-T-lymphocyte globulin", "role": "Combination.Drug"}]}]}
{"id": "train-2692", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Pleuropulmonary changes", "role": "Effect"}, {"name": "cabergoline", "role": "Treatment"}, {"name": "Parkinson's disease", "role": "Treatment.Disorder"}, {"name": "cabergoline", "role": "Treatment.Drug"}]}]}
{"id": "train-2693", "event": [{"trigger": "demonstrated", "type": "adverse_event", "arguments": [{"name": "each infant", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "hemodynamic decompensation", "role": "Effect"}, {"name": "verapamil", "role": "Treatment"}, {"name": "verapamil", "role": "Treatment.Drug"}]}]}
{"id": "train-2694", "event": [{"trigger": "prevent", "type": "potential_therapeutic_event", "arguments": [{"name": "glitazones", "role": "Treatment"}, {"name": "premature atherosclerotic cardiovascular disease, morbidity, and death", "role": "Treatment.Disorder"}, {"name": "glitazones", "role": "Treatment.Drug"}]}]}
{"id": "train-2695", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "transient global amnesia", "role": "Effect"}, {"name": "propafenone", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-2696", "event": [{"trigger": "have", "type": "adverse_event", "arguments": [{"name": "fever and autonomic instability without evidence of infection which entirely resolved", "role": "Effect"}, {"name": "24 hours of reinstitution of full preadmission dosing of oral baclofen", "role": "Treatment"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "baclofen", "role": "Treatment.Drug"}, {"name": "24 hours", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2697", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Traumatic late flap dehiscence and Enterobacter keratitis", "role": "Effect"}, {"name": "LASIK", "role": "Treatment"}, {"name": "LASIK", "role": "Treatment.Drug"}]}]}
{"id": "train-2698", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patient with subarachnoid haemorrhage", "role": "Subject"}, {"name": "pseudo-obstruction of the colon", "role": "Effect"}, {"name": "intravenous nimodipine", "role": "Treatment"}, {"name": "subarachnoid haemorrhage", "role": "Treatment.Disorder"}, {"name": "nimodipine", "role": "Treatment.Drug"}, {"name": "intravenous", "role": "Treatment.Route"}]}]}
{"id": "train-2699", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "A 73-year-old woman", "role": "Subject"}, {"name": "73-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "fever and cough", "role": "Effect"}, {"name": "2 weeks after completing the third cycle of fludarabine for chronic lymphocytic leukemia (CLL)", "role": "Treatment"}, {"name": "chronic lymphocytic leukemia (CLL)", "role": "Treatment.Disorder"}, {"name": "2 weeks", "role": "Treatment.Time_elapsed"}, {"name": "fludarabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2700", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "myoclonus", "role": "Effect"}, {"name": "quetiapine", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2701", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 21-year-old woman suffering from bipolar affective disorder", "role": "Subject"}, {"name": "21-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "systemic lupus erythematosus (SLE)", "role": "Effect"}, {"name": "18 months after starting carbamazepine maintenance treatment", "role": "Treatment"}, {"name": "bipolar affective disorder", "role": "Treatment.Disorder"}, {"name": "18 months", "role": "Treatment.Time_elapsed"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-2702", "event": [{"trigger": "produces", "type": "adverse_event", "arguments": [{"name": "neurologic symptoms", "role": "Effect"}, {"name": "Acyclovir", "role": "Treatment"}, {"name": "Acyclovir", "role": "Treatment.Drug"}]}]}
{"id": "train-2703", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "mortality rate <3%", "role": "Effect"}, {"name": "Subcutaneous IL-2", "role": "Treatment"}, {"name": "Subcutaneous", "role": "Treatment.Route"}, {"name": "IL-2", "role": "Treatment.Drug"}]}]}
{"id": "train-2704", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "Two patients with HLH", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "secondary acute myeloid leukemia (sAML)", "role": "Effect"}, {"name": "etoposide", "role": "Treatment"}, {"name": "HLH", "role": "Treatment.Disorder"}, {"name": "etoposide", "role": "Treatment.Drug"}]}]}
{"id": "train-2705", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "secondary glaucoma", "role": "Effect"}, {"name": "epithelial downgrowth", "role": "Effect"}, {"name": "filtration surgery was performed with adjunctive use of subconjunctival 5-fluorouracil", "role": "Treatment"}, {"name": "subconjunctival", "role": "Treatment.Route"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}]}]}
{"id": "train-2706", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "serotonin syndrome", "role": "Effect"}, {"name": "concurrent linezolid and fluoxetine", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "fluoxetine", "role": "Treatment.Drug"}, {"name": "linezolid", "role": "Combination.Drug"}, {"name": "fluoxetine", "role": "Combination.Drug"}]}]}
{"id": "train-2707", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "six patients with Parkinson's disease and other akinetic-rigid syndromes", "role": "Subject"}, {"name": "six", "role": "Subject.Population"}, {"name": "Parkinson's disease", "role": "Subject.Disorder"}, {"name": "akinetic-rigid syndromes", "role": "Subject.Disorder"}, {"name": "Risperidone versus clozapine", "role": "Treatment"}, {"name": "Risperidone", "role": "Treatment.Drug"}, {"name": "clozapine", "role": "Treatment.Drug"}, {"name": "psychosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2708", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "an elderly subject", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas", "role": "Effect"}, {"name": "Hydroxyurea", "role": "Treatment"}, {"name": "Hydroxyurea", "role": "Treatment.Drug"}]}]}
{"id": "train-2709", "event": [{"trigger": "received", "type": "potential_therapeutic_event", "arguments": [{"name": "Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period)", "role": "Subject"}, {"name": "Women", "role": "Subject.Gender"}, {"name": "aged < or = 75 yr; > or = 2 yr", "role": "Subject.Age"}, {"name": "RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined", "role": "Treatment"}, {"name": "60 mg/d", "role": "Treatment.Dosage"}, {"name": "10 mg/d", "role": "Treatment.Dosage"}, {"name": "60 mg/d", "role": "Treatment.Dosage"}, {"name": "10 mg/d", "role": "Treatment.Dosage"}, {"name": "RLX", "role": "Treatment.Drug"}, {"name": "ALN", "role": "Treatment.Drug"}, {"name": "RLX", "role": "Treatment.Drug"}, {"name": "ALN", "role": "Treatment.Drug"}, {"name": "ALN", "role": "Combination.Drug"}, {"name": "RLX", "role": "Combination.Drug"}]}]}
{"id": "train-2710", "event": [{"trigger": "induction", "type": "adverse_event", "arguments": [{"name": "a patient with parkinsonism", "role": "Subject"}, {"name": "Myoclonus and seizures", "role": "Effect"}, {"name": "levodopa", "role": "Treatment"}, {"name": "parkinsonism", "role": "Treatment.Disorder"}, {"name": "levodopa", "role": "Treatment.Drug"}]}]}
{"id": "train-2711", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "transient global amnesia", "role": "Effect"}, {"name": "propafenone", "role": "Treatment"}, {"name": "propafenone", "role": "Treatment.Drug"}]}]}
{"id": "train-2712", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "squamous-cell carcinoma within a basal-cell epithelioma", "role": "Effect"}, {"name": "intralesional injections of 5-FU", "role": "Treatment"}, {"name": "intralesional injections", "role": "Treatment.Route"}, {"name": "5-FU", "role": "Treatment.Drug"}]}]}
{"id": "train-2713", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "refractory coronary vasospasm", "role": "Effect"}, {"name": "cocaine", "role": "Treatment"}, {"name": "cocaine", "role": "Treatment.Drug"}]}]}
{"id": "train-2714", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "relatively young, otherwise healthy female", "role": "Subject"}, {"name": "delirium with psychotic features", "role": "Effect"}, {"name": "levofloxacin", "role": "Treatment"}, {"name": "levofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2715", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "toxicity", "role": "Effect"}, {"name": "Ticlopidine", "role": "Treatment"}, {"name": "Ticlopidine", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Treatment.Drug"}, {"name": "phenytoin", "role": "Combination.Drug"}, {"name": "Ticlopidine", "role": "Combination.Drug"}]}]}
{"id": "train-2716", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "acute pancreatitis", "role": "Effect"}, {"name": "tigecycline", "role": "Treatment"}, {"name": "tigecycline", "role": "Treatment.Drug"}]}]}
{"id": "train-2717", "event": [{"trigger": "triggered", "type": "adverse_event", "arguments": [{"name": "exacerbation of the cranial dystonia associated with inspiratory stridor and acute respiratory difficulties", "role": "Effect"}, {"name": "Abrupt, accidental withdrawal of trihexyphenidyl", "role": "Treatment"}, {"name": "trihexyphenidyl", "role": "Treatment.Drug"}]}]}
{"id": "train-2718", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "two patients", "role": "Subject"}, {"name": "two", "role": "Subject.Population"}, {"name": "anhedonic ejaculation (ejaculation without orgasm)", "role": "Effect"}, {"name": "desipramine", "role": "Treatment"}, {"name": "desipramine", "role": "Treatment.Drug"}]}]}
{"id": "train-2719", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a 24-year-old man", "role": "Subject"}, {"name": "24-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "longitudinal diffusion-weighted MRI findings of sub-acute leukoencephalopathy", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2720", "event": [{"trigger": "causes", "type": "adverse_event", "arguments": [{"name": "adverse reactions for cardiac rhythms", "role": "Effect"}, {"name": "garenoxacin", "role": "Treatment"}, {"name": "garenoxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2721", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 45-year-old woman with steroid-dependent Crohn's colitis", "role": "Subject"}, {"name": "45-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "lupus-like syndrome", "role": "Effect"}, {"name": "maintenance infliximab infusions and methotrexate", "role": "Treatment"}, {"name": "eight months after her initial infusion", "role": "Treatment"}, {"name": "eight months", "role": "Treatment.Time_elapsed"}, {"name": "infliximab", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "infusions", "role": "Treatment.Route"}, {"name": "steroid-dependent Crohn's colitis", "role": "Treatment.Disorder"}, {"name": "infliximab", "role": "Combination.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}]}]}
{"id": "train-2722", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "neurotoxicity", "role": "Effect"}, {"name": "methyl G", "role": "Treatment"}, {"name": "methyl G", "role": "Treatment.Drug"}]}]}
{"id": "train-2723", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "60-year-old woman affected by squamous lung carcinoma", "role": "Subject"}, {"name": "60-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "paroxysmal supraventricular tachycardia", "role": "Effect"}, {"name": "cisplatin and etoposide combination", "role": "Treatment"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "squamous lung carcinoma,", "role": "Treatment.Disorder"}, {"name": "etoposide", "role": "Combination.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}]}]}
{"id": "train-2724", "event": [{"trigger": "occurring", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "acute pancreatitis", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "post-traumatic petit mal epilepsy", "role": "Treatment.Disorder"}, {"name": "carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-2725", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery", "role": "Subject"}, {"name": "vascular compromised diabetic retinopathy", "role": "Subject.Disorder"}, {"name": "underlying stenosis of the carotid artery", "role": "Subject.Disorder"}, {"name": "Acute ocular ischemic change", "role": "Effect"}, {"name": "intravitreal injection of bevacizumab", "role": "Treatment"}, {"name": "bevacizumab", "role": "Treatment.Drug"}, {"name": "intravitreal injection", "role": "Treatment.Dosage"}]}]}
{"id": "train-2726", "event": [{"trigger": "proved", "type": "potential_therapeutic_event", "arguments": [{"name": "more than 90% of cases", "role": "Subject"}, {"name": "more than 90%", "role": "Subject.Population"}, {"name": "All-trans-retinoic acid (ATRA)", "role": "Treatment"}, {"name": "acute promyelocytic leukemia (APL)", "role": "Treatment.Disorder"}, {"name": "All-trans-retinoic acid", "role": "Treatment.Drug"}]}]}
{"id": "train-2727", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Vanishing bile duct and Stevens-Johnson syndrome", "role": "Effect"}, {"name": "ciprofloxacin", "role": "Treatment"}, {"name": "ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2728", "event": [{"trigger": "improve.", "type": "potential_therapeutic_event", "arguments": [{"name": "Antiasthmatic medications were prescribed", "role": "Treatment"}, {"name": "asthma", "role": "Treatment.Disorder"}, {"name": "Antiasthmatic medications", "role": "Treatment.Drug"}]}]}
{"id": "train-2729", "event": [{"trigger": "used", "type": "adverse_event", "arguments": [{"name": "a proportion of patients", "role": "Subject"}, {"name": "hepatotoxicity", "role": "Effect"}, {"name": "6-MP and AZA", "role": "Treatment"}, {"name": "AZA", "role": "Treatment.Drug"}, {"name": "6-MP", "role": "Treatment.Drug"}, {"name": "6-MP", "role": "Combination.Drug"}, {"name": "AZA", "role": "Combination.Drug"}]}]}
{"id": "train-2730", "event": [{"trigger": "treat", "type": "potential_therapeutic_event", "arguments": [{"name": "postmenopausal women with osteoporosis", "role": "Subject"}, {"name": "osteoporosis", "role": "Subject.Disorder"}, {"name": "increase bone mineral density (BMD)", "role": "Effect"}, {"name": "decrease biochemical markers of bone turnover", "role": "Effect"}, {"name": "Both raloxifene (RLX) and alendronate (ALN)", "role": "Treatment"}, {"name": "vertebral fractures", "role": "Treatment.Disorder"}, {"name": "raloxifene", "role": "Treatment.Drug"}, {"name": "alendronate", "role": "Treatment.Drug"}]}]}
{"id": "train-2731", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "a patient suffering from rheumatoid arthritis", "role": "Subject"}, {"name": "respiratory failure", "role": "Effect"}, {"name": "gold salt", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "gold", "role": "Treatment.Drug"}]}]}
{"id": "train-2732", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "a 32 year old hypertensive woman", "role": "Subject"}, {"name": "32 year old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "rupture of a cerebral arterial aneurysm", "role": "Effect"}, {"name": "nifedipine treatment", "role": "Treatment"}, {"name": "hypertensive", "role": "Treatment.Disorder"}, {"name": "nifedipine", "role": "Treatment.Drug"}]}]}
{"id": "train-2733", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "severe angioedematous reaction", "role": "Effect"}, {"name": "BP topical application", "role": "Treatment"}, {"name": "BP topical application", "role": "Treatment.Drug"}]}]}
{"id": "train-2734", "event": [{"trigger": "reduced", "type": "potential_therapeutic_event", "arguments": [{"name": "bone turnover more than either drug alone, resulting in greater BMD increment", "role": "Effect"}, {"name": "RLX+ALN", "role": "Treatment"}, {"name": "RLX+ALN", "role": "Treatment"}, {"name": "RLX+ALN", "role": "Treatment.Drug"}, {"name": "RLX+ALN", "role": "Treatment.Drug"}, {"name": "RLX+ALN", "role": "Combination.Drug"}, {"name": "RLX+ALN", "role": "Combination.Drug"}]}]}
{"id": "train-2735", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "three cases", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "Hepatotoxicity", "role": "Effect"}, {"name": "itraconazole", "role": "Treatment"}, {"name": "itraconazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2736", "event": [{"trigger": "occurred", "type": "adverse_event", "arguments": [{"name": "colon perforation", "role": "Effect"}, {"name": "intraperitoneal chromic phosphate", "role": "Treatment"}, {"name": "chromic phosphate", "role": "Treatment.Drug"}, {"name": "4 months", "role": "Treatment.Time_elapsed"}, {"name": "intraperitoneal", "role": "Treatment.Route"}, {"name": "stage IB ovarian papillary serous cystadenocarcinoma", "role": "Treatment.Disorder"}]}]}
{"id": "train-2737", "event": [{"trigger": "withdrawal", "type": "adverse_event", "arguments": [{"name": "subset of patients with progressing metastatic carcinoma of the prostate", "role": "Subject"}, {"name": "decrease in prostate-specific antigen (PSA)", "role": "Effect"}, {"name": "flutamide", "role": "Treatment"}, {"name": "progressing metastatic carcinoma of the prostate", "role": "Treatment.Disorder"}, {"name": "flutamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2738", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Bradycardia and congestive heart failure", "role": "Effect"}, {"name": "ocular timolol maleate", "role": "Treatment"}, {"name": "ocular", "role": "Treatment.Route"}, {"name": "timolol maleate", "role": "Treatment.Drug"}]}]}
{"id": "train-2739", "event": [{"trigger": "risk", "type": "adverse_event", "arguments": [{"name": "carotid insufficiency, coagulopathy and poorly controlled diabetes mellitus", "role": "Effect"}, {"name": "intravitreal injections of bevacizumab", "role": "Treatment"}, {"name": "bevacizumab", "role": "Treatment.Drug"}, {"name": "intravitreal injections", "role": "Treatment.Route"}]}]}
{"id": "train-2740", "event": [{"trigger": "result", "type": "adverse_event", "arguments": [{"name": "serotonin toxicity", "role": "Effect"}, {"name": "metaxalone abuse", "role": "Treatment"}, {"name": "using a selective serotonin reuptake inhibitor therapeutically", "role": "Treatment"}, {"name": "metaxalone", "role": "Treatment.Drug"}, {"name": "selective serotonin reuptake inhibitor", "role": "Treatment.Drug"}, {"name": "abuse", "role": "Treatment.Dosage"}, {"name": "metaxalone", "role": "Combination.Drug"}, {"name": "selective serotonin reuptake inhibitor", "role": "Combination.Drug"}]}]}
{"id": "train-2741", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "posterior reversible encephalopathy syndrome (PRES)", "role": "Effect"}, {"name": "L-asparaginase treatment", "role": "Treatment"}, {"name": "L-asparaginase", "role": "Treatment.Drug"}]}]}
{"id": "train-2742", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "Eruptive epidermoid cysts", "role": "Effect"}, {"name": "imiquimod", "role": "Treatment"}, {"name": "imiquimod", "role": "Treatment.Drug"}]}]}
{"id": "train-2743", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "hyponatremia", "role": "Effect"}, {"name": "Carbamazepine", "role": "Treatment"}, {"name": "Carbamazepine", "role": "Treatment.Drug"}]}]}
{"id": "train-2744", "event": [{"trigger": "complication", "type": "adverse_event", "arguments": [{"name": "Fulminant hepatic failure", "role": "Effect"}, {"name": "disulfiram", "role": "Treatment"}, {"name": "alcoholism", "role": "Treatment.Disorder"}, {"name": "disulfiram", "role": "Treatment.Drug"}]}]}
{"id": "train-2745", "event": [{"trigger": "increased", "type": "adverse_event", "arguments": [{"name": "toxicity", "role": "Effect"}, {"name": "ropivacaine", "role": "Treatment"}, {"name": "inhibitors of CYP1A2", "role": "Treatment"}, {"name": "ropivacaine", "role": "Treatment.Drug"}, {"name": "inhibitors of CYP1A2", "role": "Treatment.Drug"}, {"name": "inhibitors of CYP1A2", "role": "Combination.Drug"}, {"name": "ropivacaine", "role": "Combination.Drug"}]}]}
{"id": "train-2746", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Reye-like syndrome", "role": "Effect"}, {"name": "calcium hopantenate", "role": "Treatment"}, {"name": "calcium hopantenate", "role": "Treatment.Drug"}]}]}
{"id": "train-2747", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Hepatopathy subsided", "role": "Effect"}, {"name": "carbamazepine", "role": "Treatment"}, {"name": "lynestrenol", "role": "Treatment"}, {"name": "cessation", "role": "Treatment.Dosage"}, {"name": "carbamazepine", "role": "Treatment.Drug"}, {"name": "lynestrenol", "role": "Treatment.Drug"}, {"name": "lynestrenol", "role": "Combination.Drug"}, {"name": "carbamazepine", "role": "Combination.Drug"}]}]}
{"id": "train-2748", "event": [{"trigger": "resulting", "type": "adverse_event", "arguments": [{"name": "a patient with hypoparathyroidism", "role": "Subject"}, {"name": "two admissions to the hospital for milk-alkali syndrome", "role": "Effect"}, {"name": "calcium carbonate and calcitriol", "role": "Treatment"}, {"name": "hypoparathyroidism", "role": "Treatment.Disorder"}, {"name": "calcium carbonate", "role": "Treatment.Drug"}, {"name": "calcitriol", "role": "Treatment.Drug"}, {"name": "calcium carbonate", "role": "Combination.Drug"}, {"name": "calcitriol", "role": "Combination.Drug"}]}]}
{"id": "train-2749", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Recurrent hyponatremia", "role": "Effect"}, {"name": "citalopram and mirtazapine", "role": "Treatment"}, {"name": "citalopram", "role": "Treatment.Drug"}, {"name": "mirtazapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2750", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "a sharp rise in International Normalized Ratio (INR) values", "role": "Effect"}, {"name": "concomitant use of warfarin and the antineoplastic agent vismodegib", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "vismodegib", "role": "Treatment.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}, {"name": "vismodegib", "role": "Combination.Drug"}]}]}
{"id": "train-2751", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a case of juvenile idiopathic arthritis patient", "role": "Subject"}, {"name": "juvenile", "role": "Subject.Age"}, {"name": "thymic enlargement (true thymic hyperplasia), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms", "role": "Effect"}, {"name": "Etanercept", "role": "Treatment"}, {"name": "idiopathic arthritis", "role": "Treatment.Disorder"}, {"name": "Etanercept", "role": "Treatment.Drug"}]}]}
{"id": "train-2752", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 52-year-old woman", "role": "Subject"}, {"name": "52-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "symmetric sensorimotor polyneuropathy", "role": "Effect"}, {"name": "cerebellar syndrome", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "24 months", "role": "Treatment.Time_elapsed"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2753", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient under tibolone therapy", "role": "Subject"}, {"name": "a mixed-type liver injury with prolonged cholestasis and features of the vanishing bile duct syndrome", "role": "Effect"}, {"name": "under tibolone therapy", "role": "Treatment"}, {"name": "a ten weeks treatment with St. John wort (Hypericum Perforatum) infusions", "role": "Treatment"}, {"name": "Hypericum Perforatum", "role": "Treatment.Drug"}, {"name": "tibolone", "role": "Treatment.Drug"}, {"name": "infusions", "role": "Treatment.Route"}, {"name": "ten weeks", "role": "Treatment.Duration"}, {"name": "tibolone", "role": "Combination.Drug"}, {"name": "Hypericum Perforatum", "role": "Combination.Drug"}]}]}
{"id": "train-2754", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "diffuse papular eruption", "role": "Effect"}, {"name": "methotrexate injections", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "injections", "role": "Treatment.Route"}, {"name": "psoriasis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2755", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a patient with dihydropyrimidine dehydrogenase deficiency", "role": "Subject"}, {"name": "neurotoxicity", "role": "Effect"}, {"name": "5-fluorouracil", "role": "Treatment"}, {"name": "5-fluorouracil", "role": "Treatment.Drug"}, {"name": "dihydropyrimidine dehydrogenase deficiency", "role": "Treatment.Disorder"}]}]}
{"id": "train-2756", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "case", "role": "Subject"}, {"name": "Life-threatening interstitial lung disease", "role": "Effect"}, {"name": "trastuzumab", "role": "Treatment"}, {"name": "trastuzumab", "role": "Treatment.Drug"}]}]}
{"id": "train-2757", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "neuropathy", "role": "Effect"}, {"name": "proximal weakness", "role": "Effect"}, {"name": "Thalidomide", "role": "Treatment"}, {"name": "Thalidomide", "role": "Treatment.Drug"}]}]}
{"id": "train-2758", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "Crohn's disease", "role": "Effect"}, {"name": "long-term immunosuppression", "role": "Effect"}, {"name": "Copaxone", "role": "Treatment"}, {"name": "Copaxone", "role": "Treatment.Drug"}]}]}
{"id": "train-2759", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Acute vision loss", "role": "Effect"}, {"name": "ocular ischemic syndrome", "role": "Effect"}, {"name": "intravitreal injection of bevacizumab (avastin)", "role": "Treatment"}, {"name": "intravitreal injection", "role": "Treatment.Route"}, {"name": "bevacizumab", "role": "Treatment.Drug"}]}]}
{"id": "train-2760", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "persistent late onset asthma", "role": "Effect"}, {"name": "captopril", "role": "Treatment"}, {"name": "captopril", "role": "Treatment.Drug"}]}]}
{"id": "train-2761", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "a patient with AIDS", "role": "Subject"}, {"name": "AIDS", "role": "Subject.Disorder"}, {"name": "medical attention with pancytopenia", "role": "Effect"}, {"name": "48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (R-EPOCH)", "role": "Treatment"}, {"name": "diffuse large B-cell lymphoma", "role": "Treatment.Disorder"}, {"name": "48 months", "role": "Treatment.Duration"}, {"name": "etoposide", "role": "Treatment.Drug"}, {"name": "prednisone", "role": "Treatment.Drug"}, {"name": "vincristine", "role": "Treatment.Drug"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "doxorubicin", "role": "Treatment.Drug"}, {"name": "rituximab", "role": "Treatment.Drug"}, {"name": "etoposide", "role": "Combination.Drug"}, {"name": "prednisone", "role": "Combination.Drug"}, {"name": "vincristine", "role": "Combination.Drug"}, {"name": "cyclophosphamide", "role": "Combination.Drug"}, {"name": "doxorubicin", "role": "Combination.Drug"}, {"name": "rituximab", "role": "Combination.Drug"}]}]}
{"id": "train-2762", "event": [{"trigger": "reported", "type": "adverse_event", "arguments": [{"name": "prolongation of 5-FU half-life and an increase in INR", "role": "Effect"}, {"name": "the concurrent use of 5-FU and warfarin", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "5-FU", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-2763", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Graves' hyperthyroidism following transient thyrotoxicosis", "role": "Effect"}, {"name": "interferon", "role": "Treatment"}, {"name": "interferon", "role": "Treatment.Drug"}, {"name": "chronic hepatitis type C.", "role": "Treatment.Disorder"}]}]}
{"id": "train-2764", "event": [{"trigger": "attributed", "type": "adverse_event", "arguments": [{"name": "a 50-year-old woman", "role": "Subject"}, {"name": "50-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "acute generalized exanthematous pustulosis (AGEP)", "role": "Effect"}, {"name": "ingestion of nimesulide", "role": "Treatment"}, {"name": "nimesulide", "role": "Treatment.Drug"}, {"name": "ingestion", "role": "Treatment.Route"}]}]}
{"id": "train-2765", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "patients", "role": "Subject"}, {"name": "sub-acute toxic leukoencephalopathy", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2766", "event": [{"trigger": "treatment", "type": "adverse_event", "arguments": [{"name": "oral mucosa pigmentation", "role": "Effect"}, {"name": "topical tacrolimus", "role": "Treatment"}, {"name": "tacrolimus", "role": "Treatment.Drug"}, {"name": "OLP", "role": "Treatment.Disorder"}, {"name": "topical", "role": "Treatment.Route"}]}]}
{"id": "train-2767", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Progressive hypoxemia", "role": "Effect"}, {"name": "led to death", "role": "Effect"}, {"name": "rituximab administration", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}, {"name": "1 week", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2768", "event": [{"trigger": "showed.", "type": "adverse_event", "arguments": [{"name": "hyperpotassemia", "role": "Effect"}, {"name": "Angiotensin converting enzyme blockers", "role": "Treatment"}, {"name": "Angiotensin converting enzyme blockers", "role": "Treatment.Drug"}]}]}
{"id": "train-2769", "event": [{"trigger": "precipitated", "type": "adverse_event", "arguments": [{"name": "serotonin toxicity", "role": "Effect"}, {"name": "methylene blue", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment"}, {"name": "methylene blue", "role": "Treatment.Drug"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "methylene blue", "role": "Combination.Drug"}, {"name": "venlafaxine", "role": "Combination.Drug"}]}]}
{"id": "train-2770", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "diffuse and severe interstitial pneumonitis", "role": "Effect"}, {"name": "accelerated usual interstitial pneumonia", "role": "Effect"}, {"name": "toxicity", "role": "Effect"}, {"name": "drug", "role": "Treatment"}, {"name": "drug", "role": "Treatment.Drug"}]}]}
{"id": "train-2771", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "an 11-year-old girl", "role": "Subject"}, {"name": "11-year-old", "role": "Subject.Age"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "hypotension", "role": "Effect"}, {"name": "intravenous valproate", "role": "Treatment"}, {"name": "status epilepticus", "role": "Treatment.Disorder"}, {"name": "intravenous", "role": "Treatment.Route"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-2772", "event": [{"trigger": "Relief", "type": "potential_therapeutic_event", "arguments": [{"name": "post-cholecystectomy patient.", "role": "Subject"}, {"name": "naloxone", "role": "Treatment"}, {"name": "morphine-induced spasm of the sphincter of Oddi", "role": "Treatment.Disorder"}, {"name": "naloxone", "role": "Treatment.Drug"}]}]}
{"id": "train-2773", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "gastric mucosa foveolar hyperplasia", "role": "Effect"}, {"name": "prolonged PGE1 therapy", "role": "Treatment"}, {"name": "PGE1", "role": "Treatment.Drug"}, {"name": "prolonged", "role": "Treatment.Duration"}]}]}
{"id": "train-2774", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "TTP", "role": "Effect"}, {"name": "penicillamine", "role": "Treatment"}, {"name": "penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2775", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Alternating sinus rhythm and intermittent sinoatrial block", "role": "Effect"}, {"name": "propranolol", "role": "Treatment"}, {"name": "propranolol", "role": "Treatment.Drug"}]}]}
{"id": "train-2776", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "increase in the theophylline level", "role": "Effect"}, {"name": "zafirlukast administration", "role": "Treatment"}, {"name": "zafirlukast", "role": "Treatment.Drug"}]}]}
{"id": "train-2777", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "antithrombin III deficiency", "role": "Effect"}, {"name": "asparaginase", "role": "Treatment"}, {"name": "asparaginase", "role": "Treatment.Drug"}]}]}
{"id": "train-2778", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "fulminant hepatic failure", "role": "Effect"}, {"name": "Troglitazone", "role": "Treatment"}, {"name": "Troglitazone", "role": "Treatment.Drug"}]}]}
{"id": "train-2779", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A sixty-year-old woman with advanced breast cancer, previously treated with cisplatin", "role": "Subject"}, {"name": "sixty-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "an irreversible lethal renal failure with anuria", "role": "Effect"}, {"name": "the day after 5 g/m2 bolus ifosfamide", "role": "Treatment"}, {"name": "advanced breast cancer", "role": "Treatment.Disorder"}, {"name": "the day after", "role": "Treatment.Time_elapsed"}, {"name": "5 g/m2", "role": "Treatment.Dosage"}, {"name": "ifosfamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2780", "event": [{"trigger": "produced", "type": "adverse_event", "arguments": [{"name": "infectious mononucleosis-like syndrome", "role": "Effect"}, {"name": "minocycline ingestion", "role": "Treatment"}, {"name": "ingestion", "role": "Treatment.Route"}, {"name": "minocycline", "role": "Treatment.Drug"}]}]}
{"id": "train-2781", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "High-grade endometrial stromal sarcoma", "role": "Effect"}, {"name": "tamoxifen", "role": "Treatment"}, {"name": "tamoxifen", "role": "Treatment.Drug"}, {"name": "breast cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2782", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "dyserythropoietic anaemia", "role": "Effect"}, {"name": "long-term linezolid", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Duration"}]}]}
{"id": "train-2783", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "granulocytopenia", "role": "Effect"}, {"name": "Dipyrone", "role": "Treatment"}, {"name": "Dipyrone", "role": "Treatment.Drug"}]}]}
{"id": "train-2784", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "a patient with chronic hepatitis C infection", "role": "Subject"}, {"name": "severe anaemia", "role": "Effect"}, {"name": "peginterferon alfa/ribavirin", "role": "Treatment"}, {"name": "oseltamivir", "role": "Treatment"}, {"name": "chronic hepatitis C infection", "role": "Treatment.Disorder"}, {"name": "influenza", "role": "Treatment.Disorder"}, {"name": "peginterferon alfa", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "oseltamivir", "role": "Treatment.Drug"}, {"name": "peginterferon alfa", "role": "Combination.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}, {"name": "oseltamivir", "role": "Combination.Drug"}]}]}
{"id": "train-2785", "event": [{"trigger": "resulted", "type": "potential_therapeutic_event", "arguments": [{"name": "Both patients", "role": "Subject"}, {"name": "neither a relapse of the colitis nor a recurrence of the malignancies", "role": "Effect"}, {"name": "carboplatin", "role": "Treatment"}, {"name": "carboplatin", "role": "Treatment.Drug"}, {"name": "colitis", "role": "Treatment.Disorder"}, {"name": "malignancies", "role": "Treatment.Disorder"}]}]}
{"id": "train-2786", "event": [{"trigger": "develop", "type": "adverse_event", "arguments": [{"name": "toxicities", "role": "Effect"}, {"name": "anticonvulsants", "role": "Treatment"}, {"name": "anticonvulsants", "role": "Treatment.Drug"}]}]}
{"id": "train-2787", "event": [{"trigger": "increase", "type": "adverse_event", "arguments": [{"name": "QT interval causing torsades de pointes", "role": "Effect"}, {"name": "dofetilide", "role": "Treatment"}, {"name": "dofetilide", "role": "Treatment.Drug"}]}]}
{"id": "train-2788", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "nephrotic syndrome", "role": "Effect"}, {"name": "the bone marrow still remained completely remitted", "role": "Effect"}, {"name": "chemotherapy, including M-CSF", "role": "Treatment"}, {"name": "M-CSF", "role": "Treatment.Drug"}]}]}
{"id": "train-2789", "event": [{"trigger": "complained", "type": "adverse_event", "arguments": [{"name": "a patient with human immunodeficiency virus infection", "role": "Subject"}, {"name": "human immunodeficiency virus infection", "role": "Subject.Disorder"}, {"name": "thirst and polyuria", "role": "Effect"}, {"name": "foscarnet", "role": "Treatment"}, {"name": "CMV retinitis", "role": "Treatment.Disorder"}, {"name": "foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-2790", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "nonconvulsive status epilepticus", "role": "Effect"}, {"name": "ifosfamide", "role": "Treatment"}, {"name": "ifosfamide", "role": "Treatment.Drug"}]}]}
{"id": "train-2791", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "Headaches", "role": "Effect"}, {"name": "capecitabine", "role": "Treatment"}, {"name": "capecitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2792", "event": [{"trigger": "remained", "type": "potential_therapeutic_event", "arguments": [{"name": "the child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "urticaria vanished", "role": "Effect"}, {"name": "symptom-free", "role": "Effect"}, {"name": "DSCG was withdrawn", "role": "Treatment"}, {"name": "DSCG", "role": "Treatment.Drug"}]}]}
{"id": "train-2793", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "a child", "role": "Subject"}, {"name": "child", "role": "Subject.Age"}, {"name": "Hepatotoxic effects", "role": "Effect"}, {"name": "valproate and carnitine", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}, {"name": "carnitine", "role": "Treatment.Drug"}, {"name": "valproate", "role": "Combination.Drug"}, {"name": "carnitine", "role": "Combination.Drug"}]}]}
{"id": "train-2794", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "Graves' hyperthyroidism", "role": "Effect"}, {"name": "long-term interferon (IFN) therapy", "role": "Treatment"}, {"name": "long-term", "role": "Treatment.Time_elapsed"}, {"name": "interferon", "role": "Treatment.Drug"}]}]}
{"id": "train-2795", "event": [{"trigger": "simulating", "type": "adverse_event", "arguments": [{"name": "childhood cancer", "role": "Subject"}, {"name": "childhood", "role": "Subject.Age"}, {"name": "metastatic nodules to the lungs", "role": "Effect"}, {"name": "Bleomycin and cyclophosphamide toxicity", "role": "Treatment"}, {"name": "cancer", "role": "Treatment.Disorder"}, {"name": "Bleomycin", "role": "Treatment.Drug"}, {"name": "cyclophosphamide", "role": "Treatment.Drug"}, {"name": "cyclophosphamide", "role": "Combination.Drug"}, {"name": "Bleomycin", "role": "Combination.Drug"}]}]}
{"id": "train-2796", "event": [{"trigger": "presented", "type": "adverse_event", "arguments": [{"name": "The patient", "role": "Subject"}, {"name": "fulminant microangiopathic hemolytic anemia and thrombocytopenia", "role": "Effect"}, {"name": "within 48 hr of initiating therapy with trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "48 hr", "role": "Treatment.Time_elapsed"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "trimethoprim", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}]}]}
{"id": "train-2797", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "asthmatic patients", "role": "Subject"}, {"name": "Pneumocystis pneumonia", "role": "Effect"}, {"name": "fever, pulmonary infiltrates, and hypoxia", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "asthmatic", "role": "Treatment.Disorder"}]}]}
{"id": "train-2798", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Acute respiratory distress syndrome", "role": "Effect"}, {"name": "rituximab infusion", "role": "Treatment"}, {"name": "rituximab", "role": "Treatment.Drug"}, {"name": "infusion", "role": "Treatment.Route"}]}]}
{"id": "train-2799", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "recall pneumonitis", "role": "Effect"}, {"name": "Gemcitabine", "role": "Treatment"}, {"name": "Gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2800", "event": [{"trigger": "observed.", "type": "adverse_event", "arguments": [{"name": "a 61-year-old man", "role": "Subject"}, {"name": "61-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "interstitial pneumopathy", "role": "Effect"}, {"name": "chronic low-dosage amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "low-dosage", "role": "Treatment.Dosage"}]}]}
{"id": "train-2801", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 75-year-old man", "role": "Subject"}, {"name": "75-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "bilateral lower leg edema", "role": "Effect"}, {"name": "6 months after switching from troglitazone to pioglitazone", "role": "Treatment"}, {"name": "pioglitazone", "role": "Treatment.Drug"}, {"name": "6 months", "role": "Treatment.Drug"}, {"name": "troglitazone", "role": "Treatment.Drug"}]}]}
{"id": "train-2802", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "An acute ischaemic event", "role": "Effect"}, {"name": "venlafaxine", "role": "Treatment"}, {"name": "venlafaxine", "role": "Treatment.Drug"}]}]}
{"id": "train-2803", "event": [{"trigger": "post-exposure prophylaxis", "type": "potential_therapeutic_event", "arguments": [{"name": "Oseltamivir", "role": "Treatment"}, {"name": "H1N1", "role": "Treatment.Disorder"}, {"name": "Oseltamivir", "role": "Treatment.Drug"}]}]}
{"id": "train-2804", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "severe and prolonged hypoglycemia", "role": "Effect"}, {"name": "long-acting octreotide treatment", "role": "Treatment"}, {"name": "octreotide", "role": "Treatment.Drug"}]}]}
{"id": "train-2805", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "a renal transplant patient", "role": "Subject"}, {"name": "Worsening pneumonitis", "role": "Effect"}, {"name": "pharmacokinetic drug-drug interaction between everolimus and voriconazole", "role": "Treatment"}, {"name": "everolimus", "role": "Treatment.Drug"}, {"name": "voriconazole", "role": "Treatment.Drug"}, {"name": "renal transplant", "role": "Treatment.Disorder"}, {"name": "everolimus", "role": "Combination.Drug"}, {"name": "voriconazole", "role": "Combination.Drug"}]}]}
{"id": "train-2806", "event": [{"trigger": "consequence", "type": "adverse_event", "arguments": [{"name": "Vocal cord paralysis", "role": "Effect"}, {"name": "peritonsillar infiltration with bupivacaine", "role": "Treatment"}, {"name": "peritonsillar infiltration", "role": "Treatment.Route"}, {"name": "bupivacaine", "role": "Treatment.Drug"}]}]}
{"id": "train-2807", "event": [{"trigger": "drug-trigger", "type": "adverse_event", "arguments": [{"name": "erythema multiforme and Stevens-Johnson syndrome", "role": "Effect"}, {"name": "sulfonamides", "role": "Treatment"}, {"name": "sulfonamides", "role": "Treatment.Drug"}]}]}
{"id": "train-2808", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Edema", "role": "Effect"}, {"name": "ibuprofen", "role": "Treatment"}, {"name": "ibuprofen", "role": "Treatment.Drug"}]}]}
{"id": "train-2809", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A patient is presented with typical hyperthyroidism", "role": "Subject"}, {"name": "severe proximal muscle weakness and a raised creatine phosphokinase", "role": "Effect"}, {"name": "treatment for hyperthyroidism with propylthiouracil (100 mg orally, three times a day)", "role": "Treatment"}, {"name": "hyperthyroidism", "role": "Treatment.Disorder"}, {"name": "typical hyperthyroidism", "role": "Treatment.Disorder"}, {"name": "propylthiouracil", "role": "Treatment.Drug"}, {"name": "100 mg", "role": "Treatment.Dosage"}, {"name": "orally", "role": "Treatment.Route"}, {"name": "three times a day", "role": "Treatment.Freq"}]}]}
{"id": "train-2810", "event": [{"trigger": "treatment", "type": "potential_therapeutic_event", "arguments": [{"name": "most potent", "role": "Effect"}, {"name": "Atorvastatin", "role": "Treatment"}, {"name": "hyperlipidemia", "role": "Treatment.Disorder"}, {"name": "Atorvastatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2811", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "acute interstitial nephritis", "role": "Effect"}, {"name": "ampicillin", "role": "Treatment"}, {"name": "ampicillin", "role": "Treatment.Drug"}]}]}
{"id": "train-2812", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "Optic neuropathy", "role": "Effect"}, {"name": "ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}, {"name": "renal tuberculosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2813", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "necrotizing fasciitis and myonecrosis", "role": "Effect"}, {"name": "sodium warfarin", "role": "Treatment"}, {"name": "sodium warfarin", "role": "Treatment.Drug"}]}]}
{"id": "train-2814", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "severe hypomagnesemia and other electrolyte disorders", "role": "Effect"}, {"name": "foscarnet", "role": "Treatment"}, {"name": "foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-2815", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "akathisia", "role": "Effect"}, {"name": "fluvoxamine", "role": "Treatment"}, {"name": "fluvoxamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2816", "event": [{"trigger": "associated with", "type": "adverse_event", "arguments": [{"name": "Nephrotic syndrome", "role": "Effect"}, {"name": "interferon-beta-1b therapy", "role": "Treatment"}, {"name": "interferon-beta-1b", "role": "Treatment.Drug"}, {"name": "multiple sclerosis.", "role": "Treatment.Disorder"}]}]}
{"id": "train-2817", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 48-year-old woman", "role": "Subject"}, {"name": "48-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "disfiguring facial edema", "role": "Effect"}, {"name": "10 weeks", "role": "Treatment"}, {"name": "antiviral therapy with peginterferon alfa-2a and ribavirin", "role": "Treatment"}, {"name": "chronic hepatitis C infection", "role": "Treatment.Disorder"}, {"name": "10 weeks", "role": "Treatment.Time_elapsed"}, {"name": "peginterferon alfa-2a", "role": "Treatment.Drug"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "peginterferon alfa-2a", "role": "Combination.Drug"}, {"name": "ribavirin", "role": "Combination.Drug"}]}]}
{"id": "train-2818", "event": [{"trigger": "lost", "type": "adverse_event", "arguments": [{"name": "Two of these patients", "role": "Subject"}, {"name": "Two", "role": "Subject.Population"}, {"name": "lost consciousness for 48-72 h and then fully recovered", "role": "Effect"}, {"name": "anti-emetic prochlorperazine", "role": "Treatment"}, {"name": "prochlorperazine", "role": "Treatment.Drug"}]}]}
{"id": "train-2819", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "depressive patient", "role": "Subject"}, {"name": "mild parkinsonian signs and camptocormia", "role": "Effect"}, {"name": "introduction of olanzapine", "role": "Treatment"}, {"name": "olanzapine", "role": "Treatment.Drug"}, {"name": "depressive", "role": "Treatment.Disorder"}]}]}
{"id": "train-2820", "event": [{"trigger": "use", "type": "adverse_event", "arguments": [{"name": "bone fluorosis", "role": "Effect"}, {"name": "nicotinic derivative", "role": "Treatment"}, {"name": "nicotinic derivative", "role": "Treatment.Drug"}]}]}
{"id": "train-2821", "event": [{"trigger": "to", "type": "adverse_event", "arguments": [{"name": "Jehovah's Witness patient", "role": "Subject"}, {"name": "Thrombotic Thrombocytopenic Purpura", "role": "Effect"}, {"name": "allergic response", "role": "Effect"}, {"name": "trimethoprim-sulfamethoxazole", "role": "Treatment"}, {"name": "trimethoprim", "role": "Treatment.Drug"}, {"name": "sulfamethoxazole", "role": "Treatment.Drug"}, {"name": "trimethoprim", "role": "Combination.Drug"}, {"name": "sulfamethoxazole", "role": "Combination.Drug"}]}]}
{"id": "train-2822", "event": [{"trigger": "treated", "type": "potential_therapeutic_event", "arguments": [{"name": "A 25-year-old white woman with chronic depression", "role": "Subject"}, {"name": "25-year-old", "role": "Subject.Age"}, {"name": "white", "role": "Subject.Race"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "venlafaxine 150 mg/d and trimipramine 50 mg/d", "role": "Treatment"}, {"name": "chronic depression", "role": "Treatment.Disorder"}, {"name": "venlafaxine", "role": "Treatment.Drug"}, {"name": "trimipramine", "role": "Treatment.Drug"}, {"name": "150 mg/d", "role": "Treatment.Dosage"}, {"name": "50 mg/d", "role": "Treatment.Dosage"}, {"name": "venlafaxine", "role": "Combination.Drug"}, {"name": "trimipramine", "role": "Combination.Drug"}]}]}
{"id": "train-2823", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A 31-year-old female", "role": "Subject"}, {"name": "31-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "multiple episodes of grand mal seizures", "role": "Effect"}, {"name": "combination chemotherapy with cisplatin, vinblastine and bleomycin", "role": "Treatment"}, {"name": "germ cell ovarian cancer stage Ic", "role": "Treatment.Disorder"}, {"name": "bleomycin", "role": "Treatment.Drug"}, {"name": "vinblastine", "role": "Treatment.Drug"}, {"name": "cisplatin", "role": "Treatment.Drug"}, {"name": "cisplatin", "role": "Combination.Drug"}, {"name": "vinblastine", "role": "Combination.Drug"}, {"name": "bleomycin", "role": "Combination.Drug"}]}]}
{"id": "train-2824", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "Nephrogenic diabetes insipidus and renal tubular acidosis", "role": "Effect"}, {"name": "foscarnet", "role": "Treatment"}, {"name": "foscarnet", "role": "Treatment.Drug"}]}]}
{"id": "train-2825", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "angle-closure glaucoma (TiACG)", "role": "Effect"}, {"name": "Topiramate", "role": "Treatment"}, {"name": "Topiramate", "role": "Treatment.Drug"}]}]}
{"id": "train-2826", "event": [{"trigger": "managed", "type": "potential_therapeutic_event", "arguments": [{"name": "lorazepam", "role": "Treatment"}, {"name": "seizures", "role": "Treatment.Disorder"}, {"name": "lorazepam", "role": "Treatment.Drug"}]}]}
{"id": "train-2827", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "an indigent patient", "role": "Subject"}, {"name": "thrombocytopenia", "role": "Effect"}, {"name": "rifampin", "role": "Treatment"}, {"name": "after a four-month lapse in therapy for pulmonary tuberculosis", "role": "Treatment"}, {"name": "rifampin", "role": "Treatment.Drug"}, {"name": "four-month", "role": "Treatment.Time_elapsed"}, {"name": "pulmonary tuberculosis", "role": "Treatment.Disorder"}]}]}
{"id": "train-2828", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "psychosis resulted", "role": "Effect"}, {"name": "administration of quinacrine hydrochloride at a dosage of 100 mg twice daily", "role": "Treatment"}, {"name": "100 mg", "role": "Treatment.Dosage"}, {"name": "twice daily", "role": "Treatment.Freq"}, {"name": "discoid lupus", "role": "Treatment.Disorder"}, {"name": "quinacrine hydrochloride", "role": "Treatment.Drug"}]}]}
{"id": "train-2829", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "a scleroderma-like reaction", "role": "Effect"}, {"name": "long-term administration of UFT", "role": "Treatment"}, {"name": "long-term", "role": "Treatment.Duration"}, {"name": "UFT", "role": "Treatment.Drug"}]}]}
{"id": "train-2830", "event": [{"trigger": "in", "type": "adverse_event", "arguments": [{"name": "had a history of mediastinal radiation without subcarinal blocking", "role": "Subject"}, {"name": "mediastinal radiation without subcarinal blocking", "role": "Subject.Disorder"}, {"name": "four", "role": "Subject.Population"}, {"name": "hemodynamically significant pericardial effusion", "role": "Effect"}, {"name": "gemcitabine", "role": "Treatment"}, {"name": "refractory lymphoma", "role": "Treatment.Disorder"}, {"name": "gemcitabine", "role": "Treatment.Drug"}]}]}
{"id": "train-2831", "event": [{"trigger": "improved", "type": "potential_therapeutic_event", "arguments": [{"name": "Both had impaired lung function and abnormal computed tomographic scans", "role": "Subject"}, {"name": "Both", "role": "Subject.Population"}, {"name": "abnormal computed tomographic scans", "role": "Subject.Disorder"}, {"name": "nitrofurantoin was withdrawn and corticosteroid treatment commenced", "role": "Treatment"}, {"name": "corticosteroid", "role": "Treatment.Drug"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}, {"name": "impaired lung function", "role": "Treatment.Disorder"}]}]}
{"id": "train-2832", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "multiple squamous cell carcinomas and diffuse nail hyperpigmentation", "role": "Effect"}, {"name": "hydroxyurea", "role": "Treatment"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}]}]}
{"id": "train-2833", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "a patient", "role": "Subject"}, {"name": "prolonged QT", "role": "Effect"}, {"name": "oral methadone", "role": "Treatment"}, {"name": "methadone", "role": "Treatment.Drug"}, {"name": "oral", "role": "Treatment.Route"}, {"name": "chronic pain syndrome", "role": "Treatment.Disorder"}]}]}
{"id": "train-2834", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "a Japanese patient", "role": "Subject"}, {"name": "Japanese", "role": "Subject.Race"}, {"name": "severe interstitial pneumonia", "role": "Effect"}, {"name": "sorafenib", "role": "Treatment"}, {"name": "metastatic renal cell carcinoma", "role": "Treatment.Disorder"}, {"name": "sorafenib", "role": "Treatment.Drug"}]}]}
{"id": "train-2835", "event": [{"trigger": "occurs", "type": "adverse_event", "arguments": [{"name": "Neurotoxicity", "role": "Effect"}, {"name": "intermittent high dose 5-FU as bolus injection or 24- to 48-h infusions", "role": "Treatment"}, {"name": "high dose", "role": "Treatment.Dosage"}, {"name": "5-FU", "role": "Treatment.Drug"}, {"name": "injection", "role": "Treatment.Route"}, {"name": "infusions", "role": "Treatment.Route"}]}]}
{"id": "train-2836", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "increases in INR", "role": "Effect"}, {"name": "Lovastatin", "role": "Treatment"}, {"name": "Lovastatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2837", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "increased INR", "role": "Effect"}, {"name": "Pravastatin", "role": "Treatment"}, {"name": "combined with the anticoagulant fluindione", "role": "Treatment"}, {"name": "Pravastatin", "role": "Treatment.Drug"}, {"name": "anticoagulant fluindione", "role": "Treatment.Drug"}, {"name": "Pravastatin", "role": "Combination.Drug"}, {"name": "anticoagulant fluindione", "role": "Combination.Drug"}]}]}
{"id": "train-2838", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "schizophrenia", "role": "Effect"}, {"name": "Bromocriptine", "role": "Treatment"}, {"name": "Bromocriptine", "role": "Treatment.Drug"}]}]}
{"id": "train-2839", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Pulmonary toxicity", "role": "Effect"}, {"name": "erlotinib", "role": "Treatment"}, {"name": "erlotinib", "role": "Treatment.Drug"}]}]}
{"id": "train-2840", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "Multicentric hepatocellular carcinoma", "role": "Effect"}, {"name": "phosphate diethylstilbestrol", "role": "Treatment"}, {"name": "phosphate diethylstilbestrol", "role": "Treatment.Drug"}, {"name": "prostatic cancer", "role": "Treatment.Disorder"}]}]}
{"id": "train-2841", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "an elderly patient", "role": "Subject"}, {"name": "elderly", "role": "Subject.Age"}, {"name": "diabetic ketoacidosis", "role": "Effect"}, {"name": "quetiapine", "role": "Treatment"}, {"name": "quetiapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2842", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "57-year-old woman", "role": "Subject"}, {"name": "57-year-old", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "pulmonary sarcoidosis", "role": "Effect"}, {"name": "interferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes", "role": "Treatment"}, {"name": "advanced renal cell carcinoma metastatic to mediastinal lymph nodes", "role": "Treatment.Disorder"}, {"name": "interferon beta", "role": "Treatment.Drug"}]}]}
{"id": "train-2843", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hypersensitivity pneumonitis", "role": "Effect"}, {"name": "Mesalamine", "role": "Treatment"}, {"name": "Mesalamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2844", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "A girl with cystic fibrosis and cyclic neutropenia", "role": "Subject"}, {"name": "girl", "role": "Subject.Gender"}, {"name": "cystic fibrosis", "role": "Subject.Disorder"}, {"name": "erythematous papular eruption without fever or neutrophilia", "role": "Effect"}, {"name": "7 months after commencing therapy with G-CSF.", "role": "Treatment"}, {"name": "cyclic neutropenia", "role": "Treatment.Disorder"}, {"name": "G-CSF", "role": "Treatment.Drug"}, {"name": "7 months", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2845", "event": [{"trigger": "provoked", "type": "adverse_event", "arguments": [{"name": "Lichen planus and acne", "role": "Effect"}, {"name": "gold", "role": "Treatment"}, {"name": "gold", "role": "Treatment.Drug"}]}]}
{"id": "train-2846", "event": [{"trigger": "linked", "type": "adverse_event", "arguments": [{"name": "AML", "role": "Effect"}, {"name": "purine analogs, both with 2-chlorodeoxyadenosine", "role": "Treatment"}, {"name": "2-chlorodeoxyadenosine", "role": "Treatment.Drug"}, {"name": "HCL", "role": "Treatment.Disorder"}]}]}
{"id": "train-2847", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "CML", "role": "Effect"}, {"name": "treatment with hydroxyurea", "role": "Treatment"}, {"name": "hydroxyurea", "role": "Treatment.Drug"}]}]}
{"id": "train-2848", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "significant hypotension", "role": "Effect"}, {"name": "Intravenous valproate", "role": "Treatment"}, {"name": "status epilepticus", "role": "Treatment.Disorder"}, {"name": "Intravenous", "role": "Treatment.Route"}, {"name": "valproate", "role": "Treatment.Drug"}]}]}
{"id": "train-2849", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Torsade de pointes", "role": "Effect"}, {"name": "moxifloxacin", "role": "Treatment"}, {"name": "moxifloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2850", "event": [{"trigger": "due to", "type": "adverse_event", "arguments": [{"name": "a renal transplant recipient", "role": "Subject"}, {"name": "renal transplant", "role": "Subject.Disorder"}, {"name": "serious adverse effects", "role": "Effect"}, {"name": "interaction between orally administered voriconazole and everolimus", "role": "Treatment"}, {"name": "voriconazole", "role": "Treatment.Drug"}, {"name": "everolimus", "role": "Treatment.Drug"}, {"name": "orally", "role": "Treatment.Route"}, {"name": "voriconazole", "role": "Combination.Drug"}, {"name": "everolimus", "role": "Combination.Drug"}]}]}
{"id": "train-2851", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "Horner's syndrome and demyelinating peripheral neuropathy", "role": "Effect"}, {"name": "high-dose cytosine arabinoside", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "cytosine arabinoside", "role": "Treatment.Drug"}]}]}
{"id": "train-2852", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "radiation myelopathy", "role": "Effect"}, {"name": "high-dose busulfan", "role": "Treatment"}, {"name": "melphalan", "role": "Treatment"}, {"name": "high-dose", "role": "Treatment.Dosage"}, {"name": "busulfan", "role": "Treatment.Drug"}, {"name": "melphalan", "role": "Treatment.Drug"}, {"name": "Ewing's sarcoma:", "role": "Treatment.Disorder"}, {"name": "busulfan", "role": "Combination.Drug"}, {"name": "melphalan", "role": "Combination.Drug"}]}]}
{"id": "train-2853", "event": [{"trigger": "caused", "type": "adverse_event", "arguments": [{"name": "ductopenia", "role": "Effect"}, {"name": "clindamycin", "role": "Treatment"}, {"name": "clindamycin", "role": "Treatment.Drug"}]}]}
{"id": "train-2854", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "cachectic AIDS patient", "role": "Subject"}, {"name": "cachectic AIDS", "role": "Subject.Disorder"}, {"name": "hypoglycaemia", "role": "Effect"}, {"name": "Mefloquine", "role": "Treatment"}, {"name": "Mefloquine", "role": "Treatment.Drug"}]}]}
{"id": "train-2855", "event": [{"trigger": "require", "type": "potential_therapeutic_event", "arguments": [{"name": "Patients", "role": "Subject"}, {"name": "complex infections", "role": "Subject"}, {"name": "linezolid as an antimicrobial", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "complex infections", "role": "Treatment.Disorder"}]}]}
{"id": "train-2856", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "three of these patients", "role": "Subject"}, {"name": "three", "role": "Subject.Population"}, {"name": "cutaneous herpes zoster", "role": "Effect"}, {"name": "300 mg of cytarabine daily for the preceding five days", "role": "Treatment"}, {"name": "300 mg", "role": "Treatment.Dosage"}, {"name": "cytarabine", "role": "Treatment.Drug"}, {"name": "daily", "role": "Treatment.Freq"}, {"name": "preceding five days", "role": "Treatment.Duration"}]}]}
{"id": "train-2857", "event": [{"trigger": "monitored", "type": "adverse_event", "arguments": [{"name": "Patients", "role": "Subject"}, {"name": "peripheral and optic neuropathy", "role": "Effect"}, {"name": "linezolid for more than 28 days", "role": "Treatment"}, {"name": "linezolid", "role": "Treatment.Drug"}, {"name": "28 days", "role": "Treatment.Duration"}]}]}
{"id": "train-2858", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "a patient with pre-excitation and rate-dependent bilateral bundle branch block", "role": "Subject"}, {"name": "pre-excitation", "role": "Subject.Disorder"}, {"name": "rate-dependent bilateral bundle branch block", "role": "Subject.Disorder"}, {"name": "Atrioventricular block", "role": "Subject.Disorder"}, {"name": "hypothyroidism", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2859", "event": [{"trigger": "association", "type": "adverse_event", "arguments": [{"name": "acute renal failure and tubulo-interstitial disease", "role": "Effect"}, {"name": "proteinuria or nephrotic syndrome", "role": "Effect"}, {"name": "Lithium", "role": "Treatment"}, {"name": "Lithium", "role": "Treatment.Drug"}]}]}
{"id": "train-2860", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "40-year-old man with advanced HIV infection and Mycobacterium avium complex infection", "role": "Subject"}, {"name": "40-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "rapid cognitive decline", "role": "Effect"}, {"name": "commencement of ethambutol", "role": "Treatment"}, {"name": "ethambutol", "role": "Treatment.Drug"}, {"name": "ethambutol", "role": "Treatment.Disorder"}, {"name": "Mycobacterium avium complex infection", "role": "Treatment.Disorder"}, {"name": "HIV infection", "role": "Treatment.Disorder"}]}]}
{"id": "train-2861", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hemorrhagic vasculitis", "role": "Effect"}, {"name": "Ciprofloxacin", "role": "Treatment"}, {"name": "Ciprofloxacin", "role": "Treatment.Drug"}]}]}
{"id": "train-2862", "event": [{"trigger": "changes", "type": "adverse_event", "arguments": [{"name": "significant thyroid disorders", "role": "Effect"}, {"name": "warfarin", "role": "Treatment"}, {"name": "with amiodarone", "role": "Treatment"}, {"name": "warfarin", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Treatment.Drug"}, {"name": "amiodarone", "role": "Combination.Drug"}, {"name": "warfarin", "role": "Combination.Drug"}]}]}
{"id": "train-2863", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "sarcoidosis", "role": "Subject"}, {"name": "sarcoidosis", "role": "Subject.Disorder"}, {"name": "exacerbation", "role": "Effect"}, {"name": "Myotonia", "role": "Effect"}, {"name": "pravastatin", "role": "Treatment"}, {"name": "pravastatin", "role": "Treatment.Drug"}]}]}
{"id": "train-2864", "event": [{"trigger": "prophylaxis", "type": "potential_therapeutic_event", "arguments": [{"name": "patients with meningiomas", "role": "Subject"}, {"name": "meningiomas", "role": "Subject.Disorder"}, {"name": "aspirin", "role": "Treatment"}, {"name": "aspirin", "role": "Treatment.Drug"}, {"name": "vascular disease", "role": "Treatment.Disorder"}]}]}
{"id": "train-2865", "event": [{"trigger": "of", "type": "adverse_event", "arguments": [{"name": "a case report", "role": "Subject"}, {"name": "Delayed neurotoxicity", "role": "Effect"}, {"name": "intraventricular interleukin-2", "role": "Treatment"}, {"name": "interleukin-2", "role": "Treatment.Drug"}, {"name": "intraventricular", "role": "Treatment.Route"}]}]}
{"id": "train-2866", "event": [{"trigger": "cause", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "severe chronic active hepatitis", "role": "Effect"}, {"name": "benzarone", "role": "Treatment"}, {"name": "benzarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2867", "event": [{"trigger": "suffered", "type": "adverse_event", "arguments": [{"name": "a patient with Wilson's disease who presented with neurologic disease", "role": "Subject"}, {"name": "neurologic disease", "role": "Subject.Disorder"}, {"name": "sudden neurologic deterioration", "role": "Effect"}, {"name": "D-penicillamine", "role": "Treatment"}, {"name": "Wilson's disease", "role": "Treatment.Disorder"}, {"name": "D-penicillamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2868", "event": [{"trigger": "with", "type": "adverse_event", "arguments": [{"name": "a 21-year-old female patient", "role": "Subject"}, {"name": "21-year-old", "role": "Subject.Age"}, {"name": "female", "role": "Subject.Gender"}, {"name": "hypersensitivity syndrome", "role": "Effect"}, {"name": "dapsone", "role": "Treatment"}, {"name": "dapsone", "role": "Treatment.Drug"}]}]}
{"id": "train-2869", "event": [{"trigger": "related", "type": "adverse_event", "arguments": [{"name": "adverse_events", "role": "Effect"}, {"name": "ribavirin", "role": "Treatment"}, {"name": "ribavirin", "role": "Treatment.Drug"}, {"name": "hepatitis C", "role": "Treatment.Disorder"}]}]}
{"id": "train-2870", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "a young woman", "role": "Subject"}, {"name": "young", "role": "Subject.Age"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "Insulin-dependent diabetes mellitus", "role": "Effect"}, {"name": "8 weeks after the initiation of danazol", "role": "Treatment"}, {"name": "pelvic endometriosis", "role": "Treatment.Disorder"}, {"name": "8 weeks", "role": "Treatment.Time_elapsed"}, {"name": "danazol", "role": "Treatment.Drug"}]}]}
{"id": "train-2871", "event": [{"trigger": "receiving", "type": "adverse_event", "arguments": [{"name": "Four cases", "role": "Subject"}, {"name": "infants", "role": "Subject"}, {"name": "infants", "role": "Subject.Age"}, {"name": "Four", "role": "Subject.Age"}, {"name": "fat embolism", "role": "Effect"}, {"name": "prolonged intravenous infusion of fat (Intralipid 20%)", "role": "Treatment"}, {"name": "intravenous infusion", "role": "Treatment.Route"}, {"name": "Intralipid", "role": "Treatment.Drug"}]}]}
{"id": "train-2872", "event": [{"trigger": "due", "type": "adverse_event", "arguments": [{"name": "adverse effects", "role": "Effect"}, {"name": "Nevirapine", "role": "Treatment"}, {"name": "Oral", "role": "Treatment.Route"}, {"name": "Nevirapine", "role": "Treatment.Drug"}]}]}
{"id": "train-2873", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "hepatotoxicity", "role": "Effect"}, {"name": "enoxaparin", "role": "Treatment"}, {"name": "enoxaparin", "role": "Treatment.Drug"}]}]}
{"id": "train-2874", "event": [{"trigger": "produce", "type": "adverse_event", "arguments": [{"name": "problems", "role": "Effect"}, {"name": "Tizanidine", "role": "Treatment"}, {"name": "Tizanidine", "role": "Treatment.Drug"}]}]}
{"id": "train-2875", "event": [{"trigger": "inducing", "type": "adverse_event", "arguments": [{"name": "diffuse interstitial pulmonary fibrosis", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2876", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "delayed encephalopathy", "role": "Effect"}, {"name": "intrathecal methotrexate", "role": "Treatment"}, {"name": "9 and 22 months", "role": "Treatment.Time_elapsed"}, {"name": "methotrexate", "role": "Treatment.Dosage"}, {"name": "intrathecal", "role": "Treatment.Route"}]}]}
{"id": "train-2877", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Severe systemic hypersensitivity reaction", "role": "Effect"}, {"name": "ibuprofen", "role": "Treatment"}, {"name": "prolonged therapy", "role": "Treatment"}, {"name": "ibuprofen", "role": "Treatment.Drug"}, {"name": "prolonged therapy", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2878", "event": [{"trigger": "lead", "type": "adverse_event", "arguments": [{"name": "patients with chronic heart failure", "role": "Subject"}, {"name": "chronic heart failure", "role": "Subject.Disorder"}, {"name": "serious and, occasionally, fatal hyperkalaemia", "role": "Effect"}, {"name": "spironolactone", "role": "Treatment"}, {"name": "spironolactone", "role": "Treatment.Drug"}]}]}
{"id": "train-2879", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "acute hyperphosphatemia", "role": "Effect"}, {"name": "rectal administration of sodium phosphate and sodium biphosphate (Fleet enema)", "role": "Treatment"}, {"name": "rectal", "role": "Treatment.Route"}, {"name": "sodium phosphate", "role": "Treatment.Drug"}, {"name": "sodium biphosphate", "role": "Treatment.Drug"}, {"name": "sodium phosphate", "role": "Combination.Drug"}, {"name": "sodium biphosphate", "role": "Combination.Drug"}]}]}
{"id": "train-2880", "event": [{"trigger": "secondary", "type": "adverse_event", "arguments": [{"name": "a case", "role": "Subject"}, {"name": "Visual changes", "role": "Effect"}, {"name": "amiodarone", "role": "Treatment"}, {"name": "amiodarone", "role": "Treatment.Drug"}]}]}
{"id": "train-2881", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lupus", "role": "Effect"}, {"name": "infliximab", "role": "Treatment"}, {"name": "prolonged", "role": "Treatment.Duration"}, {"name": "infliximab", "role": "Treatment.Drug"}]}]}
{"id": "train-2882", "event": [{"trigger": "following", "type": "adverse_event", "arguments": [{"name": "A patient with developmental disabilities who had no history of movement disorders", "role": "Subject"}, {"name": "developmental disabilities", "role": "Subject.Disorder"}, {"name": "EPS", "role": "Effect"}, {"name": "initiation of aripiprazole", "role": "Treatment"}, {"name": "aripiprazole", "role": "Treatment.Drug"}]}]}
{"id": "train-2883", "event": [{"trigger": "associated", "type": "adverse_event", "arguments": [{"name": "Case", "role": "Subject"}, {"name": "life-threatening hypoglycaemia", "role": "Effect"}, {"name": "sulfadoxine-pyrimethamine", "role": "Treatment"}, {"name": "sulfadoxine-pyrimethamine", "role": "Treatment.Drug"}]}]}
{"id": "train-2884", "event": [{"trigger": "to", "type": "potential_therapeutic_event", "arguments": [{"name": "treatment with sodium bicarbonate", "role": "Treatment"}, {"name": "Diphenhydramine-induced wide complex dysrhythmia", "role": "Treatment.Disorder"}, {"name": "Diphenhydramine", "role": "Treatment.Drug"}, {"name": "sodium bicarbonate", "role": "Treatment.Drug"}]}]}
{"id": "train-2885", "event": [{"trigger": "treated", "type": "adverse_event", "arguments": [{"name": "an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus (SLE)", "role": "Subject"}, {"name": "infant", "role": "Subject.Age"}, {"name": "Prenatal cytomegalovirus (CMV) infection associated with severe brain damage", "role": "Effect"}, {"name": "prednisolone and azathioprine", "role": "Treatment"}, {"name": "prednisolone", "role": "Treatment.Drug"}, {"name": "azathioprine", "role": "Treatment.Drug"}, {"name": "prednisolone", "role": "Combination.Drug"}, {"name": "azathioprine", "role": "Combination.Drug"}]}]}
{"id": "train-2886", "event": [{"trigger": "provoke", "type": "adverse_event", "arguments": [{"name": "serositis", "role": "Effect"}, {"name": "Methotrexate", "role": "Treatment"}, {"name": "Methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2887", "event": [{"trigger": "responsible", "type": "adverse_event", "arguments": [{"name": "renal failure", "role": "Effect"}, {"name": "methotrexate and proton pump inhibitors (PPI)", "role": "Treatment"}, {"name": "methotrexate", "role": "Treatment.Drug"}, {"name": "proton pump inhibitors (PPI)", "role": "Treatment.Drug"}, {"name": "methotrexate", "role": "Combination.Drug"}, {"name": "proton pump inhibitors (PPI)", "role": "Combination.Drug"}]}]}
{"id": "train-2888", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "Asthma and urticaria", "role": "Effect"}, {"name": "disodium cromoglycate treatment", "role": "Treatment"}, {"name": "disodium cromoglycate", "role": "Treatment.Drug"}]}]}
{"id": "train-2889", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "lung injury", "role": "Effect"}, {"name": "nitrofurantoin", "role": "Treatment"}, {"name": "nitrofurantoin", "role": "Treatment.Drug"}]}]}
{"id": "train-2890", "event": [{"trigger": "taking", "type": "adverse_event", "arguments": [{"name": "a woman with rheumatoid arthritis", "role": "Subject"}, {"name": "woman", "role": "Subject.Gender"}, {"name": "Hepatitis with bridging fibrosis and reversible hepatic insufficiency", "role": "Effect"}, {"name": "methotrexate", "role": "Treatment"}, {"name": "rheumatoid arthritis", "role": "Treatment.Disorder"}, {"name": "methotrexate", "role": "Treatment.Drug"}]}]}
{"id": "train-2891", "event": [{"trigger": "regressed", "type": "potential_therapeutic_event", "arguments": [{"name": "Primary CNS lymphoma", "role": "Effect"}, {"name": "withdrawal of MM", "role": "Treatment"}, {"name": "MM", "role": "Treatment.Drug"}]}]}
{"id": "train-2892", "event": [{"trigger": "induced", "type": "adverse_event", "arguments": [{"name": "Pemphigus foliaceus", "role": "Effect"}, {"name": "rifampicin", "role": "Treatment"}, {"name": "rifampicin", "role": "Treatment.Drug"}]}]}
{"id": "train-2893", "event": [{"trigger": "stimulated", "type": "adverse_event", "arguments": [{"name": "this patient", "role": "Subject"}, {"name": "lymphocyte transformation", "role": "Effect"}, {"name": "L-T4", "role": "Treatment"}, {"name": "L-T4", "role": "Treatment.Drug"}]}]}
{"id": "train-2894", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "A 53-year-old man", "role": "Subject"}, {"name": "53-year-old", "role": "Subject.Age"}, {"name": "man", "role": "Subject.Gender"}, {"name": "lower leg edema", "role": "Effect"}, {"name": "4 weeks after rosiglitazone was increased from 4 mg once/day to 4 mg twice/day", "role": "Treatment"}, {"name": "4 weeks", "role": "Treatment.Time_elapsed"}, {"name": "rosiglitazone", "role": "Treatment.Drug"}, {"name": "4 mg", "role": "Treatment.Dosage"}, {"name": "twice/day", "role": "Treatment.Freq"}]}]}
{"id": "train-2895", "event": [{"trigger": "during", "type": "adverse_event", "arguments": [{"name": "A mentally retarded 23-year-old woman with myoclonic astatic epilepsy", "role": "Subject"}, {"name": "mentally retarded", "role": "Subject.Disorder"}, {"name": "23-year-old", "role": "Subject.Age"}, {"name": "abnormal posture of extreme forward flexion, called camptocormia,", "role": "Effect"}, {"name": "valproate", "role": "Treatment"}, {"name": "valproate", "role": "Treatment.Drug"}, {"name": "myoclonic astatic epilepsy", "role": "Treatment.Disorder"}]}]}
{"id": "train-2896", "event": [{"trigger": "developed", "type": "adverse_event", "arguments": [{"name": "patient", "role": "Subject"}, {"name": "a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia", "role": "Effect"}, {"name": "5 days of treatment with IL-2", "role": "Treatment"}, {"name": "IL-2", "role": "Treatment.Drug"}, {"name": "After 5 days", "role": "Treatment.Time_elapsed"}]}]}
{"id": "train-2897", "event": [{"trigger": "after", "type": "adverse_event", "arguments": [{"name": "Acute pancreatitis", "role": "Effect"}, {"name": "long-term 5-aminosalicylic acid therapy", "role": "Treatment"}, {"name": "5-aminosalicylic acid", "role": "Treatment.Drug"}, {"name": "long-term", "role": "Treatment.Time_elapsed"}]}]}
